Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.8186949022620766,-2.0365092689460567,0.0,0.0,0.0,81/142,13.41%,RPS12;RPS27;RPL19;RPL23;RPL38;RPL34;RPS13;RPL12;RPS27A;RPS18;RPS21;RPL35A;RPLP1;RPL27A;RPS16;RPS8;RPS14;RPL29;RPS23;RPL7A;RPL5;RPL18A;RPS25;RPL30;RPL35;RPS4Y1;RPL23A;RPS2;RPL27;RPL10;RPSA;RPL9;RPS15;RPS5;MRPL51;RPL10A;RPL18;RPS7;RPL41;RPS3;MRPL35;RPLP2;RPL11;RPL24;RPS6;RPL13A;RPL21;RPS11;MRPL36;RPS20;RPS24;RPL37;RPS3A;RPL13;RPL28;MRPS12;RPL15;RPS4X;RPL3;MRPL34;RPS9;RPS28;RPL36;RPS19;MRPS21;MRPL27;COPS5;RPL6;RPL32;MRPS18B;RPL31;RPL39;PCSK1;MRPS18A;RPS26;RPL8;ABCF1;RPLP0;MRPL52;RPL14;RPS29
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.8609858997409557,-2.020514258672474,0.0,0.0,0.0,60/87,7.21%,RPS12;RPS27;RPL19;RPL23;RPL38;RPL34;RPS13;RPL12;RPS27A;RPS18;RPS21;RPL35A;RPLP1;RPL27A;RPS16;RPS8;RPS14;RPL29;RPS23;RPL7A;RPL5;RPL18A;RPS25;RPL30;RPL35;RPL23A;RPS2;RPL27;RPL10;RPSA;RPL9;RPS15;RPS5;RPL10A;RPL18;RPS7;RPL41;RPS3;RPL11;RPL24;RPS6;RPL13A;RPL21;TMA7;RPS11;RPS20;RPS24;RPL37;RPS3A;RPL13;RPL28;RPL22L1;RPL15;RPS4X;RPL3;RPS9;UBA52;RPS28;RPL36;RPS19
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.8363278429592328,-2.0140292838609515,0.0,0.0,0.0,60/105,7.21%,RPS12;RPS27;RPL19;RPL23;RPL38;RPL34;RPS13;RPL12;RPS27A;RPS18;RPS21;RPL35A;RPLP1;RPL27A;RPS16;RPS8;RPS14;RPL29;RPS23;RPL7A;RPL5;RPL18A;RPS25;RPL30;RPL35;RPS4Y1;RPL23A;RPS2;RPL27;RPL10;RPSA;RPL9;RPS15;RPS5;RPL10A;RPL18;RPS7;RPL41;RPS3;RPLP2;RPL11;RPL24;RPS6;RPL13A;RPL21;RPS11;RPS20;RPS24;RPL37;RPS3A;RPL13;RPL28;RPL15;RPS4X;RPL3;RPS9;UBA52;RPS28;RPL36;RPS19
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.7925783453926223,-2.01376657854802,0.0,0.0,0.0,78/192,8.81%,RPS12;RPS27;RPL19;RPL23;RPL38;RPL34;RPS13;RPL12;RPS27A;RPS18;RPS21;RPL35A;RPLP1;RPL27A;NARS1;RPS16;RPS8;RPS14;RPL29;RPS23;RPL7A;RPL5;EEF1B2;RPL18A;RPS25;RPL30;RPL35;RPS4Y1;RPL23A;RPS2;RPL27;RPL10;RPSA;RPL9;RPS15;RPS5;MRPL51;RPL10A;RPL18;RPS7;RPL41;RPS3;MRPL35;RPLP2;RPL11;RPL24;RPS6;RPL13A;RPL21;TMA7;RPS11;MRPL36;RPS20;RPS24;RPL37;RPS3A;RPL13;RPL28;MRPS12;RPL22L1;RPL15;RPS4X;RPL3;MRPS34;MRPL34;RPS9;UBA52;AIMP1;TRMT112;RPS28;RPL36;RPS19;MRPL2;MRPS21;MRPL27;COPS5;RPL6;RPL32
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.8658490721721753,-2.0104262699330406,0.0,0.0,0.0,65/88,8.81%,RPS12;RPS27;RPL19;RPL23;RPL38;RPL34;RPS13;RPL12;RPS27A;RPS18;RPS21;RPL35A;RPLP1;RPL27A;RPS16;RPS8;RPS14;RPL29;RPS23;RPL7A;RPL5;SRP14;RPL18A;RPS25;RPL30;RPL35;RPS4Y1;RPL23A;RPS2;RPL27;RPL10;RPSA;RPL9;RPS15;RPS5;RPL10A;RPL18;RPS7;RPL41;RPS3;RPLP2;RPL11;RPL24;RPS6;RPL13A;RPL21;RPS11;RPS20;RPS24;RPL37;RPS3A;RPL13;RPL28;SEC62;RPL15;RPS4X;RPL3;RPS9;UBA52;RPS28;RPL36;RPS19;SRP54;RPL6;RPL32
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.8680443638033439,-2.0041608558479838,0.0,0.0,0.0,65/85,8.81%,RPS12;RPS27;RPL19;RPL23;RPL38;RPL34;RPS13;RPL12;RPS27A;RPS18;RPS21;RPL35A;RPLP1;RPL27A;RPS16;RPS8;RPS14;RPL29;RPS23;RPL7A;RPL5;SRP14;RPL18A;RPS25;RPL30;RPL35;RPS4Y1;RPL23A;RPS2;RPL27;RPL10;RPSA;RPL9;RPS15;RPS5;RPL10A;RPL18;RPS7;RPL41;RPS3;SEC61B;RPLP2;RPL11;RPL24;RPS6;RPL13A;RPL21;RPS11;RPS20;RPS24;RPL37;RPS3A;RPL13;RPL28;RPL15;RPS4X;RPL3;RPS9;UBA52;RPS28;RPL36;RPS19;SRP54;RPL6;RPL32
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.8228246421978506,1.9759668903459968,0.0,0.44100115369824383,0.14,11/47,5.14%,ZAP70;RELN;PDGFB;PTPN6;FGFR1;FLT1;FGFR3;SRC;EGFR;PDGFRA;EPHA3
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.7099109600226143,-1.9519797764728979,0.0,0.0011743419405990476,0.01,95/320,13.41%,RPS12;RPS27;RPL19;RPL23;RPL38;RPL34;RPS13;RPL12;RPS27A;RPS18;RPS21;RPL35A;POLR2G;RPLP1;RPL27A;NOX4;RPS16;RPS8;RPS14;RPL29;RPS23;RPL7A;RPL5;RPL18A;RPS25;RPL30;RPL35;RPS4Y1;RPL23A;RPS2;RPL27;RPL10;RPSA;RPL9;RPS15;RPS5;MRPL51;RPL10A;RPL18;RPS7;RBMS2;RPL41;RPS3;PTMA;MRPL35;RPLP2;RPL11;RPL24;RPS6;RPL13A;RPL21;POLR2J;RPS11;MRPL36;RPS20;RPS24;RPL37;RPS3A;POLR2L;RPL13;RPL28;MRPS12;RPL15;RPS4X;RPL3;MRPL34;POLR2I;RPS9;RBM3;RPS28;RPL36;RPS19;FIP1L1;MRPS21;PAX8;MRPL27;COPS5;RPL6;RPL32;MRPS18B;DHX38;RPL31;RPL39;TFIP11;MRPS18A;SRSF7;RPS26;RPL8;ABCF1;RPLP0;THAP1;UPF2;MRPL52;RPL14;RPS29
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.8021619639385144,1.9276761893608365,0.0,0.5211831816433791,0.33,10/31,8.88%,F2;CREB3L1;RAB27A;RUNX1;ADGRB1;SORBS1;SERPINF2;CYBA;SCX;MLXIPL
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.7664340040361194,-1.9261241568526795,0.0,0.002055098396048333,0.02,61/161,7.21%,RPS12;RPS27;RPL19;RPL23;RPL38;RPL34;RPS13;RPL12;RPS27A;RPS18;RPS21;RPL35A;POLR2G;RPLP1;RPL27A;RPS16;RPS8;RPS14;RPL29;RPS23;RPL7A;RPL5;RPL18A;RPS25;RPL30;RPL35;RPS4Y1;RPL23A;RPS2;RPL27;RPL10;RPSA;RPL9;RPS15;RPS5;RPL10A;RPL18;RPS7;RPL41;RPS3;RPLP2;RPL11;RPL24;RPS6;RPL13A;RPL21;RPS11;RPS20;RPS24;RPL37;RPS3A;RPL13;RPL28;RPL15;RPS4X;RPL3;RPS9;UBA52;RPS28;RPL36;RPS19
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.8132362013797004,-1.9117205938640063,0.0,0.0018267541298207406,0.02,66/97,9.26%,RPS12;RPS27;RPL19;RPL23;RPL38;RPL34;RPS13;RPL12;RPS27A;RPS18;RPS21;RPL35A;RPLP1;RPL27A;RPS16;RPS8;RPS14;RPL29;RPS23;RPL7A;RPL5;SRP14;RPL18A;RPS25;RPL30;RPL35;RPS4Y1;RPL23A;RPS2;RPL27;RPL10;RPSA;RPL9;RPS15;RPS5;RPL10A;RPL18;RPS7;RPL41;RPS3;RPLP2;RPL11;RPL24;RPS6;RPL13A;RPL21;RPS11;RPS20;RPS24;RPL37;RPS3A;RPL13;RPL28;SEC62;RPL15;RPS4X;RPL3;RPS9;UBA52;RPS28;RPL36;RPS19;SRP54;RPL6;RPL32;GET3
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.7921834168564175,-1.9023080560149013,0.0,0.0016440787168386665,0.02,17/63,6.58%,CD44;GBP3;HLA-F;B2M;IRF4;HLA-C;GBP2;GAPDH;IFNGR2;MT2A;HLA-DPA1;HLA-A;PTAFR;RPL13A;HLA-E;IRF9;IRF1
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.7166682991124789,-1.8994714785129199,0.0,0.0014946170153078786,0.02,103/278,13.59%,RPS12;RPS27;RPL19;RPL23;RPL38;RPL34;RPS13;RPL12;RPS27A;RPS18;MCM2;RPS21;RPL35A;POLR2G;RPLP1;RPL27A;RPS16;RPS8;RPS14;RPL29;RPS23;RPL7A;RPL5;EEF1B2;RPL18A;RPS25;RPL30;TYMS;RPL35;RPS4Y1;RPL23A;RPS2;RPL27;RPL10;RPSA;RPL9;RPS15;RPS5;MRPL51;RPL10A;RPL18;RPS7;RPL41;RMI1;RPS3;PTMA;MRPL35;RPLP2;RPL11;RPL24;RPS6;RPL13A;RPL21;POLR2J;RPS11;MRPL36;RPS20;RPS24;RPL37;RPS3A;POLR2L;RPL13;GCNT1;RPL28;MRPS12;RPL15;RPS4X;RPL3;POLE3;MRPL34;MCM4;POLR2I;ORC6;RPS9;RPS28;RPL36;RPS19;GRWD1;MRPS21;PAX8;MRPL27;COPS5;FAM111A;MCM3;RPL6;RPL32;MRPS18B;RPA3;CLSPN;RPL31;RPL39;MRPS18A;RPS26;RPL8;ABCF1;RPLP0;THAP1;MRPL52;RFC2;RPL14;RPS29;BRCA1;EEF2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.8641811154451469,1.8721846602370895,0.0,0.8552749647481093,0.63,2/17,1.33%,PDGFB;IGF1
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.8421303079621808,1.8414178460590618,0.024390243902439025,0.9254342392001026,0.77,2/31,2.76%,GABRE;CHRNA4
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.7434300373420094,-1.8330181076940444,0.0,0.006165295188145001,0.09,61/151,13.34%,RPS27;RPL19;RPL23;RPL38;RPL34;RPL12;RPL35A;RPLP1;RPL27A;RPS16;RPS14;RPL29;RPL7A;RPL5;RPL18A;RPS25;RPL30;RPL35;RPL23A;RPS2;RPL27;RPL10;RPL9;RPS15;RPL10A;RPL18;RPS7;RPL41;RPLP2;RPL11;RPL24;RPS6;RPL13A;RPL21;RPS24;RPL37;SBDS;RPL13;RPL28;RPL15;RPL3;RPS9;UBA52;RPS28;RPL36;RPS19;NOP53;RPL6;RPL32;NIFK;IMP3;RPL31;RPL39;WDR74;NOB1;RPL8;NOC4L;RPLP0;EXOSC4;EXOSC10;RPL14
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.7994083830846508,-1.8213701139307061,0.0,0.006323379680148718,0.1,14/45,6.58%,CD44;HLA-F;B2M;IRF4;HLA-C;GBP2;IFNGR2;MT2A;HLA-DPA1;HLA-A;PTAFR;HLA-E;IRF9;IRF1
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.7312521478177872,-1.8202666197698965,0.0,0.0058717097029952385,0.1,62/164,13.34%,RPS27;RPL19;RPL23;RPL38;RPL34;RPL12;RPL35A;RPLP1;RPL27A;RPS16;RPS14;RPL29;RPL7A;RPL5;RPL18A;RPS25;RPL30;RPL35;RPL23A;RPS2;RPL27;RPL10;RPL9;RPS15;RPL10A;RPL18;RPS7;RPL41;RPLP2;RPL11;RPL24;RPS6;RPL13A;RPL21;RPS24;RPL37;SBDS;RPL13;RPL28;RPL15;RPL3;RPS9;UBA52;RPS28;RPL36;RPS19;NOP53;NHP2;RPL6;RPL32;TSR3;IMP3;RPL31;RPL39;WDR74;NOB1;RPL8;NOC4L;RPLP0;EXOSC4;EXOSC10;RPL14
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.8466802880124349,1.8066546634445448,0.024390243902439025,1.0,0.88,4/15,7.86%,NLRP7;RUNX1;BAG2;ADAM8
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.7077368599235768,-1.795747829480272,0.0,0.011508551017870666,0.18,65/182,13.34%,RPS27;RPL19;RPL23;RPL38;RPL34;RPL12;RPL35A;RPLP1;RPL27A;RPS16;RPS14;RPL29;RPL7A;RPL5;RPL18A;RPS25;RPL30;RPL35;RPL23A;RPS2;RPL27;RPL10;RPL9;RPS15;RPL10A;RPL18;RPS7;RPL41;RPLP2;RPL11;RPL24;RPS6;RPL13A;RPL21;MRPL36;RBIS;RPS24;RPL37;SBDS;RPL13;RPL28;RPL15;RPL3;RPS9;NOP16;UBA52;RPF2;RPS28;RPL36;RPS19;NOP53;RPL6;RPL32;ZNF622;IMP3;RPL31;RPL39;WDR74;NOB1;RPL8;NOC4L;RPLP0;EXOSC4;EXOSC10;RPL14
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.7012591499563967,-1.7855023418983849,0.0,0.013871914173326248,0.2,75/190,17.33%,RPS27;RPL19;RPL23;RPL38;RPL34;RPL12;RPL35A;RPLP1;RPL27A;RPS16;RPS14;RPL29;RPL7A;RPL5;RPL18A;RPS25;RPL30;RPL35;RPL23A;RPS2;RPL27;RPL10;RPL9;RPS15;RPL10A;RPL18;RPS7;RPL41;RPLP2;RPL11;RPL24;RPS6;RPL13A;RPL21;RPS24;RPL37;SBDS;RPL13;RPL28;RPL15;RPL3;RPS9;UBA52;RPS28;RPL36;RPS19;NOP53;TRPT1;RPL6;RPL32;IMP3;RPL31;RPL39;WDR74;NOB1;RPL8;NOC4L;RPLP0;EXOSC4;EXOSC10;RPL14;SSB;INTS5;WDR12;SARS1;RPL7;POP7;INTS12;MRTO4;IMP4;EBNA1BP2;SNU13;METTL3;UTP11;DDX27
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.7861932557522565,1.7688358703281337,0.02857142857142857,1.0,0.96,4/43,4.40%,GABRE;GABRR2;ANO4;GLRB
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.8109305010337496,-1.7623680890746016,0.0,0.021276312806147453,0.28,19/30,15.58%,NDUFS5;NDUFA1;NDUFB3;NDUFA12;NDUFC1;NDUFB9;NDUFS6;NDUFA2;NDUFB11;NDUFB4;NDUFA3;NDUFB2;NDUFS8;NDUFB7;NDUFB10;NDUFB1;NDUFAB1;NDUFAF1;NDUFS7
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.7789173704471801,-1.7614165851151347,0.0,0.021464361025393702,0.29,19/44,9.17%,RPS27;MPV17L2;RPS14;RPL5;RPL23A;RPL10;RPSA;RPS15;RPS5;RPL11;RPL24;SBDS;RPL3;RPF2;RPS28;RPS19;NOP53;RPL6;MRPL20
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.9718087931113587,1.7613849566992872,0.0,1.0,0.98,1/11,0.02%,GABRE
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.768972979374652,-1.7596709806323974,0.0,0.0211999624013407,0.3,29/53,13.51%,NDUFS5;COX7C;NDUFA1;NDUFB3;NDUFA12;COX6C;COX4I1;COX6A1;NDUFC1;NDUFB9;UQCR10;UQCC3;NDUFS6;NDUFA2;NDUFB11;NDUFB4;NDUFA3;COX7B;UQCRQ;NDUFB2;CYC1;COX6B1;NDUFS8;UQCRH;NDUFB7;NDUFB10;NDUFB1;NDUFAB1;UQCRB
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.8319756301955047,1.7582936117051753,0.0,1.0,0.98,2/16,0.31%,VDR;EPB41L4B
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.766928952348058,-1.755012216920872,0.0,0.02301710203574133,0.31,29/54,13.51%,NDUFS5;COX7C;NDUFA1;NDUFB3;NDUFA12;COX6C;COX4I1;COX6A1;NDUFC1;NDUFB9;UQCR10;UQCC3;NDUFS6;NDUFA2;NDUFB11;NDUFB4;NDUFA3;COX7B;UQCRQ;NDUFB2;CYC1;COX6B1;NDUFS8;UQCRH;NDUFB7;NDUFB10;NDUFB1;NDUFAB1;UQCRB
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.7322140387120413,1.7456826711025573,0.0625,1.0,0.99,9/27,13.28%,SPRY2;FLT1;HSPB1;VEGFD;RELA;GAB1;PIK3CA;PRKD1;EGR3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.7394060077429289,1.744865415172516,0.0,1.0,0.99,11/54,5.14%,ZAP70;RELN;PDGFB;PTPN6;FGFR1;FLT1;FGFR3;SRC;EGFR;PDGFRA;EPHA3
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.751561262812909,1.7442288067459,0.0,0.9743331274545223,0.99,5/25,8.57%,MDGA2;SPOCK1;CHD5;NPY;NTRK2
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.6909107429780762,-1.7274353450448037,0.0,0.045799335683362856,0.5,75/180,20.15%,GPX4;SLC25A4;PDHX;COX7C;NDUFA1;NDUFB3;MRPS22;COX6C;COX4I1;SLC25A6;COX6A1;LDHA;ATP6V1F;NDUFC1;UQCR10;IDH3B;MRPL35;ATP5F1E;NDUFS6;SLC25A5;NDUFA2;SLC25A11;MRPS12;CYB5R3;ATP5MC3;RETSAT;TIMM8B;MRPL34;HCCS;NDUFB4;NDUFA3;TIMM10;COX7B;ETFB;UQCRQ;ISCU;NDUFB2;CYC1;COX6B1;NDUFS8;COX17;ATP5PD;SURF1;ATP5PB;UQCRH;NDUFB7;PHB2;ATP5F1B;COX7A2;IDH3G;AFG3L2;NDUFB1;TIMM50;ATP5PF;NDUFAB1;PMPCA;MGST3;UQCRB;DECR1;NDUFS7;PDHB;ATP5ME;MDH2;MDH1;ATP6V1E1;NQO2;SLC25A3;ATP5MC1;GRPEL1;NDUFS3;ATP6V1D;COX5A;UQCRC1;BAX;TIMM13
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.7211866969814709,1.7234447760884843,0.0,1.0,1.0,3/25,2.63%,B3GNT6;GAL3ST2;ST8SIA6
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.8619368887608028,1.7146222991932454,0.0,1.0,1.0,3/13,3.57%,DACT2;COL22A1;GRHL2
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.9723186687539114,1.7138589675805538,0.0,1.0,1.0,2/10,0.01%,KLRF2;CLEC2A
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.8614366847320029,1.7096803505831064,0.0,1.0,1.0,5/14,7.38%,RAB27A;STX1A;CACNA1I;NLGN1;UNC13D
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.6105269350967516,1.7047660122332815,0.0,1.0,1.0,11/65,12.86%,NUPR1;PFKFB3;IGF1;HDAC4;ARNT;P2RX7;MLXIPL;OGT;SLC4A4;NDC1;NUP42
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.8825330501152002,1.7013508976270648,0.05555555555555555,1.0,1.0,4/12,7.34%,PDGFB;NFATC4;RELA;NFIB
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.8412638137492241,1.7013150868081268,0.0,0.9510479425714652,1.0,4/9,11.85%,MYH3;MBNL1;TGFB2;MEGF8
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.7692414466719943,1.7002806776576387,0.0,0.9073229478002146,1.0,6/21,13.68%,PNLDC1;CNOT2;SAMD4A;CNOT11;CNOT4;CNOT6L
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.6260708436071021,-1.6962260436983219,0.0,0.0851931698725491,0.7,107/332,14.41%,RPS12;AFP;RPS27;RPL19;RPL23;RPL38;RPL34;RPS13;RPL12;RPS27A;RPS18;RPS21;RPL35A;RPLP1;RPL27A;RPS16;RPS8;RPS14;RPL29;RPS23;RPL7A;RPL5;MEPE;RPL18A;RPS25;RPL30;UBL5;TIMP1;RPL35;RPS4Y1;RPL23A;RPS2;RPL27;RPL10;RPSA;RPL9;RPS15;RPS5;MRPL51;RPL10A;RPL18;RPS7;RPL41;RPS3;MRPL35;RPLP2;MSRB1;RPL11;RPL24;RPS6;RPL13A;RPL21;USP6;PIGH;TMEM208;RPS11;MRPL36;RPS20;RPS24;RPL37;RPS3A;RPL13;RPL28;MRPS12;F5;RPL15;RPS4X;RPL3;MRPL34;FUCA2;RPS9;UBA52;RPS28;RPL36;RPS19;SEC11C;MRPS21;MRPL27;COPS5;GPC3;VWA1;RPL6;APH1A;RPL32;ATP23;B4GALT7;MRPS18B;SPARCL1;CHGB;RPL31;RPL39;MRPS18A;RPS26;RPL8;AFG3L2;ABCF1;RPLP0;RNF5;MRPL52;TTF1;RPL14;RPS29;SCG3;SPCS2;STOML2;NUCB1;ARAF
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.9613840138278791,1.68454320643665,0.03225806451612903,1.0,1.0,1/7,1.71%,SLC15A2
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.8415428125119008,1.68279522714507,0.04878048780487805,0.9768207372681159,1.0,3/9,5.24%,NUPR1;IGF1;CD200R1
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.7461006235904363,1.6818454658304018,0.0,0.9409239491440492,1.0,11/29,14.91%,PBX3;PBX1;ADAMTS18;MEIS1;MEIS3;FREM2;SMG9;TGFB2;C3;MEIS2;HIPK2
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.8794985255650487,-1.6768608066062984,0.0,0.12795221318005276,0.86,1/13,0.07%,CD44
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.7361158911076332,1.6747245137677287,0.0,0.9552119850855243,1.0,6/24,4.72%,F2;PDGFB;FLT1;IRS1;FGFR3;PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.8261026385168108,1.6715578779352365,0.0,0.9410251890783233,1.0,3/16,8.88%,F2;SORBS1;MLXIPL
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.8903821008625545,1.6695251194989158,0.05263157894736842,0.9188860402512499,1.0,3/9,4.72%,F2;PDGFB;PDGFRA
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.7149655340293263,1.668907937068161,0.037037037037037035,0.8886841430585822,1.0,7/59,4.76%,GABRE;SLC26A7;GABRR2;CLIC5;ANO4;GLRB;SLC26A6
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.6516991091871988,1.6667769832320325,0.034482758620689655,0.8745780455497159,1.0,4/89,2.58%,KLRF2;NOS2;KAT2A;AFAP1L2
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.7712268925303579,1.6630485621538,0.03333333333333333,0.8762750196861208,1.0,8/22,11.78%,PDGFB;PFKFB3;IGF1;ARNT;P2RX7;MLXIPL;NFKB1;SLC4A4
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7618265051826686,1.6606349065932373,0.029411764705882353,0.8677170035671818,1.0,5/14,11.47%,DSE;VCAN;CSPG4;NCAN;CSGALNACT1
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),-0.8825111199313227,-1.659506065635305,0.017241379310344827,0.16749051927793918,0.93,3/10,6.84%,TYRP1;LRMDA;SLC24A5
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.732756787392469,-1.6589392936159209,0.0,0.15713598505169565,0.93,23/50,15.58%,NDUFS5;NDUFA1;NDUFB3;NDUFA12;NDUFC1;NDUFB9;NDUFS6;NDUFA2;NDUFB11;DMAC1;NDUFB4;NDUFA3;NDUFB2;NDUFS8;NDUFAF3;TMEM126B;NDUFB7;NDUFB10;NDUFB1;NDUFAB1;TMEM126A;NDUFAF1;NDUFS7
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.732756787392469,-1.6589392936159209,0.0,0.15713598505169565,0.93,23/50,15.58%,NDUFS5;NDUFA1;NDUFB3;NDUFA12;NDUFC1;NDUFB9;NDUFS6;NDUFA2;NDUFB11;DMAC1;NDUFB4;NDUFA3;NDUFB2;NDUFS8;NDUFAF3;TMEM126B;NDUFB7;NDUFB10;NDUFB1;NDUFAB1;TMEM126A;NDUFAF1;NDUFS7
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.6661041958850186,1.6572788350898875,0.0,0.8668568132290732,1.0,13/66,9.77%,MFNG;TP63;YJEFN3;SRC;EGFR;RFNG;MAML2;NOTCH3;ARRB1;LLGL2;NOTCH4;DLL1;TGFB2
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.768561964510059,1.6552469536478238,0.0,0.8569993094351014,1.0,4/24,8.33%,RELN;NLGN1;CACNG5;CACNG4
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.8721070624574583,-1.6518125417511986,0.0,0.17354164233297037,0.95,4/18,2.74%,SLC28A2;B2M;ACTG1;PRDX1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.8742420930877655,1.6487265239358928,0.02702702702702703,0.8564898439593991,1.0,2/8,3.64%,NUPR1;HDAC4
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.8742420930877655,1.6487265239358928,0.02702702702702703,0.8564898439593991,1.0,2/8,3.64%,NUPR1;HDAC4
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.9213150166875714,1.6460972060644679,0.02564102564102564,0.8505583748689836,1.0,1/9,0.78%,REP15
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.7350001276157502,1.6460325895361279,0.0,0.8266385261962752,1.0,9/30,11.69%,KCNN4;KCNJ2;KCNMB4;KCNN2;KCNMA1;AKAP6;DLG1;NOS1AP;KCNN1
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.9662376789120827,1.6404328753712851,0.02857142857142857,0.8478507029013373,1.0,1/5,1.71%,SLC15A2
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.9366144578800781,1.6391882830700886,0.0,0.8368547691390916,1.0,1/7,0.21%,MDGA2
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.8779266186706542,1.6378474701170522,0.023809523809523808,0.8338227555171739,1.0,2/6,4.45%,HELLS;UHRF2
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.8568401100416554,-1.6345216388649917,0.0,0.2298774348722636,0.97,1/12,1.75%,ACTG1
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.9651186724033164,1.6317818373732,0.0,0.8669253448768895,1.0,1/9,0.10%,F2
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.957588214767592,-1.6315601836342015,0.0,0.2355567954642986,0.98,1/7,0.35%,BMP5
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.8228364663202715,-1.6305289444705506,0.015625,0.23318516467161754,0.98,1/21,0.03%,TYRP1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.705669374641735,1.6258772799031151,0.03125,0.8896864184078964,1.0,4/57,4.40%,GABRE;GABRR2;ANO4;GLRB
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),0.9374962088165669,1.6244937920862845,0.0,0.8784169321631685,1.0,2/7,3.54%,F2;TMEM98
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.748695194583808,1.6240342883554777,0.0625,0.8603658871573241,1.0,3/31,2.46%,PDGFB;IGF1;TAFA5
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.769393326222725,1.6232235786395985,0.05714285714285714,0.8462622561806328,1.0,1/15,0.01%,CPA1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.6317917099454299,1.620561856394645,0.03125,0.8498080082973046,1.0,10/53,12.09%,EPB41L4B;PDGFB;VIT;ADAM8;FRMD5;TGFB2;MEGF10;NPNT;CHRD;AFDN
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.8558268698492317,1.6181098190391903,0.02631578947368421,0.8517113190616588,1.0,2/13,1.33%,PDGFB;IGF1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.7541771586765647,-1.615085346372377,0.0136986301369863,0.28797894943335356,1.0,8/47,5.67%,H1-4;TINF2;POLR2G;H1-2;MAGEF1;POLR2J;POLR2L;POLR2I
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.8118705937620504,1.6146319541447964,0.027777777777777776,0.8654429755382532,1.0,3/13,4.72%,F2;PDGFB;PDGFRA
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.7970338299238097,1.6142111249083833,0.030303030303030304,0.8501569629643774,1.0,1/14,0.10%,F2
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.8780818882556232,1.6124857396546128,0.02702702702702703,0.852212456736316,1.0,1/8,1.10%,JCAD
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.678615658813669,-1.6117811005100369,0.014705882352941176,0.2928515214368875,1.0,26/56,21.75%,PSMB8;RPS27A;MCM2;PSME1;PSMB6;PSMD8;PSMC5;MCM4;ORC6;PSMD7;UBA52;MCM3;PSMD3;PSMC3;UBB;PSMA4;MCM5;PSMD2;PSMA7;ORC2;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;PSMC1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.7757331042992537,1.6116355250199772,0.0,0.84191129342392,1.0,5/26,4.45%,F2;NLRP7;NOS2;TICAM1;CLEC7A
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.6997184826586179,-1.611486990129477,0.014285714285714285,0.2852227470879202,1.0,13/62,7.17%,PSMB8;HLA-F;B2M;HLA-C;PSME1;HLA-A;PSMB6;HLA-E;PSMD8;PSMC5;PSMD7;VAMP8;CALR
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.6695302751419732,1.610653220940772,0.05714285714285714,0.834427637482374,1.0,12/25,14.05%,DSE;VCAN;CHST7;CSPG4;CHST3;CHST11;CHSY3;NCAN;CSGALNACT1;HEXB;UGDH;CHST15
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.783760355479189,1.6101169236721826,0.058823529411764705,0.8212107045099798,1.0,2/15,1.33%,PDGFB;IGF1
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.8192094674103851,1.6094371326716128,0.0,0.8092730961513809,1.0,6/11,14.63%,AK3;ADSS2;NT5E;AMPD1;AK4;AMPD3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.8977611736131039,-1.607478755578017,0.018867924528301886,0.29303285364830356,1.0,2/8,4.50%,IRF4;HLA-E
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.7591655422789135,1.6050204444327312,0.037037037037037035,0.8275390431318674,1.0,2/16,2.63%,PDGFB;PLPP4
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.7481275264801923,1.60494669225059,0.03225806451612903,0.8124617214317251,1.0,3/19,6.76%,PDGFB;EGFR;PKD1
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.6701752982000544,1.6019863067481415,0.08695652173913043,0.824417032781345,1.0,7/33,7.27%,NUPR1;ADGRB1;ALK;HDAC4;EGFR;BANP;IRAK3
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.7038848378314332,-1.5995461077157773,0.014492753623188406,0.32717166465089464,1.0,13/60,7.17%,PSMB8;HLA-F;B2M;HLA-C;PSME1;HLA-A;PSMB6;HLA-E;PSMD8;PSMC5;PSMD7;VAMP8;CALR
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.8068667488492965,1.5994187769356163,0.0,0.8137772485308902,1.0,4/14,8.12%,FHDC1;SRC;SORBS1;ARRB1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.8068667488492965,1.5994187769356163,0.0,0.8137772485308902,1.0,4/14,8.12%,FHDC1;SRC;SORBS1;ARRB1
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.7621562515144366,1.5993397455235439,0.03225806451612903,0.8008986469462359,1.0,8/18,18.59%,CGNL1;SPRY2;TGFB2;SYNGAP1;SLIT2;SPRY4;FBP1;CYRIB
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.8620112764161143,1.5986609316032576,0.0,0.7902686313575618,1.0,6/8,9.08%,SPRY2;SPRED3;SPRED2;SPRED1;NOTCH4;DLL1
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.8427129002528146,1.598599499536782,0.02702702702702703,0.777988398923215,1.0,1/13,2.07%,ITGA11
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.78965395900941,1.5951277028466866,0.0,0.7871421486526528,1.0,5/21,4.72%,PDGFB;PDGFC;IGF1;CDK6;PDGFRA
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.7351319999822675,-1.593314864838602,0.013513513513513514,0.34320143214007165,1.0,26/51,16.71%,RPL35A;RPL7A;RPL5;RPL23A;RPL10;RPL10A;RPL11;RPL24;RPL3;NOP16;RPF2;NOP53;NHP2;RPL6;MRPL20;ZNF622;WDR74;RPLP0;RPL14;SURF6;WDR12;RPL7;MRTO4;RPL26L1;EBNA1BP2;SNU13
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.6953310945525886,-1.592862948114778,0.0,0.3361474457536355,1.0,25/57,16.23%,RPL38;RPL35A;RPS16;RPL5;RPS25;RPS15;RPS7;RPL11;RPS6;MRPL36;RBIS;RPS24;NOP16;RPF2;RPS28;RPS19;ZNF622;WDR74;RPL14;SURF6;WDR12;RPL7;MRTO4;RPL26L1;EBNA1BP2
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.574625596949069,1.5902253429704358,0.0,0.8164772092907857,1.0,28/103,15.24%,EPB41L4B;CGNL1;FGFR3;FRZB;EFNB3;TMEM98;EGFR;MYH14;SLC13A4;TMEM47;RNF128;BCAM;OBSL1;COBL;NOTCH3;AGAP1;EPB41L1;TOX3;CDC42EP4;TEAD1;AQP1;SHANK2;CHRD;SHROOM3;NEO1;MPDZ;GPC6;GYG2
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.8909219388821545,1.589008794863805,0.0,0.813274854872086,1.0,1/7,6.42%,ALDH1A1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6750706780997607,1.5848907539169819,0.0,0.8270859705486476,1.0,13/40,12.69%,RELN;GRM2;HOMER1;GRM8;NLGN1;CACNG5;CACNG4;GRM1;GRM3;UNC13A;NRXN1;CDH2;NLGN3
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.9365427928803374,1.5848434946655996,0.0,0.8145671659451944,1.0,1/5,0.31%,RELN
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.7553240976758613,-1.5847020179762696,0.014084507042253521,0.3602218624458053,1.0,12/41,6.58%,PSMB8;HLA-F;IRF4;HLA-C;GBP2;IFIT2;HLA-A;HLA-E;IRF9;IFITM3;IFIT3;IRF1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.7553240976758613,-1.5847020179762696,0.014084507042253521,0.3602218624458053,1.0,12/41,6.58%,PSMB8;HLA-F;IRF4;HLA-C;GBP2;IFIT2;HLA-A;HLA-E;IRF9;IFITM3;IFIT3;IRF1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.7957411551660262,-1.5832144934103571,0.03333333333333333,0.358820179950039,1.0,4/14,10.96%,CD44;HYAL2;CEMIP;TGFB1
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.7658738922676317,1.5756167447904574,0.025,0.8741055925231032,1.0,4/11,11.13%,DSE;VCAN;CSPG4;NCAN
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.6155807364406252,-1.5741509165570957,0.0,0.39658386608620516,1.0,71/188,20.57%,HSPE1;RPL34;MCM2;EEF1B2;LDHA;TYMS;H2AZ1;RPS2;RPS5;RPL18;RPS3;DDX18;RPS6;APEX1;USP1;PSMD8;PCNA;POLE3;MCM4;PSMD7;EIF2S2;LSM7;NOP16;LSM2;CYC1;SF3A1;COPS5;NHP2;RACK1;RPL6;RANBP1;CCT7;PHB2;MRPS18B;SNRPB2;SNRPD1;CDK4;PPM1G;PSMD3;SRSF7;VBP1;RPLP0;EIF3D;NDUFAB1;C1QBP;RPL14;PPIA;SSB;IMPDH2;EIF3J;KPNA2;CANX;PSMA4;CCT2;SNRPD2;RFC4;PRPS2;MCM5;TUFM;SRSF3;IFRD1;PSMA7;MRPL9;SLC25A3;ORC2;COX5A;PSMB2;POLD2;TFDP1;NCBP1;PSMB3
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.9498159569681349,1.5737581907372158,0.0,0.8746223695010399,1.0,1/6,2.85%,ALK
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),0.8840404489967804,1.5716706389838828,0.02857142857142857,0.8763030946258775,1.0,3/8,9.36%,KYAT1;IDO1;KYNU
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),0.9716308098220425,1.570481548661605,0.0,0.8715437820123396,1.0,1/5,0.02%,GABRE
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.6912200102793177,-1.5696661763899526,0.015151515151515152,0.41141112652319967,1.0,20/44,23.24%,PSMB8;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;AZIN1;PSMD3;PSMC3;PSMA4;PSMD2;PSMA7;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;PSMC1;OAZ3;PSMD10
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.7642642440755962,1.5687961745295478,0.03333333333333333,0.8709295511564452,1.0,5/16,14.11%,RELN;CRTC1;ADCY8;PRKD1;LRP8
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.7407162268794283,1.5686933678755128,0.027777777777777776,0.859415820651379,1.0,7/20,14.86%,LEPR;ACSM1;PPARGC1A;ACADVL;PID1;GFPT2;GFPT1
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.8059259593952671,-1.5680102269909781,0.03225806451612903,0.4112108511534851,1.0,11/20,12.66%,RPL5;RPL23A;RPL10;RPL11;RPL24;RPL3;RPF2;NOP53;RPL6;MRPL20;RPLP0
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.8384752060923263,1.5677414508892422,0.03125,0.852676473101739,1.0,4/8,14.63%,ADSS2;HPRT1;AMPD1;AMPD3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.6770702508805806,-1.567460469450781,0.015873015873015872,0.4044807297676947,1.0,19/50,21.75%,PSMB8;PSME1;AVEN;PSMB6;PSMD8;PSMC5;PSMD7;RBX1;PSMD3;PSMC3;PSMA4;PSMD2;PSMA7;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;PSMC1
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.6968178242456421,1.5664964531802847,0.0,0.8501491730073243,1.0,12/39,14.91%,PBX3;PBX1;ADAMTS18;MEIS1;MEIS3;FREM2;SMG9;TGFB2;COL5A1;MEIS2;CEP290;HIPK2
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.5765016497213918,1.5651802981942147,0.0,0.8503990306163104,1.0,11/93,5.14%,F2;RELN;FGFR1;LCP2;FLT1;FGFR3;ALK;EGFR;PDGFRA;MMD2;EPHA3
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.8182524834503434,1.5635268349895093,0.02857142857142857,0.8533149596205614,1.0,5/8,15.68%,PKD1;NPNT;ROBO2;SLIT2;PKD2
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.6340255493960141,1.5626120243627177,0.05263157894736842,0.8473622646219445,1.0,7/31,11.20%,ZAP70;LEPR;CHD7;CD4;NHEJ1;GPR89B;PTPN22
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.8153821549763661,1.5625465106175893,0.0,0.8368782224057189,1.0,8/11,17.35%,IL1RAPL1;PTPRD;LRP4;NLGN4X;NLGN1;NLGN3;PTEN;CEL
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.9112744876695157,1.5618103417082774,0.0,0.831460217131926,1.0,2/9,1.58%,CLEC2A;KLRD1
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),-0.9665763175858134,-1.5608447412376707,0.0,0.4398823944608344,1.0,2/6,2.22%,TYRP1;TPH1
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.9452630197513442,1.5602637629836613,0.0,0.8225339700038458,1.0,1/5,0.10%,F2
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.9452630197513442,1.5602637629836613,0.0,0.8225339700038458,1.0,1/5,0.10%,F2
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.8340547597135711,1.5592336868325605,0.02564102564102564,0.821288343849554,1.0,2/7,10.80%,LYPD1;CHRM3
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.8073825682820046,1.5591305926741745,0.05,0.8122504619482805,1.0,2/14,1.33%,F2;NLRP7
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),-0.9668121261928709,-1.5565002559203882,0.0,0.4551596186726178,1.0,1/6,0.56%,DDIT3
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.8908780849758857,1.5560302330593627,0.05405405405405406,0.8261325007760821,1.0,1/6,4.47%,CX3CR1
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.8959620186514032,1.5559185033826206,0.02702702702702703,0.8170930466789972,1.0,3/8,6.31%,CPNE7;CPNE1;HDHD5
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.7462244780329332,1.555486058050488,0.025,0.810467360896416,1.0,4/20,7.12%,RAB27A;ADGRB1;SNCA;CYBA
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.7216535124562278,1.5550456836611182,0.03571428571428571,0.803063411667556,1.0,9/21,21.84%,KCNJ2;SCN9A;CACNA1I;SCN7A;CACNA1G;SCN3B;SLC8A1;SCN3A;ATP1A2
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.8728909516259789,-1.5550338887184922,0.01694915254237288,0.45561968695369437,1.0,4/10,9.12%,CENPE;MIS12;CHAMP1;NUF2
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.8608829419862842,1.5542375158517572,0.0,0.7990553819360029,1.0,2/8,6.25%,LEPR;SIRT1
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.5927668779641351,1.5541145423211933,0.043478260869565216,0.7910382264511543,1.0,22/88,12.02%,KCNN4;KCNJ14;KCNH4;KCNJ2;KCNQ2;ABCC8;KCNH3;KCNIP2;KCNMB4;SLC24A3;KCNN2;PKD2L1;SLC9C2;ATP1B3;KCNH7;KCNMA1;KCND2;KCNC2;SLC9A2;KCNN1;AQP1;LRRC38
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),0.9063786301751902,1.5533762596051122,0.0,0.7884566081271632,1.0,1/7,0.34%,PDGFB
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.6870239276915223,1.550837229965705,0.02857142857142857,0.7976626928171602,1.0,14/35,21.44%,MEMO1;EPHA3;DIAPH1;CAMSAP3;CLASP1;TRIM36;GSK3B;MARK4;MAPT;EFNA5;PHLDB2;MARK2;BICD2;MACF1
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.9568177005403455,-1.549300487642051,0.0,0.487058319863455,1.0,1/7,0.93%,NLRP1
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7992671026129343,-1.5491465464372347,0.015873015873015872,0.47778940668944103,1.0,7/17,7.21%,RPS27;RPS14;RPSA;RPS15;RPS5;RPS28;RPS19
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.7545702201672532,1.5489084424360398,0.07142857142857142,0.8027014006375627,1.0,3/16,6.76%,PDGFB;EGFR;PKD1
prerank,GO_Biological_Process_2021__detection of molecule of bacterial origin (GO:0032490),0.9173678744554256,1.548881664021986,0.02564102564102564,0.7941216427102434,1.0,2/5,5.74%,DMBT1;SSC5D
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.652899570223079,-1.5484069896060575,0.0,0.47234381534774894,1.0,28/76,15.58%,NDUFS5;NDUFA1;NDUFB3;NDUFA12;NDUFC1;NDUFB9;UQCC3;NDUFS6;NDUFA2;NDUFB11;DMAC1;NDUFB4;NDUFA3;NDUFB2;NDUFS8;COX17;SURF1;NDUFAF3;TMEM126B;NDUFB7;NDUFB10;NDUFB1;NDUFAB1;SMIM20;TMEM126A;SDHAF1;NDUFAF1;NDUFS7
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.8883397781075901,1.5474774964769102,0.05128205128205128,0.7952102914845492,1.0,1/6,0.25%,VAPB
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.9222654591029531,-1.5472945219426615,0.0,0.4698519078024228,1.0,2/7,1.84%,F8;SERPING1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.8103672117776287,-1.5464447960042589,0.04225352112676056,0.4661911669189643,1.0,1/14,0.07%,CD44
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.872567365646607,1.5456062430939486,0.02857142857142857,0.8012516125864934,1.0,1/7,5.76%,SPRED1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.9164497666834694,1.5452673324111237,0.024390243902439025,0.7966154811461419,1.0,3/6,7.27%,IGF1;SIRT1;CDKN2A
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.7951457055783884,-1.5448090723933723,0.03125,0.4690277395962385,1.0,4/16,10.96%,CD44;HYAL2;CEMIP;TGFB1
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.8719817458047139,1.54406926962451,0.06976744186046512,0.7986185665299321,1.0,1/8,0.37%,LEPR
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.6732744376223525,1.5435458724014097,0.05,0.7942429400407297,1.0,6/24,9.96%,RELN;IGF1;SRC;MMD2;ERBIN;RAPGEF1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.7482432452282359,-1.5423568695272956,0.027777777777777776,0.474347155710119,1.0,10/23,17.62%,RPS27A;COPS6;COPS7A;UBA52;COPS5;CETN2;RBX1;PARP1;UBB;XPA
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.8968707977590032,-1.541522789544698,0.0,0.47110328322504336,1.0,1/10,0.03%,TYRP1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.8272536591744777,1.5410756981815974,0.02702702702702703,0.8015475514651444,1.0,3/12,7.51%,PDGFB;IGF1;DOCK7
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.8252498804593148,1.540728007387183,0.0,0.7960158565529672,1.0,3/13,1.75%,F2;CREB3L1;RUNX1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.7656874353311216,-1.5403457978531596,0.0410958904109589,0.4704707399524935,1.0,9/27,11.26%,HLA-F;B2M;HLA-C;HLA-A;HLA-E;CALR;ERAP1;ERAP2;PDIA3
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.7634427161534534,1.5401819515030457,0.06666666666666667,0.7934011665171133,1.0,4/13,8.62%,ZMYND10;ODAD3;DNAAF1;DNAI2
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.8499427199898316,1.5396590391756333,0.1111111111111111,0.7901766846342371,1.0,4/6,14.63%,HPRT1;NT5E;PRTFDC1;AMPD3
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.7989686216212459,-1.5378261718004973,0.046875,0.47281436201498206,1.0,5/20,5.67%,TINF2;POLR2G;POLR2J;POLR2L;POLR2I
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.7989686216212459,-1.5378261718004973,0.046875,0.47281436201498206,1.0,5/20,5.67%,TINF2;POLR2G;POLR2J;POLR2L;POLR2I
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.7636295608287741,1.5358638009127608,0.029411764705882353,0.8107293936674784,1.0,4/12,11.13%,DSE;VCAN;CSPG4;NCAN
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.8182537052967301,1.5346270759968073,0.027777777777777776,0.810642897412953,1.0,6/11,11.73%,RELN;VIT;GLI2;PKD1;DLL1;SOX12
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.5589569173338164,1.5327664246964685,0.047619047619047616,0.8131280013410509,1.0,45/122,20.15%,KCNQ2;CELF3;MMD2;EPHA3;NPAS3;SCRT1;ASCL1;CTNND2;OLFM3;ADGRB3;AMER2;NOTCH3;HIVEP2;CTNNA2;PCDH8;NXPH1;ROBO1;SNAP91;EFR3B;GRM3;ADGRL3;UNC13A;SOX5;ZNF536;CAMKV;NCAN;UNC79;LRRC4C;NRXN1;GPM6B;ROBO2;SLC8A2;ABI2;CADM2;STIM2;ADGRA1;KIF1B;GRIA2;NOL4;SCN3B;FUT9;BCL2;ERC2;ADCYAP1R1;ST8SIA3
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.8511190688368548,1.5327661769728718,0.0196078431372549,0.8053839251378029,1.0,5/7,12.99%,PLIN5;PLA2G10;NFKB1;C3;LPL
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.6516554258833839,1.531894318274572,0.0,0.8030810031611815,1.0,5/32,4.45%,F2;RAB27A;PDGFB;ADGRB1;CLEC7A
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.7126888082440893,1.531792804184451,0.029411764705882353,0.7962000438477214,1.0,4/26,3.43%,CPA1;LGALS4;GIPC2;ANXA4
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.8238338283869227,1.5300770145787843,0.0,0.8002116893845518,1.0,3/14,1.75%,F2;CREB3L1;RUNX1
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.8048772142497167,1.5294332342726367,0.027777777777777776,0.797161384861268,1.0,3/11,8.56%,SPIRE2;COBL;SPIRE1
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.9055907297178207,1.5280343572562973,0.0,0.79267037836452,1.0,2/8,8.33%,CACNG5;CACNG4
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.9055907297178207,1.5280343572562973,0.0,0.79267037836452,1.0,2/8,8.33%,CACNG5;CACNG4
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),0.8540015811782555,1.5278816090859548,0.046511627906976744,0.7864281937297415,1.0,4/9,5.42%,TNNC2;TCAP;MYH3;MYH14
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.7284873448612892,1.5278608260032083,0.0,0.7798234399265808,1.0,10/37,11.69%,KCNN4;KCNJ2;KCNIP2;KCNMB4;KCNN2;ATP1B3;KCNMA1;AKAP6;NOS1AP;KCNN1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.8621444150966486,1.5274694703458276,0.0,0.7684692040596802,1.0,4/8,12.80%,IGF1;AKAP6;CAMTA1;SPPL3
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.8621444150966486,1.5274694703458276,0.0,0.7684692040596802,1.0,4/8,12.80%,IGF1;AKAP6;CAMTA1;SPPL3
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.7230044708391107,-1.5256383514301965,0.030303030303030304,0.5489550969783344,1.0,4/30,9.48%,CD44;ZMYM6;VIL1;SPARC
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.721928267986632,1.525121739931334,0.029411764705882353,0.7776274261920443,1.0,5/23,5.47%,PDGFB;ZSWIM6;ZSWIM4;PDGFRA;ADGRA2
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.6152783607011097,-1.5251033012711295,0.013888888888888888,0.5443270618333351,1.0,42/116,21.75%,PSMB8;RPS27A;MCM2;PSME1;PSMB6;PSMD8;PSMC5;PNKP;POLE3;MCM4;ORC6;PSMD7;UBA52;MCM3;TEFM;WDHD1;RPA3;PSMD3;PSMC3;RFC2;GINS2;UBB;MGME1;GINS4;PSMA4;RFC4;CDC34;MCM5;PSMD2;PSMA7;ORC2;RECQL;PSMD6;PSMB2;POLD2;PSMB3;PSMB4;POLD4;PSMA3;MCMBP;DBF4;PSMC1
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),0.8655977924734765,1.5249812665871247,0.05263157894736842,0.772009012651238,1.0,5/5,13.46%,SLC7A1;SLC7A2;SLC47A1;SLC22A2;SLC25A29
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.805233693297369,-1.5247421588904717,0.031746031746031744,0.5375598361860199,1.0,2/15,1.57%,DDIT3;XBP1
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.8429497186051014,-1.5239898500870719,0.014925373134328358,0.5337952349993929,1.0,1/11,0.55%,GATA1
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),-0.9920097674170579,-1.5222395051092223,0.0,0.5378486087943638,1.0,1/5,0.35%,BMP5
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.7239872185478607,-1.5218878118617027,0.017857142857142856,0.5323989282262713,1.0,6/33,5.88%,GBP3;GBP2;GAPDH;HLA-DPA1;RPL13A;IFITM3
prerank,GO_Biological_Process_2021__natural killer cell activation involved in immune response (GO:0002323),0.9731526677163236,1.5218094165855587,0.0,0.7868710878005644,1.0,1/5,0.00%,KLRF2
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.8854542164008308,1.5207199306004477,0.02040816326530612,0.7877828095730024,1.0,1/5,2.64%,LHFPL2
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.8180572072632265,1.520506095089103,0.0,0.7821088642481734,1.0,3/14,1.75%,F2;CREB3L1;RUNX1
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.8834002855444192,-1.520309765507723,0.0,0.5364755320638173,1.0,5/10,9.12%,CENPF;CENPE;MIS12;CENPH;NUF2
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),-0.8966009607353638,-1.519916363297765,0.031746031746031744,0.5317100031957779,1.0,2/7,4.81%,DDIT3;MESP1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.871187958971997,1.5195686336063934,0.06382978723404255,0.7811673328594235,1.0,1/9,0.31%,RELN
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),-0.8496529115296161,-1.5179436763447915,0.0,0.5420552067905395,1.0,3/11,4.01%,CPS1;NOX4;TST
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.8591350535654508,1.51794054147094,0.0625,0.7852799977304297,1.0,1/7,1.33%,IGF1
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.6795178474855817,-1.5175759838917122,0.014925373134328358,0.536743345791447,1.0,21/47,23.24%,PSMB8;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;AZIN1;PSMD3;PSMC3;PSMA4;BHMT;PSMD2;PSMA7;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;PSMC1;OAZ3;PSMD10
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.7193254643001783,-1.517469194653713,0.0,0.5295601374165125,1.0,16/39,15.03%,RPS27;RPS16;RPS14;RPS25;RPSA;RPS15;RPS5;RPS7;RPS6;RPS24;RPS28;RPS19;TSR3;NOB1;SURF6;RPS27L
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.9478941669346057,-1.5164199102632945,0.014925373134328358,0.5214739817353067,1.0,4/6,4.50%,HLA-F;HLA-C;HLA-A;HLA-E
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.9478941669346057,-1.5164199102632945,0.014925373134328358,0.5214739817353067,1.0,4/6,4.50%,HLA-F;HLA-C;HLA-A;HLA-E
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.75175844458228,1.5163082030375699,0.025,0.7912814492200813,1.0,4/10,11.11%,NOS2;DAO;GLS;ARG1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.8512220020831178,-1.516297091421077,0.015151515151515152,0.508763537169664,1.0,1/10,0.07%,CD44
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.8512220020831178,-1.516297091421077,0.015151515151515152,0.508763537169664,1.0,1/10,0.07%,CD44
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.614926319567946,1.5155053815545716,0.02631578947368421,0.7915819828723365,1.0,15/56,9.77%,PDGFB;PTPN6;PDGFC;FGFR1;IGF1;FLT1;SRC;PIK3R5;PDGFRA;SIRT1;IGF1R;HCLS1;NTRK2;TGFB2;GAB1
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.847670191612207,1.5152950414431812,0.025,0.787173695680041,1.0,7/9,14.70%,ERRFI1;PDGFRA;NOTCH4;FBXW7;PIK3CA;BMPR2;ACVR2B
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.7931131510125269,1.5152202897790927,0.12,0.781244468047442,1.0,2/10,4.27%,STARD13;TBXA2R
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.5201236221839675,1.5149831202349187,0.0,0.7770922262136796,1.0,43/165,15.50%,CPA1;CREB3L1;SLCO2B1;TIAM2;STARD13;STK32B;PDGFRA;HPGDS;POSTN;ADAMTS9;DUSP1;SPRED1;ALDH1A1;SLC7A5;RNF128;RAB27B;COBL;OPTN;HDC;LTC4S;IL2RA;HS2ST1;MRC1;PID1;MITF;SGCD;AQP1;SLC4A4;CD55;CDH9;MEIS2;GRIK2;NEO1;PLSCR4;LDB2;BMPR2;CSRNP1;GP1BA;LRRC66;ACER3;CFH;NIBAN2;ROR1
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.7210785246026703,1.5141722774929955,0.09302325581395349,0.7768677994007179,1.0,2/18,0.35%,PRNT;GCNA
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.7565738061184396,-1.5101250075281456,0.04477611940298507,0.5465450869490702,1.0,6/21,14.64%,TINF2;PARP2;MPG;EXOSC4;PARP1;MBD4
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.8554856969335073,1.5084377049749105,0.03125,0.8095898558026252,1.0,1/10,0.10%,F2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.7494456627571251,1.5082305273149321,0.02564102564102564,0.8053153934899865,1.0,5/14,19.51%,RUNX1;FGF2;ZFPM2;TP73;ERBB4
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.9417420965868387,-1.5075054211508083,0.014925373134328358,0.5584387374862004,1.0,5/7,4.50%,HLA-F;B2M;HLA-C;HLA-A;HLA-E
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.8181862915867034,1.5072575352827258,0.02631578947368421,0.8042685856481505,1.0,8/10,17.35%,IL1RAPL1;PTPRD;LRP4;NLGN4X;NLGN1;NLGN3;PTEN;CEL
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.7222069228784446,1.5065465234977968,0.02857142857142857,0.802225239188449,1.0,6/15,21.84%,KCNJ2;CACNA2D1;CACNA1G;SCN3B;SLC8A1;ATP1A2
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.6584490511333282,1.5058415927641795,0.024390243902439025,0.8007150134019834,1.0,9/28,11.78%,NUPR1;PFKFB3;IGF1;ARNT;PPARGC1A;P2RX7;MLXIPL;PID1;SLC4A4
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),0.8100152894952038,1.504643803326403,0.13513513513513514,0.8020197372323105,1.0,1/7,0.22%,VDR
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.614979583779933,1.504594496210165,0.03225806451612903,0.7961778404478059,1.0,4/29,6.19%,PTPN6;DUSP6;DUSP1;DUSP10
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),-0.8899507720044865,-1.504493029755137,0.017241379310344827,0.5711572165640822,1.0,1/7,0.48%,CACNA2D4
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),-0.8899507720044865,-1.504493029755137,0.017241379310344827,0.5711572165640822,1.0,1/7,0.48%,CACNA2D4
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.6543773330110715,-1.5041572686209048,0.015151515151515152,0.5676287159546832,1.0,8/46,11.90%,PKMYT1;CCNB2;CNPPD1;CDC37;CDKN1C;SERTAD1;CCNJL;CCNE2
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.58301513442346,1.5034356166499712,0.0,0.7983810993311568,1.0,13/72,6.93%,F2;CORIN;CGNL1;SLC7A9;FRZB;C6;COL22A1;EYA4;SPTSSB;PPARGC1A;NPY1R;SORBS1;RNF128
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.6412695718232423,1.5025095149762098,0.041666666666666664,0.7985037478818456,1.0,4/25,8.62%,ZMYND10;ODAD3;DNAAF1;DNAI2
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.9246080350288042,-1.5024264985880613,0.03389830508474576,0.5749072728185844,1.0,2/6,4.45%,NPR2;NPPC
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.7296038416616288,1.5013451432390115,0.05263157894736842,0.8001740300853291,1.0,4/18,7.18%,RELN;IL1RAPL1;PTPRD;OBSL1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.8587031208133123,-1.5007010663963416,0.0,0.5808735616430614,1.0,6/12,9.09%,HLA-F;B2M;HLA-A;HLA-E;ERAP1;ERAP2
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.8041654924963614,-1.500467482141318,0.045454545454545456,0.5757320099151702,1.0,3/14,3.69%,HLA-F;B2M;HLA-A
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.8096196930047463,-1.498761167278293,0.0,0.5806404834103389,1.0,2/14,1.28%,CD44;RHOC
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),-0.9491588885036535,-1.49831995787334,0.0,0.5765170006456554,1.0,1/5,0.35%,BMP5
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.809889393800259,1.497517944916036,0.046511627906976744,0.8186450455069864,1.0,3/11,5.76%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.730027773155762,-1.4972863700353443,0.045454545454545456,0.5773847874611984,1.0,11/25,16.71%,RPL7A;RPL35;RPL10A;DDX18;RPF2;NHP2;FTSJ3;NIFK;WDR12;RPL7;SNU13
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.5992984517647061,-1.4968187616987547,0.0125,0.5744604457659812,1.0,39/132,21.00%,CENPF;PSMB8;PSME1;DCTN3;AVEN;PSMB6;PSMD8;PSMC5;SSNA1;TUBB4B;RAB11A;PSMD7;CETN2;TPX2;DCTN2;CEP131;RBX1;HAUS6;CDK4;PSMD3;PSMC3;TUBA1A;CEP72;PSMA4;DYNLL1;DCTN1;TUBA4A;PLK4;PSMD2;PSMA7;CEP135;PSMD6;PSMB2;PRKACA;PSMB3;PSMB4;TUBB;CEP41;PSMA3
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.789686081389655,1.4966732098999136,0.024390243902439025,0.8181430494258979,1.0,1/9,0.10%,F2
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.7006862485414976,-1.4965042241073514,0.0273972602739726,0.5702659084104352,1.0,3/32,5.76%,CD44;XBP1;HYAL2
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.8362385405924657,1.4945897378710555,0.07692307692307693,0.8263677324511043,1.0,4/6,11.65%,DUSP1;DUSP10;PTPN22;DLG1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7661013532847891,1.4944784521580856,0.10256410256410256,0.8214893449918844,1.0,8/16,14.15%,KAT2A;ZBTB16;SCX;SCIN;TRPS1;SOX5;PTHLH;BMPR2
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.6563027692815463,-1.4939368420539112,0.0,0.5803408895875339,1.0,24/70,20.92%,RPS27A;POLR2G;COPS6;POLR2J;POLR2L;PCNA;PPIE;POLR2I;COPS7A;UBA52;COPS5;ZNF830;RPA3;RBX1;RFC2;UBB;RFC4;POLR2A;XPA;GTF2H2;ERCC8;POLD2;POLD4;UVSSA
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.9291750636672729,1.4932624360860136,0.04878048780487805,0.8240619142426603,1.0,2/6,4.45%,ZBTB1;CLEC7A
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.8269156588822403,-1.4922487969488978,0.046153846153846156,0.5876647277063666,1.0,3/10,7.95%,COPS6;COPS7A;COPS5
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.6514976080934304,-1.4913915776095965,0.0,0.5868806835276903,1.0,27/79,22.13%,MRPS22;MRPL51;MRPL35;MRPL36;MRPS12;MRPS34;MRPL34;MRPL40;MRPL2;MRPS21;MRPL27;MRPL20;MRPL14;MRPS18B;GADD45GIP1;MRPL54;MRPS18A;MRPL52;MRPL4;MRPL16;MRPL45;MRPS26;MTRF1L;MRPL9;AURKAIP1;MRPL57;ERAL1
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.7034604250537839,-1.491335929021174,0.014925373134328358,0.5807251378700135,1.0,10/25,15.89%,MICOS13;ATP5F1E;UQCC3;ATP5MC3;ATP5PD;ATP5PB;ATP5F1B;AFG3L2;ATP5PF;ATP5ME
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.6729479709176734,1.4907020871259304,0.020833333333333332,0.835600670854164,1.0,8/22,18.14%,PDGFB;DACH1;HMBOX1;TNKS;BMPR2;NIBAN2;FGF2;RGCC
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),-0.93329682423284,-1.4905152714270575,0.0,0.573819213018365,1.0,1/7,0.03%,TYRP1
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),-0.93329682423284,-1.4905152714270575,0.0,0.573819213018365,1.0,1/7,0.03%,TYRP1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.9090365476106088,1.4904863477767738,0.023255813953488372,0.8309438666130337,1.0,2/5,8.71%,JCAD;ROBO1
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.639317678172001,-1.4900251940262568,0.0,0.5710079844504187,1.0,25/78,16.31%,PSMB8;B2M;HLA-C;IL7;GBP2;PSME1;IFIT2;IRF9;IFITM3;IFIT3;CNP;PARP14;IRF1;DDX60;TRIM25;IFI44;SP110;LAP3;PARP12;PROCR;HELZ2;NMI;LGALS3BP;WARS1;PARP9
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.8249087932446768,1.489592993143565,0.04081632653061224,0.8308359219840098,1.0,2/11,6.25%,CDK6;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.8815928458934862,1.4895270183735976,0.06666666666666667,0.8253657955939714,1.0,3/6,11.35%,VDR;CASK;PTPRK
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.6351121758569906,-1.489426543992963,0.030303030303030304,0.568868726225294,1.0,19/55,21.75%,PSMB8;PSME1;AVEN;PSMB6;PSMD8;PSMC5;PSMD7;RBX1;PSMD3;PSMC3;PSMA4;PSMD2;PSMA7;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;PSMC1
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.5677795605099175,1.489168513798965,0.038461538461538464,0.8224978519732397,1.0,42/100,20.78%,EPB41L4B;MCF2L;FGFR3;ZBTB7C;MYO5B;SOWAHA;MYH14;HAMP;NDRG2;SORBS1;CAMSAP3;COBL;AGAP1;HDC;DSCAML1;TOX3;USP54;ZNF704;SLC22A23;PLEKHA7;SHANK2;SH3BGRL2;CHDH;ZDHHC11B;NEO1;DLG3;RALGPS1;ARFGEF3;ZSWIM5;EBF4;ABAT;PRKCZ;PCDH1;HID1;PPP1R13B;CGN;SRCIN1;SYT7;BAIAP3;RAI2;NEBL;SLC6A1
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.9403030135189618,1.4890089450018553,0.0,0.8183230682006867,1.0,1/7,0.05%,MFNG
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.8662104358020727,-1.4855271687830653,0.0,0.5883205892518997,1.0,2/9,4.29%,SLC25A4;SLC25A5
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.8909903702707586,1.4838580216313553,0.06818181818181818,0.8466331239584669,1.0,1/7,3.05%,PLK1
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.6795602739105253,1.4826558265182055,0.13333333333333333,0.847309862634354,1.0,4/19,9.55%,ZMYND10;HAP1;ARHGAP35;CCP110
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),0.9056689830461426,1.4817470442742933,0.0,0.846307237938456,1.0,1/5,1.72%,FLI1
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.5905277673053294,-1.4807556128970687,0.027777777777777776,0.6158444860158172,1.0,34/111,21.00%,PSMB8;RPS27A;MCM2;PSME1;PSMB6;PSMD8;PSMC5;MCM4;ORC6;PSMD7;UBA52;GRWD1;MCM3;CETN2;RPA3;RBX1;PSMD3;PSMC3;CHAF1A;PARP1;UBB;PSMA4;MCM5;XPA;GTF2H2;PSMD2;PSMA7;ORC2;PSMD6;PSMB2;NAP1L2;PSMB3;PSMB4;PSMA3
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.6371389213605031,-1.4783360964753627,0.0,0.6280550190974927,1.0,31/94,22.13%,MRPS22;MRPL51;MRPL35;MRPL36;MRPS12;MRPS34;MRPL34;MRPL40;MRPL2;MRPS21;MRPL27;MRPL20;MRPL14;MRPS18B;MTIF3;GADD45GIP1;MRPL54;MRPS18A;MRPL52;MRPL4;MRPL16;MRPL45;MRPS26;TUFM;MTRF1L;MRPL9;TSFM;FASTKD2;AURKAIP1;MRPL57;ERAL1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.8325539911989417,1.4777451743936572,0.0,0.8651448657914647,1.0,6/14,12.69%,RELN;NLGN1;CACNG5;CACNG4;NRXN1;NLGN3
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.6433860473189037,1.477289894721752,0.0,0.862477462929328,1.0,13/35,14.91%,PBX3;PBX1;ASCL1;ADAMTS18;CHD7;MEIS1;MEIS3;FREM2;SMG9;TGFB2;MAFB;MEIS2;HIPK2
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.7830330766615661,1.4770278015708551,0.1,0.8584650024190447,1.0,3/11,12.59%,GPR35;CXCL13;ACKR3
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.6433764273177951,-1.4758722133889255,0.0,0.6406874101639661,1.0,34/93,23.40%,MRPS22;EEF1B2;MRPL51;MRPL35;MRPL36;MRPS12;MRPS34;MRPL34;MRPL40;MRPL2;MRPS21;MRPL27;RACK1;MRPL20;MRPL14;MRPS18B;GADD45GIP1;MRPL54;MRPS18A;MRPL52;EEF2;MRPL4;MRPL16;MRPL45;MRPS26;EEF1A1;TUFM;MRPL9;TSFM;AURKAIP1;MRPL57;ERAL1;MRPL24;LTN1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.8081497374207882,-1.4757254404930973,0.03225806451612903,0.6361256085707588,1.0,1/15,0.38%,IL26
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.7369717629286908,1.4756598620501313,0.07894736842105263,0.8603291737745653,1.0,4/12,12.29%,AK3;DCTPP1;AK4;ENPP1
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.8116029889692831,-1.475307782109339,0.0,0.632559286303677,1.0,2/9,2.82%,GATA1;ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.7041324283905515,1.4748758543827507,0.11764705882352941,0.8540062617742938,1.0,6/19,11.78%,PFKFB3;IGF1;ARNT;P2RX7;MLXIPL;SLC4A4
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.7041324283905515,1.4748758543827507,0.11764705882352941,0.8540062617742938,1.0,6/19,11.78%,PFKFB3;IGF1;ARNT;P2RX7;MLXIPL;SLC4A4
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.5908400405249122,-1.4745304326744348,0.0136986301369863,0.6321564056280161,1.0,24/79,24.40%,HLA-F;HLA-DPA1;HLA-A;DCTN3;CENPE;HLA-E;ARF1;DCTN2;DCTN6;KIF18A;AP2S1;CLTA;CANX;DYNLL1;DCTN1;KIF4A;HLA-DRB1;HLA-DRA;AP1S1;AP2A2;HLA-DPB1;KIF22;CTSS;CTSL
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.8114203292190381,-1.4744650229390364,0.04477611940298507,0.6265229384658723,1.0,4/13,13.57%,XBP1;SFRP1;SLAMF8;CD27
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.8255983887731733,1.473911206466719,0.07894736842105263,0.8546866270168557,1.0,2/8,6.89%,CCNH;CDK12
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.762450249692452,-1.473152817890108,0.06153846153846154,0.6304962069429838,1.0,6/13,17.95%,ORMDL2;RACK1;ORMDL1;SMPD2;TNFRSF1A;ORMDL3
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.7394637821263066,1.472565015701297,0.09090909090909091,0.8580312219587232,1.0,5/9,19.54%,HDAC4;HDAC9;SMARCAD1;HDAC1;HDAC3
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.7325535045936139,1.472179900628773,0.0,0.8559389981058331,1.0,9/23,13.85%,SLC38A1;SLC7A1;SLC7A2;SLC47A1;SLC7A5;SLC25A18;SLC22A2;SLC25A29;SLC1A2
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.7294026713840585,1.4717877314588244,0.02631578947368421,0.8529651943957802,1.0,5/22,12.12%,JCAD;STARD13;TBXA2R;RHOJ;HDAC9
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.7300422097499703,1.469697200702263,0.058823529411764705,0.8594562361440211,1.0,7/15,18.14%,LEPR;PHKA1;PID1;GFPT2;GFPT1;GSK3B;PHKG2
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.8736902578421204,1.4693855901775668,0.11363636363636363,0.856823194962497,1.0,2/5,11.32%,ABHD2;MGLL
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),-0.8621309219255316,-1.469366117017473,0.014925373134328358,0.6520985295153365,1.0,1/7,0.35%,BMP5
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.6494269575148135,-1.4692933413860525,0.0,0.6469841198073686,1.0,25/85,19.05%,MRPS22;MRPL51;MRPL35;MRPL36;MRPS12;MRPS34;MRPL34;MRPL40;TRMT112;MRPL2;MRPS21;MRPL27;MRPL20;MRPL14;MRPS18B;GADD45GIP1;MRPL54;MRPS18A;MRPL52;MRPL4;MRPL16;MRPL45;MRPS26;MTRF1L;MRPL9
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.6630252666292321,1.4692196921946283,0.0625,0.8526832224306906,1.0,8/17,21.20%,KAT2A;CNOT2;ZNF706;ZC3H13;ESRRB;LOXL2;TAF5L;ELAVL1
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.7603850150866057,1.466750582921678,0.08108108108108109,0.8640499055573659,1.0,4/9,14.77%,EPB41L4B;MAPRE2;MAP4K4;PTEN
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.836367029605378,1.4667167362290783,0.06818181818181818,0.859196041962991,1.0,2/8,6.54%,SLC39A8;SLC40A1
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.6659078166266829,1.4665688844129414,0.10714285714285714,0.8551954190854653,1.0,2/22,7.59%,BICDL1;HAP1
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.7946312038494208,1.4659993051431655,0.12727272727272726,0.8540097650961149,1.0,1/11,0.25%,VAPB
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.6112264683076128,-1.4659728695520589,0.014705882352941176,0.6660845329682693,1.0,24/71,23.24%,PSMB8;RPS27A;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;UBA52;PSMD3;PSMC3;UBB;ANAPC15;PSMA4;PSMD2;PSMA7;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;CDC23;PSMC1;CDC20;PSMD10
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.6534350439180296,-1.4656746664999354,0.0,0.6627788359891204,1.0,28/79,22.13%,MRPS22;MRPL51;MRPL35;MRPL36;MRPS12;MRPS34;MRPL34;MRPL40;MRPL2;MRPS21;MRPL27;MRPL20;MRPL14;MRPS18B;GADD45GIP1;MRPL54;MRPS18A;MRPL52;MRPL4;MRPL16;MRPL45;MRPS26;TUFM;MRPL9;TSFM;AURKAIP1;MRPL57;ERAL1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.6133915194441213,-1.4656198250181285,0.029850746268656716,0.6569464539367839,1.0,22/65,21.75%,PSMB8;RPS27A;PSME1;PSMB6;PSMD8;PSMC5;ELOB;PSMD7;UBA52;RBX1;PSMD3;PSMC3;UBB;PSMA4;PSMD2;PSMA7;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;PSMC1
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.8310598966938085,1.4650188623067124,0.10810810810810811,0.8560610630612968,1.0,2/8,8.10%,AMER2;VAX2
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.8688244203485168,1.4645487496983798,0.047619047619047616,0.8540245627528634,1.0,3/7,10.95%,CPEB3;CPEB2;CPEB4
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.9428220892138213,-1.4643142178959743,0.015625,0.6598185639275915,1.0,3/5,5.06%,RPS3;DDX11;PCNA
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.9240911749082082,1.4622986209989246,0.023809523809523808,0.863899194498022,1.0,1/5,0.75%,BTLA
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.7550313909575774,-1.4622354779120952,0.029411764705882353,0.6692147686041027,1.0,3/18,4.72%,CD44;RHOC;PLET1
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.8572872585489115,1.462117043314196,0.02702702702702703,0.8598325173962431,1.0,1/7,1.33%,NLRP7
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),0.9174787369189396,1.4615165837203312,0.023809523809523808,0.857963059554699,1.0,2/5,6.35%,TICAM1;SARM1
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.6670216591051246,1.461509597575611,0.09090909090909091,0.8532131411723771,1.0,4/22,9.90%,HDAC10;HDAC4;SIRT1;ABHD17C
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),0.8862569006797822,1.4608504415416135,0.043478260869565216,0.85231369667059,1.0,4/5,11.20%,HSPA1A;ERBIN;HSPA1B;PTPN22
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.6810663398340707,-1.4589543498501392,0.045454545454545456,0.6894762546742336,1.0,19/43,25.42%,CENPE;MIS12;CHMP2A;RAB11A;CHAMP1;NUF2;DCTN2;ANKRD53;SPDL1;KIF18A;CHMP7;CHMP3;CDC23;ZW10;CHMP4B;KIF22;KPNB1;VPS4B;NUDC
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.9229467563042025,-1.4580519829216412,0.0,0.6907332501861024,1.0,3/7,4.88%,CENPF;CENPE;MIS12
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.7383478870608827,-1.4578788836987817,0.012987012987012988,0.6863664908572044,1.0,8/28,17.59%,DTX3L;PNKP;USP51;TFIP11;CYREN;KDM4D;PARP9;MRNIP
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.7457331052577642,1.4568792109514235,0.07894736842105263,0.8734706980200277,1.0,4/13,6.50%,F2;PDGFB;PDGFRA;ADAMTS18
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.5946883092669495,1.4564551532114813,0.0625,0.8710410938384449,1.0,7/44,6.25%,VDR;NFKBIZ;GCM1;TRIM29;ANXA4;ADAM19;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.7143932176402985,1.4563676526462146,0.10714285714285714,0.8667722015298138,1.0,5/23,12.20%,PDGFB;IGF1;ESPL1;DMRT1;NSMCE2
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.7858982813289699,1.455915904942209,0.10344827586206896,0.8647780199119771,1.0,4/13,8.40%,NFATC4;KAT2A;CPEB3;SGK1
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.8085943656086088,-1.4556393155609395,0.03076923076923077,0.6984450197938301,1.0,2/11,3.45%,TIMP1;CD63
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.7558454703493287,1.4543833337136327,0.06976744186046512,0.8695246253313607,1.0,1/11,0.30%,RAB27A
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.5866623228998047,1.4543334137944461,0.0,0.8649672977964222,1.0,11/49,12.50%,B3GNT6;GAL3ST2;ST8SIA6;ADAMTS9;ST8SIA1;GANC;ST8SIA4;MAN2A1;FUT8;ENGASE;FBXO2
prerank,GO_Biological_Process_2021__myelination (GO:0042552),-0.6653350180470963,-1.4539463611595584,0.0410958904109589,0.7057386596238329,1.0,9/42,15.13%,SLC8A3;DEGS1;MPZ;PMP22;KLK6;TNFRSF21;MYRF;EIF2B2;EIF2B4
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.8092341939637133,1.4535896240890305,0.14285714285714285,0.8658636660705542,1.0,2/8,7.51%,PDGFB;DOCK7
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.7627977483289988,1.453269066523865,0.125,0.8638451452712307,1.0,1/13,0.31%,RELN
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.8675494044439189,1.453260236565852,0.05128205128205128,0.85924794811476,1.0,2/7,6.07%,NPAS2;NLGN1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.5879302618086786,1.4527015106088297,0.06451612903225806,0.8578614817785974,1.0,3/44,2.14%,F2;PDGFB;PLIN5
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),-0.7809210169603971,-1.4523419610343895,0.03278688524590164,0.7118435651139831,1.0,4/12,18.86%,MAGT1;SLC41A1;MMGT1;CNNM4
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.7434287641478633,-1.451920225288694,0.014925373134328358,0.7093426805642384,1.0,6/24,11.68%,GATA1;COL9A3;MEA1;FSHR;SOX15;AR
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.8522817411805925,1.45188688815914,0.022727272727272728,0.8578476501367231,1.0,4/8,12.12%,HDAC10;HDAC4;SIRT1;HDAC9
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.8588285919366601,1.4518071665772991,0.1,0.8535689641535319,1.0,2/5,1.94%,CORIN;OXTR
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.8096911917810677,-1.4517645133845667,0.045454545454545456,0.704515595906332,1.0,1/11,2.25%,STMN1
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),0.9400027033860401,1.451301676426597,0.044444444444444446,0.8511032366627803,1.0,3/5,5.52%,NOS2;ICAM1;AGER
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.7509578820798544,1.4503311553703693,0.1,0.8521802198098759,1.0,3/11,12.28%,VEGFD;GAB1;PIK3CA
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.8064049661506298,-1.4494609228121036,0.06666666666666667,0.7153123997001846,1.0,6/12,7.91%,COX7C;COX6C;COX4I1;COX6A1;COX7B;COX6B1
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),-0.901662660649514,-1.4493169524947989,0.034482758620689655,0.710242005674304,1.0,1/6,5.45%,CARTPT
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),0.8180141401722583,1.4489628671572388,0.08888888888888889,0.8554148984792525,1.0,1/7,0.10%,F2
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.6191656693947559,1.447435036497474,0.03125,0.8593119071272914,1.0,6/34,11.38%,PDGFB;VIT;SPOCK1;NPNT;TBCD;CORO2B
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.6488931810804149,1.4470370786610651,0.09375,0.8574907029987519,1.0,10/19,14.05%,VCAN;CHST7;CSPG4;CHST3;CHST11;CHSY3;NCAN;CSGALNACT1;UGDH;CHST15
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.5038363108620919,1.4466871658858214,0.0,0.8554127345555751,1.0,23/228,7.90%,KLRF2;VDR;PDGFB;LEPR;PDGFC;KAT2A;IL4R;OXTR;SNAI1;LEF1;RFX3;TBXA2R;ZNF516;PPARGC1A;PLAC8;NLGN1;ZBTB16;SIRT1;IGF1R;HAP1;ITGAX;TRIM16;PAXIP1
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.7727860105031237,1.4466462613035558,0.03125,0.8510945342313115,1.0,5/9,18.92%,RELA;NFKB1;PID1;CHI3L1;ST3GAL6
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.7233782543905115,1.4460379782566068,0.06451612903225806,0.8505704069860222,1.0,6/15,14.15%,OXTR;TBXA2R;KCNMB4;ADRA1A;CHRM3;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.8148881246144641,-1.4454111773426126,0.034482758620689655,0.7361668171761898,1.0,1/8,0.07%,CD44
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.6109932315362283,-1.4454083630414865,0.0,0.7301326629370407,1.0,29/98,20.92%,RPS27A;POLR2G;COPS6;POLR2J;POLR2L;PNKP;RAD23A;PCNA;PPIE;POLR2I;COPS7A;UBA52;COPS5;ZNF830;CETN2;RPA3;RBX1;RFC2;PARP1;UBB;RFC4;POLR2A;XPA;RNF111;GTF2H2;ERCC8;POLD2;POLD4;UVSSA
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.6534287455740149,1.4448042632867713,0.15789473684210525,0.8539182468471763,1.0,2/19,1.79%,GPR35;CBARP
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6382541433003796,-1.4444617584766786,0.05970149253731343,0.7329516783564901,1.0,14/46,19.87%,RPS27A;MCM2;DDX11;MCM4;UBA52;CETN2;RBX1;PARP1;UBB;RAD50;XPA;GTF2H2;RECQL;DDX1
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.8511808382594597,-1.44424410228738,0.05555555555555555,0.7283003541608707,1.0,3/9,3.86%,COPS9;RPL5;RPL11
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.7206996885202656,-1.4437124968258077,0.02857142857142857,0.7268800822887113,1.0,6/28,11.68%,GATA1;COL9A3;MEA1;FSHR;SOX15;AR
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.5861659255434286,1.442851191339164,0.0625,0.8608769077779461,1.0,15/32,18.94%,RELN;CX3CR1;NLGN4X;NLGN1;GRID1;LRRC4C;PXK;NLGN3;GRIK2;LRP8;CEL;EIF4EBP2;BTBD9;BCR;NRG3
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.7317610972828789,1.4428162921877457,0.10714285714285714,0.8568195096750255,1.0,8/16,17.85%,SCN9A;KCNMB4;MYH14;CACNA1I;SCN7A;CACNA1G;GPER1;KCNMB2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.7401781200239438,1.4415523460905604,0.13157894736842105,0.8602863414946802,1.0,3/16,9.67%,F2;SNCA;AKAP6
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.7404633619439674,1.4408228397383684,0.05263157894736842,0.8605273529800045,1.0,7/11,21.04%,AKT2;WNT3;ZNF703;ERBB4;SCRIB;WNT4;CSF1R
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.8160373617102115,-1.4406431303102556,0.05084745762711865,0.7393176025091044,1.0,1/9,0.86%,TINF2
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.8160373617102115,-1.4406431303102556,0.05084745762711865,0.7393176025091044,1.0,1/9,0.86%,TINF2
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.7088139811892948,-1.4401716795716626,0.07692307692307693,0.73707388410771,1.0,8/22,15.88%,RPS27A;PCNA;UBA52;RPA3;RFC2;SPRTN;UBB;RFC4
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.5367565443043657,1.4394786621614655,0.0,0.8646030719595481,1.0,26/70,21.78%,IGF1;SPRY2;EPS8L2;STARD13;MMD2;ARHGAP44;DENND1A;ERBIN;TGFB2;DENND4B;RAPGEF1;OGT;SYNGAP1;KANK1;RALGPS1;SPRY4;FBP1;KIF14;KBTBD7;ARHGEF28;BCR;DENND4A;ARHGAP17;DENND4C;IRS2;RAF1
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.45533284928946416,1.4386774460287373,0.0,0.8649521060518325,1.0,101/420,17.66%,ZAP70;RELN;PDGFB;PTPN6;CDKL1;FGFR1;CDK6;FLT1;PASK;FGFR3;SRC;ALK;PLK1;MAPK12;STK32B;EGFR;CDK10;MAP4K5;PRKX;PDGFRA;LIMK1;EPHA3;FRK;AKT2;PKD1;NEK4;CCNH;CDK12;IRAK3;IGF1R;FNIP2;TNIK;SGK1;NTRK2;MYO3A;NLK;AURKC;PNCK;MAP3K1;MEX3B;MAPK10;TGFB2;MATK;VRK2;TSSK6;RICTOR;TNKS;PRKG2;MAPKAPK3;CAMKV;ACVR1;USP15;NUAK1;SGK3;GRK5;DYRK3;MKNK2;PXK;MAP4K2;MAP4K4;ULK3;PRKCE;ATP13A2;PRKD1;MERTK;CDKL4;RPS6KA1;HCK;ABI2;CDK17;BMPR2;SIK3;MARK1;SMG1;ACVR2B;HIPK2;RYK;PDK1;CDC25B;UHMK1;DYRK1A;CCNA2;MAST4;HIPK3;FLT3;RPS6KA6;SYK;PIM3;PDK4;ACVR2A;ACVR1C;TTBK2;GSK3B;LTK;FER;PRKCZ;PRKACB;CAMK2D;CDK18;ABL1;MAPK8
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.679897407437229,-1.4381456788586962,0.011904761904761904,0.7487567799555943,1.0,13/40,14.08%,SLC28A2;ADH4;TPH1;SLC3A1;GLOD5;GBA3;VIL1;CDH17;CYP3A4;ACSM3;ESM1;CYP3A5;SLC2A2
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),-0.9046065237044245,-1.4372572895160605,0.0392156862745098,0.749699894878432,1.0,1/6,1.67%,SFRP1
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.7576098039807585,1.4366840754532855,0.09523809523809523,0.8738137833007834,1.0,5/8,18.95%,ZBTB16;SOX5;GDF5;LOXL2;BMPR1B
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.787206365212636,1.435916080236672,0.17777777777777778,0.8738537273207625,1.0,6/8,19.16%,GALNT3;EOGT;GALNT2;GALNT16;GALNTL6;GALNT11
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.6007916971528615,1.4354221144288684,0.034482758620689655,0.8734391781984634,1.0,9/33,12.09%,CLDN15;CLDN9;GRHL2;FRMPD2;ESAM;TBCD;PARD6B;DLG1;AFDN
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.7226886530264436,-1.4349966452854332,0.04225352112676056,0.7629905770244789,1.0,4/24,4.72%,CD44;CLU;RPS3;DDIAS
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.7960024657888612,-1.4349720530242354,0.03076923076923077,0.757583999634181,1.0,3/11,10.16%,DDIT3;EIF2AK1;HSPA5
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.6478223924678566,-1.434488252314468,0.05084745762711865,0.756523439628018,1.0,22/53,23.24%,PSMB8;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;AZIN1;PSMD3;PSMC3;PSMA4;PSMD2;PSMA7;PDK2;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;PSMC1;CAV1;OAZ3;PSMD10
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),0.8414748392948549,1.4342135247055479,0.08333333333333333,0.8762565743150729,1.0,3/5,10.96%,FBLN5;TNXB;LTBP3
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.7194775813223062,-1.4334899672446773,0.031746031746031744,0.75946621322622,1.0,5/23,4.57%,HLA-F;B2M;HLA-A;HLA-E;LACC1
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.6866623478937779,-1.4331476295652015,0.04285714285714286,0.7565197769630961,1.0,9/23,20.38%,PSME1;EFNA1;RHBDF1;PINK1;ATP5IF1;NUDT15;UBB;APOE;PRKACA
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.6609197555091894,1.4326813689613447,0.02631578947368421,0.8822593010757989,1.0,5/21,4.72%,PDGFB;FLT1;IRS1;FGFR3;PDGFRA
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.7803054978196257,-1.4317732405899255,0.039473684210526314,0.7623206167929877,1.0,4/16,9.57%,FTH1;SFRP1;GSTP1;B4GALT7
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.5835609092701699,1.431571202289566,0.02564102564102564,0.8853272399747549,1.0,14/33,25.50%,LRP4;CTNND2;CTNNA2;CELSR2;DCDC2;PTEN;MAP2;EPHB3;SHANK1;PAK3;BTBD3;PHACTR1;SDC2;WASL
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),-0.8234886335437407,-1.4307861579462438,0.05454545454545454,0.7660566780247904,1.0,2/6,10.62%,PLN;SRI
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.7246219158432007,1.4305420431732505,0.05555555555555555,0.8865205010346657,1.0,4/20,8.56%,SPIRE2;ELMO1;DOCK1;SPIRE1
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.8155083250959245,1.4305310873545285,0.058823529411764705,0.882382317007602,1.0,2/7,6.25%,LEPR;SIRT1
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.9241881606458864,-1.4300738995219364,0.02,0.7661645092745988,1.0,2/5,4.29%,SLC25A4;SLC25A5
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),0.8668780662608548,1.429852067925211,0.09090909090909091,0.8814980179125559,1.0,4/5,6.76%,GRHL2;ERRFI1;ASCL1;PKD1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.5884548688848076,-1.4293821438908292,0.028985507246376812,0.7660933704290679,1.0,26/74,21.75%,PSMB8;DDIT3;RPS27A;PSME1;PSMB6;PSMD8;PSMC5;ELOB;PSMD7;UBA52;RBX1;PSMD3;PSMC3;ATF3;UBB;PSMA4;MAPK7;PSMD2;PSMA7;PSMD6;PSMB2;PSMB3;PSMB4;IMPACT;PSMA3;PSMC1
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.5545629154863624,1.4290399164043257,0.0,0.8818768269145704,1.0,14/53,14.68%,ZAP70;LEPR;IFNA2;HDAC4;PBX1;CHD7;CD4;NHEJ1;GPR89B;PTPN22;HDAC9;LFNG;NFAM1;RELB
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.582361394716379,1.4290321010516094,0.1111111111111111,0.877755907162633,1.0,9/42,10.79%,DACT2;CERS3;TP63;COL5A3;ERRFI1;PKD1;DLL1;COL5A1;ACER1
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.9053869303015312,1.4288854730095348,0.02702702702702703,0.8747299839316962,1.0,4/5,5.76%,SPRY2;SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.6788128281499674,1.428176344656212,0.07692307692307693,0.8746399143984389,1.0,6/19,16.70%,IGF1;CLEC7A;AKAP6;CAMTA1;SPPL3;GSK3B
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.8426606604319081,-1.428043569143678,0.06153846153846154,0.7711316352943647,1.0,2/8,10.16%,DDIT3;HSPA5
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),0.8159038244100986,1.4277957962911083,0.09523809523809523,0.8730726652674211,1.0,2/6,9.08%,CDK6;DLL1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.6658620712521082,1.4277081394844955,0.1,0.8693129497629684,1.0,3/15,4.67%,LIFR;RUNX1;IRAK2
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.8200101919383376,-1.427199841762494,0.031746031746031744,0.7737081081973739,1.0,2/8,10.96%,TGFBR2;TGFB1
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),0.8556646337109813,1.427046889832642,0.02631578947368421,0.8691878280445254,1.0,1/10,0.05%,MFNG
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),0.8020891497737994,1.425776761563439,0.1111111111111111,0.8734374089568937,1.0,2/8,1.79%,GPR35;CBARP
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.5169336154132717,1.4245323814691273,0.09090909090909091,0.8760158663960591,1.0,23/86,12.63%,VDR;TRHDE;ZBTB7C;GRHL2;COBLL1;MYO5B;STON2;PLD1;PPARGC1A;MYH14;ALDH1L1;PDZD2;PROM2;FRK;LARP1B;COBL;TSC22D2;CLMN;SCIN;CPEB4;THRB;LPP;SLC22A2
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.9009557471405125,-1.4242081078670716,0.029411764705882353,0.7944257827879233,1.0,1/6,1.90%,NDUFA12
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.7826825006804966,1.4238770658420312,0.08333333333333333,0.8756816520404521,1.0,3/8,12.19%,EPB41L4B;MAPRE2;MAP4K4
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.679640533433971,1.4233552350887388,0.0625,0.8744515334644346,1.0,5/19,11.67%,VDR;EGFR;SNCA;GDNF;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.7517728040842838,1.4227853138355737,0.12903225806451613,0.8739483090537843,1.0,6/9,20.90%,SNCA;BMP6;FGF1;PTH1R;PTH;WNT4
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.5974116577252964,-1.4227407866150303,0.04054054054054054,0.8021494550617747,1.0,9/62,13.45%,GBP3;GBP2;SFRP1;RPS3;HYAL2;SELE;TNFRSF21;YBX3;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.8137207268507789,1.4227055379988907,0.1111111111111111,0.8703016707259753,1.0,3/8,7.12%,RAB27A;ADGRB1;CYBA
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.8374576600735828,-1.42260404476561,0.046875,0.7978919522657654,1.0,2/9,3.05%,SEMA3E;TGFBR2
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.6034937003316214,-1.422528010740262,0.09375,0.793012865211699,1.0,8/46,8.72%,PSMB8;GAPDH;SERPING1;PSME1;TIMP1;PRELID1;SERPINB8;APH1A
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.6942511670693216,1.4217308025867628,0.05263157894736842,0.8730734827506798,1.0,4/19,6.53%,IGF1;IRS1;AKT2;SORBS1
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.726629083382464,1.4215518105057987,0.0967741935483871,0.8704636308346326,1.0,2/14,3.64%,NUPR1;HDAC4
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.7936140244067652,1.4211671976797344,0.13157894736842105,0.8683455731046626,1.0,5/8,19.82%,RUNX1;PTPN22;CBFB;ELF1;ELF2
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.8032082110044105,-1.4209092643311445,0.047619047619047616,0.7966512040844776,1.0,2/11,5.68%,SYCE2;STAG3
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.8032082110044105,-1.4209092643311445,0.047619047619047616,0.7966512040844776,1.0,2/11,5.68%,SYCE2;STAG3
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.7821289564791907,-1.420745916446232,0.05172413793103448,0.7927125488757247,1.0,4/11,7.24%,TGFBR2;HLA-A;HLA-E;CD81
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.6268901773426138,-1.4206632960240315,0.05333333333333334,0.7882198868279875,1.0,16/48,19.08%,RPS27A;CENPX;USP1;EME1;UBA52;RNF8;RPA3;FANCM;RAD51AP1;UBB;MUS81;FANCD2;XRCC3;XPA;FANCF;FANCI
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.795325944485929,1.4202530869384702,0.05263157894736842,0.8697474122957028,1.0,3/11,7.56%,IGF1;IRS1;IGF1R
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.7397655415524008,1.4187911106892164,0.08571428571428572,0.8752623688155922,1.0,3/12,12.12%,JCAD;RHOJ;HDAC9
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.8893392581751922,-1.4184813452823855,0.034482758620689655,0.7953639090401629,1.0,3/6,8.05%,MCM2;MCM4;MCM3
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.8893392581751922,-1.4184813452823855,0.034482758620689655,0.7953639090401629,1.0,3/6,8.05%,MCM2;MCM4;MCM3
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.6562523021144984,-1.4175293250200736,0.015873015873015872,0.7973240961300152,1.0,18/42,23.07%,TOMM7;SLC25A6;DNAJC19;ROMO1;TIMM8B;TSPO;TIMM10;TOMM20;PINK1;TIMM50;TIMM44;GRPEL1;TIMM13;FIS1;TOMM22;TIMM21;TOMM70;BCAP31
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.7620878201385163,1.4174879586955424,0.07317073170731707,0.8782419669805903,1.0,3/12,6.35%,PLIN5;IRS1;AKT2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.5937106931556912,-1.4172925620994612,0.01282051282051282,0.7938321255323955,1.0,27/123,16.06%,RPS27;RPL38;RPS14;EIF2S3B;RPL5;RPL23A;RPL10;RPSA;RPS15;RPS5;RPL11;RPL24;RPL3;EIF2S2;RPF2;RPS28;RPS19;NOP53;RPL6;MRPL20;SNRPD1;SNRNP200;RPLP0;PRPF6;RPS27L;SNRPD2;PRPF18
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.7669047702781532,-1.4172282033663408,0.06557377049180328,0.7889442673660874,1.0,4/16,10.91%,HLA-F;HLA-A;HLA-E;FADD
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.749013138204267,1.4170344042565446,0.058823529411764705,0.8770485326814864,1.0,4/10,15.68%,ADAMTS9;ROBO1;ROBO2;PKD2
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.8133105905167642,1.4166429850254965,0.07894736842105263,0.8755785683908688,1.0,3/7,16.42%,MLLT3;ESRRB;PRDM15
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.7746859676987783,1.4165175091701436,0.07142857142857142,0.8722936572891707,1.0,2/11,2.05%,SLC38A1;SLC29A2
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.8113578376608592,1.4158052172329392,0.0625,0.8722212373209108,1.0,1/8,0.15%,ZAP70
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),0.8956746596719432,1.4157631924919143,0.06818181818181818,0.869148267605848,1.0,2/5,7.58%,SRC;NPY
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.6150709334900238,1.4157519237978484,0.08571428571428572,0.8655373621363052,1.0,4/19,13.09%,PRKRA;XPO5;DICER1;TENT4B
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.7998787336370261,1.4150024745071184,0.1,0.8665049406507892,1.0,2/8,2.85%,PLIN5;ALK
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.7942271916834208,1.4143616440245368,0.046511627906976744,0.8657310590477888,1.0,8/10,17.16%,IRS1;SNCA;AKT2;PTH1R;PRKCE;GPLD1;SLC45A3;PTH
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.7716058596770865,-1.4140177378695387,0.05714285714285714,0.8121748861183014,1.0,4/13,11.27%,COX7A1;NOP53;COX7A2;PINK1
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.7014662337466188,-1.4134240650559644,0.02857142857142857,0.8119219509310954,1.0,9/24,18.51%,RPS27A;UBA52;CETN2;RBX1;PARP1;UBB;XPA;RNF111;GTF2H2
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),0.8419453063358558,1.413230588055846,0.17777777777777778,0.8686943180361492,1.0,4/5,14.99%,CD59;TGFB2;CD55;CFH
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.7486722585859539,-1.4122656502754698,0.031746031746031744,0.8166987205493479,1.0,3/20,7.78%,CD44;HLA-DPA1;LCK
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.7480482878175609,-1.4120822590278554,0.08196721311475409,0.8132466589526962,1.0,5/14,15.93%,CD44;LCK;FLOT1;MYADM;MAPK7
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.5786265886645942,1.4111181326131599,0.13333333333333333,0.8778989394380229,1.0,10/47,11.69%,KCNN4;KCNJ2;KCNIP2;KCNMB4;KCNN2;KCNMA1;AKAP6;DLG1;NOS1AP;KCNN1
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.4978866128612723,1.4110743581845628,0.0,0.8744369232170912,1.0,47/155,17.84%,RELN;DACH1;KCNQ2;EFNB3;CELF3;CNTNAP2;GNL3L;NLGN1;SCRT1;OLFM3;ADGRB3;ZDBF2;PCDH8;CNR1;FSD1;SNAP91;KCNH7;ADGRL3;CDH4;TCEAL1;MEGF10;NBEA;ZNF536;CAMKV;NCAN;PNOC;GPM6B;RGMB;TRIM44;CLSTN2;ATP13A2;LINGO2;KIF5C;ABI2;GDF5;PCDH19;CADM2;KIF1B;ADAM12;SLC25A46;RAB11FIP2;GRIA2;NRG1;NOL4;MAPK8;MAP2;EDIL3
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.8293400792148783,-1.4101775162330938,0.03333333333333333,0.8250379925569636,1.0,3/8,11.72%,B2M;ADAM15;BDNF
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.8425440685597643,1.410173538837865,0.17142857142857143,0.8752929744682938,1.0,2/5,10.11%,COLGALT1;AEBP1
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.6437451332631975,1.4097762368554059,0.08571428571428572,0.8737321665360263,1.0,3/21,12.34%,CGNL1;NLGN1;TJP2
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.5971969831110048,1.4094131022713985,0.07142857142857142,0.871747735115069,1.0,18/46,18.44%,RELN;FGFR1;SPOCK1;NTRK2;SH3RF1;ADGRL3;CELSR1;AUTS2;FGF13;NAV1;DCX;DCDC2;MARK1;NR4A2;ASTN2;ELP3;GPM6A;NRCAM
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),-0.8559731182357809,-1.408680053640073,0.015625,0.8337020418169077,1.0,3/5,14.06%,CYP1A2;CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.8790261389610767,1.4086745566264205,0.041666666666666664,0.8728215738445039,1.0,1/7,2.83%,SRC
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),0.9290050685840657,1.4086416367162946,0.044444444444444446,0.8658365759559362,1.0,1/5,0.34%,PDGFB
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),0.9290050685840657,1.4086416367162946,0.044444444444444446,0.8658365759559362,1.0,1/5,0.34%,PDGFB
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.6459456537179654,-1.4084592296135752,0.02857142857142857,0.8310766855274216,1.0,9/45,20.18%,LIX1;RPL23;VAMP8;PPP1CA;GABARAPL2;PYM1;HSPA8;CHMP3;MAP1LC3B
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),0.8402231160123408,1.4084375298563772,0.07894736842105263,0.8632716997975235,1.0,1/8,0.51%,NUPR1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),0.885713597078215,1.4073780977959889,0.058823529411764705,0.8660193564927573,1.0,1/6,0.51%,NUPR1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.6668796570399951,1.4067068294693776,0.10714285714285714,0.8662960004616835,1.0,5/24,10.80%,KCNJ14;KCNJ2;P2RX7;AKAP6;CHRM3
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.6099724352456279,-1.4061952595033287,0.05128205128205128,0.8451275008934566,1.0,4/68,0.55%,CD44;VAMP5;DPEP2;GATA1
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.7992304817151965,-1.4059251834581514,0.056338028169014086,0.8424642627236174,1.0,7/11,17.51%,MCM2;MCM4;MCM3;GINS2;GINS4;MUS81;MCM5
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.8364145065559229,-1.4057762771586502,0.01818181818181818,0.83848014558772,1.0,4/12,11.50%,GATA1;DDIT3;TMSB4X;ZNF593
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.761228187174868,-1.4056839999669921,0.0,0.8346937824822734,1.0,5/15,3.86%,RPL23;DTX3L;RPL5;RPS7;RPL11
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.8363597476010085,-1.4054257714937375,0.045454545454545456,0.822479736647058,1.0,2/8,1.77%,H1-4;H1-2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.8363597476010085,-1.4054257714937375,0.045454545454545456,0.822479736647058,1.0,2/8,1.77%,H1-4;H1-2
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.8363597476010085,-1.4054257714937375,0.045454545454545456,0.822479736647058,1.0,2/8,1.77%,H1-4;H1-2
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.7813971546342989,1.4049563395913576,0.07692307692307693,0.8718204625780577,1.0,3/7,15.68%,ABCC8;PKD2L1;PKD2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.9064908987110891,-1.4042119855851811,0.030303030303030304,0.828654586392412,1.0,4/7,9.09%,B2M;HLA-A;ERAP1;ERAP2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.8199170116133396,-1.403976130939907,0.09230769230769231,0.8256176473912764,1.0,1/8,0.39%,HLA-F
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.7518760701386636,1.4039013865467616,0.08695652173913043,0.8741320029407399,1.0,6/12,16.62%,IRS1;PPARGC1A;SIRT1;AKT2;GPLD1;SLC45A3
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.5593655704206253,1.403111709166441,0.03571428571428571,0.8754256974928513,1.0,17/80,9.77%,PDGFB;PTPN6;PDGFC;FGFR1;IGF1;FLT1;SRC;PIK3R5;EGFR;PDGFRA;SIRT1;IGF1R;HCLS1;PIP4K2A;NTRK2;TGFB2;GAB1
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.9395965120810204,1.4021260107968834,0.08888888888888889,0.8778621896136996,1.0,1/5,5.28%,HNRNPU
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.5686272352754589,1.4019461975045804,0.05263157894736842,0.8751638662110628,1.0,21/97,12.74%,KCNN4;KCNJ14;KCNH4;KCNJ2;KCNQ2;ABCC8;KCNH3;KCNIP2;ATP12A;SLC24A3;KCNN2;PKD2L1;SLC9C2;ATP1B3;KCNH7;KCND2;KCNC2;SLC9A2;KCNN1;LRRC38;SLC12A2
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.5678686048452285,-1.4013848312647954,0.012987012987012988,0.8414125666908534,1.0,31/144,12.74%,VAMP5;PSMB8;B2M;IRF4;IL7;APOL6;TNFAIP2;SERPING1;PSME1;IFIT2;MT2A;HLA-A;P2RY14;IRF9;IFITM3;IFIT3;PARP14;IRF1;DDX60;VAMP8;BTG1;TRIM25;IFI44;SP110;SRI;ST3GAL5;LAP3;PARP12;SELP;STAT1;HELZ2
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),0.7931686643917837,1.4011995146260645,0.05263157894736842,0.8750344787683111,1.0,3/6,16.03%,FBLN5;DHFR;SYK
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.6688743972773686,1.4002426551061404,0.06666666666666667,0.8778585333424755,1.0,3/21,5.94%,KCNJ14;KCNJ2;SNCA
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.7689467834440639,-1.400051551345636,0.05454545454545454,0.8481821217365063,1.0,7/14,15.04%,RPL35;DDX18;RPF2;FTSJ3;NIFK;WDR12;RPL7
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.6020535400206404,1.3997809608097893,0.05128205128205128,0.8769973802982391,1.0,4/26,6.26%,VDR;SRPRB;ABCC8;LMO2
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.7933682208472855,1.3992225215206002,0.11428571428571428,0.8760400540364647,1.0,3/6,10.96%,PDGFRA;SOX5;LTBP3
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.7256678096146159,-1.3990071798588144,0.07575757575757576,0.8519748957490547,1.0,2/16,5.86%,BMP5;CXCL17
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.7144017792909383,1.3988052707139376,0.15217391304347827,0.8753460726373129,1.0,4/12,6.53%,IGF1;IRS1;AKT2;SORBS1
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.7984000333335829,1.3974812288910512,0.16666666666666666,0.8794009820623897,1.0,4/7,18.49%,RELA;NFKB1;CA2;SLC30A10
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6174640618809385,1.3969685970569645,0.0625,0.8787503113328066,1.0,7/34,11.21%,PDGFB;NFATC4;ATOH8;RELA;NFIB;TGFB2;TEAD1
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.6101810741590041,1.3967386500964272,0.05128205128205128,0.877193410518465,1.0,8/31,11.69%,KCNN4;KCNJ2;KCNMB4;KCNN2;KCNMA1;AKAP6;NOS1AP;KCNN1
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.5462295222210889,-1.3965024697877877,0.05333333333333334,0.8676767159039929,1.0,26/105,21.00%,PSMB8;SLC8A3;RPS27A;SFRP1;PSME1;PSMB6;PSMD8;PSMC5;ELOB;PSMD7;UBA52;NOP53;RBX1;PINK1;PSMD3;PSMC3;UBB;PSMA4;HYOU1;PSMD2;PSMA7;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.7781609654960446,-1.3959618564518814,0.05172413793103448,0.8675098783593285,1.0,6/12,14.01%,CYP1A2;ADH4;RDH12;RETSAT;CYP3A4;LRAT
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.5528198770421375,1.3959079803705656,0.08823529411764706,0.8781697073186069,1.0,11/79,8.08%,F2;PDGFB;NFKBIZ;SNCA;FEM1A;BMP6;SERPINF2;SASH1;CYBA;ADAM8;OPTN
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.5316529952276363,1.3957241770604008,0.0,0.8763252590520013,1.0,25/146,11.20%,CREB3L1;VDR;PDGFB;IGF1;ABCC2;NOS2;RUNX1;ATOH8;IFNA2;CPNE1;MTMR2;SLC24A3;SIRT1;SLC7A5;SFMBT2;CCDC3;PICALM;OPTN;ROBO1;TGFB2;TCEAL1;NFKB1;DICER1;FBXW7;PTPN22
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.8593127914618025,1.3955051389482263,0.07692307692307693,0.8742443708599732,1.0,1/6,0.10%,F2
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.6415371348209267,-1.3953344447699074,0.1,0.8668778688785698,1.0,1/32,0.07%,CD44
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.7884596907653619,-1.3941527698006686,0.03571428571428571,0.8726621211694505,1.0,1/12,0.35%,BMP5
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.8582990166611721,1.3938840623219777,0.08,0.879209898463075,1.0,3/5,12.14%,TMEM108;LLPH;AUTS2
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.6546845723170991,-1.3938639582533072,0.046153846153846156,0.8701148062909358,1.0,7/33,11.65%,TOMM7;UBL5;ARIH2;HAX1;PINK1;ATP5IF1;ABLIM3
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.7904026246423488,1.3936581887700634,0.058823529411764705,0.8774318324454637,1.0,2/9,3.22%,ZSWIM6;ZSWIM4
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.8286200988408986,1.3935637995728278,0.10810810810810811,0.8746770357076729,1.0,3/5,16.10%,CHRM3;DOCK5;DOCK4
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.7547328929494053,-1.3930326566208329,0.09230769230769231,0.8720046557355475,1.0,1/15,0.07%,CD44
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),-0.8541705618293496,-1.392650848957454,0.0847457627118644,0.870631018272565,1.0,1/5,5.76%,HYAL2
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.7876525737365339,1.391879570451176,0.19047619047619047,0.8808681212693423,1.0,2/8,5.94%,IL1RAPL1;SNCA
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.7549752868398746,-1.3917572146491677,0.06451612903225806,0.8733146311074784,1.0,9/14,19.29%,ATP5F1E;ATP5MC3;ATP5PD;ATP5PB;ATP5F1B;ATP5PF;STOML2;ATP5ME;ATP5MC1
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.6360842913923991,1.391000248261719,0.10810810810810811,0.881658389384468,1.0,1/20,0.14%,B3GNT6
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.5415361787046102,1.3905617005468347,0.043478260869565216,0.881023283856254,1.0,12/65,14.13%,CDKL1;ODAD3;C10ORF90;TRAPPC12;TBC1D12;TBC1D5;IFT88;TBC1D22B;IFT140;HCK;DCDC2;TBC1D10A
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.7631120270945335,-1.3905373268283685,0.06060606060606061,0.8777302666023575,1.0,2/16,4.38%,CPS1;DDX11
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.7567198704776612,1.3904199264773163,0.13636363636363635,0.8784906857346569,1.0,5/9,19.64%,NFKBIZ;MALT1;CD80;PRKCZ;NFKBID
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.7163375222892492,1.3902858484300127,0.10810810810810811,0.8759765065084896,1.0,4/10,13.51%,VCAN;CSPG4;NCAN;HEXB
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.849089194324573,-1.3901222674297185,0.031746031746031744,0.8773810245161978,1.0,1/7,0.40%,CYP1A2
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.7096063814237349,1.3900163038085125,0.09375,0.8742068324573773,1.0,8/13,24.08%,NPY;NTRK2;ARHGAP35;PTEN;MAP2;MAPT;B4GALT6;B4GALT5
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.6540697188971422,1.389928244021534,0.125,0.8713403169176219,1.0,5/27,12.74%,KCNJ14;KCNJ2;ATP12A;ATP1B3;SLC12A2
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.6642699450824705,-1.3894935876769507,0.05970149253731343,0.8779290995814303,1.0,7/24,15.18%,PPIB;PPIE;NKTR;PPIF;PPWD1;PPIA;PPIL1
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.7801263727336653,1.3891341233469354,0.1282051282051282,0.8720997308037431,1.0,2/8,6.25%,LEPR;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.8190920110649144,1.3886416120704521,0.12195121951219512,0.8710335592486764,1.0,3/5,13.55%,PLIN5;HDAC9;SORT1
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.5226199771236077,1.388463351281693,0.06060606060606061,0.8684477264819529,1.0,22/97,16.58%,F2;GPR35;TBXA2R;CX3CR1;PDGFRA;LPAR2;CYSLTR1;TRPC5;ADRA1A;CXCL13;CD55;ADCY8;ACKR3;SPPL3;SLC8A2;HMGB1;P2RY1;GPER1;C5AR1;DRD2;TRPC7;ADCYAP1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.7943149242609453,-1.3881709707167296,0.05084745762711865,0.8852253026178357,1.0,6/14,14.07%,ENTPD2;NUDT1;ADPRM;NUDT18;ENTPD3;NUDT15
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.7613664717309203,-1.3881235426326926,0.10714285714285714,0.8808195921127587,1.0,2/10,14.71%,STAT1;CANX
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.7978423163288414,1.3880736987985525,0.15789473684210525,0.8672594671456026,1.0,3/7,18.82%,AGER;ADCY8;MAPT
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),0.8925704473187944,1.3879212793446336,0.05,0.865131857072334,1.0,1/5,4.47%,CX3CR1
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.7647007497502155,-1.3877834139655927,0.09523809523809523,0.8793183575648088,1.0,3/12,12.30%,SIGIRR;IL6R;CEBPB
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.750360074166583,1.387676348018046,0.15625,0.8633026118333113,1.0,1/8,6.03%,PBX1
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.5807896371644228,1.3875231127727057,0.1111111111111111,0.8607333657115105,1.0,8/26,12.03%,SLC26A7;CA12;SLC39A8;SLC26A6;CA2;AQP1;SLC4A4;SLC26A9
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.8541922405144395,-1.3875113570232007,0.015384615384615385,0.8770897601347557,1.0,1/8,0.35%,BMP5
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.7875031247700972,1.387448050647956,0.15789473684210525,0.8580414791625905,1.0,4/11,6.35%,PLIN5;IRS1;PPARGC1A;AKT2
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.6158748395716412,-1.3871670476899642,0.05970149253731343,0.8751457106219792,1.0,7/39,4.98%,RPL23;RPL5;CLU;MAGEF1;RPS7;RPL11;RAD23A
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.7541437871710955,-1.386908663400943,0.1,0.8723135549710841,1.0,3/12,14.58%,SLC25A4;PARP1;MGME1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 cell differentiation (GO:2000321),0.8670086958338469,1.3867456449647542,0.11538461538461539,0.8578916276647336,1.0,1/5,0.48%,NFKBIZ
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.8185182305144146,1.3856372270018076,0.06451612903225806,0.8607228725701654,1.0,4/8,16.31%,DIAPH1;DRD4;GABRB1;DRD2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.7135104970559849,-1.3853935555636174,0.04411764705882353,0.8800125006073354,1.0,8/20,18.51%,RPS27A;UBA52;CETN2;RBX1;PARP1;UBB;XPA;GTF2H2
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.8398587829731581,1.385323997033225,0.075,0.8595903169465453,1.0,1/6,0.48%,NFKBIZ
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.631835153029252,1.3851539111416182,0.125,0.857217089992455,1.0,1/23,0.31%,RELN
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.7663571321640383,1.3850569076354002,0.14583333333333334,0.8548141484955509,1.0,3/12,6.35%,PLIN5;IRS1;AKT2
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.7563911824661878,1.384989659929004,0.1702127659574468,0.8521981057147048,1.0,2/7,9.57%,AK3;AK4
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.600870913132365,1.3848500805383066,0.10714285714285714,0.8499203430188963,1.0,8/27,11.82%,CHRNA4;SCN9A;CACNA1I;CACNB4;P2RX7;CACNG4;SCN7A;CACNA1G
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.8142247936080156,1.3847877628319036,0.10416666666666667,0.8474300791926125,1.0,3/8,6.35%,PLIN5;IRS1;AKT2
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.8005320506797176,1.383944126158546,0.1794871794871795,0.8490476757296944,1.0,3/6,10.12%,OXTR;TBXA2R;ADRA1A
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.6739668846985852,-1.3838421868117168,0.07142857142857142,0.8896863472892577,1.0,4/29,12.07%,LIX1;ATG14;VAMP8;GABARAPL2
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.6535582249348072,1.3833581353745288,0.09090909090909091,0.8458842767905709,1.0,4/16,5.94%,IL1RAPL2;IL1RAPL1;PTPRD;SNCA
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.6535582249348072,1.3833581353745288,0.09090909090909091,0.8458842767905709,1.0,4/16,5.94%,IL1RAPL2;IL1RAPL1;PTPRD;SNCA
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.8498725914434607,1.3832854793778844,0.10869565217391304,0.8432611592142422,1.0,1/5,3.35%,AK3
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.8522148664589506,1.3832457653730443,0.0625,0.8405659573845721,1.0,2/7,4.45%,TICAM1;CLEC7A
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.8676329334991583,1.383147315717534,0.10526315789473684,0.8379781727666336,1.0,2/5,6.46%,CHD5;ASCL1
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),0.8788351649963625,1.3830311697341,0.029411764705882353,0.8358085501858735,1.0,2/5,7.25%,FBLN5;DHFR
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.8439198311918198,-1.3830286085139387,0.06451612903225806,0.8824065564324866,1.0,1/8,1.37%,DTX3L
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.8439198311918198,-1.3830286085139387,0.06451612903225806,0.8824065564324866,1.0,1/8,1.37%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.8439198311918198,-1.3830286085139387,0.06451612903225806,0.8824065564324866,1.0,1/8,1.37%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.8066083328452069,1.3824866937563245,0.16326530612244897,0.8353404517097007,1.0,3/7,8.81%,HSPA1A;CPNE1;HSPA1B
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),-0.8061100396903433,-1.3818946162743624,0.04477611940298507,0.8876766847421015,1.0,1/7,0.35%,BMP5
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.8755970789739846,1.3818256904101438,0.06060606060606061,0.8356719634348118,1.0,3/5,10.26%,NUPR1;PPP1R10;BAG3
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.8629515319012875,1.3813995392592462,0.07894736842105263,0.8349868828698023,1.0,1/5,3.13%,VEGFD
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.741324885598168,1.3813665328635314,0.08108108108108109,0.8322841749370864,1.0,2/7,21.79%,H6PD;EGR1
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.8396776364357154,-1.3812833503247495,0.05263157894736842,0.8881780580688076,1.0,3/7,10.96%,CENPF;SOX15;TGFB1
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.6558107131069811,1.378931208263874,0.08571428571428572,0.8414293249499329,1.0,4/22,8.40%,SLC26A7;ABCC2;SLC26A6;SLC25A18
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.656560884548268,-1.3784012630969074,0.057971014492753624,0.9084365253319916,1.0,13/33,23.01%,APEX1;PNKP;PCNA;MPG;RPA3;RFC2;PARP1;MBD4;RFC4;POLD2;POLD4;PARG;RFC1
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.7066270024009763,-1.3781928250125604,0.11475409836065574,0.9053173155335733,1.0,8/19,22.34%,XBP1;DDX60;RPS19;CD81;APPL2;HLA-DRB1;HLA-DRA;CD46
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),0.7905823719450054,1.3778433199625308,0.15384615384615385,0.8440512277209307,1.0,2/7,7.86%,BAG2;ADAM8
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.7320432366830313,1.377768581560084,0.10526315789473684,0.8413889349356781,1.0,7/12,22.43%,IRS1;AKT2;PRKCE;GPLD1;SLC45A3;IRS2;PPM1K
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.7835108975084306,1.377600784795349,0.11428571428571428,0.8396117006311212,1.0,3/7,14.96%,HS2ST1;CSGALNACT1;EXT2
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.6860628027691257,1.376721369890022,0.12903225806451613,0.8390230160732081,1.0,7/11,29.12%,TNIK;MAP4K4;RAP1A;RAP2C;RAP2A;RAPGEF2;MINK1
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.6860628027691257,1.376721369890022,0.12903225806451613,0.8390230160732081,1.0,7/11,29.12%,TNIK;MAP4K4;RAP1A;RAP2C;RAP2A;RAPGEF2;MINK1
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.8448138656101458,-1.376716958468285,0.05,0.9132857272038792,1.0,1/9,0.35%,BMP5
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.6585884617304713,1.3761188854324782,0.08823529411764706,0.838903393125871,1.0,2/14,2.14%,RUNX1;SNAI1
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.8581198477002338,-1.3760647100719328,0.08620689655172414,0.9142631769882684,1.0,2/6,9.13%,B2M;ADAM15
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.8393230971277211,-1.375986390705215,0.0625,0.910469631976027,1.0,1/6,7.66%,METAP2
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.8457712998426355,1.3758139145914765,0.05555555555555555,0.8383133819135614,1.0,1/7,2.83%,SRC
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.6860521880568282,-1.3756812662982119,0.07575757575757576,0.9081307710301463,1.0,2/24,1.38%,DDIT3;SELENOK
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.718070106213576,-1.3755339930168746,0.14516129032258066,0.9048074389190053,1.0,2/16,4.29%,SLC25A4;SLC25A5
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.656175420622304,1.3755139228660587,0.07407407407407407,0.8369159274656767,1.0,9/20,15.68%,GNLY;RELA;ADORA2B;CX3CR1;RAB23;CLEC5A;VEZF1;DCDC2;C5AR1
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.6759350991885141,1.3753265569580997,0.11627906976744186,0.8355273740015368,1.0,8/13,20.62%,FGFR1;CAMSAP3;TGFB2;RICTOR;UBR3;CELF1;SCEL;RAI2
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.8506528278434569,1.3741355069661592,0.06818181818181818,0.8397476514000037,1.0,1/5,2.69%,SLC39A8
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.6923340216636987,-1.3730644123517168,0.14285714285714285,0.9207642803914504,1.0,8/18,21.00%,PSMB8;PSMB6;PSMA4;PSMA7;PSMB2;PSMB3;PSMB4;PSMA3
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),0.9133419903302675,1.3728480125891636,0.07142857142857142,0.8430108360012267,1.0,1/5,4.47%,CX3CR1
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.8416182298858891,-1.372721361489981,0.08333333333333333,0.9189681740310109,1.0,4/9,10.16%,DDIT3;XBP1;CALR;HSPA5
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.616790491054133,1.372322444826962,0.08333333333333333,0.8430495241045292,1.0,12/30,17.51%,GLRB;CYSLTR1;NPY;GPR149;PNOC;SORT1;NXPH2;SORCS3;NMU;SORCS2;ADCYAP1;GLRA3
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.8056888805372524,-1.3719144041467761,0.05,0.9207635055222543,1.0,4/9,3.86%,RPL23;RPL5;RPS7;RPL11
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.5543046060202163,-1.3715845018041637,0.05263157894736842,0.9194194054936237,1.0,12/107,6.21%,PSMB8;GBP3;RPS27A;GBP2;SFRP1;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;HYAL2;UBA52
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.6941905823404066,-1.371252449751734,0.07575757575757576,0.9174195232120071,1.0,2/19,2.80%,TRPM1;JPH3
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.6972347520030122,1.3697434816133822,0.12195121951219512,0.8531317344413998,1.0,4/12,11.83%,AK3;RAB23;AK4;RHOQ
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.7650113900953542,1.3689594868238666,0.075,0.8538506236038383,1.0,3/8,14.33%,PIP4K2A;ATP13A2;RUBCNL
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.7825205519608924,1.3687967953463116,0.16666666666666666,0.8521846157543904,1.0,2/11,7.51%,PDGFB;DOCK7
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.7235309302246931,-1.3684255061856279,0.09375,0.9377120395683395,1.0,3/14,14.70%,DDX11;NOP53;NCL
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),-0.8616495817801981,-1.3679897745911893,0.06557377049180328,0.9370079909641416,1.0,1/5,1.64%,TMEM107
prerank,GO_Biological_Process_2021__CRD-mediated mRNA stabilization (GO:0070934),0.8250195015092722,1.3670901504765354,0.15384615384615385,0.8572316393656696,1.0,3/5,16.94%,HNRNPU;SYNCRIP;DHX9
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.5176543096363557,1.3664818004717603,0.15,0.857474575245569,1.0,22/96,11.58%,MFNG;EPB41L4B;ONECUT1;FGFR3;EFNB3;ABCC8;HNF4G;SLC7A2;LRP4;CXXC4;SOWAHA;MYH14;CAMSAP3;COBL;EPB41L1;CACNG4;TOX3;CD276;NPNT;TEAD1;CKMT1A;ARX
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.8634436348999759,-1.3664555823455768,0.06060606060606061,0.9464309745424099,1.0,3/6,11.33%,TOMM7;PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.8388557677343971,-1.3661146488859126,0.10606060606060606,0.9403131520909748,1.0,3/6,10.16%,GBA3;FUCA2;FUCA1
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.8388557677343971,-1.3661146488859126,0.10606060606060606,0.9403131520909748,1.0,3/6,10.16%,GBA3;FUCA2;FUCA1
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.8203403808320887,-1.3659271564687732,0.05084745762711865,0.9376601500407317,1.0,2/10,1.77%,H1-4;H1-2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.6622874468532504,-1.3658947547235165,0.07042253521126761,0.9337758193600353,1.0,15/34,24.42%,RPS27A;PCNA;UBA52;RPA3;RBX1;RFC2;PARP1;UBB;RFC4;XPA;GTF2H2;POLD2;POLD4;RFC1;UBC
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.6434874371123325,-1.3656648092824237,0.057971014492753624,0.9315562148797155,1.0,3/22,5.44%,IL7;SIGIRR;IL6R
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.5947147658638792,1.3654778481381278,0.14285714285714285,0.8600329282226657,1.0,8/37,6.59%,CREB3L1;BACE2;REP15;LGALS4;PDIA5;DMBT1;PLA2G10;FCGBP
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.709546831437391,-1.3654203712510353,0.05172413793103448,0.9292061408334502,1.0,4/17,4.50%,DDIT3;IRF4;ZFPM1;HLA-E
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.6242410274020931,-1.3648159274892988,0.05714285714285714,0.929880412151696,1.0,7/41,11.19%,GPX4;FTL;SELENOS;PRDX1;NDUFB4;LAMTOR5;TXNRD2
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.7721604655788046,1.3645931254818715,0.14634146341463414,0.8620392922085013,1.0,4/8,15.09%,NFIB;NCAM1;GDNF;RYK
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.7028979586312417,1.3644497501380803,0.1388888888888889,0.8601270054135071,1.0,4/19,9.67%,F2;SNCA;P2RX7;AKAP6
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),-0.7403418681316531,-1.3640240116440687,0.1095890410958904,0.9321926324475239,1.0,1/15,0.17%,GPAT3
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),-0.704307188069563,-1.3640234965175981,0.07936507936507936,0.928011762588414,1.0,6/19,15.13%,SLC8A3;EIF2B1;CDK5;MYRF;EIF2B2;EIF2B4
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),0.8758335427249407,1.3639260402437785,0.07317073170731707,0.8598251718554251,1.0,2/6,11.58%,GDNF;ARX
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.6587025186974269,-1.3636571724103776,0.11267605633802817,0.9263124590188306,1.0,11/24,24.42%,RPS27A;PCNA;UBA52;RPA3;RFC2;UBB;RFC4;POLD2;POLD4;RFC1;UBC
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.8306621030148421,1.3633101613895127,0.13157894736842105,0.859852124345385,1.0,2/6,10.41%,UBA7;UBE2E2
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.8230852915266333,1.3633079240924961,0.07692307692307693,0.8546250597596987,1.0,1/9,0.59%,CA12
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.8230852915266333,1.3633079240924961,0.07692307692307693,0.8546250597596987,1.0,1/9,0.59%,CA12
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.5662410322249214,1.3631586354218324,0.13953488372093023,0.8528452063255293,1.0,12/33,17.72%,STON2;NLGN4X;STX1A;SNCA;NLGN1;PICALM;SNAP91;DNAJC6;NLGN3;SYNJ2;CEL;SYT5
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.6936545733463729,1.362895313269543,0.18604651162790697,0.851479843586557,1.0,4/13,6.53%,IGF1;IRS1;AKT2;SORBS1
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.8288281265428037,1.362208072031243,0.14285714285714285,0.8527793393803389,1.0,2/6,10.26%,IGF1;BAG3
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.8292043959678967,-1.362062346945443,0.07246376811594203,0.93417584847815,1.0,1/6,9.65%,EIF2AK1
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.6119704136543921,1.362013593920069,0.06666666666666667,0.8509809322205169,1.0,17/35,18.77%,KCNJ2;CHRNA4;SCN9A;KCNMB4;MYH14;CACNA1I;AKAP6;KCND2;SCN7A;CACNA1G;DMD;GPER1;GNAQ;KCNMB2;KCNE4;SCN3B;GNA14
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),0.8251029447212631,1.3618907389154262,0.15789473684210525,0.8486331400780032,1.0,1/5,3.17%,COL22A1
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.7099406798600529,1.3617120154540838,0.14285714285714285,0.8468578463916797,1.0,2/13,6.07%,RAB27A;NLGN1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.8709722846196954,-1.3614424001122007,0.06779661016949153,0.9354000538727852,1.0,4/8,11.50%,DDIT3;LAMTOR5;TMSB4X;ZNF593
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.6411354794699977,-1.3609032781482657,0.028169014084507043,0.9357730705419726,1.0,6/34,11.35%,H1-4;TTN;H1-2;NCAPH;NCAPD3;SMC4
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.5821790290770774,-1.3601795149544662,0.07042253521126761,0.9379614573256349,1.0,12/62,10.60%,TAGLN2;ACTL8;EDF1;TST;DNPH1;MESP1;PCNA;OVOL2;CBR1;VIL1;TPP1;GSTK1
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),0.8061190710202709,1.3597469482209312,0.11538461538461539,0.8537635971578735,1.0,5/6,16.31%,SNCA;GDNF;DRD4;RAB3B;DRD2
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.7217174428447611,1.3593405602715796,0.08571428571428572,0.853688772306069,1.0,8/14,21.67%,HDAC4;SIRT1;HDAC9;SMARCAD1;SFPQ;HDAC1;HDAC3;PER1
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.6627926686418976,1.3591146208362364,0.18421052631578946,0.8523491905528724,1.0,3/24,3.97%,PDGFB;IGF1;PRR5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.7700529690277048,1.3584086999458864,0.12121212121212122,0.8529491340456693,1.0,2/8,9.12%,NUPR1;PPP1R10
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.802229850092675,1.358167827001767,0.16666666666666666,0.8514623879291494,1.0,1/7,1.36%,ABCC2
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.5045354164930694,1.357866373870439,0.03225806451612903,0.8507681547707434,1.0,14/66,12.30%,ZNF423;KCNQ2;EFNB3;LEF1;CNTNAP2;NLGN4X;IGLON5;SEMA5B;MEX3A;MYO3A;TOX3;CAMKV;VASH2;IGDCC3
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.7188995775068221,-1.357246740097701,0.09090909090909091,0.9587079284049969,1.0,9/15,22.99%,EMC6;EMC3;GET3;EMC7;CAMLG;MMGT1;EMC10;EMC4;UBL4A
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.8341653781356242,1.3569646245936027,0.15,0.8526178605082119,1.0,2/7,8.16%,ARNT;SESN2
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.6531259420521811,1.3566439602912583,0.08108108108108109,0.8516126175047455,1.0,8/19,18.95%,ZNF423;SMAD4;BMPR2;GDF5;ACVR2B;ACVR2A;SMAD2;BMPR1B
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.6023433319221426,1.3565646015407744,0.16216216216216217,0.8491758473123601,1.0,9/44,11.83%,EPB41L4B;IGF1;PDGFRA;DYSF;SYTL4;MYOF;AHNAK2;TGFB2;FGF1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.7584054929694687,-1.3560268119009748,0.1044776119402985,0.9643819631140496,1.0,6/14,14.74%,MIS12;IK;CHAMP1;MTBP;SPDL1;ZWILCH
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.6483714079657434,-1.355534274307823,0.07042253521126761,0.9646578025678054,1.0,15/36,24.42%,RPS27A;PCNA;UBA52;RPA3;RBX1;RFC2;PARP1;UBB;RFC4;XPA;GTF2H2;POLD2;POLD4;RFC1;UBC
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.6390456735305775,1.3543930053716544,0.09090909090909091,0.8576765520585432,1.0,8/24,17.16%,IGF1;IRS1;AKT2;SORBS1;RHOQ;C3;C2CD5;PTH
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.720902746618672,1.3543178991248204,0.09090909090909091,0.8558543146610075,1.0,7/10,23.76%,XPO5;FXR1;DHX9;PUM2;PUM1;ZFP36;WTIP
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),0.782078614362209,1.3539055154823036,0.0851063829787234,0.855429012832538,1.0,1/7,1.33%,IGF1
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.8255418833153205,1.3538513749863526,0.08108108108108109,0.8532396929659769,1.0,3/8,5.76%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.5985867560657074,-1.353325065350251,0.05714285714285714,0.979227580085778,1.0,12/44,12.71%,MICOS13;ATP5F1E;UQCC3;ROMO1;ATP5MC3;TIMM8B;TIMM10;ATP5PD;ATP5PB;ATP5F1B;AFG3L2;ATP5PF
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.7631558824813434,-1.3527547801944346,0.07575757575757576,0.9797214535343146,1.0,6/13,15.13%,COL9A3;ZNF830;FSHR;CEBPB;EIF2B2;EIF2B4
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.7191824125379711,1.352750459352673,0.17142857142857143,0.8563088304379463,1.0,5/14,12.99%,PLIN5;PLA2G10;NFKB1;C3;LPL
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.5558504599356822,-1.3524825002280185,0.037037037037037035,0.9776953455545113,1.0,32/134,16.80%,GPX4;POLR2G;TYMS;EDF1;EIF1B;NPR2;GTF2F1;POLR2J;PCNA;POLR2I;ADRM1;MRPL40;MPG;COX17;SURF1;CETN2;DAD1;RPA3;VPS28;RBX1;BRF2;POLR3GL;GMPR2;RFC2;NT5C;IMPDH2;APRT;TK2;GTF2A2;RFC4;SUPT5H;POLR2A
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.6318380903935095,1.352086219696327,0.13513513513513514,0.8568022414708737,1.0,7/21,21.44%,LIMK1;L1CAM;MEGF8;RUFY3;MAPT;ZFYVE27;MACF1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.5329350605117816,1.352082313508055,0.09090909090909091,0.8544373557192427,1.0,8/30,12.69%,NRP2;TMEM108;CPNE1;SEMA5B;ALCAM;LLPH;AUTS2;NLGN3
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.7722007166157089,-1.3520415114326656,0.14035087719298245,0.97695673278926,1.0,2/9,1.77%,H1-4;H1-2
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.8259074336888467,-1.3517757657216227,0.06779661016949153,0.9743625489366937,1.0,3/9,8.05%,MCM2;MCM4;MCM3
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.7552479048455902,-1.3517466317393614,0.06779661016949153,0.9665928896668009,1.0,3/9,15.26%,RACK1;SMPD2;TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.7552479048455902,-1.3517466317393614,0.06779661016949153,0.9665928896668009,1.0,3/9,15.26%,RACK1;SMPD2;TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.6348519005704437,-1.3512279691291977,0.08333333333333333,0.9669541448951129,1.0,10/38,16.80%,POLR2G;GTF2F1;POLR2J;POLR2L;POLR2I;IFITM3;TRIM13;HEXIM1;SUPT5H;POLR2A
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.606368315200108,1.3510010681812221,0.12121212121212122,0.857325073417161,1.0,7/20,18.36%,RUNX1;SNAI1;PDLIM5;RAPGEF1;CBFB;RAP1A;TJP1
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),0.8119670373749343,1.3507579171805493,0.1875,0.8536516939375438,1.0,1/6,4.14%,RELA
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),0.8119670373749343,1.3507579171805493,0.1875,0.8536516939375438,1.0,1/6,4.14%,RELA
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.616160770336428,-1.3504159932171347,0.05263157894736842,0.9689357194007376,1.0,18/59,14.81%,CYP1A2;GPX4;XBP1;ASAH2B;GSTM4;DEGS1;ELOVL2;DECR2;ABHD1;OXSM;SCD;ACSM6;CYP3A4;ACSM3;NDUFAB1;ACSBG2;ASAH2;CYP2E1
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.8097426263053132,1.3495606898240828,0.09523809523809523,0.8567054422419662,1.0,1/6,1.59%,ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.7087178578749544,-1.3492498762428173,0.11475409836065574,0.9744433917731435,1.0,5/25,5.67%,POLR2G;GTF2F1;POLR2J;POLR2L;POLR2I
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.7174175054798398,-1.349052628822009,0.045454545454545456,0.9722327995305323,1.0,3/15,14.64%,TINF2;MPG;MBD4
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.5266706051090788,-1.3490040854161454,0.04819277108433735,0.9687785003247263,1.0,59/233,19.80%,POLR2G;CSTF2T;SNRNP27;UBL5;FRG1;GTF2F1;POLR2J;POLR2L;SNRNP25;PPIE;POLR2I;LSM7;SF3B5;LSM2;IK;PHF5A;ZMAT2;RNPC3;SF3B6;FIP1L1;DHX16;PRPF3;SF3A1;RBM22;SNRPB2;DHX38;SNRPD1;SNRPN;PNN;SNRNP200;TFIP11;SRSF7;PPWD1;PRPF6;ESS2;PRPF4;DDX41;PPIL1;BUD13;SNRPD2;CPSF3;RBM4B;EIF4A3;DNAJC8;SNU13;POLR2A;HSPA8;METTL3;PQBP1;DDX5;CRNKL1;SRSF3;ZCRB1;MAGOHB;HNRNPH2;SYF2;SNW1;CLP1;PRPF8
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.5955822135185985,1.3489980008441103,0.14285714285714285,0.8566263472415666,1.0,6/29,12.44%,IGF1;ICAM1;AGER;IGF1R;CACNA2D1;GRIN1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.7803322436918032,-1.3488285621435825,0.1111111111111111,0.9661679946909545,1.0,6/9,19.91%,XBP1;COPS5;RACK1;HSPA5;FICD;BAX
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.7267059488896087,1.3480615083255019,0.1111111111111111,0.8584193580008597,1.0,4/9,13.55%,GALNT3;POGLUT2;GALNT2;GALNT16
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.7293977815635684,-1.3478430477032302,0.1,0.9693636961113579,1.0,2/13,10.96%,DDIT3;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),-0.896836041448647,-1.347493468001736,0.061224489795918366,0.9687262177044881,1.0,2/5,9.01%,HLA-F;CEACAM1
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.7646139838721799,1.3473309886550129,0.15384615384615385,0.8595304355049739,1.0,3/8,17.10%,DOCK7;PCM1;KIF14
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.763635206694582,-1.346855905365169,0.1076923076923077,0.9698722324273162,1.0,1/11,0.07%,CD44
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.6742618465318052,-1.3464513405550795,0.014705882352941176,0.9692378695509254,1.0,6/29,8.13%,RPS21;RPS16;RPS8;RPS14;RPS19;NOP9
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),0.869904313885662,1.3459562576895578,0.15384615384615385,0.8642461201495846,1.0,2/5,10.53%,HSD3B7;CXCL13
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.6876921835558056,-1.345877326745616,0.10606060606060606,0.9694073859124834,1.0,7/19,15.18%,PPIB;PPIE;NKTR;PPIF;PPWD1;PPIA;PPIL1
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.7002066976587519,-1.3455810786674656,0.14492753623188406,0.9680839315320585,1.0,5/18,13.73%,NFE2L1;TSPO;PGRMC1;ATP5IF1;UROD
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.5727078637907093,1.3453092084954854,0.09375,0.8649265051489126,1.0,4/22,11.82%,MAIP1;MCUB;CACNA1I;CACNA1G
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.5490879067519507,-1.345079257243973,0.07246376811594203,0.9687519250384303,1.0,24/94,21.35%,MCM2;RMI1;PNKP;POLE3;MCM4;ORC6;GRWD1;FAM111A;MCM3;WDHD1;RPA3;CLSPN;RFC2;BRCA1;KAT5;RFC4;RAD50;MCM5;KIN;ORC2;POLD2;POLD4;MCMBP;DBF4
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.5998883803273667,-1.3447565445151388,0.1232876712328767,0.963194323948709,1.0,4/51,5.67%,POLR2G;POLR2J;POLR2L;POLR2I
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.5998883803273667,-1.3447565445151388,0.1232876712328767,0.963194323948709,1.0,4/51,5.67%,POLR2G;POLR2J;POLR2L;POLR2I
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.7962708711597992,1.3445452665014102,0.1282051282051282,0.8666766566258107,1.0,3/6,16.94%,HNRNPU;UHRF1;DHX9
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),0.7724150206235928,1.3441641638314419,0.14285714285714285,0.8659806682951117,1.0,2/8,9.08%,ASCL1;DLL1
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.6975999860608266,1.3441577703217327,0.15789473684210525,0.8635950466193677,1.0,7/14,18.95%,ZBTB16;SCX;SOX5;BMPR2;GDF5;LOXL2;BMPR1B
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.6631901418930793,1.343581707482712,0.10204081632653061,0.8639026096964183,1.0,2/15,1.93%,CREB3L1;SPRY2
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.7742303321709719,1.3431897650268085,0.18604651162790697,0.8632565547444743,1.0,1/7,0.10%,F2
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.7573716187981392,1.3428514213780205,0.04878048780487805,0.8624679790947356,1.0,4/8,16.23%,IRS1;PID1;LPL;PDK4
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.5267829092910555,1.3427696223341212,0.047619047619047616,0.8605913026590944,1.0,7/52,4.91%,VAPB;CERS3;ST8SIA6;ACER2;SPTSSB;PPM1L;SGMS1
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.7882736268625361,1.3427167981229577,0.045454545454545456,0.858434310957904,1.0,2/5,9.47%,TMEM108;DOK5
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.7773388824398376,1.3425626163179163,0.07317073170731707,0.8546248401972026,1.0,5/9,16.89%,IRS1;SIRT1;SORBS1;GKAP1;PRKCZ
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.7773388824398376,1.3425626163179163,0.07317073170731707,0.8546248401972026,1.0,5/9,16.89%,IRS1;SIRT1;SORBS1;GKAP1;PRKCZ
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.8194604410468775,-1.3424995364895635,0.09836065573770492,0.9778680098149347,1.0,4/6,16.75%,COX7A1;COX7A2;RAB5IF;HIGD1B
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.7195129296933145,1.341969962603946,0.125,0.8548427166190248,1.0,2/11,4.15%,APOLD1;PRKX
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.6907843887532501,-1.3410272377352004,0.14705882352941177,0.9854074965273335,1.0,7/21,15.88%,RPS27A;PCNA;UBA52;RPA3;RFC2;UBB;RFC4
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.5249273152550229,1.3409071547331386,0.058823529411764705,0.8571789286733298,1.0,26/97,15.23%,ZNF423;KCNQ2;EFNB3;CASKIN1;CELF3;LRP4;MMD2;SCRT1;CTNND2;CACNG5;SEMA5B;PCDH8;SNAP91;EFR3B;ADGRL3;MEGF10;UNC13A;SRRM3;ZNF536;CAMKV;NCAN;LRRC4C;SLC8A2;PCDH19;CADM2;LGR5
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.8867420887138193,-1.340840443580305,0.06451612903225806,0.9834374009562317,1.0,2/5,2.32%,SLC28A2;AQP9
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.7453658250267496,-1.3404173850610999,0.14285714285714285,0.9829656516440123,1.0,1/11,1.57%,XBP1
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.5902248299349688,1.3401603780640328,0.125,0.8581053401760206,1.0,4/18,6.47%,ABCC2;SLC15A2;SLC47A1;SLC7A5
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.6809932544296872,-1.3400645267787954,0.125,0.9817269259747764,1.0,4/19,9.52%,XBP1;HLA-E;LACC1;PHB2
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.792682254461119,1.3399193472775952,0.125,0.8565613074424162,1.0,3/7,12.50%,GLI2;CLEC5A;PTHLH
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.8217774632481095,1.339914336430593,0.09302325581395349,0.854277143955903,1.0,2/5,9.47%,P2RX7;KCNMA1
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),0.813679546013893,1.339307903961034,0.20454545454545456,0.8553460481062167,1.0,2/5,5.42%,ZNF516;PPARGC1A
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.7510966912993258,-1.3392990878068856,0.08620689655172414,0.984016296591921,1.0,2/14,7.56%,EHHADH;DECR2
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.7989465136155741,-1.3387927459658249,0.125,0.9838664088616509,1.0,2/8,7.18%,TINF2;MPG
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.6530081098820454,1.3386543626581282,0.125,0.8569409927381275,1.0,5/12,28.05%,GRAMD1B;GPLD1;OSBPL7;SMO;GRAMD1A
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.7245325551490335,-1.3384253274653863,0.11666666666666667,0.9826702925104625,1.0,9/15,19.29%,ATP5F1E;ATP5MC3;ATP5PD;ATP5PB;ATP5F1B;ATP5PF;STOML2;ATP5ME;ATP5MC1
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),0.7684707117941179,1.3371895000874763,0.13157894736842105,0.8619568004102037,1.0,1/7,1.55%,NOS2
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),0.7082712933495195,1.3371886624786455,0.08333333333333333,0.8596825080608363,1.0,5/10,13.88%,BCO1;RDH10;BCO2;ALDH1A3;ALDH8A1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.8580029601205753,1.3361990942426556,0.15,0.8623436435274829,1.0,3/7,10.22%,NFKBIZ;CLEC7A;MALT1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.8221349769089701,1.3361612050155127,0.16666666666666666,0.8580386559381903,1.0,3/5,16.94%,HNRNPU;UHRF1;DHX9
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.8221349769089701,1.3361612050155127,0.16666666666666666,0.8580386559381903,1.0,3/5,16.94%,HNRNPU;UHRF1;DHX9
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.7700562014015995,-1.3359450457903612,0.06060606060606061,0.9988410542762916,1.0,3/10,6.21%,B2M;RPS27A;UBA52
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.7081338926821037,1.335502284557887,0.1282051282051282,0.8591130948934376,1.0,3/6,14.63%,HPRT1;AMPD1;AMPD3
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),0.8422020834934258,1.3352290794107968,0.12195121951219512,0.8581982678502756,1.0,2/5,10.48%,HPRT1;DRD4
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.8121797791215862,1.3351032876155706,0.12121212121212122,0.856593976463224,1.0,1/6,2.60%,ZSWIM6
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.6950586384811235,-1.3350891128578966,0.07352941176470588,1.0,1.0,2/20,4.85%,GPAT3;DGAT2L6
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.5125599770096486,1.3349817790677942,0.02702702702702703,0.8550326183769451,1.0,7/58,6.25%,PDGFB;FGFR1;JCAD;NRP2;VEGFD;ARNT;SIRT1
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.5931252840987709,-1.3347777135961783,0.1038961038961039,1.0,1.0,2/64,0.77%,SLC28A2;RIMS1
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.7967511825172893,1.334767974102297,0.2,0.8539627696310053,1.0,2/6,7.03%,BMP6;SASH1
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.7332972882151713,-1.3345180655885938,0.14925373134328357,0.9986684236066965,1.0,1/11,0.48%,CACNA2D4
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.6957367656192545,-1.3341720872451088,0.14754098360655737,0.9905265231600178,1.0,3/16,6.53%,CENPF;BUB1;IK
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.6957367656192545,-1.3341720872451088,0.14754098360655737,0.9905265231600178,1.0,3/16,6.53%,CENPF;BUB1;IK
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.6957367656192545,-1.3341720872451088,0.14754098360655737,0.9905265231600178,1.0,3/16,6.53%,CENPF;BUB1;IK
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.5408571733098763,-1.333708157196164,0.10294117647058823,0.9908191248183891,1.0,21/78,21.75%,PSMB8;PSME1;AVEN;PSMB6;PSMD8;PSMC5;PSMD7;RBX1;CDK4;PSMD3;PSMC3;PSMA4;PSMD2;PSMA7;PSMD6;PSMB2;DACT1;PSMB3;PSMB4;PSMA3;PSMC1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.5182455883948329,-1.3336630955344992,0.03614457831325301,0.9875821351875849,1.0,61/256,19.87%,POLR2G;CSTF2T;SNRNP27;UBL5;FRG1;GTF2F1;POLR2J;POLR2L;SNRNP25;PPIE;SCNM1;POLR2I;LSM7;SF3B5;LSM2;IK;PHF5A;ZMAT2;RNPC3;SF3B6;FIP1L1;DHX16;PRPF3;SF3A1;RBM22;SNRPB2;DHX38;SNRPD1;SNRPN;PNN;SNRNP200;TFIP11;SRSF7;PPWD1;PRPF6;ESS2;PRPF4;DDX41;PPIL1;BUD13;SNRPD2;CPSF3;RBM4B;EIF4A3;DNAJC8;SNU13;POLR2A;HSPA8;METTL3;PQBP1;DDX5;CRNKL1;SRSF3;ZCRB1;MAGOHB;HNRNPH2;SYF2;SNW1;CLP1;PRPF8;DDX1
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.8038869728904864,-1.3336547721315588,0.08,0.983941385218799,1.0,1/9,0.40%,CYP1A2
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.781950377934767,-1.3334712813682204,0.11666666666666667,0.981697669365666,1.0,2/9,12.98%,SLC25A4;YBX3
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.7396061136964485,1.3329373516035876,0.2,0.8604413325280793,1.0,1/7,1.66%,KAT2A
prerank,GO_Biological_Process_2021__sensory perception of sour taste (GO:0050915),0.7879846557087656,1.332422019724708,0.18181818181818182,0.860428051376974,1.0,1/5,7.40%,PKD2L1
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.6080048657758735,-1.3317890497571259,0.08823529411764706,0.9905725936731273,1.0,8/44,12.00%,CD44;HYAL2;GPC3;CEMIP;SGSH;FUCA1;TGFB1;PRELP
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.6228565753300432,1.3316938415658308,0.08333333333333333,0.8613742814037648,1.0,5/20,14.23%,DAO;SULT2A1;SULT2B1;ENPP1;PPA2
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.5401408933305212,1.3313867791090757,0.09090909090909091,0.8603675146900637,1.0,14/34,25.50%,BICDL1;MYO5B;HAP1;MYO1D;MYO7A;MYO1B;TRAK1;NDE1;FBXW11;TANC2;PPFIA2;MYO5A;TRAK2;WASL
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.7618308023031553,-1.3313349932948793,0.1694915254237288,0.9906480930010045,1.0,3/10,6.76%,ROMO1;TIMM8B;TIMM10
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.6551471247125632,1.3312872103900393,0.13157894736842105,0.8584454275877766,1.0,4/15,5.76%,SPRY2;SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.792380130137831,-1.3312610930815258,0.07462686567164178,0.9875914607119889,1.0,2/9,10.96%,FADD;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.8079461147516225,1.3312567270004803,0.14634146341463414,0.8563971050883084,1.0,2/6,6.25%,PPARGC1A;SIRT1
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.5601300618854398,-1.3309205582100445,0.08571428571428572,0.9869272530862186,1.0,23/81,23.60%,PSMB8;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;RBX1;PSMD3;FBXO48;PSMC3;PSMA4;PSMD2;PSMA7;FBXL16;FBXL13;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;PSMC1;PSMD10;FBXO6
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.56985654567827,-1.33083600491543,0.09333333333333334,0.9838764888368704,1.0,5/62,5.67%,POLR2G;DND1;POLR2J;POLR2L;POLR2I
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.8184826212920532,1.3305213118813461,0.15555555555555556,0.8580223184974983,1.0,2/5,12.17%,SLC38A1;SLC38A2
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.6793045110925338,-1.3302792689777838,0.078125,0.984511267846053,1.0,7/25,7.78%,CENPF;P2RY10;STMN1;TYMS;H2AZ1;PCNA;LCK
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.7620236205092659,1.330045397058423,0.16279069767441862,0.8583198518852662,1.0,1/7,1.79%,CBARP
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),-0.7319613997334061,-1.32984649239145,0.058823529411764705,0.9844292273460695,1.0,6/14,15.33%,CENPX;RMI1;EME1;FANCM;MEIOB;MUS81
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.6968608354009986,-1.3297685886260382,0.09375,0.9812725219117113,1.0,8/20,19.10%,NOP10;BUD23;TRMT112;NHP2;FTSJ3;TSR3;DIMT1;GAR1
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.5467444940902696,1.3297067329836982,0.05555555555555555,0.8577047231706892,1.0,12/59,9.68%,FHDC1;EPB41L4B;TCAP;MYH3;SRC;MYH14;SORBS1;OBSCN;EPB41L1;ARRB1;FRMD5;FRMD3
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.7424171056477539,-1.3296349566195012,0.09722222222222222,0.9786687931633181,1.0,4/15,16.31%,DTX3L;PNKP;KDM4D;PARP9
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.5946323670397891,1.3294645585592932,0.15625,0.8566887536539429,1.0,10/26,13.33%,KCNN4;IL4R;LGALS4;TM4SF20;DMBT1;DLL1;WNT3;SLC26A3;KLF15;GPA33
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.8487251975824486,-1.3292781644722005,0.03571428571428571,0.9777277411942522,1.0,3/6,13.78%,FAM111A;TEX264;SPRTN
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.6910219568228686,1.3287418507375572,0.20454545454545456,0.8581961692837988,1.0,2/9,10.69%,RAB39A;RAB34
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.7188967563206409,-1.3283275939266102,0.12307692307692308,0.9813277679066382,1.0,9/21,14.81%,CYP1A2;GPX4;ASAH2B;GSTM4;GSTP1;CYP3A4;ACSBG2;ASAH2;CYP2E1
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.596139890621945,1.326961165329403,0.08333333333333333,0.8646194868018656,1.0,4/29,2.83%,RELN;PDGFB;CASS4;SRC
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7442637035552475,1.3266624070120228,0.17647058823529413,0.8638277143955904,1.0,2/7,7.12%,MFHAS1;CYBA
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.8861053604052761,-1.326305656951432,0.06451612903225806,0.9949591270059817,1.0,2/6,8.20%,NOP10;NHP2
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.7993104624724716,-1.326305045025796,0.06060606060606061,0.9914433703734519,1.0,4/10,8.11%,MCM2;MCM4;MCM3;ZNF830
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.8374973545039276,1.3255811594679503,0.175,0.8666724101168691,1.0,2/6,8.56%,SPIRE2;SPIRE1
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.6414579540205595,1.3252532677542177,0.10526315789473684,0.8658129841753927,1.0,6/21,14.20%,SLC38A1;SLC7A9;SLC7A5;LLGL2;SLC38A2;SLC43A1
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),-0.8021440680552068,-1.3245879665552318,0.05263157894736842,1.0,1.0,2/7,4.81%,EDF1;MESP1
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.8705572287402278,-1.3244263269378351,0.09722222222222222,1.0,1.0,1/5,2.64%,CLU
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.7333022061992889,1.3242675903122436,0.1875,0.8681743894258005,1.0,2/12,4.57%,F2;KLK14
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.711446908551947,-1.3239854341390727,0.12307692307692308,1.0,1.0,3/20,4.72%,CD44;CLU;DDIAS
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.8279178275184378,1.3235682871141021,0.15151515151515152,0.8688371064384991,1.0,2/6,14.14%,DIAPH1;GABRB1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.5324699194237914,-1.323539680209389,0.08571428571428572,1.0,1.0,22/74,23.24%,PSMB8;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;PSMD3;PSMC3;AP2S1;PSMA4;PSMD2;PSMA7;PSMD6;PSMB2;DACT1;PSMB3;PSMB4;PSMA3;PSMC1;AP2A2;RHOA;PSMD10
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.8097850210758232,-1.323270692507224,0.09523809523809523,0.9963458355263809,1.0,3/7,6.21%,B2M;RPS27A;UBA52
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.8097850210758232,-1.323270692507224,0.09523809523809523,0.9963458355263809,1.0,3/7,6.21%,B2M;RPS27A;UBA52
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.735999498278129,1.3228366725004348,0.21951219512195122,0.8702554753189289,1.0,1/6,2.66%,PIWIL4
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.8132387706872419,-1.3225879498015665,0.0967741935483871,0.998437666262213,1.0,1/6,0.32%,APIP
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.684662044228488,-1.3220197934993823,0.09836065573770492,0.9994699154719735,1.0,1/17,0.55%,GATA1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.7181264853885408,-1.3214208699908219,0.10606060606060606,1.0,1.0,2/15,3.74%,SELENOS;SEC61B
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.7296405205283856,1.3208851783991507,0.23076923076923078,0.8769991595115695,1.0,2/7,5.42%,ACSM1;PPARGC1A
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),-0.6751122661716138,-1.3206399771098545,0.13043478260869565,1.0,1.0,5/18,20.34%,DDIT3;C1QBP;HLA-DRB1;CR1;PDCD1LG2
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.8284092473128691,1.320337341053762,0.15,0.8773726325642746,1.0,2/5,13.82%,JAM2;GPLD1
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),0.7960357799938721,1.320251939254027,0.21951219512195122,0.875844537276518,1.0,1/6,0.15%,ZAP70
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),0.7649236155377154,1.3202074230962533,0.21052631578947367,0.8738664781551109,1.0,1/6,0.34%,PDGFB
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.7199889406950096,1.3200175830446577,0.1794871794871795,0.8725173601883437,1.0,5/11,22.98%,CX3CR1;SMARCD3;DRD2;KDM1A;FZD3
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.7887832970955038,-1.3199400239275083,0.1694915254237288,1.0,1.0,4/8,15.88%,PCNA;DSCC1;RFC2;RFC4
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.7887832970955038,-1.3199400239275083,0.1694915254237288,1.0,1.0,4/8,15.88%,PCNA;DSCC1;RFC2;RFC4
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.6893616400656821,-1.3193968859880572,0.11940298507462686,1.0,1.0,4/21,12.98%,SLC25A4;CDC37;FLOT1;YBX3
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.7474614529172887,-1.3192799418551164,0.140625,0.9998987832409709,1.0,3/8,15.08%,ACTA2;HTR2B;EDN1
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.8184797283911356,1.3191419319872486,0.175,0.8740036136112065,1.0,2/5,8.57%,TMEM108;NTRK2
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.7329528284508855,1.3189517724069242,0.12121212121212122,0.8728877645758635,1.0,6/13,15.28%,FHDC1;OPTN;VAMP4;VTI1A;TRIP11;GOLPH3
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.8111802331015625,-1.3188884921836255,0.11475409836065574,0.9994398656003646,1.0,2/6,3.96%,TIMP1;SVBP
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.5415644546942783,-1.318849684571337,0.041666666666666664,0.9963996798606514,1.0,37/135,22.25%,PSMB8;SFRP1;PSME1;RSPO4;JUP;TMEM198;PSMB6;PSMD8;PSMC5;ATP6AP2;PSMD7;SFRP4;RSPO2;BAMBI;GPC3;TGFB1;PSMD3;ILK;PSMC3;DEPDC1B;PSMA4;PLEKHA4;PSMD2;PSMA7;PSMD6;PSMB2;DACT1;PPM1N;PSMB3;PSMB4;TMEM9;PSMA3;ATP6V1C2;PTK7;USP8;PSMC1;CAV1
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.761966300704219,1.3180140597540657,0.15789473684210525,0.8747865720325791,1.0,1/6,3.05%,PLK1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.49678240593743606,1.3178478616298035,0.10714285714285714,0.8733837077743657,1.0,13/56,13.27%,FLT1;MAPK11;SRC;NRP2;HSPB1;VEGFD;ELMO1;CYBA;DOCK1;MAPKAPK3;ELMO2;PIK3CA;PRKD1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.5359765915026026,1.3178194139635147,0.14285714285714285,0.8715045800430281,1.0,14/56,14.66%,CDKL1;ODAD3;CDK10;EVI5L;ARHGAP35;CCP110;TBC1D5;IFT88;TBC1D22B;IFT140;DCDC2;TBC1D10A;CEP97;TESK1
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.7500149852702367,-1.3175407576986118,0.11864406779661017,1.0,1.0,4/12,16.31%,IFNGR2;CDC37;STAT1;PARP9
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.6617539652849783,1.3170671310592033,0.15625,0.873007528620591,1.0,5/13,16.86%,PLIN5;FBXW7;C3;GPLD1;NR1H3
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.7206466449335293,-1.3170464507145931,0.08620689655172414,1.0,1.0,7/12,14.81%,CYP1A2;CYP2A6;CYP2U1;CYP3A4;CYP3A5;NUDT15;CYP2E1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.6522907022687529,1.316817832308131,0.16666666666666666,0.8716831175490323,1.0,5/23,14.53%,PDGFB;CRACR2A;P2RX7;GRIN1;STIM2
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.742890285721027,-1.3162436271295472,0.11538461538461539,1.0,1.0,3/14,5.29%,DDX4;BTBD18;ZSCAN21
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.8411148436329989,-1.316099904804072,0.1346153846153846,1.0,1.0,2/6,1.16%,IRF4;GBP2
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.4376548060286925,1.3159503989462815,0.047619047619047616,0.8735940644341389,1.0,22/98,15.30%,ZNF423;KCNQ2;PTPRD;CPT1C;ADGRB3;SEMA5B;CTNNA2;SNAP91;ASXL3;EFR3B;CADPS;ADGRL3;UNC13A;NCAN;NRXN1;GPM6B;ROBO2;DCX;MAGI2;ABI2;FMN2;TMEM132B
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.5908439424661625,1.3156762240826163,0.10714285714285714,0.873008141970661,1.0,4/39,5.53%,CPA1;CYP4F11;CYP2C8;PLA2G10
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.6521777134182336,1.3156607566759284,0.15384615384615385,0.8710568242166755,1.0,8/21,17.25%,CHRNA4;ARRB2;DRD4;GRIN1;NLGN3;DRD2;GSK3B;GRIN2B
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.8023470718575724,-1.3149320330243746,0.09230769230769231,1.0,1.0,3/8,8.05%,MCM2;MCM4;MCM3
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.8061475406269843,-1.3147857974850945,0.08064516129032258,1.0,1.0,2/7,4.95%,TINF2;PNKP
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.7282641676746904,1.3142105070105163,0.14285714285714285,0.8756220272630862,1.0,4/11,14.25%,TRAF2;MALT1;TNFRSF10A;CHI3L1
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.8128566332208281,-1.3141282177437,0.0847457627118644,1.0,1.0,5/7,15.01%,PM20D1;TST;CYP3A4;CYP3A5;NIT1
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),0.7341869697969496,1.3140501082354847,0.15789473684210525,0.873927103160307,1.0,5/8,22.97%,ALDH1A3;RARG;MFAP5;KDM2B;FBN1
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.6680643037876315,-1.3132371364731041,0.12280701754385964,1.0,1.0,10/22,23.14%,GAPDH;LDHA;ENO4;PFKL;TPI1;GCK;GAPDHS;PGAM1;ENO1;ALDOB
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.5363068428701581,-1.3130895908404598,0.06944444444444445,1.0,1.0,19/90,11.99%,TAGLN2;TTN;F8;SERPING1;TPH1;TIMP1;CLU;TLN1;CD9;CD63;ANXA5;F5;MANF;SPARC;CFD;TMSB4X;TGFB1;TEX264;SELP
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.7537747910581485,1.3124734737471058,0.13513513513513514,0.8792221582793985,1.0,5/7,22.67%,PICALM;SNAP91;AP3D1;DNM2;DNM3
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.7427162140543523,1.3124577197369456,0.1951219512195122,0.8772115572991368,1.0,3/10,7.65%,CHRNA4;SCN9A;P2RX7
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.5688845012145841,-1.3118382314947474,0.08974358974358974,1.0,1.0,24/62,23.01%,RPS27A;RNASE1;PCNA;UBA52;IHO1;RPA3;RBX1;RFC2;PARP1;UBB;EDC4;MUS81;RFC4;REXO4;RAD50;XPA;GTF2H2;PNRC2;ISG20;DDX1;POLD2;POLD4;DNASE1L1;RFC1
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),0.722662950043187,1.3115508522243546,0.23333333333333334,0.8789522459413198,1.0,2/10,5.71%,ZMYND10;DNAAF1
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.5461771398665698,-1.3110926088205248,0.08333333333333333,1.0,1.0,24/84,23.24%,PSMB8;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;PSMD3;PSMC3;ANAPC15;PSMA4;PSMD2;PSMA7;GTSE1;PSMD6;PSMB2;PSMB3;PSMB4;TCIM;PSMA3;CDC23;DBF4;PSMC1;CDC20;PSMD10
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.5807555058419318,-1.3107016472839614,0.18055555555555555,1.0,1.0,8/36,16.11%,XBP1;SELENOS;PFKL;RACK1;EIF2B1;EIF2B2;EIF2B4;GCK
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),0.8117349464223539,1.3102711101522304,0.1875,0.8819081970350496,1.0,2/5,13.93%,GRHL2;KDM1B
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.6239015814152223,-1.3101171160127758,0.07352941176470588,1.0,1.0,12/35,19.53%,RPS16;RPS8;RPS14;RPS28;RPS19;TSR3;NOB1;SNU13;NGDN;TSR2;DDX52;DHX37
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.6996225857975833,-1.309957236709084,0.10606060606060606,1.0,1.0,2/17,3.74%,SELENOS;SEC61B
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.7915694818605625,-1.3094656443336985,0.13432835820895522,1.0,1.0,2/10,5.77%,EIF2S3B;EIF2S2
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.747872479759981,1.3093762008877703,0.15384615384615385,0.8840052932624082,1.0,6/8,22.52%,RUNX1;CBFB;HMGB1;CD274;TARM1;TWSG1
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.5606662234837781,1.3093597520627807,0.10810810810810811,0.8820023073964876,1.0,11/44,12.65%,FGFR1;IGF1;IRS1;PLCL2;PDGFRA;PLCL1;IGF1R;OGT;PIK3CA;PLCD3;PI4KA
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.8119959695019514,-1.3085021894963111,0.1111111111111111,1.0,1.0,3/8,10.16%,GBA3;FUCA2;FUCA1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.6593614628059505,-1.3083756986746606,0.1076923076923077,1.0,1.0,4/22,10.55%,XBP1;HLA-E;PHB2;C17ORF99
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.8223826133069193,1.3083047188421577,0.10256410256410256,0.8842140105760155,1.0,3/6,13.41%,ROBO1;SLIT3;SLIT2
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.9046703280857132,-1.3082618506088897,0.06976744186046512,1.0,1.0,1/5,1.67%,SFRP1
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.48782380820469307,1.3078436664508142,0.11538461538461539,0.8844264152180847,1.0,28/86,15.23%,ZNF423;DACT2;NOS2;MCF2L;ZBTB7C;FRZB;CLIC5;MYO5B;MYH14;PBX1;NDRG2;TNFRSF19;COBL;ASXL3;TOX3;NPNT;ZNF704;CDS1;SH3BGRL2;SLC12A2;LRRN1;RIMBP2;NEO1;ARHGAP32;PCDH19;DLG3;RALGPS1;LGR5
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.8119724646274356,1.3075224983675426,0.14285714285714285,0.8835216110969174,1.0,2/5,9.08%,CDK6;DLL1
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),0.7912413740249307,1.3066489022956542,0.18421052631578946,0.8851266842570039,1.0,2/5,13.26%,LETM2;ATP13A2
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7003937833632208,1.3065324941725287,0.16216216216216217,0.8836997714215001,1.0,2/11,1.93%,CREB3L1;SPRY2
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),0.7924733724141143,1.3061408047207288,0.20588235294117646,0.8836034846058376,1.0,3/5,16.20%,MTHFS;DHFR;QDPR
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.4760509089431784,1.306122010677265,0.045454545454545456,0.881664375477945,1.0,23/111,10.42%,ZAP70;FGFR1;LIFR;LCP2;CASS4;FLT1;FGFR3;SRC;ALK;EGFR;CNKSR1;PTPRD;PDGFRA;GUCA1B;EPHA3;FRK;IGF1R;NTRK2;SHC3;CD4;RAPGEF1;ANGPTL1;MPZL1
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.7630092439575842,1.3056600930451139,0.1951219512195122,0.8816958011734558,1.0,5/9,12.74%,KCNJ2;ATP12A;ATP1B3;KCNMA1;SLC12A2
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.8265921797641431,-1.3055249246592877,0.06666666666666667,1.0,1.0,1/5,8.72%,APH1A
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),0.755218787506874,1.3055129232044536,0.18604651162790697,0.8800757369309867,1.0,3/8,9.36%,ACSM1;KYAT1;KYNU
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.8011647823832058,1.305054405262958,0.225,0.8795614541865902,1.0,3/5,15.66%,KANK1;TESK1;ANLN
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.7672986475372068,1.304589812420296,0.17073170731707318,0.8793539260634479,1.0,3/6,22.63%,NLGN1;BTRC;FBXW11
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.7563884667909777,-1.304333822111753,0.12903225806451613,1.0,1.0,2/9,4.38%,BUB1;DDX11
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),-0.8741742714227227,-1.3042589518502525,0.08571428571428572,1.0,1.0,1/5,4.77%,SBDS
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,0.605213067667809,1.3037704298264792,0.1724137931034483,0.8813037518499959,1.0,5/26,8.86%,F2;CYP2C8;DAO;SLC39A11;SERPINC1
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.8203319229886309,-1.3033371187676135,0.12857142857142856,1.0,1.0,4/8,13.24%,DDIT3;SELENOS;ATG10;TMCO1
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.7746074347874595,1.3032201986099727,0.11428571428571428,0.8820932167252236,1.0,3/13,6.77%,HNRNPU;SIRT1;FTO
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.5823224119327073,-1.302777271467248,0.08,1.0,1.0,11/51,13.37%,TOMM7;SLC25A4;SLC25A6;SLC25A5;DNAJC19;TIMM8B;TSPO;TIMM10;TOMM20;TMEM14C;PPIF
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.6899652801266853,1.3027489380608672,0.2608695652173913,0.8818813691944588,1.0,2/13,6.25%,CDK6;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),-0.7112503336511486,-1.3027187447179749,0.18309859154929578,1.0,1.0,1/13,0.57%,B2M
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.5059372885694045,1.302640493434452,0.09375,0.8801621630380778,1.0,16/75,13.01%,VDR;FGFR1;STARD13;ABCC8;SPRED2;SOWAHA;CTNND2;CAMSAP3;EPB41L1;NTRK2;KIRREL2;CD276;NPNT;LGI2;GALNT18;SLC8A2
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.6879290452876403,-1.3026126822555804,0.1323529411764706,1.0,1.0,5/20,13.73%,NFE2L1;TSPO;PGRMC1;ATP5IF1;UROD
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.8395788150472743,-1.3024331913100657,0.1076923076923077,1.0,1.0,1/7,2.64%,CLU
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.7601272514964578,-1.3014800759453427,0.11267605633802817,1.0,1.0,3/9,14.56%,RPS27A;UBA52;UBB
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.5183083065959713,-1.301060176034067,0.136986301369863,1.0,1.0,21/75,24.40%,HLA-DPA1;DCTN3;CENPE;ARF1;DCTN2;DCTN6;KIF18A;AP2S1;CLTA;CANX;DYNLL1;DCTN1;KIF4A;HLA-DRB1;HLA-DRA;AP1S1;AP2A2;HLA-DPB1;KIF22;CTSS;CTSL
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.7874900169603838,-1.3001493426002158,0.14492753623188406,1.0,1.0,5/9,17.78%,DBI;PRELID1;TRIAP1;ABCA12;APOE
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),0.7240070530169784,1.2999211654409273,0.20588235294117646,0.8899783724886275,1.0,2/11,2.93%,ICAM1;IFNA2
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.734157070306,-1.299882213226871,0.16923076923076924,1.0,1.0,6/10,20.82%,EMC6;EMC3;EMC7;MMGT1;EMC10;EMC4
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.5390386033311589,-1.2994230040566255,0.13636363636363635,1.0,1.0,20/63,21.75%,PSMB8;GATA1;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;PSMD3;PSMC3;PDCD2;PSMA4;METTL3;PSMD2;PSMA7;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;PSMC1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.6884133824456602,-1.298978035405779,0.09230769230769231,1.0,1.0,1/26,0.15%,VAMP5
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.7503573696350802,1.2984418269592588,0.20512820512820512,0.8943749648921413,1.0,4/6,22.67%,PICALM;SNAP91;DNM2;DNM3
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),0.7936032335623009,1.29804123176514,0.16666666666666666,0.8939576994555718,1.0,2/5,7.12%,MFHAS1;CYBA
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.8164729702279726,-1.297992784257459,0.09333333333333334,1.0,1.0,3/7,10.16%,SEC61B;SEC62;HSPA5
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.6056935597791931,1.2979327613099878,0.15625,0.8925557212162611,1.0,6/25,12.44%,IGF1;ICAM1;AGER;IGF1R;CACNA2D1;GRIN1
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.6986820554377008,1.297781518421621,0.1875,0.8912494906788506,1.0,7/18,13.57%,GPR35;CBARP;PDE4B;CACNB4;DRD4;NOS1AP;DMD
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),-0.8109286385240015,-1.2976800207817538,0.11864406779661017,1.0,1.0,1/5,8.35%,TNIP2
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.671137107883072,1.2975519135077145,0.13513513513513514,0.8905741054841635,1.0,5/9,19.57%,UNC13D;ADGRE2;SYK;FER;GAB2
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),-0.8211860509286426,-1.2973411827297683,0.08064516129032258,1.0,1.0,3/5,14.81%,CYP1A2;CYP3A4;CYP2E1
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.5456540749039053,-1.2973130119775063,0.09333333333333334,1.0,1.0,22/82,21.75%,PSMB8;RPS27A;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;UBA52;TNIP2;RBX1;PSMD3;PSMC3;UBB;PSMA4;PSMD2;PSMA7;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;PSMC1
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),-0.7874894105846963,-1.2970257700441916,0.15625,1.0,1.0,1/6,5.57%,CHMP2A
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.6462117813999158,1.2968007665176413,0.23404255319148937,0.8915647566551297,1.0,4/16,11.67%,CBARP;DIAPH1;CACNA2D1;NOS1AP
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.5207100779786491,-1.296731850534552,0.09210526315789473,1.0,1.0,33/115,25.12%,PSMB8;PSME1;EDF1;PSMB6;PSMD8;PSMC5;PSMD7;AZIN1;SCD;GPS2;PSMD3;PSMC3;HELZ2;C1QTNF2;PSMA4;APOE;PSMD2;PSMA7;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;FASN;PSMC1;OAZ3;PSMD10;LACTB;OPA3;TM7SF2;NR1D1;CERS2;SREBF1
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.685375894206744,-1.2966980956572332,0.1076923076923077,1.0,1.0,3/23,4.88%,SELENOS;SEC61B;TMED9
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),-0.8355872057700838,-1.2964997060281034,0.1076923076923077,1.0,1.0,1/6,4.18%,CPTP
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.6568574803218075,1.2963889448420824,0.125,0.8910990858810245,1.0,4/12,28.72%,PNPT1;PRR5L;CNOT7;NUDT21
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.5913797320280643,1.296361242277701,0.13793103448275862,0.8892458903045106,1.0,1/18,0.10%,F2
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.5879757460523765,-1.2963328734576813,0.08695652173913043,1.0,1.0,15/43,23.14%,PDHX;GAPDH;LDHA;ENO4;PFKL;SLC16A1;SLC16A8;TPI1;PDHB;GCK;GAPDHS;LDHC;PGAM1;ENO1;ALDOB
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.6143639694302949,-1.2963125122844148,0.1,1.0,1.0,2/38,1.72%,CD44;BEX3
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.6956609879947393,1.2956762276913731,0.11428571428571428,0.8907049189652201,1.0,3/10,3.58%,CLDN15;CLDN9;CLDN12
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),0.7725102214793365,1.2955835354847822,0.2,0.8893611572446094,1.0,4/6,17.16%,SNCA;PTH1R;GPER1;PTH
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.5743066068003035,-1.2954597210547991,0.09722222222222222,1.0,1.0,8/67,5.76%,CD44;POLR2G;SFRP1;GTF2F1;POLR2J;POLR2L;POLR2I;HYAL2
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.6880499929876303,1.2953254863159078,0.18181818181818182,0.8885519748806507,1.0,5/17,12.74%,KCNJ2;ATP12A;ATP1B3;KCNMA1;SLC12A2
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.5319001431143379,-1.2949782687998856,0.07228915662650602,1.0,1.0,15/75,12.48%,TAGLN2;ACTL8;TST;ALDH1A2;DNPH1;PCNA;CBR1;PAX8;MTHFD1;VIL1;TPP1;GSTK1;TGFB1;STAT1;IFT122
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.5278005401606539,-1.2944626494538372,0.109375,1.0,1.0,21/72,23.24%,PSMB8;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;PSMD3;PSMC3;AP2S1;PSMA4;PSMD2;PSMA7;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;PSMC1;AP2A2;RHOA;PSMD10
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.6164444687569225,-1.2943151757016214,0.13846153846153847,1.0,1.0,2/42,1.72%,CD44;BEX3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.6379528117359878,-1.2940754166422277,0.14285714285714285,1.0,1.0,9/26,18.51%,RPS27A;UBA52;CETN2;RPA3;RBX1;PARP1;UBB;XPA;GTF2H2
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.7123343900125013,1.2937165668700985,0.19047619047619047,0.8934903757278081,1.0,2/8,10.69%,RAB39A;RAB34
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.8107106925693885,-1.2937102193299272,0.13793103448275862,1.0,1.0,3/8,7.48%,CPS1;NIT2;GLYATL1
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.6156443422757343,1.2936681769747966,0.15,0.8916229810631358,1.0,2/13,10.73%,PRKRA;DICER1
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),-0.8523148625188108,-1.293319601743404,0.14754098360655737,1.0,1.0,2/5,14.07%,NUDT18;NUDT15
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.5175516232739977,-1.2932780807938025,0.025974025974025976,1.0,1.0,49/167,23.24%,CENPF;PSMB8;RPS27A;PSME1;DCTN3;CENPE;PSMB6;PSMD8;PSMC5;SSNA1;TUBB4B;PSMD7;UBA52;CETN2;TPX2;MAD2L1BP;DCTN2;NEK6;CEP131;HAUS6;PSMD3;PSMC3;TUBA1A;CEP72;UBB;ANAPC15;PSMA4;DYNLL1;APPL2;DCTN1;TUBA4A;PLK4;PSMD2;PSMA7;CEP135;PSMD6;PSMB2;PRKACA;PSMB3;PSMB4;TUBB;CEP41;PSMA3;CDC23;PSMC1;ZW10;CDC20;TUBB4A;PSMD10
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.6563385819529254,1.2932056432335575,0.10256410256410256,0.8915727969037672,1.0,5/12,21.13%,CAMSAP3;PCM1;CLASP1;SAXO2;BICD2
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.6375872961178473,-1.2930916314893595,0.1111111111111111,1.0,1.0,9/37,16.80%,POLR2G;PTMA;POLR2J;POLR2L;POLR2I;PAX8;THAP1;HOXD3;POLR2A
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.6941931824660811,-1.2929821754910502,0.14705882352941177,1.0,1.0,6/19,16.31%,IFNGR2;PARP14;CDC37;IRGM;STAT1;PARP9
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.6487746278905069,-1.292925747006691,0.15384615384615385,1.0,1.0,8/20,25.80%,MT1E;MT2A;HAAO;MT1M;MT1G;HVCN1;ZACN;GLRA2
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.6945927936970892,-1.2927043236874052,0.14285714285714285,1.0,1.0,3/17,10.26%,GOLGB1;DCTN2;CEP131
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.5838357556515948,-1.2924047844572992,0.07142857142857142,1.0,1.0,19/48,23.07%,TOMM7;SLC25A6;DNAJC19;ROMO1;TIMM8B;TSPO;TIMM10;TOMM20;TIMM50;PMPCA;TIMM44;IMMP1L;GRPEL1;TIMM13;FIS1;TOMM22;TIMM21;TOMM70;BCAP31
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated immunity (GO:0002705),0.922225783602357,1.2919498942748076,0.075,0.8949001426832324,1.0,2/5,4.45%,NOS2;CLEC7A
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.7253681646999369,1.2916634519634884,0.17073170731707318,0.8946106407762662,1.0,3/7,20.23%,DPYSL3;DPYSL4;DPYD
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),-0.7959964549640619,-1.2910254525943197,0.16071428571428573,1.0,1.0,1/6,0.72%,MPV17L2
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),0.7951904340369208,1.2910113533888625,0.16326530612244897,0.8954819324848781,1.0,3/6,16.31%,NOS2;DRD4;DRD2
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.7160974258279597,-1.2909250191333104,0.18181818181818182,1.0,1.0,2/11,3.15%,MT1E;MT2A
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),0.875185584729819,1.2908364005800466,0.11428571428571428,0.89412217381388,1.0,2/5,10.72%,GNGT1;PDE6B
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.6201025744899151,-1.290802012876437,0.14285714285714285,1.0,1.0,11/32,23.14%,GAPDH;LDHA;ENO4;PFKL;ENOSF1;TPI1;GCK;GAPDHS;PGAM1;ENO1;ALDOB
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.7684017181841785,-1.2907628110323315,0.19298245614035087,1.0,1.0,1/8,0.46%,GPX4
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.5601009094032368,1.2907449485832363,0.13513513513513514,0.8924507933994174,1.0,2/22,0.34%,F2;PDGFB
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.6725698349467985,1.290360132173627,0.18518518518518517,0.8921402649527691,1.0,6/22,15.35%,TAL1;EIF4EBP1;PPP1R10;EIF4E;MEIS2;CDC25B
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.5841310543025356,-1.2903231088319518,0.08450704225352113,1.0,1.0,7/40,15.17%,SFRP1;JUP;CFTR;ADAM15;MAP4K1;BRCA1;AHR
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.878070796034434,-1.2902140700131026,0.09523809523809523,1.0,1.0,1/5,4.13%,POLR3H
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6094218948617182,1.2900889602819776,0.17857142857142858,0.8914862031749444,1.0,7/26,14.15%,RUNX1;FGFR3;NFIB;SCX;SOX5;GPLD1;BMPR2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.6988357345823866,1.2897656675047051,0.18604651162790697,0.8906055292790129,1.0,3/8,20.23%,DPYSL3;DPYSL4;DPYD
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.7734831417792207,1.2889158712595163,0.2619047619047619,0.8921896028813086,1.0,3/5,20.55%,RYK;NR4A2;WNT5A
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),-0.7676074056513615,-1.2888294939355185,0.16666666666666666,1.0,1.0,4/7,21.24%,CALR;SLAMF8;C1QBP;CCR7
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.7327170995422686,1.2880934773567587,0.16279069767441862,0.8936812423785248,1.0,3/9,7.27%,IFNA2;TICAM1;IRAK3
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.6493837974241298,-1.2880148423986861,0.1076923076923077,1.0,1.0,6/18,23.07%,SELENOK;TMCO1;CCDC47;BAX;FIS1;BCAP31
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.6677558077529064,-1.2878440882925533,0.19047619047619047,1.0,1.0,3/13,10.09%,CPS1;FABP3;FABP6
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.5373097504495351,-1.287756264140742,0.125,1.0,1.0,19/59,21.75%,PSMB8;GATA1;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;PSMD3;PSMC3;PSMA4;METTL3;PSMD2;PSMA7;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;PSMC1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.5813023408278822,1.287495867399298,0.125,0.8939127863165539,1.0,5/17,17.09%,COL7A1;DUSP1;COL6A1;COL12A1;COL4A2
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.6998201279050024,-1.2873317297637425,0.1694915254237288,1.0,1.0,2/14,9.27%,TINF2;TPP1
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.5991080412265507,1.2870241648730738,0.15151515151515152,0.8939443115585292,1.0,6/17,18.76%,KCNJ2;CACNA2D1;CACNA1G;PIK3CA;CAMK2D;SCN3B
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.5037724553223715,-1.2870217072948795,0.06329113924050633,1.0,1.0,11/119,6.60%,CD44;GPX4;DDIT3;TIMP1;CLU;BCL2L2;RETSAT;TSPO;IFITM3;IRF1;BTG3
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.7308006963161093,-1.2869923745213898,0.09230769230769231,1.0,1.0,1/11,3.02%,NEURL1
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.6957323335864978,-1.286980864544256,0.14285714285714285,1.0,1.0,3/17,6.53%,CENPF;BUB1;IK
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.5682350647256987,-1.2868666528377286,0.1388888888888889,1.0,1.0,6/59,5.37%,CACNA2D4;TRPM1;BEST1;RDH12;DNAJC19;GPR179
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.6279843557856749,1.2863466566231445,0.20930232558139536,0.894940384092518,1.0,5/20,16.03%,MAPK11;CLEC7A;AGER;HMGB1;SYK
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.5434746247107538,-1.2863121229320484,0.08955223880597014,1.0,1.0,23/63,29.13%,H1-4;H1-2;POLE3;GRWD1;RNF8;PAF1;CHAF1A;MCM3AP;H1-10;SMARCD1;NAP1L2;ACTR6;H1-0;CHAF1B;SMARCA5;SET;SART3;ZNHIT1;H2BC11;PADI4;LIN54;ANP32E;H2AX
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.6686485325598269,1.2861636123949542,0.2647058823529412,0.8935822683532532,1.0,4/20,9.67%,F2;SNCA;HAP1;AKAP6
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.8295981668074468,1.2860134193214428,0.1875,0.8901783932277427,1.0,2/5,12.74%,DLG2;SLC12A2
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.8295981668074468,1.2860134193214428,0.1875,0.8901783932277427,1.0,2/5,12.74%,DLG2;SLC12A2
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.6741384483824107,-1.2858993915349113,0.19047619047619047,1.0,1.0,1/10,1.67%,SFRP1
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.6690448716612974,1.285067199472137,0.22857142857142856,0.8922712337824437,1.0,8/14,12.99%,PLIN5;PLA2G10;SIRT1;FTO;NFKB1;FBXW7;C3;LPL
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.6102420486551223,1.284638106954891,0.1388888888888889,0.8919689110101161,1.0,5/17,11.83%,STRIP1;LLGL2;FMNL2;DLG1;RHOQ
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.7137029013849483,-1.2843309996001984,0.1206896551724138,1.0,1.0,6/11,14.81%,CYP1A2;CYP2A6;CYP2U1;CYP3A4;NUDT15;CYP2E1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.6148764386044043,-1.2840137969973389,0.10606060606060606,1.0,1.0,7/27,13.59%,GATA1;ACTG1;TLN1;MYL12A;ILK;PIK3CB;PPIA
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.7154068974977685,1.2839062640493357,0.21212121212121213,0.8926764348063746,1.0,4/7,16.86%,UNC13D;ADGRE2;SYK;FER
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.5352803230127542,-1.2833807277807727,0.06756756756756757,1.0,1.0,33/115,22.25%,PSMB8;SFRP1;PSME1;JUP;TMEM198;PSMB6;PSMD8;PSMC5;ATP6AP2;PSMD7;SFRP4;BAMBI;GPC3;TGFB1;PSMD3;ILK;PSMC3;PSMA4;PLEKHA4;PSMD2;PSMA7;PSMD6;PSMB2;DACT1;PPM1N;PSMB3;PSMB4;TMEM9;PSMA3;PTK7;USP8;PSMC1;CAV1
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.7361657381359157,-1.2832651107609914,0.18055555555555555,1.0,1.0,4/11,10.16%,SEC61B;SEC62;GET3;HSPA5
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.5252568834634274,-1.283058310645284,0.12121212121212122,1.0,1.0,12/86,8.28%,HLA-F;B2M;IRF4;HLA-C;FGL1;HLA-A;MADCAM1;HLA-E;IRF1;CD81;ERAP1;COLEC12
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.7214219331455797,1.282781922299414,0.25806451612903225,0.8949186591784446,1.0,4/6,16.86%,UNC13D;ADGRE2;SYK;FER
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.6132437146461239,-1.2826437196766274,0.1076923076923077,1.0,1.0,13/33,25.31%,CENPX;RNF8;CENPK;CENPH;MIS18BP1;CENPQ;CENPN;ITGB3BP;CENPU;ACTR6;MIS18A;SMARCA5;ZNHIT1
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.6684618289737254,1.2822858855004053,0.16216216216216217,0.8952264831953721,1.0,6/13,25.50%,CTNND2;PTEN;EPHB3;SHANK1;PAK3;WASL
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.7726088585980454,-1.2819689015769784,0.1016949152542373,1.0,1.0,6/10,14.74%,MIS12;IK;CHAMP1;MTBP;SPDL1;ZWILCH
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.779102883172367,1.2818078157982113,0.25,0.8955887065760799,1.0,3/5,20.55%,WNT3;RYK;WNT5A
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.5186387452763134,1.281754676597807,0.18181818181818182,0.8939768236973723,1.0,8/38,12.89%,CERS3;COL7A1;GRHL2;KLK14;DLL1;ACER1;PTHLH;ATP2C1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.592691858517754,1.2813149682863858,0.14705882352941177,0.893536098414875,1.0,6/27,12.40%,MAPK11;MAPK12;CTNNA2;MEGF10;HDAC9;CDH2
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.6651133098650036,-1.2812348134118228,0.15942028985507245,1.0,1.0,6/18,17.85%,RPS27A;UBA52;TRIM13;RNF5;UBB;MAN1B1
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.7947326761472835,-1.2809969583195355,0.12280701754385964,1.0,1.0,1/5,0.65%,RPL23
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.6593539766030905,-1.2806523192102879,0.10606060606060606,1.0,1.0,6/24,11.68%,GATA1;COL9A3;MEA1;FSHR;SOX15;AR
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.6430869808848362,-1.2806210476525426,0.15384615384615385,1.0,1.0,7/23,12.07%,RPL23;RPL5;RPS7;RPL11;EFNA1;PDCL3;GABARAPL2
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.5550817635835991,1.28046572473938,0.07142857142857142,0.8945912731366659,1.0,9/44,9.36%,RAB27A;IL1RAPL1;SYTL4;SNCA;RAB27B;UNC13D;HAP1;STXBP5;CADPS
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.7538924867058868,1.2804453005241339,0.16666666666666666,0.8928809985157656,1.0,4/6,7.92%,RUNX1;LEF1;TESC;HCLS1
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.7263023167019963,-1.2799973230111692,0.2,1.0,1.0,2/8,5.45%,SFRP1;CARTPT
prerank,GO_Biological_Process_2021__cell junction disassembly (GO:0150146),0.8099236056661042,1.2795324648196513,0.23076923076923078,0.8953659787206768,1.0,1/5,4.47%,CX3CR1
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.6030702383656331,-1.2789740022761287,0.14705882352941177,1.0,1.0,4/41,4.38%,P2RY10;IRF4;CD9;PPIB
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.492684326322225,-1.2788703581977625,0.07228915662650602,1.0,1.0,67/276,20.82%,POLR2G;CSTF2T;SNRNP27;UBL5;FRG1;GTF2F1;POLR2J;POLR2L;SNRNP25;PPIE;POLR2I;LSM7;SF3B5;LSM2;IK;PHF5A;ZMAT2;RNPC3;SF3B6;FIP1L1;DHX16;PRPF3;SF3A1;RBM22;SNRPB2;DHX38;SNRPD1;SNRPN;PNN;SNRNP200;TFIP11;SRSF7;PPWD1;PRPF6;ESS2;PRPF4;DDX41;PPIL1;BUD13;SNRPD2;CPSF3;RBM4B;PRPF18;EIF4A3;DNAJC8;SUPT5H;SNU13;POLR2A;HSPA8;PRMT9;METTL3;PQBP1;KIN;DDX5;CRNKL1;SRSF3;GTF2H2;ZCRB1;MAGOHB;HNRNPH2;SYF2;SNW1;CLP1;PRPF8;PRKACA;NCBP1;AURKAIP1
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.8166219938186388,1.2787255482573365,0.15,0.8963558803002464,1.0,2/6,5.52%,ZBTB1;AGER
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.6027516630200923,-1.2785015984683221,0.1044776119402985,1.0,1.0,7/42,12.79%,SEMA3E;PDXDC1;FAT2;GPC3;HTR2B;SEMA3A;SGPL1
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.8231977032243503,1.2783930908331214,0.2222222222222222,0.8938324426670814,1.0,1/5,2.69%,SLC39A8
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.8231977032243503,1.2783930908331214,0.2222222222222222,0.8938324426670814,1.0,1/5,2.69%,SLC39A8
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.7974466604413685,-1.2780181788929328,0.1746031746031746,1.0,1.0,4/8,14.99%,RPS7;PTTG1IP;UBB;EIF5A
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.7669105160526652,1.2775893342953744,0.16666666666666666,0.8955572787191826,1.0,2/6,10.19%,SNCA;NFKB1
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.696428888905303,1.277301729729598,0.19444444444444445,0.8949568867413649,1.0,5/15,12.74%,GPR35;DUSP1;CXCL13;ACKR3;SLC12A2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.6844956921297561,1.2772615750706815,0.21739130434782608,0.8933519019834264,1.0,2/15,2.21%,FGFR1;FLT1
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.5742856716216119,1.2770912027451535,0.06666666666666667,0.8924053279598301,1.0,7/30,8.28%,IL1RAPL1;PTPRD;SARM1;ADGRB3;NSMF;OBSL1;TNIK
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.4837428261727948,1.277076609301627,0.13333333333333333,0.8907036025183228,1.0,22/106,12.89%,LEPR;DACT2;ETV1;FRZB;ABCC8;CELF3;PTPRD;RXRG;SOWAHA;PPARGC1A;PLPPR4;NPTX2;SORBS1;SNAP91;ASXL3;CADPS;MAPK10;TOX3;RCAN2;NRXN1;SEMA6D;RIMBP2
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.6946327960737141,1.2768422566709148,0.21052631578947367,0.8900096894045038,1.0,2/13,1.75%,LEPR;RUNX1
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.4485726078834493,1.27657568237139,0.0625,0.8892915826642273,1.0,35/187,14.31%,GABRE;GABRR2;KCNQ2;HOMER1;CHRNA4;KCNIP2;GLRB;KCNMB4;NLGN4X;SNCA;NLGN1;NPTX2;CACNB4;NPY;HAP1;HTR4;GRM1;GRM3;KCND2;DLG2;DRD4;CHRM3;DLG1;KCNN1;CHRNB3;NRXN1;GRIN1;PNOC;NLGN3;GRIK2;CHRNA5;SLC1A2;RPS6KA1;GABRB1;GABRG3
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.5617952710392726,1.27643423466158,0.14705882352941177,0.888010570915226,1.0,2/20,0.66%,PDGFB;PDGFC
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),-0.7563666866797364,-1.2763309461092311,0.1323529411764706,1.0,1.0,2/8,3.13%,CYP1A2;CYP2A6
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.6376029147173347,-1.2757481190766427,0.14492753623188406,1.0,1.0,5/26,11.65%,TOMM7;UBL5;ARIH2;PINK1;ABLIM3
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.7310040749276471,-1.275730023440885,0.15714285714285714,1.0,1.0,3/10,12.86%,CLU;DEGS1;MYRF
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.7304914433069645,-1.2757223720734692,0.1388888888888889,1.0,1.0,1/10,0.77%,RIMS1
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.5329897315900873,1.2757190246417232,0.18181818181818182,0.889396692938041,1.0,5/26,11.91%,HSD17B7;DHCR7;HMGCR;HMGCS1;MVD
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),0.7992071062569818,1.2756826513062525,0.11363636363636363,0.8877180945291228,1.0,1/5,11.82%,CACNA1G
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),0.7658937121455185,1.275612550396497,0.125,0.88623369030074,1.0,1/6,3.54%,TMEM98
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.7818844852579158,-1.275473810126073,0.16129032258064516,1.0,1.0,2/8,4.02%,SELENOS;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.4658940450597873,1.275438066801912,0.043478260869565216,0.8848888604025126,1.0,28/194,9.61%,F2;LEPR;FGFR1;PFKFB3;IGF1;FLT1;FGFR3;ALK;IFNA2;VEGFD;FGF17;EGFR;ARNT;PDGFRA;EPHA3;AGER;PROM2;LIMCH1;SIRT1;AKT2;IGF1R;P2RX7;ARRB1;TNIK;NTRK2;MLXIPL;CD4;WDFY2
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.5701733271731599,-1.2749212726594266,0.15384615384615385,1.0,1.0,9/34,14.92%,CYP1A2;GPX4;CYP2A6;CBR1;CYP2U1;AWAT1;FAAH2;CYP2E1;PTGES2
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.7489948624424764,-1.274801665685609,0.171875,1.0,1.0,2/8,4.19%,ZFPM1;EFNA1
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.7668573220576199,-1.2746525696061586,0.15,1.0,1.0,2/9,0.93%,APIP;NLRP1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.62711701996978,-1.2744107997106822,0.18840579710144928,1.0,1.0,9/38,15.25%,CENPX;DDX11;PCNA;EME1;FAM111A;ZNF830;FANCM;BOD1L1;GEN1
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.6287096291445753,1.274082906270859,0.20588235294117646,0.8893376559277292,1.0,7/18,20.84%,SRC;ARHGEF7;SORBS1;PTPRK;BCR;WHAMM;PEAK1
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.80338010863609,-1.273883965038716,0.1791044776119403,1.0,1.0,3/6,12.30%,SIGIRR;IL6R;CEBPB
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.7334967809630024,-1.2738727221980666,0.13114754098360656,1.0,1.0,3/10,8.85%,CD44;CORO1B;VIL1
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.5834025514782021,-1.2735056730477032,0.14492753623188406,1.0,1.0,21/64,22.28%,CYP1A2;GPX4;ACOT2;ASAH2B;GSTM4;GSTP1;ELOVL2;AWAT1;CYP3A4;FAAH2;ACSBG2;ACOT1;ASAH2;CYP2E1;ELOVL1;GLYATL2;EPHX1;HPGD;FADS2;DAGLA;ALOX5
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.651039164882895,-1.2732074371697235,0.06349206349206349,1.0,1.0,8/31,9.44%,CENPF;CENPX;CENPE;MIS12;CENPK;CENPH;MIS18BP1;CENPQ
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.72382973331728,1.2730896048717533,0.1111111111111111,0.8919052670231776,1.0,9/15,23.00%,ABHD2;GDPD3;MGLL;PNPLA6;GPCPD1;PLA2G4A;PLA2G4C;SMPD4;PRDX6
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.6244802479483519,-1.2729418432923592,0.18055555555555555,1.0,1.0,9/35,15.25%,CENPX;DDX11;PCNA;EME1;FAM111A;FANCM;ZGRF1;BOD1L1;GEN1
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.7380177017250041,-1.2723909447289532,0.15,1.0,1.0,5/7,25.61%,PEX11A;PEX11G;DNM1L;FIS1;ACOT8
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.6492956271180035,-1.2723275498289228,0.1774193548387097,1.0,1.0,7/23,16.80%,SYCE2;RNF212;STAG3;RNF212B;IHO1;MEIOB;FANCD2
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.845868160264297,-1.272096522829811,0.10344827586206896,1.0,1.0,2/5,13.28%,CEACAM1;CELA2A
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.7879717142459463,-1.2720392926828108,0.18181818181818182,1.0,1.0,3/5,11.33%,HAX1;PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.5802820493250364,1.2710591091249839,0.15625,0.8992714651712849,1.0,11/35,16.82%,TP63;SRC;MAML2;NOTCH4;ROBO1;DLL1;TGFB2;ROBO2;KAT2B;CREBBP;TSPAN14
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.7606523582551894,-1.270704003449141,0.18181818181818182,1.0,1.0,1/6,2.07%,RPS23
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.7441005296459318,1.2706918124374484,0.21052631578947367,0.8988394726561307,1.0,1/7,8.67%,PHF14
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.6712758846299753,-1.2706038063070326,0.16417910447761194,1.0,1.0,8/19,19.81%,UQCR10;NDUFS8;SURF1;UQCRH;UQCRB;NDUFS7;MDH2;UQCRC1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.5808168905887732,1.270504734385206,0.12903225806451613,0.8976682349686065,1.0,5/28,4.72%,PDGFB;FLT1;IRS1;FGFR3;PDGFRA
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.7593434291786749,1.270142171228258,0.2564102564102564,0.8977693267256199,1.0,1/6,11.06%,NUAK1
prerank,GO_Biological_Process_2021__negative regulation of retinoic acid receptor signaling pathway (GO:0048387),-0.7858094058121949,-1.2700845984750775,0.22033898305084745,1.0,1.0,3/5,21.06%,CALR;PRAME;EZH2
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.5184178405236427,1.269639616405766,0.15625,0.8979227363507486,1.0,13/29,28.52%,HSD17B7;DHCR7;HMGCR;HMGCS1;MVD;SC5D;FDFT1;MSMO1;ACAT2;DHCR24;PRKAG2;LBR;ARV1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.6748417420009692,-1.2695733306204666,0.203125,1.0,1.0,1/16,1.22%,POLR2G
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.7031434669758121,1.2690718998292898,0.20512820512820512,0.8982333806386623,1.0,2/8,15.20%,PIWIL2;SFPQ
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.6948389371540225,-1.2689626665843283,0.16417910447761194,1.0,1.0,4/15,6.54%,GSAP;CLU;EFNA1;LRRTM3
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.6654033192823597,1.268072558442896,0.13157894736842105,0.9007482039101833,1.0,5/9,28.05%,GRAMD1B;GPLD1;OSBPL7;SMO;GRAMD1A
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.5302860174288903,-1.2679537872321356,0.125,1.0,1.0,17/65,22.62%,POLR2G;DDX24;DNASE2;GTF2F1;POLR2J;POLR2L;POLR2I;WDR74;KPNA2;POLR2A;RAD50;METTL3;HNRNPH2;DDX1;NCBP1;RAN;DNASE1L1
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.768573583627221,-1.2677715348034124,0.15384615384615385,1.0,1.0,1/6,15.07%,CAV2
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),-0.7846007769403668,-1.267421812096361,0.18333333333333332,1.0,1.0,1/6,1.18%,FBXO43
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),-0.8687438134655037,-1.2672568786210534,0.1,1.0,1.0,3/5,11.02%,DBI;PRELID1;TRIAP1
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.6909744775546258,1.2672084323700161,0.3333333333333333,0.9023622537080465,1.0,3/8,10.13%,HOMER1;STIM1;GRAMD2A
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.6633852436146472,1.2670466088077033,0.21428571428571427,0.9011455704283987,1.0,4/9,16.21%,KAT2A;SIRT1;KAT2B;CREBBP
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),0.8015239464586124,1.2669119652902983,0.2558139534883721,0.8998292361355916,1.0,2/5,8.56%,SPIRE2;SPIRE1
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.821528529423804,-1.2667425946695423,0.18055555555555555,1.0,1.0,3/7,10.21%,DEGS1;DECR2;SCD
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.8349899853019507,-1.2662682484729713,0.2,1.0,1.0,2/5,3.05%,ZFPM1;TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.7322362418328308,-1.2659332598957045,0.208955223880597,1.0,1.0,1/10,1.15%,IL7
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.49986580475708675,1.2656943568073706,0.15789473684210525,0.90255579019334,1.0,24/105,11.85%,LIFR;GFAP;FGFR3;EFNB3;EGFR;LEF1;MTCL1;LRP4;SLC13A4;TNFRSF19;OBSL1;DOCK1;AGAP1;ALCAM;EPB41L1;ADGRB2;CHST3;MEIS3;SHC3;FMNL2;SRRM3;NUAK1;TEAD1;MEGF8
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.6065288143235641,1.2654848216278192,0.1935483870967742,0.9017878207772424,1.0,5/15,15.68%,ROBO1;ROBO2;BMPR2;ACVR2B;PKD2
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.695238084241608,1.2654355189932849,0.1875,0.9002962652286302,1.0,6/12,21.42%,EPHA3;ARHGAP35;MEGF8;NRCAM;EPHB3;CNTN4
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.7052670330411295,1.2646105426854892,0.21875,0.9022809016733097,1.0,3/10,20.55%,LGI2;FGF13;WNT5A
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),0.7172265596019345,1.2643941866182922,0.1702127659574468,0.8997775381732567,1.0,1/10,0.14%,B3GNT6
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.7172265596019345,1.2643941866182922,0.1702127659574468,0.8997775381732567,1.0,1/10,0.14%,B3GNT6
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.6732869418413238,-1.2635743170379239,0.20588235294117646,1.0,1.0,1/13,0.72%,MPV17L2
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.5702752808310418,1.2633233346221482,0.13157894736842105,0.9023696754454927,1.0,6/33,9.58%,FGFR1;MMD2;CPNE1;DLX1;ASCL1;BRINP3
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5639362577487047,1.263300710737128,0.12903225806451613,0.9008142447220772,1.0,6/37,8.80%,PDGFB;FGFR1;JCAD;HSPB1;SIRT1;RHOJ
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),-0.7765709635758733,-1.2631887830060018,0.22033898305084745,1.0,1.0,2/5,6.51%,XBP1;USF1
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.48641275788421606,1.263169037509596,0.13333333333333333,0.8996238855149482,1.0,18/59,13.39%,RAB27A;IGF1;MYOM1;PLA2G10;SYTL4;STX1A;SNCA;BMP6;RAB27B;UNC13D;ADAM8;STXBP5;CADPS;TGFB2;NMB;SLC12A2;ATP13A2;CLASP1
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.5962847312691713,1.2630887818312104,0.225,0.8981052753331064,1.0,7/16,18.82%,CLEC7A;CD22;SLA2;ITPR1;SLC8A2;GPR143;MAPT
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.6110362058094849,-1.262526217319124,0.14516129032258066,1.0,1.0,3/23,8.85%,ACTG1;SYNPO2L;VIL1
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.7459076552674881,-1.262126126005825,0.10526315789473684,1.0,1.0,6/12,14.74%,MIS12;IK;CHAMP1;MTBP;SPDL1;ZWILCH
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.5519386168773992,-1.2618984710409784,0.12307692307692308,1.0,1.0,13/54,16.94%,RPS27A;UFC1;CFTR;ATG14;UBA52;PHB2;TEX264;ARL13B;LGALS8;ACBD5;UBB;DYNLL1;UFL1
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.7108917967245354,-1.2618513932545972,0.22727272727272727,1.0,1.0,3/13,17.69%,POLR1G;NIFK;SNAPC2
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.6811279487062579,1.2611357996285133,0.21212121212121213,0.9042836102544093,1.0,2/10,3.62%,MAIP1;MCUB
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),-0.8086482924664153,-1.2609476196499874,0.18461538461538463,1.0,1.0,2/6,10.74%,CPS1;DDAH2
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.79217884675622,-1.2609266200075924,0.13793103448275862,1.0,1.0,2/5,9.96%,CD63;RAB32
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.79217884675622,-1.2609266200075924,0.13793103448275862,1.0,1.0,2/5,9.96%,CD63;RAB32
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.6292523913522147,1.260794209031936,0.2,0.9040625663572199,1.0,3/14,6.50%,IGF1;MAPK12;MBNL1
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.7700094810986853,1.2607598118145467,0.30952380952380953,0.9023405424213014,1.0,4/7,18.95%,FGFR3;SCX;BMPR2;BMPR1B
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.6678447162305935,1.2603154015439466,0.21875,0.9027845947409492,1.0,3/12,6.48%,SLC26A7;SLC26A6;SLC13A4
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.712366916689752,-1.260310714949736,0.14705882352941177,1.0,1.0,4/11,19.83%,RIC3;TMEM35A;MAP1A;RANGRF
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.7455210033766414,1.2601372147790322,0.2,0.9017815552766917,1.0,3/8,12.02%,KCNIP2;ATP1B3;LRRC38
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.6319376894028871,-1.2600028322179044,0.19444444444444445,1.0,1.0,5/30,5.67%,POLR2G;GTF2F1;POLR2J;POLR2L;POLR2I
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.6319376894028871,-1.2600028322179044,0.19444444444444445,1.0,1.0,5/30,5.67%,POLR2G;GTF2F1;POLR2J;POLR2L;POLR2I
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.6816063899026993,1.259956604653153,0.23404255319148937,0.9006051453193646,1.0,3/8,6.26%,KCNIP2;CNTNAP2;AGRN
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.7622890382402185,-1.2599156519635333,0.17857142857142858,1.0,1.0,3/11,7.24%,MADCAM1;RHOG;CD81
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.452108008697027,1.259841891243819,0.0,0.8993826587595163,1.0,41/105,20.78%,CELF3;MMD2;SCRT1;OLFM3;AMER2;CTNNA2;PSD2;NXPH1;GRM1;SNAP91;CADPS;GLS;GRM3;UNC13A;DLG2;DIRAS2;KCNC2;NCAN;UNC79;NRXN1;KCTD16;GRIN1;MEIS2;SLC8A2;MAGI2;SLC1A2;TMEM132B;CA10;ADGRA1;GRIN2B;GRIA2;NOL4;SPHKAP;TMEM196;SCN3B;FUT9;ADCYAP1R1;ST8SIA3;TNR;GRM5;SLC6A1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6768290946362419,1.259536299244867,0.15789473684210525,0.8990220774791814,1.0,4/10,24.31%,FGF2;ZFPM2;ERBB4;BMPR1A
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.7379615742539007,-1.259486994999408,0.1774193548387097,1.0,1.0,1/10,0.35%,BMP5
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.5035412413338584,-1.2594533215760717,0.10975609756097561,1.0,1.0,28/137,17.67%,CENPF;GPX4;RPL38;COX7A1;CLU;BBS12;CENPE;MIS12;CHMP2A;ADRM1;CCDC39;VAMP8;TBCC;SRP54;COX7A2;TGFB1;HOPX;RAB5IF;TMEM35A;VBP1;AP2S1;CLTA;NDUFAF1;CCT2;CALY;HIGD1B;TESPA1;PFDN6
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.690139892424467,1.2593893311143642,0.2702702702702703,0.8960442101600624,1.0,6/10,21.29%,SESN2;RRAGD;SESN1;UBR1;RPTOR;KLHL22
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.690139892424467,1.2593893311143642,0.2702702702702703,0.8960442101600624,1.0,6/10,21.29%,SESN2;RRAGD;SESN1;UBR1;RPTOR;KLHL22
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.7362402918547171,-1.2592209151723088,0.2,1.0,1.0,3/8,13.03%,SIGIRR;GSTP1;APOD
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.6021998377151547,-1.258931648130148,0.1044776119402985,1.0,1.0,6/39,11.33%,GATA1;RPS14;ZFPM1;SLC25A5;RPS19;ATP5IF1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.6128187057677371,-1.2589297510538764,0.14754098360655737,1.0,1.0,4/23,8.72%,PSME1;EFNA1;PRELID1;APH1A
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.5523777667666484,1.2588016445027002,0.13157894736842105,0.8965945338705553,1.0,5/25,2.93%,ZAP70;ZBTB1;KAT2A;RUNX1;IFNA2
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.6129797576348917,1.2587187866888434,0.18181818181818182,0.8952909019154848,1.0,10/25,20.59%,IL1RAPL1;PTPRD;NLGN1;AGRN;NRXN1;NLGN3;CLSTN2;SEMA4A;IL1RAP;EPHB3
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.612840805536391,-1.2585600982404472,0.15873015873015872,1.0,1.0,17/38,24.35%,CNP;COX6B1;ATP5PB;HSPA5;ATP5PF;DYNLL1;CKB;ACTB;CALM3;NDUFS3;INA;S100A1;RHOA;PLP1;G6PD;CALM1;MAOB
prerank,GO_Biological_Process_2021__positive regulation of calcium-mediated signaling (GO:0050850),0.840750478924594,1.2584044722972516,0.1951219512195122,0.8951661481214366,1.0,1/5,4.45%,CLEC7A
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5721420823584247,1.2582420591468855,0.10810810810810811,0.8940695031444496,1.0,8/29,11.81%,ICAM1;IL1RAPL1;PTPRD;HMCN1;NLGN1;ALCAM;CADM1;CRTAM
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),-0.6849318252900815,-1.25803441981483,0.22857142857142856,1.0,1.0,3/17,9.98%,SDF2L1;RXYLT1;DPM3
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.7369820801887681,-1.258003509970108,0.1896551724137931,1.0,1.0,1/8,6.49%,PARP14
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.6171949423089875,1.2579051871185596,0.13333333333333333,0.8937732879110901,1.0,2/14,6.25%,TICAM1;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.7080230718995125,1.2574311469931057,0.24242424242424243,0.8939998041429251,1.0,3/10,7.86%,ICAM1;AGER;ADAM8
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.5506964418983569,1.2574133454808298,0.1111111111111111,0.8924155577789726,1.0,12/32,16.89%,IRS1;GRB14;SIRT1;SORBS1;PIP4K2A;OGT;PID1;ENPP1;PTPRE;KANK1;GKAP1;PRKCZ
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.5197363920738743,-1.2571790461931323,0.08974358974358974,1.0,1.0,11/88,10.69%,FBXO43;PKMYT1;SFRP1;BUB1;RAB11A;USP51;KIF20B;IHO1;CETN2;ANKK1;USP19
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.7234427427752403,1.2570700566512167,0.2619047619047619,0.8920993035080974,1.0,2/9,2.64%,RUNX1;YJEFN3
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.8018054448284606,1.256733597988664,0.2222222222222222,0.8920065345430618,1.0,1/5,2.14%,SNAI1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.7908914307486515,1.256710986262762,0.19047619047619047,0.8904100784694553,1.0,1/6,4.34%,TICAM1
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.578300961070292,1.2561903269710881,0.1891891891891892,0.8906160918595929,1.0,10/24,20.11%,CBARP;STX1A;CACNA1I;SYT3;CACNA1G;SYT17;SYT5;DOC2A;STXBP3;SYT7
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.5878081648329918,1.256011133536172,0.16129032258064516,0.8898632905283637,1.0,8/28,17.56%,CHRNA4;SCN9A;OR3A2;PCDH15;P2RX7;PNOC;C5AR1;MYO7A
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.771102087936721,1.25560336518771,0.1891891891891892,0.8896281822255204,1.0,2/6,13.68%,CNOT2;CNOT6L
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.8114767245550868,-1.255565819407363,0.16666666666666666,1.0,1.0,1/5,4.01%,TST
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.6638046462696053,1.2550651929978383,0.13333333333333333,0.8900547760149092,1.0,3/10,8.81%,HSPA1A;ARHGEF7;HSPA1B
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.7431312804308243,1.2548808537111318,0.30612244897959184,0.8891116828175827,1.0,2/7,7.56%,MTMR2;IGF1R
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.6547989676923577,-1.25395069119494,0.15384615384615385,1.0,1.0,3/14,9.52%,XBP1;HLA-E;PHB2
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.525758725372859,1.2537459325499136,0.15789473684210525,0.8919275158434675,1.0,6/42,10.30%,FGFR1;SNAI1;LEF1;NOTCH4;TGFB2;FBXL17
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.5979224801382953,-1.253501129735339,0.16417910447761194,1.0,1.0,1/33,0.14%,EPN1
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.8069329065067381,-1.2532383471309432,0.1864406779661017,1.0,1.0,2/6,8.15%,CPS1;MTHFD1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),-0.7093857932662625,-1.253130757730211,0.234375,1.0,1.0,1/12,0.41%,IGSF1
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),0.7854849894209921,1.2530755397269153,0.16216216216216217,0.8925423250346916,1.0,1/5,13.49%,SLC6A13
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.5010146948553987,-1.2522759517703557,0.08450704225352113,1.0,1.0,24/137,13.64%,TAGLN2;RIMS1;TTN;F8;SERPING1;TPH1;TIMP1;CLU;TLN1;CD9;CD63;ANXA5;F5;MANF;SPARC;CFD;TMSB4X;SYT11;TGFB1;TEX264;CDK5;SELP;ABCA12;SCG3
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.47760966551879264,1.252036384764224,0.10344827586206896,0.8963864772581603,1.0,18/96,15.45%,IGF1;TIAM2;MAPK11;RRAS2;ARHGAP31;CNKSR1;PLD1;CDKN2A;SHC3;MRAS;ZNF304;SIAH2;RUNDC3A;PRKD1;ARHGAP32;RASGRP2;G3BP1;CCNA2
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.8119867096718584,-1.2518790668435742,0.1746031746031746,1.0,1.0,1/5,3.40%,DBI
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.6015616481503032,-1.251816499353082,0.2153846153846154,1.0,1.0,6/35,14.15%,DTX3L;NEURL1;TRIM25;RBX1;PAF1;ATXN7L3
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.6315283230286032,-1.2516696160984933,0.1694915254237288,1.0,1.0,4/25,4.50%,HLA-F;B2M;HLA-A;HLA-E
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.6332483169956002,-1.2516061302194188,0.14864864864864866,1.0,1.0,10/27,24.22%,CHMP2A;RAB11A;VPS25;VPS28;SNF8;CHMP7;CHMP3;CHMP4B;VPS36;VPS4B
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.7327433608169286,-1.251513096497526,0.2537313432835821,1.0,1.0,5/9,21.05%,ZNF830;CEBPB;EIF2B2;EIF2B4;SOD1
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.7965560664217994,1.2513740581475734,0.21052631578947367,0.8975002855746307,1.0,3/6,18.49%,RELA;NFKB1;SLC30A10
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.7466955846279769,1.2513499490919096,0.23255813953488372,0.8959954270076859,1.0,2/5,12.29%,DCTPP1;ENPP1
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),-0.840337628403542,-1.251337590951415,0.10344827586206896,1.0,1.0,1/5,1.67%,SFRP1
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.7654598355912041,-1.2509922293932332,0.25396825396825395,1.0,1.0,2/7,6.97%,ATG14;VAMP8
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.6000334852229217,-1.2504196904919649,0.14084507042253522,1.0,1.0,5/35,10.09%,GPAT3;CPS1;FABP3;SLC27A5;FABP6
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.7775821875446024,1.2503711665013368,0.3023255813953488,0.8980242135229568,1.0,5/5,22.26%,TTBK2;ABL1;MAP2;MARK2;PPP2CB
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.5758105926428627,-1.2503221651616159,0.12121212121212122,1.0,1.0,2/45,4.91%,ARHGEF16;RHOG
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.7378540092258434,-1.2500416079606493,0.21428571428571427,1.0,1.0,2/7,12.76%,BEX4;FNTA
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5418186003519336,1.2494337893383136,0.2,0.9002386531024209,1.0,1/28,0.10%,F2
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),0.7641733514141085,1.2492935716995484,0.3076923076923077,0.8992667260261158,1.0,3/7,9.77%,DAO;SNCA;TGFB2
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.6839792061222495,-1.2489197591192815,0.2054794520547945,1.0,1.0,3/15,7.22%,FBXO43;PKMYT1;KIF20B
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.5245551888527529,1.2488070016188753,0.2,0.8997404178951416,1.0,9/27,23.63%,HSD17B7;DHCR7;HMGCR;HMGCS1;MVD;SC5D;FDFT1;MSMO1;ACAT2
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),0.7513090179915272,1.2479557905758403,0.20512820512820512,0.901699927068228,1.0,2/7,11.89%,CX3CR1;C3
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.7223949426943883,-1.2477606923727205,0.18333333333333332,1.0,1.0,3/8,10.55%,RNF8;GPR183;C17ORF99
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.5786598264462073,1.2476469926362135,0.15384615384615385,0.9013532866616218,1.0,2/22,2.05%,NUPR1;ICAM1
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.6888897900150485,-1.247072910105436,0.1643835616438356,1.0,1.0,6/17,22.83%,VPS35;WDR91;PTTG1IP;ATRAID;DACT1;MSN
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.6459539217478668,1.2464903199881934,0.2702702702702703,0.9035658700698663,1.0,5/15,17.25%,ARRB2;GRIN1;DRD2;GSK3B;GRIN2B
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.7437872589908738,-1.246062116010123,0.15254237288135594,1.0,1.0,4/9,16.31%,PARP2;PARP14;PARP1;PARP9
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.79232757992153,1.24581182960575,0.23529411764705882,0.9047921397439889,1.0,4/5,19.85%,OGT;ZNF304;PHF1;PHF19
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.8209895205534231,-1.2457241031031328,0.13559322033898305,1.0,1.0,2/5,7.17%,TIMP1;CALR
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.6272339992856785,1.245680861215211,0.1282051282051282,0.9021904870303606,1.0,2/13,7.19%,RAB27A;RAB27B
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.6272339992856785,1.245680861215211,0.1282051282051282,0.9021904870303606,1.0,2/13,7.19%,RAB27A;RAB27B
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.5417756357188828,1.2452566584200229,0.18518518518518517,0.9021783653459741,1.0,15/56,10.27%,GLT8D2;TPM2;PCDH18;FBLN5;PDGFRA;POSTN;ADGRA2;ADAMTS2;MSRB3;EHD2;GLI2;COL6A1;CDH11;LOX;COL5A1
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.6184295914530824,-1.2448550413942796,0.16417910447761194,1.0,1.0,2/18,3.15%,MT1E;MT2A
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.7851312079818382,-1.2446100690186008,0.14925373134328357,1.0,1.0,2/7,3.95%,SLC25A45;SLC22A4
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.7268740912775318,1.2443466981041393,0.24390243902439024,0.9047963708962573,1.0,3/6,22.63%,MTCL1;MAP2;FBXW11
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.6612133267066935,1.2440422175504997,0.15789473684210525,0.9041647145305856,1.0,5/8,27.73%,ADRA1A;DRD2;ADRB1;RAPGEF2;ADCY9
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.6217775562596636,-1.2438445418409898,0.2028985507246377,1.0,1.0,6/17,23.09%,SLC8A3;SRI;C12ORF57;CALM3;PRKACA;CALM1
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.773685566684858,-1.2433205632817683,0.20967741935483872,1.0,1.0,4/9,12.79%,PDXDC1;FUCA1;SMPD2;SGPL1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.6446878409640902,1.242890936576856,0.15,0.907549113708807,1.0,4/11,15.49%,PDGFRA;GLI2;TGFB2;PCSK5
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),-0.7856795719303747,-1.242523913595042,0.25862068965517243,1.0,1.0,2/5,13.17%,SBDS;C1QBP
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.5439511087485511,-1.241872769365199,0.17391304347826086,1.0,1.0,5/53,5.78%,XBP1;SFRP1;ATG14;CARTPT;RRAGA
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.4568230466460467,1.2417616076338303,0.08,0.9099552424767141,1.0,35/161,14.58%,MFNG;LIFR;RUNX1;HOMER1;KCTD8;YJEFN3;SRC;TMEM108;IRAK2;RFNG;SIRT1;NCAM1;LLGL2;GSKIP;DLL1;DOK5;RGS5;ZDHHC3;OGT;GDNF;FBXL17;AMFR;ACVR1;MGLL;GRK5;CD55;GNG7;LFNG;SLC8A2;RIC8B;PRKD1;CD80;DCDC2;GDF5;CBFB
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.7871162079082741,-1.241690209996234,0.2037037037037037,1.0,1.0,2/5,13.57%,XBP1;CD27
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.514364092027084,1.2415397035343603,0.12903225806451613,0.9090590363098988,1.0,22/91,13.70%,RELN;COLEC11;ADAM33;TPM2;PCDH18;GFAP;FRZB;PDGFRA;POSTN;ADAMTS2;TMEM47;COL6A1;CDH11;COL14A1;RGS5;HTRA1;COL5A1;SLIT3;ADAMTS5;FBXL7;PLSCR4;LDB2
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.7388726209519724,-1.241043676602377,0.16666666666666666,1.0,1.0,2/10,4.71%,CD9;PMP22
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.6351851685524634,1.240822933374413,0.2962962962962963,0.9106320355936522,1.0,3/7,24.37%,PRMT6;PRDM4;PRMT5
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.7115115359785408,-1.2407752750942145,0.26153846153846155,1.0,1.0,4/11,26.65%,IFITM3;IFNAR1;RO60;KLHL20
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.6225827469444345,-1.2407614048727464,0.2413793103448276,1.0,1.0,4/21,5.27%,CYP1A2;ADH4;RDH12;RETSAT
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.5815593789451623,-1.2402103634635382,0.2,1.0,1.0,12/37,21.40%,CD44;TIMP1;MMP19;ADAM15;FLOT1;CAPNS1;TLL2;TIMP2;SCUBE3;LCP1;FURIN;A2M
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.6230317245630771,-1.2398804878290404,0.15942028985507245,1.0,1.0,2/28,5.15%,CYP1A2;CYB5R3
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5682625968666142,-1.2398605959529612,0.16,1.0,1.0,15/44,23.01%,APEX1;PNKP;PCNA;MPG;RPA3;RFC2;PARP1;MBD4;RFC4;XPA;POLD2;POLD4;POLQ;PARG;RFC1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.6959216716957919,-1.2395430767650575,0.19402985074626866,1.0,1.0,6/11,13.51%,UQCR10;UQCC3;UQCRQ;CYC1;UQCRH;UQCRB
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.7211003432388311,1.2394917091679287,0.225,0.9138875582752549,1.0,6/9,17.35%,LRP4;NLGN4X;NLGN1;NRXN1;NLGN3;CEL
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.7764230775464636,1.239321248709644,0.1891891891891892,0.9130359819601914,1.0,2/6,11.47%,DSE;CSGALNACT1
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5846727767685084,1.2390823845641268,0.17142857142857143,0.9123509246169802,1.0,5/25,11.21%,PDGFB;ATOH8;RELA;TGFB2;TEAD1
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),-0.8368225147323411,-1.238951275912665,0.11594202898550725,1.0,1.0,2/5,13.45%,JUP;BRCA1
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),-0.8368225147323411,-1.238951275912665,0.11594202898550725,1.0,1.0,2/5,13.45%,JUP;BRCA1
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.7389707350339534,1.23884295178107,0.2,0.9101032678290597,1.0,3/7,20.25%,KCNC2;AQP1;MTR
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.7389707350339534,1.23884295178107,0.2,0.9101032678290597,1.0,3/7,20.25%,KCNC2;AQP1;MTR
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.6702148519849294,1.238786343181371,0.19047619047619047,0.9087528912123863,1.0,2/8,5.60%,PLIN5;ACADVL
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.5695352935549486,1.238772994832714,0.175,0.9071983960389692,1.0,14/38,23.72%,PLPP4;MTMR2;PLPPR4;MTMR11;PTEN;SYNJ2;INPP5B;MTMR3;MTMR12;PIP4P2;MTM1;PLPPR2;PLPPR3;MTMR9
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.7590347194228456,-1.2387576278652632,0.19047619047619047,1.0,1.0,2/8,2.09%,PLAAT4;PLAAT5
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.5996864840372255,1.2387541249433804,0.22580645161290322,0.9056261284548464,1.0,2/31,1.33%,PDGFB;IGF1
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.5521495626315691,-1.2385711995694182,0.16883116883116883,1.0,1.0,12/50,14.06%,CYP1A2;ADH4;ALDH1A2;RBP1;RDH12;RETSAT;GPC3;GPIHBP1;RBP2;CYP3A4;LRAT;CYP3A5
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.6915227079467314,-1.2383454446043565,0.12307692307692308,1.0,1.0,8/13,23.34%,TMEM50A;VPS25;VPS28;SNF8;TMEM50B;CHMP7;CHMP4B;VPS36
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.6977805304233728,-1.2379547721254824,0.18461538461538463,1.0,1.0,5/13,19.91%,COPS5;HSPA5;UFL1;FICD;BAX
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.6948590836714961,-1.237513499342942,0.2191780821917808,1.0,1.0,2/12,12.16%,IDH3B;IDH3G
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.6289785083992432,-1.2374838867037412,0.23529411764705882,1.0,1.0,4/20,14.15%,DTX3L;RNF8;PAF1;ATXN7L3
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.727508908196072,-1.2370998933905433,0.2698412698412698,1.0,1.0,2/11,7.24%,CD9;CD81
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.7245058771465582,-1.237094073490843,0.15384615384615385,1.0,1.0,1/10,0.93%,NLRP1
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.6386341045010345,1.2370930943327163,0.21951219512195122,0.9100475207463865,1.0,2/12,9.39%,CDK6;CD4
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.743840739612264,-1.2365057742490926,0.14754098360655737,1.0,1.0,4/9,14.06%,CYP1A2;CYP3A4;MGST3;CYP3A5
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.743840739612264,-1.2365057742490926,0.14754098360655737,1.0,1.0,4/9,14.06%,CYP1A2;CYP3A4;MGST3;CYP3A5
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.743840739612264,-1.2365057742490926,0.14754098360655737,1.0,1.0,4/9,14.06%,CYP1A2;CYP3A4;MGST3;CYP3A5
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.5077715204953904,-1.236251723836221,0.10126582278481013,1.0,1.0,24/114,19.06%,CENPF;RPS27;BUB1;STMN1;CENPE;SBDS;MIS12;ERCC6L;CENPK;CENPH;NUF2;CENPQ;DCTN2;NEK6;SPDL1;DCTN6;KIF18A;ZWILCH;DYNLL1;CENPN;KIF4A;ITGB3BP;PTPA;CENPU
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.4041470472890852,1.2358586430203062,0.05555555555555555,0.9132765295800392,1.0,48/240,15.58%,GABRE;GABRR2;KCNQ2;TSPOAP1;HOMER1;CHRNA4;KCNIP2;GLRB;KCNMB4;NLGN4X;STX1A;SNCA;NLGN1;NPTX2;CACNB4;NPY;HAP1;HTR4;GRM1;GRM3;SNPH;KCND2;UNC13A;DLG2;DRD4;CHRM3;GRID1;DLG1;KCNN1;CDH8;CHRNB3;NRXN1;GRIN1;PNOC;NLGN3;RIMBP2;GRIK2;CHRNA5;NAPB;SLC1A2;RPS6KA1;GABRB1;GABRG3;PTEN;DNAJC5;SLC32A1;PTPRN2;GABRR1
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.7483734707987988,-1.2356211901022982,0.19672131147540983,1.0,1.0,4/5,23.34%,VPS25;VPS28;SNF8;VPS36
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),-0.7483734707987988,-1.2356211901022982,0.19672131147540983,1.0,1.0,4/5,23.34%,VPS25;VPS28;SNF8;VPS36
prerank,GO_Biological_Process_2021__regulation of dendritic cell cytokine production (GO:0002730),0.8349038281923141,1.2353861165139937,0.2127659574468085,0.9134990982588439,1.0,1/5,4.45%,CLEC7A
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),-0.6250342049689757,-1.2351738947251578,0.15,1.0,1.0,2/28,0.90%,LRTM1;SEMA3E
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.6156903459909356,1.234971307552953,0.16129032258064516,0.9136058950030901,1.0,5/16,12.93%,CDK6;ZBTB16;MEIS1;MAFB;MEIS2
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.6155573869501535,-1.234812135037922,0.13432835820895522,1.0,1.0,4/22,6.56%,DDIT3;HES6;ATP6AP2;BHLHE41
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.6906260082421873,1.2343802593198385,0.20512820512820512,0.9141715574397677,1.0,3/8,18.66%,OTUD7B;YOD1;OTUD7A
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.6737907071896706,1.2343583216268743,0.225,0.9127868881655891,1.0,2/9,15.43%,CX3CR1;UBAP2L
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.6451011286565097,1.233851389972617,0.1891891891891892,0.9129172388330966,1.0,4/14,10.20%,NUPR1;HDAC4;MLXIPL;PID1
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),-0.6324386727308456,-1.2337256100520597,0.2191780821917808,1.0,1.0,3/21,9.98%,SDF2L1;RXYLT1;DPM3
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.6017473471156825,-1.2336955032596046,0.17647058823529413,1.0,1.0,15/40,22.52%,SEC61B;DNAJC19;ROMO1;SEC62;PEX10;SRP54;TOMM20;HSPA5;TIMM50;ZFAND2B;TIMM44;GRPEL1;PEX1;TIMM21;TOMM70
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.7446056255281902,-1.2336486560275755,0.19642857142857142,1.0,1.0,2/15,1.77%,H1-4;H1-2
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),0.7072437393590265,1.2335799261555205,0.2682926829268293,0.9124532029095547,1.0,2/7,7.86%,ICAM1;ADAM8
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.7147780925504597,-1.233354606529745,0.1791044776119403,1.0,1.0,8/16,22.52%,DNAJC19;ROMO1;TOMM20;TIMM50;TIMM44;GRPEL1;TIMM21;TOMM70
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.662353077229887,1.2332438061372726,0.1590909090909091,0.9119679458264954,1.0,5/13,21.17%,MTERF1;TOP1MT;HMGB1;ABL1;TOP2B
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.6230165363437491,-1.2325265194823825,0.140625,1.0,1.0,10/25,24.10%,CENPX;CENPK;CENPH;MIS18BP1;CENPQ;CENPN;ITGB3BP;CENPU;MIS18A;SMARCA5
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.6230165363437491,-1.2325265194823825,0.140625,1.0,1.0,10/25,24.10%,CENPX;CENPK;CENPH;MIS18BP1;CENPQ;CENPN;ITGB3BP;CENPU;MIS18A;SMARCA5
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.4500450008006427,1.232489476255058,0.047619047619047616,0.9132373279361599,1.0,38/125,19.18%,KCNN4;OXTR;KCNQ2;GFAP;CELF3;MMD2;AGER;SCRT1;OLFM3;ADGRB3;AMER2;CDH20;CTNNA2;PSD2;NXPH1;GRM1;SNAP91;GRM3;KCND2;KCNC2;NCAN;NRXN1;ADCY8;SLC8A2;SORCS3;NGB;CADM2;SLC32A1;NR4A2;CA10;ADGRA1;GRIN2B;GRIA2;MAP2;SPHKAP;TMEM196;SATB2;KCNB2
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.7093838201270679,-1.2324646316457804,0.16666666666666666,1.0,1.0,3/10,13.13%,DTX3L;RNF8;PAF1
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.7389219387785263,1.2318191431491112,0.21621621621621623,0.9139569364471849,1.0,2/6,6.29%,DYSF;MYOF
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.8137432713243951,-1.2315155067254786,0.10638297872340426,1.0,1.0,1/7,1.67%,SFRP1
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.7252691353254462,-1.2313193701135001,0.21875,1.0,1.0,3/11,13.91%,KDELR1;HSPA5;KDELR3
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.6746162505962281,-1.2309155003816834,0.2,1.0,1.0,1/11,0.35%,BMP5
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.5734001886683017,-1.2309013386872836,0.18461538461538463,1.0,1.0,12/37,21.40%,CD44;TIMP1;MMP19;ADAM15;FLOT1;CAPNS1;TLL2;TIMP2;SCUBE3;LCP1;FURIN;A2M
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.7679345920383334,1.230865308347445,0.2,0.9159219824892939,1.0,4/5,23.14%,DRD2;SLC8A1;ATP1A2;SMAD3
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.6896732241505088,1.2308316118261247,0.25,0.9145281243821414,1.0,5/9,25.76%,KDM4C;PHF8;KDM2B;KDM7A;KDM2A
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.733062492971704,-1.229892644229507,0.2777777777777778,1.0,1.0,1/8,1.66%,LOXL4
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.6365812610662326,1.2295858685133074,0.3076923076923077,0.918000555701241,1.0,3/11,7.33%,KCNJ2;KCNIP2;KCNN2
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.6541644652272183,1.2293633572534484,0.23684210526315788,0.917623715081573,1.0,4/16,12.40%,SPIRE2;SPIRE1;SCIN;JMY
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.5049407324394009,-1.2292438312965053,0.22580645161290322,1.0,1.0,22/75,26.72%,COPE;CENPE;TMED9;ARF5;KDELR1;USE1;KIF18A;ARCN1;KDELR3;KIF4A;TMEM115;LMAN2;COPZ1;ZW10;TMED2;NAPA;BNIP1;KIF22;TAPBP;ARF4;SURF4;RER1
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.662180562898816,1.2287766588394637,0.2972972972972973,0.9186904303573309,1.0,7/13,17.66%,ICAM1;CD59;CYBA;TGFB2;CD55;CFH;MAPK8
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.7906660914985273,-1.2285138664289774,0.15151515151515152,1.0,1.0,3/5,16.46%,PRPS1;DCK;DCTD
prerank,PanglaoDB_Augmented_2021__Macrophages,0.4818949260386158,1.2282094893934092,0.14285714285714285,0.9193710920252389,1.0,28/100,14.47%,STAB1;CTSK;IL4R;LCP2;C1ORF162;SAMSN1;SLCO2B1;PIK3R5;NRP2;CLEC7A;CX3CR1;HPGDS;CD200R1;CSF3R;MARCHF1;ITGAX;ADAM8;CD83;MRC1;CPM;CLEC5A;LAIR1;EGLN3;ADGRE1;CD80;HCK;NFAM1;TFEC
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.7711706749379306,-1.2280532894569387,0.18461538461538463,1.0,1.0,2/7,1.50%,DUOX1;NOX4
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.4465186536964804,1.2276616505641151,0.125,0.9197574863812977,1.0,15/96,12.45%,EPB41L4B;DACT2;SRC;PRKX;DUSP1;TESC;ADAM8;PLXNA1;DLL1;FRMD5;NUAK1;CELSR2;PLXNB2;CHRD;PKP4
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.7767669298094051,1.2272898089408202,0.21739130434782608,0.9195371828942942,1.0,2/7,4.45%,TICAM1;CLEC7A
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.678560817140327,1.2272739291886574,0.20512820512820512,0.9180640737336213,1.0,3/10,12.99%,PLA2G10;NFKB1;LPL
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.47794345764849355,1.227199333559864,0.1724137931034483,0.9168417114005194,1.0,4/41,5.63%,F2;PLK1;TM4SF20;CLN6
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.5680369541935315,-1.2270483245860893,0.17647058823529413,1.0,1.0,7/33,13.59%,GATA1;ACTG1;TLN1;MYL12A;ILK;PIK3CB;PPIA
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.6904141523688656,-1.2269148342412861,0.2153846153846154,1.0,1.0,3/11,13.17%,TIMP1;CALR;C1QBP
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.5412607208195834,1.2268599217098466,0.1875,0.9164265892883473,1.0,10/34,16.43%,TP63;IGF1;BMP6;ACVR1;NPNT;PRKD1;BMPR2;ACVR2B;DNAI3;ACVR2A
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),0.8122002818442794,1.226544043981772,0.18181818181818182,0.9161910332008717,1.0,2/5,17.87%,BMP6;PTPN23
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.7361769273685294,-1.22616794451378,0.15151515151515152,1.0,1.0,2/8,11.87%,RHOG;SLAMF8
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.7536286550999647,1.2260867292831898,0.26666666666666666,0.9166233327737965,1.0,4/5,23.80%,TANK;ITCH;OTUD4;TNIP1
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.6921413494121829,-1.2260686643471619,0.16666666666666666,1.0,1.0,4/19,11.97%,NLRP1;GAPDH;TNFRSF21;CDK5
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.697250953723962,-1.225827861591343,0.24193548387096775,1.0,1.0,2/9,10.62%,PLN;SRI
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.5802193170211085,1.2257098137551674,0.11428571428571428,0.9163660336586885,1.0,1/16,0.10%,F2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.647497976929839,1.2254637085166569,0.225,0.9156885104027358,1.0,2/12,3.09%,FGFR1;HSPB1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),0.7821212271484869,1.2252962854207399,0.23404255319148937,0.9146813513465331,1.0,1/5,0.34%,PDGFB
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.7105448660998475,1.2249448578322324,0.2894736842105263,0.914737779962518,1.0,1/6,1.36%,ABCC2
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.6722404083490157,-1.2248474411580206,0.21666666666666667,1.0,1.0,3/14,12.03%,RPS13;TGFB1;RPS26
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.554685740861852,-1.224234756514384,0.18421052631578946,1.0,1.0,6/48,12.22%,B2M;DTX3L;RPL11;BAMBI;BDNF;FLOT1
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.5984098953519522,-1.2241651730115484,0.16417910447761194,1.0,1.0,6/23,17.85%,RPS27A;UBA52;TRIM13;RNF5;UBB;MAN1B1
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),0.7849796255285505,1.2240140896904517,0.21621621621621623,0.916977196373656,1.0,1/6,13.49%,SLC6A13
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.5181608763748204,1.2239987615438164,0.1724137931034483,0.9155325733383989,1.0,7/52,6.64%,LEPR;NUPR1;DAPL1;RASIP1;FOXK1;SNCA;USP36
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),-0.7760944889663448,-1.2238036157906005,0.2463768115942029,1.0,1.0,2/6,10.54%,GALK1;GALE
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.5756235397617177,1.2237094572785916,0.2727272727272727,0.9154774248746786,1.0,7/25,12.69%,RELN;KCNIP2;HAP1;AKAP6;LRRC38;ATPSCKMT;NLGN3
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.6849948825345437,1.2236672472692134,0.3225806451612903,0.9140180651337487,1.0,3/7,16.86%,UNC13D;ADGRE2;FER
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.6760494175001026,-1.2236101065073228,0.16666666666666666,1.0,1.0,7/18,15.88%,PCNA;POLE3;MCM4;MCM3;GINS2;GINS4;RFC4
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.6574269388727263,1.223542051227275,0.22857142857142856,0.9130235509949335,1.0,2/10,7.02%,NLRP7;SERPINF2
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.7218644865041269,1.2233086483886892,0.24324324324324326,0.9122947538514828,1.0,2/6,9.98%,SNPH;UNC13A
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.6273992432043365,1.2232556589902803,0.23809523809523808,0.9095144659790761,1.0,7/18,19.53%,HELLS;DNMT3A;TEX15;ATRX;EHMT1;MTRR;PPM1D
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.6273992432043365,1.2232556589902803,0.23809523809523808,0.9095144659790761,1.0,7/18,19.53%,HELLS;DNMT3A;TEX15;ATRX;EHMT1;MTRR;PPM1D
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),-0.7504388043269222,-1.2231537036527855,0.1875,1.0,1.0,6/8,24.69%,VIL1;STMN2;KATNB1;CFL2;WDR1;NES
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.7140157048274816,-1.2227642589894296,0.21875,1.0,1.0,5/10,15.08%,SELENOS;GSTP1;TGFB1;AR;EDN1
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.7174119762272124,-1.2225286810935887,0.2112676056338028,1.0,1.0,2/8,17.15%,POLR2L;GTF3C6
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),-0.8021180647191055,-1.2218812565029185,0.25,1.0,1.0,1/5,5.13%,GBA3
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.8122315138241668,-1.2218647349547211,0.16666666666666666,1.0,1.0,2/6,12.38%,STAT5A;STAT1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.8122315138241668,-1.2218647349547211,0.16666666666666666,1.0,1.0,2/6,12.38%,STAT5A;STAT1
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.7806572541724748,-1.2218560041850517,0.171875,1.0,1.0,1/6,3.45%,CD63
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.4557593010607773,1.2217641926326048,0.14814814814814814,0.9138226453052247,1.0,19/112,7.92%,PDGFB;FGFR1;SPRY2;CASS4;IRS1;FGFR3;SRC;PIK3R5;FGF17;EGFR;CX3CR1;PDGFRA;CPNE1;MFHAS1;AKT2;NRG2;IGF1R;ADAM8;HCLS1
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.7173957513185948,1.2213547664577822,0.17857142857142858,0.9138795526527242,1.0,6/10,26.88%,TCOF1;CDH2;KBTBD8;NRG1;NOLC1;TAPT1
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.6634995421239803,-1.2213325163497795,0.2413793103448276,1.0,1.0,1/8,11.78%,JMJD4
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.6241401764497616,-1.2211379592354759,0.2153846153846154,1.0,1.0,7/24,16.57%,GBP2;HLA-A;HLA-E;ROMO1;RPL39;PPP1R11;PGLYRP1
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.6271820116172262,-1.2210095607599296,0.15151515151515152,1.0,1.0,9/35,15.44%,MRPL51;MRPS12;MRPS34;MRPL2;MRPS21;TEFM;MRPS18B;MRPS18A;MRPL16
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.6465317176829415,-1.221007935992877,0.1724137931034483,1.0,1.0,4/18,13.17%,RPS13;SRSF7;RPS26;C1QBP
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.5932490796604467,-1.2209182166557717,0.23943661971830985,1.0,1.0,5/24,9.98%,PIGH;PGAP4;PIGC;PGAP2;DPM3
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.5506475984040218,-1.2204556543373988,0.11538461538461539,1.0,1.0,21/76,20.76%,CENPF;DCTN3;SSNA1;TUBB4B;CETN2;ATAD5;TPX2;DCTN2;CEP131;HAUS6;TUBA1A;CEP72;DYNLL1;DCTN1;TUBA4A;PLK4;CEP135;GTSE1;PRKACA;TUBB;CEP41
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.7268348584050421,1.2201145614928526,0.3181818181818182,0.9166263649182506,1.0,1/5,6.35%,AKT2
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.749388563926501,-1.2198128899413856,0.2698412698412698,1.0,1.0,2/7,10.50%,PNKD;SYT11
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),0.6717752689052999,1.2197181436712676,0.27586206896551724,0.9164186343561904,1.0,4/12,15.68%,SH2B2;SLA2;GPLD1;C5AR1
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.45263836544033165,-1.2196757014347683,0.05,1.0,1.0,59/280,20.60%,PSMB8;AFP;FBXW10;BTBD6;PSME1;MEPE;TIMP1;COPS6;PSMB6;PSMD8;PSMC5;ELOB;F5;ASB18;RAB11A;COPS7A;PSMD7;FUCA2;COPS5;GPC3;VWA1;DSCC1;DDA1;SPARCL1;RBX1;CHGB;PSMD3;PSMC3;RAB8A;SCG3;NUCB1;PSMA4;LGALS1;ASB13;FBXW8;RCN1;RABGGTB;PRSS23;APOE;CST3;CKAP4;SCG2;PSMD2;FSTL1;PSMA7;CP;HSP90B1;FBXL16;MFGE8;SPSB3;FBXL13;PSMD6;SHISA5;RBBP5;IGFBP7;PSMB2;ERCC8;PSMB3;PSMB4
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.7074321060573633,-1.2195473727980168,0.18055555555555555,1.0,1.0,2/11,14.16%,DEGS2;ASAH2
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.7337754003435035,1.2195467355627425,0.25,0.9154547338342234,1.0,4/6,25.23%,PDGFRA;EPHB3;NIPBL;BBS7
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.6159943259449856,1.2188588554132416,0.24324324324324326,0.916501736760065,1.0,3/17,4.92%,PPP1R36;ENSA;MFHAS1
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.7433922699867038,1.2187962247183384,0.26666666666666666,0.915325268472611,1.0,4/7,21.38%,PLA2G10;PLA2G4A;CHPT1;PLA2G4C
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.7559077728442021,-1.2186583836354081,0.20833333333333334,1.0,1.0,1/8,2.64%,CLU
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.6360811016654113,1.2186409114886156,0.24324324324324326,0.9143032263298339,1.0,8/22,22.51%,IL1RAPL1;CTNNA2;PDLIM5;ABHD17C;ABL1;WNT5A;ARHGAP22;CAMK2B
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.6299992505154498,-1.2186401517700949,0.23728813559322035,1.0,1.0,4/15,14.05%,DDX60;NOP53;C1QBP;GPATCH3
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.6942547425225741,-1.2183607154135765,0.2830188679245283,1.0,1.0,5/12,22.28%,GSTP1;ELOVL2;ELOVL1;FADS2;ALOX5
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.5555116435931492,-1.2182782647912498,0.2028985507246377,1.0,1.0,19/46,30.11%,H1-4;H1-2;POLE3;GRWD1;PAF1;CHAF1A;H1-10;NAP1L2;H1-0;CHAF1B;SMARCA5;SART3;H2BC11;PADI4;EZH1;LIN54;H2AX;CDAN1;ASF1A
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.5954135102021945,-1.2182529465490213,0.18666666666666668,1.0,1.0,16/32,24.61%,SEC61B;EMC6;EMC3;GET3;EMC7;CAMLG;MMGT1;TRAM1L1;CCDC47;EMC10;EMC4;EMD;SERP1;TRAM2;UBL4A;CYB5A
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.5061093030508237,1.2181830876473856,0.14285714285714285,0.914766935643093,1.0,9/38,16.29%,KAT2A;LEF1;SUPT3H;TRIM16;PHF14;TAF12;KAT2B;JADE2;JADE3
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.7164805683236732,1.218169279917634,0.25,0.9133629614510055,1.0,1/9,1.36%,ABCC2
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.6894975188099108,1.218008797170146,0.2553191489361702,0.9124132261149951,1.0,1/8,2.14%,SNAI1
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.7524422322929607,-1.2180011007293126,0.24193548387096775,1.0,1.0,4/5,20.41%,CALR;TAPBPL;HLA-DRB1;HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.6264137850033169,1.2175566487083669,0.2857142857142857,0.9125570055121138,1.0,4/18,4.72%,FGFR1;FLT1;FGFR3;PDGFRA
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.7218474194707891,-1.2174499150240763,0.24074074074074073,1.0,1.0,1/9,6.33%,LCLAT1
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.48126531966333497,1.2171342291328866,0.17647058823529413,0.9133621048010147,1.0,9/61,8.88%,LEPR;BACE2;IRS1;PPARGC1A;FOXK1;SIRT1;IGF1R;LRRC8A;MLXIPL
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.684493322423912,1.2170594803352088,0.23809523809523808,0.9122250919861212,1.0,3/8,17.30%,CACNA2D1;NOS1AP;CAMK2D
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.47553437509023744,1.2170538512744324,0.1935483870967742,0.9107725042600288,1.0,15/62,14.77%,FGFR1;IGF1;IRS1;PIK3R5;PLCL2;PDGFRA;PLCL1;IGF1R;PLEKHA1;OGT;PIK3CA;PLCD3;PI4KA;GPR143;PTEN
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),-0.8110596913483703,-1.2167365550177454,0.31666666666666665,1.0,1.0,2/5,10.96%,DND1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),-0.8110596913483703,-1.2167365550177454,0.31666666666666665,1.0,1.0,2/5,10.96%,DND1;TGFB1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.6338752290478834,1.2162812393284774,0.3076923076923077,0.9124051908065269,1.0,2/11,10.12%,DPYSL3;DPYSL4
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.7698695746750053,-1.2162668729227786,0.2,1.0,1.0,3/7,11.93%,CPS1;SLC25A15;ARG2
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.7150559118030244,1.2158435216028576,0.2727272727272727,0.9128448123256482,1.0,1/9,1.15%,RIDA
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.7010788708908734,1.215669817043137,0.2564102564102564,0.9119487911562396,1.0,3/9,16.86%,MLXIPL;SLC45A3;NR1H3
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.6279264408121369,1.2152481672259685,0.13157894736842105,0.9105452515201904,1.0,2/12,7.19%,RAB27A;RAB27B
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.6279264408121369,1.2152481672259685,0.13157894736842105,0.9105452515201904,1.0,2/12,7.19%,RAB27A;RAB27B
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.6824344946678454,1.215215001897317,0.3,0.9091722953095474,1.0,3/8,13.26%,GFAP;SNCA;ATP13A2
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.4993462298015959,-1.2151811011206266,0.09722222222222222,1.0,1.0,30/93,22.45%,CLGN;PARP2;BUB1;CCNB2;CFTR;DDX4;GSG1;MEP1B;PEBP1;PCSK1N;NCAPH;HSPA2;TALDO1;TSN;ART3;ZC2HC1C;SCG3;RFC4;GSTM3;SEPTIN4;GAPDHS;LDHC;NEFH;SCG5;EZH2;NPHP1;DBF4;RPL39L;CCT6B;OAZ3
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.44639045271341726,1.2151457814086453,0.058823529411764705,0.9080772503424253,1.0,27/92,16.24%,SLC26A7;KCNN4;SLC15A2;CHRNA4;PIEZO2;GLRB;SLC26A6;SLC24A3;PANX2;KCNN2;PKD2L1;LRRC8A;SLC25A18;P2RX1;SLC26A3;SLC9A2;KCNN1;SLC26A9;GRIN1;SLC12A2;SLC8A2;SLC1A2;GABRB1;SLC24A4;SLC32A1;SLC9A9;SLC5A5
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.4880333579072514,1.2151180855347161,0.0967741935483871,0.9067545162328005,1.0,20/69,12.54%,ADAM33;ZNF521;ITGA11;PCDH18;CPED1;PDGFRA;POSTN;ADGRA2;SSC5D;ADAMTS2;MSRB3;CDH11;COL14A1;AEBP1;COL5A1;SGCD;AQP1;ADAMTS5;ZCCHC24;VSTM4
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.7583098117814476,1.2150697796324028,0.3055555555555556,0.9056247468172679,1.0,1/5,11.85%,MEGF8
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.6380690954265897,-1.21491067847818,0.21212121212121213,1.0,1.0,1/16,1.67%,SFRP1
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.6191963107476002,1.2148817929019338,0.17142857142857143,0.9047917657048229,1.0,3/10,16.86%,PLIN5;GPLD1;NR1H3
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),-0.8117756764716815,-1.2148552646291515,0.2153846153846154,1.0,1.0,1/5,0.57%,B2M
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.513445366256516,1.2147173150966684,0.14285714285714285,0.9038149978364396,1.0,7/24,11.85%,DNAAF1;GLI2;PKD1;COBL;NPY;TGFB2;MEGF8
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.5731382293417772,1.2145907760298642,0.15151515151515152,0.9029665667863095,1.0,3/17,9.52%,GRM2;GRM3;STIM1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.5758968458583099,1.214023620058833,0.14285714285714285,0.9037677876811266,1.0,6/15,18.95%,MYH3;MBNL1;TGFB2;MEGF8;PCSK5;BMPR1B
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.820142477210013,-1.2138140720417843,0.13846153846153847,1.0,1.0,2/5,16.94%,UFC1;UFL1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.820142477210013,-1.2138140720417843,0.13846153846153847,1.0,1.0,2/5,16.94%,UFC1;UFL1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.820142477210013,-1.2138140720417843,0.13846153846153847,1.0,1.0,2/5,16.94%,UFC1;UFL1
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.6281473080744838,-1.2135315820624124,0.21875,1.0,1.0,4/19,6.54%,GSAP;CLU;EFNA1;LRRTM3
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.5922191739826059,1.2134745948905572,0.1875,0.9043375399990655,1.0,9/16,18.24%,PKD1;TMEM120B;CPSF6;KCNC2;CPSF7;GRIN1;PKD2;GRIN2B;CBR4
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.4373055500618359,1.2133853926756464,0.11764705882352941,0.9033052049194953,1.0,32/108,20.15%,KCNQ2;CHRNA4;ABCC8;CASKIN1;CELF3;CHD5;LONRF2;MYT1;SCRT1;CTNND2;OLFM3;PCDH8;NXPH1;SNAP91;UNC13A;CAMKV;NCAN;NRXN1;RIMBP2;SLC8A2;NR4A2;ADGRA1;GRIA2;NOL4;TMEM196;MAPT;KCNB2;ERC2;ADCYAP1R1;SRCIN1;HS6ST3;ST8SIA3
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.6614798355999477,1.2132674423048075,0.23333333333333334,0.9022553248070602,1.0,1/8,2.19%,CASS4
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.7148880054851797,1.2131929007311721,0.24390243902439024,0.9011258246557537,1.0,3/5,14.65%,UBQLN4;CLEC16A;TMEM39A
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.7110228216680603,1.2131683558058957,0.3902439024390244,0.8998757006226479,1.0,1/8,0.34%,PDGFB
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.5507563551431787,1.2129653676741239,0.2631578947368421,0.8991251567438645,1.0,9/23,17.72%,STON2;NLGN4X;STX1A;SNCA;NLGN1;NLGN3;SYNJ2;CEL;SYT5
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.5342179296057671,-1.2125969121986568,0.19696969696969696,1.0,1.0,1/39,0.07%,CD44
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell chemotaxis (GO:2000510),-0.7608564839569103,-1.2125153321493793,0.22413793103448276,1.0,1.0,3/6,21.24%,CALR;C1QBP;CCR7
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.6556462563795833,-1.2122527643313772,0.23943661971830985,1.0,1.0,2/15,6.85%,PIGH;PIGC
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.4347171082473052,1.2122075071864074,0.07692307692307693,0.9002948636689503,1.0,21/338,4.49%,KLRF2;VDR;RAB27A;EPB41L4B;PDGFB;IGF1;KAT2A;SPRY2;MYOM1;PASK;HSPA1A;MAPK11;FGF17;ADAM19;EGFR;LEF1;CPEB3;TICAM1;PLD1;CLEC7A;PIWIL2
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.6928949352388162,1.212071515184574,0.24390243902439024,0.8993400751237101,1.0,7/10,20.55%,LRP4;NLGN4X;NLGN1;NRXN1;NLGN3;CEL;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.6942240370571766,-1.2119081413977577,0.23728813559322035,1.0,1.0,2/10,14.70%,DDX11;NCL
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.5228565704982026,-1.2118778427822203,0.14084507042253522,1.0,1.0,15/53,22.57%,DDIT3;BTN3A1;ZFPM1;HLA-DPA1;HLA-A;RASGRP1;FADD;C1QBP;HLA-DRB1;CR1;PDCD1LG2;ZP3;CCR7;CD226;HLA-DPB1
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.626037947601148,-1.2114919297289717,0.21428571428571427,1.0,1.0,4/16,11.37%,GATA1;SRP54;JAGN1;CDK4
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.47360823176104516,-1.2114352168538363,0.14492753623188406,1.0,1.0,20/76,21.75%,PSMB8;GATA1;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;PSMD3;PSMC3;PSMA4;METTL3;PSMD2;PSMA7;PTN;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;PSMC1
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.6560453063581421,1.21140450115398,0.28205128205128205,0.900608649778628,1.0,5/13,9.77%,RELN;GCM1;CDK6;NFIB;TGFB2
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),0.7358531465412117,1.211245573040499,0.3170731707317073,0.8996973683510976,1.0,3/6,20.52%,OAS3;ADCYAP1;DDX3X
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),-0.72979670741884,-1.21122098095898,0.2459016393442623,1.0,1.0,1/10,4.68%,VPS35
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.7227615530129448,-1.210905718957296,0.2318840579710145,1.0,1.0,2/7,17.15%,POLR2L;GTF3C6
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.8031063222337188,1.210905633655756,0.2926829268292683,0.8992807965472415,1.0,1/6,6.25%,SIRT1
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.6262671311116831,1.2107849156495947,0.23809523809523808,0.8983743396466428,1.0,3/17,8.52%,KAT2A;DUSP6;SCX
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.7485703892534542,-1.210716801540916,0.22413793103448276,1.0,1.0,2/9,4.29%,SLC25A4;SLC25A5
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.49214364006142075,1.2105614987377373,0.11764705882352941,0.8964473139575958,1.0,1/22,0.88%,TP63
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.49214364006142075,1.2105614987377373,0.11764705882352941,0.8964473139575958,1.0,1/22,0.88%,TP63
prerank,GO_Biological_Process_2021__monoacylglycerol biosynthetic process (GO:0006640),-0.7764676124534875,-1.2105048181343785,0.21052631578947367,1.0,1.0,1/5,4.85%,DGAT2L6
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.6553692442487578,-1.2104547584443248,0.2033898305084746,1.0,1.0,3/13,12.30%,IRF4;HLA-E;CEBPB
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.6085146525408753,1.2103548057079716,0.25,0.8957122933738951,1.0,2/12,11.72%,HNRNPU;AQP1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.4704992063708799,-1.2103150907178442,0.13157894736842105,1.0,1.0,36/152,21.15%,PSMB8;DDIT3;SFRP1;TAX1BP3;PSME1;PSMB6;PSMD8;PSMC5;NFATC1;SHISA2;KREMEN1;PSMD7;SFRP4;RACK1;TRABD2B;RBX1;FUZ;PSMD3;PSMC3;ANKRD6;PSMA4;GREM1;APOE;RNF213;PSMD2;PSMA7;GLI3;DKK3;PSMD6;PSMB2;DACT1;PSMB3;PSMB4;TPBG;PSMA3;EMD
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.5953673545600212,-1.2101737413616382,0.30434782608695654,1.0,1.0,6/25,17.01%,HSPE1;SDF2L1;HSPA2;HSPA5;DNAJC7;HSPA8
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.6342642124505482,1.2101656877232916,0.3076923076923077,0.8948778080786974,1.0,2/10,3.66%,KCNJ2;KCNIP2
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.5204964751663401,1.2095627194608867,0.14285714285714285,0.8956503121531063,1.0,7/24,18.83%,MYH3;MBNL1;TGFB2;RARG;MEGF8;CREBBP;HDAC1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),0.6817240622802148,1.2093524193323546,0.2894736842105263,0.8946967812188585,1.0,3/11,16.03%,TGFB2;CXCL13;SYK
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.5547740147430121,1.2090334780902185,0.17142857142857143,0.8948395310624512,1.0,8/32,18.44%,CDK6;NRP2;L1CAM;TLE3;CELSR1;UNC5C;SLIT1;NRCAM
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.6208226845908857,-1.2089393177349377,0.17567567567567569,1.0,1.0,4/25,6.86%,PPIB;SBDS;RPL13;SFRP4
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.6420079153644119,1.2088883827520798,0.21212121212121213,0.892560011478891,1.0,5/7,16.41%,NRP2;ALCAM;SLIT3;SLIT2;SLIT1
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.6420079153644119,1.2088883827520798,0.21212121212121213,0.892560011478891,1.0,5/7,16.41%,NRP2;ALCAM;SLIT3;SLIT2;SLIT1
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.5165706368273828,1.2088558151235207,0.24242424242424243,0.8914959562557533,1.0,7/56,5.85%,LEPR;NUPR1;DAPL1;PLIN5;MTMR2;RASIP1;FOXK1
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.693640748353605,-1.2082334386254021,0.2112676056338028,1.0,1.0,2/13,13.23%,CPTP;ABCA12
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.521181183033144,-1.208045136939214,0.15492957746478872,1.0,1.0,11/54,17.78%,NLRP1;LACC1;IRF1;ERAP1;TMSB4X;SELE;GRN;APPL2;UFL1;RNF135;APOE
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.6546662996463034,-1.2077114334642893,0.2535211267605634,1.0,1.0,3/18,12.93%,EIF2S3B;EIF2S2;EIF3D
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.7032938358645097,1.2075417153099068,0.2553191489361702,0.8950842145662511,1.0,1/8,6.25%,SIRT1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.42572237097007987,1.2074793092589706,0.15625,0.8939190849833212,1.0,19/123,10.12%,PDGFB;PTPN6;FGFR1;JCAD;IGF1;FLT1;FGFR3;EGFR;PHLPP1;DUSP1;SPRED1;TMEM106A;IGF1R;P2RX7;TNIK;NTRK2;CD4;VRK2;ADRA1A
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.7016908995298542,1.2074705931847123,0.325,0.891258703426136,1.0,3/6,26.20%,CNTNAP1;PARD3;NF1
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.7016908995298542,1.2074705931847123,0.325,0.891258703426136,1.0,3/6,26.20%,CNTNAP1;PARD3;NF1
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.6996092998936166,-1.2073829665350708,0.2542372881355932,1.0,1.0,5/14,17.03%,IFITM3;IRF1;IRGM;STAT1;CDC34
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.7812459958121115,1.20714571378036,0.275,0.8912848575378406,1.0,1/5,0.31%,RELN
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.5843442560274509,-1.206684378885953,0.27692307692307694,1.0,1.0,5/26,11.97%,PDZK1;VAMP8;GPC3;AR;CDK5
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.5981618187239922,1.2060986449464566,0.15789473684210525,0.8937879069200626,1.0,6/15,22.98%,TAFA1;CX3CR1;SMARCD3;DRD2;KDM1A;FZD3
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.7029270715992769,1.2060849642984979,0.34146341463414637,0.8924538951186894,1.0,5/7,21.27%,PIK3CA;EPDR1;CAMK2D;CCDC88C;PDPN
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.6564188162016278,1.2058249621699473,0.24324324324324326,0.8921594942449771,1.0,2/10,5.34%,HDAC10;SMS
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.49242250442654617,-1.205771700319864,0.11594202898550725,1.0,1.0,33/129,22.25%,PSMB8;DDIT3;SFRP1;PSME1;PSMB6;MESP1;PSMD8;PSMC5;KREMEN1;PSMD7;SFRP4;RBX1;FUZ;PSMD3;PSMC3;ANKRD6;PSMA4;GREM1;APOE;PSMD2;PSMA7;GLI3;DKK3;PSMD6;PSMB2;DACT1;PSMB3;PSMB4;TPBG;PSMA3;EMD;PSMC1;CAV1
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.6554595988197258,1.2055106786175274,0.29411764705882354,0.8904811894996508,1.0,1/10,0.39%,GRM2
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.6554595988197258,1.2055106786175274,0.29411764705882354,0.8904811894996508,1.0,1/10,0.39%,GRM2
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.6563088611809436,-1.2053417518842353,0.2459016393442623,1.0,1.0,6/14,27.34%,EME1;MUS81;FANCD2;MDC1;RAD9A;HUS1
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.6783914224201435,-1.205211031497575,0.22950819672131148,1.0,1.0,4/10,20.41%,TGFBR2;CD81;HLA-DRB1;HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.6344068236917436,-1.2050795944738002,0.25,1.0,1.0,1/13,0.86%,TINF2
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),0.646945544466515,1.2050497383570111,0.3,0.8906074013945561,1.0,4/8,21.56%,DAO;CBS;GLDC;DLD
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6401732020016716,1.20468741930959,0.25,0.890317480664872,1.0,3/15,4.72%,PDGFB;PDGFC;PDGFRA
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.5920639083145374,1.2045946039683468,0.325,0.8894551240965162,1.0,3/15,13.31%,IRAK3;IGF1R;CLEC16A
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.6182170253216613,-1.20439611067688,0.2222222222222222,1.0,1.0,10/28,22.52%,DNAJC19;ROMO1;PEX10;TOMM20;TIMM50;TIMM44;GRPEL1;PEX1;TIMM21;TOMM70
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.6748752610353241,1.2038579149626913,0.17647058823529413,0.8910627581170235,1.0,2/9,4.46%,ZNF366;CNOT2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.7477986672042289,1.2038264758915573,0.2857142857142857,0.8898076375504389,1.0,2/5,10.19%,PLA2G10;NFKB1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.5723872128999784,-1.203575095615257,0.2,1.0,1.0,16/40,25.61%,GPX4;GSTP1;DEGS1;ELOVL2;DECR2;SCD;AWAT1;FAAH2;ELOVL1;EPHX1;FADS2;DAGLA;ALOX5;PTGR1;CYP4F12;ACOT8
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.4887021220849271,1.2032527667461008,0.13793103448275862,0.890170088839107,1.0,11/47,13.85%,NOS2;PASK;ABCC8;RFX3;ENSA;STX1A;CHD7;KCNC2;ITPR1;RAPGEF3;RAPGEF4
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),0.692657260079152,1.202988921734218,0.26666666666666666,0.8897846806970449,1.0,2/6,3.54%,JAM2;TMEM98
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.570045355696216,-1.2029888739253567,0.20634920634920634,1.0,1.0,9/37,20.80%,B2M;RPS27A;UBA52;APH1A;ITM2B;UBB;CST3;MFGE8;FURIN
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.7128526731588184,-1.2027610968301359,0.2878787878787879,1.0,1.0,4/8,17.78%,PPIB;CAV2;CFL1;APOE
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.6493493036198384,1.2026356318119151,0.2,0.8896162640393445,1.0,4/14,10.32%,PDGFB;TMEM106A;NFKB1;SLCO1C1
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.5650906404436287,1.2025040377451903,0.2962962962962963,0.8887037378845707,1.0,3/26,4.46%,RUNX1;ZNF366;CNOT2
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.8085816806317389,-1.202411333086754,0.23943661971830985,1.0,1.0,3/5,14.78%,SEC61B;SRP54;ZFAND2B
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.6220815745498286,1.2021993460582836,0.24242424242424243,0.8885373970337925,1.0,5/18,11.67%,VDR;NPR3;DHFR;GDNF;NOS1AP
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.6737412944763412,-1.201916183543078,0.21875,1.0,1.0,2/11,3.05%,ZFPM1;TGFBR2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.5646157585526491,1.201821019039151,0.1388888888888889,0.8887427556521094,1.0,5/17,13.08%,DPYSL3;NT5E;NT5M;DPYSL4;UPP1
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.7066432289309397,-1.2017096317143787,0.23728813559322035,1.0,1.0,3/8,12.77%,MANF;LMX1B;CDNF
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.6008069769292771,-1.2016020089908193,0.26666666666666666,1.0,1.0,4/22,8.15%,CPS1;NOX4;TST;MTHFD1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.7483418796105992,1.2015333317877002,0.32558139534883723,0.8885573344985718,1.0,1/6,0.34%,PDGFB
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.5578262715749567,-1.2015119175613813,0.13043478260869565,1.0,1.0,8/56,9.98%,SELENOK;ZDHHC12;PIGH;PGAP4;PIGC;PGAP2;ATG10;DPM3
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.5282903838199339,-1.2014668912806314,0.21621621621621623,1.0,1.0,11/64,15.03%,HSPE1;NLRP1;BEX3;KHDC1;LCK;RACK1;FADD;PDCD2;MTCH1;NLRP12;RPS27L
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.6209953515263413,-1.2010546218704174,0.19402985074626866,1.0,1.0,3/20,13.23%,CPTP;AQP11;ABCA12
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),-0.7468712946704517,-1.2010423100485963,0.24489795918367346,1.0,1.0,3/6,22.34%,HLA-DRB1;HLA-DRA;CD46
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),-0.7468712946704517,-1.2010423100485963,0.24489795918367346,1.0,1.0,3/6,22.34%,HLA-DRB1;HLA-DRA;CD46
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.5016571477842529,1.2009698087862821,0.23529411764705882,0.8894244047354325,1.0,6/49,8.88%,LEPR;BACE2;IRS1;VGF;IGF1R;MLXIPL
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.7030638482677076,1.2006859896655298,0.3333333333333333,0.8891412700980559,1.0,3/6,25.44%,PRKD1;RNF112;SP1
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.6225358593447443,-1.200405945966792,0.25806451612903225,1.0,1.0,3/21,7.21%,DUOX1;PHPT1;RPS19
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.7349044920322714,1.1997888129090364,0.2682926829268293,0.8908596244369387,1.0,1/7,0.34%,PDGFB
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.6312283056317873,1.199324227400728,0.2631578947368421,0.8909825393603477,1.0,5/13,19.51%,IGF1;AKAP6;FGF2;ZFPM2;ERBB4
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.5647280064848434,1.1992627311722999,0.21875,0.8899430396326,1.0,2/25,5.52%,RELN;AGER
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.7061086383750556,1.199135935000848,0.3235294117647059,0.8891579635324501,1.0,2/6,12.99%,PLIN5;LPL
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.657189677957666,-1.1987962094301492,0.21212121212121213,1.0,1.0,8/13,26.54%,LSM2;PRPF3;PRPF6;PRPF8;DDX20;SART3;SRSF10;USP4
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.6177603108556429,1.1986466644717582,0.24489795918367346,0.889224869643954,1.0,3/14,4.72%,FGFR1;FLT1;PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.6156075420889404,1.1985348169393308,0.24242424242424243,0.8882309738289741,1.0,3/16,7.03%,MFHAS1;AGER;SASH1
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.7987755295513332,-1.1984158175840833,0.21052631578947367,1.0,1.0,3/7,9.39%,AQP9;CFTR;AQP11
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.7131209563639144,-1.198405768404772,0.2361111111111111,1.0,1.0,2/9,4.11%,ADH4;SNX17
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.5839363203689899,1.1980761875271768,0.1951219512195122,0.8882990228475106,1.0,6/14,27.15%,HMGCS1;ACACB;MVD;MLYCD;ACSS1;ACACA
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),-0.6495528840770531,-1.197799605113017,0.32786885245901637,1.0,1.0,2/13,10.46%,SLC8A3;SLC24A1
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),-0.6495528840770531,-1.197799605113017,0.32786885245901637,1.0,1.0,2/13,10.46%,SLC8A3;SLC24A1
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),0.7605664135766655,1.1976020551391764,0.26666666666666666,0.8883861043455967,1.0,3/6,18.11%,DNAAF1;MEGF8;SETDB2
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.6955981827294677,1.1975476579554982,0.3409090909090909,0.8873208949780974,1.0,1/8,2.83%,SRC
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.758793859827522,1.19747720934075,0.24489795918367346,0.8849507391786153,1.0,1/5,8.63%,GDPD3
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.758793859827522,1.19747720934075,0.24489795918367346,0.8849507391786153,1.0,1/5,8.63%,GDPD3
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,0.5150120782412425,1.1970058983471692,0.2631578947368421,0.8851759403575971,1.0,2/23,1.86%,ZAP70;GNLY
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",-0.7299355250214704,-1.1968379949464327,0.24193548387096775,1.0,1.0,2/7,7.24%,TGFBR2;CD81
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.7033594562099093,1.1967439965172824,0.3333333333333333,0.8847132235793945,1.0,2/10,7.56%,MTMR2;IGF1R
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.5942037765931955,1.196476337085135,0.24324324324324326,0.8840802534369108,1.0,4/13,15.23%,UBA7;DESI2;UBA3;UBA2
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.5175218767075809,1.196135071620082,0.23529411764705882,0.8837917448672481,1.0,11/30,26.78%,PRKRA;NOTCH4;XPO5;DICER1;TNRC6B;PUM2;PUM1;ZFP36;WTIP;CNOT7;TNRC6A
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.6853169940235277,1.1959644001558332,0.2972972972972973,0.88304782933508,1.0,1/8,3.18%,GMNN
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.6248226235237598,1.1957487096072354,0.3023255813953488,0.8824578871007214,1.0,5/13,16.31%,DAO;SNCA;TGFB2;DRD4;DRD2
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.6629582966161316,1.1956644234102711,0.23255813953488372,0.8816800628397341,1.0,3/9,21.17%,TOP1MT;HMGB1;TOP2B
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),0.7567887595969839,1.1954099044899658,0.3157894736842105,0.8812640875924602,1.0,1/5,11.89%,C3
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5876365058252241,1.1949342302382335,0.25,0.8813785433884279,1.0,2/18,6.77%,RIDA;FTO
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.4184454181230585,1.1946998721895756,0.11764705882352941,0.8808697928774885,1.0,18/220,7.16%,KLRF2;NOS2;KAT2A;RUNX1;HSPA1A;AFAP1L2;MAPK11;PDE4B;RELA;TICAM1;ARNT;CLEC7A;AGER;SLC7A5;TRAF2;SERPINF2;CYBA;TMEM106A
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.7236472577788382,1.1946968784198724,0.1891891891891892,0.8796273813219491,1.0,2/7,16.70%,RFX3;GSK3B
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.7237226755635899,-1.1944091853509915,0.265625,1.0,1.0,2/7,10.96%,ACMSD;TGFB1
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.5674730133888886,-1.1941782243559582,0.24615384615384617,1.0,1.0,4/23,14.56%,RPS27A;UBA52;FADD;UBB
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.5674730133888886,-1.1941782243559582,0.24615384615384617,1.0,1.0,4/23,14.56%,RPS27A;UBA52;FADD;UBB
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.6815961314026969,-1.1937804741788391,0.21428571428571427,1.0,1.0,1/13,1.24%,GJC3
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),-0.7490089999689437,-1.1937748169841496,0.1746031746031746,1.0,1.0,4/7,23.04%,TST;TXN2;GLYATL2;MPST
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.5743341708554389,-1.1935019893342598,0.21212121212121213,1.0,1.0,7/30,17.01%,HSPE1;SDF2L1;HSPA2;HSPA5;DNAJC7;CCT2;HSPA8
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.5274831758168309,-1.1930450380150024,0.2714285714285714,1.0,1.0,2/62,1.72%,CD44;BEX3
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.4782230751357319,1.192771010426592,0.17647058823529413,0.8847126858059008,1.0,11/42,18.35%,ISYNA1;IP6K2;INPP1;NUDT3;PLCD3;IPMK;PTEN;FGF2;INPP5D;INPP5B;ITPKC
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.5733939282568811,1.1926337717653483,0.2571428571428571,0.8840322321545923,1.0,5/19,11.78%,KCNIP2;ATP12A;SLC40A1;ATP1B3;SLC4A4
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.5882420937259154,1.1925707016634175,0.25925925925925924,0.8830346134678786,1.0,8/28,11.65%,MFHAS1;AGER;PHLPP1;DUSP1;DUSP10;SASH1;PTPN22;DLG1
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.6701049241555579,1.1917334263099686,0.38461538461538464,0.8832563213722868,1.0,2/7,16.14%,EIF4E2;TNRC6B
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.6701049241555579,1.1917334263099686,0.38461538461538464,0.8832563213722868,1.0,2/7,16.14%,EIF4E2;TNRC6B
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.5989242446504708,-1.1914124073440717,0.2698412698412698,1.0,1.0,5/18,10.91%,HLA-F;HLA-A;HLA-E;CEACAM1;FADD
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.7053986718884439,1.1913006822003662,0.30434782608695654,0.8833293293042043,1.0,2/8,8.12%,IWS1;ARRB1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6220181856504841,1.1909173218714566,0.23809523809523808,0.8833648046125012,1.0,4/8,21.59%,OAS3;LPL;HMGB1;MAP2K5
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.6284257300172068,1.1905326295610836,0.2647058823529412,0.8834747342230022,1.0,5/13,20.80%,PPARGC1A;MLXIPL;SLC45A3;NR1H3;MLYCD
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.7255906730383626,1.1904437021481955,0.32432432432432434,0.8824862286422105,1.0,4/7,14.65%,IRAK3;UBQLN4;CLEC16A;TMEM39A
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.7443750932093911,-1.1903744053716117,0.17857142857142858,1.0,1.0,2/8,13.36%,ENTPD2;ENTPD3
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.7742713834991762,-1.1902076590509965,0.2982456140350877,1.0,1.0,1/7,2.74%,PRDX1
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.5807366446397771,-1.189719017955327,0.2,1.0,1.0,5/19,19.68%,MT1E;MT2A;HAAO;MT1M;MT1G
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.443709360794448,1.189678531981501,0.2222222222222222,0.8834520519907668,1.0,34/108,14.45%,ZNF423;GFAP;EFNB3;PTPRD;LRP4;PLPPR4;NPAS3;NLGN1;DPYSL3;TMEM47;ADGRB3;NOTCH3;SEMA5B;NTRK2;SNAP91;ASXL3;SHC3;DOK5;MAPK10;ADGRL3;CACNA2D1;CDH4;MEGF10;ZNF536;RCAN2;NCAN;CORO2B;LRRC4C;SEMA6D;GPM6B;FBXL7;SLIT2;MARK1;PCDH19
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.5730086994230481,-1.189675370318818,0.2638888888888889,1.0,1.0,11/33,24.10%,CENPX;CENPK;CENPH;MIS18BP1;CENPQ;CENPN;ITGB3BP;CENPU;ASF1B;MIS18A;SMARCA5
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.6530756065067429,-1.1896456999307572,0.2909090909090909,1.0,1.0,3/12,14.29%,BTN3A1;RASGRP1;DOCK8
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.5457001353846792,1.1896026309812993,0.24324324324324326,0.8825220057257616,1.0,7/23,16.23%,CX3CR1;SIRT1;MITF;NOS1AP;C3;ADIPOR2;PDK4
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.5593583718118705,1.1895981886326232,0.21621621621621623,0.8813165156641782,1.0,5/23,4.54%,VDR;CTSK;RUNX1;GRHL2;ERRFI1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5087270366633844,1.1895163188868936,0.14285714285714285,0.8802624388307345,1.0,9/23,16.70%,HOMER1;IL1RAPL1;ZNF804A;CTNNA2;NTNG1;MARK1;PTEN;GSK3B;NCS1
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.6385750583128535,-1.1893156105577882,0.2413793103448276,1.0,1.0,3/12,13.57%,PARP2;PARP12;PARP1
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.6604023173541702,-1.1891823849077825,0.2459016393442623,1.0,1.0,2/10,7.18%,ALKBH2;MPG
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.6604023173541702,-1.1891823849077825,0.2459016393442623,1.0,1.0,2/10,7.18%,ALKBH2;MPG
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.7490166597686135,-1.1889628071857385,0.24561403508771928,1.0,1.0,2/7,11.27%,TOMM7;PINK1
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.6182834042280683,-1.1887494594830672,0.23076923076923078,1.0,1.0,5/18,15.13%,SELENOS;PFKL;EIF2B1;EIF2B2;EIF2B4
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),-0.7366624496564489,-1.1885735382031075,0.23636363636363636,1.0,1.0,2/7,17.43%,GEN1;XRCC3
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),-0.7366624496564489,-1.1885735382031075,0.23636363636363636,1.0,1.0,2/7,17.43%,GEN1;XRCC3
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.5620307597863132,-1.1885016877258818,0.18055555555555555,1.0,1.0,1/44,0.15%,VAMP5
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.7022271683355853,1.1882776208257317,0.391304347826087,0.8829449730085676,1.0,4/5,21.35%,OTUD7B;ZRANB1;OTUD7A;USP9X
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.563908478851799,-1.1882327202800245,0.21311475409836064,1.0,1.0,9/34,19.00%,B2M;CLU;CD63;SFRP4;SELE;GREM1;DGKD;ANGPT1;SERPINE1
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.5151654570345591,-1.187608686848137,0.16901408450704225,1.0,1.0,13/69,17.69%,POLR2G;GTF2F1;POLR2J;POLR2L;POLR2I;PHAX;TAF11;INTS5;GTF2A2;INTS12;POLR2A;SNAPC1;SNAPC2
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.5086834934995588,-1.1874308735442396,0.22058823529411764,1.0,1.0,17/64,21.75%,PSMB8;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;PSMD3;PSMC3;PSMA4;PSMD2;PSMA7;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;PSMC1
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.5201244293933726,1.1874014086870046,0.2222222222222222,0.8844941521876003,1.0,9/28,17.72%,STON2;NLGN4X;STX1A;SNCA;NLGN1;NLGN3;SYNJ2;CEL;SYT5
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.4966982253936835,1.1871665683063597,0.25806451612903225,0.883974600957437,1.0,12/43,21.67%,HDAC10;HDAC4;SIRT1;TBL1XR1;HDAC9;SMARCAD1;SFPQ;MIER2;HDAC1;HDAC3;MIER1;PER1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.4306728837929427,1.1870637705285632,0.125,0.8832171866077777,1.0,17/82,13.86%,B3GNT6;GALNT3;EOGT;ST8SIA6;POGLUT2;GALNT14;OGT;C1GALT1;TMTC1;GCNT3;TMTC2;GALNT18;GALNT2;MUCL1;GALNT16;POMK;GXYLT2
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.7465568499720181,-1.1870412505097232,0.26153846153846155,1.0,1.0,2/6,16.97%,TIMP1;TIMP2
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),-0.7480962291866411,-1.1868027782005885,0.2222222222222222,1.0,1.0,2/5,10.50%,RAB11A;SYT11
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.7060904696707593,-1.1867096838677986,0.22580645161290322,1.0,1.0,5/8,20.99%,LIMA1;PLEKHH2;VIL1;CFL2;WDR1
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.7407746052754676,1.186554133146884,0.19444444444444445,0.8838588834676611,1.0,2/7,2.88%,APOLD1;ATOH8
prerank,GO_Biological_Process_2021__response to heparin (GO:0071503),-0.7856462293901788,-1.1862177655698405,0.25,1.0,1.0,2/5,10.07%,SFRP1;GPIHBP1
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.5394383837658919,1.1862099757541922,0.22857142857142856,0.8840215434482196,1.0,8/32,13.49%,SLC38A1;SLC29A2;SLC7A1;SLC47A1;SLC7A5;LRRC8A;SLC22A2;SLC6A13
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.6644592837880214,1.186029780763006,0.25,0.8832671816370486,1.0,3/9,7.25%,FBLN5;AIFM2;DHFR
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.6018964831961419,-1.186025036225334,0.2542372881355932,1.0,1.0,6/27,16.48%,OST4;DAD1;DPM3;MCFD2;DDOST;MAGT1
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.7281503830852329,-1.1857840754299012,0.28125,1.0,1.0,2/7,9.39%,AQP9;AQP11
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6768918083585235,-1.1857797036885367,0.26,1.0,1.0,5/9,22.94%,ATP5MC3;ATP5PD;ATP5PB;ATP5MC1;VPS9D1
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.5290857790052306,1.1854870209124424,0.2857142857142857,0.8837780281066882,1.0,4/20,9.87%,HELLS;SIRT1;CDKN2A;BAHD1
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.7221323878491903,-1.185413146056755,0.2786885245901639,1.0,1.0,3/5,23.58%,GDI1;KCNE1;INPP5K
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.5168532661450004,-1.1851383909256807,0.18309859154929578,1.0,1.0,13/68,17.69%,POLR2G;GTF2F1;POLR2J;POLR2L;POLR2I;PHAX;TAF11;INTS5;GTF2A2;INTS12;POLR2A;SNAPC1;SNAPC2
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.5796604510849563,-1.1849248334018785,0.26785714285714285,1.0,1.0,7/26,15.67%,RPS27A;CFTR;UBA52;ARL13B;ACBD5;UBB;DYNLL1
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),0.7115866293919939,1.1845999529735491,0.30952380952380953,0.8854392023471684,1.0,1/5,3.84%,EGFR
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),-0.7904556643210574,-1.1844877976501462,0.25806451612903225,1.0,1.0,2/7,12.79%,TFIP11;CYREN
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.6364112084981183,-1.1841111095117793,0.21875,1.0,1.0,2/15,11.87%,CXCL17;SLAMF8
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),-0.7574531110530425,-1.1839360999313977,0.23728813559322035,1.0,1.0,2/5,11.99%,SELE;SELP
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.648475920533423,-1.1837956578466196,0.21311475409836064,1.0,1.0,3/12,18.65%,ACTG1;FUZ;ACTB
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),-0.7357130880581376,-1.1834057453437226,0.3050847457627119,1.0,1.0,2/6,15.08%,ACTA2;EDN1
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.5439846455011083,1.1832057365415882,0.24242424242424243,0.8890127579272099,1.0,9/18,23.45%,ID1;ROBO1;EGR3;SLIT2;GPLD1;FGF2;MIA3;KDR;PIK3R3
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.584832820675711,1.183049999583775,0.16666666666666666,0.8882557033912992,1.0,4/17,7.25%,MTHFD2L;MTHFS;ALDH1L1;DHFR
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),-0.7829141577231968,-1.1827596619251233,0.359375,1.0,1.0,1/5,1.82%,SLC6A12
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.6015697920247649,-1.1823870792592956,0.2830188679245283,1.0,1.0,1/18,2.05%,BUB1
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.5622738041919477,-1.1823735388088825,0.3,1.0,1.0,5/27,9.98%,PIGH;PGAP4;PIGC;PGAP2;DPM3
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.5151084013530893,1.1813133267299896,0.14814814814814814,0.8923254703948735,1.0,5/26,13.57%,KCNJ2;KCNIP2;CACNA2D1;CACNA1G;DMD
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.7539553731026555,-1.1812957161075328,0.2786885245901639,1.0,1.0,1/6,1.37%,DTX3L
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.7140784412414044,1.1811405277099882,0.3953488372093023,0.8915296050480184,1.0,3/5,14.77%,MTMR2;NLGN4X;PTEN
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.662812668703139,-1.180825907954315,0.2714285714285714,1.0,1.0,2/12,7.25%,CSTF2T;FIP1L1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.5255703973494069,1.1800748248670396,0.21428571428571427,0.89382261994003,1.0,20/60,17.60%,CREB3L1;SPRY2;DLX1;CASK;SMAD4;SMURF2;CHRD;SLIT2;BMPR2;CRIM1;LEMD3;ACVR2B;HIPK2;NIBAN2;SPRY4;TRIM33;ACVR2A;UBE2D3;VWC2L;FGF2
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.5750473968611561,-1.1798228557618355,0.2857142857142857,1.0,1.0,7/31,20.66%,TRMO;TRMT112;TRMT10A;DALRD3;TRMT5;HSD17B10;WDR6
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.5607080735627841,-1.1795092339000677,0.2608695652173913,1.0,1.0,6/29,13.03%,GALK1;FUCA2;FUCA1;PMM1;AKR1A1;APOD
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.4824511374932724,1.179372906760212,0.23809523809523808,0.8947313403267194,1.0,11/60,16.86%,CDKL1;ODAD3;PLD1;TBC1D5;IFT88;TBC1D22B;IFT140;DCDC2;TBC1D10A;FXR1;FER
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.64854949866478,-1.178965237291279,0.2698412698412698,1.0,1.0,6/17,21.48%,CLU;IFI6;TIMM50;DNM1L;BAX;FIS1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.7054967257061783,1.1788441388785365,0.28,0.894804632093238,1.0,4/6,24.31%,TGFB2;SMAD4;SMAD3;BMPR1A
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.774374249720403,-1.1788354175968956,0.3148148148148148,1.0,1.0,1/6,2.74%,PRDX1
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.7165192048660939,1.178645446180029,0.22857142857142856,0.8918852923973725,1.0,4/8,13.83%,HSPB1;RAB27B;DLG2;KIF5C
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.7165192048660939,1.178645446180029,0.22857142857142856,0.8918852923973725,1.0,4/8,13.83%,HSPB1;RAB27B;DLG2;KIF5C
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.7165192048660939,1.178645446180029,0.22857142857142856,0.8918852923973725,1.0,4/8,13.83%,HSPB1;RAB27B;DLG2;KIF5C
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),0.765263684179615,1.1786440648566732,0.38636363636363635,0.8906832906555969,1.0,1/5,4.45%,CLEC7A
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),-0.7304806407215444,-1.178641375220936,0.3076923076923077,1.0,1.0,1/7,9.57%,ITGB4
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.5370857220402033,-1.1786308612927991,0.22857142857142856,1.0,1.0,12/37,21.92%,UQCR10;ETFB;NDUFS8;SURF1;UQCRH;UQCRB;NDUFS7;MDH2;ETFRF1;COQ10B;UQCRC1;MTLN
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.6944127069180877,1.1786046405717783,0.25,0.8895924410422585,1.0,4/5,27.27%,FTO;ALKBH5;ALKBH1;JMJD6
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.5915450832080686,-1.1785797874134059,0.2676056338028169,1.0,1.0,4/33,11.76%,VAMP5;NECTIN3;GORASP2;AMN
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.6840931854732561,1.1784240446018177,0.26666666666666666,0.8889535719159248,1.0,1/8,3.35%,MAPK12
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.5039201505264301,1.1784097710733858,0.29545454545454547,0.8878141590864705,1.0,7/30,12.74%,LETM2;SNCA;SCNN1B;CNNM2;TMTC2;GRIN1;SLC12A2
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),-0.7491949399531963,-1.178010553287439,0.3275862068965517,1.0,1.0,1/7,15.78%,APPL2
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),-0.7491949399531963,-1.178010553287439,0.3275862068965517,1.0,1.0,1/7,15.78%,APPL2
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.625850233915739,-1.1776091745180433,0.30985915492957744,1.0,1.0,3/18,2.74%,DUOX1;NOX4;PRDX1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.46228786403772154,-1.1775827652555189,0.11764705882352941,1.0,1.0,26/104,23.24%,PSMB8;SFRP1;PSME1;PSMB6;PSMD8;PSMC5;NFATC1;PSMD7;FZD8;SFRP4;PSMD3;PSMC3;AP2S1;PSMA4;PSMD2;PSMA7;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;PSMC1;AP2A2;RHOA;CALM1;PSMD10
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.5429802441586176,1.1775184576527553,0.2647058823529412,0.889687314096323,1.0,2/33,1.33%,PDGFB;IGF1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),-0.7472420397297129,-1.1774059041880818,0.18461538461538463,1.0,1.0,1/6,0.35%,BMP5
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.7019161137103628,1.1773255336050772,0.275,0.8889614347661124,1.0,6/9,11.20%,ANXA4;MAPKBP1;SSC5D;ARRB1;OTUD7B;PTPN22
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.7577565858523231,-1.1771388004020817,0.3333333333333333,1.0,1.0,1/5,4.56%,SLC25A11
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.7577565858523231,-1.1771388004020817,0.3333333333333333,1.0,1.0,1/5,4.56%,SLC25A11
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.6632783306013794,-1.17695611224667,0.32786885245901637,1.0,1.0,3/13,8.00%,SFRP1;SFRP4;GPC3
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.5144264324254068,1.1766997745667769,0.25,0.8896310342085582,1.0,19/51,16.70%,TIAM2;EFNB3;LRP4;PLXNA1;NTRK2;KIF13B;ROBO1;ARHGAP35;PLXNB2;LRRC4C;CDH2;MCF2;ROBO2;SLIT2;PTEN;CHODL;RUFY3;PLXNA4;GSK3B
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.5181436310123966,1.1766215209725277,0.3076923076923077,0.8886930640674768,1.0,11/51,8.71%,PDGFB;PDGFC;FGFR1;FLT1;PIK3R5;EGFR;TRAF2;SASH1;ADAM8;TPD52L1;ROBO1
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.6054607160572927,1.176567703347464,0.25806451612903225,0.8876685040379437,1.0,5/14,17.45%,PTPRD;LRRC4C;NTNG1;GPC6;GPC4
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.40268078338395946,1.1765593022824852,0.13043478260869565,0.886504316511028,1.0,38/261,11.20%,CREB3L1;VDR;PDGFB;RIDA;HELLS;IGF1;ABCC2;NOS2;RUNX1;HSPA1A;ATOH8;IFNA2;AEBP2;CPEB3;CPNE1;SLC24A3;IGF2BP2;SIRT1;EIF4E2;SLC7A5;SAMD4A;SFMBT2;SYNCRIP;CCDC3;DHFR;PICALM;ZC3H12D;NANOS3;ROBO1;HSPA1B;TGFB2;TCEAL1;NFKB1;PUS7;DICER1;DNMT3A;FBXW7;PTPN22
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.571718529195558,1.176556737790435,0.28205128205128205,0.885343225227535,1.0,5/18,9.88%,CTSK;RUNX1;ERRFI1;DLL1;SULT2B1
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.5834094394136692,1.1761583040809729,0.30952380952380953,0.8854630190939867,1.0,2/11,12.99%,PLIN5;LPL
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.4985120685852174,1.1760460460476292,0.17142857142857143,0.8846608626997083,1.0,8/47,6.87%,ARAP1;CDK6;ZSWIM6;ZSWIM4;EGFR;MEMO1;NRG2;DIAPH1
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.6402952119168944,-1.1760437238077714,0.22388059701492538,1.0,1.0,7/17,20.44%,MCM4;MCM3;GINS2;GINS4;RFC4;RAD50;POLD2
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.6573493918996275,1.1759876843702926,0.25806451612903225,0.8836307282730776,1.0,3/9,18.14%,BMP6;NOTCH4;RGCC
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.5917891971286607,1.1754515469073081,0.2571428571428571,0.8841942323226774,1.0,2/15,3.57%,DACT2;GRHL2
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.596797243872061,-1.1753434681635995,0.26666666666666666,1.0,1.0,6/28,16.48%,OST4;DAD1;DPM3;MCFD2;DDOST;MAGT1
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.4345584833025343,1.1752651042907272,0.16666666666666666,0.883767653674452,1.0,25/193,11.89%,CPA1;BACE2;ADAM33;TRHDE;CTSK;VASH1;ADAM19;KLK14;CPNE1;ADAMTS9;OLR1;ATG4C;HTRA1;CPA2;CPA4;OGT;AEBP1;MALT1;LVRN;CPM;NAPSA;VASH2;MMP16;CASP7;DESI2
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.4426615621723897,1.1748478104466422,0.21052631578947367,0.8839768868005894,1.0,7/64,6.67%,VAPB;CERS3;ACER2;SPTSSB;PPM1L;SGMS1;ST8SIA1
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.7713992063686304,-1.174844257044347,0.2631578947368421,1.0,1.0,2/5,16.94%,HSPA5;UFL1
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.5667189663628904,-1.1746990554066932,0.18840579710144928,1.0,1.0,16/36,29.88%,LSM2;PRPF3;SNRPD1;PRPF6;SNRPD2;PRPF8;DDX20;SMN1;GEMIN6;SART3;SRSF10;USP4;SNRPE;SNUPN;SNRPG;GEMIN2
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.5724986480335487,1.1742964554134832,0.2,0.8848898463914376,1.0,6/16,14.58%,KAT2A;RUNX1;DUSP10;IL2RA;SOX12;CBFB
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),0.6289755421157065,1.1742537923229406,0.2894736842105263,0.8838837716487091,1.0,4/13,10.53%,SRC;RASIP1;FBLIM1;CXCL13
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.479308105392596,-1.1741276361105673,0.1625,1.0,1.0,21/88,17.51%,MCM2;RMI1;AP5S1;MCM4;MCM3;RPA3;FANCM;RAD51AP1;BRCA1;KDM4D;GINS2;PARP1;MEIOB;SFR1;GINS4;GEN1;MUS81;RAD50;XRCC2;XRCC3;MCM5
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),-0.8275349681126505,-1.1740186256179326,0.15789473684210525,1.0,1.0,2/5,11.72%,B2M;BDNF
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-0.7571098760023804,-1.1736663381254484,0.26229508196721313,1.0,1.0,1/5,0.89%,GLYCTK
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),-0.7571098760023804,-1.1736663381254484,0.26229508196721313,1.0,1.0,1/5,0.89%,GLYCTK
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.734381471597819,-1.1733984614018902,0.2857142857142857,1.0,1.0,1/6,12.38%,STAT1
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.734381471597819,-1.1733984614018902,0.2857142857142857,1.0,1.0,1/6,12.38%,STAT1
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.7194584143455487,1.1733206713748823,0.2978723404255319,0.8853915170752898,1.0,1/5,2.83%,SRC
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5028377748662775,1.1732711915963816,0.23333333333333334,0.8843172740825677,1.0,12/37,15.76%,SPRY2;SPRED3;SPRED2;DUSP6;SPRED1;DUSP10;SMAD4;DLG1;PTEN;GPER1;PTPRR;RPS6KA6
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.5287977694488735,-1.1731712616186394,0.21875,1.0,1.0,3/52,0.47%,CD44;P2RY10;DPEP2
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.7145197644846797,1.1729109031082308,0.34146341463414637,0.8842091522023172,1.0,3/5,16.58%,CHD7;DRD2;ADCYAP1
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.469643095516137,1.1727943657322193,0.19444444444444445,0.8832442192603848,1.0,10/41,18.35%,ISYNA1;IP6K2;INPP1;NUDT3;PLCD3;IPMK;PTEN;INPP5D;INPP5B;ITPKC
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),-0.7285236373507988,-1.1725959808365722,0.26153846153846155,1.0,1.0,3/6,16.53%,CHRM5;CHRM2;OPRM1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3890806307917457,1.172542153772497,0.0,0.882963094223717,1.0,37/325,7.59%,ZAP70;PDGFB;SH2B2;PDGFC;NFATC4;FGFR1;IGF1;GALNT3;ATP6V0A4;LCP2;CASS4;FLT1;IRS1;MAPK11;FGFR3;SRC;ALK;EFNB3;NRP2;VEGFD;SPRED2;ARHGEF7;FGF17;EGFR;CNKSR1;PDGFRA;GRB14;EPHA3;SPRED1;FRK;AKT2;SORBS1;ELMO1;CYBA;DOCK1;IGF1R;HAP1
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),-0.7370710968273697,-1.172538580196616,0.3225806451612903,1.0,1.0,2/6,13.20%,EXOSC4;EXOSC10
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.7545009097451205,-1.1724796137736868,0.2647058823529412,1.0,1.0,1/5,7.89%,SF3A1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.5027854613623379,1.1713660138519222,0.27586206896551724,0.8856659770806649,1.0,5/37,8.86%,F2;PLK1;MFHAS1;SESN2;OTUD7B
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.7291276299617013,1.1713514909808556,0.35,0.8845635325394549,1.0,2/7,14.04%,PICALM;RAB3B
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.8032218704732335,-1.171284298894977,0.2711864406779661,1.0,1.0,2/5,17.78%,ABCA12;APOE
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.621852847166301,-1.171035029854808,0.29850746268656714,1.0,1.0,4/20,3.86%,RPL23;RPL5;RPS7;RPL11
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.5053684175108611,1.1710277677174494,0.2,0.8845253963834766,1.0,3/33,6.87%,F2;SNCA;DIAPH1
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.5017379547527657,-1.170986225379991,0.21621621621621623,1.0,1.0,19/91,15.01%,PLAAT4;PM20D1;PLAAT5;ACOT2;DBI;ORMDL2;MTHFD1;OXSM;ORMDL1;PDZD11;ACSM6;DHFR2;SMPD2;SGPL1;ACSM3;ABCA12;ACOT1;ASAH2;NIT1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.7393805028528048,1.1705812916061047,0.32432432432432434,0.8850955889253637,1.0,4/5,24.52%,HS2ST1;HS3ST5;HS6ST3;HS6ST1
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.5715385696756579,-1.1704072764955866,0.2571428571428571,1.0,1.0,6/30,9.73%,MCM2;POLE3;MCM4;ORC6;MCM3;RPA3
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.619401765552517,-1.1703682832274758,0.29508196721311475,1.0,1.0,2/17,7.59%,DTX3L;RNF8
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.5656518343129797,1.1703641429429168,0.24324324324324326,0.8846403308267173,1.0,6/21,14.05%,SRC;IFNA2;EGFR;SNCA;PTH1R;PTGES3
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.5557729733215688,1.1700592254677318,0.3,0.8843075840321777,1.0,8/17,25.13%,HAP1;MARK1;TRAK1;MARK2;MTM1;MFN1;TLE6;TRAK2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),0.694063637903521,1.1698862791486433,0.3235294117647059,0.8837506633598855,1.0,2/5,25.39%,FGF1;SCAP
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.700649417837067,1.1698693949691013,0.2857142857142857,0.8826246776004603,1.0,3/7,11.91%,PHYH;HMGCR;MVD
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.6845617739669292,-1.1694797710011502,0.30357142857142855,1.0,1.0,2/10,4.81%,EDF1;MESP1
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.7324932975609136,-1.1693898822975115,0.21666666666666667,1.0,1.0,3/7,18.16%,TGFB1;TNFRSF1A;CST3
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.6503361390507294,-1.1693383870743865,0.35,1.0,1.0,5/9,25.20%,VPS35;DNM1L;BAX;FIS1;BNIP3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.5433493120539042,-1.1688931283367368,0.18571428571428572,1.0,1.0,3/45,8.28%,ARHGEF16;RHOG;RACK1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.4917430583954191,-1.1685464805752694,0.2777777777777778,1.0,1.0,9/78,11.72%,CD44;RACK1;CAMK1;IRGM;HAX1;TGFB1;MTCP1;PINK1;BDNF
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),-0.7259223593277084,-1.168352929565918,0.36363636363636365,1.0,1.0,2/6,12.93%,LARP6;EIF3D
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.6555288691100785,-1.1682663641474413,0.2898550724637681,1.0,1.0,2/14,12.22%,RIMS1;FLOT1
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.6715044428473719,1.1680794826289682,0.2,0.887613668094629,1.0,1/12,0.60%,BACE2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.6266645515200719,-1.16794652047544,0.2631578947368421,1.0,1.0,1/17,1.72%,BEX3
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.4172524034438506,1.167874729252121,0.19047619047619047,0.8871236111168543,1.0,23/75,19.99%,ATP6V0A4;ZBTB7C;TACC2;ALDH1L1;DNAAF1;PDZD2;PROM2;FRK;BPIFB1;SCIN;ATP6V0D2;SCNN1B;CCDC30;ESRRG;HYDIN;WFDC2;MUC20;NWD1;ITGB8;CCDC60;ERBB4;DNAH7;SLC22A6
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.7560432712381147,1.1678605054488083,0.32608695652173914,0.8859976318129978,1.0,3/5,18.36%,CAMSAP3;PLEKHA7;TJP1
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.5837529572918009,1.167593249770608,0.28888888888888886,0.8858033001412055,1.0,1/15,1.33%,IGF1
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),0.6946916885616397,1.1673594637698608,0.37142857142857144,0.8854720523932567,1.0,2/7,12.63%,SLC29A2;SLC22A2
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.786000411779354,-1.1673267029983114,0.27586206896551724,1.0,1.0,4/8,17.78%,DBI;PRELID1;TRIAP1;APOE
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.5688863407359234,-1.1671737877362771,0.22580645161290322,1.0,1.0,5/28,18.07%,ACOT2;ELOVL2;SLC27A5;ACOT1;ELOVL1
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.5688452484375576,-1.1664304573148516,0.2459016393442623,1.0,1.0,10/33,24.42%,RPS27A;UBA52;MAD2L1BP;PHB2;UBB;ANAPC15;CDC23;ZW10;CDC20;UBC
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),-0.7385689078955782,-1.1661075685528255,0.24074074074074073,1.0,1.0,2/7,12.38%,TGFBR2;STAT1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.497507081681559,1.1658845983723514,0.13793103448275862,0.8891044382414354,1.0,12/55,17.33%,RELN;NLGN1;NPTX2;CACNG5;CACNG4;DLG2;DLG1;GRIN1;DLG3;SHISA9;GRIN2B;GRIA2
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.5547857864724256,1.1655593483761246,0.2857142857142857,0.8890953329454805,1.0,3/29,3.48%,F2;NLRP7;TM4SF20
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.6340835697526768,-1.1655462862608927,0.3287671232876712,1.0,1.0,2/14,4.45%,NPR2;NPPC
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.44500090230183514,-1.1654523211177625,0.14457831325301204,1.0,1.0,52/265,21.19%,RPS27A;PARP2;DTX3L;NUDT1;CENPX;ALKBH2;APEX1;USP1;PNKP;RAD23A;PCNA;EME1;UBA52;MPG;RNF8;NOP53;FAM111A;UBXN1;CETN2;ABRAXAS1;WDHD1;RPA3;FANCM;RAD51AP1;TEX264;RFC2;BRCA1;PARP1;SPRTN;KPNA2;UBB;MGME1;MBD4;KAT5;MUS81;RFC4;PARP9;FANCD2;REXO4;RAD50;XRCC2;XRCC3;XPA;FANCF;GTF2H2;FANCI;RECQL;DDX1;ERCC8;POLD2;POLD4;POLQ
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.5140724611944191,1.1652836425684645,0.20689655172413793,0.8889664741428961,1.0,10/30,22.63%,BICDL1;HAP1;ARHGAP21;RHOT1;BORCS5;MAPT;TRAK1;NDE1;BICD2;FBXW11
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.6923735667729198,1.1652098039372663,0.37777777777777777,0.8868323444140426,1.0,5/5,30.78%,SLC8A1;RYR3;RYR2;CASQ2;RYR1
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.6923735667729198,1.1652098039372663,0.37777777777777777,0.8868323444140426,1.0,5/5,30.78%,SLC8A1;RYR3;RYR2;CASQ2;RYR1
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),0.6236576110427735,1.1651575527006226,0.2631578947368421,0.8859568631965029,1.0,1/11,0.36%,KCNN4
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.6996213945626377,-1.1650661502706243,0.30158730158730157,1.0,1.0,3/9,20.80%,EFNA1;ATRAID;FURIN
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.5951021863263602,1.1647525363294386,0.22857142857142856,0.8860539682565604,1.0,7/23,13.85%,SLC7A9;SLC7A1;SLC7A2;SLC7A5;SLC25A18;SLC38A2;SLC1A2
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.608688904368204,1.1645601717066123,0.3076923076923077,0.8855387496807514,1.0,5/11,16.21%,RUNX1;MAFB;CBFB;IL17D;CREBBP
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.5389196949823206,1.1644195556873722,0.23684210526315788,0.8848889962466937,1.0,3/24,6.48%,SLC26A7;SLC26A6;SLC13A4
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.6720388164111384,-1.1637886133993238,0.3,1.0,1.0,5/7,26.05%,HAX1;PINK1;ATP5IF1;SREBF1;DNAJA1
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.6477602779079736,-1.1634094800494892,0.2608695652173913,1.0,1.0,1/10,0.35%,BMP5
prerank,PanglaoDB_Augmented_2021__Interneurons,0.39010227708074463,1.1632570611139483,0.0,0.8875987687378359,1.0,68/271,15.63%,RELN;ETV1;CLDN9;KCNQ2;VEGFD;KCNIP2;CELF3;MMD2;DLX1;LYPD1;L1CAM;NRIP3;CACNA1I;SCRT1;VGF;CTNND2;FRYL;OLFM3;ELMO1;NCALD;ADGRB3;SPOCK3;AMER2;NPY;HAP1;AGAP1;HIVEP2;CTNNA2;PCDH8;PSD2;NXPH1;GRM1;SNAP91;ADARB1;KCNMA1;GRM3;CDH4;CASK;UNC13A;NBEA;FAM81A;KCNC2;NMB;PCF11;CAMKV;NCAN;ARX;DNAJC6;ACSL4;NRXN1;DCAF7;NTNG1;ADCY8;PNOC;PTPN4;SLC8A2;ARHGAP21;TMEM132D;RAB3B;CDK17;FBXO11;CADM2;TIMELESS;PVALB;CALN1;SHISA9;CPNE5;CA10
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.6114335094524126,-1.1628820508020625,0.26666666666666666,1.0,1.0,1/22,0.07%,CD44
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.6069486945099345,1.1628003846264405,0.2972972972972973,0.8879812376594012,1.0,7/15,17.35%,NLGN4X;NLGN1;NCAM2;NRXN1;NLGN3;ASTN2;CEL
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.5777592526471101,1.1627331021698903,0.21875,0.8870263711727967,1.0,5/16,13.70%,SPTSSB;FEM1A;HMBOX1;FEM1B;LDB2
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.7059787265128923,-1.1627218441647507,0.3684210526315789,1.0,1.0,2/9,11.43%,APEX1;TFIP11
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.5296007091200292,-1.1626427217768973,0.25,1.0,1.0,10/45,20.92%,TRPM1;USP1;USF1;OPN4;SLC24A1;SPRTN;CIRBP;GTF2H2;ERCC8;UVSSA
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.48797410895029014,1.162562376163158,0.25,0.886513180017927,1.0,10/36,12.09%,CLDN15;CLDN9;GRHL2;CLDN12;FRMPD2;ESAM;TBCD;PARD6B;DLG1;AFDN
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.5110355885334659,-1.162419488271261,0.24285714285714285,1.0,1.0,6/59,6.83%,ARHGEF16;ENTPD2;TMC4;EFNA1;TMEM125;OVOL2
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.741104630950828,1.1622102404380443,0.225,0.8863893712150346,1.0,2/5,17.40%,CNTNAP2;CNTNAP1
prerank,MSigDB_Hallmark_2020__Myogenesis,0.42578720820227045,1.1619806180319676,0.1388888888888889,0.8860805021763789,1.0,28/142,11.35%,TNNC2;IGF1;PDLIM7;TCAP;TPM2;MYOM1;MYH3;MYH4;VIPR1;CTF1;MAPK12;GNAO1;SMTN;PDE4DIP;PTP4A3;AGRN;AKT2;CKM;SORBS1;REEP1;NCAM1;TPD52L1;SGCG;ENO3;AEBP1;MRAS;PLXNB2;SGCD
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.6379499757552354,1.1619543967276607,0.34210526315789475,0.8850655166924605,1.0,3/11,9.79%,KCNJ2;AKAP6;CACNA2D1
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.45983763303429037,1.1617039353989753,0.28,0.8847927092075761,1.0,14/64,16.43%,TP63;IGF1;CDK6;BMP6;HEMGN;ACVR1;NPNT;CHRD;PRKD1;BMPR2;CRIM1;ACVR2B;DNAI3;ACVR2A
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.7238882964970678,1.161616998663044,0.2894736842105263,0.8838658344278758,1.0,2/6,13.82%,PLIN5;GPLD1
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.6419228815823533,-1.1614174232071373,0.2698412698412698,1.0,1.0,3/16,3.96%,PSMB8;CSTB;SVBP
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),-0.7153955451867897,-1.160869253746628,0.234375,1.0,1.0,2/6,18.64%,GREM1;FSTL1
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.7262556068505956,-1.1605534452306383,0.29850746268656714,1.0,1.0,1/6,6.81%,TRMT112
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.5164567879701448,-1.1605208064866723,0.26229508196721313,1.0,1.0,6/54,9.57%,ARHGEF16;BTN3A1;TMEM125;SGMS2;OVOL2;ITGB4
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.49438468379391487,1.160455688493776,0.23333333333333334,0.886512756061741,1.0,13/22,28.26%,SLC4A4;AP3D1;CAMK2D;SLC4A7;KLHL3;SLC30A3;WNK1;SLC4A10;FHL1;SLC30A8;WNK2;SLC4A3;UNC80
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.6708247086792655,1.160155972335445,0.3409090909090909,0.8862726534963224,1.0,4/6,32.72%,GSK3B;MARK4;APC;BICD1
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.6220113837825257,-1.159871269640891,0.23809523809523808,1.0,1.0,5/17,12.28%,PSME1;PRELID1;APH1A;PINK1;GRN
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.622224621113346,-1.1595673270009137,0.25806451612903225,1.0,1.0,3/16,7.24%,B2M;HLA-A;CD81
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.7164175261029313,1.1594319074086614,0.27906976744186046,0.8874715445967504,1.0,4/5,27.67%,PTPN22;HMGB1;RSAD2;RTN4
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.4742053092092365,1.1594188135114547,0.2903225806451613,0.8864123189334702,1.0,21/77,13.41%,ADAM33;ITGA11;PCDH18;PDGFRA;POSTN;HMCN1;ADGRA2;SSC5D;ADAMTS2;MSRB3;CDH11;RHOJ;COL14A1;CACNA2D1;COL5A1;SGCD;AQP1;SLIT3;ADAMTS5;VSTM4;SLIT2
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.45476948735311545,1.159254108988058,0.23809523809523808,0.8858729337975011,1.0,22/89,15.28%,LIFR;EFNB3;NXN;GLRB;LRP4;EYA4;GLI2;OBSL1;EPB41L1;ZFHX4;MEX3A;CHST3;MEIS3;CACNA2D1;CD276;TEAD1;CDH2;SLIT2;FIGN;MPDZ;GPC6;ADAMTS15
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.46670691879932646,-1.1589305395888694,0.2,1.0,1.0,21/77,24.40%,HLA-DPA1;DCTN3;CENPE;ARF1;DCTN2;DCTN6;KIF18A;AP2S1;CLTA;CANX;DYNLL1;DCTN1;KIF4A;HLA-DRB1;HLA-DRA;AP1S1;AP2A2;HLA-DPB1;KIF22;CTSS;CTSL
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),-0.7107984941973027,-1.1587512376539384,0.2903225806451613,1.0,1.0,1/6,0.35%,BMP5
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,0.5592041453139629,1.158380178381262,0.28,0.8876010524899136,1.0,5/21,5.78%,NUPR1;TP63;TRIM29;POSTN;PROM2
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.5207442218051949,1.1581767445092066,0.2564102564102564,0.8869949616894598,1.0,5/39,9.77%,FGFR1;SNAI1;LEF1;NOTCH4;TGFB2
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.5478683349727748,-1.1581131277719041,0.22727272727272727,1.0,1.0,8/30,21.48%,IFIT2;CLU;VPS35;IFI6;TIMM50;DNM1L;BAX;FIS1
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.6634592092628186,-1.1581122573191835,0.2714285714285714,1.0,1.0,4/10,22.62%,MUS81;REXO4;ISG20;DNASE1L1
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.6506573207073821,-1.1580001955229036,0.26666666666666666,1.0,1.0,1/10,5.81%,ADRM1
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.6724290462743864,-1.1579371531289757,0.24615384615384617,1.0,1.0,2/10,3.15%,MT1E;MT2A
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.5551000794670355,1.1573426950594865,0.21428571428571427,0.8884514423141311,1.0,3/16,12.13%,PLIN5;AUP1;CDS1
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.6311064047101379,-1.1573315636982493,0.3114754098360656,1.0,1.0,1/13,0.98%,ENTPD2
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.4690699333371531,-1.1572884843809181,0.17391304347826086,1.0,1.0,13/92,14.68%,SLC8A3;PKMYT1;CCNB2;CNPPD1;CDC37;SERTAD1;CAMK1;IRGM;MTCP1;CCNJL;CCNE2;SYAP1;SNF8
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.5287009724007683,-1.1566944973429727,0.25757575757575757,1.0,1.0,3/42,4.15%,APIP;B2M;ALDH1A2
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.5040016915983664,1.156653759198592,0.2222222222222222,0.8893232751653913,1.0,7/33,16.33%,NUPR1;TBC1D12;PIP4K2A;IFT88;TMEM39A;SCFD1;LRSAM1
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.6969571508526866,-1.1563309606162946,0.2786885245901639,1.0,1.0,2/9,9.97%,FBXO43;TOM1L1
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),0.6515392388310373,1.1562742633777923,0.3684210526315789,0.8894799944525785,1.0,3/6,16.28%,TEKT5;CFAP54;DNAI3
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.6398989495557259,1.1562419844515468,0.2777777777777778,0.8884937066022895,1.0,2/13,7.86%,BAG2;ADAM8
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),-0.7120316105270409,-1.1562310530336941,0.2708333333333333,1.0,1.0,1/5,5.76%,HYAL2
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),-0.7374276120068266,-1.1560871140264768,0.3,1.0,1.0,3/5,14.21%,HLA-A;HLA-E;STOML2
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.51883963187295,-1.1560288722124434,0.26229508196721313,1.0,1.0,6/35,10.91%,BTN3A1;ZFPM1;HLA-DPA1;HLA-A;RASGRP1;FADD
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.4563643896126439,-1.1553369444173693,0.14102564102564102,1.0,1.0,18/182,10.69%,DDIT3;HSPE1;MCM2;SDF2L1;XBP1;GAPDH;BUB1;LDHA;PRDX1;CD9;MCM4;EIF2S2;PFKL;CALR;COPS5;HSPA5;SCD;PNO1
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.6978965387179905,-1.155097334809048,0.2835820895522388,1.0,1.0,3/10,12.28%,IL31RA;SYT11;GRN
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.5353858660555988,-1.155046059640475,0.234375,1.0,1.0,3/32,7.80%,CENPF;HYAL2;PAX8
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.5420117660164641,1.1549698016089265,0.26666666666666666,0.8920746784811796,1.0,5/26,8.56%,SPIRE2;PSTPIP1;DIAPH1;COBL;SPIRE1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.42502137674505397,1.1547775605331334,0.16129032258064516,0.8916162217483765,1.0,5/53,3.31%,PDGFB;CDK6;CASS4;VIT;ARHGEF7
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.7335164366902176,1.1546060924280221,0.28205128205128205,0.8909114216126138,1.0,2/5,15.55%,AKT2;C2CD5
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.6397061655607023,-1.1543637777419766,0.26666666666666666,1.0,1.0,4/12,25.61%,ELOVL2;ELOVL1;FADS2;ACOT8
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.44810910764516687,-1.1540710262115579,0.20833333333333334,1.0,1.0,25/155,15.07%,TOMM7;SLC25A4;COX7A1;SLC25A6;IFIT2;DNAJC19;TIMM8B;TSPO;TIMM10;CHCHD2;ATP23;PHB2;RAB32;TOMM20;ATP5F1B;HAX1;COX7A2;PINK1;RAB5IF;AFG3L2;TIMM50;PARP1;STOML2;MGME1;CAV2
prerank,GO_Biological_Process_2021__negative regulation of meiotic cell cycle (GO:0051447),-0.7454548126924415,-1.1539483928149543,0.27692307692307694,1.0,1.0,2/5,4.45%,FBXO43;NPPC
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.6297343825342939,1.1534308270401104,0.30434782608695654,0.8931414465027168,1.0,1/12,0.51%,NUPR1
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),-0.726840231158954,-1.1532904767931944,0.3181818181818182,1.0,1.0,2/5,3.97%,SLC22A4;PDZK1
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.6632196841902745,-1.152907295746466,0.3283582089552239,1.0,1.0,2/11,7.25%,CSTF2T;FIP1L1
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.4741946462592333,-1.1527901977623078,0.2,1.0,1.0,16/86,17.62%,RPS27A;COPS6;POLE3;COPS7A;UBA52;COPS5;CETN2;CENPH;NUF2;SOX15;RBX1;PARP1;UBB;HMGN2;GATAD1;XPA
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.7618634389348538,-1.1527451850965058,0.21311475409836064,1.0,1.0,1/5,6.21%,FABP3
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.47658410252831457,-1.1525494232199514,0.21176470588235294,1.0,1.0,32/133,22.50%,PSME1;EHHADH;LDHA;H2AZ1;ACOT2;IDH3B;APEX1;CA6;RETSAT;HCCS;CBR3;CBR1;BPHL;IDH3G;ACSM3;TP53INP2;UROD;DECR1;LGALS1;PDHB;MDH2;MDH1;GAPDHS;HMGCL;EPHX1;GSTZ1;HSD17B10;PTS;HPGD;FASN;GPD1;ECHS1
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.742131444254897,1.1523225054281665,0.35135135135135137,0.8954153518905938,1.0,4/5,25.72%,ALDH1A1;ABAT;GAD1;GAD2
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.4577717727395902,-1.1522688207530638,0.2375,1.0,1.0,23/129,15.19%,SLC28A2;BEST1;SELENOS;AQP9;TIMP1;IFNGR2;PTAFR;RHOG;ADRM1;SGMS2;IRF1;LCK;GPC3;RASGRP1;GPR183;SRI;SELE;OSMR;VIP;CXCR6;EDN1;AHR;NMI
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.6761587434227445,1.1518231581664962,0.358974358974359,0.8958755406038871,1.0,3/10,15.90%,SESN2;SESN1;KPTN
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.729994142782556,-1.1517030318068415,0.36065573770491804,1.0,1.0,1/5,3.59%,RPS3
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.5946626269348511,-1.1516289316985222,0.28169014084507044,1.0,1.0,1/20,0.72%,MPV17L2
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.5666188470140139,-1.1513460679598937,0.17142857142857143,1.0,1.0,14/25,35.13%,PRPF3;PRPF6;PRPF4;PRPF8;WDR83;SRSF10;MPHOSPH10;SF3B4;GEMIN2;DDX23;SLU7;SMNDC1;LSM1;SF3A3
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.6307086772702235,1.1512649171463252,0.2571428571428571,0.8967614480849964,1.0,5/15,6.07%,IL1RAPL1;PTPRD;LRP4;NLGN4X;NLGN1
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.5976345484494097,-1.1511267384802009,0.2982456140350877,1.0,1.0,4/21,14.02%,TGFBR2;MESP1;TGFB1;MYH6
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),0.47602377093434267,1.150996552929497,0.22580645161290322,0.8964973815689825,1.0,5/38,4.72%,PDGFB;PDGFC;IGF1;CDK6;PDGFRA
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.5671527646375681,1.1507560360282327,0.325,0.8959227983591846,1.0,8/21,20.00%,HELLS;DNMT3A;TEX15;ATRX;EHMT1;MTRR;PPM1D;PICK1
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.5286847043932292,1.1507266815917614,0.23076923076923078,0.8949243396438676,1.0,8/29,17.33%,RELN;NLGN1;DLG2;DLG1;GRIN1;DLG3;GRIN2B;GRIA2
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.5622773332312648,-1.150652592356822,0.2777777777777778,1.0,1.0,4/30,4.81%,BMP5;TTN;ZFPM1;MESP1
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.4605432991138595,1.1505979721708706,0.2631578947368421,0.8943040732976056,1.0,21/110,11.21%,ZNF423;LIFR;RUNX1;EGFR;ERRFI1;CSPG4;LIMCH1;FOXK1;TMEM47;OBSL1;DOCK1;NOTCH3;RND3;EPB41L1;COL6A1;NCAM1;CHST3;HTRA1;CD276;NUAK1;TEAD1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.6237864350984582,-1.1505086620143798,0.3283582089552239,1.0,1.0,7/17,22.83%,VPS35;CD81;ATP5IF1;PTTG1IP;APOE;DACT1;MSN
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),0.7073648896713852,1.1504350028588681,0.23809523809523808,0.8936690045842718,1.0,1/6,0.34%,PDGFB
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.5386380475890176,1.1501783151074472,0.28,0.8935895882641688,1.0,2/11,9.52%,NOS2;STIM1
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.5111044194607621,-1.1501218065948173,0.23684210526315788,1.0,1.0,10/42,14.16%,PM20D1;CPS1;DEGS1;SGMS2;DEGS2;SLC25A15;PCSK1;ARG2;SMPD2;ASAH2
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.7000233258533184,-1.1499692449908534,0.3389830508474576,1.0,1.0,2/5,19.73%,DPM3;DPY19L2
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.7000233258533184,-1.1499692449908534,0.3389830508474576,1.0,1.0,2/5,19.73%,DPM3;DPY19L2
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.5896494124336652,1.1499390226339468,0.25,0.8932987603794199,1.0,8/10,37.35%,MGAT5;CRLF2;HES1;JAK3;DOT1L;PTPRC;JAK2;PTPRT
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.5895040188349723,-1.1498832226270577,0.24242424242424243,1.0,1.0,10/20,32.41%,CLU;GNPTAB;HSPA8;NAGPA;AP3M1;M6PR;AP4M1;HGS;NEDD4;NCOA4
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.6971930399047636,1.1495323073043968,0.25,0.8932362452128072,1.0,2/9,16.31%,NAF1;SHQ1
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.6649118322823884,1.1492851048627082,0.38095238095238093,0.8919277526032883,1.0,2/6,28.32%,MAGI2;IQGAP1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.6649118322823884,1.1492851048627082,0.38095238095238093,0.8919277526032883,1.0,2/6,28.32%,MAGI2;IQGAP1
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.6639661060492363,-1.149223284580251,0.288135593220339,1.0,1.0,1/12,0.55%,GATA1
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.6037806968496856,1.1491831415240985,0.32608695652173914,0.8910410087284847,1.0,7/14,19.65%,SLC39A8;TRPC5;ATP2C1;TMEM165;TRPC7;SLC30A10;SLC39A14
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.6409645780180983,-1.1490876998836097,0.29310344827586204,1.0,1.0,2/16,5.47%,MCM2;MCM4
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.5174392224495112,-1.1490774624496187,0.2857142857142857,1.0,1.0,2/51,0.50%,GPX4;PLAAT4
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.5144334517661316,1.1489288169634333,0.23684210526315788,0.8907550267504664,1.0,11/32,15.21%,NUPR1;KAT2A;CDK10;EVI5L;CCP110;SMAD4;CEP97;TMEM39A;TESK1;KAT2B;SCFD1
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),0.7506638953734521,1.1488509572810515,0.325,0.8899041638384809,1.0,1/5,16.03%,SYK
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.7477439302129092,-1.1488348269990678,0.2903225806451613,1.0,1.0,2/5,11.08%,ATG14;GPS2
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.6547562330112717,-1.148807291936144,0.3220338983050847,1.0,1.0,2/10,14.71%,STAT1;CANX
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.6048754126322904,1.1485023389878615,0.3076923076923077,0.8898300617349318,1.0,1/8,3.83%,ADAM19
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.725977992801838,-1.1484546206789954,0.3064516129032258,1.0,1.0,2/6,3.97%,SLC22A4;PDZK1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.6875698578298298,-1.1484535064540855,0.2777777777777778,1.0,1.0,3/10,11.32%,HLA-F;TGFB1;CUEDC2
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.5967970530737753,1.1484428679365006,0.36585365853658536,0.8889501268666029,1.0,4/10,24.39%,BCL2L1;DFFA;FZD3;TP53
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.4946314233522354,-1.148251221261061,0.2602739726027397,1.0,1.0,8/62,11.72%,CD44;CAMK1;IRGM;HAX1;TGFB1;MTCP1;PINK1;BDNF
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.5099949459252849,1.1481791328484228,0.21621621621621623,0.8888290503380011,1.0,7/32,9.36%,RAB27A;SYTL4;SNCA;RAB27B;UNC13D;STXBP5;CADPS
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.5668528194881511,-1.1481717438498251,0.2638888888888889,1.0,1.0,8/29,20.12%,POLR1G;POLR2L;POLR1F;POLR1H;TTF1;TAF1D;GTF2H2;POLR1E
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.558019854779025,-1.1481562116113582,0.3088235294117647,1.0,1.0,9/23,30.69%,PEX11A;PEX10;PEX11G;DNM1L;PEX1;FIS1;ACOT8;PEX16;PEX12
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.5688984576495725,-1.1479866719411767,0.28169014084507044,1.0,1.0,6/32,14.07%,ENTPD2;NUDT1;ADPRM;NUDT18;ENTPD3;NUDT15
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),0.7255658610007224,1.1478696929710723,0.3170731707317073,0.888869079545018,1.0,2/5,23.17%,MAFB;ZFP36
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.533743504506623,-1.1477189685962386,0.2876712328767123,1.0,1.0,9/38,19.00%,B2M;CLU;GPC3;VPS28;FLOT1;APPL2;CALY;APOE;SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.6868927154904185,-1.147650393820247,0.3230769230769231,1.0,1.0,2/6,14.05%,C1QBP;GPATCH3
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.5519443770777821,-1.1474671683036073,0.25,1.0,1.0,9/34,13.77%,RPL23;RPL5;RPS7;RPL11;NOP53;UBXN1;PDCL3;GIPC1;CAMLG
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),0.6680410545713209,1.1473005331827082,0.3888888888888889,0.889535434621301,1.0,3/6,16.85%,GLS;PYCR1;ALDH18A1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.6310765760960078,1.1470418345882774,0.34375,0.8894140914922564,1.0,2/8,6.23%,ADGRB1;EHD2
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.7992137371315289,-1.1470281836905163,0.288135593220339,1.0,1.0,2/6,6.81%,BUD23;TRMT112
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.6138005180932473,-1.1467106321691058,0.296875,1.0,1.0,1/18,0.77%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.6310005029974947,-1.1466775848979949,0.32857142857142857,1.0,1.0,10/19,25.20%,HRK;PINK1;PPIF;CIDEB;DNM1L;BAX;MOAP1;PDCD5;PLAUR;BNIP3
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.7464845556908872,1.1465722064599804,0.4,0.8899019356492758,1.0,3/5,18.16%,PGAP1;PIGT;PIGK
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.6523683659726041,1.1465665999004626,0.24444444444444444,0.8888521892249344,1.0,3/8,13.27%,HSPB1;GAB1;PRKD1
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.7346857927933592,-1.1465561896370315,0.36666666666666664,1.0,1.0,1/5,14.07%,NUDT15
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.5448616832223311,-1.1465492329527338,0.28169014084507044,1.0,1.0,1/26,0.35%,BMP5
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.6827113347632819,-1.1462878898225612,0.3387096774193548,1.0,1.0,3/7,30.33%,GARS1;AARS2;DARS2
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.6344957675493148,1.1462124229730821,0.3409090909090909,0.8889239218502842,1.0,3/9,11.56%,SIRT1;DIP2B;KLF15
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.7804531457598916,-1.1461767387428885,0.20689655172413793,1.0,1.0,2/5,12.16%,IDH3B;IDH3G
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.6059444560009908,-1.1461347820894097,0.29508196721311475,1.0,1.0,4/13,11.39%,HLA-A;HLA-E;WFDC3;RPL39
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.4444326305606488,1.1460257399223313,0.20833333333333334,0.8885484307452541,1.0,15/84,10.83%,PDGFB;PDGFC;FGFR1;FLT1;SRC;PIK3R5;EGFR;SNCA;SIRT1;PKD1;ADAM8;TPD52L1;ROBO1;DIRAS2;PARP16
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.7097822819854789,-1.1458323288468852,0.3389830508474576,1.0,1.0,2/7,4.38%,RPS3;DDX11
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.5751943105884421,1.1456909283939136,0.23333333333333334,0.8882695184112923,1.0,2/20,1.79%,GPR35;CBARP
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.6522531518536424,-1.145505546151888,0.3939393939393939,1.0,1.0,1/9,2.83%,JUP
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.4819472989483594,1.1453290581576825,0.25806451612903225,0.8885009699713019,1.0,8/52,10.22%,ZAP70;CHRNA4;IFNA2;HDAC4;CD22;LAT2;NHEJ1;MALT1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.6827267912171567,-1.1451792740332385,0.375,1.0,1.0,4/8,24.89%,TGFB1;GREM1;MYOCD;EFNB2
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.5121778889034698,1.1450373685132296,0.2727272727272727,0.8883182330104199,1.0,6/20,20.53%,SRC;ROBO2;PTEN;SLIT1;CORO1C;PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),-0.6964496398904052,-1.1449084935853646,0.2878787878787879,1.0,1.0,3/7,17.68%,SFRP1;ATRAID;GREM1
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.679992791931312,1.144693233437324,0.3448275862068966,0.8883583936386704,1.0,4/8,28.96%,KDM1B;KDM1A;KDM5B;KDM5A
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.47075890936470993,-1.1445740684757206,0.22077922077922077,1.0,1.0,29/139,19.41%,CENPF;RPS27;BUB1;STMN1;CENPE;SBDS;MIS12;RAB11A;ERCC6L;CENPK;ABRAXAS1;CENPH;NUF2;TPX2;CENPQ;DCTN2;NEK6;SPDL1;DCTN6;KIF18A;ZWILCH;DYNLL1;CENPN;KIF4A;ITGB3BP;PTPA;GOLGA2;CENPU;WRAP73
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.4992547349185586,1.1444915209057454,0.3170731707317073,0.8880651606575807,1.0,4/34,9.08%,KAT2A;LEF1;NOTCH4;DLL1
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.4078931229697203,1.1442661253877486,0.2,0.8877250658164547,1.0,21/60,20.94%,GALNT3;CDK10;NLK;TNKS;ACVR1;DYRK3;GALNT2;PRKD1;GALNT16;HIPK2;DYRK1A;HIPK3;GALNTL6;GSK3B;CAMK2D;MAPK8;SBK1;GALNT11;WNK1;MARK2;MAP3K10
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.6988393453207581,-1.1441962601999707,0.25862068965517243,1.0,1.0,3/8,20.99%,PDZD11;CRB2;WDR1
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.6988393453207581,-1.1441962601999707,0.25862068965517243,1.0,1.0,3/8,20.99%,PDZD11;CRB2;WDR1
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.5995754934318429,-1.1437274354924463,0.3230769230769231,1.0,1.0,2/15,10.26%,DCTN2;CEP131
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.5736721996634814,1.1434565454691101,0.2903225806451613,0.8891116538710858,1.0,7/18,20.81%,UNC13A;GRID1;CDH8;GRIK2;NAPB;GRIA2;GRIK1
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),-0.6776479651599641,-1.1432470503126884,0.3620689655172414,1.0,1.0,1/7,1.46%,SIGIRR
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.7399837574015217,1.1431488125998424,0.36585365853658536,0.8889925354737559,1.0,2/5,20.55%,ADRA1A;WNT5A
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.4287251093654987,1.1430451619412867,0.2,0.8883524207207478,1.0,26/147,8.57%,PDGFB;GRM2;FGFR1;SPRY2;CASS4;IRS1;FGFR3;SRC;PIK3R5;FGF17;EGFR;CX3CR1;PDGFRA;CPNE1;MFHAS1;PHLPP1;SIRT1;AKT2;NRG2;IGF1R;PLEKHA1;ADAM8;HCLS1;ARRB2;PHLPP2;NTRK2
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.6512807351913212,-1.14300139563912,0.3150684931506849,1.0,1.0,3/9,16.97%,SPAG17;SPEF2;SPA17
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.6159312546540454,-1.1429725800304746,0.30158730158730157,1.0,1.0,4/14,21.06%,ATAD5;PHB2;PAF1;EZH2
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.6453991698442703,-1.1428948569646615,0.3220338983050847,1.0,1.0,2/13,3.15%,MT1E;MT2A
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5753063456899697,1.1427553559467702,0.3,0.8883764788427362,1.0,8/16,21.10%,ADAM19;BMP6;SERPINF2;NOTCH4;AFDN;RGCC;TJP1;PTPRU
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.5955044748771106,1.1427316563557315,0.20588235294117646,0.8874076603023802,1.0,6/18,13.26%,TMC8;SNCA;CNNM2;TMTC2;GRIN1;ATP13A2
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.7022222360358357,1.1426445037300617,0.2894736842105263,0.8865985288648778,1.0,3/6,12.69%,CHRNA4;DRD4;NLGN3
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.5815489189535994,-1.1424420827889856,0.28169014084507044,1.0,1.0,7/28,17.69%,POLR3H;POLR2L;POLR3K;POLR3GL;SNAPC1;GTF3C6;SNAPC2
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),-0.6509118518884969,-1.1424243550168265,0.27586206896551724,1.0,1.0,4/11,23.99%,RAG2;FADD;GLI3;ADAM17
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),-0.7119972127470042,-1.142207341930095,0.3103448275862069,1.0,1.0,2/6,11.72%,ZFPM1;OLFM1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.7544050943347235,-1.1421208697546654,0.3333333333333333,1.0,1.0,2/5,17.78%,LRPAP1;APOE
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.7043456985979293,1.1421053830702814,0.43478260869565216,0.8871591123309983,1.0,2/6,8.44%,SLC7A5;LLGL2
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",-0.6914847880373207,-1.1421039189856157,0.3188405797101449,1.0,1.0,5/8,22.34%,CR2;C4BPB;C4BPA;CR1;CD46
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.6914847880373207,-1.1421039189856157,0.3188405797101449,1.0,1.0,5/8,22.34%,CR2;C4BPB;C4BPA;CR1;CD46
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.6914847880373207,-1.1421039189856157,0.3188405797101449,1.0,1.0,5/8,22.34%,CR2;C4BPB;C4BPA;CR1;CD46
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.4550808433075469,1.1417895661584299,0.20689655172413793,0.8869960177150448,1.0,20/83,15.68%,PDGFB;PDLIM7;KAT2A;ALPK3;NXN;GLI2;PKD1;PDLIM5;NOTCH4;SMG9;RBM20;TGFB2;ACVR1;FBXW7;HDAC9;PIK3CA;KAT2B;PTEN;PCSK5;PKD2
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.6194107712492979,1.1416949512702004,0.3076923076923077,0.8863156989623937,1.0,2/10,3.66%,KCNJ2;KCNIP2
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),-0.7356216355123033,-1.141597656575597,0.3230769230769231,1.0,1.0,1/6,4.18%,CPTP
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.7276734123245792,-1.1414760010824445,0.3157894736842105,1.0,1.0,2/8,10.96%,DND1;TGFB1
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6133646600319691,1.1413377228248027,0.3055555555555556,0.8862636422149863,1.0,1/13,6.25%,SIRT1
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.46911525245394403,1.14122945966264,0.125,0.8855857742972363,1.0,16/61,16.86%,SH2B2;ATP6V0A4;IRS1;GRB14;AKT2;SORBS1;IGF1R;GAB1;ATP6V0D2;RHOQ;PIK3CA;GPLD1;C2CD5;PDK4;GSK3B;FER
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.4787518132833279,-1.1410355788917699,0.24675324675324675,1.0,1.0,19/84,18.01%,MPV17L2;POLR2G;EIF2S3B;RPL5;RPS4X;RPS9;RBM3;LARP6;JMJD4;EIF3D;YBX3;C1QBP;EEF2;EIF5A;RPS27L;PYM1;EIF4A3;METTL3;CIRBP
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.6629772507947858,-1.1409863325406315,0.3225806451612903,1.0,1.0,2/10,2.82%,TTN;ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.6189007786332819,-1.1408949282504939,0.31343283582089554,1.0,1.0,1/13,5.86%,CXCL17
prerank,PanglaoDB_Augmented_2021__Decidual Cells,0.5534298342159745,1.1407423382843354,0.3055555555555556,0.8858785535817496,1.0,2/15,1.86%,ZAP70;GNLY
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5530190370488233,-1.1402080510543557,0.2835820895522388,1.0,1.0,3/22,8.19%,CFTR;PDZK1;COX17
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.49552401472951113,1.1400510571100373,0.3333333333333333,0.8869200135496648,1.0,2/29,3.09%,PDGFB;HSPB1
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.44033278237278833,1.140049933004046,0.2,0.885900694597243,1.0,31/99,16.31%,RELN;GRM2;HOMER1;TMEM108;GRM8;CX3CR1;KCNMB4;NLGN4X;AGER;NLGN1;NPTX2;CACNG5;GRM1;GRM3;UNC13A;GRID1;USP46;LRRC4C;PXK;CDH2;NLGN3;SLC12A2;SLC8A2;CLSTN2;GRIK2;LRP8;PTEN;NMU;RIMS3;DGKI;DRD2
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.5601139896353737,1.1398171061642433,0.28125,0.885506766659824,1.0,2/17,4.87%,SRC;MTMR2
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.47917765814454827,1.139494682752822,0.21212121212121213,0.8854715724783202,1.0,7/30,12.03%,SLC26A7;SLCO2B1;SLC13A4;LRRC8A;SLC26A3;SLCO1A2;SLC26A9
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.636883720691738,-1.1391586924104682,0.2857142857142857,1.0,1.0,3/11,14.02%,ZFPM1;MESP1;MYH6
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.7284760163333754,1.1384705129571522,0.30952380952380953,0.8870369928721124,1.0,3/6,19.51%,AKT2;ZNF703;ERBB4
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.4748508641997746,1.1384219898610852,0.22727272727272727,0.8862240479309585,1.0,10/36,15.40%,ZNF207;PLK1;MTCL1;NCKAP5;SPEF1;NAV1;CLASP1;DCX;JHY;CFAP74
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.5498359681062261,-1.1383226945975928,0.25333333333333335,1.0,1.0,6/22,24.22%,VPS25;VPS28;TOM1L1;SNF8;VPS36;VPS4B
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.6490221113079768,1.1382320214035961,0.35714285714285715,0.884820601928356,1.0,2/6,12.17%,UGT8;B4GALT3
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.6490221113079768,1.1382320214035961,0.35714285714285715,0.884820601928356,1.0,2/6,12.17%,UGT8;B4GALT3
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.51774165703231,1.137952973070339,0.2631578947368421,0.8847245367403039,1.0,7/29,14.77%,RELN;ARHGAP44;NLGN1;PDLIM5;ABI2;LRP8;PTEN
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.45088809276773234,1.1379068391469844,0.26666666666666666,0.8837326324696775,1.0,12/57,11.86%,AFF2;IGF2BP2;MBNL1;USP36;OAS3;CLK1;AHNAK2;RBM20;MBNL2;MITF;RBM12B;PTBP2
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),-0.6901411528485635,-1.1375222714416187,0.3392857142857143,1.0,1.0,2/9,12.38%,TGFBR2;STAT1
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.7044330102723557,1.1375112686194224,0.41025641025641024,0.8838695178240014,1.0,3/6,27.26%,TENT4B;SND1;LIN28B
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.5061637235063733,-1.137378625500003,0.22727272727272727,1.0,1.0,13/47,23.14%,GAPDH;SLC25A11;G6PC3;AKR1A1;APOD;TPI1;MDH2;MDH1;SLC25A1;GAPDHS;PGAM1;ENO1;ALDOB
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.5930761973581741,-1.1368713604485081,0.2753623188405797,1.0,1.0,7/20,24.05%,DNASE2;ENDOG;MUS81;REXO4;H1-0;DNASE1L1;KPNB1
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.7003020522888308,1.1367801738007606,0.3333333333333333,0.8850542184947453,1.0,3/6,19.85%,OGT;PHF1;PHF19
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.5071396965301027,-1.136229686277958,0.2876712328767123,1.0,1.0,21/52,27.01%,H1-4;H1-2;POLR1G;POLR2L;POLR1F;SERTAD1;POLR1H;MYBBP1A;TAF1D;ACTB;H1-10;SMARCD1;POLR1E;H1-0;DDX21;SMARCA5;POLR1B;ELOF1;POLR2K;ATAD2;WBP2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.7242385811962575,-1.136031122087003,0.34375,1.0,1.0,2/5,11.36%,PINK1;LANCL1
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.479235540758923,1.1359689341124426,0.3125,0.8864979203304314,1.0,6/29,7.86%,ZAP70;ZBTB1;LEF1;DUSP10;GLI2;ADAM8
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.43975871647954384,1.1353947464357503,0.1724137931034483,0.8869540935488339,1.0,10/51,13.68%,PNLDC1;CNOT2;EXOSC7;SAMD4A;PATL1;DCP1B;DCP1A;CNOT11;CNOT4;CNOT6L
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.610705172075098,-1.1352880138776518,0.3484848484848485,1.0,1.0,2/13,2.40%,DUOX1;TYMS
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),-0.7273541688322129,-1.1352386750087191,0.36764705882352944,1.0,1.0,1/5,10.66%,SLC35B2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),-0.7273541688322129,-1.1352386750087191,0.36764705882352944,1.0,1.0,1/5,10.66%,SLC35B2
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.6548201833612701,1.134807228923847,0.37142857142857144,0.8877010683864579,1.0,2/7,8.81%,HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.49965702820502234,1.1344013284422476,0.2972972972972973,0.887893983387864,1.0,9/35,13.49%,SLC38A1;SLC7A9;SLC7A1;SLC47A1;SLC7A5;SLC25A18;SLC38A2;SLC22A2;SLC6A13
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.6124941839843189,1.1342273081117946,0.35294117647058826,0.8874274675441516,1.0,4/15,19.14%,MTHFS;GLS;ALDH18A1;GAD1
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.6833960894346393,-1.1339055252017007,0.3090909090909091,1.0,1.0,3/12,16.94%,UFC1;TEX264;UFL1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.5331891157886447,1.133244291003872,0.3157894736842105,0.8896408778326508,1.0,7/21,20.55%,CERS3;ACER1;TXNIP;CDSN;BCR;SCEL;WNT5A
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),-0.72444110232295,-1.133126533896021,0.3064516129032258,1.0,1.0,1/5,6.81%,TRMT112
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.6613260416462383,-1.1331264398709493,0.3,1.0,1.0,4/10,14.07%,DNPH1;HINT1;NT5C;NUDT15
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.4763314280099293,-1.133093615577875,0.234375,1.0,1.0,14/72,15.78%,RHOC;CLU;RPS3;CHMP2A;HRK;SYNPO2L;RACK1;VIL1;TRABD2B;BRK1;TGFB1;FLOT1;SNF8;WARS1
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.7014572883884224,-1.1330484673111965,0.36923076923076925,1.0,1.0,2/6,9.01%,XBP1;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.6937144591946532,-1.1330279953162588,0.31343283582089554,1.0,1.0,3/10,15.04%,BUD23;TRMT112;DIMT1
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.3746514901509489,1.1325701427159525,0.19047619047619047,0.8904578111061864,1.0,28/113,14.11%,KCNQ2;EFNB3;CASKIN1;CELF3;EGFR;MYT1;PBX1;SCRT1;SIRT1;ASCL1;SEMA5B;PCDH8;CNR1;NCAM1;ADGRB2;SNAP91;ADGRL3;UNC13A;CAMKV;NCAN;B4GALNT4;IGDCC3;NTNG1;PPM1E;SLC8A2;DCX;KIF5C;LRP8
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.665724654200399,-1.1318392160188842,0.3333333333333333,1.0,1.0,3/8,27.98%,TGFB1;HEY2;HEY1
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.7072123331336353,-1.1316165283748707,0.38461538461538464,1.0,1.0,3/7,24.60%,MDH2;MDH1;MDH1B
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.557955072237885,-1.1315236299231577,0.2727272727272727,1.0,1.0,8/21,23.14%,GAPDH;PFKL;TPI1;GCK;GAPDHS;PGAM1;ENO1;ALDOB
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.649988184873677,-1.131294541486861,0.34328358208955223,1.0,1.0,1/10,7.24%,CD81
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.626098308243754,1.1312127650726547,0.3111111111111111,0.8936859743256359,1.0,2/6,21.70%,DLG1;PARD3
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.5883045755366179,-1.1306967565528716,0.352112676056338,1.0,1.0,1/14,5.86%,CXCL17
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.6430723777873686,1.130314813445598,0.36363636363636365,0.8952897020578675,1.0,2/8,6.25%,PLIN5;SIRT1
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.4955980954932955,1.1302898205460064,0.24242424242424243,0.89436027483539,1.0,8/16,23.45%,ROBO1;EGR3;SLIT2;GPLD1;FGF2;MIA3;KDR;PIK3R3
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.5768441147486875,-1.1302446160508461,0.34375,1.0,1.0,8/19,27.08%,BUD23;TRMT112;FTSJ3;DIMT1;MRM3;EMG1;METTL5;NSUN4
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.5796052400191846,1.1298450350573122,0.2727272727272727,0.8946810525138561,1.0,4/14,11.83%,AK3;RAB23;AK4;RHOQ
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.4323629663572316,-1.1291004143286798,0.21951219512195122,1.0,1.0,31/283,11.02%,CD44;APIP;GPX4;GATA1;RPS27A;IL7;XBP1;SFRP1;RPL10;PRDX5;ANXA5;PTMA;GSTP1;AVEN;BCL2L2;IL31RA;RPS3A;PSMC5;PRELID1;IFIT3;UBA52;COPS5;ZNF830;HTR2B;NAA38;PHB2;MYDGF;HSPA5;HAX1;DDAH2;TRIAP1
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.7397489989873389,1.1290754020114477,0.425,0.8959284995841523,1.0,3/5,18.07%,ACVR2B;ACVR2A;SMAD2
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.4886796468601456,1.1289833138717953,0.3333333333333333,0.8952900487699712,1.0,3/33,2.19%,RELN;PDGFB;CASS4
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.4671485944577598,1.1289518005836332,0.30303030303030304,0.8943800097807537,1.0,15/32,21.19%,ZBTB16;BMP6;P2RX7;TGFB2;ACVR1;GPM6B;BMPR2;ACVR2B;ACVR2A;PTH;BMPR1B;WNT5A;SLC8A1;WNT4;NELL1
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.5878114130736912,-1.1286837233545681,0.2786885245901639,1.0,1.0,3/11,11.61%,IRF4;HLA-E;TNFRSF21
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.6193150532531084,1.128551134096518,0.36666666666666664,0.8945780978716318,1.0,3/10,15.70%,ZBTB1;C5AR1;HIPK3
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.4762257604179583,1.1285387345906777,0.2222222222222222,0.8935952544342327,1.0,14/42,19.18%,TIAM2;LIMK1;L1CAM;PLXNA1;NTRK2;ROBO1;PLXNB2;ROBO2;SLIT2;CHODL;RUFY3;PLXNA4;MAPT;ZFYVE27
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.6291511121687188,-1.128378069600531,0.4406779661016949,1.0,1.0,4/10,25.10%,GRN;PTN;SCARF1;CERS2
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.6536505320244012,-1.128327695316977,0.36666666666666664,1.0,1.0,2/10,3.05%,ZFPM1;TGFBR2
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.7318684837582221,-1.1280628725345077,0.3442622950819672,1.0,1.0,3/6,22.91%,GSTP1;PPIA;FOXM1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.593230631439391,-1.1280408561689481,0.3181818181818182,1.0,1.0,3/25,8.20%,TINF2;NOP10;NHP2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.6307550064152831,-1.127865659819436,0.2909090909090909,1.0,1.0,1/16,0.65%,IRF4
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),0.6303798955567018,1.1277826182668853,0.35555555555555557,0.8948671086373078,1.0,3/10,10.53%,SRC;RASIP1;CXCL13
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.6559952896434661,-1.1277536789619256,0.31746031746031744,1.0,1.0,3/7,27.62%,MCM3AP;POLQ;POLL
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.6283580483701044,-1.1277334492980653,0.3142857142857143,1.0,1.0,7/15,27.50%,CHMP2A;CHMP7;CHMP3;RHOA;CHMP4B;VPS4B;CNTROB
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.6357528637136985,1.1276605492347491,0.3076923076923077,0.8941428630401577,1.0,7/15,23.00%,GDPD3;PNPLA6;GPCPD1;PLA2G4A;PLA2G4C;SMPD4;PRDX6
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.7239015190990153,-1.1275053201931537,0.2982456140350877,1.0,1.0,2/7,9.81%,PHB2;IRGM
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5408903044758665,1.12747334275776,0.29411764705882354,0.893721915318491,1.0,4/18,8.85%,PPARGC1A;PAXIP1;ARRB1;DIP2B
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.6120411804862995,-1.127277025835479,0.28125,1.0,1.0,2/14,7.41%,RPL23;GRWD1
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.44865903921222183,-1.1272729373233326,0.23943661971830985,1.0,1.0,26/155,14.55%,RPL23;GAPDH;RPL5;CLU;RPS7;RPL11;EFNA1;PPIB;GBA3;CDC37;CALR;NOP53;TNIP2;CCT7;PHB2;IRGM;GPIHBP1;USP19;GLMP;PDCL3;PINK1;FLOT1;GRN;PER3;CAMLG;LAMP1
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.629569172714038,-1.1271536634775998,0.25,1.0,1.0,3/10,16.97%,SPAG17;SPEF2;SPA17
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.5541940731303809,1.12682107127341,0.32432432432432434,0.8944770761185042,1.0,1/18,2.92%,MTHFS
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),-0.6581070385045795,-1.1266080048429399,0.3466666666666667,1.0,1.0,1/11,1.57%,XBP1
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),-0.652314459341998,-1.1265373167077133,0.3466666666666667,1.0,1.0,2/9,18.42%,IFT122;C12ORF57
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.6525493374259017,-1.1262120536538822,0.35,1.0,1.0,4/10,9.01%,HLA-F;HLA-A;HLA-E;CEACAM1
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.5650800499259608,1.1262006961304678,0.2894736842105263,0.89583250328267,1.0,2/18,3.83%,BACE2;ADAM19
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.7118338817723571,-1.1261709613419189,0.4,1.0,1.0,1/6,6.05%,DPH6
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.7118338817723571,-1.1261709613419189,0.4,1.0,1.0,1/6,6.05%,DPH6
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.6179569253558479,-1.125818263747607,0.2835820895522388,1.0,1.0,7/15,19.85%,GSTM4;GSTP1;GSTK1;AKR1A1;MGST3;GSTM3;GSTZ1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.6179569253558479,-1.125818263747607,0.2835820895522388,1.0,1.0,7/15,19.85%,GSTM4;GSTP1;GSTK1;AKR1A1;MGST3;GSTM3;GSTZ1
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),0.5774696592176033,1.125605874687579,0.36,0.8965084298125084,1.0,2/9,5.71%,ZMYND10;DNAAF1
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.711176037535487,1.1255684104195904,0.4411764705882353,0.8955912091362529,1.0,3/5,27.91%,DICER1;RNF10;HES1
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.6415041899260449,1.1255339299957159,0.3409090909090909,0.8947210428430785,1.0,1/8,1.07%,TNNC2
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.7037904336604353,1.1253199185095488,0.36363636363636365,0.8945419855336472,1.0,3/6,24.39%,SIRT1;MAPKAPK5;TP53
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.4712942803781134,-1.1252820457931199,0.273972602739726,1.0,1.0,11/71,13.88%,CD44;GATA1;RHOG;FAM78A;STAT5A;TALDO1;PTPN7;GMFG;USE1;ADGRE5;DOCK2
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.6071173650605005,-1.1249891858966818,0.30985915492957744,1.0,1.0,6/17,19.63%,DUOX1;ACTG1;HRAS;GRN;PTN;SCARF1
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.5718113307536024,-1.1249570166118759,0.36585365853658536,1.0,1.0,5/22,16.31%,TIMP1;PHPT1;PLN;ATP5IF1;PARP9
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.4001698368654364,1.1249526597483352,0.20833333333333334,0.8948422066083066,1.0,18/121,10.36%,FGFR1;GCM1;RUNX1;CDK6;ALK;EPHA3;DLX1;NLGN1;SERPINF2;HEMGN;NOTCH4;DLL1;MOSMO;MEGF10;SCIN;GDNF;TRPS1;MAFB
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.4896192396731156,-1.124748168706505,0.2647058823529412,1.0,1.0,18/67,12.94%,PRB3;NLRP1;GBP2;RPL30;HLA-A;HLA-E;ROMO1;IL6R;RPS19;COLEC12;WFDC3;IRGM;RPL39;SLAMF8;SELP;DEFB109B;CEBPB;PPP1R11
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.6453588374358482,-1.1244682681434153,0.3448275862068966,1.0,1.0,2/13,5.34%,DNASE2;ENDOG
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.5625924305157493,-1.124461416680359,0.3387096774193548,1.0,1.0,7/19,19.68%,MT1E;MT2A;LCK;SLC39A7;SLC39A6;MT1M;MT1G
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.42142032323021006,-1.124285074065092,0.17857142857142858,1.0,1.0,26/233,12.40%,PSMB8;RPS27A;PSME1;CFTR;USP6;COPS6;PSMB6;USP1;PSMD8;PSMC5;RAD23A;COPS7A;PSMD7;ADRM1;UBA52;USP51;JOSD2;COPS5;TNIP2;ABRAXAS1;TOMM20;CLSPN;USP19;PSMD3;AR;PSMC3
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.6466659215545462,1.1239397104674358,0.4358974358974359,0.8967113147600247,1.0,2/6,16.29%,JADE2;JADE3
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.6541358035686273,-1.12374902188197,0.3333333333333333,1.0,1.0,1/13,0.55%,GATA1
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.45403130688222865,-1.1236330045817193,0.2465753424657534,1.0,1.0,24/125,15.26%,PSMB8;GBP3;GBP2;SFRP1;PSME1;RPS3;PSMB6;PSMD8;PSMC5;PSMD7;HYAL2;TMSB4X;PSMD3;TNFRSF21;ILK;STAT1;PSMC3;TXNDC17;YBX3;BRCA1;CD27;EIF5A;PSMA4;TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.634418810634767,-1.1232533233233892,0.328125,1.0,1.0,1/10,5.86%,CXCL17
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.42243672176037284,1.1232034063660634,0.21212121212121213,0.8975907686953184,1.0,7/68,7.03%,PDGFB;FGFR1;ATOH8;NRP2;HSPB1;SIRT1;SASH1
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),-0.6953138528550652,-1.1231198556149773,0.3559322033898305,1.0,1.0,1/6,4.66%,USP1
prerank,PanglaoDB_Augmented_2021__T Helper Cells,0.44884572382017224,1.1225943487739818,0.2,0.8985279188107752,1.0,10/46,10.27%,ZAP70;KLRD1;IL4R;GNLY;LCP2;HPGDS;IL2RA;CD4;NFKB1;STAT6
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.5345709618310936,1.1222592317837632,0.3157894736842105,0.8985988847154919,1.0,5/17,22.69%,RYBP;PCGF5;RNF168;RNF2;KDM2B
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.7094559228576269,-1.12202766859481,0.3709677419354839,1.0,1.0,2/7,10.82%,TRMT10A;TRMT10B
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.4260967879003349,1.1218343901423142,0.30434782608695654,0.8992500747291549,1.0,47/146,21.29%,PDGFB;PLK1;MAPK12;STK32B;PRKX;AKT2;PKD1;SGK1;NLK;PNCK;VRK2;RICTOR;TNKS;MAPKAPK3;CAMKV;SGK3;DYRK3;MKNK2;ULK3;PRKCE;PRKD1;RPS6KA1;MARK1;SMG1;HIPK2;UHMK1;DYRK1A;MAST4;HIPK3;RPS6KA6;TTBK2;GSK3B;PRKCZ;CAMK2D;MAPK8;SBK1;MKNK1;DMPK;WNK1;PIKFYVE;SRPK2;MARK2;MAPKAPK2;MAP3K10;MAST3;LATS2;TLK2
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.7379193445477381,-1.121721772340038,0.41304347826086957,1.0,1.0,1/5,6.33%,LCLAT1
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.4201432956618302,1.1217196183915825,0.13043478260869565,0.8985916924885846,1.0,29/122,13.46%,KCNN4;KCNH4;KCNJ2;ABCC8;SCN9A;KCNH3;KCNIP2;PIEZO2;SLC7A1;KCNMB4;SLC47A1;PANX2;SCNN1D;SLC22A16;KCNN2;PKD2L1;SGK1;KCNMA1;SCN7A;KCNN1;AQP1;SLC4A4;SCNN1B;GRIN1;SLC22A2;SLC12A2;SLC8A2;FGF13;SLC25A29
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.4449768396096854,1.121705396426122,0.2857142857142857,0.897608105798402,1.0,31/133,14.19%,RELN;FGFR1;RUNX1;CDK6;IL1RAPL1;ATOH8;SPOCK1;CTF1;TAFA1;PTPRD;CX3CR1;NLGN4X;ASCL1;DOCK7;VAX2;NTRK2;DLL1;SH3RF1;SNPH;WNT3;ADGRL3;TGFB2;CELSR1;PLXNB2;ACSL4;AUTS2;FGF13;NAV1;DCX;DCDC2;MARK1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.5509756654284403,1.1216197345156056,0.2702702702702703,0.8967898549106015,1.0,2/15,1.59%,ZAP70;ZBTB1
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.5012917002412698,-1.1215715225745149,0.2714285714285714,1.0,1.0,6/52,7.72%,RHOC;ACTG1;TLN1;JUP;CD9;CDH12
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.6550458383168936,1.1215291504524854,0.3142857142857143,0.8960178651267349,1.0,3/10,7.12%,NOS2;CLEC7A;CYBA
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.6727637251274441,-1.1213798416263039,0.359375,1.0,1.0,4/7,27.34%,ZNF830;CLSPN;TOPBP1;HUS1
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.7264969537087946,-1.1213695805196215,0.35,1.0,1.0,1/5,7.17%,CALR
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),0.6485624061363655,1.1212609388604282,0.30952380952380953,0.8958691512843784,1.0,3/5,29.32%,CRACD;CARMIL1;WASHC2C
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.7255570380128539,1.121219058803585,0.47368421052631576,0.8950111909864062,1.0,2/5,18.09%,SIRT1;CTBP2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.6860173853515156,-1.1209678829795195,0.3888888888888889,1.0,1.0,3/6,29.47%,PLN;TRDN;SLC8B1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.7391126272929562,1.1208884007639266,0.42105263157894735,0.8951592478935623,1.0,3/6,20.52%,PTPN22;MARCHF7;DDX3X
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.6637483093632554,1.1203862651943053,0.29545454545454547,0.895749483637265,1.0,1/7,3.66%,TAL1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.5630212576084914,1.1203655588245114,0.2413793103448276,0.8947618877346881,1.0,6/17,26.06%,PDE4DIP;CAMSAP3;CAMSAP2;ARMH3;MYO5A;RBSN
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.6812739102615025,1.120361072151404,0.4222222222222222,0.8928373192401922,1.0,3/6,22.99%,IWS1;NSUN2;SETD2
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.6812739102615025,1.120361072151404,0.4222222222222222,0.8928373192401922,1.0,3/6,22.99%,IWS1;NSUN2;SETD2
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.5961618545116163,-1.1198464389141616,0.3114754098360656,1.0,1.0,3/16,17.02%,TINF2;TFIP11;RAD50
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5397327443602804,1.119776870229843,0.3333333333333333,0.8933981414048072,1.0,3/25,7.76%,PTPN6;TTLL12;OAS3
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.6259834535494413,1.1197609010347176,0.3235294117647059,0.8924761398064449,1.0,6/16,11.66%,OXTR;GLI2;NOTCH4;ARHGAP35;WNT3;GPAT4
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.7291839908515909,-1.1197592196743549,0.3050847457627119,1.0,1.0,3/5,25.28%,RACK1;LTN1;MTRES1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.5418388171872673,-1.1197050951953837,0.3382352941176471,1.0,1.0,2/35,6.31%,EPN1;VPS25
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.44398074952237676,-1.1196826535965234,0.24675324675324675,1.0,1.0,24/112,21.75%,PSMB8;RPS27A;PSME1;PSMB6;APEX1;PSMD8;PSMC5;PSMD7;UBA52;PSMD3;PSMC3;EXOSC4;UBB;PSMA4;HSPA8;PSMD2;PSMA7;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;PSMC1;YWHAB
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.60055436202655,1.119407157395689,0.3409090909090909,0.892537921082992,1.0,2/7,20.18%,CDKN2A;E2F3
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.5086500750359806,1.1191745615293043,0.3,0.892292187945124,1.0,9/21,18.95%,ZBTB16;SCIN;TRPS1;SOX5;PTHLH;GDF5;ADAMTS7;LOXL2;BMPR1B
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.4300010141286723,1.119130321889772,0.23809523809523808,0.8914182858787391,1.0,34/112,14.45%,ZNF423;LIFR;PCDH18;FRZB;EFNB3;PTPRD;VCAN;LRP4;PLPPR4;PBX1;DPYSL3;TMEM47;CCDC3;COL23A1;SEMA5B;CDH11;ASXL3;GFRA1;DOK5;MAPK10;ADGRL3;TGFB2;CACNA2D1;SCN7A;MEGF10;RCAN2;COL25A1;SEMA6D;FBXL7;SLIT2;LDB2;MARK1;MPDZ;PCDH19
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.54971229508728,-1.1190531370524845,0.2923076923076923,1.0,1.0,6/26,16.31%,PARP2;PARP14;ART3;PARP12;PARP1;PARP9
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.5625939752771508,1.1188989244115737,0.34615384615384615,0.8912911543496945,1.0,3/17,5.53%,SLC15A2;SLC29A2;PLA2G10
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.48848300443059994,-1.1187954941071514,0.2878787878787879,1.0,1.0,18/56,31.32%,TRMO;BUD23;TRMT112;TRMT10A;FTSJ3;DIMT1;METTL3;TRMT5;WDR6;RBM15B;METTL5;CMTR1;NSUN4;HENMT1;THUMPD2;TRMT61A;NSUN3;THUMPD3
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.6829462487052916,-1.118721836838158,0.35384615384615387,1.0,1.0,2/7,19.35%,MTHFD1;MEOX1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.5580272354582572,-1.1186603645008992,0.2878787878787879,1.0,1.0,8/20,23.14%,GAPDH;PFKL;TPI1;GCK;GAPDHS;PGAM1;ENO1;ALDOB
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.5580272354582572,-1.1186603645008992,0.2878787878787879,1.0,1.0,8/20,23.14%,GAPDH;PFKL;TPI1;GCK;GAPDHS;PGAM1;ENO1;ALDOB
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.6355650831133125,1.1186472949189845,0.4,0.8901779013036525,1.0,2/9,2.52%,ABCC2;SLCO2B1
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.6355650831133125,1.1186472949189845,0.4,0.8901779013036525,1.0,2/9,2.52%,ABCC2;SLCO2B1
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),0.7178149785870538,1.1186294332439863,0.47058823529411764,0.8892664381053879,1.0,2/6,3.92%,TMEM98;LEF1
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.6967914595789753,-1.1184754150592444,0.3870967741935484,1.0,1.0,2/7,6.04%,ADH4;ADH5
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.6846757734201224,1.118307332308604,0.425,0.8890694937550906,1.0,4/5,31.06%,PER1;LMO3;CRY1;CLOCK
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.6913765602313838,1.1181829586978551,0.34285714285714286,0.88852436003188,1.0,4/8,19.13%,CLEC16A;SMG1;LARP1;RPTOR
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),-0.7390085944008027,-1.1179004569755386,0.3448275862068966,1.0,1.0,3/7,25.49%,TOM1L1;AURKAIP1;NME6
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),-0.6770971511363814,-1.1176448767616955,0.4090909090909091,1.0,1.0,1/10,9.86%,SLC27A5
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.6750022041343202,-1.1176108700504843,0.3125,1.0,1.0,4/7,26.23%,TRMT10A;TRMT10B;HSD17B10;TRNT1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.5875878031029298,-1.1175942925868918,0.27692307692307694,1.0,1.0,9/26,26.17%,TINF2;NOP10;NHP2;PPIA;RAD50;GAR1;RFC1;TERF2IP;TERF1
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.7276104769075229,-1.1168526999337147,0.3090909090909091,1.0,1.0,2/6,9.39%,UBXN1;AQP11
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.4289854361826354,-1.1165271964397445,0.2602739726027397,1.0,1.0,41/180,21.77%,GPX4;COX6A1;UQCR10;TST;RETSAT;HSPB8;PFKL;COX7B;ETFB;UQCRQ;STAT5A;CYC1;DHRS7;TALDO1;NDUFB7;JAGN1;SPARCL1;COQ3;IDH3G;RMDN3;NDUFAB1;MGST3;ARAF;ESYT1;OMD;DECR1;MDH2;NMT1;APOE;SLC25A1;SSPN;UCK1;LAMA4;ANGPT1;GRPEL1;NDUFS3;UQCRC1;REEP5;SOD1;RIOK3;SNCG
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.7024317339671164,-1.1164033312143375,0.3939393939393939,1.0,1.0,2/7,13.91%,KDELR1;KDELR3
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.7140131830494953,-1.1162164906826155,0.34375,1.0,1.0,4/7,13.31%,HLA-A;HLA-E;IRF1;MAPK8IP1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.7312422123077528,-1.1161970349187957,0.3389830508474576,1.0,1.0,3/6,20.24%,FABP3;HTR2B;HTR2A
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.4900914035057737,1.1160342228281825,0.2571428571428571,0.8932039949776756,1.0,1/27,0.25%,VAPB
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.634590862480545,-1.1160280102148168,0.3684210526315789,1.0,1.0,3/10,16.62%,FLII;MYH6;LMOD1
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.6468580462552164,1.116025243194447,0.30952380952380953,0.8923076981898699,1.0,1/6,3.13%,VEGFD
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.5061327950958016,1.115658560734755,0.23076923076923078,0.8921662264317864,1.0,9/23,17.37%,NRP2;SEMA5B;ALCAM;SLIT3;AUTS2;NLGN3;SLIT2;SLIT1;CYFIP1
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.6887861075554605,-1.1155555542061042,0.38461538461538464,1.0,1.0,3/7,23.58%,PPP1R3D;PPP1R3E;INPP5K
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.6111328925134051,-1.1152329894000426,0.38333333333333336,1.0,1.0,5/18,15.61%,NOP10;NHP2;CCT7;EXOSC10;CCT2
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.45664866088669603,-1.115229319497195,0.3333333333333333,1.0,1.0,11/69,12.70%,HLA-F;PM20D1;CLU;VPS35;PSMC5;CHMP2A;HTR2B;PINK1;CDK5;LRPAP1;TM7SF3
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.7160105553443474,-1.1152290526483373,0.3770491803278688,1.0,1.0,2/7,18.89%,ALG10B;GOLGA2
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.5544510861019147,-1.115219069233466,0.3717948717948718,1.0,1.0,5/25,14.56%,RPS27A;LACC1;UBA52;IRGM;UBB
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.5718025636850685,-1.1150494871764784,0.3287671232876712,1.0,1.0,4/20,8.96%,PTK6;HYAL2;VPS25;SH3BP5
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.4885532440304186,-1.114951142991969,0.3076923076923077,1.0,1.0,10/67,14.99%,ARHGEF16;MBNL3;KDELR1;TEAD3;TMEM54;GIPC1;PSMD3;RPL8;LRRC42;EIF5A
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.644101410686098,1.114919554714737,0.45714285714285713,0.8936159741425093,1.0,1/9,0.31%,RELN
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.6429710627432725,1.1145427939998271,0.358974358974359,0.893718996525047,1.0,2/6,9.37%,ADARB2;ADARB1
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.5753357966648187,-1.1144493921309058,0.29577464788732394,1.0,1.0,4/24,6.62%,MMP21;TGFBR2;MESP1;CCDC39
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.5505997748783877,1.1139191974893354,0.3409090909090909,0.8945433769221036,1.0,4/13,16.94%,CPEB3;CPEB2;CPEB4;DHX9
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.6440732963036204,1.1133733290091783,0.40625,0.8951497380843632,1.0,1/10,0.31%,RELN
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),-0.4888079837951339,-1.1132465600606778,0.3157894736842105,1.0,1.0,6/45,12.70%,DDIT3;HSPE1;HSPB8;HSPA2;HSPA5;TM7SF3
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),-0.6807999850307983,-1.112912405069245,0.3770491803278688,1.0,1.0,3/6,19.00%,EDN1;APOE;SERPINE1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.48428758796574667,1.1127821565035985,0.28125,0.8962156086863311,1.0,5/41,6.25%,PDGFB;FGFR1;VASH1;HSPB1;SIRT1
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.5515731723212314,-1.1126444733896956,0.2916666666666667,1.0,1.0,6/29,12.22%,B2M;CLU;ARF1;PIK3CB;LRPAP1;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.5715287159962709,-1.1125789704580247,0.3287671232876712,1.0,1.0,3/18,13.45%,BMP5;CEACAM1;BRCA1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.6057343759057874,1.1124234864949416,0.358974358974359,0.8962290791291283,1.0,3/7,21.36%,DUSP10;PTPRO;PTPRB
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.6356938017254495,-1.1122111732568833,0.3442622950819672,1.0,1.0,1/11,0.35%,BMP5
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.687189524842947,-1.1119681395348027,0.35714285714285715,1.0,1.0,5/12,17.78%,CLU;VBP1;PFDN2;PFDN6;APOE
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.7235149558188124,-1.1119307962348501,0.3770491803278688,1.0,1.0,1/5,8.69%,BEX4
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),-0.6453529852020794,-1.111746095837009,0.323943661971831,1.0,1.0,5/13,24.22%,CHMP2A;CHMP7;CHMP3;CHMP4B;VPS4B
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.5986613240887668,1.1115681319436428,0.42857142857142855,0.8977513222043493,1.0,4/10,21.42%,ARHGAP35;NRCAM;EPHB3;CNTN4
prerank,GO_Biological_Process_2021__leukocyte chemotaxis involved in inflammatory response (GO:0002232),-0.7213941933250734,-1.1114551367553227,0.375,1.0,1.0,4/5,22.28%,SLAMF8;NINJ1;PTN;ALOX5
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),0.6295891951725241,1.1108662740479855,0.43902439024390244,0.898796609705082,1.0,5/6,35.42%,ST3GAL2;ST8SIA3;ST3GAL1;ST6GAL1;ST6GALNAC2
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.47421027989613646,1.1108243866480567,0.21739130434782608,0.8980043000979846,1.0,13/71,8.71%,PDGFB;PDGFC;FGFR1;SPRY2;FLT1;PIK3R5;EGFR;DUSP1;CDK12;IRAK3;ADAM8;TPD52L1;ROBO1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),-0.6242747285888299,-1.1103403586632459,0.390625,1.0,1.0,3/12,11.72%,XBP1;BHLHE41;BDNF
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.6026562563817308,1.1098631803890313,0.3170731707317073,0.9000640325195343,1.0,2/10,9.57%,TTLL11;TTLL9
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),-0.7583338798991803,-1.109760205333307,0.3,1.0,1.0,1/5,5.13%,GBA3
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.5860948024301836,-1.1095697116810341,0.34328358208955223,1.0,1.0,3/24,3.59%,H1-4;H1-2;RPS3
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),-0.7041341567418092,-1.1094338827376797,0.265625,1.0,1.0,1/6,1.77%,ZDHHC12
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.6165998615053184,1.109390568063615,0.45714285714285713,0.9002879304717701,1.0,3/10,12.29%,SULT2A1;SULT2B1;ENPP1
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.4353800686671215,-1.109042480297447,0.275,1.0,1.0,30/136,17.03%,HLA-F;SLC25A4;PARP2;SLC6A12;ATP6V1F;TST;POLE3;HYAL2;CNP;IRF1;BTG3;C4BPB;CDKN1C;PRPF3;BTG1;HSPA2;RASGRP1;PDLIM3;OLFM1;PSMC3;CCK;GGH;PPIF;UROD;AP2S1;ATF3;RFC4;SELENOW;TUBA4A;CDC34
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.6480507353797416,-1.1085902078379184,0.3728813559322034,1.0,1.0,3/13,10.66%,SLC25A4;SLC25A5;SLC35B2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),-0.7509988488610263,-1.1083618636738526,0.35294117647058826,1.0,1.0,4/5,24.89%,TGFB1;GREM1;MYOCD;EFNB2
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.5274560656187357,-1.1083499913490298,0.38461538461538464,1.0,1.0,10/32,21.72%,H1-4;H1-2;USP51;RAD51AP1;KPNA2;FIGNL1;RAD50;H1-10;PPP4C;H1-0
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.4767626422663578,1.1083178106685703,0.4,0.9024837416291754,1.0,10/32,14.77%,IL1RAPL1;PTPRD;LRP4;NLGN4X;NLGN1;PICALM;NSFL1C;NRXN1;NLGN3;PTEN
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.4751384072656471,1.108161117971006,0.2413793103448276,0.9018622078366021,1.0,4/25,16.21%,KAT2A;CPA4;KAT2B;CREBBP
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.5798995409111524,-1.1080795335536424,0.2898550724637681,1.0,1.0,5/20,6.83%,BMP5;SFRP1;EFNA1;IL17RD;OVOL2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.4693908499873922,1.108020001879667,0.36363636363636365,0.9012562628795777,1.0,3/63,3.57%,RELN;DACT2;GRHL2
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.43709210911114976,1.1079908371872773,0.28,0.9003809172133362,1.0,8/84,5.45%,LEPR;PDGFC;IL4R;OXTR;CLEC7A;ZNF516;PPARGC1A;PLAC8
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.5591960937792496,-1.1079600042028308,0.36486486486486486,1.0,1.0,2/23,6.21%,RPS27A;UBA52
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.6324033139101084,1.107850048280573,0.30303030303030304,0.8998063040168931,1.0,3/11,20.26%,HNRNPU;ESRRB;N4BP2L2
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),0.6391931264911691,1.107328700510088,0.35294117647058826,0.9002991637733296,1.0,2/7,6.23%,ADGRB1;EHD2
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.5466953025199807,-1.1071353097583432,0.3230769230769231,1.0,1.0,7/22,21.84%,CPS1;FABP3;FABP6;ABHD12B;LIPH;LIPI;DAGLA
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.42886067455053506,1.1069855571983993,0.3333333333333333,0.900308122844819,1.0,29/116,14.73%,ZNF423;LIFR;FRZB;EFNB3;ABCC8;LRP4;PLPPR4;LIMCH1;DPYSL3;TMEM47;OBSL1;EPB41L1;COL6A1;CHST3;MEIS3;GFRA1;HTRA1;CACNA2D1;SRRM3;NUAK1;TEAD1;CBS;SEMA6D;PTH1R;FBXL7;SLIT2;FIGN;MPDZ;GPC6
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.48028230909511366,-1.106982427397505,0.2876712328767123,1.0,1.0,7/83,5.96%,CD44;DPEP2;RHOC;AQP9;PTAFR;IFITM3;IFIT3
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.549136042490556,-1.1066837457429144,0.3291139240506329,1.0,1.0,5/25,15.79%,RPS3;STMN2;ANKRD53;KATNB1;DCTN1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.5478217251719558,1.1064586930693714,0.1724137931034483,0.9007568440106896,1.0,7/17,26.76%,PAXIP1;MITF;MED13;BCLAF1;MED14;MED4;MED30
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.47757602647483777,-1.1059080451472154,0.3380281690140845,1.0,1.0,6/66,11.97%,ARHGEF16;RHOG;VAMP8;TGFB1;AR;CDK5
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.39587816503403594,1.105841241969966,0.2631578947368421,0.901502213803788,1.0,36/123,21.36%,PTPN6;PPP4R2;PPM1M;DUSP6;PTPRD;EYA4;PPM1L;MTMR2;DUSP1;DUSP10;PTPN22;PTPRK;PTPRE;PPP2R2C;PPM1E;PTPN4;DUSP18;PTEN;RPRD1B;PTPRN2;PPP2R2A;PTPRR;PTPN14;CDC14B;PTPRO;BTRC;MTMR3;SSH2;PPM1D;PPP3CA;PPP1R15B;SSH1;PPP2R5C;PTPRU;PTPN18;PTPRB
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.5090353492706641,-1.105648962143118,0.36764705882352944,1.0,1.0,7/49,9.57%,ARHGEF16;TMC4;CFTR;EFNA1;TMEM125;OVOL2;ITGB4
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.6087575515452481,1.1053726361305976,0.37209302325581395,0.9018071550474842,1.0,2/7,6.46%,NRP2;ASCL1
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.7375687402345186,1.105240740225371,0.4878048780487805,0.9013336711003677,1.0,2/5,20.60%,SLC38A2;SFXN1
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.44813661259408016,-1.1052221272739255,0.2597402597402597,1.0,1.0,14/87,13.02%,SFRP1;TAX1BP3;RSPO4;NFATC1;SHISA2;KREMEN1;ATP6AP2;SFRP4;RSPO2;GPC3;RACK1;TRABD2B;PPP1CA;DEPDC1B
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",-0.7303461523005543,-1.1051736286437863,0.36,1.0,1.0,2/5,20.41%,HLA-DRB1;HLA-DRA
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.4305979950007016,1.1050926228440368,0.2916666666666667,0.9009600736935932,1.0,17/92,7.65%,CDKL1;TP63;TRIM29;ICAM1;LGALS4;NRP2;TM4SF20;GRHL2;MYO5B;SPTSSB;AGER;SEC23B;FZD6;SCNN1D;RNF128;CDKN2A;P2RX7
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),0.6509821047692205,1.104705893323294,0.37142857142857144,0.9014904067615407,1.0,2/8,2.69%,NOS2;SLC39A8
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),-0.42756589065377737,-1.1045390569125397,0.275,1.0,1.0,44/206,21.75%,PSMB8;DDIT3;SFRP1;PSME1;JUP;TMEM198;PSMB6;PSMD8;PSMC5;KREMEN1;ATP6AP2;PSMD7;SFRP4;BAMBI;GPC3;RBX1;TGFB1;PPP1CA;FUZ;PSMD3;ILK;PSMC3;ANKRD6;PSMA4;PLEKHA4;GREM1;APOE;PSMD2;PSMA7;GLI3;DKK3;PSMD6;PSMB2;DACT1;PPM1N;PSMB3;PSMB4;TPBG;TMEM9;PSMA3;EMD;PTK7;USP8;PSMC1
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.45567068426296936,-1.1038036055753644,0.3466666666666667,1.0,1.0,11/95,10.66%,SLC25A4;EHHADH;PRDX1;PRDX5;RETSAT;TSPO;PEX11A;HRAS;FABP6;GSTK1;SLC35B2
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.5401802555196487,1.103585160109644,0.23333333333333334,0.9036689348493134,1.0,3/25,7.12%,RAB27A;CLEC7A;CYBA
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.5277103351860944,1.1033482738774638,0.2727272727272727,0.903308139549805,1.0,5/13,15.06%,MGAM;PHKA1;PYGB;PHKA2;PGM2
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.559755030675419,-1.1032532890049171,0.35135135135135137,1.0,1.0,2/22,6.21%,RPS27A;UBA52
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.5606571422611212,1.1031129015324144,0.34146341463414637,0.903398248537637,1.0,5/12,22.99%,IWS1;CPSF6;DHX9;NSUN2;SETD2
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.3857149137196034,1.1030271970751893,0.2692307692307692,0.902616929723076,1.0,19/95,13.01%,KCNQ2;EFNB3;CASKIN1;CELF3;MMD2;SCRT1;PCDH8;PSD2;ADGRB2;NXPH1;SNAP91;PNCK;SRRM3;CAMKV;CELSR2;NCAN;B4GALNT4;GRIN1;SLC8A2
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.710122977571732,-1.1024824519081768,0.463768115942029,1.0,1.0,5/9,17.78%,CLU;VBP1;PFDN2;PFDN6;APOE
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.5985146337210827,1.102426105850126,0.3103448275862069,0.9033252241417014,1.0,3/12,9.40%,KCNJ2;KCNIP2;ATP1B3
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.4899934689616281,-1.1023341664155366,0.3142857142857143,1.0,1.0,24/64,27.66%,POLR2G;GTF2F1;POLR2J;POLR2L;ELOB;POLR2I;ADRM1;RTF1;PAF1;TCEA2;SUPT5H;POLR2A;GTF2H2;POLR1E;NCBP1;NELFCD;NELFE;SSRP1;ELOF1;CTR9;POLR2K;LEO1;POLR2C;NCBP2
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.6750311623002208,-1.1022661887596643,0.35714285714285715,1.0,1.0,4/8,25.05%,ATG14;PHB2;MAP1LC3B;SQSTM1
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5853055101482207,1.1020063244025635,0.34375,0.9034010088033216,1.0,4/10,19.69%,HSPA1A;BAG3;VHL;DNAJB1
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.6980324746732804,1.1019928972131732,0.3076923076923077,0.9024680556193811,1.0,3/6,26.23%,MEGF10;AKIRIN1;THBS4
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.43823390623107283,1.1019184157717807,0.29411764705882354,0.9017469568608133,1.0,17/77,13.41%,STAB1;ZNF521;PCDH18;EGFR;CSPG4;EHD2;GLI2;NOTCH3;RND3;COL6A1;CHST3;COL14A1;LOX;COL5A1;TEAD1;TEAD2;SLIT2
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.5796241033707896,-1.101363223847898,0.3787878787878788,1.0,1.0,1/16,1.57%,XBP1
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),0.659905280445936,1.1012668648935129,0.41304347826086957,0.9027327724318147,1.0,3/5,30.78%,DRD2;RYR2;RYR1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5468107590943414,1.1011846175704592,0.4,0.9020827247049349,1.0,5/23,9.39%,RUNX1;LEF1;TESC;HCLS1;CD4
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.73553132932005,-1.101180714091212,0.34375,1.0,1.0,1/6,2.03%,SELENOS
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.5556018441218864,-1.1008322996870434,0.3684210526315789,1.0,1.0,7/31,13.23%,ARHGEF16;HR;ITGB4;TMEM54;KRT86;S100A16;ABCA12
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.5485133489559448,-1.100822212059185,0.3188405797101449,1.0,1.0,9/24,17.55%,STMN1;VIL1;STMN2;KIF18A;DSTN;STMN3;KATNB1;CFL1;CFL2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.4296327101888332,-1.1004023102720042,0.3013698630136986,1.0,1.0,22/150,15.09%,PSMB8;FBXO43;PKMYT1;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;BTG3;KIF20B;CDKN1C;BTG1;DYNLT3;NEK6;TGFB1;PSMD3;PSMC3;THAP1;ASAH2;ANAPC15;CAV2;PSMA4
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.5310775891343393,1.1003606781814708,0.3076923076923077,0.903345122768105,1.0,4/30,7.27%,MAPK11;CLEC7A;AGER;IRAK3
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.5926373659070746,-1.1003042014286044,0.359375,1.0,1.0,2/17,7.17%,B2M;CALR
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),-0.7405942199384283,-1.0999505573228847,0.30357142857142855,1.0,1.0,1/5,2.25%,STMN1
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.5611238102554967,1.0998973832048675,0.38235294117647056,0.9035179575784981,1.0,8/12,27.73%,ADCY10;ADCY8;PTHLH;PTH;ADCY6;ADCY2;ADCY5;ADCY9
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.6486836726395494,-1.0997263324403141,0.375,1.0,1.0,3/11,16.53%,PTK6;NLRP12;OPRM1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.4813364094474942,1.0996417314589633,0.3103448275862069,0.9032449766055634,1.0,8/56,9.77%,PDGFB;NUPR1;TAL1;EGFR;PKD1;EIF4EBP1;EIF4E;TGFB2
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.6668359762926834,-1.0993351878945874,0.36666666666666664,1.0,1.0,1/7,0.89%,GLYCTK
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.48274806451121133,1.0992319582719552,0.35294117647058826,0.9037930180780741,1.0,9/27,22.68%,NSMF;SLC8A2;GRIK2;ZDHHC2;SHISA9;DRD2;SLC4A10;CAMK2B;APP
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.5533843656459753,-1.0986996354957974,0.352112676056338,1.0,1.0,5/23,15.14%,TTN;NCAPH;NCAPD3;SMC4;SMC2
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.4940303852365804,1.0985105235809194,0.34375,0.9049372568312448,1.0,8/20,17.60%,ERRFI1;DNAAF1;GLI2;PKD1;FGF1;CHI3L1;RCN3;FGF2
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.5069168775218371,1.0982942247024328,0.3333333333333333,0.9045803896856421,1.0,7/28,23.08%,SIRT1;SESN2;SESN1;KPTN;UBR1;MINAR1;MAPKAPK5
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.4135030057208073,1.0982329701284534,0.2631578947368421,0.9038499692293945,1.0,36/114,20.15%,LIFR;CELF3;PTPRD;PLD1;LRP4;STX1A;PLPPR4;DPYSL3;ADGRB3;NPY;SNAP91;ASXL3;SHC3;CADPS;MAPK10;CACNA2D1;UNC13A;NRXN1;SEMA6D;KCTD16;SLC12A2;RIMBP2;SLC8A2;RAPGEF4;P2RY1;NFASC;ADGRA1;NCS1;KIF1B;GRIA2;MAP2;TMEM196;ERC2;ADCYAP1R1;KCNIP1;ST8SIA3
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.41693936216200317,-1.0981495845377223,0.23170731707317074,1.0,1.0,40/244,17.62%,TINF2;RPS27A;MCM2;PARP2;TYMS;NUDT1;DNASE2;APEX1;PNKP;PCNA;POLE3;ENDOG;MCM4;ORC6;UBA52;MPG;NOP53;MCM3;WDHD1;RPA3;RAD51AP1;TSN;RFC2;BRCA1;PARP1;NUDT15;KPNA2;UBB;MBD4;KAT5;GEN1;MUS81;RFC4;REXO4;RAD50;CDC34;XRCC2;XRCC3;MCM5;XPA
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.5817295271396845,-1.098064479649254,0.375,1.0,1.0,1/16,0.86%,TINF2
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.5626735905461981,1.0979935027756764,0.3448275862068966,0.9036334520683876,1.0,5/11,20.89%,FUT8;CSGALNACT1;GFPT2;GFPT1;EXTL2
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.5251836867284666,-1.0979069547797446,0.2714285714285714,1.0,1.0,5/31,13.37%,SLC25A4;MICOS13;SLC25A5;TIMM50;PPIF
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.5829047740960898,-1.0976259267480113,0.3333333333333333,1.0,1.0,7/25,14.16%,PM20D1;CPS1;ASAH2B;CYB5R3;DDAH2;ARG2;ASAH2
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.40427205420915796,1.0975686780569713,0.3333333333333333,0.9039430762579412,1.0,15/78,16.66%,DACT2;CHRNA4;ABCC8;CELF3;TMEM74B;CAMSAP3;SEMA5B;CACNG4;TOX3;RIMBP2;ARVCF;XKR7;EBF4;LRRC75B;SEMA6C
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.6914118466977538,1.0975569127789322,0.47368421052631576,0.9030359245168764,1.0,2/6,18.14%,PTEN;RGCC
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.49365082931851234,1.0973927844590692,0.2857142857142857,0.9025448104237537,1.0,7/18,19.18%,HAP1;NTRK2;RAPGEF1;SORT1;MAGI2;RAP1A;ZFYVE27
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),0.6845125124437117,1.0973678478014486,0.38636363636363635,0.9016823476231316,1.0,2/5,12.55%,SIRT1;STARD4
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.7465873964615176,-1.0970862933201186,0.42592592592592593,1.0,1.0,2/5,22.01%,RPF2;RAN
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.4032600857463301,-1.0970852204473813,0.2826086956521739,1.0,1.0,66/391,15.83%,CD44;PSMB8;IL26;HLA-F;B2M;IRF4;RPS27A;HLA-C;IL7;GBP2;DUOX1;PSME1;NDN;TIMP1;IFIT2;IFNGR2;MT2A;HLA-DPA1;HLA-A;PTAFR;PSMB6;HLA-E;IL31RA;PSMD8;PSMC5;IL6R;IRF9;PSMD7;IFITM3;IFIT3;UBA52;IRF1;STAT5A;LCK;CNN2;TNIP2;ARF1;TALDO1;TRIM25;CEACAM1;IL5;JAGN1;TMSB4X;RBX1;TGFB1;PSMD3;ILK;PIK3CB;STAT1;IFI6;PSMC3;TXNDC17;RPLP0;CD27;PPIA;OSMR;IFNLR1;UBB;IL3RA;CANX;EIF5A;PSMA4;TNFRSF1A;CEBPD;APPL2;IFIT5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.5794108747159303,-1.097043397029635,0.3582089552238806,1.0,1.0,5/18,18.51%,RPA3;RBX1;PARP1;XPA;GTF2H2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.5794108747159303,-1.097043397029635,0.3582089552238806,1.0,1.0,5/18,18.51%,RPA3;RBX1;PARP1;XPA;GTF2H2
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-0.6399388011645706,-1.0970110974134533,0.38596491228070173,1.0,1.0,2/7,5.66%,VPS35;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5997274142480595,-1.096934714977393,0.3709677419354839,1.0,1.0,1/13,1.22%,POLR2G
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.48089045508827716,1.0965266411369976,0.30303030303030304,0.9029295411505529,1.0,3/34,4.54%,PDGFB;PDGFC;ERRFI1
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.6000380448024487,1.0964323620781928,0.3611111111111111,0.9023574772095421,1.0,4/11,17.54%,TCOF1;CDH2;KBTBD8;NRG1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.4005662963207647,1.0964222197884412,0.2857142857142857,0.9014428745285901,1.0,43/139,21.04%,FGFR1;FLT1;PASK;FGFR3;SRC;ALK;EGFR;PRKX;PDGFRA;CDK12;IGF1R;TNIK;NTRK2;MYO3A;MEX3B;VRK2;MAPKAPK3;GRK5;MKNK2;ULK3;ATP13A2;PRKD1;HCK;SMG1;UHMK1;DYRK1A;FLT3;PIM3;GSK3B;FER;CAMK2D;ABL1;MKNK1;ERBB4;SIK2;PIKFYVE;EPHB3;KDR;MARK2;PEAK1;MAPKAPK2;MAP3K10;CSF1R
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.5485206021349217,1.0964098180844108,0.20689655172413793,0.9005438863149413,1.0,1/19,0.51%,NUPR1
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.6729877839731264,-1.096261155387656,0.4307692307692308,1.0,1.0,2/7,12.40%,PSMC5;PSMC3
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.5033675139109557,-1.09624076764828,0.30434782608695654,1.0,1.0,6/28,12.38%,SERPING1;LPA;F5;CYB5R3;PLN;STAT1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.7176058777918687,-1.0962209615026008,0.43103448275862066,1.0,1.0,1/5,0.94%,PDHX
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.5250254945935616,1.0961092493828302,0.38235294117647056,0.9004288069738862,1.0,4/17,8.81%,HSPA1A;PLK1;HNRNPU;HSPA1B
prerank,PanglaoDB_Augmented_2021__T Cells,0.4136397593916763,1.0959798807112189,0.32,0.8998616548174296,1.0,12/70,9.39%,ZAP70;GNLY;LCP2;PSTPIP1;LEF1;BATF3;NOTCH3;NABP1;GDPD3;SYT3;IL2RA;CD4
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.6671390235343807,-1.0957610720573057,0.39655172413793105,1.0,1.0,2/8,11.36%,PINK1;LANCL1
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.4148474635901462,1.0956797164480583,0.25,0.8997201257299926,1.0,23/90,14.41%,IGF1;NOS2;MYOM1;ABCC8;RFX3;ENSA;SYTL4;STX1A;BMP6;ADAM8;STXBP5;LLGL2;TGFB2;HMGCR;DRD4;KCNC2;ARFIP1;ITPR1;SLC12A2;RAPGEF3;ATP13A2;RAPGEF4;SERGEF
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.45517060426004474,1.0954244592811013,0.20588235294117646,0.8993737122907766,1.0,7/56,8.08%,NFKBIZ;NPAS2;SNCA;FEM1A;CYBA;ADAM8;OPTN
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.5432061381623242,-1.0952094114766788,0.3380281690140845,1.0,1.0,3/20,11.68%,PRDX5;BRF2;AR
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.36387060221586676,1.0951565365177174,0.1111111111111111,0.8990143429778941,1.0,86/348,20.00%,ZAP70;PDGFB;CDKL1;FGFR1;CDK6;PASK;ALK;PLK1;CDK10;MAP4K5;LIMK1;FRK;NEK4;CDK12;IRAK3;FNIP2;TNIK;SGK1;NLK;AURKC;MAP3K1;MEX3B;MAPK10;TGFB2;MATK;VRK2;TSSK6;PRKG2;ACVR1;NUAK1;SGK3;GRK5;DYRK3;MKNK2;PXK;MAP4K2;MAP4K4;PIK3CA;PRKCE;PI4KA;PRKD1;MERTK;CDKL4;POMK;HCK;CDK17;BMPR2;SIK3;MARK1;ACVR2B;HIPK2;RYK;PDK1;CDC25B;DYRK1A;HIPK3;DGKI;SYK;PIM3;PDK4;ACVR2A;ACVR1C;GSK3B;LTK;FER;PRKCZ;DGKE;PRKACB;CAMK2D;CDK18;ABL1;MAPK8;MARK4;PANK3;DGKK;BCR;DGKB;GRK4;BMPR1B;LMTK3;MKNK1;DMPK;COPS2;WNK1;SIK2;PICK1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.5591196764256846,-1.0951295697525094,0.3283582089552239,1.0,1.0,3/25,6.39%,PLAAT4;PLAAT5;CHKB
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.42714116239192385,1.0948211371581094,0.34375,0.8991744202931475,1.0,19/74,18.37%,RELN;HOMER1;NLGN1;CACNB4;CACNG5;CACNG4;DLG2;DLG1;GRIN1;FGF13;DMD;SLMAP;DLG3;SHISA9;GRIN2B;CAMK2D;GRIA2;JPH1;FGF14
prerank,PanglaoDB_Augmented_2021__T Memory Cells,0.39422553294013035,1.094704801491299,0.25806451612903225,0.8985296233606889,1.0,6/58,3.92%,ZAP70;GNLY;LCP2;PSTPIP1;TMC8;LEF1
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.5056098499661501,1.0946823508298498,0.3333333333333333,0.8976818035169175,1.0,8/46,16.29%,LEF1;CHD5;TRIM16;MSL2;OGT;JADE2;KANSL2;JADE3
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),0.6592736388242294,1.0946730604386792,0.45454545454545453,0.8968084931405995,1.0,3/5,28.12%,ST3GAL2;ST8SIA3;ST3GAL1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.4020785257906443,1.093995801953881,0.21428571428571427,0.8980441508985663,1.0,15/75,14.15%,EPB41L4B;SRC;ATOH8;NRP2;SASH1;DOCK1;MAPRE2;TGFB2;FGF1;MAP4K4;PRKCE;PRKD1;CLASP1;GPLD1;BMPR2
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.48638995876754565,1.0939451923160852,0.3793103448275862,0.8972401521380936,1.0,5/18,9.08%,ODAD3;CFAP53;DNAH11;DNAI2;DLL1
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.41937834674057367,-1.0939248923474516,0.3375,1.0,1.0,28/175,17.51%,CENPF;MCM2;BUB1;CCNB2;STMN1;H2AZ1;MT2A;CENPE;ORC6;KIF20B;MCM3;TPX2;SNRPD1;TGFB1;SMC4;CDK4;CHAF1A;GINS2;KPNA2;NCL;SMC2;HMGN2;ILF3;CBX1;HSPA8;KIF4A;PLK4;MCM5
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.5542815361834129,-1.0938550410008179,0.36666666666666664,1.0,1.0,5/17,21.35%,SNF8;CENATAC;TMEM9;FURIN;HPGD
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),0.6129591233353666,1.093502760236639,0.35714285714285715,0.8975909960782069,1.0,2/8,3.92%,IFNA2;LEF1
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.44974116262075026,-1.0933500659500852,0.2702702702702703,1.0,1.0,11/75,15.78%,TINF2;DBI;PNKP;ATG14;FBLN1;BEX4;TGFB1;CADM4;PPIA;MYADM;WARS1
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.5828808144179889,1.0924267572247843,0.375,0.8995404318320869,1.0,1/10,3.13%,VEGFD
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.6094294038135204,-1.0924064201785262,0.4153846153846154,1.0,1.0,2/14,8.28%,KIF20B;RACK1
prerank,PanglaoDB_Augmented_2021__T Cells Naive,0.46621259241254875,1.0920551728104757,0.34375,0.8994820436472761,1.0,5/36,2.91%,ZAP70;GNLY;LCP2;PSTPIP1;PIK3R5
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.571210636654087,1.0912765443628556,0.325,0.900600534188755,1.0,2/12,7.34%,GLI2;NFIB
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.6212289619787208,-1.0912727338310746,0.3684210526315789,1.0,1.0,3/13,9.85%,CD9;FBLN1;SPINT2
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.4583212173104572,1.0912152540107407,0.3,0.8997980153175767,1.0,6/42,2.91%,ZAP70;GNLY;LCP2;C1ORF162;PSTPIP1;PIK3R5
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.6978463483524757,-1.0910770471226525,0.34375,1.0,1.0,2/7,24.12%,IFNAR1;RO60
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.6202778238495777,-1.0910480663631212,0.30434782608695654,1.0,1.0,3/10,22.34%,GREM1;FSTL1;CD46
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.5497184489457367,1.0910428195426003,0.2777777777777778,0.8994965680390626,1.0,4/21,8.45%,RELN;CPEB3;NLGN1;LLPH
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.7371335329203902,-1.0910147813507731,0.39344262295081966,1.0,1.0,2/5,18.89%,ALG10B;GOLGA2
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.5697145210635998,-1.090977917348147,0.421875,1.0,1.0,2/19,5.34%,DNASE2;ENDOG
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),-0.7063267196724291,-1.0908500046235439,0.40350877192982454,1.0,1.0,2/5,24.75%,GREM1;MYOCD
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.651053789680651,-1.0905510812515975,0.38235294117647056,1.0,1.0,5/8,27.24%,SNX17;APOE;SCARF1;AKR1D1;CYP27A1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.651053789680651,-1.0905510812515975,0.38235294117647056,1.0,1.0,5/8,27.24%,SNX17;APOE;SCARF1;AKR1D1;CYP27A1
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.6136905700913647,-1.090223190285544,0.3384615384615385,1.0,1.0,2/10,8.17%,JUP;SERPINB8
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.39522603585862226,1.0901586109724217,0.23076923076923078,0.9008543886388857,1.0,51/128,21.43%,GFAP;EGFR;DAO;MMD2;ALDH1L1;PLPPR4;NPAS3;ADGRB3;AMER2;P2RX7;CDH20;CTNNA2;PSD2;ZEB2;NTRK2;MAPK10;GRM3;AKAP6;DLG2;SLCO1C1;CDC42EP4;NCAN;LRRC4C;SLC4A4;NRXN1;ADCY8;GPM6B;MAGI2;RAPGEF4;SLC1A2;CADM2;P2RY1;CA10;GRIN3A;RUFY3;NFASC;ADGRA1;KIF1B;GRIN2B;GRIA2;SPHKAP;RFTN2;ADCYAP1R1;KCNIP1;FABP7;ST8SIA3;TNR;GRM5;SLC6A1;BICD2;GABRG1
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.5189938513707051,-1.0899305186847303,0.3283582089552239,1.0,1.0,11/33,23.14%,GAPDH;SLC25A11;G6PC3;TPI1;MDH2;MDH1;SLC25A1;GAPDHS;PGAM1;ENO1;ALDOB
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.5278030521999048,-1.0899266596515536,0.359375,1.0,1.0,6/29,11.99%,PCDHB11;PCDHB4;PCDHB2;CDH12;CDH17;SELP
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.5771142727402702,1.0897493618065242,0.4146341463414634,0.9011048133820726,1.0,4/12,9.30%,DYSF;SYTL4;MYOF;AHNAK2
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),0.6861411104239021,1.0897195091142422,0.4583333333333333,0.9002511878754409,1.0,5/5,31.40%,KDM6A;PHF8;KDM7A;UTY;KDM6B
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),-0.7093164802938814,-1.0895708731307732,0.45161290322580644,1.0,1.0,3/5,22.80%,PDCL3;SGTB;PDCD5
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.6049264241934946,-1.0894870896193607,0.4696969696969697,1.0,1.0,5/14,15.05%,STMN1;STMN2;KIF18A;STMN3;KATNB1
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),0.6352039508884275,1.089477952887213,0.38461538461538464,0.8999773864311365,1.0,3/8,16.20%,KYAT1;KYNU;QDPR
prerank,PanglaoDB_Augmented_2021__NK Cells,0.3931380031527692,1.0888263795431603,0.2222222222222222,0.9010472178866387,1.0,9/62,7.95%,ZAP70;KLRD1;GNLY;LCP2;PSTPIP1;ZBTB16;PCDH15;ITGAX;HMBOX1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.699501816380443,-1.0887517411758167,0.421875,1.0,1.0,2/7,8.13%,RPS21;NOP9
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.6518848208628159,-1.0886497128282815,0.45098039215686275,1.0,1.0,2/7,17.09%,ABCA12;METTL3
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.4637305304925547,1.088529811111798,0.27586206896551724,0.9009341751057556,1.0,7/38,13.91%,SPIRE2;SPIRE1;SCIN;CDC42EP4;PRKCE;BAIAP2L1;HCK
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.45526560953484296,-1.0883426024819636,0.30985915492957744,1.0,1.0,14/107,15.67%,LIX1;TOMM7;ATG14;CHMP2A;VPS25;VAMP8;ATG10;VPS28;TOMM20;PINK1;GABARAPL2;ACBD5;SNF8;DYNLL1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.6595431352139184,-1.0882447544713731,0.39655172413793105,1.0,1.0,4/10,17.03%,IRF1;IRGM;STAT1;CDC34
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5199722220614713,1.088197927999553,0.35135135135135137,0.9012502833458714,1.0,4/14,9.08%,JCAD;SPRY2;ROBO1;DLL1
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.6846824340773674,-1.0880288047351707,0.3880597014925373,1.0,1.0,3/6,8.85%,LIMA1;PLEKHH2;VIL1
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.7344119367840058,1.0880134786686417,0.37254901960784315,0.9007757214210501,1.0,1/5,6.25%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.5454962720489022,1.0877949331967067,0.34210526315789475,0.9003288636668972,1.0,1/14,1.33%,IGF1
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.44493509785119273,-1.08747571412898,0.35064935064935066,1.0,1.0,26/95,25.37%,MCM2;DDX11;DHX16;MCM3;FTSJ3;DHX38;USP19;SNRNP200;EIF3D;CHAF1A;NEMP1;CHD4;MCM3AP;ILF3;NOL6;DHX37;PRPF8;PDCD11;LSG1;TTF2;DDX21;SSRP1;KPNB1;EFTUD2;NOP14;TOPBP1
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.5387485393604091,1.0874220255269715,0.42424242424242425,0.9006446288937315,1.0,6/18,11.04%,ST8SIA6;ST8SIA1;GANC;ST8SIA4;MAN2A1;FUT8
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.7165984446028425,-1.0873849714669623,0.4461538461538462,1.0,1.0,4/5,26.95%,RTF1;PAF1;CTR9;LEO1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.4662040266704139,1.0870501156238481,0.36363636363636365,0.9006527058379385,1.0,10/44,17.49%,CLN6;OSBPL1A;SULT2A1;SOAT1;DHCR7;SULT2B1;HMGCR;LCAT;SC5D;FDX1
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),0.66143259546778,1.0869852995820921,0.4583333333333333,0.8999672427993648,1.0,3/6,18.81%,SULT2A1;SULT2B1;HS3ST5
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.6232030862806962,1.0869269641476798,0.3953488372093023,0.8991499095841562,1.0,4/8,14.77%,TMEM108;NLGN1;NRXN1;PTEN
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5183711126394395,1.0868904395501355,0.3333333333333333,0.8983208940931569,1.0,2/14,2.41%,CREB3L1;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.6055767818038948,1.08680331906123,0.42424242424242425,0.8976132030528042,1.0,4/14,4.47%,IGF1;NLRP7;CARD18;CX3CR1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.7059517331737606,1.0865563429547425,0.425,0.8976508211339578,1.0,3/5,14.64%,RUNX1;CBFB;HMGB1
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.6174804708101969,-1.0864173693945112,0.265625,1.0,1.0,7/15,26.10%,COLEC12;FLOT1;CGAS;PQBP1;RIOK3;CAV1;IFIT1
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.5445687278310417,1.086367032031468,0.35555555555555557,0.8975158444153329,1.0,3/11,9.57%,NMNAT2;AK3;AK4
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),-0.6563094099839719,-1.0863393830391397,0.3559322033898305,1.0,1.0,4/8,19.00%,PROCR;EDN1;APOE;SERPINE1
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.6178259473345434,1.0860747403947988,0.4,0.8974341659494205,1.0,4/7,20.55%,NLGN1;PLXNB2;PTEN;WNT5A
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.40152204620075477,1.0858431307966507,0.18181818181818182,0.8972864270279189,1.0,27/91,22.47%,ZBTB1;KAT2A;HDAC4;ARID1B;SIRT1;SMARCA2;KDM4C;BAHD1;ARID1A;SMARCD2;MBD3;SMARCAD1;ATRX;KAT2B;SMARCD3;RSF1;KDM6A;HDAC1;SMARCC1;SATB2;BAZ2B;HNRNPC;PBRM1;DR1;SMARCE1;ACTR5;ZBTB7A
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),-0.7305969355038673,-1.085824480932797,0.2711864406779661,1.0,1.0,2/5,11.76%,TCN2;AMN
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.6379644026908113,-1.085763817077507,0.3939393939393939,1.0,1.0,4/7,26.74%,BRCA1;UBE2D4;RNF4;UBE2S
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.5888555002776981,1.0855690031704408,0.34375,0.8972712942362048,1.0,3/10,9.52%,KCNIP2;KCNMB4;STIM1
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.5430933551019369,1.0853912252462528,0.391304347826087,0.8969918259737681,1.0,4/18,16.23%,ATP6V0A4;SCNN1B;SLC12A2;PDK4
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),-0.6988496265574422,-1.0851965753436938,0.3968253968253968,1.0,1.0,1/5,3.48%,NPR2
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),-0.6988496265574422,-1.0851965753436938,0.3968253968253968,1.0,1.0,1/5,3.48%,NPR2
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.5757569026130744,-1.0850647562954707,0.4246575342465753,1.0,1.0,2/16,6.21%,SLC22A9;FABP3
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.5480470922274421,-1.0845347837954742,0.38333333333333336,1.0,1.0,7/17,30.16%,CHMP2A;SNF8;CHMP3;VPS4B;SDC4;HGS;SMPD3
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.47219695365163955,1.0840011559999652,0.2692307692307692,0.8994992090808263,1.0,28/105,13.66%,VDR;TNC;PCDH18;PBX3;FRZB;NRP2;PDGFRA;CSPG4;POSTN;HMCN1;AGER;LTBP2;ADAMTS2;COL9A1;TMEM47;COL6A1;CDH11;RHOJ;COL14A1;HTRA1;AEBP1;COL5A1;SGCD;SLIT3;ADAMTS5;PTHLH;FBXL7;TCF4
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.5084757032903482,1.0837955784715254,0.3333333333333333,0.8991521323929792,1.0,1/17,1.33%,IGF1
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),-0.48624569631103853,-1.0836089047733892,0.31343283582089554,1.0,1.0,4/36,10.46%,SLC8A3;LCK;HTR2B;SLC24A1
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),0.7450444051273284,1.0835494910891303,0.425,0.898950711067994,1.0,3/6,14.42%,CA2;AQP1;NGB
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.4035531892174919,-1.0834843008007198,0.25842696629213485,1.0,1.0,92/350,24.05%,CD44;B2M;HLA-C;FTH1;FTL;SRP14;TRAPPC1;CSTB;JUP;CD63;PTAFR;GSTP1;DEGS1;RHOG;NIT2;CYB5R3;PPIE;TUBB4B;ATP6AP2;PSMD7;FUCA2;PFKL;PGRMC1;VAMP8;CNN2;CEACAM1;CFD;FUCA1;GMFG;PSMD3;GRN;PSMC3;LRRC7;DDOST;GGH;COMMD9;PPIA;EEF2;ADGRE5;DOCK2;IMPDH2;PRSS3;LAMP1;APRT;PTGES2;PYGL;CCT2;DYNLL1;CLEC12A;MAGT1;PGLYRP1;TIMP2;ARPC5;HSPA8;LAMTOR1;EEF1A1;STK10;ORMDL3;LILRB3;CST3;CKAP4;AGA;PSMD2;CR1;CYSTM1;ATP6V1D;PSMD6;VAT1;CTSZ;ITGAV;TMEM179B;TUBB;AGL;ARL8A;LGALS3;C6ORF120;FRMPD3;ILF2;PGAM1;ALOX5;AP2A2;RHOA;DNASE1L1;LAMTOR2;HGSNAT;BRI3;GLIPR1;CTSS;NPC2;ADGRE3;SVIP;KPNB1
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.4555783774290524,-1.0833365243599375,0.3493975903614458,1.0,1.0,23/96,19.91%,DDIT3;SELENOK;SELENOS;UFC1;CFTR;RASGRF2;TTC23L;ATG10;HSPA5;USP19;GORASP2;PDIA3;FLOT1;CEBPB;RNF5;TMCO1;ATF3;UFL1;HYOU1;CCDC47;HSP90B1;FICD;BAX
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.5265347315612726,1.0832359832928018,0.32142857142857145,0.8990130102052093,1.0,2/37,5.88%,RAB27A;ALS2CL
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.535392345339833,-1.0830338369070354,0.273972602739726,1.0,1.0,7/31,20.12%,POLR1G;POLR2L;POLR1F;POLR1H;TAF1D;GTF2H2;POLR1E
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.41238709946797725,1.0830204216495474,0.22727272727272727,0.8986805901121097,1.0,32/108,20.84%,RELN;IL1RAPL1;TIAM2;PTPRD;EPHA3;PROM2;ZNF804A;DPYSL3;OBSL1;PLXNA1;NTRK2;ROBO1;ARHGAP35;RAPGEF1;PLXNB2;ROBO2;PRKD1;SLIT2;MAGI2;SS18L1;CHODL;ROR1;PLXNA4;LTK;RAP1A;FUT9;CUL7;CUX1;CBFA2T2;ABL2;WNT5A;MARK2
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),-0.6884042546123539,-1.0829237273684127,0.4098360655737705,1.0,1.0,2/5,16.97%,TIMP1;TIMP2
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.6354784422537448,-1.08284907573655,0.4482758620689655,1.0,1.0,3/10,17.36%,ACMSD;GCK;PGP
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.38574607607447703,1.0827659875009739,0.23529411764705882,0.8985459280426569,1.0,44/217,12.07%,CREB3L1;PDGFB;COL20A1;ADAMTSL3;COL5A3;TNC;ADAMTSL2;CTSK;ICAM1;ITGA11;FBLN5;SLC39A8;VIT;COL7A1;COL22A1;JAM2;COLGALT1;ADAM19;VCAN;ITGA10;POSTN;ADAMTS9;ADAMTS2;AGRN;ADAMTS18;COL9A1;SERPINF2;COL23A1;ITGAX;ADAM8;COL6A1;SCX;COL14A1;ADAMTS10;HTRA1;LOX;TGFB2;COL5A1;NPNT;NCAN;RECK;MMP16;ADAMTS5;COL25A1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.48098813932718654,-1.0826454415156967,0.3888888888888889,1.0,1.0,22/62,27.66%,POLR2G;GTF2F1;POLR2J;POLR2L;ELOB;POLR2I;ADRM1;RTF1;PAF1;SUPT5H;POLR2A;GTF2H2;NCBP1;NELFCD;NELFE;SSRP1;ELOF1;CTR9;POLR2K;LEO1;POLR2C;NCBP2
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),-0.7065765168796084,-1.0823845128399852,0.38235294117647056,1.0,1.0,2/5,24.82%,URM1;CTU2
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.4472714147431832,1.0823750972304305,0.2571428571428571,0.8988316066475786,1.0,9/36,14.08%,SLC26A7;CLIC5;ANO4;SLC26A6;SLC13A4;SLC26A9;ENPP1;ANO8;CLCN4
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.48841084722465394,-1.082295324014911,0.4,1.0,1.0,20/66,24.43%,CSTF2T;POLR1G;POLR2L;POLR3K;POLR1F;FIP1L1;LSM10;POLR1H;TTF1;TAF1D;CPSF3;POLR2A;GTF2H2;CLP1;POLR1E;NCBP1;SMN1;TTF2;SSU72;POLR1B
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.5514259926857856,1.08221386011362,0.2777777777777778,0.8984347707617566,1.0,3/13,16.86%,PLIN5;GPLD1;NR1H3
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),-0.6931755301587851,-1.0817829719985725,0.373134328358209,1.0,1.0,1/7,0.56%,DDIT3
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.5153788298777863,1.0815815278761851,0.3684210526315789,0.8993750801179335,1.0,8/26,18.77%,ARHGEF7;ARHGEF6;SPEF1;GOLPH3;CYFIP1;PTPRO;SNX1;WHAMM
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.6868330897431747,-1.0812306947739998,0.3770491803278688,1.0,1.0,1/6,11.30%,PMM1
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.6027975780368947,-1.0810732003446148,0.48333333333333334,1.0,1.0,1/9,2.57%,ROGDI
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.6001037155696904,-1.081057339972249,0.35714285714285715,1.0,1.0,4/16,16.52%,TCN2;AMN;PRSS3;MMACHC
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.6001037155696904,-1.081057339972249,0.35714285714285715,1.0,1.0,4/16,16.52%,TCN2;AMN;PRSS3;MMACHC
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.404099327168413,-1.0810394595206192,0.2840909090909091,1.0,1.0,93/353,24.05%,CD44;B2M;HLA-C;FTH1;FTL;SRP14;TRAPPC1;CSTB;JUP;CD63;PTAFR;GSTP1;DEGS1;RHOG;NIT2;CYB5R3;PPIE;TUBB4B;ATP6AP2;PSMD7;FUCA2;PFKL;PGRMC1;VAMP8;CNN2;CEACAM1;CFD;FUCA1;GMFG;PSMD3;GRN;PSMC3;LRRC7;DDOST;GGH;COMMD9;PPIA;EEF2;ADGRE5;DOCK2;IMPDH2;PRSS3;LAMP1;APRT;PTGES2;PYGL;CCT2;DYNLL1;CLEC12A;MAGT1;PGLYRP1;TIMP2;ARPC5;HSPA8;LAMTOR1;EEF1A1;STK10;ORMDL3;LILRB3;CST3;CKAP4;AGA;PSMD2;CR1;CYSTM1;ATP6V1D;PSMD6;VAT1;CTSZ;ITGAV;TMEM179B;TUBB;AGL;ARL8A;LGALS3;C6ORF120;FRMPD3;ILF2;PGAM1;ALOX5;AP2A2;RHOA;DNASE1L1;LAMTOR2;HGSNAT;BRI3;GLIPR1;CTSS;NPC2;ADGRE3;ADAM17;SVIP;KPNB1
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.6462721910238126,-1.080942848982898,0.43478260869565216,1.0,1.0,4/9,13.31%,HLA-A;HLA-E;IRF1;MAPK8IP1
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.6926981401873322,-1.0809017121873252,0.38461538461538464,1.0,1.0,2/7,15.79%,MYADM;DCTN1
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.5501006118133827,1.0808441985898378,0.40540540540540543,0.9003397251488765,1.0,1/12,0.39%,GRM2
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.612031055884804,-1.0808348373159935,0.4067796610169492,1.0,1.0,1/12,1.23%,QPRT
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.5656324305765633,1.0805551084688803,0.35714285714285715,0.9000994904812997,1.0,1/11,2.83%,SRC
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.6993531739687864,-1.0805509024991926,0.4666666666666667,1.0,1.0,1/5,1.57%,XBP1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.5294257245346398,-1.0805389574731912,0.4142857142857143,1.0,1.0,3/22,18.81%,DDX11;NCL;RASL11A
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.5961737565977095,1.0804976984725434,0.3902439024390244,0.8993241335703633,1.0,7/8,30.78%,P2RY1;SLC8A1;RYR3;RYR2;CASQ2;TRPM2;RYR1
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.7610185947769188,1.0804330411916299,0.4375,0.8987460479325567,1.0,3/8,5.94%,FGFR1;FGFR3;SNCA
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.6267317352172034,-1.08033481972817,0.4153846153846154,1.0,1.0,2/8,7.32%,KIF20B;CHAMP1
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.44496723763174073,1.080154857290174,0.3333333333333333,0.8986514862072091,1.0,9/61,9.71%,FGFR1;ALK;MMD2;CPNE1;NLGN1;ASCL1;DLL1;BRINP3;MOSMO
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.46352444283166827,-1.0800820592626807,0.30120481927710846,1.0,1.0,6/75,4.38%,B2M;DTX3L;STMN1;EDF1;RPL11;DDX11
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.34851612589118697,1.079662298119044,0.3076923076923077,0.8990390345817112,1.0,37/363,9.19%,CREB3L1;VDR;PDGFB;ZNF423;TP63;DACH1;ATOH8;IFNA2;ATXN1;SPINDOC;GMNN;HDAC10;HDAC4;LEF1;RFX3;RELA;HIC2;SAMD13;HMX1;ID1;ZNF706;FOXK1;ZBTB16;YAF2;SIRT1;ASCL1;SMARCA2;SFMBT2;FOXN3;CDKN2A;ZNF93;ZHX2;PHF10;HMBOX1;ARID5A;MLXIPL;PHC3
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.4829571649586333,-1.0794273916963197,0.34782608695652173,1.0,1.0,17/72,18.65%,NLRP1;IFIT2;RNASE1;IFITM3;IFIT3;IRF1;FADD;STAT1;IFI6;EXOSC4;IFNLR1;CGAS;IFIT5;AGBL5;PQBP1;NLRP9;ISG20
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),-0.7154695275572115,-1.0793454183435525,0.3333333333333333,1.0,1.0,2/6,19.58%,SEMA3A;PTN
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.5087952631511531,-1.0792627849053524,0.35294117647058826,1.0,1.0,8/35,20.80%,GSAP;VPS35;SNF8;MAPK7;APOE;CENATAC;TMEM9;FURIN
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.6700276858767368,-1.0791438461044485,0.3898305084745763,1.0,1.0,1/8,1.39%,CPS1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.6029871370124265,-1.0791169341552633,0.4057971014492754,1.0,1.0,7/10,33.93%,RACK1;PINK1;PARK7;NR4A3;FBXO7;REST;NONO
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.40722320786628585,1.078943148082328,0.25806451612903225,0.8998422230590616,1.0,7/58,11.65%,PTPN6;CDK6;EGFR;PKD1;CDKN2A;UBE2E2;DLG1
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.46345993785748724,-1.0782831555695744,0.32857142857142857,1.0,1.0,16/71,23.60%,SELENOS;SEC61B;TRIM13;TRIM25;HSPA5;USP19;RNF5;FAM8A1;UBXN8;MAN1B1;HSP90B1;SEL1L2;SGTB;FOXRED2;RNF175;FBXO6
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.6066864906600097,-1.0779898368881955,0.45,1.0,1.0,4/12,22.66%,NEFL;UXT;UBB;MAP1S
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.4954523543467622,-1.077824523998173,0.37333333333333335,1.0,1.0,12/34,29.86%,IFITM3;FAM111A;IFIT5;ILF3;ISG20;INPP5K;IFIT1;MORC2;BTBD17;RNASEL;SETDB1;ISG15
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),-0.594819739134889,-1.077660451045342,0.3870967741935484,1.0,1.0,4/11,27.11%,CCT7;CCT2;TERF1;CCT6A
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.402415770391647,-1.0776503535260855,0.2840909090909091,1.0,1.0,92/352,24.05%,CD44;B2M;HLA-C;FTH1;FTL;SRP14;TRAPPC1;CSTB;JUP;CD63;PTAFR;GSTP1;DEGS1;RHOG;NIT2;CYB5R3;PPIE;TUBB4B;ATP6AP2;PSMD7;FUCA2;PFKL;PGRMC1;VAMP8;CNN2;CEACAM1;CFD;FUCA1;GMFG;PSMD3;GRN;PSMC3;LRRC7;DDOST;GGH;COMMD9;PPIA;EEF2;ADGRE5;DOCK2;IMPDH2;PRSS3;LAMP1;APRT;PTGES2;PYGL;CCT2;DYNLL1;CLEC12A;MAGT1;PGLYRP1;TIMP2;ARPC5;HSPA8;LAMTOR1;EEF1A1;STK10;ORMDL3;LILRB3;CST3;CKAP4;AGA;PSMD2;CR1;CYSTM1;ATP6V1D;PSMD6;VAT1;CTSZ;ITGAV;TMEM179B;TUBB;AGL;ARL8A;LGALS3;C6ORF120;FRMPD3;ILF2;PGAM1;ALOX5;AP2A2;RHOA;DNASE1L1;LAMTOR2;HGSNAT;BRI3;GLIPR1;CTSS;NPC2;ADGRE3;SVIP;KPNB1
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.5225416248257024,1.077188975711636,0.4,0.9037897715398154,1.0,4/18,7.25%,MTHFD2L;MTHFS;ALDH1L1;DHFR
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.5197831404996234,1.0771776879150508,0.30303030303030304,0.9029374270996878,1.0,7/15,16.88%,PBX1;MAML2;NOTCH3;NOTCH4;KAT2B;CREBBP;WWC1
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.6474512002016317,1.0771229176887809,0.3939393939393939,0.9021775587645599,1.0,1/7,1.53%,ISYNA1
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.5257119931445638,1.0771086247961918,0.29411764705882354,0.901328431493836,1.0,4/9,20.89%,CSGALNACT1;GFPT2;GFPT1;EXTL2
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.6568727454359778,1.0771072848482972,0.4523809523809524,0.9004550512307606,1.0,6/7,34.16%,PHYH;HACL1;SLC27A2;PECR;SLC25A17;PEX13
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.5251646031804023,-1.0766738359024055,0.36486486486486486,1.0,1.0,4/24,10.96%,JUP;HYAL2;RBM22;TGFB1
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.570029169944119,1.076530731009751,0.3611111111111111,0.9011616464392022,1.0,4/10,17.54%,SGK1;SCIN;GPLD1;NRG1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.5873213046777295,-1.0764615832649236,0.36923076923076925,1.0,1.0,5/18,4.70%,RPL23;RPS15;RPS7;RPS20;RPL37
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.6609244043335659,1.076433639491961,0.3888888888888889,0.9005356774921234,1.0,3/8,11.78%,ATP12A;ATP1B3;SLC4A4
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.6897752679344,-1.0763728949471805,0.38333333333333336,1.0,1.0,3/7,24.77%,SYT11;GRN;NR1D1
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.6095197151028715,-1.0761210521829252,0.4264705882352941,1.0,1.0,3/16,12.86%,RIMS1;CARTPT;MYRF
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.3868137390850616,1.0760403721130851,0.3333333333333333,0.9005177708543498,1.0,35/146,16.56%,KCNQ2;ADGRB1;CHRNA4;CELF3;CNTNAP2;MMD2;NRIP3;SLC24A3;SCRT1;CTNND2;OLFM3;ADGRB3;AMER2;HIVEP2;CTNNA2;PCDH8;PSD2;NXPH1;SNAP91;CADPS;KCNMA1;GRM3;NCAN;SHANK2;NRXN1;GRIN1;PKP4;PPM1E;SLC8A2;CADM2;PVALB;SLC32A1;CA10;ABAT;ADGRA1
prerank,MSigDB_Hallmark_2020__Apical Surface,0.47755675912666806,1.075977757255609,0.3125,0.8998420346564815,1.0,3/33,3.09%,ATP6V0A4;AFAP1L2;HSPB1
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.7248631516047314,-1.0759312113467698,0.5151515151515151,1.0,1.0,3/5,26.22%,VAMP8;SNX6;VAMP3
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),-0.5900849708840246,-1.075875217161884,0.36231884057971014,1.0,1.0,3/11,10.69%,UBXN1;AQP11;USP19
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.4888729286532485,1.075811126518562,0.34146341463414637,0.8994768862929202,1.0,6/26,12.95%,KAT2A;MAML2;NOTCH3;ARRB1;DLL1;LFNG
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5036996401913567,1.0757542207069903,0.4411764705882353,0.8987519571005051,1.0,5/19,9.57%,AK3;ADSS2;HPRT1;AMPD1;AK4
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.42521977224910695,-1.0755377794846634,0.35064935064935066,1.0,1.0,14/143,10.07%,CD44;TNFAIP2;IFIT2;IFNGR2;EFNA1;SNN;IRF1;BTG3;STAT5A;BTG1;SERPINB8;TNIP2;GPR183;EIF1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.709831008719842,-1.0753361626258606,0.48214285714285715,1.0,1.0,3/5,12.22%,USP19;TGFB1;FLOT1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.5572159288275558,1.0753051031792735,0.43902439024390244,0.8990831115529104,1.0,6/12,26.56%,KAT2B;CREBBP;NAA16;NAA30;NAA25;NAA50
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.6704321568080926,-1.0747535198250204,0.390625,1.0,1.0,3/5,27.05%,AIF1L;INPP5K;ARF6
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.506598651360771,1.0746178961836066,0.35135135135135137,0.9002617083115577,1.0,5/18,12.82%,FBLN5;TNXB;LTBP3;NTNG1;GPM6B
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.6380441054594724,1.0744552715083868,0.37142857142857144,0.899871885190216,1.0,2/7,13.11%,SRC;UBR5
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.6318728971509175,-1.0742508159686543,0.48333333333333334,1.0,1.0,2/10,17.68%,GSTP1;GREM1
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.5741324117752246,1.0741934271673719,0.3939393939393939,0.8996367105354129,1.0,3/9,24.79%,ZDHHC3;MIA3;ZDHHC17
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.6175564144045276,1.0739250313957824,0.425,0.899517301356379,1.0,1/6,5.56%,MOGAT1
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.6269901593898994,-1.0738678196631146,0.41935483870967744,1.0,1.0,5/11,23.10%,PPIB;CAV2;CFL1;APOE;TBC1D20
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.5398032884075279,1.0732184931766409,0.3225806451612903,0.9008061705911561,1.0,3/13,13.55%,SLC2A9;SLC2A5;SORT1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.5985637171242894,1.0732010491806376,0.3939393939393939,0.8999953079258026,1.0,6/9,26.85%,RAPGEF1;RAPGEF3;RAP1A;RAP2C;RAP2A;RAPGEF2
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.6874220091120655,-1.0730871980262255,0.484375,1.0,1.0,4/6,22.77%,PRPS1;PRPSAP1;PRPS2;G6PD
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.6683601686159479,-1.0729960021325353,0.4153846153846154,1.0,1.0,4/7,29.98%,CD81;ZP3;C1S;C1QC
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.6224738993571404,-1.0728528598169913,0.4393939393939394,1.0,1.0,2/10,13.55%,HR;KDM4D
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.5721571382029491,-1.0727491948399088,0.46774193548387094,1.0,1.0,1/17,0.77%,RIMS1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.5416172741759154,-1.0724987707944724,0.3380281690140845,1.0,1.0,9/26,27.14%,ELOVL2;SCD;ACSBG2;SLC25A1;ELOVL1;FASN;HSD17B8;PPT1;HSD17B12
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.44043852476800793,-1.0724311966778806,0.33783783783783783,1.0,1.0,23/98,23.24%,PSMB8;PSME1;VAV3;PSMB6;PSMD8;PSMC5;NFATC1;PSMD7;PSMD3;PIK3CB;PSMC3;PSMA4;PSMD2;PSMA7;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;PSMC1;SHC1;CALM1;PSMD10
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.5552314884601345,-1.0722912182668565,0.4090909090909091,1.0,1.0,7/17,28.27%,FTSJ3;EXOSC4;EXOSC10;WDR12;NSA2;PES1;LAS1L
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.3830210924324317,1.0722582780984953,0.4166666666666667,0.9013962395858942,1.0,12/132,6.19%,PTPN6;PPP4R2;PPM1M;PLPP4;DUSP6;PTPRD;ACP6;PPM1L;MTMR2;DUSP1;PLPPR4;DUSP10
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.5976821504412398,-1.0722501183828168,0.423728813559322,1.0,1.0,5/15,14.16%,PDXDC1;ASAH2B;SMPD2;SGPL1;ASAH2
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),-0.7149473027124656,-1.0720571315930982,0.46551724137931033,1.0,1.0,4/5,14.01%,ALDH1A2;RBP1;RBP2;LRAT
prerank,PanglaoDB_Augmented_2021__Platelets,-0.43863099881660644,-1.071987405041559,0.3333333333333333,1.0,1.0,30/110,24.47%,DPEP2;AQP9;PPDPF;CD9;OST4;HLA-A;HLA-E;F5;SPARC;CYP2U1;GMFG;ILK;SELP;LGALS8;ADGRE5;CLEC12A;ANGPT1;SERPINE1;RTL8B;CD226;F13A1;CD46;AGPAT1;CCR3;CTSS;MPL;ADGRE3;AOAH;CXCL14;HFE
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.4269389923852419,-1.0716149817713863,0.29411764705882354,1.0,1.0,48/180,24.17%,MCM2;CCNB2;STMN1;H2AZ1;CENPE;USP1;PCNA;MCM4;ORC6;PHF5A;MCM3;RANBP1;DSCC1;NAA38;RPA3;PRPS1;RAD51AP1;PNN;SMC4;CDK4;TCF19;RFC2;PSMC3IP;BRCA1;KPNA2;DCK;GINS4;DIAPH3;POP7;ILF3;RAD50;KIF4A;PLK4;MCM5;CSE1L;PAICS;ORC2;POLD2;TUBB;EZH2;ASF1B;RAN;ZW10;CDC20;RFC1;KIF22;SSRP1;CKS2
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.5086987437587132,-1.0713548873047904,0.3880597014925373,1.0,1.0,4/27,11.08%,ZFPM1;BBS12;TGFB1;GPS2
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.4610725926334759,-1.0712031190709568,0.31343283582089554,1.0,1.0,9/61,12.69%,OST4;ALG10B;TMEM258;DAD1;B4GALT7;DPM3;PMM1;MCFD2;DDOST
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.524886260366375,1.0711192663362032,0.34210526315789475,0.9038794159443962,1.0,6/13,28.88%,SLC8A2;GRIK2;SHISA9;SLC4A10;PPFIA3;RAB3GAP1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),-0.7339947584019535,-1.0710752224741058,0.5,1.0,1.0,1/5,4.81%,MESP1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.5070949392194052,-1.0706207172059634,0.390625,1.0,1.0,6/30,11.97%,SEMA3E;PHPT1;HRAS;HAX1;BAIAP2L2;CDK5
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.475829087679187,1.0701391281519443,0.3548387096774194,0.9056692672988684,1.0,8/24,15.68%,PRKX;RASIP1;GLI2;PKD1;ACVR1;MEGF8;SLIT2;PKD2
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.5255466000524922,-1.0701049142423,0.3783783783783784,1.0,1.0,3/25,6.62%,SPAG17;RSPH6A;CCDC39
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.5905117919139162,1.06986924645694,0.3448275862068966,0.9054810931452776,1.0,2/15,3.63%,RUNX1;COLGALT1
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.568326125572469,1.0698299502611373,0.39473684210526316,0.9046950940355631,1.0,4/11,12.48%,CORO2B;DYRK3;SLC38A2;ADCY8
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.5233534989071517,1.0697290561244348,0.3125,0.9032927191258994,1.0,5/19,3.19%,TNNC2;TCAP;TPM2;MYH3;MYH4
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.5233534989071517,1.0697290561244348,0.3125,0.9032927191258994,1.0,5/19,3.19%,TNNC2;TCAP;TPM2;MYH3;MYH4
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.5669452341469488,-1.0695067575238826,0.38235294117647056,1.0,1.0,7/19,17.67%,CLU;BBS12;HOPX;TMEM35A;NDUFAF1;CCT2;PFDN6
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),-0.6925198220138357,-1.0692394857530387,0.4626865671641791,1.0,1.0,1/5,25.22%,CTR9
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),-0.6976280978894942,-1.0691119098410327,0.4576271186440678,1.0,1.0,1/5,10.91%,FADD
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.4970974193964848,-1.0688970904483686,0.375,1.0,1.0,10/29,31.71%,ZNF830;CLSPN;FBXO6;RAD9A;HUS1;E2F1;DONSON;NBN;H2AX;STK33
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.48242219074953047,1.068876500891829,0.4166666666666667,0.9047573526806958,1.0,9/42,21.12%,HDAC10;HDAC4;SIRT1;TBL1XR1;HDAC9;MIER2;HDAC1;HDAC3;MIER1
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.5115490272636785,1.0688037501981107,0.3548387096774194,0.904215924246563,1.0,6/14,19.82%,OR3A2;UBR3;SLC24A4;C5AR1;DRD2;MKKS
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.5045089706839458,-1.0685943070227262,0.3972602739726027,1.0,1.0,1/33,0.35%,BMP5
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),-0.6295382663522304,-1.068540098141737,0.46153846153846156,1.0,1.0,1/8,10.91%,FADD
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.4370465798996574,1.0684389610906746,0.32142857142857145,0.9043342055429764,1.0,6/42,7.25%,CASS4;IL1RAPL1;ARHGEF7;PTPRD;OBSL1;DOCK1
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.5846953405783242,-1.0680536467650075,0.35294117647058826,1.0,1.0,4/14,16.70%,CHRM5;CHRM2;OPRM1;GNA11
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.4778827157368386,1.0678598905141654,0.3611111111111111,0.9050343924438592,1.0,4/36,7.90%,RIDA;CPEB3;FTO;ZC3H12D
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.6665422668550045,-1.06769333272962,0.45588235294117646,1.0,1.0,1/7,8.35%,TNIP2
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),-0.6960312259669669,-1.067676418698499,0.4074074074074074,1.0,1.0,2/5,17.00%,FNTA;RABGGTB
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.5750929578145746,-1.0676010705447554,0.3709677419354839,1.0,1.0,4/16,11.72%,ZFPM1;TGFBR2;EFNA1;OLFM1
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.6094169728413963,1.0675160050740264,0.40476190476190477,0.9044729796892406,1.0,2/8,5.94%,PDE4B;SNCA
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.6094169728413963,1.0675160050740264,0.40476190476190477,0.9044729796892406,1.0,2/8,5.94%,PDE4B;SNCA
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.5832495249505981,-1.0674941633627981,0.4067796610169492,1.0,1.0,4/14,14.02%,TTN;ZFPM1;TGFB1;MYH6
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),-0.7274539705984613,-1.0673720757425398,0.5245901639344263,1.0,1.0,1/5,6.86%,SFRP4
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.7000260237664238,1.067306953696652,0.45714285714285713,0.9042877120787521,1.0,2/7,14.25%,CTBS;CHI3L1
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.4971585213200106,1.0670745115660045,0.39473684210526316,0.9042162591636775,1.0,3/17,8.51%,HNRNPU;RANGAP1;TAF3
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.45765612722804055,1.0668542420917009,0.3333333333333333,0.9038426524258412,1.0,13/34,21.09%,ST8SIA6;ST6GAL2;ST8SIA1;ST8SIA4;FUT8;MAN2C1;ST8SIA5;ST3GAL2;ST3GAL6;FUT9;NEU4;ST8SIA3;NAGA
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.602242762435781,1.0665881968955329,0.4418604651162791,0.9036962521826479,1.0,4/9,7.92%,RUNX1;LEF1;TESC;HCLS1
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.4722491788464515,1.066517195743642,0.358974358974359,0.9030095461384633,1.0,6/27,6.29%,IGF1;TCAP;SGCZ;ALPK3;DYSF;MYOF
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),0.4805596869900276,1.0664785746570982,0.4583333333333333,0.902223652163353,1.0,6/19,16.28%,RFX3;DNAH3;TEKT5;CFAP54;DNAH8;DNAI3
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.4437892365393836,1.0664449722232483,0.3793103448275862,0.901514522334623,1.0,6/46,3.61%,ZAP70;GNLY;LCP2;PSTPIP1;PIK3R5;TMC8
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.3546482388927228,1.0663685716421358,0.21052631578947367,0.9008317955099324,1.0,57/217,15.94%,RELN;PDGFC;IL1RAPL2;NPAS2;PCDH18;KLHL17;PBX3;VIT;SPOCK1;ATXN1;GRHL2;AFF2;VCAN;TBX6;CNTNAP2;CX3CR1;ADGRA2;PBX1;ZBTB16;PKD1;NFIB;HAP1;CHD7;VAX2;UGT8;DSCAML1;MEIS1;MEIS3;DLL1;SMG9;ADGRL3;NHEJ1;SCIN;NPAS1;CELSR1;NCAN;PLXNB2;SOX12;C3;CHST8;CDH2;GRIN1;ROBO2;PSPN;MEIS2;DCX;POMK;JHY;PITPNM1;PTEN;JRKL;TBC1D23;NR4A2;CA10;PKD2;RPS6KA6;SH3GL3
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.42274321245096147,-1.0663294585939276,0.28205128205128205,1.0,1.0,15/149,11.99%,CD44;GPX4;GATA1;IRF4;XBP1;IFITM3;PTRH2;LCLAT1;CD81;CDKN1C;ETV4;SYT11;HOPX;TNFRSF21;SELP
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),0.6467674734643596,1.0661177340433772,0.47619047619047616,0.9007515257397972,1.0,4/5,34.05%,ZFP36;LGALS9;MAPK14;ZFP36L1
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.5924153504902242,1.0657625544876466,0.3548387096774194,0.9009592007074864,1.0,1/9,5.34%,SMS
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.7175074931718304,-1.0657084762882107,0.45161290322580644,1.0,1.0,2/5,16.92%,GSTM4;GSTM3
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.6799635728142046,-1.0655544452779226,0.38461538461538464,1.0,1.0,3/7,28.16%,APPL2;PPT1;ANKFY1
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.5726855244920893,1.0653883557138892,0.4166666666666667,0.9009664696030312,1.0,8/12,33.01%,ARHGAP35;PTEN;B4GALT6;B4GALT5;SPTBN4;MYCBP2;EPHB2;EPHB1
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.4943492961382423,-1.0652611107346284,0.375,1.0,1.0,6/47,10.39%,XBP1;RBP1;ORMDL2;FABP3;USF1;ORMDL1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.5894656245560493,-1.0652403918902735,0.4090909090909091,1.0,1.0,5/12,20.41%,HLA-A;HLA-E;HLA-DRB1;GLI3;HLA-DRA
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.5069260309981775,1.0648868149194,0.34210526315789475,0.9016856214216485,1.0,7/23,18.77%,ARHGEF7;ARHGEF6;SPEF1;GOLPH3;CYFIP1;PTPRO;WHAMM
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.6945450780090632,1.0648630623877322,0.3902439024390244,0.9000781687958107,1.0,2/5,20.53%,CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.6945450780090632,1.0648630623877322,0.3902439024390244,0.9000781687958107,1.0,2/5,20.53%,CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.39328883984653407,1.0648451510623744,0.34615384615384615,0.8992642351274533,1.0,23/112,14.57%,NUPR1;NPAS2;BAG2;VASH1;HSPA1A;AIFM2;SIRT1;NEK4;HSPA1B;BAG3;AMFR;NUAK1;CHORDC1;CORO2B;DYRK3;NDC1;SLC38A2;HSPH1;ADCY8;NUP42;PTGES3;DNAJB6;SMG1
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),0.5901890475329801,1.0643248286387557,0.46875,0.8997707642409404,1.0,3/7,5.71%,RFX3;CFAP53;DNAAF1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.6773521486942969,1.0640083034407015,0.4074074074074074,0.8998536860211721,1.0,3/9,11.82%,STX1A;CACNA1I;CACNA1G
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.6158464675012001,1.0635002218284049,0.4897959183673469,0.9004829235028012,1.0,4/6,24.99%,RFWD3;FEM1B;CRY1;WDR76
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5045969582538886,-1.0633475149742995,0.42857142857142855,1.0,1.0,2/33,1.67%,BMP5;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.44356652283729453,1.0632112397101436,0.32,0.9003292735486023,1.0,10/73,10.27%,LEPR;PDGFC;IL4R;OXTR;ZNF516;PPARGC1A;PLAC8;IGF1R;OGT;STAT6
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.6811290833143548,1.0632074486143015,0.42424242424242425,0.8994940886937334,1.0,1/6,10.63%,NECAB2
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.3266666485504313,1.0630880900398427,0.0,0.8991187057005002,1.0,54/393,11.42%,PDGFB;ZNF423;TP63;GCM1;NPAS2;IGF1;KAT2A;FLI1;RUNX1;MYRFL;SNAI1;AFAP1L2;ATOH8;IFNA2;HDAC4;TAL1;EGFR;LEF1;RFX3;RELA;ZNF516;ZXDC;SUPT3H;PPARGC1A;CREB5;ARID1B;FOXK1;NPAS3;MLLT3;ZBTB16;HIVEP3;YAF2;GLI2;TBL1XR1;SMARCA2;NEK4;RYBP;NFIB;PICALM;TESC;TRIM16;NOTCH4;SCX;MLXIPL;CD4;NFKB1;MAFB;ACVR1;RNF14;WAC;MITF;TEAD1;ARID1A;SMAD4
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.49006887707692764,1.0630443795243032,0.3,0.898323309689641,1.0,8/25,15.21%,NUPR1;USP36;UBQLN4;PIK3CA;CLEC16A;SMG1;TMEM39A;SCFD1
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),-0.6305833654588304,-1.0629456089849796,0.43548387096774194,1.0,1.0,1/8,9.57%,ITGB4
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),-0.4978480621067427,-1.0629298827498292,0.3835616438356164,1.0,1.0,6/33,18.61%,TRPM1;OPN4;RAD51AP1;KDM4D;FIGNL1;ECT2
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),-0.6650529943697394,-1.0626988045264503,0.4230769230769231,1.0,1.0,1/6,4.01%,TST
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.398278875287964,1.0621532508045994,0.5,0.90005129919419,1.0,38/111,20.78%,GFAP;ABCC8;CELF3;MMD2;DLX1;PLPPR4;SCRT1;CTNND2;OLFM3;ADGRB3;PSD2;NXPH1;NTRK2;SNAP91;KCNC2;ZNF536;NCAN;KCTD16;SLC8A2;CADM2;PVALB;SLC32A1;CA10;ADGRA1;GRIA2;MAP2;SEMA3C;TNFAIP8L3;NKAIN2;SPHKAP;TMEM196;GAD1;ADCYAP1R1;KCNIP1;HS6ST3;ST8SIA3;GRM5;SLC6A1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.6114658887839366,-1.0621193109875486,0.45901639344262296,1.0,1.0,3/13,16.94%,RACK1;HSPA5;UFL1
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.4183930560934378,1.0619410301426364,0.3333333333333333,0.8996887929198139,1.0,8/60,10.20%,RAB27A;CLEC7A;SNCA;AKT2;CYBA;SGK1;DLL1;SCIN
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.541188748479239,-1.0619395947059058,0.3384615384615385,1.0,1.0,1/22,0.86%,TINF2
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.44909391841927426,-1.061853981735328,0.3974358974358974,1.0,1.0,8/60,13.22%,XBP1;SFRP1;ZFPM1;BBS12;TGFB1;GPS2;CEBPB;SYAP1
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.43904874531954396,1.0618136538711087,0.375,0.899006129266047,1.0,10/27,27.62%,PRKRA;PUS10;DICER1;SMAD2;PUM2;PUM1;SMAD3;SMAD1;LIN28B;DROSHA
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.6521494245958495,1.061535541038291,0.4838709677419355,0.8989041463129668,1.0,1/9,3.18%,GMNN
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.4848285662435528,-1.0614977310574214,0.391304347826087,1.0,1.0,9/34,19.00%,GAPDH;SERPING1;TIMP1;SERPINB8;SERPINF1;TIMP2;CRB2;CR1;SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.4520717267359046,1.061457334735409,0.4,0.8983096814363277,1.0,10/37,12.04%,ZNF423;PLCL2;ID1;PLCL1;ALDH1A1;NPR3;DOCK7;TLE3;ARRDC3;ADAMTS5
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.5020916055664891,1.061373398565546,0.43902439024390244,0.8977409221512187,1.0,8/18,25.50%,MYO5B;SYNE2;MYO1D;MYO7A;MYO1B;SUN2;MYO5A;WASL
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),-0.6063573415888236,-1.0611958830161845,0.3939393939393939,1.0,1.0,1/10,1.88%,TAX1BP3
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.7152479247719246,-1.06117055967043,0.46296296296296297,1.0,1.0,3/5,22.25%,FLOT1;CAV2;CAV1
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.6666568304562807,-1.060831304095819,0.45901639344262296,1.0,1.0,1/7,3.05%,TGFBR2
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.4670720265443456,1.0607787123036474,0.34285714285714286,0.8984640883560914,1.0,5/30,7.64%,IGF1;IRS1;PIK3R5;IGF1R;PLEKHA1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.6619975642824167,-1.0605925859513508,0.4489795918367347,1.0,1.0,2/6,4.50%,HLA-F;HLA-E
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.599830522797846,-1.0604781305706308,0.4838709677419355,1.0,1.0,5/10,31.70%,COX17;CUTC;ATOX1;SLC31A2;STEAP4
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.6640438246053542,1.0604515857847485,0.4666666666666667,0.8983875441119917,1.0,4/6,26.46%,BCL2L1;DFFA;FZD3;PAK2
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.46983636763878267,1.0604464318065399,0.36363636363636365,0.8975625785067465,1.0,6/31,12.80%,BACE2;ADAM19;RELA;NFKB1;NAPSA;SPPL3
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.42338964822793623,-1.0602950432760379,0.37333333333333335,1.0,1.0,20/149,14.52%,CD44;HR;XBP1;PDZK1;ELOVL2;HSPB8;BLVRB;OVOL2;PEX11A;SLC16A1;SH3BP5;RASGRP1;DYNLT3;PDLIM3;AR;OLFM1;PPIF;THSD4;MYBBP1A;CALB2
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),-0.7296692189263796,-1.060100961205797,0.3939393939393939,1.0,1.0,4/5,24.90%,FUCA2;ITGAV;CAV1;EXOC7
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.6388736054905446,-1.0599714998495602,0.48333333333333334,1.0,1.0,3/9,11.72%,XBP1;BHLHE41;BDNF
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.5898162453768268,1.0598808282165408,0.4888888888888889,0.8982226167193338,1.0,1/6,5.94%,SNCA
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),-0.5781818730176029,-1.0597972567237164,0.38333333333333336,1.0,1.0,3/9,17.48%,CA6;TAS2R39;PIP
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),-0.5781818730176029,-1.0597972567237164,0.38333333333333336,1.0,1.0,3/9,17.48%,CA6;TAS2R39;PIP
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.43834849303061446,-1.0596594375060755,0.33783783783783783,1.0,1.0,23/98,23.24%,PSMB8;PSME1;VAV3;PSMB6;PSMD8;PSMC5;NFATC1;PSMD7;PSMD3;PIK3CB;PSMC3;PSMA4;PSMD2;PSMA7;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;PSMC1;SHC1;CALM1;PSMD10
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.5051820723374065,-1.0594912526723066,0.42857142857142855,1.0,1.0,5/32,18.89%,UFC1;MTIF3;TEX264;UFL1;GOLGA2
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.4097342482489267,1.0592376758598598,0.34375,0.8990529311208426,1.0,8/38,14.80%,SRC;EGFR;ERBIN;SHC3;GAB1;REPS2;PIK3CA;FAM83A
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.5396577227805617,-1.0587326151435867,0.40298507462686567,1.0,1.0,2/21,10.50%,RIMS1;SYT11
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.3860962730922149,1.0586027596938385,0.3333333333333333,0.8999306759770163,1.0,28/121,15.43%,BICDL1;ETV1;RUNX1;PBX3;ALK;TMEM108;CNTNAP2;L1CAM;AGER;PBX1;NLGN1;GLI2;ASCL1;FRYL;DOCK7;NPY;NTRK2;TGFB2;GDNF;TBCD;GPM6B;DCX;UGDH;HMGB1;TBC1D23;RYK;UHMK1;ATXN10
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.6450185035808539,-1.0584489150529124,0.4126984126984127,1.0,1.0,2/7,8.13%,RPS15;NOP9
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.625249349290883,-1.0584251949853718,0.4696969696969697,1.0,1.0,2/9,12.80%,CYB5R3;RGN
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.3762081662320976,1.0583974541100465,0.23529411764705882,0.8996452879278737,1.0,34/156,12.04%,PDGFB;ADAMTSL3;COL5A3;TNC;ADAMTSL2;ICAM1;ITGA11;FBLN5;SLC39A8;VIT;COL7A1;COL22A1;JAM2;ADAM19;VCAN;ITGA10;POSTN;ADAMTS9;ADAMTS2;AGRN;ADAMTS18;COL9A1;COL23A1;ITGAX;COL6A1;COL14A1;ADAMTS10;LOX;COL5A1;NPNT;NCAN;RECK;MMP16;ADAMTS5
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.5848467435757324,1.0582335347114102,0.425,0.899213836551682,1.0,4/8,35.98%,NR1H3;PPARA;PPARG;ABCG1
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),-0.6730977720588694,-1.0579900131714108,0.4339622641509434,1.0,1.0,1/5,1.37%,DTX3L
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.465202747091719,-1.0577470514446083,0.34210526315789475,1.0,1.0,8/55,13.57%,SEMA3E;SFRP1;ACTG1;JUP;PLET1;ADAM15;PIK3CB;PLEKHA2
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.6278352512385316,-1.0575798407642998,0.4444444444444444,1.0,1.0,1/8,5.13%,GBA3
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),0.6916774861221259,1.0575421129242586,0.574468085106383,0.9001866638102246,1.0,2/5,15.15%,TENT4B;TENT4A
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.5408691698812185,1.0573648885563096,0.30434782608695654,0.8997311195364248,1.0,5/22,8.74%,TICAM1;MFHAS1;SARM1;IRAK3;BPIFB1
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),-0.47976294788143825,-1.0573486286767402,0.4,1.0,1.0,6/49,13.57%,TRPM1;COPS9;PCNA;OPN4;TRIAP1;PARP1
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.5156989517723896,1.0572638904001332,0.37037037037037035,0.8991667676478847,1.0,2/11,10.60%,NOS2;KCNC2
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.6427306689077282,1.0571181684198014,0.4090909090909091,0.8987738366175557,1.0,1/6,3.24%,HDAC10
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.536954225388789,-1.057110337194863,0.3898305084745763,1.0,1.0,5/21,15.99%,RNASE1;LACTB2;NHP2;POP7;CPSF3
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.4140005157856128,-1.0568066246078127,0.3132530120481928,1.0,1.0,47/196,24.12%,POLR2G;XBP1;PTMA;GTF2F1;POLR3H;POLR2J;POLR2L;DRAP1;ELOB;POLR3K;POLR2I;IRF9;PAX8;TEFM;RTF1;BRF2;TAF11;POLR3GL;THAP1;BTF3;TTF1;PAF1;NFIC;PARP1;HOXD3;GTF2A2;CEBPD;TCEA2;SUPT5H;POLR2A;GTF3C6;SNAPC2;DDX5;GTF2H2;RRAGC;TFDP1;NCBP1;NFE2L3;NAT14;NELFCD;SMN1;TTF2;DDX21;NELFE;SSRP1;SMARCA5;RO60
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.4488411404540667,1.0563824443027636,0.39285714285714285,0.8998408022396045,1.0,18/76,13.70%,ADAM33;TPM2;PCDH18;GFAP;PDGFRA;POSTN;TMEM47;COL6A1;CDH11;COL14A1;HTRA1;COL5A1;AQP1;SLIT3;ADAMTS5;FBXL7;PLSCR4;LDB2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.5340463398136734,-1.055838502904814,0.36764705882352944,1.0,1.0,3/29,10.50%,RIMS1;PNKD;SYT11
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.668164597482251,1.055594646401575,0.41304347826086957,0.9009665718847234,1.0,2/7,18.63%,PLA2G10;PLA2G4A
prerank,GO_Biological_Process_2021__regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188),-0.6547477038226496,-1.0555329542867655,0.4098360655737705,1.0,1.0,2/5,21.61%,CD81;LGALS3
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.47865789833792116,-1.0553204916458108,0.37142857142857144,1.0,1.0,6/51,13.41%,ATG16L2;ATG14;EMC6;IRGM;GABARAPL2;TP53INP2
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.4075698364491328,1.0551778500551465,0.35714285714285715,0.9013134800366194,1.0,32/93,18.36%,LIFR;PPFIBP1;PCDH18;TACC2;ADAMTS9;LIMCH1;GLI2;DPYSL3;TMEM47;OBSL1;CHST3;CDH11;CACNA2D1;PYGO1;SLIT3;SEMA6D;APBB2;FBXL7;CSRP2;NAV1;SLIT2;PDE10A;FIGN;ABI2;MPDZ;AMOTL1;NFASC;PTPN14;COL4A2;FGF2;RNF150;TJP1
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.4514162534273107,-1.0549423121429677,0.32051282051282054,1.0,1.0,18/71,18.01%,RPL5;GSAP;CLU;EFNA1;RPS4X;RBM3;LRRTM3;RACK1;LARP6;SMPD2;EIF3D;EEF2;RPS27L;TNFRSF1A;PYM1;EIF4A3;METTL3;CIRBP
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.6665284772331095,1.0549184448253042,0.43243243243243246,0.9011261818776549,1.0,3/6,21.45%,MITF;RALY;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.5976379933566784,-1.0548876469874509,0.3787878787878788,1.0,1.0,3/11,17.78%,CLU;LRPAP1;APOE
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),0.6611777174907117,1.0548694341954508,0.42857142857142855,0.9004303618698256,1.0,3/6,21.27%,BMPR2;ACVR2B;PDPN
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.4976817568494117,-1.0548669039387424,0.3582089552238806,1.0,1.0,11/36,23.14%,GAPDH;SLC25A11;G6PC3;TPI1;MDH2;MDH1;SLC25A1;GAPDHS;PGAM1;ENO1;ALDOB
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.5291200535794925,1.0546571296210734,0.3870967741935484,0.9001473647469945,1.0,3/15,13.41%,HNRNPU;SLIT3;SLIT2
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.47440164077647234,1.0545335322132643,0.35294117647058826,0.8997802230947303,1.0,4/27,11.35%,SRC;ARHGEF7;SORBS1;PTPRK
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.5115861528050775,1.054406710560359,0.3333333333333333,0.8993412480386318,1.0,9/13,30.42%,PTPRN2;ADCYAP1;RAB11FIP2;CAMK2G;RIMS2;SLC30A8;PTPRN;SNX19;RAB11FIP5
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.4957926573451209,1.0542752137194364,0.45454545454545453,0.8988547781901355,1.0,1/20,0.15%,TNFSF13B
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.7015774588423332,-1.0542681876716935,0.39285714285714285,1.0,1.0,2/6,13.96%,BRCA1;DNMT3B
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),-0.6912871181793178,-1.0541079367242419,0.45901639344262296,1.0,1.0,3/6,24.77%,SYT11;GRN;NR1D1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.39298072542136486,1.0539721617837199,0.25925925925925924,0.8990325455821873,1.0,29/103,21.20%,SGSM1;CELF3;KCNT1;CACNB4;AMER2;PKD2L1;P2RX7;CTNNA2;C4ORF50;ST18;CADPS;FAM135B;KCNC2;RUNDC3A;NRXN1;GNG7;FGF13;NAPB;SLC1A2;SLC24A4;GRIA2;ST8SIA5;CABP1;OTUD7A;SCN3B;ST8SIA3;TNR;SLC4A10;RPH3A
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.628822721259049,1.0539717096801169,0.5,0.8982218760189933,1.0,3/7,19.88%,CXCL13;ADA;WNK1
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.3977035783711535,-1.0539412468507439,0.30952380952380953,1.0,1.0,28/225,15.09%,PSMB8;RPS27A;PSME1;CFTR;USP6;PSMB6;USP1;PSMD8;PSMC5;RAD23A;PSMD7;ADRM1;UBA52;USP51;JOSD2;COPS5;TNIP2;ABRAXAS1;TOMM20;CLSPN;USP19;PSMD3;AR;PSMC3;BRCA1;ATXN7L3;UBB;PSMA4
prerank,GO_Biological_Process_2021__innate immune response in mucosa (GO:0002227),0.6411176640215392,1.0538122341140996,0.5,0.8978460834889497,1.0,2/5,8.74%,NOS2;BPIFB1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.4215086607179461,-1.053299470586396,0.379746835443038,1.0,1.0,23/127,16.62%,GFRA3;STMN1;PCDHB4;TCEAL6;TST;MPZ;PMP22;HSPB8;CNP;TNS2;TCEAL7;ITGB4;SPARCL1;ART3;GPR62;APOD;CMTM5;MAG;NACAD;CADM4;OLIG1;SLC22A17;LMOD1
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.519367429498752,-1.0531544168663736,0.47761194029850745,1.0,1.0,8/24,26.63%,EEF1AKMT2;TRMT112;ANTKMT;METTL18;SETD7;METTL21A;ETFBKMT;CSKMT
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.6974905320147831,-1.0531281543352462,0.38181818181818183,1.0,1.0,2/6,17.36%,GCK;PGP
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.4184365057627841,1.0530721506597083,0.3333333333333333,0.8991910439601838,1.0,31/121,15.84%,PDGFB;ADAM33;TPM2;PCDH18;LEF1;PDGFRA;POSTN;HMCN1;LTBP2;EHD2;TMEM47;COL6A1;CDH11;RHOJ;MRC1;COL14A1;HTRA1;OGT;COL5A1;ECM1;FGF1;ADAMTS5;FBXL7;PLSCR4;PAWR;MIB1;LDB2;CRIM1;DYRK1A;NR4A2;COL12A1
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.5953494489385103,-1.0527711858707154,0.421875,1.0,1.0,3/9,20.99%,VIL1;CFL2;WDR1
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.4860626667818168,-1.0527071391448684,0.41379310344827586,1.0,1.0,4/40,8.85%,RHOC;SFRP1;SYNPO2L;VIL1
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.6368897589845625,1.0526869137175006,0.42857142857142855,0.8992356749134727,1.0,3/7,9.05%,PATL1;DCP1B;DCP1A
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.38188019466272694,1.0526278093178636,0.4,0.8986558672587072,1.0,49/155,21.29%,PDGFB;GALNT3;PLK1;MAPK12;POGLUT2;STK32B;PRKX;AKT2;PKD1;SGK1;PNCK;VRK2;RICTOR;TNKS;MAPKAPK3;CAMKV;SGK3;DYRK3;MKNK2;ULK3;PRKCE;GALNT2;PRKD1;GALNT16;RPS6KA1;MARK1;SMG1;HIPK2;UHMK1;DYRK1A;MAST4;HIPK3;RPS6KA6;TTBK2;GSK3B;PRKCZ;CAMK2D;MAPK8;SBK1;MKNK1;DMPK;WNK1;SRPK2;MARK2;MAPKAPK2;MAP3K10;MAST3;LATS2;TLK2
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.4874562185609116,-1.0525989871310166,0.3382352941176471,1.0,1.0,6/32,11.72%,TTN;ZFPM1;MESP1;SYNPO2L;HTR2B;OLFM1
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.6762944311417349,-1.0525230453933112,0.47619047619047616,1.0,1.0,2/8,7.30%,SLC3A1;SLC7A7
prerank,PanglaoDB_Augmented_2021__Microglia,0.3943973510122422,1.0519446214655412,0.35294117647058826,0.8995526226094938,1.0,21/81,14.18%,LCP2;C1ORF162;SLCO2B1;PIK3R5;CLEC7A;CX3CR1;HPGDS;CSF3R;ITGAX;P2RX7;LTC4S;SLC2A5;CD4;OTULINL;AEBP1;MAFB;APBB1IP;LAIR1;MERTK;HCK;NFAM1
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.5741378857998582,1.051866084972534,0.4418604651162791,0.8989735707104355,1.0,3/7,13.93%,DNMT3A;PCGF5;KDM1B
prerank,GO_Biological_Process_2021__hydrogen peroxide biosynthetic process (GO:0050665),-0.6859621875862368,-1.0516981243822219,0.4576271186440678,1.0,1.0,1/5,1.49%,DUOX1
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),0.6973617792883995,1.051659368767745,0.4864864864864865,0.8988386173264249,1.0,2/5,14.70%,BMPR2;ACVR2B
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.6681194795600949,-1.0515257646458334,0.43103448275862066,1.0,1.0,4/5,27.04%,TMEM9;ALDOB;VMA21;PIP4P1
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.49585201501113024,-1.0512803021012553,0.38666666666666666,1.0,1.0,9/38,22.83%,CNN2;ARF1;TALDO1;RPLP0;PPIA;CFL1;LCP1;SOD1;MSN
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.563622126852307,1.0509517981202452,0.42857142857142855,0.8999361868190119,1.0,1/8,6.25%,SIRT1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.5381287889727471,-1.0505770802010581,0.359375,1.0,1.0,7/30,21.11%,TAX1BP3;RIC3;BDNF;TMEM35A;MAP1A;RANGRF;GOPC
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.44908647896361176,1.0503824842359641,0.3448275862068966,0.9007090566114752,1.0,9/63,9.31%,CREB3L1;ADAM33;FRZB;PDGFRA;POSTN;ADAMTS2;FBLIM1;CDH11;COL14A1
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.4617330874727677,-1.0502000640114082,0.4305555555555556,1.0,1.0,21/71,24.93%,FTH1;MT1E;FTL;MT2A;ISCU;LCK;ARF1;SLC39A7;SLC22A17;SLC39A6;MT1M;CP;MT1G;HJV;SOD1;ATP6AP1;NUBP1;HEPH;HFE;ATOX1;CCDC22
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.4474149533240628,-1.0501556941327808,0.4189189189189189,1.0,1.0,11/77,14.21%,CACNA2D4;SLC8A3;TRPM1;SLC24A5;PHB2;SLC24A1;AFG3L2;PMPCA;TMCO1;ORAI1;STOML2
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.43544974324296465,1.0500144222213597,0.32432432432432434,0.9009670170147294,1.0,21/54,22.52%,ZNF423;DLX1;SMAD4;SMURF2;CHRD;BMPR2;CRIM1;GDF5;LEMD3;ACVR2B;HIPK2;TRIM33;ACVR2A;UBE2D3;VWC2L;SMAD2;BMPR1B;SMAD5;ELAPOR2;PCSK6;TWSG1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.37714659822575225,1.0496954835581982,0.3333333333333333,0.9008904249913015,1.0,10/82,7.91%,F2;RIDA;TM4SF20;CPEB3;IGF2BP2;EIF4E2;SAMD4A;SYNCRIP;DHFR;NANOS3
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.6791514230649995,-1.0496682964837438,0.5074626865671642,1.0,1.0,4/6,26.95%,RTF1;PAF1;CTR9;LEO1
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.4595447420673583,-1.0496589526155349,0.3783783783783784,1.0,1.0,6/49,11.27%,SLC25A4;SLC25A5;HSPB8;TRIM13;IRGM;PINK1
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.5962719925094325,-1.049470553309388,0.4838709677419355,1.0,1.0,2/10,9.01%,CD9;CEACAM1
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.6449963332896204,1.0492867531710544,0.5,0.9012073693976195,1.0,4/6,21.34%,DENND1A;DENND4B;DENND4A;DENND4C
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.5983541591199768,-1.0491926142116799,0.4339622641509434,1.0,1.0,2/11,4.50%,HLA-F;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.537792459715356,-1.0489336294794922,0.38235294117647056,1.0,1.0,6/24,21.55%,HLA-E;RPS19;FADD;NMI;IFI35;RIOK3
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.6134985156256341,-1.0489245167060501,0.5,1.0,1.0,5/9,31.74%,C1QBP;GPATCH3;RIOK3;DHX58;TKFC
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.5322707930855877,-1.0488908029034205,0.38235294117647056,1.0,1.0,5/21,16.33%,ISCU;ISCA2;CIAO2B;GLRX5;NUBP2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.6699992759789348,-1.0488286979386228,0.5072463768115942,1.0,1.0,2/7,12.28%,IL31RA;GRN
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.4721221297249474,-1.0486244617835059,0.38571428571428573,1.0,1.0,5/59,5.37%,TRPM1;BEST1;RDH12;DNAJC19;GPR179
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.6369801902385149,-1.0485985834728198,0.4482758620689655,1.0,1.0,1/8,4.38%,DDX11
prerank,PanglaoDB_Augmented_2021__Nuocytes,0.5095732662766086,1.048526754907001,0.2962962962962963,0.9025123270223823,1.0,2/25,1.86%,ZAP70;GNLY
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),-0.7107380486506025,-1.0480034361294888,0.48333333333333334,1.0,1.0,2/6,10.54%,GALK1;GALE
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.6238292490667205,1.0478279949032034,0.5,0.9035293612036632,1.0,4/6,37.28%,RPGRIP1L;RP1;RPGRIP1;BBS4
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.5889946010567796,1.0477783370530935,0.475,0.9028206245572129,1.0,1/6,1.59%,ZBTB1
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),0.6574178727907445,1.0472800244643634,0.42105263157894735,0.9033247874204162,1.0,3/5,30.65%,GSK3B;APC;AXIN1
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.658034695352492,-1.0472033331994037,0.453125,1.0,1.0,5/6,31.74%,DDX60;C1QBP;RIOK3;DHX58;TKFC
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.5552290151533985,-1.0471436629900155,0.45,1.0,1.0,5/13,16.95%,HLA-F;HLA-E;RASGRP1;LAMP1;CD160
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.5552290151533985,-1.0471436629900155,0.45,1.0,1.0,5/13,16.95%,HLA-F;HLA-E;RASGRP1;LAMP1;CD160
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.6613343916685926,-1.0470406803924674,0.484375,1.0,1.0,3/6,25.04%,EME1;MUS81;SMC1A
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.4657129591675344,1.0469727833521765,0.4117647058823529,0.9034957432473816,1.0,8/27,18.83%,LEF1;TLE3;PYGO1;ASH2L;CREBBP;TLE4;KMT2D;HDAC1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.3743904308372145,1.046860345839656,0.26666666666666666,0.9029786468574378,1.0,34/155,12.04%,PDGFB;ADAMTSL3;COL5A3;TNC;ADAMTSL2;ICAM1;ITGA11;FBLN5;SLC39A8;VIT;COL7A1;COL22A1;JAM2;ADAM19;VCAN;ITGA10;POSTN;ADAMTS9;ADAMTS2;AGRN;ADAMTS18;COL9A1;COL23A1;ITGAX;COL6A1;COL14A1;ADAMTS10;LOX;COL5A1;NPNT;NCAN;RECK;MMP16;ADAMTS5
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.6256870912477583,-1.0467707927334724,0.4838709677419355,1.0,1.0,1/9,4.38%,DDX11
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.3756309270380026,1.046603246979317,0.2777777777777778,0.9028534257746552,1.0,13/102,8.86%,F2;VDR;EPB41L4B;LEPR;NOS2;C6;CYP2C8;GRB14;HAMP;ZHX2;RND3;KIF13B;SERPINC1
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.4899889544292532,-1.046361331775405,0.4666666666666667,1.0,1.0,6/25,15.13%,NLRP1;STAT5A;EIF2B1;STAT1;EIF2B2;EIF2B4
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.5322597440932134,-1.0462085524528935,0.41935483870967744,1.0,1.0,7/19,16.93%,DNPH1;MTHFD1;PRPS1;NT5C;NUDT15;PRPSAP1;PRPS2
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.3770731178138108,1.0461870251487613,0.391304347826087,0.9030953652350219,1.0,4/64,3.00%,VAPB;BET1;CD59;COL7A1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.5327239069840267,-1.046186629186481,0.47692307692307695,1.0,1.0,4/19,15.78%,IRF1;GPS2;FLOT1;APPL2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.6569099904566599,-1.0459650568835936,0.547945205479452,1.0,1.0,1/7,10.14%,PRPS1
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.38956337967253085,-1.0455544054240158,0.40963855421686746,1.0,1.0,61/294,23.60%,PSMB8;DDIT3;RPS27A;SELENOS;PSME1;SEC61B;PSMB6;PSMD8;PSMC5;RAD23A;PSMD7;KCTD2;UBA52;TRIM13;UBXN1;TRIM25;HSPA5;USP19;RBX1;PSMD3;RMND5B;FBXO48;PSMC3;RNF5;FAM8A1;KCTD5;UBB;ZFAND2B;ANAPC15;PSMA4;KAT5;NHLRC1;UBXN8;CDC34;PRAME;MAN1B1;HECTD3;PSMD2;PSMA7;HSP90B1;FBXL16;SPSB3;FBXL13;ZFAND2A;PSMD6;PSMB2;ERCC8;PSMB3;PSMB4;PSMA3;CDC23;SEL1L2;PSMC1;SGTB;RNF187;FOXRED2;CDC20;PSMD10;LTN1;RNF175;FBXO6
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.5758505096348543,-1.0453465169462481,0.4117647058823529,1.0,1.0,3/14,13.71%,EXOSC4;EXOSC10;SSB
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.6244077042730181,-1.0453096330851042,0.4375,1.0,1.0,1/7,12.30%,CEBPB
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.6312851809397129,-1.0451537220548375,0.4666666666666667,1.0,1.0,2/8,9.01%,CD9;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.48978744260025325,-1.045094983420416,0.42857142857142855,1.0,1.0,7/32,13.77%,RPL11;NOP53;UBXN1;AQP11;GIPC1;GABARAPL2;CAMLG
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.449957469548931,-1.0448687775247316,0.38461538461538464,1.0,1.0,5/65,1.67%,BMP5;IL26;B2M;TINF2;SFRP1
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.4056772473196239,1.044852841292031,0.25,0.9056429967567127,1.0,18/72,19.79%,NOS2;DAO;KYAT1;ACAD8;IDO1;HDC;KYNU;GLS;ARG1;CBS;BCKDHB;CARNMT1;QDPR;ABAT;ALDH4A1;GAD1;MTRR;GLDC
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.4661432481644565,-1.0445452141720297,0.36923076923076925,1.0,1.0,3/41,7.80%,CENPF;HYAL2;PAX8
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.715113412055683,-1.0444797952845315,0.4482758620689655,1.0,1.0,1/5,18.57%,HMGCL
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.604033111991402,-1.0443927850013806,0.375,1.0,1.0,2/11,15.61%,CCT7;CCT2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.604033111991402,-1.0443927850013806,0.375,1.0,1.0,2/11,15.61%,CCT7;CCT2
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.6259745831842584,-1.0443342530391964,0.4576271186440678,1.0,1.0,5/8,33.42%,XRCC3;TERF1;BLM;RECQL4;SLX4
prerank,PanglaoDB_Augmented_2021__Sebocytes,0.4577294371057783,1.0441596334044563,0.3235294117647059,0.9067564112198089,1.0,3/39,1.75%,VDR;GALNT3;TRIM29
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.606974461124312,1.044078209595487,0.4,0.9061678861956177,1.0,5/10,21.84%,ATP12A;ATP1B3;SLC12A2;SLC8A1;ATP1A2
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.49251021430195197,-1.0439750301104074,0.3835616438356164,1.0,1.0,3/47,1.66%,B2M;FTH1;FTL
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.5864921131341554,-1.0437420000593107,0.41935483870967744,1.0,1.0,4/15,15.61%,NOP10;NHP2;CCT7;CCT2
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.5169013734760398,1.043719144800827,0.375,0.9062527118470904,1.0,8/22,16.89%,IRS1;GRB14;PIP4K2A;PID1;ENPP1;PTPRE;KANK1;PRKCZ
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.5252273873494855,-1.0437158121740262,0.4057971014492754,1.0,1.0,5/22,16.33%,ISCU;ISCA2;CIAO2B;GLRX5;NUBP2
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4723681902703587,1.0436136607368072,0.41379310344827586,0.9057481607635434,1.0,5/33,5.76%,SPRY2;PLK1;SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.6220290444305694,-1.043314191430398,0.3770491803278688,1.0,1.0,6/12,26.10%,COLEC12;FLOT1;CGAS;PQBP1;CAV1;IFIT1
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.44867436067649347,1.0428738027996511,0.3333333333333333,0.9067515912056909,1.0,7/25,16.53%,JAM2;FAM9B;PLD6;SOX30;GALNTL5;SYCP3;ACRBP
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.5991262754550446,1.0427055853597689,0.5,0.9064121823944564,1.0,2/11,14.86%,GFPT2;GFPT1
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.5239182373040543,1.0425527428895573,0.46875,0.906038110261894,1.0,6/22,11.85%,FGFR1;FGFR3;PDGFRA;WWOX;DSCAML1;MEGF8
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),-0.6790356879525565,-1.0424717684609823,0.4857142857142857,1.0,1.0,1/5,11.08%,GPS2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),-0.6714121322017226,-1.042050336425603,0.509090909090909,1.0,1.0,4/5,32.87%,HYOU1;ENO1;NOL3;TMBIM6
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.566171422057091,1.0419226685071932,0.43243243243243246,0.9069094663407806,1.0,2/9,7.02%,RUNX1;SERPINF2
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.47690499813233966,-1.041872096556809,0.38095238095238093,1.0,1.0,7/38,11.43%,CLU;RPL13A;CPTP;NOP53;ANKRD27;HSPA5;TFIP11
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.48839973039596396,-1.0418001230842504,0.4155844155844156,1.0,1.0,9/40,22.83%,CNN2;ARF1;TALDO1;RPLP0;PPIA;CFL1;LCP1;SOD1;MSN
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.6757883855141857,1.0417402424431028,0.45714285714285713,0.9065121488330383,1.0,3/6,21.84%,NLGN3;TSHZ3;ATP1A2
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.5179040447027143,-1.0416113094228865,0.43859649122807015,1.0,1.0,6/32,15.17%,SFRP1;CFTR;ADAM15;MAP4K1;AR;AHR
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.48230483833907384,-1.0414556140853661,0.3870967741935484,1.0,1.0,3/35,7.28%,RHOC;SFRP1;SYNPO2L
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.6130953830440682,1.0413501702678611,0.45714285714285713,0.9068071569771756,1.0,1/11,5.28%,HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.5083283079724172,-1.0413217730108764,0.35384615384615387,1.0,1.0,1/26,0.55%,GATA1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.5977556891322058,-1.0409618055930554,0.43333333333333335,1.0,1.0,2/10,15.61%,CCT7;CCT2
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.5242544802521024,-1.0407655047818773,0.484375,1.0,1.0,5/27,15.79%,TMEM107;FUZ;ARL13B;IFT122;DCTN1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.5275831257248094,-1.0403257538690118,0.38235294117647056,1.0,1.0,3/30,8.20%,TINF2;NOP10;NHP2
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.4791594590934041,-1.0400976763637797,0.4696969696969697,1.0,1.0,6/43,13.59%,IL26;GSTP1;COPS5;RASGRP1;MAPK8IP1;PPIA
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.47611361777199224,-1.0399407874131232,0.4084507042253521,1.0,1.0,12/64,17.50%,GAPDH;POLR3H;POLR2L;POLR3K;IRF1;POLR3GL;FLOT1;STAT1;DDX41;CGAS;PQBP1;RNF135
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.4261581104611203,-1.0396817995156606,0.39473684210526316,1.0,1.0,16/127,11.65%,TOMM7;UBL5;JUP;PDZK1;HYAL2;KIF20B;CD81;CEMIP;RBM22;HRAS;CAMK1;ARIH2;CEP131;TGFB1;PINK1;ABLIM3
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),0.5490386306675797,1.0394496254727237,0.34285714285714286,0.9110955234957743,1.0,6/11,24.14%,TICAM1;IPMK;PGAM5;TRPM7;MLKL;CYLD
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.4673551775698869,1.039403908311782,0.37142857142857144,0.9104030344576148,1.0,1/22,1.33%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.4392598957619545,-1.0391419670876862,0.4225352112676056,1.0,1.0,13/92,15.03%,HSPE1;NLRP1;BEX3;RPS3;KHDC1;LCK;RACK1;PRR7;FADD;PDCD2;MTCH1;NLRP12;RPS27L
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.60539006362756,-1.0389331555721992,0.4262295081967213,1.0,1.0,1/8,7.66%,METAP2
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.4720079905264513,1.038509939398033,0.42105263157894735,0.9122722505796249,1.0,5/21,6.53%,IGF1;IRS1;PASK;AKT2;SORBS1
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.41165207017206906,1.0380314143738993,0.3142857142857143,0.9127948227903361,1.0,20/59,22.92%,CPNE7;CPNE1;NLGN1;SYT3;ACER1;ADCY8;GPLD1;RASGRP2;CPNE2;SYT17;CPNE5;PKD2;CAMK2D;SYT5;CPNE9;SYT7;WNT5A;RYR3;CPNE8;CPNE6
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.568838729224721,1.0378429433281946,0.4,0.9124644752184385,1.0,5/16,15.47%,PSTPIP1;NT5E;P2RX7;C3;TXNIP
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),-0.45774950451161817,-1.0377550505848574,0.4177215189873418,1.0,1.0,5/75,4.91%,ARHGEF16;TAX1BP3;USP6;ARHGAP42;RHOG
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.5697145015797487,1.0376516479415168,0.45454545454545453,0.9121813487464019,1.0,4/12,28.48%,GFPT2;GFPT1;UAP1L1;NANP
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.6240125528114892,-1.0376494689448879,0.421875,1.0,1.0,1/9,2.03%,SELENOS
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.6532407909307412,1.0376310369920863,0.5531914893617021,0.911455978806732,1.0,2/6,15.15%,TENT4B;TENT4A
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.5968187963003266,1.0375544888337487,0.43902439024390244,0.9107667950637973,1.0,4/5,35.57%,ATP13A2;LRRK2;PRKN;D2HGDH
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.4439875147573271,-1.0373413331837542,0.3974358974358974,1.0,1.0,19/79,19.08%,CENPF;BUB1;MCM4;ERCC6L;MCM3;CENPH;ATAD5;WDHD1;ZGRF1;DEPDC1B;CHAF1A;PARP1;DNMT3B;NCL;RFC4;FANCD2;PLK4;PAICS;FANCI
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.6919806829395356,1.0372732366537913,0.5128205128205128,0.910730129999401,1.0,2/6,10.76%,SRC;CA2
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.505759562908322,-1.0370824884228722,0.4266666666666667,1.0,1.0,7/25,22.80%,JUP;HYAL2;RBM22;TGFB1;ECT2;RAN;PDCD5
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.5789913589540105,1.0367052641024128,0.4594594594594595,0.9112861784721021,1.0,5/10,26.85%,AFDN;TJP2;TJP1;RAP2C;RAPGEF2
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.4169249557294464,1.0366707522511116,0.3076923076923077,0.9105989385619768,1.0,17/74,10.27%,TNC;PCDH18;PDGFRA;CSPG4;POSTN;LTBP2;SSC5D;ADAMTS2;EHD2;TMEM47;COL6A1;CDH11;COL14A1;RGS5;HTRA1;LOX;COL5A1
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.5313038160466899,1.0363059053079287,0.47058823529411764,0.9107133200070504,1.0,2/14,8.64%,CHST7;CHST3
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.38392405467059804,1.036259036310283,0.25,0.9100973111170727,1.0,32/131,15.42%,RUNX1;IRS1;FBLN5;ATXN1;ANXA4;SLC7A1;ADORA2B;ID1;DUSP1;NFIB;IGF1R;RND3;PDLIM5;RASA2;KCNMA1;NFKB1;SPOP;MGLL;GRK5;DLG1;MMP16;BCKDHB;PRKCE;SCAF8;CELF2;APBB2;ATP2C1;MAGI2;ATRX;PTEN;TENT4A;DYRK1A
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.555052242809269,1.0362212373498907,0.43902439024390244,0.9094360486157288,1.0,3/8,14.52%,NRP2;ASCL1;UNC5C
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),-0.41416540391573214,-1.0361177381332398,0.41333333333333333,1.0,1.0,21/115,20.77%,POLR2G;DDX24;RNASE1;RBMS2;GTF2F1;POLR2J;POLR2L;POLR2I;RBM3;PCBP3;TFIP11;WDR74;PRPF4;LAGE3;POLR2A;METTL3;ISG20;HNRNPH2;CLP1;NCBP1;FASTKD2
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.6253962580708199,-1.0358851525756543,0.43548387096774194,1.0,1.0,2/10,10.26%,ZNF830;CLSPN
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.5447457497033862,-1.035238283321096,0.4838709677419355,1.0,1.0,2/12,11.61%,SFRP1;TNFRSF21
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.5452202200151235,1.0349664037852113,0.43902439024390244,0.9121428821146805,1.0,7/12,18.24%,PKD1;CPSF6;CPSF7;GRIN1;PKD2;GRIN2B;CBR4
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-0.6348977387872821,-1.034689787931282,0.45454545454545453,1.0,1.0,1/7,3.05%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.4975815675592936,1.0345346567483191,0.3870967741935484,0.9127063826880504,1.0,2/13,10.11%,RUNX1;AEBP1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.6310582666179875,-1.034517057968254,0.4918032786885246,1.0,1.0,5/7,23.09%,SRI;CALM3;TRDN;CAV1;CALM1
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.5844503616061394,1.0343283532439498,0.46875,0.9124488394713043,1.0,4/11,24.78%,HNRNPU;GPER1;ZFP36;BCL2L11
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.4251649826058588,-1.03419782881496,0.3561643835616438,1.0,1.0,19/84,21.75%,PSMB8;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;HRAS;PSMD3;PSMC3;PSMA4;PSMD2;PSMA7;PSMD6;PSMB2;PRKACA;PSMB3;PSMB4;PSMA3;PSMC1
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.4251649826058588,-1.03419782881496,0.3561643835616438,1.0,1.0,19/84,21.75%,PSMB8;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;HRAS;PSMD3;PSMC3;PSMA4;PSMD2;PSMA7;PSMD6;PSMB2;PRKACA;PSMB3;PSMB4;PSMA3;PSMC1
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.4251649826058588,-1.03419782881496,0.3561643835616438,1.0,1.0,19/84,21.75%,PSMB8;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;HRAS;PSMD3;PSMC3;PSMA4;PSMD2;PSMA7;PSMD6;PSMB2;PRKACA;PSMB3;PSMB4;PSMA3;PSMC1
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.49569005893313234,1.0341445751529494,0.4838709677419355,0.912203281364884,1.0,2/18,2.93%,HELLS;IFNA2
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.7014338391864192,-1.0339689964794632,0.45161290322580644,1.0,1.0,4/5,23.09%,RACK1;MAPK7;CALM3;CALM1
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),0.5931169017910658,1.0337054107869743,0.45454545454545453,0.9126960891609326,1.0,3/8,10.20%,TESC;MTURN;SCIN
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.4816745871076802,1.0334731259035128,0.3225806451612903,0.9126696290042391,1.0,7/20,16.86%,MTMR2;EPHA3;PROM2;PICALM;PRKD1;LRSAM1;NR1H3
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.49351715451605604,-1.0334267067841116,0.4426229508196721,1.0,1.0,5/32,12.03%,DDIT3;HYAL2;NOP53;RACK1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.4129323160321645,1.0330184452604134,0.32142857142857145,0.9130575918346121,1.0,7/47,6.25%,NPAS2;SPRED3;SPRED2;EGFR;EYA4;SPRED1;SIRT1
prerank,GO_Biological_Process_2021__cellular response to salt stress (GO:0071472),0.6603781629483354,1.0329753392457055,0.5,0.912386833763534,1.0,3/5,29.14%,AQP1;SLC12A6;CAPN3
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.584002904875181,-1.03296829966786,0.5166666666666667,1.0,1.0,5/10,21.21%,NOP10;NHP2;TSR3;GAR1;RPUSD2
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.506394029031777,1.0329604541205977,0.375,0.9116482850546201,1.0,5/14,15.06%,MGAM;PHKA1;PYGB;PHKA2;PGM2
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.43519753929312144,-1.0328881234587421,0.43243243243243246,1.0,1.0,7/102,5.76%,CD44;BMP5;MEPE;PRDX1;PPIB;RPL13;HYAL2
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.5918296584156051,-1.032733171105951,0.43283582089552236,1.0,1.0,3/10,20.97%,ATG10;APOE;WDR45B
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.6151031065131747,1.0323783190037894,0.4666666666666667,0.9125183197501774,1.0,4/8,23.17%,CX3CR1;CD274;MAPKAPK2;ZFP36
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.5439163021787399,-1.0321243196988772,0.4411764705882353,1.0,1.0,3/16,14.38%,TRIM25;PPIA;KPNA2
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.6578509874304546,-1.0320708784847499,0.5,1.0,1.0,3/9,20.05%,CLU;APOE;ABCA5
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.48828315293200997,-1.0318630385185001,0.4492753623188406,1.0,1.0,10/30,24.13%,IL6R;CXCL17;CALR;C1QBP;SERPINE1;PTN;CCR7;ZNF580;ADAM17;CREB3
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.6097990025555363,1.031841817276966,0.45,0.9130886157986788,1.0,4/6,33.40%,ARFIP1;USP7;LRRK2;PRKN
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.6582324390239002,1.0317060148987427,0.5526315789473685,0.9118444046294243,1.0,2/5,12.05%,CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.6582324390239002,1.0317060148987427,0.5526315789473685,0.9118444046294243,1.0,2/5,12.05%,CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.4785598107814144,1.0313606458735118,0.3611111111111111,0.9122307488678129,1.0,8/24,20.87%,PAXIP1;OGT;ASH2L;KMT2D;CXXC1;KMT2C;KDM6A;TET2
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.5463139295166393,-1.031347402575049,0.45,1.0,1.0,2/13,8.16%,BUB1;IHO1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.6615209412367581,-1.031049144487147,0.5161290322580645,1.0,1.0,2/7,17.68%,GSTP1;GREM1
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.5566649925026262,-1.0308283217036536,0.41935483870967744,1.0,1.0,5/14,26.39%,SRSF7;C1QBP;SAP18;SRSF9;SRSF10
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),-0.6128959949567195,-1.030683212754591,0.49206349206349204,1.0,1.0,1/8,0.55%,GATA1
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),0.6768243737856126,1.0306444718604468,0.47368421052631576,0.9125331564986737,1.0,1/5,13.83%,KIF5C
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),0.6768243737856126,1.0306444718604468,0.47368421052631576,0.9125331564986737,1.0,1/5,13.83%,KIF5C
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.6273521878655975,-1.0304788276981685,0.45454545454545453,1.0,1.0,1/8,4.18%,CPTP
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.6616452104963306,1.0304087709529208,0.48717948717948717,0.9124386109162251,1.0,2/6,10.32%,SLC7A5;SLCO1C1
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.651639078163719,-1.0304042330465935,0.46551724137931033,1.0,1.0,2/7,14.16%,NOP53;PIK3IP1
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),-0.6158114106085181,-1.0303847353466713,0.4696969696969697,1.0,1.0,4/6,38.24%,G6PD;XYLB;DCXR;RPE
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.46010657383935316,1.030347637166457,0.4375,0.911808311527401,1.0,6/24,11.42%,SRC;RELA;ST18;NFKB1;PID1;SMAD4
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),-0.6172752634154262,-1.0301055487998385,0.453125,1.0,1.0,1/7,4.85%,DGAT2L6
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),-0.6081000042190734,-1.0300002571771878,0.5,1.0,1.0,1/10,7.66%,METAP2
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.5873431067920203,-1.02997886743925,0.42857142857142855,1.0,1.0,4/17,20.12%,POLR1G;NIFK;GTF3C6;POLR1E
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.47575466866371624,1.0298064766377362,0.34285714285714286,0.9125120361315078,1.0,9/26,25.28%,ATP10A;ATP11C;P2RX7;PLSCR4;ATP8A1;ATP10D;ABCC1;ATP11A;PLSCR2
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),0.6138203680018106,1.02969477339781,0.5588235294117647,0.9120193442635123,1.0,2/6,13.26%,ULK3;ATP13A2
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.6992776333933534,-1.0296747317310009,0.5517241379310345,1.0,1.0,1/5,1.57%,XBP1
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.46276622806555645,-1.0296404863733517,0.44776119402985076,1.0,1.0,6/48,4.40%,ARHGEF16;SERPING1;SLC3A1;CFTR;EFNA1;TMEM125
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.6385355043790644,1.0292599128505149,0.5,0.9124942246902334,1.0,2/5,14.72%,ZNF304;ATRX
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.5346215252642463,-1.0285437061935006,0.44776119402985076,1.0,1.0,4/21,20.53%,TRIM13;HRAS;FANCD2;TMEM109
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.3802349052985767,1.0284157234572702,0.5,0.913604662798333,1.0,39/120,20.78%,GFAP;SPOCK1;ATXN1;CELF3;MMD2;PLPPR4;SCRT1;OLFM3;ADGRB3;AMER2;ABHD2;NPY;PSD2;NXPH1;SNAP91;PRSS12;GRM3;KCNC2;ZNF536;NCAN;LRRC4C;NRXN1;NEGR1;SLC8A2;PDE10A;GABRB1;CADM2;CA10;NFASC;ADGRA1;GRIA2;SPHKAP;TMEM196;SCN3B;ADCYAP1R1;KCNIP1;ST8SIA3;GRM5;SLC6A1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.519541281879461,-1.0284037736402065,0.4520547945205479,1.0,1.0,6/30,15.27%,POLR2G;LSM7;LSM2;EXOSC4;NT5C3B;EDC4
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.5909311823511285,-1.0282462333536055,0.5,1.0,1.0,3/8,16.11%,TGFBR2;MTHFD1;EIF4A3
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),-0.598568904919963,-1.0281733658363166,0.43548387096774194,1.0,1.0,5/13,21.21%,NOP10;NHP2;PUSL1;GAR1;RPUSD2
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.5511769048141884,-1.0280405067154808,0.3968253968253968,1.0,1.0,4/13,16.32%,MAGEF1;ISCA2;CIAO2B;GLRX5
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.5529583998746965,1.02777280473757,0.48717948717948717,0.9144634257617017,1.0,6/9,23.14%,ACVR1;ACVR2B;ACVR2A;ACVR1C;SMAD2;SMAD3
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.4463896811228965,1.0273638037681325,0.5,0.9147194789575758,1.0,16/47,24.76%,CASS4;TNIK;MKLN1;GAB1;RICTOR;AUTS2;ATP2C1;THSD7B;FER;WHAMM;THSD7A;RALA;MCU;FLNA;RAP2A;PHACTR1
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),0.6332806647261402,1.027277658291289,0.5116279069767442,0.9142156694858394,1.0,2/5,7.12%,MAPKBP1;CYBA
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.511239533392469,-1.02726192238131,0.35135135135135137,1.0,1.0,8/33,20.12%,POLR1G;POLR2L;POLR1F;POLR1H;TTF1;TAF1D;GTF2H2;POLR1E
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.5194584757323395,-1.0272580408328562,0.4057971014492754,1.0,1.0,2/28,1.66%,B2M;FTL
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.4377188824402877,-1.0270795563218842,0.4,1.0,1.0,4/70,4.68%,HLA-F;PM20D1;CLU;VPS35
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),0.5459291378121794,1.026981405686318,0.5333333333333333,0.9141430694456817,1.0,1/8,7.40%,PKD2L1
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),-0.4364502413906316,-1.0269305251186214,0.4155844155844156,1.0,1.0,8/61,14.44%,POLR2G;EIF1B;MIF4GD;EIF5B;EIF1;CEBPB;EIF2B2;ATF3
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.5525728629242818,1.0268548971419382,0.4473684210526316,0.9137877034588479,1.0,6/13,22.07%,TSPOAP1;RIMBP2;KIF1B;ERC2;ERC1;DTNA
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033),0.6181732442724843,1.0268442712561006,0.45098039215686275,0.9130146174153124,1.0,2/5,13.27%,HSPB1;PRKD1
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.5736019388768874,1.026636730132175,0.4634146341463415,0.9126946953828123,1.0,3/9,21.38%,PLA2G4A;CHPT1;PLA2G4C
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.645333934034482,-1.0264719258394974,0.5,1.0,1.0,3/6,24.55%,VPS35;CAV2;DTNBP1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5837138581075647,1.026270425687219,0.38235294117647056,0.9126236252195664,1.0,5/8,24.64%,PRKCE;CAMK2D;ATP1A2;STK39;HECW2
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.5753264869622963,1.0262352706192295,0.4634146341463415,0.9119436975785318,1.0,4/10,18.07%,TGFB2;ACVR1;MDM4;SMAD2
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.4762694627307134,-1.0259322627182605,0.4375,1.0,1.0,5/43,7.21%,GATA1;RPS14;ZFPM1;SLC25A5;RPS19
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.5284679003256019,-1.0258972428724487,0.46875,1.0,1.0,1/19,2.07%,RPS23
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.4284609465568805,-1.0257510369497829,0.4305555555555556,1.0,1.0,9/74,14.56%,RPS27A;SFRP1;VPS35;UBA52;FZD8;SFRP4;RBX1;WNT9A;UBB
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.6075998518783766,-1.0256733384673595,0.4444444444444444,1.0,1.0,3/7,17.88%,PHB2;PPIF;ANTKMT
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.5268748068012907,-1.02542603342358,0.4444444444444444,1.0,1.0,1/14,0.84%,PPP1R17
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.3767201875304624,1.0251741011372206,0.3,0.9138677901155493,1.0,10/133,4.91%,B3GNT6;VAPB;CERS3;GAL3ST2;CHKA;ACER2;HPGDS;SPTSSB;PPM1L;SGMS1
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.6158952593659552,1.0251702488306118,0.4782608695652174,0.9131204097891236,1.0,3/8,20.88%,SIRT1;WNT5A;LILRB1
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.43624721307308445,-1.0250981225157587,0.43243243243243246,1.0,1.0,27/86,25.42%,TTN;CENPE;MIS12;CHMP2A;RAB11A;NCAPH;NCAPD3;CENPK;DCTN2;ANKRD53;SMC4;SPDL1;KIF18A;SMC2;WRAP73;CHMP7;CHMP3;CDC23;RAN;ZW10;CHMP4B;KIF22;KPNB1;VPS4B;SET;SMC1A;NUDC
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.5636490798506462,-1.024989525930804,0.5,1.0,1.0,1/14,1.46%,SIGIRR
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.6459627342320345,1.024364781580409,0.47619047619047616,0.9142191042588428,1.0,3/5,28.39%,VPS41;C9ORF72;VPS39
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.6679350698838062,1.02420088715584,0.5121951219512195,0.9138098682438008,1.0,3/5,13.41%,ROBO1;SLIT3;SLIT2
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),0.5299975789764125,1.0241651799109914,0.5,0.9131430305746193,1.0,5/10,17.18%,VASH1;NEK4;NUAK1;MARCHF5;PNPT1
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.4785751800154086,-1.02408662040379,0.4657534246575342,1.0,1.0,7/37,14.01%,ADH4;RBP1;RDH12;GPC3;GPIHBP1;RBP2;LRAT
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.5877308359536833,-1.024067110299209,0.49206349206349204,1.0,1.0,3/9,30.12%,GABARAPL2;MAP1LC3B;MAP1LC3A
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.5877308359536833,-1.024067110299209,0.49206349206349204,1.0,1.0,3/9,30.12%,GABARAPL2;MAP1LC3B;MAP1LC3A
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),0.5186412191010797,1.0239161201988785,0.3783783783783784,0.9129597962154953,1.0,4/16,11.31%,TSPOAP1;HSD17B7;DHCR7;HSD17B6
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.6262268558860664,-1.02374768414648,0.4745762711864407,1.0,1.0,2/7,10.96%,TGFBR2;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.48622828874247054,1.0233585241379646,0.375,0.9134495373162449,1.0,6/20,23.07%,CX3CR1;SMARCD3;DRD2;KDM1A;FZD3;MDK
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.626482661452429,-1.0232771907916296,0.4918032786885246,1.0,1.0,2/7,9.27%,IL7;TPP1
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),-0.713644550585695,-1.0231708695833475,0.5166666666666667,1.0,1.0,4/5,25.18%,GPR62;CGAS;GPR61;SCTR
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),-0.5985854082349482,-1.0228187749700177,0.4666666666666667,1.0,1.0,1/9,1.57%,XBP1
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),0.5367648669213019,1.0228027205940133,0.45714285714285713,0.9140056678099063,1.0,4/12,13.91%,TICAM1;PTPN22;PRKCE;HCK
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5844345022797899,-1.022773344889016,0.4861111111111111,1.0,1.0,3/13,4.72%,CLU;RPS3;DDIAS
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3268096610460792,1.0227349867189592,0.2,0.9133856695347008,1.0,43/431,7.95%,CREB3L1;VDR;PDGFB;ZNF423;TP63;DACH1;RIDA;PASK;ATOH8;IFNA2;ATXN1;SPINDOC;GMNN;HDAC10;HDAC4;LEF1;RFX3;CPEB3;RELA;HIC2;SAMD13;HMX1;ID1;ZNF706;FOXK1;IGF2BP2;ZBTB16;YAF2;SIRT1;EIF4E2;ASCL1;SAMD4A;SMARCA2;SFMBT2;SYNCRIP;FOXN3;DHFR;CDKN2A;ZNF93;ZHX2;NANOS3;PHF10;HMBOX1
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),-0.6149316493093969,-1.0227249182477776,0.45098039215686275,1.0,1.0,3/9,17.00%,AIPL1;FNTA;RABGGTB
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),0.567128764318808,1.0219051660485545,0.38235294117647056,0.9147572808764459,1.0,2/7,8.74%,MFHAS1;BPIFB1
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.46453450741284125,-1.0217995380912956,0.4444444444444444,1.0,1.0,13/44,22.34%,XBP1;CD81;FADD;GRN;NMI;HLA-DRB1;IFI35;HLA-DRA;ZP3;CCR7;RIOK3;CD226;CD46
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5570150176015236,1.0217445098952578,0.5294117647058824,0.9136531079011462,1.0,3/13,16.14%,CPEB3;NANOS3;TNRC6B
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5570150176015236,1.0217445098952578,0.5294117647058824,0.9136531079011462,1.0,3/13,16.14%,CPEB3;NANOS3;TNRC6B
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.44281742560929693,-1.0217086660500128,0.44594594594594594,1.0,1.0,4/39,10.83%,GPAT3;LCLAT1;DDHD2;PLA2G12A
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.5168315188207617,1.0216131070736238,0.43333333333333335,0.9132920386689006,1.0,6/14,19.79%,IRS1;PID1;LPL;FOXO3;PDK4;GLDC
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.6135731663189123,-1.0212286432379651,0.46774193548387094,1.0,1.0,4/9,27.94%,AP2S1;CLTA;AP2A2;AP2A1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.6135731663189123,-1.0212286432379651,0.46774193548387094,1.0,1.0,4/9,27.94%,AP2S1;CLTA;AP2A2;AP2A1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.5956120695502725,-1.0211959728764428,0.3939393939393939,1.0,1.0,2/10,12.40%,PSMC5;PSMC3
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.5112215187345324,-1.0211349984306934,0.41379310344827586,1.0,1.0,5/17,16.95%,HLA-F;HLA-E;RASGRP1;LAMP1;CD160
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.5419205098740668,1.0208031106274713,0.4444444444444444,0.9145365497612152,1.0,4/13,17.00%,CAMSAP3;BAG3;ARHGAP21;BORCS5
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.5154717755149598,-1.0207980152459775,0.4444444444444444,1.0,1.0,1/21,1.67%,SFRP1
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),0.5930003164277796,1.0203168741750697,0.425,0.9149771663889245,1.0,2/6,16.20%,KYAT1;QDPR
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),-0.3854007491091035,-1.0203067105327759,0.3780487804878049,1.0,1.0,35/187,21.00%,PSMB8;DDIT3;PSME1;PSMB6;PSMD8;PSMC5;RAD23A;PSMD7;KCTD2;TRIM13;UBXN1;RBX1;PSMD3;RMND5B;PSMC3;RNF5;KCTD5;ZFAND2B;PSMA4;KAT5;NHLRC1;CDC34;PRAME;HECTD3;CCDC47;PSMD2;PSMA7;SPSB3;ZFAND2A;PSMD6;PSMB2;ERCC8;PSMB3;PSMB4;PSMA3
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6023754971505472,1.0197962042861528,0.4318181818181818,0.9157731171124862,1.0,1/11,0.98%,FGFR1
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.464498901857449,1.0197247351449161,0.3888888888888889,0.9151780105839923,1.0,7/25,18.36%,ICAM1;RAPGEF1;AFDN;TJP2;RAPGEF3;RAP1A;TJP1
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.5151251098156724,1.0195531112339038,0.47058823529411764,0.9148616089567134,1.0,7/18,13.85%,SLC7A1;SLC7A2;SLC47A1;SLC7A5;SLC22A2;SLC6A13;SLC1A2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.47323425510486117,-1.019502147054745,0.45454545454545453,1.0,1.0,10/26,21.74%,HLA-F;HLA-A;HLA-E;RASGRP1;FADD;LAMP1;CD160;HLA-DRB1;HLA-DRA;CD226
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.3833993930858548,1.0194171843210162,0.47619047619047616,0.9144902359395954,1.0,19/102,10.19%,PDGFB;IGF1;IRS1;PASK;EGFR;CPEB3;PLD1;PIWIL2;GLI2;DNA2;SIRT1;AKT2;SORBS1;SAMD4A;TMEM106A;PRR16;STN1;TGFB2;NFKB1
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.6164976320371246,-1.0193805371312614,0.4,1.0,1.0,1/7,15.26%,TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.5495416590137605,-1.0190842764081731,0.49230769230769234,1.0,1.0,3/18,11.72%,XBP1;BHLHE41;BDNF
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.3858487572885455,1.0190178958408458,0.37037037037037035,0.914818160880534,1.0,7/67,8.26%,B3GNT6;IGF1;GAL3ST2;ST8SIA6;ST8SIA1;TMEM106A;ST8SIA4
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.43018158602149775,1.0189962909123615,0.375,0.9141150101307334,1.0,1/46,0.05%,MFNG
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.6290511138304373,-1.0189436747509248,0.43859649122807015,1.0,1.0,3/6,28.94%,PRPS1;PAICS;GART
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),0.6295585333011178,1.0185068106746045,0.5405405405405406,0.9146419951046151,1.0,1/5,4.39%,PLD1
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),-0.6436317657571461,-1.0183284749497257,0.46296296296296297,1.0,1.0,1/5,15.08%,EDN1
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-0.6642465223370362,-1.0183006709758349,0.5185185185185185,1.0,1.0,3/5,28.71%,OSGEP;LAGE3;TPRKB
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.38468724146660943,1.0182007171445366,0.5,0.9145928502119357,1.0,11/54,13.74%,HSD17B7;CLN6;OSBPL1A;SULT2A1;SOAT1;DHCR7;SULT2B1;HMGCR;HMGCS1;MVD;LCAT
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),-0.5945369396094877,-1.0181811077084812,0.4126984126984127,1.0,1.0,1/9,2.46%,GRIN3B
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.6130979870216866,1.0181672185123336,0.5,0.9139026841058425,1.0,4/9,27.15%,ACACB;CPT1A;PRKAG2;ACACA
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.5108122439226813,1.0180802091150747,0.3902439024390244,0.9133351466913016,1.0,10/24,23.72%,MTMR2;MTMR11;PTEN;SYNJ2;INPP5B;MTMR3;MTMR12;PIP4P2;MTM1;MTMR9
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.5219684283174629,-1.0179208331193208,0.4782608695652174,1.0,1.0,5/20,14.87%,RPS21;NOP9;FTSJ3;EXOSC10;WDR12
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.4709500781223249,1.0172748360241668,0.4375,0.9148431710304984,1.0,4/22,12.86%,ICAM1;COL22A1;RAPGEF1;RAPGEF3
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.47594820766034907,-1.0171658922565645,0.4084507042253521,1.0,1.0,7/45,10.16%,XYLT2;HYAL2;B3GALT6;GPC3;SGSH;B4GALT7;FUCA1
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.46710532391702025,1.0171068014574285,0.42857142857142855,0.9144411861388677,1.0,7/27,12.29%,IGF1;IRS1;AKT2;SORBS1;PID1;RHOQ;ENPP1
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.3418320432395743,1.0170910717416068,0.38095238095238093,0.9137313868801356,1.0,49/187,18.44%,TP63;FGFR1;IGF1;SNAI1;MAPK11;FRZB;MAPK12;LEF1;MMD2;CPNE1;DLX1;PLA2G10;ZBTB16;ASCL1;BMP6;SERPINF2;CTNNA2;LRRC8A;BRINP3;WDFY2;TGFB2;NFKB1;GDNF;SOX5;ACVR1;NPNT;SMAD4;XKR8;CDS1;CDH2;LPL;PRKD1;TCF4;RPS6KA1;BMPR2;GDF5;ACVR2B;DNAI3;ACVR2A;VHL;ZNF268;ZNF703;RAP1A;ABL1;SMAD2;RGCC;AKIRIN1;LOXL2;NRCAM
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.4857807464250889,1.0168400103673743,0.4666666666666667,0.9136281951348695,1.0,4/22,8.81%,HSPA1A;PLK1;HNRNPU;HSPA1B
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),-0.5465525913733804,-1.0165935115773568,0.46774193548387094,1.0,1.0,1/18,0.90%,SEMA3E
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.5807056868329865,1.016484890583337,0.4782608695652174,0.9137121546620329,1.0,2/9,11.38%,RXRG;RARG
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.4069865191023831,-1.016267118595463,0.379746835443038,1.0,1.0,21/149,13.55%,CD44;IGSF1;HR;XBP1;COX6C;CD9;PDZK1;TST;HSPB8;BLVRB;BTG3;OVOL2;ETFB;SLC16A1;DYNLT3;GALE;PDLIM3;OLFM1;MEST;PPIF;GINS2
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.44292309740493174,-1.016225759399247,0.47297297297297297,1.0,1.0,4/38,10.83%,GPAT3;LCLAT1;DDHD2;PLA2G12A
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.5799935995009263,-1.0161997421122915,0.42592592592592593,1.0,1.0,3/9,9.01%,HLA-F;HLA-E;CEACAM1
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.38309315138379957,-1.0158623146006036,0.4578313253012048,1.0,1.0,46/305,15.56%,GBP3;IL26;IRF4;RPS27A;IL7;GBP2;SIGIRR;DUOX1;XBP1;GAPDH;SFRP1;NDN;TIMP1;IFNGR2;MT2A;NPR2;HLA-DPA1;RPS3;PTAFR;RPL13A;IL31RA;IL6R;HYAL2;UBA52;IRF1;STAT5A;LCK;IL5;PTPN7;IRGM;HAX1;TGFB1;TNFRSF21;PIK3CB;STAT1;YBX3;BRCA1;OSMR;ASAH2;DOCK8;IFNLR1;UBB;IL3RA;NLRP12;TNFRSF1A;CEBPD
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),0.5771782681635441,1.01571883546618,0.4,0.9151477290360885,1.0,4/9,11.81%,KAT2A;CLEC7A;CD4;CRTAM
prerank,MSigDB_Hallmark_2020__Coagulation,0.40517838906208603,1.0156320175346107,0.36666666666666664,0.9147032221076097,1.0,5/86,3.34%,F2;PDGFB;SH2B2;CTSK;DUSP6
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.6240256688207906,-1.0155885687985118,0.5357142857142857,1.0,1.0,1/8,1.67%,SFRP1
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.5900729209027713,-1.0145831080192098,0.5223880597014925,1.0,1.0,4/8,22.18%,FLG;KRT10;TGM1;F13A1
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.684603096379916,1.014474391780456,0.5128205128205128,0.9167171317558757,1.0,2/5,25.20%,DYRK3;KLC1
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.5971882894893905,-1.0144107420033808,0.5285714285714286,1.0,1.0,4/11,8.34%,SERPING1;CR2;C4BPB;C4BPA
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.5756567477643126,-1.0143584623946953,0.5223880597014925,1.0,1.0,2/8,27.26%,MBD4;OGG1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.3846806226088669,-1.0142911491244626,0.4523809523809524,1.0,1.0,44/347,14.56%,CD44;APIP;GATA1;RPS27A;IL7;XBP1;SFRP1;BEX3;RPL10;PRDX5;ANXA5;PTMA;GSTP1;AVEN;BCL2L2;IL31RA;RPS3A;NRBP2;PRELID1;PTRH2;IFIT3;UBA52;COPS5;ZNF830;HTR2B;NAA38;PHB2;MYDGF;LAMTOR5;HSPA5;HAX1;DDAH2;TRIAP1;PINK1;BDNF;GRN;IFI6;MAG;PPIF;CD27;VIP;ASAH2;ARAF;UBB
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),0.616571104276766,1.0140484635389453,0.5208333333333334,0.9170613893446067,1.0,2/5,25.17%,STK39;CAB39
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.4347523685612753,-1.013957587753472,0.4722222222222222,1.0,1.0,19/79,18.65%,NLRP1;IFIT2;RNASE1;IFITM3;IFIT3;IRF1;PHB2;FADD;STAT1;IFI6;EXOSC4;IFNLR1;CGAS;IFIT5;AGBL5;PQBP1;RNF135;NLRP9;ISG20
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.5880634731908773,1.013921807003338,0.4772727272727273,0.9158875870194931,1.0,3/6,21.33%,MAPRE2;MAP4K4;PIK3R1
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.5880634731908773,1.013921807003338,0.4772727272727273,0.9158875870194931,1.0,3/6,21.33%,MAPRE2;MAP4K4;PIK3R1
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.6100982178962829,-1.0138639048073976,0.5517241379310345,1.0,1.0,2/11,12.86%,CLU;MYRF
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.5657455545737408,-1.0138387234388877,0.46153846153846156,1.0,1.0,4/9,23.09%,SRI;CALM3;TRDN;CALM1
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.5657455545737408,-1.0138387234388877,0.46153846153846156,1.0,1.0,4/9,23.09%,SRI;CALM3;TRDN;CALM1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6086164775765299,1.0137073332782212,0.4883720930232558,0.9155864601269174,1.0,1/6,4.40%,ARNT
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.37413466316836425,1.0136576725875155,0.36,0.9149252360144615,1.0,39/108,18.57%,LIFR;ETV1;FRZB;ABCC8;PTPRD;LONRF2;CXXC4;SOWAHA;PPARGC1A;PLPPR4;LIMCH1;PBX1;NFIB;NTRK2;MEIS1;SNAP91;ASXL3;MAPK10;TOX3;RCAN2;ARX;PXK;NRXN1;SEMA6D;RIMBP2;EGR3;ESRRG;RAPGEF4;PCDH19;UNC5C;NFASC;SERTM1;ADGRA1;ADCYAP1;GRIA2;NOL4;MAP2;FGF14;TMEM196
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.4396173868492357,1.0135707412027062,0.42105263157894735,0.9143961087190933,1.0,1/27,0.15%,TNFSF13B
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.5094692726172566,-1.0135631804476037,0.45454545454545453,1.0,1.0,3/22,12.30%,XBP1;CCDC39;CEBPB
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.5627953279427442,-1.0134739386257698,0.47540983606557374,1.0,1.0,5/13,26.39%,SRSF7;C1QBP;SAP18;SRSF9;SRSF10
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.42238346351060563,-1.0134411240597045,0.42105263157894735,1.0,1.0,17/84,23.60%,SELENOS;SEC61B;TRIM13;TRIM25;HSPA5;USP19;RNF5;FAM8A1;UBXN8;MAN1B1;CCDC47;HSP90B1;SEL1L2;SGTB;FOXRED2;RNF175;FBXO6
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.6358407853687853,1.01320854257901,0.5,0.9145769380691644,1.0,2/6,8.57%,SRC;NTRK2
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.5426124799652481,-1.0131867504753125,0.5161290322580645,1.0,1.0,3/14,17.09%,PRELID1;SLAMF8;METTL3
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.5137693768118967,1.0131495268948894,0.42857142857142855,0.9139617562729335,1.0,7/14,26.07%,SEC23B;SEC24B;SEC31A;SEC31B;MIA3;SCAP;SEC24D
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.5909153354888499,-1.0131379359964665,0.4915254237288136,1.0,1.0,5/9,33.82%,CAV1;BCAP31;SVIP;HERPUD1;UBQLN2
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.6141713957417837,-1.0130958918989998,0.5555555555555556,1.0,1.0,3/8,21.24%,CEACAM1;NLRP12;CCR7
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.4121044752133328,-1.0126531330880557,0.463768115942029,1.0,1.0,12/87,10.96%,CD44;GATA1;NOX4;PTK6;EFNA1;IL31RA;IL6R;PARP14;CD81;IL5;HAX1;TGFB1
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.5340963654329903,1.0124233736882344,0.48484848484848486,0.915003060544241,1.0,2/12,8.64%,CHST7;CHST3
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.48383116990674013,1.0123726637258326,0.4146341463414634,0.9143558862619717,1.0,1/23,0.40%,PPP1R36
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.5116641131781811,-1.0120966611010962,0.49230769230769234,1.0,1.0,6/24,14.04%,ACOT2;DBI;OXSM;ACSM6;ACSM3;ACOT1
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.5116641131781811,-1.0120966611010962,0.49230769230769234,1.0,1.0,6/24,14.04%,ACOT2;DBI;OXSM;ACSM6;ACSM3;ACOT1
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.5554898003899457,-1.012065315653039,0.5,1.0,1.0,1/19,0.40%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),-0.6147784794918101,-1.012036760950767,0.42105263157894735,1.0,1.0,1/6,4.81%,MESP1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.3749007676191682,-1.012011865943489,0.40476190476190477,1.0,1.0,45/283,21.75%,PSMB8;RPS27A;DTX3L;FBXW10;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;UBA52;RNF8;DDA1;ANAPC13;ARIH2;RBX1;PSMD3;PSMC3;RNF5;BRCA1;UBB;PSMA4;FBXW8;NHLRC1;RNF167;RNF26;CDC34;PRAME;UBE2D4;RNF135;RNF213;PSMD2;PSMA7;FBXL16;FBXL13;DCAF15;ZNF738;PSMD6;PSMB2;ERCC8;PSMB3;PSMB4;PSMA3;CDC23;DZIP3;PSMC1
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),0.5652106577430401,1.011992736396039,0.5555555555555556,0.9146775167774385,1.0,2/7,9.37%,ADARB2;ADARB1
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.4230612165448654,1.011986538428909,0.35714285714285715,0.9139447412933301,1.0,12/64,9.75%,TP63;TNC;TRIM29;EGFR;POSTN;LTBP2;EHD2;MYOF;FBLIM1;RND3;AHNAK2;ALDH1A3
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.5924375722266156,1.0119851336060965,0.5121951219512195,0.9132240122936186,1.0,4/10,17.65%,TGFB2;ACVR1;BMPR2;MDM4
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.5080595809267076,-1.0118069950691024,0.4444444444444444,1.0,1.0,2/22,6.21%,RPS27A;UBA52
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",-0.6568545966666297,-1.0114602677518385,0.5471698113207547,1.0,1.0,2/6,18.07%,ELOVL2;ELOVL1
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",-0.6568545966666297,-1.0114602677518385,0.5471698113207547,1.0,1.0,2/6,18.07%,ELOVL2;ELOVL1
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",-0.6568545966666297,-1.0114602677518385,0.5471698113207547,1.0,1.0,2/6,18.07%,ELOVL2;ELOVL1
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",-0.6568545966666297,-1.0114602677518385,0.5471698113207547,1.0,1.0,2/6,18.07%,ELOVL2;ELOVL1
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.5966589035572054,-1.0113412363028422,0.5,1.0,1.0,1/7,1.57%,XBP1
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),-0.6265922044839091,-1.0113241667285324,0.4166666666666667,1.0,1.0,1/5,1.57%,XBP1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.43671737484096285,1.0112547410780934,0.40625,0.9142291479031159,1.0,2/23,4.45%,F2;CLEC7A
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.6152699048373783,1.011175023791109,0.4318181818181818,0.9136827707222014,1.0,2/5,20.52%,STMP1;DDX3X
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),-0.44224665588761314,-1.0109568352763383,0.43243243243243246,1.0,1.0,8/57,17.62%,COPS9;TIMP1;PCNA;HYAL2;TRIAP1;PARP1;METTL3;XPA
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.45355368912867017,1.0102427765694673,0.45714285714285713,0.9151190877120229,1.0,2/19,4.14%,KCNN4;RELA
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.45051481448487674,-1.0100468953053403,0.3972602739726027,1.0,1.0,8/53,21.70%,COX7A1;COX7A2;PINK1;ATP5IF1;GCK;NUP50;FIS1;PGAM1
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),-0.5547889918460638,-1.0098851903307338,0.5901639344262295,1.0,1.0,2/15,10.96%,TGFBR2;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.6222008754052246,-1.0098793903966194,0.48,1.0,1.0,2/6,11.99%,SOX15;SELP
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.41101492737851053,-1.0095695493671042,0.4246575342465753,1.0,1.0,20/94,19.91%,RHOC;CLU;RPS3;PSMC5;HRK;RACK1;IL5;TRABD2B;RPA3;BRK1;RBX1;TGFB1;PSMC3;PARP1;TPPP3;WARS1;XPA;GTF2H2;LCP1;BAX
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.5195713068673401,-1.0095304545040182,0.47692307692307695,1.0,1.0,3/21,11.37%,RAB11A;ATAD5;CDK4
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.49732793578315415,-1.0094594299167956,0.4189189189189189,1.0,1.0,3/27,8.35%,RPS27A;UBA52;TNIP2
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.5561547485247131,-1.009164322058186,0.484375,1.0,1.0,5/15,24.75%,MESP1;MYEF2;MTLN;CBY1;MYOCD
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.4883527220876792,1.0091336111601539,0.45161290322580644,0.9170941180072937,1.0,5/16,13.39%,DUSP6;DUSP1;DUSP10;PPM1E;DUSP18
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.4975997240853146,-1.0090212293400682,0.4857142857142857,1.0,1.0,3/26,7.80%,SEMA3E;TGFBR2;PAX8
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.4573161016848545,-1.0090189449022369,0.46875,1.0,1.0,4/45,5.76%,GBP3;GBP2;SFRP1;HYAL2
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.36244031411242883,1.0087751526647495,0.4444444444444444,0.9172603431474432,1.0,26/120,13.01%,GFAP;CHRNA4;VCAN;PDGFRA;MMD2;CSPG4;PLPPR4;SCRT1;ASCL1;CTNND2;PCDH15;ETV5;ADGRB3;PSD2;NXPH1;SNAP91;SHC3;ADGRL3;MEGF10;SLCO1C1;ZNF536;NCAN;CORO2B;LRRC4C;ADCY8;SLC8A2
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.42518339103503516,1.008417300835638,0.4444444444444444,0.9172858567455595,1.0,11/67,16.29%,KAT2A;LEF1;CHD5;SUPT3H;TRIM16;CPA4;TAF12;KAT2B;JADE2;CREBBP;JADE3
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.6489407214907861,-1.0079433081244145,0.5357142857142857,1.0,1.0,4/6,24.40%,CAV2;TPCN2;CAV1;CTSL
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),-0.5577174794732163,-1.0079215707900222,0.46774193548387094,1.0,1.0,4/14,21.61%,SCG2;ANGPT1;FGF7;LGALS3
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.5211215919090159,1.0077574103661342,0.48717948717948717,0.9181533051870447,1.0,2/15,5.13%,HDAC4;GNL3L
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.3638446800268927,1.007665089002945,0.3,0.9177250510814874,1.0,21/76,21.11%,BAG2;HSPA1A;SIRT1;HSPA1B;BAG3;CHORDC1;NDC1;HSPH1;NUP42;PTGES3;DNAJB6;CREBBP;GSK3B;CAMK2D;FKBP4;MAPT;RPTOR;DNAJB1;NUP98;MAPKAPK2;CAMK2G
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.5614523024970609,-1.0076098626392735,0.48333333333333334,1.0,1.0,4/10,17.17%,COLEC12;TNIP2;FADD;SCARA3
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.5586611837022435,1.0075928787032615,0.5277777777777778,0.9172112704740086,1.0,2/11,6.07%,EPS8L2;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4947691595532304,1.0073765537694326,0.4444444444444444,0.9171721305591,1.0,2/16,9.67%,IGF1;AKAP6
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.5606776775476949,1.0069484691671207,0.5161290322580645,0.9173374898672102,1.0,2/10,5.24%,IGF1;CD200R1
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.5599473231452754,-1.0068972509825878,0.5,1.0,1.0,3/12,7.24%,ERVFRD-1;CD9;CD81
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.3614430370802714,1.0068910038972103,0.3333333333333333,0.9167715053549976,1.0,34/118,22.47%,ZBTB1;KAT2A;SNAI1;HDAC10;HDAC4;SIRT1;SMARCA2;BRWD1;KDM4C;FAM47E;ARID1A;SMARCD2;SMARCAD1;ATRX;KAT2B;SMARCD3;PHF1;EHMT1;SETDB2;LOXL2;RSF1;KDM6A;HDAC1;SMARCC1;SATB2;HDAC3;PHF19;BAZ2B;PBRM1;HP1BP3;CHD1;DR1;SMARCE1;ZBTB7A
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.3819018371184023,1.0068469847132289,0.4166666666666667,0.9161956882846664,1.0,13/84,6.53%,TNNC2;TCAP;TPM2;OXTR;MYOM1;MYH3;MYH4;KCNIP2;GNAO1;SMTN;DYSF;MYOF;SORBS1
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.49079122651031776,-1.0065940629380752,0.44776119402985076,1.0,1.0,7/29,18.75%,TPP1;GRN;GNPTAB;LAMTOR1;SNAPIN;TPCN2;NAGPA
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.5506712326863127,1.0064836599780909,0.43243243243243246,0.9163506995550462,1.0,8/13,30.96%,PAXIP1;TFRC;SHLD1;KMT5B;HMCES;TP53BP1;KMT5C;PARP3
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.36982717360996104,1.0064825671442321,0.4,0.9156259908646522,1.0,16/111,14.06%,FHDC1;BET1;ARHGEF7;TRAPPC12;SPTBN5;OBSL1;OPTN;ZFP69B;VAMP4;NSFL1C;ARHGAP21;PRKD1;CLASP1;VTI1A;TRIP11;RAB30
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.5672796472422937,1.0062028933638025,0.475,0.9154918606347325,1.0,3/10,10.24%,NRP2;ASCL1;GDNF
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.5084439253869235,1.006151980905742,0.3448275862068966,0.9149082064183093,1.0,6/15,18.35%,ISYNA1;IP6K2;IPMK;ACER3;FGF2;ITPKC
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.620783349914141,-1.006081513727258,0.5254237288135594,1.0,1.0,3/5,34.37%,BAX;APAF1;CYCS
prerank,GO_Biological_Process_2021__negative regulation of protein sumoylation (GO:0033234),0.6452696477889575,1.0054701965592738,0.525,0.915812716831586,1.0,1/5,5.13%,GNL3L
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.397428475567384,1.005271636579807,0.27586206896551724,0.9156466863222663,1.0,17/64,16.65%,IL1RAPL1;TIAM2;PTPRD;CX3CR1;OBSL1;PLXNA1;NTRK2;ROBO1;PLXNB2;ROBO2;SLIT2;SS18L1;CHODL;SMARCD3;GPER1;DRD2;PLXNA4
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.3815330708069005,1.005127366228194,0.35714285714285715,0.915224543861898,1.0,9/78,10.32%,F2;PDGFB;PLA2G10;SNCA;ARRB2;ARRB1;TBC1D5;PID1;SLCO1C1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.35716881968032504,1.0049202099943957,0.3333333333333333,0.9150379006459808,1.0,29/148,14.15%,RELN;PDGFB;FGFR1;SRC;ALK;ARHGEF7;CPEB3;DLX1;NLGN1;ZBTB16;SIRT1;SERPINF2;COBL;PAXIP1;PLD6;LLPH;SCX;SPIRE1;GDNF;SOX5;ACVR1;SMURF2;NRXN1;RAPGEF3;CLASP1;RPS6KA1;ESRRB;LRP8;BMPR2
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),-0.6296094699953048,-1.0048295001394627,0.5,1.0,1.0,1/6,0.35%,BMP5
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),0.6307732718132734,1.0047910260728612,0.5277777777777778,0.9146062525186317,1.0,2/6,11.11%,NOS2;ARG1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.4746214516156469,1.0047649782224675,0.48717948717948717,0.9138982151104417,1.0,6/13,23.14%,SERPINF2;TGFB2;SMAD4;ITGB8;LILRB1;SMAD3
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.5096532578569892,-1.0046967171572245,0.4722222222222222,1.0,1.0,1/24,1.30%,HR
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),-0.6390949085215445,-1.0042210757214525,0.5423728813559322,1.0,1.0,1/5,1.57%,XBP1
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.41974409957148345,-1.0041780542211156,0.49333333333333335,1.0,1.0,8/88,5.78%,XBP1;SFRP1;AQP9;JUP;NEURL1;CFTR;TSHR;RRAGA
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.4751392131048452,-1.003706661977854,0.44,1.0,1.0,2/34,2.83%,SFRP1;JUP
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.46498100083024335,1.0034121262177336,0.40540540540540543,0.9164922925909488,1.0,10/44,7.65%,IGF1;NLRP7;CARD18;HSPB1;CLEC7A;CX3CR1;AGER;TMEM106A;P2RX7;TRIM16
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.574746996146467,-1.0033897170684365,0.5094339622641509,1.0,1.0,1/7,7.59%,RNF8
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.5764937025585412,-1.003365713278772,0.515625,1.0,1.0,6/11,25.87%,VIL1;DSTN;CFL1;CFL2;WDR1;TWF1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.5603078153921291,-1.003148377876529,0.53125,1.0,1.0,1/14,3.46%,FGL1
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.5439223075791411,-1.003108441098164,0.4262295081967213,1.0,1.0,6/13,30.16%,CHMP2A;SNF8;VPS4B;SDC4;HGS;SMPD3
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.7114756049076603,1.002901314245728,0.5675675675675675,0.9171138642195963,1.0,3/5,21.08%,HMGB1;RAD51;APLF
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),0.4141737241374406,1.0028626255309796,0.5,0.9165543613373109,1.0,9/28,21.27%,PTCH2;GLI2;PKD2L1;ULK3;HIPK2;TTBK2;PTCHD1;MAP3K10;KIAA0586
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.4811388737608005,-1.0026447596091947,0.5,1.0,1.0,9/42,15.88%,RPS27A;PCNA;UBA52;TRIM25;RPA3;RFC2;SPRTN;UBB;RFC4
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.40780596693755633,1.0023826773851272,0.34146341463414637,0.9170261741340487,1.0,11/43,8.86%,NOS2;HSPA1A;AFAP1L2;ANXA4;RELA;MAPKBP1;CLEC7A;SSC5D;ARRB1;HSPA1B;OTUD7B
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.5785851697764417,-1.002363005429461,0.5223880597014925,1.0,1.0,1/11,10.91%,FADD
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.5946189268147446,-1.0021929689429019,0.5,1.0,1.0,3/9,9.57%,XYLT2;B3GALT6;B4GALT7
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.6185203207499954,-1.002044651055514,0.5245901639344263,1.0,1.0,3/9,15.02%,B2M;ARG2;CGAS
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.47971567786512526,1.001431466685524,0.4482758620689655,0.9185586886836263,1.0,6/21,9.98%,PPFIBP1;LRP4;AGRN;CACNB4;PPFIBP2;UNC13A
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.4163121164590935,1.0011388870963847,0.40540540540540543,0.9185827061243675,1.0,8/50,9.08%,ZNF423;SNAI1;PBX1;ASCL1;MAML2;NOTCH3;NOTCH4;DLL1
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.6029519127550227,1.0007393209359035,0.46511627906976744,0.9189246157973403,1.0,1/8,5.18%,ESPL1
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),0.616802892151744,1.000398242209591,0.4090909090909091,0.9183265224843273,1.0,4/5,37.64%,KMT5B;KMT5C;BEND3;SMYD5
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),0.616802892151744,1.000398242209591,0.4090909090909091,0.9183265224843273,1.0,4/5,37.64%,KMT5B;KMT5C;BEND3;SMYD5
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.4809930940583335,-1.000159996220366,0.5428571428571428,1.0,1.0,10/44,15.88%,RPS27A;PCNA;UBA52;TRIM25;RPA3;RFC2;BRCA1;SPRTN;UBB;RFC4
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.48037238458925124,0.9999499893067573,0.5,0.9186043881910627,1.0,8/21,14.66%,CDK10;EVI5L;ARHGAP44;CCP110;SLIT2;CEP97;KANK1;TESK1
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.4641940899972448,-0.9998829419572934,0.4166666666666667,1.0,1.0,8/40,20.78%,TINF2;APEX1;PCNA;RPA3;PARP1;RAD50;POLD2;POLD4
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.627091331663421,-0.9998767012593275,0.5079365079365079,1.0,1.0,3/8,15.02%,B2M;ARG2;CGAS
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.5963347905939937,0.9998411827815251,0.5111111111111111,0.9180895020553258,1.0,3/7,2.73%,FGFR1;PLIN5;FGFR3
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.4069123093644003,-0.9997962274521944,0.4605263157894737,1.0,1.0,24/149,17.43%,PARP2;DTX3L;RMI1;AP5S1;EME1;RNF8;UBXN1;ATP23;ABRAXAS1;RPA3;RAD51AP1;CYREN;BRCA1;KDM4D;PARP1;KPNA2;MEIOB;SFR1;KAT5;GEN1;PARP9;RAD50;XRCC2;XRCC3
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.5642391759313747,0.9996649454192579,0.4878048780487805,0.9177654341313637,1.0,1/8,1.79%,CBARP
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.540211716227821,-0.9995845320187956,0.5,1.0,1.0,1/15,1.22%,POLR2G
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.5709161241469285,-0.9994982908910226,0.46875,1.0,1.0,3/14,17.91%,ARF1;DCTN1;MAP1A
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),-0.649416340363615,-0.9992042743593519,0.5245901639344263,1.0,1.0,2/6,11.61%,OPALIN;TNFRSF21
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.5318559159146443,-0.9991017159753276,0.5373134328358209,1.0,1.0,8/21,25.66%,TMEM50A;CHMP2A;TMEM50B;CHMP7;CHMP3;CHMP4B;VPS4B;LAPTM4B
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.4059816159151812,-0.9990299091243656,0.47297297297297297,1.0,1.0,11/88,17.78%,CLU;C4BPB;GPC3;C4BPA;RASGRP1;VPS28;TGFB1;VIP;SNF8;MAPK7;APOE
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.4459224252751742,-0.9990073569291802,0.4492753623188406,1.0,1.0,2/49,1.67%,BMP5;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.6106982357319912,-0.9989303660112002,0.43103448275862066,1.0,1.0,1/7,18.51%,GTF2H2
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.6038552616451683,0.998871838355265,0.6,0.9190134539446959,1.0,2/8,17.43%,ROBO1;ZNF703
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.4045774335731701,0.9988189804447455,0.34375,0.9183940716570753,1.0,9/40,12.09%,CLDN15;CLDN9;GRHL2;FRMPD2;ESAM;TBCD;PARD6B;DLG1;AFDN
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),0.6072536285297788,0.9983928949658332,0.5588235294117647,0.9186707893120328,1.0,1/5,2.35%,CARD18
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.4435325859232739,-0.9983700317796387,0.42857142857142855,1.0,1.0,13/57,15.26%,CD44;IL7;IFNGR2;CD9;IRF9;IRF1;HAX1;TGFB1;TNFRSF21;STAT1;OSMR;IL3RA;TNFRSF1A
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.5924037808273948,-0.9981266479773491,0.53125,1.0,1.0,1/7,5.45%,CARTPT
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.6178887877875419,0.9979911371436601,0.4444444444444444,0.91881027770516,1.0,2/7,12.17%,UGT8;B4GALT3
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.6191506289802516,0.99790899399651,0.4594594594594595,0.9182450887139386,1.0,4/8,26.13%,ATP1B3;DLG1;WNK1;WNK2
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.5993825260783183,-0.9976995060595958,0.5081967213114754,1.0,1.0,1/6,5.45%,CARTPT
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),-0.6572332557588005,-0.9976770950212369,0.5373134328358209,1.0,1.0,1/6,6.97%,VAMP8
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.42304575868357974,0.9976715210885612,0.4482758620689655,0.9181325477140088,1.0,11/53,11.44%,FGFR1;IGF1;SRC;TMC8;RELA;WWOX;TRAF2;SH3RF1;ACVR1;SIAH2;FEM1B
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.559163049344493,0.9973791838549586,0.5,0.9180726724160588,1.0,5/7,24.18%,SIRT1;TDP1;LIG4;APLF;ERCC6
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.4914958206567327,-0.9972615347721105,0.4305555555555556,1.0,1.0,3/21,14.08%,TCN2;AMN;SLC2A2
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.3895108459717139,-0.9972432677788031,0.4805194805194805,1.0,1.0,21/142,17.02%,RPL23;RPL5;RPS15;RMI1;RPL11;RPS20;RPL37;RPF2;NOP53;TPX2;RPA3;TAF11;CDK5;RFC2;BRCA1;CHD4;SETD9;KAT5;RFC4;HEXIM1;RAD50
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.35542223761715874,0.9970551480996043,0.3157894736842105,0.9181492551069711,1.0,24/140,12.12%,RELN;KCNN4;CSF2RA;GALNT3;ETV1;SPRY2;DUSP6;ANKH;ADGRA2;AKT2;ETV5;CAB39L;ADAM8;SNAP91;MAP3K1;LAT2;ALDH1A3;WDR33;MAFB;PRKG2;CA2;ARG1;PTBP2;HDAC9
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.5294106106054471,-0.996864966709183,0.5352112676056338,1.0,1.0,3/16,18.07%,ELOVL2;ACSBG2;ELOVL1
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.5323817793489249,-0.9966577364994934,0.5396825396825397,1.0,1.0,5/21,15.19%,PTK6;IL31RA;STAT5A;STAT1;NMI
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.36002336513739885,-0.9963612411581854,0.4777777777777778,1.0,1.0,66/356,23.38%,CENPF;TMEM107;TTC36;RPS23;ATG16L2;RPS3;CENPE;FLII;MIS12;ATG14;CHMP2A;RAB11A;EMC6;VPS25;CCDC28B;IRGM;VPS28;RAB32;NEK6;CEP131;HAUS6;GORASP2;FUZ;ABLIM3;GABARAPL2;ARL13B;IFT122;TXNDC15;RAB8A;IFT81;SCLT1;TP53INP2;DNAH5;MYH6;FAM149B1;SNF8;GOLGA8B;PATL2;DYNLL1;DYNC2H1;CFAP410;LMOD1;RP2;PLK4;CIRBP;INTU;GOLGA2;DHX37;ATP6V1D;CHMP7;CHMP3;MAP1LC3B;CEP41;EIF2A;WDR45B;SMIM22;TUBGCP4;CC2D2A;GOLGA8M;TUBGCP2;CHMP4B;SEPTIN2;LSM3;DYNC2I1;VPS36;DHX29
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.4621129997209082,-0.9963061653271971,0.453125,1.0,1.0,3/32,3.63%,DUOX1;AQP9;CFTR
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.5277102622627287,0.9962909320586807,0.46511627906976744,0.9191795169548398,1.0,8/19,23.00%,PLA2G10;GDPD3;PNPLA6;GPCPD1;PLA2G4A;PLA2G4C;SMPD4;PRDX6
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.6807719110532064,-0.9962840122150631,0.5740740740740741,1.0,1.0,1/5,4.38%,PPIB
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5306650045011556,0.9962568136012305,0.5185185185185185,0.9185534147016761,1.0,2/10,7.69%,NPTX2;CACNG5
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.5936527854645965,-0.9962296558737928,0.5692307692307692,1.0,1.0,2/9,6.04%,ADH4;ADH5
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.45710933025831146,-0.9959445194260701,0.4857142857142857,1.0,1.0,6/49,13.41%,ATG16L2;ATG14;EMC6;IRGM;GABARAPL2;TP53INP2
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6229530675953646,0.9959379953278986,0.5263157894736842,0.9186608357039542,1.0,2/5,20.62%,IL33;KDR
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.3944500808471829,0.9958689351405398,0.39285714285714285,0.9180988593613554,1.0,10/62,11.35%,NUPR1;CDK6;PLK1;GMNN;TRIM35;DUSP1;CDKN2A;BRINP3;HECA;PTPRK
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.4217877505612373,-0.9958073941973822,0.4805194805194805,1.0,1.0,1/72,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.43080200181798795,-0.9954928285570259,0.463768115942029,1.0,1.0,4/62,2.25%,RHOC;SFRP1;ACTG1;STMN1
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.621749110620594,0.9954420708630377,0.5555555555555556,0.9184258869399776,1.0,4/7,27.29%,KIF1C;TANC2;PPFIA2;SYT4
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.601730254380618,-0.9953899085542666,0.5223880597014925,1.0,1.0,1/10,2.22%,TPH1
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.491603049051356,0.9953352699511683,0.5483870967741935,0.9180215777624663,1.0,6/12,26.33%,DLL1;FGF1;FGF2;TJP1;PDPK1;SMAD1
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),-0.6657482114400227,-0.9952524642729043,0.5862068965517241,1.0,1.0,3/5,29.16%,MAOB;COMT;LRTOMT
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.4109337141680072,-0.9952053531987404,0.42857142857142855,1.0,1.0,13/84,13.59%,NOX4;SELENOS;PRDX1;PRDX5;GSTP1;CHCHD2;RBM11;TXNRD2;PINK1;BRF2;GPX7;PARP1;PPIA
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.5786199356482826,0.9951063373339805,0.5365853658536586,0.9179100019303356,1.0,1/9,6.25%,SIRT1
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.5357353842783302,0.9949007686746945,0.45454545454545453,0.917715207518697,1.0,5/15,9.51%,GRM2;HOMER1;GRM8;GRM1;GRM3
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.47366458125196437,-0.9948338210944315,0.42857142857142855,1.0,1.0,14/33,23.07%,DDIT3;RPS7;RPS3;LCK;RACK1;UBB;EIF5A;SEPTIN4;DNM1L;BAX;SOD1;FIS1;CAV1;BCAP31
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.5176717878828194,0.9946116458780827,0.5,0.9177915316131003,1.0,2/15,5.86%,CBARP;HAMP
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.4697758399162836,-0.9945676648780931,0.5074626865671642,1.0,1.0,7/38,14.74%,BUB1;BTG3;CDKN1C;BTG1;TOM1L1;TGFB1;ZWILCH
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.4220198335401032,-0.9945041681706649,0.49333333333333335,1.0,1.0,1/70,0.04%,SLC28A2
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.38222505544534036,-0.9944484673662247,0.38095238095238093,1.0,1.0,23/184,15.17%,NLRP1;MCM2;GAPDH;IFIT2;TGFBR2;TCHP;MAGEH1;IFI27L1;KREMEN1;IRF1;BCL2L14;ADAM15;PAK5;FADD;IFI27L2;TNFRSF21;CDK5;IFI6;PARP1;PPIA;CIDEB;DDX41;AHR
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.45225946382944693,-0.9942839325425151,0.44,1.0,1.0,16/51,21.45%,ARHGEF16;TMC4;CD9;TMEM125;OVOL2;BTG1;ITGB4;AR;UXT;CEBPD;PIP;DDR1;ATP2C2;SLC44A3;KLF5;CBLC
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.6179163287312937,-0.994279904763939,0.5757575757575758,1.0,1.0,2/8,7.75%,CCDC39;SRP54
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.6222329729691842,0.9940776126678575,0.5476190476190477,0.918460983914116,1.0,3/7,24.31%,TGFB2;NRG1;BMPR1A
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.6524357290927029,-0.9937790508109023,0.578125,1.0,1.0,1/6,4.88%,TMED9
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.6524357290927029,-0.9937790508109023,0.578125,1.0,1.0,1/6,4.88%,TMED9
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.6524357290927029,-0.9937790508109023,0.578125,1.0,1.0,1/6,4.88%,TMED9
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.455708966441161,-0.993728959931705,0.5,1.0,1.0,5/35,8.85%,ARHGEF16;CFTR;OVOL2;EFNA2;VIL1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.40746008968712155,0.9935783170071277,0.3076923076923077,0.9189213993816019,1.0,21/61,17.70%,ADGRB1;TBXA2R;LPAR2;ADGRB3;CNR1;ADGRB2;ADGRL3;ADRA1A;PTH1R;ADCY8;PTHLH;ADGRE1;ADGRE2;LGR5;GPER1;LGR4;DRD2;ADCYAP1;PTH;GPR26;GNAQ
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.3972363746589997,0.9934452718246394,0.42857142857142855,0.9185913328494194,1.0,24/100,12.82%,ZNF423;NOS2;GFAP;FRZB;PTPRD;RXRG;ACKR1;L1CAM;PLPPR4;NDRG2;ALDH1A1;SORBS1;CCDC3;NTRK2;ADGRL3;ALDH1A3;MEGF10;SLCO1C1;ZNF536;RCAN2;INTS6;AQP1;NRXN1;GPM6B
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.5907881902066239,-0.993219537960782,0.49122807017543857,1.0,1.0,2/12,10.66%,SLC25A4;SLC35B2
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.44420841957793483,-0.9931131608392327,0.5454545454545454,1.0,1.0,6/42,16.53%,B2M;HES6;BHLHE41;SERPINF1;APPL2;OPRM1
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.3895059994730186,-0.9930212779158316,0.45454545454545453,1.0,1.0,29/137,21.75%,PSMB8;RPS27A;PSME1;DND1;PSMB6;APEX1;PSMD8;PSMC5;PSMD7;UBA52;PSMD3;PSMC3;EXOSC4;VIP;UBB;PSMA4;HSPA8;METTL3;CIRBP;PSMD2;PSMA7;MEX3D;PSMD6;PSMB2;PSMB3;PSMB4;PSMA3;PSMC1;YWHAB
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.48116852094571405,0.992990858160419,0.5,0.918853643472282,1.0,8/24,20.11%,CHRNA4;STX1A;SNCA;SYT3;SYT17;DRD2;SYT5;SYT7
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.5085074107558525,-0.9929134159992578,0.4935064935064935,1.0,1.0,4/16,23.09%,DEGS2;ASAH2;PTS;CALM1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.6383803205310461,0.992908672447739,0.5675675675675675,0.9168618066258648,1.0,3/5,23.23%,NSMCE2;SLF2;SMC5
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.6383803205310461,0.992908672447739,0.5675675675675675,0.9168618066258648,1.0,3/5,23.23%,NSMCE2;SLF2;SMC5
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.6383803205310461,0.992908672447739,0.5675675675675675,0.9168618066258648,1.0,3/5,23.23%,NSMCE2;SLF2;SMC5
prerank,PanglaoDB_Augmented_2021__Neurons,0.31836071011299094,0.9925946928223425,0.3076923076923077,0.917145347013546,1.0,45/264,12.05%,IGF1;LUZP2;CBARP;KCNQ2;CELF3;TMEM191C;CNTNAP2;MMD2;GNL3L;RIN1;STX1A;SCRT1;VGF;CACNB4;OLFM3;NCALD;ADGRB3;SPOCK3;AMER2;SAFB2;TESC;NPY;HAP1;CTNNA2;PSD2;NXPH1;NWD2;SNAP91;PNCK;CADPS;KCNMA1;GRM3;RNF220;CACNA2D1;MATK;UNC13A;NBEA;CTTNBP2;NECAB2;NCAN;FBXW7;UNC79;AQP1;ACSL4;NRXN1
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.5816770449909714,-0.9925209067053179,0.4827586206896552,1.0,1.0,1/8,18.61%,ECT2
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.5543811523374004,0.9922634856260866,0.5142857142857142,0.9172112371082061,1.0,1/10,4.04%,BDH2
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.5422058988451575,0.9920675539058289,0.4634146341463415,0.9169669633050197,1.0,5/9,15.04%,HSPA1A;HSPA1B;SACS;DNAJB6;DNAJA4
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.5243824497630523,-0.9917608986053742,0.5238095238095238,1.0,1.0,1/18,0.77%,RIMS1
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),-0.6402324888539137,-0.9917026514405342,0.46296296296296297,1.0,1.0,1/5,3.38%,ALKBH2
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.4760062476470299,-0.9916817303100876,0.45454545454545453,1.0,1.0,4/26,9.69%,XBP1;NEURL1;RRAGA;LAMTOR5
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.44411331469610454,0.9914680972410228,0.4857142857142857,0.9176938437924673,1.0,8/27,17.33%,SORBS1;MLXIPL;ASXL3;C3;ADIPOR2;GPER1;PDK4;ZBTB20
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),0.6377563157143535,0.9913479042722064,0.55,0.9172844635798104,1.0,5/5,36.24%,RPS6KA4;RPS6KA5;MST1;HMGA2;VRK1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.5808887331420666,-0.9907642457203901,0.5692307692307692,1.0,1.0,3/10,21.46%,DCK;DCTD;ERH
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.3773633089356735,0.990696035435179,0.4482758620689655,0.918309010122159,1.0,24/93,13.41%,ZNF423;LIFR;PCDH18;FRZB;LRP4;PDGFRA;POSTN;ADAMTS9;SLC47A1;DPYSL3;TMEM47;OBSL1;COL6A1;CDH11;GFRA1;COL14A1;HTRA1;CACNA2D1;CHRD;SLIT3;SEMA6D;PTH1R;FBXL7;SLIT2
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.5494646865123577,0.9904036095202453,0.5609756097560976,0.9184561772075758,1.0,1/8,0.60%,BACE2
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.4343624194804568,0.9902869627348874,0.3793103448275862,0.9181089293794858,1.0,2/27,4.45%,F2;CLEC7A
prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.364024278106066,0.9902136233343559,0.5,0.9176079012787193,1.0,9/116,2.05%,F2;ZAP70;PTPN6;STAB1;NOS2;KLRD1;IL4R;LCP2;ICAM1
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),0.6363022627994416,0.9899768710962894,0.5405405405405406,0.9176010718546932,1.0,2/5,23.14%,DLL1;PRKCA
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.49615620986525244,-0.9897247697556429,0.42028985507246375,1.0,1.0,7/21,28.14%,EEF1AKMT2;BHMT;METTL21A;ETFBKMT;CSKMT;FAM98A;PRMT2
prerank,GO_Biological_Process_2021__type B pancreatic cell development (GO:0003323),-0.6349472780233102,-0.9892459781578352,0.5645161290322581,1.0,1.0,1/5,0.35%,BMP5
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.4438632456065987,-0.9890199427117315,0.4025974025974026,1.0,1.0,15/51,18.47%,HSPE1;DDX18;MCM4;NOP16;GRWD1;CDK4;WDR74;NOC4L;MYBBP1A;RABEPK;MRTO4;IMP4;PLK4;MCM5;NIP7
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.5436535537148424,-0.9887801092965689,0.5757575757575758,1.0,1.0,3/15,13.28%,CD9;CEACAM1;CELA2A
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.6083127339296076,0.9884990211146435,0.5555555555555556,0.9208298843414802,1.0,2/9,2.21%,PDGFB;FLT1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5660992101618494,0.9884011052196553,0.5121951219512195,0.9202971289867717,1.0,1/7,4.01%,ACER2
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.5696574263992061,0.9882214219086851,0.5106382978723404,0.9200933859061106,1.0,1/7,2.89%,STARD13
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.4928355766867997,-0.9881954863159131,0.42857142857142855,1.0,1.0,7/21,15.05%,STMN1;STMN2;KIF18A;TPPP3;MAP7D3;STMN3;KATNB1
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),0.6395215782718804,0.9881003513741682,0.48717948717948717,0.9197157356733405,1.0,4/5,14.53%,CRACR2A;ORAI2;STIM1;STIM2
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.6273867726903488,-0.98793341102923,0.5178571428571429,1.0,1.0,2/5,13.59%,GPS2;PPIA
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.5180493382671302,0.9875808457521814,0.48936170212765956,0.9202910178034941,1.0,4/12,20.36%,AFF2;DYRK3;HIPK2;SRPK2
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.5889216206997551,-0.9873266064213286,0.5483870967741935,1.0,1.0,2/9,15.17%,CFTR;AHR
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.5889216206997551,-0.9873266064213286,0.5483870967741935,1.0,1.0,2/9,15.17%,CFTR;AHR
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.35021874127842445,0.9871391043026982,0.5,0.9206607685471666,1.0,23/152,9.64%,APOLD1;PDGFB;PALMD;STAB1;LIFR;FLI1;ICAM1;FLT1;TDRD10;NRP2;PDGFRA;POSTN;ACKR1;RASIP1;ID1;PLAC8;SLC7A5;SGK1;NOTCH4;LTC4S;RHOJ;RGS5;LOX
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.6223769518368674,-0.9870080675506697,0.5373134328358209,1.0,1.0,1/8,2.03%,SELENOS
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.4706239497933008,-0.986933024704033,0.5342465753424658,1.0,1.0,6/44,9.97%,ARHGEF16;RHBDF1;OVOL2;TEAD3;TMEM54;TOM1L1
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.432726159522287,-0.9868827839595085,0.42857142857142855,1.0,1.0,14/76,17.50%,GAPDH;POLR3H;POLR2L;POLR3K;IRF1;TRIM25;NLRX1;POLR3GL;GPATCH3;DDX41;CGAS;RNF26;PQBP1;RNF135
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.5903704576312747,0.9868486867510323,0.525,0.920784560902723,1.0,1/7,2.07%,ITGA11
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.4065813457696173,-0.9867148055836178,0.4810126582278481,1.0,1.0,6/86,9.33%,ARHGEF16;PDZK1;RHOG;CD81;CEMIP;HRAS
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.4961728668004166,-0.9866931055159143,0.532258064516129,1.0,1.0,3/30,12.71%,SEMA3E;HTR2B;SEMA3A
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.496623447233027,0.9864568389053581,0.4772727272727273,0.9210818508330502,1.0,2/9,11.44%,RFWD3;FEM1B
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.45376049241866145,0.9863843135990196,0.4,0.920684469846719,1.0,7/31,10.12%,FGFR1;FLT1;EGFR;PDGFRA;LPAR2;NTRK2;ADRA1A
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.6438179343183215,-0.986306494253866,0.5714285714285714,1.0,1.0,3/7,28.84%,CXCL17;LGALS3;SFTPD
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.376920962427835,-0.9861559615346217,0.5,1.0,1.0,21/168,17.29%,H4C3;GATA1;SLC22A4;MARCHF2;SLC10A3;RAD23A;CROCCP2;NFE2L1;HEBP1;BLVRB;EIF2AK1;LRP10;CTNS;ARL2BP;MGST3;UROD;GYPE;NARF;GLRX5;TMEM9B;EPOR
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.5146321641462202,0.9861505743170564,0.4375,0.9206753440300763,1.0,4/13,12.66%,DOCK7;CLMN;SYNE2;PCM1
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.5877086415706569,-0.9861176104795872,0.5692307692307692,1.0,1.0,3/9,25.12%,RAN;KPNB1;SREBF1
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.5111200901775941,0.9857810026223615,0.53125,0.9210026174547241,1.0,8/20,20.11%,CHRNA4;SNCA;SYT3;GDNF;SYT17;DRD2;SYT5;SYT7
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.4628094247198009,-0.9855365206794704,0.5151515151515151,1.0,1.0,6/30,14.46%,VAV3;PEX11A;LAMTOR5;NEB;PPP1CA;PEX11G
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),-0.6000796161170592,-0.9853983628657815,0.5428571428571428,1.0,1.0,1/7,2.49%,TIMP1
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.40373761600347224,0.9853906847194724,0.4166666666666667,0.9212479061861987,1.0,11/43,11.72%,ACER2;RXRG;EPHA3;ASCL1;TESC;TRIM16;BRINP3;WNT3;STRA8;RARG;AQP1
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.6445508609702786,0.985294019167229,0.5238095238095238,0.9207091177893981,1.0,3/5,22.30%,NAA16;NAA30;NAA25
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.5685611758532291,0.9850901700173306,0.4444444444444444,0.9205169370043298,1.0,2/12,6.11%,HNRNPU;MLLT3
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.5219153301740133,0.9848092238240685,0.46875,0.9205384607511078,1.0,4/8,25.29%,AUP1;CDS1;PLA2G4C;CDS2
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.5524199252023294,0.9848075297661206,0.5227272727272727,0.9198389634405065,1.0,2/5,14.64%,LPL;HMGB1
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),-0.6216983861651316,-0.9847496112332099,0.55,1.0,1.0,1/6,0.35%,BMP5
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.5084277666166884,-0.9842124792503548,0.5277777777777778,1.0,1.0,4/26,15.44%,IGSF10;KIF20B;SEMA3A;NTNG2
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5123322236062836,0.9840031152713239,0.45,0.9210989099873009,1.0,8/19,24.91%,HSPA1A;HSPA1B;DCUN1D1;ITCH;EGR1;EPAS1;ZMIZ1;DNAJB2
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.45882607234169415,0.98394927120423,0.5135135135135135,0.9205926966680082,1.0,2/22,1.51%,RAB39A;ATP6V0A4
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.48184457929826596,-0.9837158328948304,0.5517241379310345,1.0,1.0,1/27,0.35%,BMP5
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.3873657649673461,0.9835990728451686,0.4642857142857143,0.9205837026978617,1.0,15/119,9.08%,F2;PTPN6;UBA7;NLRP7;IFNA2;ANXA4;LEF1;MAPKBP1;CD200R1;AGER;SSC5D;IRAK3;ARRB1;OTUD7B;DLL1
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.4153347529991606,0.9833110337978163,0.4,0.9206455903089347,1.0,4/49,6.23%,SNX31;DENND1B;DENND1A;EHD2
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.5443201481156895,0.9831972467390543,0.5555555555555556,0.9202521493925205,1.0,4/14,12.74%,ATP12A;ATP1B3;SCNN1B;SLC12A2
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),-0.6361533417618599,-0.9830293930192658,0.5263157894736842,1.0,1.0,1/5,3.05%,TGFBR2
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.6212988541191489,-0.9829686755630391,0.5303030303030303,1.0,1.0,1/5,12.40%,PSMC3
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.4255372130748832,-0.982966316749284,0.48484848484848486,1.0,1.0,3/70,3.84%,CD44;CD63;MADCAM1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.5012581246547264,0.982690936522364,0.3939393939393939,0.9209510408398318,1.0,6/16,21.22%,MFHAS1;RAB23;OTUD7B;GSK3B;CABP1;LATS2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.4401772715906192,0.9825724417704841,0.4482758620689655,0.9205983679631746,1.0,1/22,0.18%,CREB3L1
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.40826819900814454,-0.9825403893340904,0.4647887323943662,1.0,1.0,12/89,18.15%,GBP2;RPL11;RPF2;CALR;NOP53;PHB2;ARL2BP;PAF1;PTTG1IP;APPL2;XPA;CSE1L
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.40984216615934926,0.9821633857028554,0.5,0.9208013652289524,1.0,11/41,12.04%,ZNF423;PLCL2;ID1;PLCL1;ALDH1A1;NPR3;CCDC3;DOCK7;TLE3;ARRDC3;ADAMTS5
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.5962819881266201,0.9820112564368696,0.5128205128205128,0.920560281337903,1.0,2/7,11.66%,OXTR;GPAT4
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.44605760983429965,-0.9820014658862964,0.49206349206349204,1.0,1.0,12/36,29.12%,CEP131;IFT122;DYNLRB1;IFT81;DYNLRB2;DYNLL1;DYNC2H1;DYNC2I1;IFT22;DYNC2I2;WDR35;KIF3A
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.5310215251488563,0.9818724215129372,0.4444444444444444,0.9201179974025837,1.0,3/11,12.34%,SPRY2;PROM2;NTNG1
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.4707935457820005,0.9818638533289221,0.5172413793103449,0.9194548271061032,1.0,4/19,8.57%,IGF1;PICALM;HAP1;NTRK2
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.46777858096340447,0.9815245716962583,0.5172413793103449,0.9196782000454067,1.0,7/18,24.19%,CAMSAP3;CYTH3;CLASP1;GOLPH3;PARD3;FBF1;RAP2A
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.5595280695121829,-0.9811810090869947,0.5,1.0,1.0,2/12,8.13%,RPS15;NOP9
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.5244261208487747,-0.9811228695603712,0.5,1.0,1.0,1/14,1.67%,SFRP1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.40080571598727294,-0.9809512222320267,0.5,1.0,1.0,21/110,15.05%,TOMM7;ZDHHC12;SRP14;SLC25A6;NACA;RPL11;YIF1B;DNAJC19;TIMM8B;TSPO;CDC37;TIMM10;SRP54;AQP11;TOMM20;SRPRA;GIPC1;NACAD;SPCS2;ZFAND2B;KATNB1
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.631438790579863,0.9809140318488236,0.4857142857142857,0.9205045628519583,1.0,1/6,1.01%,DACH1
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),-0.6289109660815916,-0.9808972876858589,0.5714285714285714,1.0,1.0,2/5,24.31%,CRB2;USH1C
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),-0.6289109660815916,-0.9808972876858589,0.5714285714285714,1.0,1.0,2/5,24.31%,CRB2;USH1C
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.4166895823202675,-0.9807669233377923,0.4875,1.0,1.0,15/83,20.01%,DDIT3;SELENOK;BCL2L2;HINT1;ZNF622;CEBPB;IFI6;C1QBP;BRCA1;MYBBP1A;CIDEB;DDX5;PDK2;BAX;MOAP1
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.5379709161887627,-0.9805676874562835,0.4375,1.0,1.0,3/11,16.31%,PARP14;PARP12;PARP9
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.46191746878330864,-0.9800582762953373,0.5,1.0,1.0,11/36,30.11%,GRWD1;CHAF1A;NAP1L2;ASF1B;CHAF1B;SMARCA5;SART3;H2BC11;PADI4;H2AX;ASF1A
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.5722251938605576,-0.9799314381990438,0.5492957746478874,1.0,1.0,1/10,15.26%,TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.40056754297222386,0.9799207943227649,0.5,0.9222540873398726,1.0,16/54,18.40%,PDGFB;NPAS2;EGFR;EYA4;SIRT1;PPP1R10;RNF168;HMGB1;ATRX;RAD51;DHX9;UIMC1;FGF2;CEBPG;RGCC;OTUD4
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.3600523224546935,0.9797018871524856,0.4642857142857143,0.922002958452513,1.0,10/91,9.39%,RELN;LCP2;HSPB1;MMD2;SPRED1;SNCA;SIRT1;GSKIP;CEP85;CD4
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.4437744215607991,0.9796020106976157,0.4482758620689655,0.9214411902608928,1.0,10/25,14.05%,VCAN;CHST7;CSPG4;CHST3;CHST11;CHSY3;NCAN;CSGALNACT1;UGDH;CHST15
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.4846629410811973,-0.9795249321964792,0.47761194029850745,1.0,1.0,2/26,5.32%,SEMA3E;CORO1B
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.5484869256430273,0.9793107526474748,0.4473684210526316,0.9207309081006222,1.0,3/9,13.50%,NFATC4;ADGRB2;NFAT5
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.5484869256430273,0.9793107526474748,0.4473684210526316,0.9207309081006222,1.0,3/9,13.50%,NFATC4;ADGRB2;NFAT5
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.5605068886962106,-0.9791709834928659,0.4696969696969697,1.0,1.0,5/9,32.52%,ATP6AP1;CAV1;ATP6V1G1;FAS;ATP6V0D1
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.6140889117953319,-0.9789206672480507,0.5333333333333333,1.0,1.0,2/8,17.91%,DCTN1;MAP1A
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.5336266344817283,0.9788831885300624,0.42105263157894735,0.921142348503289,1.0,3/10,12.08%,KLRD1;SLA2;CD55
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),0.6088000384049721,0.978845310092382,0.43137254901960786,0.9205428954294973,1.0,2/5,18.82%,BAG3;MAPT
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.44415207188171246,-0.9787838132604331,0.4520547945205479,1.0,1.0,10/48,24.05%,CCNB2;CHMP2A;REEP4;ANKLE2;CHMP7;CHMP3;EMD;RAN;CHMP4B;KPNB1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.44415207188171246,-0.9787838132604331,0.4520547945205479,1.0,1.0,10/48,24.05%,CCNB2;CHMP2A;REEP4;ANKLE2;CHMP7;CHMP3;EMD;RAN;CHMP4B;KPNB1
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.6188002441034464,0.9785792216027148,0.5365853658536586,0.920444102394866,1.0,1/5,2.69%,SLC39A8
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),-0.5897101375228422,-0.978403142345571,0.5737704918032787,1.0,1.0,3/8,23.04%,TST;TXN2;MPST
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.5874559102026127,-0.978368046337916,0.5238095238095238,1.0,1.0,1/9,1.10%,RPS21
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.5979312115314597,-0.9779367498270364,0.603448275862069,1.0,1.0,4/7,33.42%,TERF1;BLM;RECQL4;SLX4
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.4594206483096022,0.9778155111055735,0.5,0.9214241390232252,1.0,10/19,31.48%,TNRC6B;MOV10L1;CELF1;WTIP;HELZ;CNOT7;TNRC6A;AGO3;TNRC6C;AGO2
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),-0.5441018700020739,-0.9778085034563023,0.5423728813559322,1.0,1.0,1/12,1.77%,ZDHHC12
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.4208473685186678,0.9777685429736072,0.4117647058823529,0.9208557595735365,1.0,10/23,24.39%,EGFR;EIF4E2;FXR1;TNRC6B;DHX9;PUM2;PUM1;ZFP36;WTIP;TP53
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.5911740981595616,-0.9776822806196723,0.543859649122807,1.0,1.0,3/5,33.86%,AKR1A1;XYLB;DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.5911740981595616,-0.9776822806196723,0.543859649122807,1.0,1.0,3/5,33.86%,AKR1A1;XYLB;DCXR
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.5911740981595616,-0.9776822806196723,0.543859649122807,1.0,1.0,3/5,33.86%,AKR1A1;XYLB;DCXR
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.6090253246345549,-0.977674355320444,0.5517241379310345,1.0,1.0,1/11,0.57%,B2M
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.446202704863481,-0.9775722903187981,0.532258064516129,1.0,1.0,6/36,8.49%,GAPDH;SERPING1;TIMP1;CSTB;SERPINB8;UBXN1
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.5270148528178157,0.9775314728981241,0.45161290322580644,0.9207569542366364,1.0,6/11,29.62%,ADRA1A;DRD2;ADRB1;RAPGEF2;ADCY9;LMBRD2
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),-0.6184290129185712,-0.9775196434847463,0.5555555555555556,1.0,1.0,1/6,7.24%,CD81
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.41935272950299685,-0.9771486256441226,0.47761194029850745,1.0,1.0,7/50,13.03%,PRDX5;RPS3;GSTP1;ROMO1;HYAL2;TXNRD2;APOD
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.4330483489084872,-0.9767870891369403,0.47761194029850745,1.0,1.0,4/51,11.27%,SLC8A3;SFRP1;NOP53;PINK1
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),0.6497501804520562,0.9766428764400584,0.5757575757575758,0.9224221812897847,1.0,2/7,11.20%,TICAM1;PTPN22
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),-0.6828572788908203,-0.9766005134386995,0.5862068965517241,1.0,1.0,3/5,20.55%,LARP6;EIF3D;NCBP1
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.6006897908046361,0.9763970527232372,0.4634146341463415,0.9223721461060725,1.0,1/5,1.91%,IMMP2L
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.5003976711247213,-0.976267010684436,0.46774193548387094,1.0,1.0,2/18,11.37%,RAB11A;CDK4
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.6275641047110363,-0.9762018056257701,0.5,1.0,1.0,3/6,26.23%,SSB;HSD17B10;TRNT1
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.4959111910474568,-0.9761265903837445,0.5072463768115942,1.0,1.0,15/32,25.20%,CLU;HRK;PRELID1;TRIAP1;PINK1;PPIF;CIDEB;DNM1L;BAX;MOAP1;PDCD5;PSMD10;NOL3;PLAUR;BNIP3
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),0.6343657811598127,0.975846955514052,0.47368421052631576,0.9231978392521417,1.0,2/6,23.14%,DLL1;PRKCA
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.556086121839382,-0.9756731121143986,0.5161290322580645,1.0,1.0,2/11,13.20%,EXOSC4;EXOSC10
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.37842872697010804,-0.9752537148675249,0.5421686746987951,1.0,1.0,33/203,21.34%,EPN1;RIMS1;RPS27A;ACTG1;GRIN3B;CFTR;CPTP;CHMP2A;UBA52;VAMP8;CHRM2;BAIAP2L2;TIMM50;REEP4;NEMP1;AP2S1;CLTA;UBB;MYADM;MTCH1;CLTCL1;ARPC5;HSPA8;DNM1L;ACTB;CR1;CHRNB1;CHMP7;STEEP1;CHMP3;EMD;TRDN;SERP1
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.5098638290415912,-0.9752088002628808,0.5692307692307692,1.0,1.0,5/21,27.94%,TGFB1;AP2S1;CLTA;AP2A2;AP2A1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.5837810369367771,-0.9749507844632928,0.49230769230769234,1.0,1.0,2/7,24.75%,DDX5;MYOCD
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.4687421453034815,0.9744278647177447,0.4857142857142857,0.9257325354350175,1.0,8/23,16.89%,IRS1;GRB14;PIP4K2A;PID1;ENPP1;PTPRE;KANK1;PRKCZ
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.5714415174708343,-0.9743743286895614,0.5849056603773585,1.0,1.0,2/9,9.01%,HLA-F;CEACAM1
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.5172708856023089,-0.9740804153432114,0.48484848484848486,1.0,1.0,3/19,18.02%,CARTPT;CEBPB;LILRB3
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.5677828252904396,0.9740593660007226,0.5666666666666667,0.9258888027414272,1.0,2/12,14.86%,GFPT2;GFPT1
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.6037354863533152,-0.9738541523027578,0.543859649122807,1.0,1.0,2/7,24.22%,TFIP11;TERF2IP
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.5516909804296282,0.9738434486670865,0.4772727272727273,0.9256973426845685,1.0,2/6,20.62%,ADIPOR2;KDR
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),-0.5734353028359244,-0.9735326925430441,0.546875,1.0,1.0,2/9,19.35%,MESP1;MEOX1
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.5422155746986229,0.973295372538603,0.5319148936170213,0.9264685099763066,1.0,4/7,29.09%,PLOD1;PLOD3;JMJD6;P3H4
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.5594188918215028,-0.9730468208588441,0.5294117647058824,1.0,1.0,4/11,26.74%,CHMP2A;CHMP7;CHMP4B;UBE2S
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.6913849486008558,0.9729180180515666,0.55,0.9268717261007015,1.0,1/5,6.25%,SIRT1
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.37897582896321724,0.9727870178796599,0.48148148148148145,0.9264620234105433,1.0,17/101,10.36%,IGF1;LIFR;VIT;FRZB;TACC2;EGFR;PDGFRA;POSTN;ALDH1A1;TMEM47;SASH1;CDH11;COL14A1;HTRA1;DHCR7;ALDH1A3;MAFB
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.4221146947708331,-0.9725692450514692,0.5277777777777778,1.0,1.0,3/54,3.15%,TTN;AQP9;MT2A
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.3963982720363589,0.9725085266240643,0.5,0.9263894942243873,1.0,8/61,11.38%,DACT2;SPOCK1;ACER2;DUSP1;PLXNA1;PLXNB2;TBCD;CORO2B
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),0.6175502220883325,0.9723740360917048,0.5609756097560976,0.9260895635711075,1.0,2/6,17.25%,GRIN1;GRIN2B
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.43838097140730836,0.9720589010090579,0.4722222222222222,0.9262151046103176,1.0,2/32,1.51%,REP15;ATP6V0A4
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.4868498255033403,0.971867268966255,0.52,0.9260836563394711,1.0,4/30,7.12%,RAB27A;CLEC7A;DYSF;CYBA
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.40686816669228426,0.9716327415230686,0.36666666666666664,0.9258438347392116,1.0,7/27,17.33%,PLIN5;SORBS1;MLXIPL;GPLD1;SLC45A3;NR1H3;ZBTB20
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.43948882051097854,-0.9716039522170168,0.527027027027027,1.0,1.0,5/66,3.53%,ADH4;ACTG1;CLU;CD9;ANXA5
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),-0.6254894011284116,-0.9714858795090049,0.5373134328358209,1.0,1.0,1/6,2.03%,SELENOS
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),-0.5292298727813405,-0.9711260730894257,0.5625,1.0,1.0,2/12,18.07%,ELOVL2;ELOVL1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),0.41283853210446964,0.9710528659155238,0.42424242424242425,0.9265215785089524,1.0,10/63,8.12%,PTPN6;NOS2;AFAP1L2;CLEC7A;CD200R1;AGER;CYBA;TMEM106A;IRAK3;ARRB1
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.5788599404854405,0.9709345694854918,0.5172413793103449,0.9260551177350759,1.0,6/9,27.73%,ADCY10;ADCY8;ADCY6;ADCY2;ADCY5;ADCY9
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.5325758903239852,-0.9707881136545733,0.5223880597014925,1.0,1.0,4/17,10.86%,CORO1B;ARF1;BRK1;GMFG
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.3542799609410915,0.9704997379805506,0.48148148148148145,0.9265052040169822,1.0,13/120,8.88%,PFKFB3;IGF1;PLIN5;IRS1;TICAM1;ARNT;SNCA;AKT2;TRIM65;P2RX7;ADAM8;OPTN;MLXIPL
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.5379227422294688,-0.9704119399882303,0.5671641791044776,1.0,1.0,2/12,8.13%,RPS21;NOP9
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.5822066758556455,-0.9703872726170505,0.5671641791044776,1.0,1.0,5/13,21.61%,RPS19;SLAMF8;GRN;CR1;LGALS3
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.455615101403499,-0.9703344682521082,0.5294117647058824,1.0,1.0,3/58,9.69%,GPAT3;RRAGA;LAMTOR5
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.4844304883334809,-0.970302770604483,0.4576271186440678,1.0,1.0,7/21,19.68%,MT1E;MT2A;LCK;SLC39A7;SLC39A6;MT1M;MT1G
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",0.5390908767319521,0.9702987061212053,0.48717948717948717,0.9263051411972976,1.0,3/8,17.70%,GNGT1;PDE6B;GNAQ
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.650624759788048,-0.9700778536368766,0.609375,1.0,1.0,2/5,23.76%,NOP53;MAF1
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.4864917394142641,0.9699715273082855,0.4583333333333333,0.9263512092891244,1.0,5/11,14.66%,CDK10;EVI5L;CCP110;CEP97;TESK1
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.5024650825452279,-0.9691991009647271,0.5396825396825397,1.0,1.0,2/15,12.38%,DUOX1;STAT1
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.5036334998606599,-0.9690241694541076,0.5217391304347826,1.0,1.0,3/22,6.62%,TGFBR2;MESP1;CCDC39
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.36905682348908414,0.9688335577582458,0.47619047619047616,0.9285295013082788,1.0,28/111,14.54%,RAB27A;ZNF423;PCDH18;FRZB;CELF3;PTPRD;PDGFRA;PLPPR4;OLFM3;ADGRB3;CDH11;SNAP91;ASXL3;COL14A1;CADPS;MAPK10;CACNA2D1;ZNF536;CPEB4;SGCD;NRXN1;SEMA6D;KCTD16;ROBO2;RIMBP2;MAGI2;CADM2;FMN2
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5279826197261669,0.9685672037390307,0.5135135135135135,0.9284069441915782,1.0,3/11,10.63%,BACE2;SOAT1;NECAB2
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.6312871392134435,-0.9682259924016933,0.5806451612903226,1.0,1.0,3/6,22.66%,UXT;UBB;MAP1S
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.47881407550746985,0.9681968561424106,0.5,0.9285200502364152,1.0,4/19,11.42%,PPARGC1A;PAXIP1;ARRB1;SMAD4
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),0.5800853415568229,0.967873906237543,0.5625,0.9287016225227629,1.0,3/7,8.86%,NOS2;BPIFB1;OTUD7B
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.39309765543032815,-0.9676999994355638,0.4788732394366197,1.0,1.0,15/104,13.59%,NOX4;SELENOS;PRDX1;PRDX5;RPS3;GSTP1;ROMO1;CHCHD2;RBM11;TXNRD2;PINK1;BRF2;GPX7;PARP1;PPIA
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.422592929817162,0.9674018832936302,0.47619047619047616,0.9291474587249323,1.0,9/29,20.55%,CERS3;ACER1;ERCC2;TXNIP;CDSN;BCR;HDAC1;SCEL;WNT5A
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.566499339441942,-0.967008818226853,0.5081967213114754,1.0,1.0,3/8,17.50%,TRIM25;PHB2;RNF135
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.5595925787285345,-0.9665577639866679,0.609375,1.0,1.0,4/8,16.31%,DTX3L;DDX11;KDM4D;PARP9
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),-0.6564683629079209,-0.966417427981685,0.6166666666666667,1.0,1.0,3/5,28.84%,CXCL17;LGALS3;SFTPD
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.4667153857318478,0.966376249058694,0.5,0.9310318062913883,1.0,11/36,20.59%,IL1RAPL1;PTPRD;CX3CR1;NLGN1;NRXN1;NLGN3;CLSTN2;GPER1;IL1RAP;LIG4;EPHB3
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),-0.6236744526016844,-0.9662876464338839,0.6190476190476191,1.0,1.0,1/6,7.64%,STAT5A
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.448884814723889,0.9662180562327121,0.37037037037037035,0.9306045908068625,1.0,1/17,0.26%,SRPRB
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.47846536990049127,-0.9661648216612454,0.4647887323943662,1.0,1.0,6/34,10.98%,PIGH;PGAP4;PIGC;PGAP2;DPM3;ST3GAL5
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.35834508948174526,0.9658741503662901,0.45,0.9309600733010519,1.0,17/108,9.77%,RUNX1;IL1RAPL1;PBX3;ALK;ATOH8;SPOCK1;CTF1;PTPRD;NLGN4X;PBX1;GLI2;ASCL1;VAX2;NTRK2;SNPH;WNT3;TGFB2
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),-0.4334853406785831,-0.9655343866808304,0.5555555555555556,1.0,1.0,3/40,4.45%,SLC8A3;NPR2;NPPC
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.42455609718428267,0.9654135614532633,0.4,0.9312466547248779,1.0,2/37,1.21%,SPIRE2;PPP4R2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4367114990876134,0.965253582579689,0.4482758620689655,0.9309666429422385,1.0,1/29,0.88%,TP63
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.6030874423306275,-0.9652231276901139,0.559322033898305,1.0,1.0,4/7,33.82%,CAV1;BCAP31;HERPUD1;UBQLN2
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.5531151259292101,0.9652017629152434,0.5,0.9304334228159032,1.0,4/6,30.42%,PTPRN2;RAB11FIP2;PTPRN;RAB11FIP5
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.355052381859811,-0.9651328561399745,0.5795454545454546,1.0,1.0,87/562,18.75%,CD44;ARHGEF16;APIP;GATA1;RPS27A;IL7;XBP1;SFRP1;IFIT2;CLU;RPL10;NEURL1;PRDX5;ANXA5;RPS3;PTMA;RPS6;GSTP1;AVEN;VAV3;APEX1;BCL2L2;IL31RA;RPS3A;RASGRF2;HRK;PRELID1;IFIT3;TMEM219;UBA52;BCL2L14;SFRP4;CALR;NOP53;PAX8;COPS5;ZNF830;RACK1;APH1A;HTR2B;NAA38;PHB2;MYDGF;PRR7;ZNF622;HSPA5;HAX1;DDAH2;BEX2;FADD;TRIAP1;PINK1;LANCL1;OLFM1;CDK5;STAT1;IFI6;PDCD2;C1QBP;PPIF;CD27;PPIA;VIP;ARAF;UBB;MTCH1;CIDEB;LGALS1;CFL1;FIGNL1;RABGGTB;UTP11;PRAME;SEPTIN4;ANKLE2;GREM1;TEK;DNM1L;ITGB3BP;TNFSF9;TPT1;PTPA;TP53I3;ECT2;FSTL1;ANGPT1;HSP90B1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),0.6309559000358489,0.9650303055470016,0.6888888888888889,0.9300861809502624,1.0,1/5,1.58%,KLRD1
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.5086091757187842,0.9648151253433308,0.45454545454545453,0.9298660689759817,1.0,1/10,2.17%,SLC7A9
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.5454481001061934,0.9648083577858576,0.4634146341463415,0.9292374836064587,1.0,5/10,15.04%,HSPA1A;HSPA1B;SACS;DNAJB6;DNAJA4
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),-0.5135908330244872,-0.9645594008514304,0.5161290322580645,1.0,1.0,1/22,0.90%,SEMA3E
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.5098467633633136,-0.9644718180828609,0.5277777777777778,1.0,1.0,2/17,8.85%,FLII;VIL1
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.5098467633633136,-0.9644718180828609,0.5277777777777778,1.0,1.0,2/17,8.85%,FLII;VIL1
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.4390093390617855,-0.9638744876416937,0.5675675675675675,1.0,1.0,2/42,2.25%,RHOC;STMN1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.45202628524138727,0.9636952970705642,0.45454545454545453,0.9313623015524267,1.0,5/25,18.76%,KCNJ2;CACNA2D1;CACNA1G;KCNE4;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.36582672792659227,0.963588819228092,0.4666666666666667,0.9308890468587944,1.0,5/61,8.16%,F2;PLK1;GNL3L;TRAPPC12;SESN2
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.5839587534435446,-0.9631753477038681,0.6,1.0,1.0,2/7,23.99%,APH1A;ADAM17
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.45798191340908684,-0.9630960711487321,0.4927536231884058,1.0,1.0,7/31,18.75%,TPP1;GRN;GNPTAB;LAMTOR1;SNAPIN;TPCN2;NAGPA
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.39549458502424173,-0.9630016263239185,0.5428571428571428,1.0,1.0,20/78,25.10%,SIGIRR;SELENOS;VPS35;CXCL17;GPS2;C1QBP;NLRP12;NMI;TNFRSF1A;MAPK7;RNF26;TEK;APOE;SERPINE1;MMP26;ALOX5;AOAH;TNFAIP6;NR1D1;CERS2
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.570561927480745,-0.962919891771824,0.5737704918032787,1.0,1.0,4/11,28.67%,PPIB;TBC1D20;FBXL2;NUCKS1
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.36832555774405595,0.9626159026562283,0.44,0.93240743397537,1.0,15/75,10.27%,COL20A1;COL5A3;COL7A1;COL22A1;COLGALT1;ADAMTS2;COL9A1;SERPINF2;COL23A1;COL6A1;SCX;COL14A1;LOX;TGFB2;COL5A1
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.37625423830714455,-0.9622666122446006,0.5662650602409639,1.0,1.0,34/164,20.83%,GAPDH;RPL5;TYMS;RPL10;EIF1B;RPS3;RPL13A;RPS4X;MIF4GD;RBM3;CALR;RACK1;EIF5B;EIF1;LARP6;EIF3D;EEF2;EIF2B2;NCL;PATL2;RPS27L;EIF2B4;PYM1;ILF3;RBM4B;EIF4A3;METTL3;CIRBP;TSFM;METTL18;DDX1;NCBP1;IMPACT;EIF2A
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.5966696434423976,-0.9621660193453794,0.5967741935483871,1.0,1.0,3/10,8.85%,CORO1B;ARF1;VIL1
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.4761417332973558,0.9621424290531991,0.4411764705882353,0.9327007961383645,1.0,2/13,4.14%,KCNN4;RELA
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.6189269236080261,-0.9620812792870344,0.5833333333333334,1.0,1.0,1/6,8.15%,MTHFD1
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.47178897714701007,-0.9620470104815708,0.5606060606060606,1.0,1.0,2/31,3.37%,RIMS1;STX19
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),-0.6170030229760894,-0.9619679108427952,0.6031746031746031,1.0,1.0,1/7,8.28%,RACK1
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.5496279339492126,-0.9618695155702659,0.5,1.0,1.0,5/10,35.53%,CD81;BCAP31;SAR1A;SAR1B;TMEM30A
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.4825871664342789,0.9618237265233306,0.5641025641025641,0.9327803792785301,1.0,4/18,11.83%,QRICH2;RHOJ;SCIN;RHOQ
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.5158329284758191,0.9617189290182061,0.5,0.9323946865739958,1.0,1/17,0.30%,RAB27A
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.42994073528169785,-0.9616819180007914,0.547945205479452,1.0,1.0,7/58,5.67%,POLR2G;GTF2F1;POLR2J;POLR2L;RAD23A;PPIE;POLR2I
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.5263098228605597,0.9616674254429489,0.55,0.9318546117275933,1.0,3/10,17.55%,KLF15;MAGI2;PTPRO
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.5437179796821697,-0.9615627200425138,0.532258064516129,1.0,1.0,2/11,7.64%,IL7;STAT5A
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.5437179796821697,-0.9615627200425138,0.532258064516129,1.0,1.0,2/11,7.64%,IL7;STAT5A
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),-0.6196082209102187,-0.9615084943693318,0.6129032258064516,1.0,1.0,2/5,28.18%,TMLHE;ALDH9A1
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),-0.6196082209102187,-0.9615084943693318,0.6129032258064516,1.0,1.0,2/5,28.18%,TMLHE;ALDH9A1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.38250080138301884,0.9613464536958831,0.5142857142857142,0.9320410796031368,1.0,11/70,9.77%,PDGFB;RUNX1;FLT1;YJEFN3;TAL1;PRKX;ZBTB16;NOTCH4;MEIS1;DLL1;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.5418253354432532,0.961207833478745,0.55,0.9317244477358371,1.0,2/8,7.27%,SIRT1;CDKN2A
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.4009204014000621,0.9611891203092069,0.45454545454545453,0.931079738094649,1.0,5/39,6.52%,ARAP1;ARHGAP44;NLGN1;AGRN;DPYSL3
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),-0.631119749713783,-0.961033842379344,0.559322033898305,1.0,1.0,1/5,1.57%,XBP1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.35414089782579083,-0.9609904978516132,0.5280898876404494,1.0,1.0,54/316,21.75%,PSMB8;DDIT3;DTX3L;XBP1;PSME1;PSMB6;PSMD8;PSMC5;RAD23A;PSMD7;ADRM1;KCTD2;RNF8;TRIM13;UBXN1;TRIM25;VPS28;TOM1L1;ARIH2;RBX1;PINK1;PSMD3;RMND5B;PSMC3;RNF5;PPP1R11;WDR91;KCTD5;ZFAND2B;ANAPC15;PSMA4;KAT5;UBL7;NHLRC1;RNF167;CDC34;PRAME;UBE2D4;RNF111;HECTD3;RNF213;PSMD2;PSMA7;SPSB3;ZFAND2A;PSMD6;PSMB2;ERCC8;PSMB3;PSMB4;PSMA3;CDC23;CBLC;PSMC1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.5801775750337631,-0.9609464330171873,0.6037735849056604,1.0,1.0,2/11,11.08%,GSTP1;GPS2
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.5484534658681283,-0.9607177137130651,0.5737704918032787,1.0,1.0,3/13,14.07%,ENTPD2;ENTPD3;NUDT15
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.3813903758960905,0.9601159902713562,0.44,0.9330623463865977,1.0,12/64,14.18%,VDR;LCP2;C1ORF162;CLEC7A;SLC40A1;CSF3R;ITGAX;CD4;CLEC5A;ADGRE1;HCK;NFAM1
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.5796084992099501,-0.9599839338148632,0.578125,1.0,1.0,4/7,23.84%,SFRP1;UFL1;MEOX1;SP7
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.42329546751916275,-0.9597086342099158,0.5,1.0,1.0,17/75,21.76%,CLU;RPS3;SYNPO2L;VIL1;STMN2;ANKRD53;BAIAP2L2;KATNB1;EDN1;DCTN1;LMOD1;CFL2;APOE;CDC42EP1;WDR1;CCR7;PFN2
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.49522253986255527,-0.9595677338994589,0.5573770491803278,1.0,1.0,2/16,8.15%,NIT2;MTHFD1
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.5379046599343581,0.9594427819521627,0.5365853658536586,0.9340482591096115,1.0,2/7,11.49%,CKM;CKMT1A
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.4779194997994442,0.9594339871401111,0.5531914893617021,0.9327206677789908,1.0,4/14,20.53%,SRC;PTEN;CORO1C;PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.4779194997994442,0.9594339871401111,0.5531914893617021,0.9327206677789908,1.0,4/14,20.53%,SRC;PTEN;CORO1C;PHLDB2
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.5362552676344209,-0.9591435244795438,0.5303030303030303,1.0,1.0,6/13,31.23%,FUCA2;TRIM25;CAV1;EXOC7;TRIM14;TRIM22
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.6101817138554753,-0.9587334828435408,0.6349206349206349,1.0,1.0,1/8,4.21%,UQCC3
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.6101817138554753,-0.9587334828435408,0.6349206349206349,1.0,1.0,1/8,4.21%,UQCC3
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.5432623049712613,-0.9587058894451821,0.5555555555555556,1.0,1.0,2/11,8.00%,MESP1;GPC3
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.5721986950425233,-0.9579778837543526,0.5084745762711864,1.0,1.0,3/10,14.07%,DNPH1;NT5C;NUDT15
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.4035069450762459,0.9577565950859693,0.46875,0.9362946291523255,1.0,9/33,14.98%,IP6K2;PIP4K2A;EFR3B;SOCS7;SLA2;PIK3CA;PI4KA;SMG1;SOCS4
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.4348760670189137,0.9575583170103115,0.3793103448275862,0.9360823624816333,1.0,2/24,1.86%,CGNL1;ARAP1
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.502113052762361,0.9574549025251718,0.4594594594594595,0.9343817547706086,1.0,2/11,12.20%,ESPL1;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.502113052762361,0.9574549025251718,0.4594594594594595,0.9343817547706086,1.0,2/11,12.20%,ESPL1;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.502113052762361,0.9574549025251718,0.4594594594594595,0.9343817547706086,1.0,2/11,12.20%,ESPL1;NSMCE2
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.5315164371600165,-0.9574284257445662,0.5737704918032787,1.0,1.0,6/17,27.29%,G6PC3;TALDO1;GCK;RBKS;G6PD;HK1
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.39365741501305135,-0.9574139455463763,0.5974025974025974,1.0,1.0,10/107,7.30%,CENPF;SLC6A12;AQP9;SLC3A1;TCN2;SLC25A45;SLC22A4;CHMP2A;SLC7A14;SLC7A7
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.4509874132635537,0.9573373496487266,0.625,0.9339412281065811,1.0,7/13,24.21%,DUSP1;PPP2R2C;PPP2R2A;PPP3CA;PPP1R15B;PPP2CB;NCK1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.4093333111907108,-0.9572939050690148,0.5223880597014925,1.0,1.0,9/78,13.59%,SLC8A3;PTK6;GSTP1;HYAL2;CDKN1C;SH3BP5;CEACAM1;DUSP26;PPIA
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),0.552345365189852,0.9566791998213814,0.5333333333333333,0.9348051062871863,1.0,2/9,5.24%,CX3CR1;CD200R1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.4249366606305016,0.9565787862605871,0.5652173913043478,0.9343840671102273,1.0,10/23,17.87%,VASH1;ADGRB1;ADAMTS9;DUSP10;SLIT2;PTEN;DNAJA4;PTPRR;CORO1C;PTPN23
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.5158871658896932,0.9560173749920515,0.5294117647058824,0.9350070696615561,1.0,2/11,9.39%,SRC;CD4
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.6272776586750595,0.9558266613302561,0.5789473684210527,0.9347586762962037,1.0,2/5,12.63%,SNCA;SLC22A2
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.34817957333604244,0.9557971734062061,0.5806451612903226,0.9341473911400155,1.0,28/87,22.03%,HOMER1;CPNE7;KCNIP2;CPNE1;KCNMB4;NLGN1;SYT3;KCNMA1;STIM1;ACER1;ADCY8;GPLD1;RASGRP2;CPNE2;SYT17;SEC31A;CPNE5;PKD2;CAMK2D;SYT5;KCNMB2;CPNE9;PPP3CA;SYT7;WNT5A;RYR3;CPNE8;RYR2
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.5418023981576545,-0.9554918072556754,0.6153846153846154,1.0,1.0,4/12,22.49%,SFRP1;ATRAID;GREM1;RHOA
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.43837162295847837,0.9554174113270245,0.5,0.9344922101315982,1.0,6/39,8.81%,RIDA;HSPA1A;EXOSC7;DNA2;ZC3H12D;HSPA1B
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.39579655994377455,0.9552306557957607,0.53125,0.9342065348764809,1.0,10/74,7.76%,PTPN6;IGF1;HSPB1;CLEC7A;CX3CR1;AGER;CYBA;TMEM106A;IRAK3;OAS3
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.6358863301994827,0.9552111078977641,0.5135135135135135,0.9335874141211239,1.0,4/6,25.50%,ATP10A;ASAP1;DNM2;WASL
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.4181712099508591,0.9550365156176113,0.4117647058823529,0.9332646643019723,1.0,5/31,10.72%,LEF1;GNAO1;FZD6;NLK;PDE6B
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.40634859143776264,-0.9549740178225319,0.5,1.0,1.0,17/58,24.77%,SELENOS;VPS35;CXCL17;GPS2;C1QBP;NLRP12;NMI;TNFRSF1A;MAPK7;RNF26;TEK;APOE;MMP26;ALOX5;AOAH;TNFAIP6;NR1D1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.5031393888817857,-0.9549617139863142,0.5652173913043478,1.0,1.0,6/17,33.50%,POLR2L;RASL11A;MAF1;POLR2K;EIF2AK3;HEATR1
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.5822104701691149,-0.9548047877976616,0.546875,1.0,1.0,1/8,2.03%,SELENOS
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.429536382693417,-0.9547560536669343,0.5394736842105263,1.0,1.0,9/57,11.72%,BMP5;SFRP1;TGFBR2;EFNA1;IL17RD;OVOL2;BAMBI;TGFB1;OLFM1
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.5442565265466768,-0.9546552607750399,0.5409836065573771,1.0,1.0,2/11,16.31%,NUDT12;PARP9
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.460638905287786,0.9544559460423215,0.4146341463414634,0.933923456639649,1.0,10/23,26.02%,MTMR2;CTNND2;IGF1R;PTEN;PICK1;EPHB3;SHANK1;PAK3;WASL;ITGA3
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.5499738720304931,-0.95432743620824,0.609375,1.0,1.0,2/10,26.01%,ACOT8;BCKDK
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.49053189235896,-0.9542717784144867,0.5466666666666666,1.0,1.0,4/29,15.02%,MAGEF1;TFIP11;CYREN;CGAS
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.568504002179001,-0.9541932811514071,0.5396825396825397,1.0,1.0,2/8,11.93%,AZIN1;ARG2
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.6198916509622067,-0.9540879495379587,0.609375,1.0,1.0,4/7,36.67%,MCRS1;GLUL;NVL;NMD3
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.598752896994693,0.9539347513545432,0.575,0.9345051642513507,1.0,5/6,39.62%,ATP11A;MAPK14;RBM24;MAML1;SMYD1
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.43685853514582595,-0.9536814536053303,0.5,1.0,1.0,3/43,5.32%,ARHGEF16;RHOG;CORO1B
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.3643055923814114,0.9533145731515075,0.375,0.9352287164571017,1.0,18/97,11.42%,VDR;ONECUT1;STAB1;CTSK;NRP2;GRM8;CX3CR1;DYSF;AGER;FCGRT;IRAK3;MRC1;KCNMA1;PID1;MAFB;CA2;CLEC5A;SMAD4
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",-0.6473290027358024,-0.9531522445877207,0.5614035087719298,1.0,1.0,1/5,6.25%,PFKL
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),-0.5710851734991185,-0.953149188923109,0.5806451612903226,1.0,1.0,2/5,29.19%,GREM1;SMAD7
prerank,GO_Biological_Process_2021__alditol phosphate metabolic process (GO:0052646),0.5989290340106174,0.9531118853419108,0.6486486486486487,0.9350102696831186,1.0,1/5,4.31%,ACP6
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.5091352608692399,-0.9528363819070124,0.5362318840579711,1.0,1.0,7/20,24.22%,CHMP2A;CEP131;GEN1;XRCC3;CHMP3;CHMP4B;VPS4B
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),-0.6034094549919815,-0.9528110329232836,0.5636363636363636,1.0,1.0,1/5,24.75%,MYOCD
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.33217692452880027,0.9523292180174732,0.5,0.9363877956710488,1.0,35/196,13.01%,KCNN4;KCNJ14;ATP6V0A4;KCNH4;KCNJ2;KCNQ2;SLC39A8;ABCC8;SCN9A;KCNH3;ATP12A;SLC24A3;SLC40A1;SLC39A11;PKD1;SCNN1D;KCNN2;PKD2L1;P2RX7;TRPC5;SLC9C2;ATP1B3;KCNH7;KCND2;SCN7A;KCNC2;SLC9A2;KCNN1;SLC4A4;CACNA1G;LRRC38;SCNN1B;SLC12A2;ATP2C1;SLC8A2
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.44094194476715426,-0.9522472857355413,0.52,1.0,1.0,2/35,1.77%,SELENOK;ZDHHC12
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),-0.46412062511649843,-0.9521608416033653,0.53125,1.0,1.0,8/22,18.67%,MTHFD1;PRPS1;GMPR2;PRPSAP1;APRT;DCK;PRPS2;PAICS
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.43961377561586845,0.9520916812092634,0.5238095238095238,0.9363017133948446,1.0,2/18,6.35%,PDGFB;AKT2
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.43244363930092766,0.9520435553690978,0.41379310344827586,0.9357225589083453,1.0,4/25,6.52%,ARAP1;NLGN1;AGRN;DPYSL3
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.40432398575632816,-0.9520202878164425,0.5606060606060606,1.0,1.0,7/70,9.33%,ACTG1;EFNA1;VAV3;EPHA10;EFNA2;APH1A;HRAS
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.5328110830285706,-0.9517712138831979,0.6031746031746031,1.0,1.0,2/10,19.16%,DGAT2L6;ABHD12B
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.5708167083357049,0.9516137529151166,0.5675675675675675,0.9360256595581035,1.0,1/6,0.60%,BACE2
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.37536276245442735,0.9516049682513325,0.5,0.9353622820531013,1.0,22/78,17.26%,TNC;PCDH18;NRP2;NXN;GLI2;DPYSL3;TMEM47;FBLIM1;NOTCH3;RND3;CHST3;CDH11;CD276;FBXL7;CSRP2;SLIT2;GFPT2;ADAMTS15;ROR1;PTPN14;COL4A2;ADAMTS7
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.5420130030141612,-0.9514963214570221,0.5970149253731343,1.0,1.0,2/11,8.37%,MT2A;ARF1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.40371553910072155,-0.9513889502607941,0.5180722891566265,1.0,1.0,9/67,10.89%,CLU;MAGEF1;ELOB;RAD23A;NOP53;RACK1;DDA1;ARIH2;RBX1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.6153730625191742,-0.9512128659045412,0.639344262295082,1.0,1.0,3/7,24.93%,TMSB4X;PSMD10;CCDC22
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.5515440803225405,0.951176713352381,0.5384615384615384,0.9356841372483299,1.0,3/8,20.53%,CLASP1;PTEN;PHLDB2
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.491762652206014,-0.9511469256991402,0.53125,1.0,1.0,1/17,0.55%,GATA1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.36582101986368243,0.9510207867308977,0.5454545454545454,0.9354097044012268,1.0,11/36,20.59%,SRC;ADAM8;MEGF10;CELSR2;ADA;AFDN;ZDHHC2;PTPRR;FUT9;EFNA5;EPHB3
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.4151416784553589,0.9509331596097955,0.5517241379310345,0.9349371893531947,1.0,12/36,18.82%,NPAS2;NEK4;RFWD3;SMYD2;FEM1B;SMG1;BCLAF1;FXR1;POLH;ABL1;ANKLE1;MAPT
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.5387900256761814,-0.95091591657922,0.421875,1.0,1.0,3/15,3.27%,DUOX1;PRDX1;PRDX5
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.5990986685666866,-0.9508239344479981,0.5454545454545454,1.0,1.0,1/7,4.95%,PNKP
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.4030345562706836,-0.9508174930861221,0.5753424657534246,1.0,1.0,20/99,14.08%,SLC28A2;CPS1;TMC4;PDZK1;GBA3;DEGS2;CBR1;TREH;VIL1;CEACAM1;AQP11;FABP6;ART3;RBP2;CDH17;TMEM45B;CYP3A4;SLC51A;ASPN;SLC2A2
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,0.3455462669873603,0.9507779891005622,0.5416666666666666,0.9346825608567897,1.0,9/75,9.39%,TNFSF13B;LCP2;PSTPIP1;PIK3R5;GRM8;ITGAX;HCLS1;CD83;CD4
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.4231828287823375,-0.9507527704589946,0.5571428571428572,1.0,1.0,3/57,1.67%,GATA1;XBP1;SFRP1
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),-0.633885286861822,-0.9505869428862542,0.6271186440677966,1.0,1.0,2/5,10.47%,BRK1;NEB
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.6012587228189283,-0.9505444694574907,0.5740740740740741,1.0,1.0,1/6,3.97%,PDZK1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.5302693908726472,0.9504347602872294,0.5142857142857142,0.9347963592238282,1.0,6/8,32.05%,PRKCE;CAMK2D;STK39;HECW2;COMMD1;NEDD4L
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.4381913265299333,-0.950216055265597,0.4722222222222222,1.0,1.0,9/43,15.88%,RPS27A;PCNA;UBA52;TRIM25;RPA3;RFC2;SPRTN;UBB;RFC4
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.42427160087076343,0.9498204566588847,0.4666666666666667,0.9353909759682839,1.0,3/29,3.15%,F2;CD59;C6
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.47866932099475645,-0.9496757389516494,0.559322033898305,1.0,1.0,3/21,9.33%,PDZK1;CEMIP;HRAS
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.5586210620282257,0.9496752115382483,0.5652173913043478,0.9350611716808213,1.0,3/6,21.10%,PTPRD;TRIO;PTPRU
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.6356255507298513,-0.9496715178627329,0.5945945945945946,1.0,1.0,3/5,27.30%,KCNQ1;KCNE1;KCND3
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),-0.6148182620698934,-0.9492137834536577,0.5384615384615384,1.0,1.0,2/7,19.53%,ARF1;CHRNB1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.600364330626691,-0.9491411892700962,0.6119402985074627,1.0,1.0,2/5,15.93%,MYADM;MAPK7
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.600364330626691,-0.9491411892700962,0.6119402985074627,1.0,1.0,2/5,15.93%,MYADM;MAPK7
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.5213263053940369,-0.9490658180033321,0.5,1.0,1.0,3/17,21.19%,MAGEF1;CGAS;POLQ
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.3683418971283733,0.9488960698427138,0.5862068965517241,0.9362857475040469,1.0,22/90,13.73%,PRNT;GCNA;MORN5;EGFR;PIWIL2;DNAH6;DMC1;CREB5;DNAAF1;DNAH3;EFCAB10;SPATA20;DMRT1;TSSK6;STRA8;TEX15;CCDC30;MYO1D;OSBP2;TMCO5A;GALNTL5;SLFNL1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.481005054221202,-0.9484954060788313,0.5714285714285714,1.0,1.0,5/21,27.14%,ELOVL2;ACSBG2;ELOVL1;FAR2;HSD17B12
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.4312502750879378,0.948459809708048,0.4838709677419355,0.9365863170305001,1.0,6/27,19.85%,AEBP2;DNMT3A;EED;PHF1;PPM1D;PHF19
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.556365185124025,0.9481765553227762,0.5531914893617021,0.9365761178780289,1.0,1/5,5.87%,AFG1L
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.3726997229795484,-0.9481434679445556,0.5679012345679012,1.0,1.0,22/153,11.93%,CYP1A2;SLC6A12;AQP9;JUP;MT2A;GSTM4;HES6;RETSAT;ADH5;BLVRB;PGRMC1;FBLN1;SERTAD1;CBR1;MTHFD1;DHRS7;BPHL;SPINT2;DDAH2;PINK1;PMM1;ARG2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),0.5147769126849744,0.9481352862925215,0.42857142857142855,0.9359926672821888,1.0,5/16,11.20%,PTPN6;CD200R1;IRAK3;ARRB1;PTPN22
prerank,PanglaoDB_Augmented_2021__Pericytes,0.3637059309075604,0.9478859817700397,0.5172413793103449,0.9359828996462695,1.0,27/104,13.70%,COLEC11;ADAM33;ICAM1;PCDH18;FRZB;PDGFRA;CSPG4;POSTN;ADGRA2;PDZD2;ADAMTS2;NT5E;NOTCH3;COL6A1;EMID1;CDH11;COL14A1;RGS5;HTRA1;ECM1;SGCD;AQP1;SLIT3;ADAMTS5;PTH1R;PLSCR4;LDB2
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.5443472231047719,-0.947825337343323,0.582089552238806,1.0,1.0,4/9,20.96%,SEC11C;SPCS2;FURIN;SPCS1
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.4988942574509355,0.9478077266061837,0.5555555555555556,0.9355133002971386,1.0,3/13,19.93%,NDC1;AHCTF1;NUP98
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.6089348628175804,-0.9477590088989202,0.6290322580645161,1.0,1.0,2/6,8.55%,HCCS;SURF1
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.5711879637566003,0.9475644563600493,0.5,0.9354476146782802,1.0,3/7,32.04%,SMC5;SMC6;RAD18
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.4586537948214048,-0.9473341439890425,0.5833333333333334,1.0,1.0,3/24,14.15%,DTX3L;PAF1;ATXN7L3
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.5222730249874958,-0.9472861554567624,0.5970149253731343,1.0,1.0,3/18,10.91%,SFRP1;HYAL2;FADD
prerank,GO_Biological_Process_2021__aspartate metabolic process (GO:0006531),0.5873971179677417,0.9472699379535523,0.5714285714285714,0.9354663641317607,1.0,1/5,28.73%,ASS1
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),-0.6110996906901971,-0.9471482946914745,0.5846153846153846,1.0,1.0,1/6,8.28%,RACK1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.4336689006714574,0.9471387232555154,0.46153846153846156,0.9352041411685401,1.0,4/32,5.42%,TNNC2;TCAP;MYH3;MYH14
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.3263998744530016,0.9470323053375274,0.5882352941176471,0.934839344018597,1.0,22/119,14.90%,VDR;HDAC10;HNF4G;RXRG;PPARGC1A;TBL1XR1;CCNH;MAML2;NOTCH3;NOTCH4;TAF3;TAF4;TEAD1;RARG;THRB;HDAC9;TEAD2;ESRRG;TAF12;ESRRB;KAT2B;ERCC2
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.4612405654903097,0.9468931315752146,0.5172413793103449,0.9344937609602902,1.0,4/18,11.62%,CPEB3;CPSF6;ZC3H14;CPSF7
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.44157884659553254,-0.9464194377932801,0.4805194805194805,1.0,1.0,11/44,18.88%,SFRP1;GPC3;RACK1;FUZ;IFT122;TXNDC15;GLIS2;IFT81;INTU;TEDC1;GLI3
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.4202411586746819,0.9461174361799413,0.6428571428571429,0.9356719328613957,1.0,11/42,14.73%,IL1RAPL2;IL1RAPL1;PTPRD;SNCA;NLGN1;PDLIM5;NRXN1;NLGN3;ROBO2;CLSTN2;GPC6
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.5657287908788267,-0.946032660083934,0.5892857142857143,1.0,1.0,3/10,20.49%,MADCAM1;PIK3CB;ZP3
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.6170269012336645,-0.9458527861390021,0.625,1.0,1.0,3/7,24.13%,CXCL17;SERPINE1;CREB3
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.3510150327187612,0.945831046542442,0.5,0.9357558309059446,1.0,43/147,21.11%,RELN;IL1RAPL1;SPOCK1;EPHA3;ARHGAP44;ZNF804A;DPYSL3;CTNNA2;PDLIM5;NTRK2;KIF13B;ARHGAP35;RAPGEF1;PLXNB2;LRRC4C;NTNG1;CDH2;PRKD1;MAGI2;ABI2;MARK1;KANK1;PTEN;ROR1;RUFY3;GSK3B;NCS1;LTK;CAMSAP2;RAP1A;PTPRO;FKBP4;RAB29;FUT9;ADCY6;SRCIN1;CBFA2T2;ABL2;WNT5A;EPHB3;MINAR1;MARK2;CAMK2G
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),-0.6364161016746177,-0.9457646458136586,0.5555555555555556,1.0,1.0,1/5,8.28%,RACK1
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.44797466655982343,0.9456929635816975,0.43243243243243246,0.9354196640023948,1.0,4/25,11.83%,QRICH2;RHOJ;SCIN;RHOQ
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.40442044519449677,-0.9451787594792391,0.6,1.0,1.0,13/73,22.83%,VPS35;C4BPB;GPC3;C4BPA;VPS28;PTTG1IP;VIP;SNF8;APOE;DACT1;FURIN;OAZ3;MSN
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.3776030383897594,0.94492410422946,0.45,0.9366600028822328,1.0,6/46,17.18%,NOS2;OGT;NDC1;NUP42;RUBCNL;PNPT1
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),-0.638941169466759,-0.9449173791856156,0.5517241379310345,1.0,1.0,2/5,22.83%,AR;MSN
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),-0.638941169466759,-0.9449173791856156,0.5517241379310345,1.0,1.0,2/5,22.83%,AR;MSN
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.4441649295476886,0.9448985439313944,0.42857142857142855,0.9361093336923332,1.0,2/21,1.86%,CGNL1;ARAP1
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.5163859797198447,-0.9447185879144278,0.5915492957746479,1.0,1.0,4/11,17.04%,SSB;RPP25;POP7;RPP38
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.41882013304425725,0.9447101702881319,0.5925925925925926,0.9358294992109918,1.0,4/23,10.73%,JAM2;TMEM98;ITGAX;DICER1
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.44131771586487867,0.9442345505705037,0.5,0.9362573239842474,1.0,4/23,4.32%,F2;NOS2;ADGRB1;DMBT1
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.5447512192740734,0.9440773136070529,0.5135135135135135,0.9359498768826544,1.0,1/7,4.87%,MTMR2
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),0.6362036294146567,0.9438802582804886,0.5813953488372093,0.9356614438539762,1.0,2/5,8.57%,SRC;NTRK2
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.5333379382100202,-0.9438613217213372,0.5964912280701754,1.0,1.0,3/13,16.53%,PTK6;NLRP12;OPRM1
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.43464175401106075,-0.9438114446144918,0.5797101449275363,1.0,1.0,11/42,20.83%,RPL10;VPS35;RBM3;TGFB1;WDR91;EDN1;EIF2B4;RBM4B;APOE;METTL18;EIF2A
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.3995409687357376,0.9430730963018703,0.5517241379310345,0.9368592959385207,1.0,7/44,8.56%,SPIRE2;NPAS2;HDAC10;EGFR;EYA4;SIRT1;SPIRE1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.5747523248071567,-0.9427306364732315,0.5555555555555556,1.0,1.0,1/6,7.59%,RNF8
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.4986144834506729,-0.9419956221693488,0.6031746031746031,1.0,1.0,1/14,1.67%,SFRP1
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.5570567127407693,-0.9414435919215366,0.6176470588235294,1.0,1.0,3/9,23.58%,PPP1R3D;PPP1R3E;INPP5K
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.544213035973803,0.941398234307582,0.575,0.9399115498013075,1.0,1/9,6.23%,EHD2
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.39180818381294286,0.9413673681602923,0.5,0.9393427513919503,1.0,8/32,10.20%,HSPA1A;MAPK11;TAL1;ARNT;TESC;MTURN;HSPA1B;SCIN
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.48212151127620295,0.9413268513762854,0.5454545454545454,0.9387469395171607,1.0,5/19,16.29%,MSL2;OGT;JADE2;KANSL2;JADE3
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),-0.6058042141306421,-0.9412572251651915,0.6166666666666667,1.0,1.0,1/6,9.81%,IRGM
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),-0.4867299255545179,-0.9411038761755185,0.49295774647887325,1.0,1.0,2/15,9.47%,CHRM5;CHRM2
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.363317876844746,0.9404792011726565,0.5454545454545454,0.9401986418394572,1.0,7/68,6.25%,PDGFB;VASH1;ATOH8;NRP2;VEGFD;ARNT;SIRT1
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.38471041119719207,-0.9402694376214679,0.5384615384615384,1.0,1.0,7/116,7.76%,TYRP1;TRPM1;PMP22;RHBDF1;HSPB8;FILIP1L;TNS2
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.37060710850232653,-0.9401923108685255,0.5285714285714286,1.0,1.0,5/109,4.50%,CD44;SERPING1;TGFBR2;RNASE1;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.4588590705675832,-0.9400482895392304,0.6376811594202898,1.0,1.0,6/27,17.91%,RPL11;NOP53;UBXN1;GIPC1;CAMLG;MAP1A
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.5220766844126642,-0.9399725841522009,0.6206896551724138,1.0,1.0,3/13,14.07%,DNPH1;NT5C;NUDT15
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.37437378410360744,0.9399404033899719,0.4878048780487805,0.9407136168706263,1.0,5/32,7.40%,ABCC8;SLC7A1;SLC7A2;SLC7A5;PKD2L1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.29852890345129707,0.9396811377799005,0.8333333333333334,0.9407747165765724,1.0,109/791,12.17%,CREB3L1;VDR;RAB27A;EPB41L4B;PDGFB;NFKBIZ;ZNF423;ONECUT1;GCM1;CRX;IGF1;ABCC2;NOS2;RUNX1;SPRY2;MYOM1;CDK6;BNC2;HSPA1A;SLC39A8;MAPK11;ATOH8;IFNA2;ATXN1;HDAC10;HDAC4;FGF17;ADAM19;LEF1;RFX3;RELA;AFF2;TICAM1;BACH1;CLEC7A;ZNF98;ZNF516;CPNE1;SUPT3H;PPARGC1A;PTP4A3;MYT1;SLC24A3;SCRT1;IGF2BP2;ZNF804A;YAF2;SIRT1;ASCL1;SLC7A5;MBNL1;MLLT6;BMP6;USP36;NSD2;SMARCA2;SFMBT2;CCDC3;FOXN3;RYBP;PICALM;TESC;ITGAX;P2RX7;ZNF488;NFIA;CHD7;ZNF451;HCLS1;TRIM11;SCX;NTRK2;NLK;ROBO1;HSPA1B;MLXIPL;CLK1;AHNAK2;RBM20;WNT3;TGFB2;TCEAL1;FUBP1;CD276;NFKB1;PID1;GDNF;MAFB;MBNL2;DICER1;ZNF536;RNF14;CELSR2;MITF;PRRX2;FBXW7;PTPN22;CIAO3;ZNF460;RBM12B;SERPINB9;NOS1AP;SOX12;FGF1;MEGF8;PTBP2;SLC26A9;AFDN;SLC38A2
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.36877540042043044,0.9395686721206273,0.5384615384615384,0.9403736407876211,1.0,14/73,13.72%,NOS2;ACER2;RXRG;LOC400499;SNCA;ASCL1;IRAK3;TRIM16;ERBIN;MAPKAPK3;PTPN22;RARG;PELI1;FOXO3
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.43798642445023106,-0.9394799737576085,0.6567164179104478,1.0,1.0,6/48,12.76%,ID3;IFNGR2;CDKN1C;TGFB1;PPP1CA;FNTA
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.4847436805383115,-0.9393806563363366,0.5428571428571428,1.0,1.0,1/15,2.05%,BUB1
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.46350131895163177,0.9389922306460976,0.48484848484848486,0.941025958697727,1.0,3/17,7.31%,ICAM1;OLR1;NT5E
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.4013890646525362,-0.9387873009578259,0.5294117647058824,1.0,1.0,11/64,13.78%,HLA-F;HLA-C;SIGIRR;HLA-E;IRF1;VAMP8;LRP10;PARP12;CEBPB;HELZ2;ADGRE5
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.5677217175479021,0.938664513872549,0.5853658536585366,0.941326671534532,1.0,3/7,26.13%,ATP1B3;WNK1;WNK2
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.54497198146521,0.938489456082818,0.5813953488372093,0.9410274947497043,1.0,5/6,35.17%,CD274;TWSG1;LGALS9;VSIR;ZBTB7B
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.4380373823919946,0.9383949693744099,0.40625,0.9407010816473573,1.0,3/20,7.59%,ARAP1;AFAP1L2;HAP1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.5958783783664897,-0.9383414234465148,0.6545454545454545,1.0,1.0,4/5,38.00%,PINK1;PARK7;NONO;HIF1A
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),-0.5881602694797932,-0.9382609501873559,0.5882352941176471,1.0,1.0,1/6,1.05%,TTN
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),-0.611141342093237,-0.9381846299776799,0.6290322580645161,1.0,1.0,2/5,9.47%,COL9A3;FSHR
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.35408208741656366,-0.9380308179318995,0.5875,1.0,1.0,32/248,17.09%,CENPF;RPL23;SFRP1;CCNB2;PTK6;DDIAS;RAD23A;IRF1;USP51;CALR;KIF20B;NOP53;RACK1;SPATA22;ANKK1;HRAS;DYNLT3;NEK6;GADD45GIP1;BEX2;TGFB1;CDK4;CDK5;THAP1;BRCA1;ASAH2;MYBBP1A;WDR12;FIGNL1;PRR11;RNF167;METTL3
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.5425673324110986,-0.937786224244008,0.5671641791044776,1.0,1.0,4/14,20.86%,RAD51AP1;PARP1;MRNIP;OOEP
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.49707968900440636,0.9377065795447753,0.5789473684210527,0.9415079451811784,1.0,3/12,11.58%,ASCL1;GDNF;ARX
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.4531075628166376,-0.9376842573905713,0.5909090909090909,1.0,1.0,8/32,21.40%,SERPING1;RPS19;SLAMF8;GRN;NMI;METTL3;CR1;A2M
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.3627014904283433,0.9376601892674054,0.6451612903225806,0.9409607636656036,1.0,10/44,12.19%,GPR35;IGF1;MMD2;ERBIN;MAPRE2;ARRB1;ROBO1;RAPGEF1;AUTS2;MAP4K4
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),-0.6247455737707648,-0.9376487523487474,0.6271186440677966,1.0,1.0,2/5,22.25%,FLOT1;CAV1
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.5181443213240189,0.9373335498330452,0.5476190476190477,0.9411961054986774,1.0,2/12,9.77%,SNAI1;TGFB2
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.4471953400370865,-0.9369049247810073,0.5757575757575758,1.0,1.0,12/30,23.44%,ENTPD2;CLCA2;ITGB4;DUOXA1;FLG;KRT10;IL13RA1;DMKN;KLF5;CBLC;TGM1;C6ORF132
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.5592044913989171,-0.9368396937272987,0.578125,1.0,1.0,1/12,4.88%,TMED9
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.5803240092177131,-0.9364033401226365,0.5833333333333334,1.0,1.0,2/6,10.86%,CORO1B;GMFG
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.5803240092177131,-0.9364033401226365,0.5833333333333334,1.0,1.0,2/6,10.86%,CORO1B;GMFG
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),-0.629938472105661,-0.9363768937333817,0.6551724137931034,1.0,1.0,1/5,12.89%,EXOSC4
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.5495979183863958,-0.9363430533363111,0.5483870967741935,1.0,1.0,5/10,23.09%,SRI;CALM3;TRDN;CAV1;CALM1
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.600966142121197,-0.9361414573629169,0.640625,1.0,1.0,3/7,28.59%,PDZD11;CAV1;AP4M1
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),-0.581193864366677,-0.9361168793170019,0.5522388059701493,1.0,1.0,3/6,36.57%,EZH2;EZH1;RIF1
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.5571225008605256,-0.9358389564379902,0.5303030303030303,1.0,1.0,3/11,20.16%,CHMP2A;CAV2;CHMP3
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.46215575460975916,-0.9357024544973672,0.5507246376811594,1.0,1.0,6/26,16.31%,IL7;PARP14;IRGM;FADD;EDN1;PARP9
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.4145947147520735,0.9356526028670898,0.5294117647058824,0.9448593556675536,1.0,4/22,11.18%,ARAP1;AFAP1L2;HAP1;FBXW7
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.3523915375169753,0.9355651452193978,0.5357142857142857,0.94444876879385,1.0,17/114,10.84%,PTPN6;LIFR;IL1RAPL1;SRC;PTPN20;HDAC4;LEF1;RELA;IRAK2;SNCA;DPYSL3;IRAK3;HCLS1;KYNU;AKAP6;PID1;MAPKAPK3
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.4886681508440891,-0.9355382047124224,0.581081081081081,1.0,1.0,3/18,9.01%,ZFPM1;CARTPT;CEACAM1
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),-0.58014768799961,-0.9349641803820992,0.603448275862069,1.0,1.0,2/5,13.99%,ZFHX2;VIP
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.6073175421303351,-0.9349374147506353,0.603448275862069,1.0,1.0,2/6,27.68%,MOCS1;MOCOS
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.5123686153444444,0.9349340821226529,0.5128205128205128,0.9453604276924203,1.0,2/5,10.19%,RELA;NFKB1
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5441461252427493,-0.9348525847511346,0.5357142857142857,1.0,1.0,3/9,25.54%,HTR2B;DGKD;GAP43
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.4429484337561772,0.9345549144262439,0.5483870967741935,0.9457021683069159,1.0,2/18,10.38%,PLK1;FAM47E
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.3895481358134538,-0.9342989910357823,0.6142857142857143,1.0,1.0,4/87,1.38%,CACNA2D4;SLC8A3;TRPM1;SELENOK
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.44292260360199237,-0.9340112881924926,0.56,1.0,1.0,5/31,13.03%,JUP;HYAL2;RBM22;TGFB1;APOD
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.5716074848463174,-0.9333408382059204,0.6226415094339622,1.0,1.0,2/10,12.71%,RHOG;SEMA3A
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),-0.5302715623795565,-0.9333247515203626,0.6229508196721312,1.0,1.0,2/11,18.07%,ELOVL2;ELOVL1
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5131145530743131,-0.9331963502695662,0.5555555555555556,1.0,1.0,5/15,17.76%,HRAS;HAX1;BAIAP2L2;CDK5;TEK
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.5371893039083138,-0.9330258876735674,0.6,1.0,1.0,5/15,24.86%,SCD;SLC25A1;FASN;HSD17B8;PPT1
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.44221358679142636,-0.9329480391825119,0.6619718309859155,1.0,1.0,12/44,25.90%,FTH1;FTL;ISCU;SLC22A17;CP;HJV;SOD1;ATP6AP1;NUBP1;HEPH;HFE;HEPHL1
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.4933520828181637,0.9328692279847011,0.5238095238095238,0.9490681394123259,1.0,1/12,3.30%,AIFM2
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),-0.5100827944519754,-0.9327321043588419,0.5967741935483871,1.0,1.0,1/11,3.97%,PDZK1
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.48583622262138093,-0.9325910743328701,0.5657894736842105,1.0,1.0,4/16,25.69%,PPP1CA;CAV1;WNT8B;DVL3
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.5672940190423627,-0.9325800729083802,0.5967741935483871,1.0,1.0,2/7,23.46%,APH1A;BACE1
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.547233916403323,-0.9323691914426705,0.5555555555555556,1.0,1.0,4/13,11.93%,CPS1;CYB5R3;DDAH2;ARG2
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),-0.6230008638432369,-0.9322593537582913,0.5254237288135594,1.0,1.0,1/5,2.03%,SELENOS
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),-0.6307468937817338,-0.9320885858708485,0.5873015873015873,1.0,1.0,2/6,4.55%,DDX4;BTBD18
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.42931390322902857,-0.9318971552013093,0.5277777777777778,1.0,1.0,9/46,20.78%,TINF2;APEX1;PCNA;RPA3;PARP1;RAD50;XRCC3;POLD2;POLD4
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.3936667805443886,-0.9317527293296431,0.5974025974025974,1.0,1.0,15/81,22.78%,FTH1;FTL;CHMP2A;GOLGB1;VAMP8;ARF1;BLOC1S4;CLTA;HSPA8;RP2;GOPC;SCAMP3;AP1S1;NAPA;DOP1B
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.38372780327564177,-0.9314409589891315,0.6794871794871795,1.0,1.0,11/102,17.97%,ARHGAP4;RHOC;ZMYM6;RHOG;CNN2;PAK5;DIAPH3;CFL1;CFAP410;APOE;FGD5
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.5458970585969599,-0.9313822563689688,0.6612903225806451,1.0,1.0,1/12,0.40%,CYP1A2
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.44500965969699846,-0.9312903362893404,0.6,1.0,1.0,4/32,9.69%,XBP1;NEURL1;RRAGA;LAMTOR5
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.5776739590878113,0.931122686429408,0.5789473684210527,0.9524111774917874,1.0,2/5,7.27%,SIRT1;CDKN2A
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.4803512624479149,0.9309728388676134,0.5681818181818182,0.9521432754494068,1.0,2/11,5.53%,MFHAS1;PLA2G10
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,0.4390071397129314,0.9308088041189568,0.6571428571428571,0.9517751238652864,1.0,5/29,11.34%,LGALS4;ANXA4;DMBT1;GPR39;GCNT3
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.4037507906724832,0.9306890588874775,0.5666666666666667,0.9513709131962632,1.0,1/41,0.14%,B3GNT6
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.3522835198439175,0.9302755138111666,0.47619047619047616,0.9515153209146556,1.0,21/116,12.68%,EPB41L4B;PLIN5;CHKA;CLDN12;EGFR;SLC7A2;ERRFI1;TMEM47;OBSL1;RND3;EPB41L1;COL6A1;CHST3;DHCR7;CD276;FKBP5;CDC42EP4;TEAD1;KCTD3;GALNT18;EPDR1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.4814548636301482,-0.93023275682731,0.6,1.0,1.0,9/26,28.82%,LSM10;EXOSC4;EXOSC10;SSB;CPSF3;NCBP1;NCBP2;SNRPE;SNRPG
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),0.6104798995058329,0.9301173367695825,0.5681818181818182,0.9512396345781646,1.0,3/5,28.55%,STK39;CAB39;SLC12A6
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.4803912286008667,-0.9300231733682954,0.5588235294117647,1.0,1.0,4/18,15.00%,CXCL17;TGFB1;BRCA1;SARS1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.36289246309677364,-0.9298159990444694,0.6265060240963856,1.0,1.0,29/251,14.81%,ARHGEF16;DDIT3;RPS27A;SFRP1;IFIT2;CLU;NEURL1;RPS3;RPS6;VAV3;RASGRF2;HRK;PTRH2;UBA52;SFRP4;BTG1;RACK1;APH1A;PRR7;ZNF622;FADD;OLFM1;CDK5;GRN;PDCD2;C1QBP;MYBBP1A;UBB;MTCH1
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),-0.6140287411541006,-0.9298008036543909,0.5970149253731343,1.0,1.0,1/5,15.08%,EDN1
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.5690024936415884,0.9294933496656758,0.5681818181818182,0.9518582766802016,1.0,3/6,19.08%,SNCA;CHRM3;BCL2
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.389840530622123,-0.9294007288743373,0.6419753086419753,1.0,1.0,12/97,14.04%,GPX4;XBP1;ACOT2;OXSM;SLC27A5;ACSM6;SGPL1;ACSM3;NDUFAB1;ACBD5;ACSBG2;ACOT1
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.501106210162144,-0.929392851979183,0.640625,1.0,1.0,1/18,0.81%,SLC8A3
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.49737908002525405,0.9293353266075212,0.5588235294117647,0.9515736167731671,1.0,2/13,6.27%,CHKA;LPIN3
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.45252723181628,-0.9288919258236596,0.5423728813559322,1.0,1.0,6/19,23.09%,JPH3;SRI;CALM3;PRKACA;TRDN;CALM1
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.35236191034320097,0.928873379203952,0.5714285714285714,0.9520089973258632,1.0,34/100,20.62%,FRZB;ABCC8;TMEM98;CELF3;PTPRD;SOWAHA;PLPPR4;ALDH1A1;TMEM47;ASXL3;CADPS;GLS;MAPK10;TOX3;CACNA2D1;MAFB;RCAN2;ARX;SEMA6D;RIMBP2;LDB2;RAPGEF4;GPC6;NFASC;ADCYAP1;NOL4;EDIL3;FGF14;TMEM196;KCNB2;KCNIP1;SYT7;ST8SIA3;RAI2
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.5893167681579607,-0.9288345307244953,0.6307692307692307,1.0,1.0,1/7,9.87%,MTIF3
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.46174804153360366,0.9288253503380073,0.6111111111111112,0.9515425562013113,1.0,7/19,17.19%,KAT2A;SUPT3H;USP36;USP15;USP49;UIMC1;USP3
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.37112028763747035,-0.9286769761869514,0.6329113924050633,1.0,1.0,31/166,16.89%,RPS12;DDIT3;H1-2;TAX1BP3;TCN2;RPL18;CLCA2;PCNA;RETSAT;VAMP8;RPL36;HINT1;CD81;ISCU;BTG1;RACK1;HRAS;ITGB4;FUCA1;TGFB1;TRIAP1;PMM1;PROCR;TM7SF3;NUDT15;ATF3;RPS27L;H2AJ;HEXIM1;NINJ1;VWA5A
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.3559097013848318,0.9286753796471074,0.6086956521739131,0.9512223040648032,1.0,25/92,17.87%,PDGFB;PTPN6;IL1RAPL1;PTPN20;LEF1;DPYSL3;HCLS1;AKAP6;PID1;ACVR1;SLIT3;PTPN4;ROBO2;SLIT2;NFAT5;BMPR2;ACVR2B;FLT3;ACVR2A;PTPN14;ACVR1C;GHR;NCOA2;MAPK8;PTPN23
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.5034441925154718,0.9285799235496942,0.5,0.950738850853763,1.0,5/9,27.48%,SNCA;RAB29;SCRIB;INPP5F;ANXA2
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.4797474543546334,-0.9282363095917383,0.5915492957746479,1.0,1.0,4/25,10.16%,HYAL2;GPC3;SGSH;FUCA1
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.5174673663240764,0.9280424408638852,0.5576923076923077,0.9511554454792396,1.0,2/8,11.91%,HMGCR;MVD
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),-0.45881234417191086,-0.9279391306070239,0.5454545454545454,1.0,1.0,3/28,13.11%,SEMA3E;SEMA3A;MAG
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.3933475779538265,0.9277579333825253,0.6060606060606061,0.9512718809043436,1.0,6/52,5.76%,STAB1;SPRY2;VASH1;YJEFN3;ADGRB1;SPRED1
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.40202766248048233,0.9275964407349033,0.5135135135135135,0.950952682185244,1.0,5/23,12.19%,DAO;KYAT1;IDO1;KYNU;CBS
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.518643067703509,0.9274854151113242,0.5,0.9505160551555769,1.0,3/7,26.53%,KMT2D;KMT2C;KMT2A
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.46799339119536787,0.9274660885898318,0.53125,0.9499350583041288,1.0,5/13,15.55%,SLC26A6;P2RX7;CA2;C3;C2CD5
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.3402247915382087,0.927462250715129,0.64,0.9492914708662533,1.0,8/74,4.76%,SLC26A7;ABCC2;SLC38A1;SLC7A9;SLCO2B1;SLC7A1;SLC7A2;SLC26A6
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.49999855394647297,-0.9274405158598873,0.5277777777777778,1.0,1.0,2/14,8.37%,MT2A;ARF1
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.4098055913349643,-0.9273975568287902,0.6164383561643836,1.0,1.0,11/52,27.63%,C4BPB;GPC3;C4BPA;VPS28;VIP;SNF8;DACT1;OAZ3;APC2;DDB1;PLK2
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.5004637707005977,-0.9267960694867386,0.5633802816901409,1.0,1.0,1/11,2.95%,EEF1AKMT2
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.5696769096232916,0.9267340689102925,0.5609756097560976,0.9504583244843788,1.0,3/6,20.59%,NLGN1;GPER1;BAIAP3
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.47829595952176723,-0.9267142621115092,0.5441176470588235,1.0,1.0,2/14,12.07%,HSPA5;GABARAPL2
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.436529997457222,-0.9265969400646971,0.582089552238806,1.0,1.0,3/30,8.80%,SFRP1;SOX21;HTR2B
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.3194970349342529,0.9265671543737531,0.631578947368421,0.9502763819356979,1.0,5/72,3.56%,NUPR1;BAG2;HSPA1A;PLK1;RNF144A
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.4054908443403621,0.9265364011697202,0.4857142857142857,0.949670011620188,1.0,5/27,15.68%,CDK6;CDKN2A;DLG1;PTEN;PKD2
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),0.5742365928868813,0.9264424622877442,0.5777777777777777,0.9485589851056164,1.0,2/5,12.29%,SLC52A1;ENPP1
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),0.5742365928868813,0.9264424622877442,0.5777777777777777,0.9485589851056164,1.0,2/5,12.29%,SLC52A1;ENPP1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.45782878708603625,-0.9261361556862155,0.6129032258064516,1.0,1.0,6/35,19.97%,NARS1;AIMP1;SARS1;WARS1;AARS1;GARS1
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.3803348270134106,-0.9260873137795222,0.6447368421052632,1.0,1.0,19/88,22.14%,AQP9;PRDX5;RBP1;RETSAT;NUDT12;PEX11A;LCK;SLC27A5;GSTK1;SLC35B2;AR;PEX11G;ISOC1;PEX1;ABCA5;SOD1;GCLM;FADS2;AKR1D1
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.48938456881597764,-0.9260239380397245,0.5263157894736842,1.0,1.0,3/18,5.94%,QPRT;NMNAT3;NUDT12
prerank,"GO_Biological_Process_2021__complement activation, classical pathway (GO:0006958)",-0.6038402616643301,-0.9259769398168657,0.609375,1.0,1.0,3/5,37.95%,C1S;C1QC;C1R
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),0.5627616002516715,0.9257206828566138,0.6829268292682927,0.9495961537164082,1.0,1/8,1.51%,ACSM1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),-0.45680381575788104,-0.9256511804710035,0.5517241379310345,1.0,1.0,6/19,25.20%,VPS35;PINK1;DNM1L;FIS1;DCN;BNIP3
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.5506797979592507,0.9252499858166909,0.5555555555555556,0.9498389343206254,1.0,2/7,21.86%,SMAD4;MLIP
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.5422455163288429,-0.9250697077260134,0.6229508196721312,1.0,1.0,1/8,2.05%,BUB1
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.5380603200439928,-0.9247875518398163,0.5,1.0,1.0,2/6,12.38%,TGFB1;STAT1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.5380603200439928,-0.9247875518398163,0.5,1.0,1.0,2/6,12.38%,TGFB1;STAT1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.44581411112897495,-0.924079472303646,0.5735294117647058,1.0,1.0,5/28,22.75%,COPE;GABARAPL2;TRAPPC3;COPZ1;NAPA
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.4462986873567208,-0.9240662703680991,0.6190476190476191,1.0,1.0,9/41,20.83%,RPL10;ATG14;RBM3;EIF2B4;RBM4B;PARP9;MEX3D;METTL18;EIF2A
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),-0.5180295470023707,-0.924020497604129,0.6610169491525424,1.0,1.0,1/12,3.05%,TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.38049402192531,0.9239931234150052,0.5416666666666666,0.9520715301549217,1.0,18/73,18.22%,ARAP1;EPS8L2;NLGN1;AGRN;DPYSL3;P2RX7;ARHGAP35;CCP110;CDC42EP4;RHOQ;AUTS2;PIK3CA;ABI2;ANLN;CYFIP1;GPM6A;AKIRIN1;MARK4
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.40866956852717656,-0.9238647495965359,0.6086956521739131,1.0,1.0,13/55,12.38%,IL26;B2M;TINF2;SFRP1;AIMP1;CDKN1C;CEACAM1;AQP11;SPARC;PTPRM;TGFB1;ATP5IF1;STAT1
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),-0.5949644601851652,-0.9236709000738256,0.6515151515151515,1.0,1.0,1/7,7.33%,LIMA1
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.5554848402864414,-0.9233653397008111,0.6875,1.0,1.0,1/8,5.13%,GBA3
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.43930436402092526,0.9233013461058239,0.5517241379310345,0.9529512533358194,1.0,5/25,9.90%,HOMER1;IL1RAPL1;ARHGAP44;PDLIM5;ABHD17C
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),-0.6095151138111123,-0.9232755814397057,0.6140350877192983,1.0,1.0,1/5,21.37%,ATL3
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.411862713084136,-0.9232342654373269,0.5714285714285714,1.0,1.0,13/61,24.82%,TRMO;TRMT112;TRMT10A;QTRT2;PUSL1;SSB;OSGEP;AARS1;TRMT5;WDR6;AARS2;URM1;CTU2
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.5057332115586877,-0.9231552560872276,0.6551724137931034,1.0,1.0,1/15,1.67%,SFRP1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.4899856786976483,-0.9230873572501076,0.5303030303030303,1.0,1.0,6/18,24.86%,SCD;SLC25A1;FASN;FAR2;HSD17B8;PPT1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.5107260457105438,0.9230578483219533,0.5833333333333334,0.9529484736660223,1.0,4/14,19.63%,TAFA5;PTEN;GPER1;TPM1
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),-0.5925182150605988,-0.9230045756791654,0.625,1.0,1.0,2/5,9.47%,PAX8;FSHR
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.4178953485658733,0.9229949621881955,0.4642857142857143,0.9524873606551397,1.0,15/42,21.45%,BAG2;PLK1;MAPK12;CLN6;ADAM8;OGT;TANK;GPLD1;TBC1D10A;RCN3;BTRC;ASPH;SH3D19;RHBDD1;TNFRSF1B
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.441214653589504,0.9229739212506505,0.4878048780487805,0.9518741910673156,1.0,6/20,22.03%,PDE4B;SNCA;ABL1;ADCY6;GABPA;RYR2
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.5790915974258802,-0.9228616587424691,0.625,1.0,1.0,2/7,10.46%,ARF1;SLC24A1
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.32642817542086866,0.922461622486216,0.5483870967741935,0.9525093604004032,1.0,12/79,10.48%,FGFR1;FLT1;FGFR3;ALK;EGFR;PDGFRA;EPHA3;HNRNPU;IGF1R;NTRK2;CD4;DRD4
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.4094291648529133,0.9223648480032334,0.5833333333333334,0.9520853461395845,1.0,4/34,6.31%,CPNE7;CPNE1;SGMS1;HDHD5
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.3527052908092755,0.9222490320211292,0.5,0.9517336037762274,1.0,11/49,10.10%,SPRY2;BAG2;HSPA1A;ADGRB1;NXN;LIMK1;GNL3L;ARRB2;ARRB1;HSPA1B;OGT
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,0.3950012264501566,0.9221953623214959,0.5666666666666667,0.95123902276913,1.0,9/38,7.62%,IL4R;LCP2;ICAM1;C1ORF162;PSTPIP1;PIK3R5;CLEC7A;CSF3R;ITGAX
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),-0.6394101377192005,-0.9221903473638932,0.6101694915254238,1.0,1.0,1/5,6.57%,WWC2
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.46688760171880495,0.9221317315499641,0.5882352941176471,0.9507540551802098,1.0,2/14,4.03%,AIFM2;COQ2
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),0.5638960833089032,0.9219949894131156,0.59375,0.9504218000060748,1.0,3/7,33.60%,SERPINE2;HES1;BIN1
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),-0.615598335130539,-0.9219373619028912,0.6923076923076923,1.0,1.0,1/6,7.33%,LIMA1
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.41489397383447135,0.9215221623308658,0.5517241379310345,0.9509302469154327,1.0,7/15,16.93%,IGF1;JAM2;ADGRB3;ADAMTS5;SORT1;ADAMTS15;ADAM12
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.5351119629487029,-0.9214831908833536,0.5636363636363636,1.0,1.0,1/10,3.05%,TGFBR2
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.48899210785938096,-0.9213588513923332,0.5857142857142857,1.0,1.0,4/14,21.61%,PHPT1;CEACAM1;CD160;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.5169889329335402,-0.9213332429738865,0.6,1.0,1.0,3/12,16.29%,IFITM3;TRIM13;HEXIM1
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),-0.610561567591481,-0.9212533359157057,0.5901639344262295,1.0,1.0,2/5,28.03%,SDK2;PROM1
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.5674428547294308,-0.9207760596603263,0.6363636363636364,1.0,1.0,2/8,13.62%,GSTP1;OSMR
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.5412159712078501,0.920758416855338,0.5588235294117647,0.9519382584640527,1.0,2/6,15.86%,DCX;AGTPBP1
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.49376778616406625,-0.9207457126995445,0.6111111111111112,1.0,1.0,7/14,33.10%,SCNM1;PQBP1;DDX5;SRSF9;PUF60;RSRC1;SLU7
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.37770478974012145,0.9204222055635523,0.5217391304347826,0.9520968613293758,1.0,10/41,10.55%,ODAD3;CFAP53;DNAH11;DNAAF1;CAMSAP3;TEKT5;ADCY10;DNAI2;SPEF1;CFAP54
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.42421921717597755,-0.920338971446976,0.49230769230769234,1.0,1.0,11/40,23.65%,VPS35;ARF1;PINK1;FLOT1;LAMTOR1;PDK2;TBC1D16;FASN;FOXM1;AGPAT1;NPC2
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.5473730510711238,0.9201012960075805,0.6222222222222222,0.9519787011661406,1.0,5/7,21.10%,ADAM19;SERPINF2;AFDN;TJP1;PTPRU
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.5189737558608972,-0.9198008535524897,0.5692307692307692,1.0,1.0,1/8,5.66%,RAB11A
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.31178619120413686,0.9197500586520213,0.6153846153846154,0.9519944245187087,1.0,25/137,11.83%,STAB1;RUNX1;SPRY2;FLT1;VASH1;YJEFN3;ADGRB1;HSPB1;VEGFD;ADGRA2;SPRED1;SIRT1;SASH1;ITGAX;RHOJ;CEMIP2;STIM1;TGFB2;GAB1;CXCL13;ZNF304;ECM1;VASH2;AQP1;FGF1
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.40359431188159023,-0.9197476389267616,0.6617647058823529,1.0,1.0,20/62,25.70%,SYNPO2L;VIL1;HRAS;HAX1;BAIAP2L2;CDK5;EDN1;PFDN2;LMOD1;PLK4;CFL2;TEK;KATNBL1;CDC42EP1;WDR1;CCR7;PFN2;NES;DYNC1H1;PFN1
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5403913427139077,-0.9197182775385501,0.6428571428571429,1.0,1.0,2/9,10.96%,TGFBR2;TGFB1
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.45772569734622137,-0.9197074273981889,0.6086956521739131,1.0,1.0,2/22,3.05%,ZFPM1;TGFBR2
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.4141104185925615,-0.9192713743962286,0.618421052631579,1.0,1.0,20/52,29.69%,EME1;NOP53;ZNF830;ABRAXAS1;CLSPN;BRCA1;RPS27L;MUS81;FANCD2;MRNIP;MDC1;TOPBP1;RAD9A;BLM;BRSK1;HUS1;CDK1;DONSON;NBN;RPA2
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.3185205353560663,0.919143714940162,0.65,0.9528564927573386,1.0,51/212,17.75%,RELN;PDLIM7;DOK4;ADGRB1;SRC;EFNB3;NRP2;EPHA3;L1CAM;PLA2G10;PLPPR4;GLI2;SPTBN5;NOTCH3;DOCK7;SEMA5B;CTNNA2;NCAM1;DSCAML1;ROBO1;SHC3;GFRA1;DOK5;ARHGAP35;GAB1;GDNF;PARD6B;SLIT3;NRXN1;AUTS2;SEMA6D;PIK3CA;NTNG1;NLGN3;ROBO2;PSPN;SLIT2;KIF5C;UNC5C;PTEN;RYK;NIBAN2;DRD2;SLIT1;SEMA6C;SH3KBP1;CNTN6;SEMA4A;CYFIP1;PTPRO;SEMA3C
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.5365696283758927,-0.9190231635369762,0.5892857142857143,1.0,1.0,3/13,10.79%,CD81;LAMTOR5;GLMP
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.39199673543330954,-0.9189506741643295,0.6385542168674698,1.0,1.0,10/76,13.52%,ZDHHC12;SRP14;NACA;YIF1B;SEC62;GET3;AQP11;SRPRA;NACAD;ACBD5
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.5608194063383121,-0.9188693741573773,0.6521739130434783,1.0,1.0,1/8,13.77%,CAMLG
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.5059343067177484,-0.9183392758087304,0.6376811594202898,1.0,1.0,1/18,0.35%,BMP5
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.41146608213788466,-0.9182987772336767,0.6103896103896104,1.0,1.0,6/51,11.87%,TNFAIP2;AQP9;PTAFR;PLET1;TRIM25;SLAMF8
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.4303905638185106,-0.9182766775223455,0.6029411764705882,1.0,1.0,5/38,10.74%,CPS1;NOX4;MTHFD1;PYCR3;DDAH2
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.5248267996238469,-0.917996922542254,0.6206896551724138,1.0,1.0,2/11,8.15%,SEPHS2;MTHFD1
prerank,PanglaoDB_Augmented_2021__Myocytes,0.37068651327214347,0.917988648018825,0.45454545454545453,0.954785793789057,1.0,15/83,9.98%,TNNC2;TCAP;IL4R;TPM2;MYH4;ALPK3;PLD1;MYH14;CKM;DOCK1;NOTCH3;SGCG;DLL1;MRC1;ENO3
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.47959584637252717,-0.9177132636563298,0.5733333333333334,1.0,1.0,4/18,9.46%,TTN;JUP;PKDREJ;LHFPL5
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.3849513049994218,0.9174985884664254,0.6,0.9552266848918786,1.0,5/52,7.86%,NFKBIZ;NUPR1;SNCA;FEM1A;ADAM8
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.6193635665395242,0.9173584623081691,0.6170212765957447,0.9549023347996993,1.0,3/5,23.72%,MTMR2;MTMR3;MTMR9
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.5022825011618426,-0.9173062392526282,0.6,1.0,1.0,2/16,6.57%,NEK8;WWC2
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.3974771347829815,-0.9172668286518928,0.6176470588235294,1.0,1.0,3/59,4.15%,APIP;B2M;ALDH1A2
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.4036189448290702,-0.9171127762152296,0.5571428571428572,1.0,1.0,14/73,14.31%,TMEM208;SEC11C;METAP2;FAM111A;APH1A;ATP23;KLK6;PCSK1;AFG3L2;MYRF;SPRTN;SPCS2;STOML2;PRSS3
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5041714484949043,0.9171023616601526,0.55,0.954720582740347,1.0,3/9,10.20%,NOS2;PPARGC1A;PID1
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.43071819038428943,-0.916473687079713,0.5753424657534246,1.0,1.0,2/38,1.67%,XBP1;SFRP1
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.5884129096311081,-0.9164421154974602,0.6851851851851852,1.0,1.0,1/7,2.82%,ZFPM1
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.45440225835472564,0.9163097706665894,0.6153846153846154,0.9560485899030748,1.0,4/16,18.49%,MYO5B;MYO1D;MYO7A;MYO1B
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.6209194259319917,-0.9162404225620632,0.6911764705882353,1.0,1.0,1/5,24.57%,MFSD2A
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.5743564640822562,-0.9160518429316983,0.6268656716417911,1.0,1.0,2/7,13.59%,HYAL2;PPIA
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.5743564640822562,-0.9160518429316983,0.6268656716417911,1.0,1.0,2/7,13.59%,HYAL2;PPIA
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.4382320778241905,-0.9159765787439906,0.6027397260273972,1.0,1.0,2/26,3.05%,ZFPM1;TGFBR2
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),-0.5756007370600166,-0.915898278763594,0.6181818181818182,1.0,1.0,2/6,21.21%,TSR3;RPUSD2
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.47340791633854923,-0.9158128861523545,0.5970149253731343,1.0,1.0,4/23,15.08%,RIMS1;CARTPT;ILK;EDN1
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.327595129637762,0.9155887770580038,0.6296296296296297,0.9572151082888034,1.0,15/148,5.96%,ZAP70;COLEC11;ZDHHC11;NOS2;KLRD1;SRC;RELA;DMBT1;CLEC7A;CX3CR1;TRIM35;MFHAS1;AGER;SNCA;FRK
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),0.5552526836026732,0.9153710528973653,0.5483870967741935,0.9565038888437414,1.0,2/6,15.29%,NAPSA;RCN3
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),0.5552526836026732,0.9153710528973653,0.5483870967741935,0.9565038888437414,1.0,2/6,15.29%,NAPSA;RCN3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.5280144423915416,0.9153305015835923,0.5588235294117647,0.9559585825643497,1.0,4/17,4.47%,IGF1;NLRP7;CARD18;CX3CR1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.41350316893093453,-0.9152964050445875,0.5138888888888888,1.0,1.0,10/51,24.05%,CCNB2;CHMP2A;REEP4;ANKLE2;CHMP7;CHMP3;EMD;RAN;CHMP4B;KPNB1
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.5939440498578248,-0.9152522318122301,0.7049180327868853,1.0,1.0,2/6,17.01%,DCTN1;HSPA8
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.4839798860648321,-0.9151240469071823,0.5671641791044776,1.0,1.0,2/17,3.97%,SLC22A4;PDZK1
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.5287312668796347,-0.9148492399351432,0.6271186440677966,1.0,1.0,4/12,23.99%,IL6R;PTN;ZNF580;ADAM17
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),0.5210158010942919,0.9147865616872684,0.5641025641025641,0.9566618645427527,1.0,1/9,1.55%,NOS2
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3756415994713952,0.9147737172666651,0.5428571428571428,0.956037577187876,1.0,18/65,19.65%,KCTD8;KLK14;GUCA1B;RNF157;RGS5;ZDHHC3;PDE6B;MGLL;GRK5;C3;GNG7;RIC8B;GPER1;ADCYAP1;GUCA1C;PPP1R9B;GRK4;SLC39A14
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.40952150098070517,-0.9145027251610413,0.5901639344262295,1.0,1.0,3/51,3.89%,HLA-F;HLA-DPA1;PTAFR
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.356505591119838,-0.9143321701025812,0.5540540540540541,1.0,1.0,32/126,21.00%,PSMB8;BTN3A1;PSME1;HLA-DPA1;HLA-A;PSMB6;PSMD8;PSMC5;PSMD7;HHLA2;LCK;EIF2B1;BTN3A3;PSMD3;BTN2A1;TNFRSF21;PIK3CB;PSMC3;EIF2B2;STOML2;PSMA4;EIF2B4;HLA-DRB1;PSMD2;PSMA7;PRKD2;PSMD6;PSMB2;HLA-DRA;PSMB3;PSMB4;PSMA3
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.446669043871511,0.9141409105444863,0.6129032258064516,0.9567133614331088,1.0,1/16,0.22%,VDR
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.5937026717919711,0.9139759867831861,0.627906976744186,0.9565314935389254,1.0,2/5,14.83%,TRIP11;TBC1D23
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.4855429137999974,-0.9136441318429795,0.6575342465753424,1.0,1.0,1/20,1.57%,XBP1
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.577041878456926,-0.9131847133491545,0.6949152542372882,1.0,1.0,3/5,17.50%,TRIM25;PHB2;RNF135
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),-0.6408753364792316,-0.9131680354715477,0.6923076923076923,1.0,1.0,1/5,17.50%,PLK4
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.4455956020140629,0.9126309695908917,0.5641025641025641,0.9593068209085412,1.0,6/16,21.71%,SLC39A8;SLC39A11;SLC30A10;SLC30A3;SLC39A14;SLC39A10
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.41113138779263825,-0.9125502137292085,0.5882352941176471,1.0,1.0,10/47,20.16%,IFITM3;FAM111A;TRIM13;STAT1;PPIA;IFIT5;ILF3;HEXIM1;ISG20;CHMP3
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.4835780667739908,-0.9124074586616537,0.576271186440678,1.0,1.0,1/12,6.49%,PARP14
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.5254793677005503,-0.9122086733967048,0.6101694915254238,1.0,1.0,2/11,10.19%,CCNB2;NEK6
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.46085324918908727,-0.9121771977151295,0.5571428571428572,1.0,1.0,11/35,27.18%,CLU;LIMA1;APOE;OSBP;ABCA5;STARD5;CAV1;NPC2;ABCG5;OSBPL2;NPC1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.47244538467260455,-0.9121047527523618,0.582089552238806,1.0,1.0,3/19,2.03%,DDIT3;XBP1;SELENOS
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.44689370223256264,0.9120630172406421,0.5833333333333334,0.9598644372833642,1.0,2/16,6.64%,SLC39A8;SLC39A11
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),0.5960652867084599,0.9120365151226973,0.627906976744186,0.9592665416685973,1.0,2/5,7.23%,SLC26A6;SLC22A16
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.34310371530387573,0.9120188846967354,0.6333333333333333,0.9586518157628491,1.0,4/70,5.83%,CRX;KCNJ14;ZNF385C;GNGT1
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.3175044943130165,0.9119719298102236,0.7272727272727273,0.9581435414432021,1.0,17/115,15.12%,B3GNT6;EOGT;ST8SIA6;SLC39A8;ST8SIA1;ST8SIA4;OGT;FUT8;GCNT3;GALNT18;GALNT2;GALNTL5;POMK;TMEM165;GFPT2;GFPT1;MGAT5
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.5631844833007938,-0.911876048637742,0.5925925925925926,1.0,1.0,3/8,29.25%,INPP5K;MORC2;SETDB1
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.30746800084012155,0.9118584857043787,0.5625,0.9577327107925512,1.0,55/401,10.99%,RELN;PDGFB;PTPN6;NUPR1;PDGFC;FGFR1;JCAD;IGF1;SPRY2;CASS4;FLT1;IRS1;FGFR3;SRC;PIK3R5;FGF17;EGFR;RELA;CHD5;TICAM1;IQCJ-SCHIP1;MAP3K14;CLEC7A;CX3CR1;PDGFRA;CPNE1;MFHAS1;AGER;PTP4A3;NLGN1;SIRT1;AKT2;TRAF2;NRG2;CASP10;SASH1;TNFRSF19;MIB2;TMEM106A;IGF1R;ADAM8;HCLS1;C18ORF32;NTRK2;WDR59;CD4;TGFB2;GAB1;RICTOR;ADRA1A;MALT1;EEF1D;RRAGD;USP15;ECM1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.3891147906447113,-0.9118572712970863,0.6,1.0,1.0,22/73,20.24%,SLC8A3;MT1E;MT2A;SLC24A5;CALR;LCK;HTR2B;SLC24A1;RMDN3;RGN;SLC39A7;TMCO1;STOML2;EDN1;SLC39A6;SLC41A1;MT1M;TPCN2;TPT1;ATP2C2;MT1G;HTR2A
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.44977190793860145,0.9117667351878811,0.45454545454545453,0.9573663801536915,1.0,4/16,13.51%,ST8SIA6;CLN6;ST8SIA4;HEXB
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.3611736106168284,0.9117643316014076,0.5454545454545454,0.9567457340597865,1.0,26/125,12.04%,CREB3L1;ZNF423;COL5A3;ADAM33;FBLN5;C6;EGFR;ARNT;PDGFRA;POSTN;PPARGC1A;LTBP2;ADAMTS2;ZBTB16;COL6A1;COL14A1;HTRA1;LOX;EPSTI1;CYTH3;STAT6;MPZL1;NMB;AQP1;C3;ADAMTS5
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.5411603065333954,-0.9116360736587865,0.6507936507936508,1.0,1.0,1/10,3.37%,STX19
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),-0.6292473191734514,-0.9113076558723331,0.6774193548387096,1.0,1.0,1/5,9.81%,IRGM
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.4215654030762046,0.9112598932877443,0.5428571428571428,0.9573639309020828,1.0,3/23,4.27%,VASH1;STARD13;TBXA2R
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.4929410228837716,0.9111873406493636,0.5135135135135135,0.9568406217261067,1.0,3/10,18.20%,PSPH;CBS;SRR
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),-0.44844110625247285,-0.9109809126465637,0.5945945945945946,1.0,1.0,2/27,2.80%,TRPM1;JPH3
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.5280663136579988,0.9107307661773013,0.6590909090909091,0.9574316385845949,1.0,2/9,15.21%,PGAP1;SCFD1
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.3348184286216115,0.9107060786420907,0.5555555555555556,0.9568388668119471,1.0,18/138,13.55%,NFKBIZ;IGF1;CDK6;AFF2;MTMR2;IGF2BP2;ASCL1;ZNF451;TRIM11;MKLN1;FUBP1;GDNF;CIAO3;MEGF8;PTHLH;TRIM44;SLC8A2;SORT1
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.4190398136822793,0.9105271997324211,0.5384615384615384,0.9565095915552045,1.0,21/60,23.62%,CPNE7;ACP6;CPNE1;PLA2G10;HDHD5;PIGP;GDPD3;LCAT;GPLD1;ABHD3;PNPLA6;GPCPD1;PLAAT1;PLA2G4A;PIGX;CSF1R;PLA2G4C;SMPD4;CPNE6;PRDX6;PLCB1
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.49848161114505335,-0.9101199687893308,0.6612903225806451,1.0,1.0,4/15,13.98%,GRIN3B;PLN;SRI;ORAI1
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.4749313061220844,0.91011833879268,0.6153846153846154,0.9566183268529626,1.0,3/13,8.26%,ST8SIA6;ST8SIA1;ST8SIA4
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.5917182346725472,-0.9101095418603063,0.6785714285714286,1.0,1.0,3/5,32.52%,ATP6AP1;ATP6V1G1;ATP6V0D1
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.39434529994692524,0.9097877149221122,0.5333333333333333,0.9566744446778538,1.0,12/28,21.19%,BMP6;P2RX7;ACVR1;GPM6B;BMPR2;ACVR2B;ACVR2A;PTH;BMPR1B;SLC8A1;WNT4;NELL1
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),0.565369230447225,0.9096592247871831,0.6216216216216216,0.9563371828786519,1.0,1/6,0.37%,LEPR
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.4203691297443742,-0.9096299969521922,0.64,1.0,1.0,9/41,22.01%,JUP;HYAL2;RBM22;CAMK1;TGFB1;ECT2;GTSE1;EMD;RAN
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.5488494821565093,0.9093398007703066,0.6428571428571429,0.9562885979927159,1.0,2/7,8.12%,ARRB2;ARRB1
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.5710955770628686,-0.9092572467172088,0.6825396825396826,1.0,1.0,2/6,27.81%,BAX;PTPN1
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.4384151431922739,-0.908971969331302,0.578125,1.0,1.0,5/36,7.30%,SLC6A12;SLC3A1;SLC25A45;SLC7A14;SLC7A7
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.4942625586439812,-0.9086707113486412,0.625,1.0,1.0,2/11,19.00%,CORO1B;SERPINE1
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.3297066175025561,0.9085930561437199,0.7142857142857143,0.9575319272320261,1.0,18/76,13.37%,KCNQ2;EFNB3;CASKIN1;CELF3;GRM8;MYT1;VGF;CACNG4;PCDH8;MEX3A;SNAP91;UNC13A;CAMKV;NCAN;IGDCC3;PPM1E;SLC8A2;KLHL23
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.44536371044161016,-0.9082569266162379,0.5774647887323944,1.0,1.0,6/29,14.04%,ACOT2;DBI;OXSM;ACSM6;ACSM3;ACOT1
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),0.5686486431116453,0.9081434832417624,0.6486486486486487,0.9577792086975525,1.0,2/6,3.73%,IFNA2;DENND1B
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.39523844987603773,0.9081108366189393,0.5,0.9572328902586879,1.0,4/47,5.60%,VAPB;SRPRB;PDIA5;ACADVL
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.4062380459584901,0.9079572575403553,0.6206896551724138,0.956974768554227,1.0,22/82,12.04%,COL5A3;ADAM33;TNC;ICAM1;PCDH18;FBLN5;PDGFRA;POSTN;ADGRA2;LTBP2;SSC5D;ADAMTS2;COL6A1;CDH11;RHOJ;COL14A1;HTRA1;AEBP1;COL5A1;SGCD;AQP1;ADAMTS5
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.5016719152973165,-0.9077571602640931,0.6461538461538462,1.0,1.0,4/11,16.31%,DTX3L;DDX11;KDM4D;PARP9
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.4642484184394682,-0.9074849931853662,0.5806451612903226,1.0,1.0,4/16,15.13%,EIF2B1;MYRF;EIF2B2;EIF2B4
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.3746175642057214,0.9074808323527277,0.46153846153846156,0.9574744029726415,1.0,3/61,1.37%,GSTT2;BACE2;TRHDE
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),-0.5572796310409334,-0.9073988809343333,0.6721311475409836,1.0,1.0,2/7,17.95%,PIP;ORMDL3
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),-0.4253652122179797,-0.9073686062311833,0.6338028169014085,1.0,1.0,4/34,14.44%,XBP1;ATG14;HSPA5;MYBBP1A
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.48825313233219514,-0.9073099277920128,0.6619718309859155,1.0,1.0,1/17,0.57%,B2M
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.34597764530182723,0.9072236776240039,0.6,0.9573121635046788,1.0,28/108,14.73%,ZNF423;LIFR;PCDH18;FRZB;EFNB3;TMEM98;LRP4;PBX1;GLI2;DPYSL3;TMEM47;OBSL1;AGAP1;EPB41L1;CHST3;CDH11;MEIS3;GFRA1;ADGRL3;CACNA2D1;NUAK1;TEAD1;SEMA6D;FBXL7;SLIT2;FIGN;MPDZ;GPC6
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.5130726192727177,-0.9070988609703585,0.6,1.0,1.0,1/12,6.57%,WWC2
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.5055639211095899,0.907079636813813,0.6382978723404256,0.9571240512097569,1.0,4/10,18.23%,SESN2;RRAGD;SESN1;GCN1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.387425406021598,-0.9070275652442149,0.6349206349206349,1.0,1.0,11/61,12.21%,B2M;IFIT2;ZFPM1;GTF2F1;DDX11;RACK1;ADAM15;CAMK1;PPP1CA;TFIP11;LRPAP1
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.3392117207201131,0.9065734925253858,0.6571428571428571,0.9576921259303056,1.0,30/118,19.37%,GFAP;SPOCK1;PTCH2;TMC8;STON2;HNRNPU;MLLT3;CD22;TRAF2;CAMSAP3;IRAK3;PICALM;SGK1;RAPGEF1;SGK3;RASGRP2;ITCH;KIF14;CAMSAP2;CAMK2D;RAP1A;ABL1;ARHGEF11;ANKRA2;MARK4;TJP1;NRG3;RPTOR;TFRC;CHPT1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.3960897401796919,-0.9064702141653117,0.6716417910447762,1.0,1.0,2/52,0.65%,CD44;IRF4
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.4833604547730161,-0.9062769687728232,0.6507936507936508,1.0,1.0,4/19,21.61%,PPP1R11;BOD1L1;PTPA;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.41637443119011147,0.9061473124995967,0.5588235294117647,0.958025012037993,1.0,12/31,21.40%,SPRY2;RASIP1;ARHGAP44;ARHGAP35;TGFB2;SYNGAP1;KANK1;SPRY4;FBP1;ARHGAP24;ABL2;KCTD10
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.3456496231268738,0.9059687162853787,0.6111111111111112,0.9578628364328916,1.0,26/90,20.55%,LIFR;EGFR;ERRFI1;LRP4;GLI2;OBSL1;DOCK1;RND3;CHST3;CACNA2D1;CD276;NUAK1;TEAD1;SLIT2;FIGN;MPDZ;ADAMTS15;COL12A1;COL4A2;KIF7;TJP1;MYO1B;RAI14;ADCY6;SH3D19;WNT5A
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.48218239710147603,-0.9059619226466745,0.5757575757575758,1.0,1.0,1/15,3.37%,STX19
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.49449390120645415,0.9059099465698502,0.5581395348837209,0.9573973485986297,1.0,5/14,20.80%,FOXK1;SIRT1;PDK1;PDK4;MLYCD
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.47883186589192483,-0.9058644732002746,0.5901639344262295,1.0,1.0,6/18,18.72%,CD63;SFRP4;SELE;APLN;GREM1;ANGPT1
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.5525199033115246,-0.90561378596228,0.6338028169014085,1.0,1.0,2/9,10.54%,GALK1;GALE
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.5169481536903974,-0.9055352704829908,0.6111111111111112,1.0,1.0,2/13,9.01%,GSTP1;CEACAM1
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.5966750362494998,-0.9054939052321693,0.5862068965517241,1.0,1.0,1/5,8.86%,ATP23
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.49919848398598204,-0.9050452717275471,0.5970149253731343,1.0,1.0,5/13,20.49%,SSB;RPP25;POP7;RPP38;HSD17B10
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.4697434176062615,-0.9048402948900489,0.6212121212121212,1.0,1.0,1/14,2.91%,DND1
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),-0.5595674997263078,-0.9044912047533732,0.6229508196721312,1.0,1.0,1/6,5.73%,ORC6
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.472286415736792,0.904471722801638,0.5357142857142857,0.9598097270777914,1.0,2/14,7.26%,SRC;ABHD2
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.4038042689424255,0.9044619702297855,0.55,0.9591963466139202,1.0,2/29,1.51%,RAB39A;ATP6V0A4
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.3237452747119962,0.9042596681959675,0.64,0.9591463504745306,1.0,46/177,17.75%,RELN;PDLIM7;DOK4;SRC;EFNB3;NRP2;EPHA3;L1CAM;PLA2G10;GLI2;SPTBN5;NFIB;NOTCH3;SEMA5B;ALCAM;PLXNA1;NCAM1;DSCAML1;ROBO1;SHC3;GFRA1;DOK5;ARHGAP35;GAB1;GDNF;PLXNB2;SLIT3;NRXN1;SEMA6D;PIK3CA;ROBO2;PSPN;SLIT2;KIF5C;UNC5C;RYK;NIBAN2;SLIT1;PLXNA4;SEMA6C;SH3KBP1;CNTN6;SEMA4A;CYFIP1;PTPRO;SEMA3C
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.39111415452258236,-0.9040164077430881,0.5945945945945946,1.0,1.0,7/66,10.86%,P2RY10;DPEP2;IL7;CR2;ZBTB32;MAP4K1;GMFG
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.5073592445405753,0.9039331382110425,0.5555555555555556,0.9592348130623034,1.0,2/7,12.53%,ARHGEF7;PRKCE
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.5400096408364174,-0.9038955815908448,0.6388888888888888,1.0,1.0,2/10,3.95%,RIMS1;SLC22A4
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.32447868850041767,0.903264107020056,0.625,0.9602480724848194,1.0,28/121,14.83%,RELN;PCDH18;KLHL17;PBX3;ATXN1;GRHL2;AFF2;CNTNAP2;CX3CR1;PBX1;NFIB;HAP1;CTNNA2;DSCAML1;MEIS1;MEIS3;SMG9;ADGRL3;PLXNB2;CDH2;GRIN1;ROBO2;MEIS2;POMK;JHY;PITPNM1;PTEN;TBC1D23
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.4494267483424532,-0.9031874394886715,0.6060606060606061,1.0,1.0,3/21,15.08%,CPS1;HTR2B;EDN1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.5155900696716371,-0.9028367231828459,0.625,1.0,1.0,1/11,3.63%,CFTR
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.538930532276902,-0.9028183199637859,0.6323529411764706,1.0,1.0,1/7,1.49%,DUOX1
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.3918450407097699,-0.902661653050201,0.6962025316455697,1.0,1.0,21/88,21.59%,DCTN3;SSNA1;TUBB4B;RAB11A;CETN2;DCTN2;CEP131;HAUS6;TUBA1A;SCLT1;CEP72;DYNLL1;DCTN1;TUBA4A;PLK4;CEP135;PRKACA;TUBB;CEP41;NPHP1;CC2D2A
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.48771427713201576,-0.9026484152702894,0.6617647058823529,1.0,1.0,1/18,2.95%,EEF1AKMT2
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.5192709623957296,0.9022110934900427,0.6521739130434783,0.9619510973805672,1.0,6/13,26.77%,CASP7;RAD51;SLC8A1;RYR3;RYR2;CASQ2
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.36826874813719235,-0.9019589907887127,0.7397260273972602,1.0,1.0,27/170,18.65%,CD44;STMN1;LDHA;XYLT2;GALK1;POLR3K;B3GALT6;GPC3;TALDO1;B4GALT7;PRPS1;HSPA5;HAX1;GALE;AKR1A1;PPIA;KDELR3;TPI1;PYGL;MDH2;MDH1;CHPF;TXN;GAPDHS;GLRX;IL13RA1;ISG20
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.43224601136690743,0.9016441134016036,0.6666666666666666,0.9626591427853116,1.0,3/15,19.26%,ADAMTS9;FBXO2;NEU4
prerank,PanglaoDB_Augmented_2021__Clara Cells,0.36811076852050284,0.9012696548823746,0.5625,0.9627192272861675,1.0,7/43,6.42%,LEPR;TRIM29;GRHL2;TMC5;PROM2;ALS2CL;ALDH1A1
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.505686859603525,0.9010422701666707,0.48484848484848486,0.9626240432368058,1.0,2/8,17.70%,PCGF5;RNF2
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.5177255365518083,-0.9004282647283522,0.6417910447761194,1.0,1.0,1/8,2.03%,SELENOS
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.46449187039048495,-0.9004202185045375,0.5833333333333334,1.0,1.0,5/20,21.24%,TGFBR2;TGFB1;ADH6;SOD1;CCR7
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.4525119813690702,-0.9003590111128454,0.6266666666666667,1.0,1.0,3/19,8.95%,CHMP2A;TRIM13;TRIM25
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),-0.5112559880186557,-0.9000433933107074,0.5789473684210527,1.0,1.0,1/8,11.27%,PINK1
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.3717296822895519,-0.8999665169280417,0.64,1.0,1.0,10/106,13.23%,CENPF;AQP9;TCN2;SLC22A4;CHMP2A;SLC22A9;AMN;SLC48A1;SLC22A25;ABCA12
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.3581238823441958,0.8999358356369964,0.6333333333333333,0.9645796291057264,1.0,29/91,21.13%,CDK10;IQCJ-SCHIP1;EPHA3;ARHGAP44;DIAPH1;CAMSAP3;P2RX7;RND3;ARHGAP35;RICTOR;SPEF1;CELSR1;CORO2B;RHOQ;GPM6B;RHOF;CLASP1;TESK1;TRIM36;GSK3B;ABL1;RHOBTB1;TJP1;MAPT;ARHGAP17;EFNA5;PHLDB2;MARK2;BICD2
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.40125103412859164,0.8997838277403097,0.5625,0.9642939355184441,1.0,2/17,6.27%,CYP4F11;LPIN3
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.4884025944520144,0.8995725273098765,0.5853658536585366,0.9641118706775009,1.0,4/10,21.77%,P2RX7;P2RY1;SSH1;RYR3
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.37660978325089217,-0.8994040401924396,0.6172839506172839,1.0,1.0,15/79,17.95%,GAPDH;TYMS;CLU;RPS3;RPL13A;ORMDL2;CALR;RACK1;ORMDL1;NCL;PATL2;ILF3;EIF4A3;APOE;ORMDL3
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.2901464622376664,0.8991681405063657,0.8333333333333334,0.9643600167090746,1.0,92/538,14.72%,VDR;PDGFB;NFATC4;DACH1;ZBTB1;RUNX1;SNAI1;HSPA1A;ZNF366;ZGLP1;ATXN1;PLK1;HDAC10;HDAC4;CPEB3;RELA;TBX6;BACH1;CNOT2;DLX1;HNRNPU;ID1;ZNF202;HAMP;SNCA;FRK;WWOX;SCRT1;ZBTB16;GLI2;SIRT1;ASCL1;TBL1XR1;BMP6;ETV5;SMARCA2;BATF3;NFIB;ZBTB2;FNIP2;ZHX2;ZNF451;HMBOX1;PHF21A;ZFP69B;ZNF778;ARID5A;NOTCH4;TAF3;ZEB2;OTUD7B;NRIP1;JAZF1;ZNF785;DMRT1;SOX30;SMYD2;AEBP1;NFKB1;TRPS1;BAG3;PURA;DICER1;ZNF536;DNMT3A;MITF;KLF11;RARG;SMAD4;MNT;DLG1;LCOR;THRB;SMURF2;SLA2;HDAC9;JDP2;MEIS2;EED;MYPOP;ZNF281;TRIB3;LDB2;FOXO3;MCPH1;ZNF556;KDM1B;TFEC;CBFB;HMGB1;ACVR2B;ATRX
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.4483238799888667,-0.8991432571326035,0.5633802816901409,1.0,1.0,4/31,6.54%,GSAP;CLU;EFNA1;LRRTM3
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.42718050082333003,-0.8991070197155622,0.6176470588235294,1.0,1.0,8/39,22.20%,NARS1;AIMP1;SARS1;WARS1;AARS1;GARS1;TARS3;AARS2
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.36155930574368544,-0.8989545197235753,0.620253164556962,1.0,1.0,10/125,10.96%,CD44;SFRP1;TGFBR2;CORO1B;HYAL2;OVOL2;RACK1;VIL1;STMN2;TGFB1
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.5221614520403314,-0.8988325984846659,0.6031746031746031,1.0,1.0,2/8,10.83%,LCLAT1;PLA2G12A
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.5230297313785184,0.8986936167240411,0.5294117647058824,0.9647195655928358,1.0,2/6,18.95%,BMPR2;BMPR1B
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),-0.5508259797995302,-0.8984123168201881,0.6428571428571429,1.0,1.0,6/11,31.64%,HIRIP3;CHAF1A;CHAF1B;CDAN1;MTA2;SUPT16H
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.5460191228313882,-0.8984110506814741,0.6428571428571429,1.0,1.0,3/8,24.47%,VAMP8;EDN1;HFE
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.49665871848737897,0.8983420636770071,0.65625,0.9648381749554882,1.0,2/14,1.86%,F2;GNLY
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.42950662940033135,-0.8981883443914317,0.6229508196721312,1.0,1.0,3/26,7.32%,DTX3L;PHPT1;CDKN1C
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.4442771556855849,0.8978772156421805,0.5357142857142857,0.9654716096622166,1.0,4/14,19.93%,XPO1;ANP32A;HMGA1;NUP98
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.48646582890195544,-0.8977371013978025,0.6470588235294118,1.0,1.0,5/16,25.62%,SFRP1;TXNDC15;TEDC1;PDCL;EVC
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.26391846421821674,0.8975289632190753,1.0,0.9657611331222306,1.0,163/686,18.23%,VDR;PDGFB;ONECUT1;TP63;GCM1;CRX;NPAS2;IGF1;ETV1;KAT2A;RUNX1;CCDC62;ATOH8;ZGLP1;GRHL2;HDAC4;TAL1;EGFR;LEF1;HNF4G;RFX3;RELA;ARNT;RXRG;LMO7;DLX1;HNRNPU;ATF1;PPARGC1A;PLAC8;WWOX;PBX1;GLI2;SIRT1;AGRN;LMO2;LPIN3;ASCL1;MLLT6;TBL1XR1;BMP6;EAF2;ETV5;PKD1;SMARCA2;CDK12;SERPINF2;MAML2;NFIB;NOTCH3;NFIA;ZNF451;PAXIP1;HCLS1;PHF10;ARRB1;NRF1;NOTCH4;SCX;ZEB2;MEIS1;ST18;MLXIPL;NRIP1;MEIS3;ASXL3;DLL1;TCF12;DMRT1;TOX3;TGFB2;SOX30;GABPB1;OGT;NFKB1;PID1;GDNF;STAT6;TNKS;CRTC1;ACVR1;ZNF304;MITF;TEAD1;RARG;SMAD4;PCGF5;KLF15;SOX12;THRB;RHOQ;FGF1;NCOA7;AUTS2;GRIN1;ELL;MEIS2;SMARCD2;PRKD1;SSBP4;NFAT5;VEZF1;TCF4;LDB2;TFDP2;FOXO3;RPS6KA1;KDM1B;ESRRB;MLLT10;BMPR2;ZNF143;SS18L1;TFEC;CSRNP1;HMGB1;ATRX;KAT2B;ZNF24;HIPK2;SSBP2;SMARCD3;RPRD1B;SFPQ;MED13;BCLAF1;THAP3;GPER1;NR4A2;PKD2;PRDM10;HMGA1;CREBBP;PPRC1;SS18;PRDM15;ACVR2A;ADCYAP1;HIVEP1;KMT2D;UHRF1;NR1H3;WWC1;DHX9;PTH;NCOA2;MRTFA;ZNF268;KMT2C;PLAGL1;ABL1;E2F5;GLIS1;CAMTA2;FGF2;ELF1;CEBPG;MAFF;SMAD2;CTBP2;RGCC;AKIRIN1;GCN1
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.3786800450971659,-0.8975105717935185,0.7083333333333334,1.0,1.0,14/99,12.22%,B2M;DTX3L;IFIT2;ZFPM1;RPL11;GTF2F1;DDX11;BAMBI;RACK1;CAMK1;PPP1CA;TFIP11;LRPAP1;FLOT1
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.28508690259546476,0.8973525193033547,1.0,0.9656045437177303,1.0,73/363,15.94%,RELN;PDGFC;IL1RAPL2;NPAS2;KCNQ2;ADGRB1;SPOCK1;ATXN1;EFNB3;GRHL2;HDAC4;FGF17;VCAN;TBX6;GLRB;LIMK1;L1CAM;ADGRA2;NLGN1;IGF2BP2;ZBTB16;ASCL1;MBNL1;PKD1;ADORA1;OBSL1;HAP1;CHD7;VAX2;ST8SIA4;UGT8;ADGRB2;ZEB2;TRPC5;DSCAML1;ROBO1;GFRA1;ADGRL3;NHEJ1;DPYSL4;SCIN;GDNF;FBXL17;HMGCR;NPAS1;CELSR1;CHRM3;NCAN;TEAD1;SHANK2;CHST8;NRXN1;CDH2;NLGN3;GPM6B;ROBO2;PSPN;FGF13;NAV1;DCX;MERTK;LDB2;CRIM1;TMOD2;PTEN;JRKL;RYK;DYRK1A;ATXN10;NAV2;PKD2;RPS6KA6;SH3GL3
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.3894186131622826,-0.8970208805084668,0.6612903225806451,1.0,1.0,10/66,10.96%,CD44;GATA1;SFRP1;EFNA1;IL6R;CD81;IL5;HAX1;PDCL3;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.4637275562065318,0.8968192532036132,0.5555555555555556,0.9661163386350862,1.0,2/9,16.33%,PIP4K2A;LRSAM1
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.44031435320096524,-0.8967331201798752,0.5733333333333334,1.0,1.0,8/26,24.31%,CORO1B;LIMA1;BAIAP2L2;AIF1L;HSP90B1;LCP1;CALD1;USH1C
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),-0.5683743724856503,-0.8967060474377906,0.6349206349206349,1.0,1.0,2/6,13.31%,IRF1;MAPK8IP1
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.5600476655352805,0.8966133322044901,0.696969696969697,0.9660282100530648,1.0,3/5,23.86%,ADRA1A;TPM1;ADRB1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.5041750246250126,0.896001762482455,0.6,0.9668727424387136,1.0,1/10,4.87%,MTMR2
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),-0.5570486080605257,-0.8959520327343818,0.6153846153846154,1.0,1.0,1/7,12.46%,ARL13B
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.33959819088330323,-0.8959401739219307,0.7530864197530864,1.0,1.0,27/280,11.68%,BMP5;IL26;B2M;TINF2;FTH1;NOX4;SFRP1;NEURL1;GSTP1;ALDH1A2;INCA1;IFIT3;FABP3;IRF1;BTG3;SFRP4;CDKN1C;FBLN1;TNS2;BTG1;HRAS;AQP11;B4GALT7;FABP6;TGFB1;FUZ;AR
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.5841787497759587,-0.8958590197069811,0.6428571428571429,1.0,1.0,2/7,9.39%,AQP9;AQP11
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.38056188621703746,0.895708211219674,0.6060606060606061,0.9669552429544812,1.0,9/37,18.76%,CRACR2A;P2RX7;GDNF;DRD4;DLG1;RAB3B;STIM2;DRD2;SCN3B
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.3914463834837383,-0.8956896943124261,0.618421052631579,1.0,1.0,9/75,13.11%,HLA-F;PM20D1;VPS35;NRBP2;PINK1;BDNF;CDK5;GRN;MAG
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.5547480126515828,-0.8955797423038581,0.6551724137931034,1.0,1.0,1/7,1.05%,TTN
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.4637848866593238,0.8954165805481872,0.5294117647058824,0.9669351034082783,1.0,6/17,14.77%,RELN;NLGN1;NRXN1;GRIN1;NLGN3;PTEN
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.4204342221816618,-0.895257215257142,0.6,1.0,1.0,1/36,0.35%,BMP5
prerank,GO_Biological_Process_2021__negative regulation of pinocytosis (GO:0048550),0.550507182361768,0.8952237639777585,0.5862068965517241,0.9667185905960283,1.0,2/5,16.86%,PROM2;NR1H3
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),-0.5919592943807008,-0.8952147872302212,0.6190476190476191,1.0,1.0,2/5,9.81%,LACC1;IRGM
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5298801906893211,-0.8951877939967856,0.6323529411764706,1.0,1.0,2/12,16.95%,SFRP4;CD160
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.4586102466470397,-0.89500611653522,0.609375,1.0,1.0,8/20,22.52%,ROMO1;TIMM8B;TIMM10;BAX;MOAP1;TIMM13;TOMM22;TOMM70
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),0.4692003971739494,0.8949330013177674,0.6222222222222222,0.9667412960613655,1.0,1/11,1.79%,CBARP
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.4838261895731455,0.894831115658342,0.5862068965517241,0.9663205067470036,1.0,1/11,0.18%,CREB3L1
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.43387382051890516,-0.8947670056582128,0.6666666666666666,1.0,1.0,7/25,23.58%,PDZK1;CEMIP;HRAS;GDI1;FIS1;KCNE1;INPP5K
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-0.5690733840939923,-0.8947636664402651,0.5909090909090909,1.0,1.0,1/6,6.49%,PARP14
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),-0.5690733840939923,-0.8947636664402651,0.5909090909090909,1.0,1.0,1/6,6.49%,PARP14
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.4615027976924881,0.894725536183191,0.6060606060606061,0.9659172996528442,1.0,9/16,18.93%,NRP2;ROBO1;TGFB2;ACVR1;SMAD4;ROBO2;BMPR2;SEMA3C;ZFPM2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.4973821266976737,0.8947078497380566,0.5128205128205128,0.9653698121263564,1.0,1/9,1.93%,SPRY2
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.3587656438480988,0.8946864073334857,0.6111111111111112,0.964780462573392,1.0,4/41,7.91%,RIDA;CPEB3;FTO;NANOS3
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.49162398985118916,-0.8946830546138941,0.7101449275362319,1.0,1.0,3/15,15.08%,CLU;DDAH2;EDN1
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.32887558507365133,0.8944951341747021,0.6071428571428571,0.9646001740787774,1.0,32/175,11.20%,PDGFB;PDGFC;FGFR1;JCAD;IGF1;SPRY2;ICAM1;FLT1;FGFR3;PIK3R5;EGFR;PDGFRA;MFHAS1;AGER;SERPINF2;TMEM106A;IGF1R;ADAM8;ARRB2;ARRB1;MTURN;NTRK2;TPD52L1;ROBO1;CD4;TGFB2;ADRA1A;DIRAS2;NECAB2;NPNT;FBXW7;PTPN22
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.3336536866924884,0.8944689678790457,0.52,0.9640375671155881,1.0,28/124,18.44%,ADGRB1;CNTNAP2;LRP4;CPNE1;PLPPR4;NLGN1;CTNND2;DOCK7;ALCAM;CTNNA2;TNIK;SGK1;DSCAML1;DICER1;CELSR2;PARD6B;MAP4K4;NTNG1;DCDC2;PTEN;TRIO;RYK;DRD2;NYAP2;CNTNAP1;MAP2;GPM6A;NRCAM
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.3718137019763276,-0.8942897679500061,0.582089552238806,1.0,1.0,14/96,11.99%,RHOC;CLU;RPS3;HRK;NOP53;RACK1;TRABD2B;IRGM;BRK1;HSPA5;TGFB1;PINK1;TFIP11;SELP
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.3323148001691419,-0.894108069206906,0.7439024390243902,1.0,1.0,42/308,20.36%,DDIT3;PARP2;DTX3L;NUDT1;RPS3;DDX11;VAV3;APEX1;BCL2L2;PNKP;POLE3;RNF8;NOP53;FAM111A;WDHD1;RAD51AP1;RFC2;BRCA1;PARP1;SPRTN;BOD1L1;MBD4;CIDEB;CGAS;MUS81;RFC4;CBX1;REXO4;UFL1;RAD50;METTL3;XRCC2;XRCC3;KIN;MRNIP;XPA;FANCF;RECQL;BAX;MOAP1;RBBP5;ERCC8
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.3637163983045478,-0.89348285705143,0.7529411764705882,1.0,1.0,33/119,29.00%,PKMYT1;CCNB2;DCTN3;SSNA1;TUBB4B;CETN2;DCTN2;CEP131;HAUS6;TUBA1A;CEP72;DYNLL1;DCTN1;TUBA4A;PLK4;CEP135;PRKACA;TUBB;CEP41;FOXM1;TUBB4A;USH1C;NES;DYNC1H1;OFD1;CEP76;BRSK1;BORA;YWHAE;CDK1;MAPRE1;FBXL15;TUBG1
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),0.33959037393908403,0.8933842784733748,0.6176470588235294,0.9657015380931895,1.0,7/75,5.13%,PDGFB;BAG2;CARD18;TMC8;LEF1;CPNE1;GNL3L
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),-0.5833279579738608,-0.8932249666059605,0.65,1.0,1.0,1/5,4.19%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase A signaling (GO:0010739),-0.591647423456422,-0.8930648587591868,0.6557377049180327,1.0,1.0,2/5,33.38%,TCIM;RAMP3
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.5823417176381198,0.8929897236268773,0.6046511627906976,0.9661068360733734,1.0,3/5,22.86%,PRPF39;SFSWAP;SRSF12
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.575211982994108,-0.8926617043578723,0.6774193548387096,1.0,1.0,2/6,21.24%,GPR183;CCR7
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.509944251927286,0.8925164066255643,0.5897435897435898,0.9666473773203681,1.0,2/8,15.03%,SOAT1;MTTP
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.31976647691163557,0.8924978153017291,0.6470588235294118,0.9660594608461625,1.0,29/273,8.57%,F2;RELN;PDGFB;LEPR;PDGFC;IGF1;SPRY2;LCP2;SRC;PLK1;VEGFD;FGF17;EGFR;CX3CR1;MMD2;CSPG4;AGER;PROM2;LIMCH1;SNCA;SIRT1;AKT2;BMP6;DOCK7;FNIP2;HCLS1;ARRB1;TNIK;NTRK2
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.5203205269131234,0.8922628986366473,0.5952380952380952,0.9659383660306627,1.0,3/9,19.35%,HDAC4;UBA2;PIAS1
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.5202706958865193,-0.8922478326798459,0.6666666666666666,1.0,1.0,4/11,21.06%,CALR;PRAME;SNW1;EZH2
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.4846305363398768,0.8922467915609804,0.5454545454545454,0.9653601127475615,1.0,2/10,6.67%,IGF1;SOAT1
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.4628582676756224,-0.8920574064078941,0.6060606060606061,1.0,1.0,2/18,10.07%,XBP1;GPIHBP1
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.3073833351123018,0.8918235483096095,0.7619047619047619,0.9655612225223393,1.0,30/199,12.53%,PDGFB;PDGFC;IGF1;SPRY2;SNAI1;CASS4;FLT1;SRC;ARHGEF7;EGFR;LEF1;CLEC7A;PDGFRA;TMSB15B;AKT2;NSMF;DOCK1;IGF1R;ITGAX;SEMA5B;TGFB2;GAB1;SYNE2;ACVR1;ZNF304;FGF1;SMURF2;MAP4K4;SEMA6D;PRKCE
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.4735022745871773,-0.8914734112916657,0.65625,1.0,1.0,2/16,2.40%,SFRP1;H2AZ1
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.3784153254170958,0.8913712211264414,0.6666666666666666,0.9659481541639419,1.0,9/39,15.64%,HSD3B7;OSBPL1A;OSBPL6;DHCR7;HMGCR;PNPO;OSBPL7;SC5D;OSBPL3
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.504384079273198,-0.8912034661422945,0.6190476190476191,1.0,1.0,4/13,11.99%,MADCAM1;GCNT1;SELE;SELP
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.38714752219062126,-0.8910796953694645,0.6901408450704225,1.0,1.0,16/82,16.57%,GBP3;HLA-C;DTX3L;TNFAIP2;ANXA5;LRP10;MARCKSL1;PARP12;GRN;HELZ2;NFIC;TBC1D2;AHR;TNFRSF1A;CEBPD;PGLYRP1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.3824866149391866,-0.8910403043327022,0.6470588235294118,1.0,1.0,26/88,21.75%,PSMB8;PSME1;PSMB6;PSMD8;PSMC5;PSMD7;TMSB4X;PSMD3;ILK;STAT1;PSMC3;TXNDC17;CD27;EIF5A;PSMA4;TNFRSF1A;TNFSF9;PSMD2;PSMA7;PSMD6;PSMB2;PSMB3;PSMB4;PLVAP;PSMA3;PSMC1
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.5725159401526645,-0.8910351386164872,0.6984126984126984,1.0,1.0,2/7,25.68%,TGFB1;ESR1
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),-0.47614281919181833,-0.890892766661482,0.6212121212121212,1.0,1.0,2/10,12.36%,SGMS2;SMPD2
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.4238409501642426,-0.8908128037439266,0.6351351351351351,1.0,1.0,4/56,9.01%,EPN1;PTK6;RHBDF1;CEACAM1
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.34122443067000496,0.8906277765160271,0.6956521739130435,0.966917830560817,1.0,4/104,3.62%,F2;VAPB;MAIP1;MCUB
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.5244885600370272,-0.890589263370128,0.6612903225806451,1.0,1.0,1/10,4.69%,IL31RA
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.5000293692503189,-0.8905140844593227,0.6271186440677966,1.0,1.0,4/10,16.93%,MTHFD1;PRPS1;PRPSAP1;PRPS2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.5117282650486714,-0.8905019600939341,0.6363636363636364,1.0,1.0,3/12,18.18%,TGFB1;CST3;DDR1
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.4231917382299556,-0.8904056115465699,0.5714285714285714,1.0,1.0,2/29,5.44%,IL7;IL6R
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.3650984770949051,-0.8903969483047298,0.6133333333333333,1.0,1.0,15/80,24.52%,CLU;PHB2;GPIHBP1;ACBD5;PTTG1IP;APPL2;APOE;CSE1L;NUP50;FIS1;TOMM22;RAN;ATAD1;KPNB1;PXMP4
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3481300895680976,0.890386468779875,0.65,0.9667796812331265,1.0,34/129,12.89%,CLDN15;CLDN9;ICAM1;IL1RAPL1;CLDN12;IGSF11;PTPRD;HMCN1;L1CAM;NLGN1;PKD1;OBSL1;CDH20;ALCAM;DSCAML1;ROBO1;CDH11;ADGRL3;TGFB2;CDH4;CDH26;CADM1;CDH10;ACVR1;CELSR2;PLXNB2;LRRC4C;CDH8;CRTAM;CDH9;NTNG1;CDH2;ROBO2;ATP2C1
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.5597673776141828,-0.8903559928152949,0.703125,1.0,1.0,1/5,12.38%,STAT1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.40331000173471687,0.8902705365750392,0.7045454545454546,0.9664053307061804,1.0,1/17,2.14%,PLIN5
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.4690068246944612,-0.8899176536759161,0.59375,1.0,1.0,3/16,17.76%,KIF20B;RACK1;TEK
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.45374694809573973,0.8897724804976619,0.6,0.966951048913698,1.0,7/14,28.62%,P2RX7;P2RY1;SSH1;RYR3;TRPC3;ABCC9;KCNJ11
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.48769288004374145,-0.8897198860915826,0.6764705882352942,1.0,1.0,5/19,14.21%,SLC8A3;PHB2;AFG3L2;PMPCA;STOML2
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.4269545684602207,-0.8894290101599611,0.5932203389830508,1.0,1.0,4/27,13.03%,SEMA3E;PLET1;ADAM15;APOD
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.5313034778465747,-0.8890799495961583,0.647887323943662,1.0,1.0,3/9,21.35%,STOML2;WIZ;DBF4
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.3912241503511813,0.8890561781749319,0.5,0.9681790169261646,1.0,7/28,9.08%,ODAD3;RFX3;CFAP53;DNAH11;DNAAF1;DNAI2;DLL1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.3408819735098906,-0.8889651997176328,0.7058823529411765,1.0,1.0,22/215,13.56%,RIMS1;TINF2;ACTG1;SYCE2;SPAG17;RHOG;ELOB;CORO1B;STAG3;RSPH6A;LRRTM3;LIMA1;CLDN14;VIL1;NIFK;BAIAP2L2;TGFB1;GORASP2;ILK;AFG3L2;CHAF1A;AIF1L
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),-0.5111853697360252,-0.8889280984880168,0.6567164179104478,1.0,1.0,3/12,18.33%,ABHD1;OXSM;GLYATL2
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.3587751971105827,-0.8888780712484804,0.631578947368421,1.0,1.0,23/114,21.42%,GBP2;SEC61B;RPL11;VPS35;ARL1;RAB11A;CALR;GABARAPL2;IFT122;PAF1;SCG3;SSB;FSIP2;LAMP1;FAM149B1;XPA;TRAM1L1;CCDC47;ATP6V1D;DDX1;EMD;SERP1;TRAM2
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.4056927744869707,0.8886280581857969,0.5806451612903226,0.9688240408923549,1.0,3/32,3.15%,F2;CD59;C6
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.41601977475978746,0.8883478556614384,0.7142857142857143,0.9688535399344129,1.0,18/40,24.31%,DLX1;SMAD4;SMURF2;CHRD;BMPR2;CRIM1;LEMD3;ACVR2B;HIPK2;TRIM33;ACVR2A;UBE2D3;VWC2L;BMPR1B;SMAD5;FBN1;SMAD9;BMPR1A
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.40986578580481814,-0.8881586931964351,0.6493506493506493,1.0,1.0,17/42,28.82%,SF3A1;SNRPD1;SNRNP200;PRPF6;SNRPD2;CRNKL1;DDX1;NCBP1;SMN1;SRSF9;NOL3;SRSF10;SRSF5;KHDC4;SNRPE;PUF60;SNRPG
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.46909519844920095,-0.8880889022588104,0.582089552238806,1.0,1.0,5/16,26.32%,FSHR;AKAP7;TCIM;AKAP5;PRKAR1B
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.5023439211176688,-0.8879293795168284,0.6153846153846154,1.0,1.0,6/11,26.12%,BLOC1S4;AP3B2;SNAPIN;BLOC1S2;DTNBP1;AP3M1
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.5023439211176688,-0.8879293795168284,0.6153846153846154,1.0,1.0,6/11,26.12%,BLOC1S4;AP3B2;SNAPIN;BLOC1S2;DTNBP1;AP3M1
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.3342653215291956,0.8879150518185922,0.6086956521739131,0.9690260637966391,1.0,14/71,12.03%,SLC26A7;CA12;SLCO2B1;SLC39A8;SLC26A6;SLC25A41;SLC52A1;LRRC8A;SLCO1C1;CA2;SLCO1A2;AQP1;SLC4A4;SLC26A9
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.48450503520058796,-0.8878311168128497,0.6746987951807228,1.0,1.0,3/21,5.29%,DDX4;BTBD18;ZSCAN21
prerank,PanglaoDB_Augmented_2021__Basophils,-0.3718815516784854,-0.8877586946008303,0.6363636363636364,1.0,1.0,3/80,3.89%,CD44;AQP9;PTAFR
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.4472811860113198,0.8877485052291978,0.5833333333333334,0.9687862749196521,1.0,4/19,15.68%,ADAMTS9;TGFB2;BMPR2;PKD2
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.4290612570277054,0.8876781683564744,0.6,0.9683618815197856,1.0,6/21,23.28%,ATP10A;ATP11C;ATP8A1;ATP10D;ABCC1;ATP11A
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.3999081465821227,-0.88756396521631,0.639344262295082,1.0,1.0,11/49,14.84%,PDXDC1;TST;ERAP1;ERAP2;TPP1;USE1;SMPD2;CYP3A4;SGPL1;CYP3A5;TXN2
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.4936055240654377,0.88739522994834,0.59375,0.968307601460626,1.0,3/10,17.56%,DCX;CEP290;MYO7A
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.49409838778423615,-0.8873590323110409,0.6833333333333333,1.0,1.0,3/14,14.50%,SFRP1;AR;SFR1
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.36733118287977606,0.8873277652576068,0.6111111111111112,0.9678840418925805,1.0,10/56,13.01%,KCNJ14;KCNJ2;SLC39A8;ATP12A;SLC9C2;ATP1B3;CACNA2D1;SLC9A2;SLC12A2;SLC8A2
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.48862660704002747,-0.8873102010480259,0.6896551724137931,1.0,1.0,6/15,18.90%,TRPT1;DTD1;SSB;SARS1;POP7;AARS1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.46325513455290007,-0.887251020743473,0.603448275862069,1.0,1.0,3/22,11.26%,TPP1;TGFB1;USE1
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),0.3544630349780572,0.886820258197641,0.6428571428571429,0.9685431946408918,1.0,15/60,17.96%,TP63;PLK1;TAL1;MLLT3;FSD1;AURKC;DLL1;CCP110;FGF1;ESRRB;TXNIP;AHCTF1;PRDM15;CSPP1;BCL2L1
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.454890242743777,0.8867682636674354,0.5625,0.9680026464451282,1.0,3/15,7.25%,SARM1;DPYSL3;DHFR
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.5050143743260873,0.8867341851262115,0.5757575757575758,0.9674879114847024,1.0,1/5,7.83%,CHD7
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4455400796106973,0.886682587762707,0.6086956521739131,0.9670324341490824,1.0,1/12,1.33%,IGF1
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.38694119661928733,0.8865743460037383,0.6,0.9666026311833086,1.0,5/39,10.33%,SRC;GRHL2;NAF1;HMBOX1;TNKS
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.4966193947126401,0.8864029185567022,0.5675675675675675,0.966432611332041,1.0,4/9,23.07%,RELA;NFAT5;FUT9;MDK
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.4134847025683127,-0.886012023058559,0.6714285714285714,1.0,1.0,1/43,0.28%,PSMB8
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.4078993211506713,-0.8857418849395883,0.647887323943662,1.0,1.0,1/42,0.08%,C1GALT1C1L
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.4138921307279749,-0.8854998583871673,0.65,1.0,1.0,7/53,17.41%,DTX3L;RNF8;ARIH2;RBX1;RNF5;CDC34;UBE2D4
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.4519789906090734,0.8853524300218969,0.5853658536585366,0.9681265306583824,1.0,4/13,19.88%,TESC;DRD4;DMD;WNK1
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),-0.6055677892298323,-0.8852645504475134,0.7142857142857143,1.0,1.0,1/5,7.80%,PAX8
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),-0.591180824988909,-0.8851378440262228,0.6417910447761194,1.0,1.0,1/5,3.79%,LPA
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.5205571730669161,0.8850940232372221,0.6428571428571429,0.9680643507242662,1.0,3/9,19.93%,NDC1;AHCTF1;NUP98
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.37162801177594185,-0.8850831087093358,0.6756756756756757,1.0,1.0,16/94,22.17%,APIP;B2M;ALDH1A2;CHMP2A;AQP11;APPL2;NINJ1;RNF135;MCOLN1;RNF213;ECT2;GOLGA2;HSD17B10;POLQ;ATL3;USP16
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),-0.5346067023188892,-0.885079111918326,0.6779661016949152,1.0,1.0,2/6,15.08%,HTR2B;EDN1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.3184347213086632,0.8849793267947601,0.6842105263157895,0.9676600182827023,1.0,41/260,12.17%,VDR;RAB27A;EPB41L4B;PDGFB;IGF1;SPRY2;MYOM1;HSPA1A;MAPK11;FGF17;ADAM19;LEF1;TICAM1;CLEC7A;PPARGC1A;SNCA;SLC24A3;ZNF804A;BMP6;TESC;ITGAX;P2RX7;ARRB2;ARRB1;SCX;NTRK2;ROBO1;HSPA1B;TBC1D5;WNT3;FUBP1;PID1;ZNF304;MITF;PTPN22;SERPINB9;NOS1AP;FGF1;SLC26A9;AFDN;SLC38A2
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.4534290552573403,-0.8849175315219912,0.6031746031746031,1.0,1.0,6/17,26.94%,TPX2;ANKRD53;DCTN1;DYNC1H1;RNF4;BORA
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.5211160822685658,-0.8848499217367753,0.6714285714285714,1.0,1.0,3/8,28.97%,ZNF830;BLM;DONSON
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.41096007134939844,-0.8845545888853485,0.647887323943662,1.0,1.0,9/48,23.95%,RIMS1;RHBDF1;VAMP8;RAB8A;SEPTIN4;SCG5;LGI3;SEPTIN2;MCTP2
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.32646018433869844,0.8842772567266586,0.6285714285714286,0.9686325987208977,1.0,23/85,16.31%,DACH1;SRGAP2B;LIMCH1;DUSP10;DPYSL3;SPOCK3;ROBO1;TMEFF2;ADARB1;FRMD5;MITF;PTPRK;RECK;CHRD;AFDN;ZMYND8;SLIT2;MAGI2;FOXO3;KANK1;PTEN;DNAI3;DRD2
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.4032604342521823,-0.8840998938990199,0.7142857142857143,1.0,1.0,3/44,4.91%,ARHGAP4;TAX1BP3;RHOG
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),-0.6026057023409932,-0.8839796507016959,0.6440677966101694,1.0,1.0,1/5,3.97%,PDZK1
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),0.4908868964507791,0.8838019841897912,0.6521739130434783,0.9690620825920634,1.0,1/7,9.57%,AK4
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.40993892611214805,-0.883694544949235,0.6956521739130435,1.0,1.0,4/39,11.08%,SIGIRR;GSTP1;PARP14;GPS2
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.41309059702326795,-0.8835601643647529,0.7037037037037037,1.0,1.0,2/45,2.82%,GATA1;ZFPM1
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.29967792208992045,0.8834643138160145,0.7,0.9692244240379694,1.0,50/303,12.34%,PDGFB;PDGFC;DACH1;IGF1;SPRY2;SNAI1;CASS4;FLT1;SRC;SRGAP2B;FGF17;EGFR;LEF1;PRKX;CLEC7A;PDGFRA;OSGIN1;TMSB15B;LIMCH1;DUSP10;AKT2;DPYSL3;SASH1;CAMSAP3;IGF1R;ITGAX;SEMA5B;PLXNA1;CTNNA2;SGK1;ROBO1;TMEFF2;ADARB1;FRMD5;SYNE2;ACVR1;ZNF304;MITF;SGK3;PLXNB2;PTPRK;PARD6B;RECK;FGF1;CHRD;AFDN;MAP4K4;ZMYND8;SEMA6D;NTNG1
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.5557029171368782,-0.8833788042672497,0.625,1.0,1.0,3/6,33.73%,DDR1;AAMP;PLAT
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.5364575791479014,0.8832317683284826,0.625,0.9690202070906319,1.0,6/8,30.29%,RELB;NLRC3;LILRB1;YY1;PTPRS;CACTIN
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.3474968301271019,0.883181506284721,0.71875,0.9684917219317445,1.0,18/66,16.89%,SPRY2;HSPA1A;SRC;TMC8;MTMR2;EPHA3;BMP6;IRAK3;HSPA1B;TMEFF2;RAPGEF3;PRKD1;SACS;DNAJB6;DNAJA4;LRSAM1;GSK3B;PRKCZ
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),-0.5533174347452721,-0.8829883192543537,0.6571428571428571,1.0,1.0,3/9,24.22%,CHMP2A;CHMP7;VPS4B
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),-0.5533174347452721,-0.8829883192543537,0.6571428571428571,1.0,1.0,3/9,24.22%,CHMP2A;CHMP7;VPS4B
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.44658902654067634,0.8829273157994707,0.5833333333333334,0.9685044288116813,1.0,3/9,16.20%,DHFR;PRKG2;QDPR
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.39644309069179434,0.8829240334164569,0.5185185185185185,0.9679104358032935,1.0,11/42,17.54%,MTMR2;EPHA3;DYSF;HAMP;SNCA;PXK;PRKD1;PTEN;LRSAM1;NR1H3;NRG1
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.34047942285547533,0.8827941287493668,0.6764705882352942,0.9676660153130118,1.0,4/64,8.09%,VAPB;SPTSSB;STX1A;REEP1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),-0.5610783954027205,-0.8827694524085115,0.7,1.0,1.0,1/6,0.81%,SLC8A3
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.4881278594903894,0.8824877366386898,0.5526315789473685,0.9678950222180467,1.0,5/11,27.37%,OGT;KMT2D;TET2;KMT2A;TET3
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.4650132270848535,0.8824274427756019,0.5813953488372093,0.9674518283837459,1.0,4/8,32.73%,PIK3CA;MAP3K7;MTOR;AKT1
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.3226227072089001,0.8823253484678317,0.6923076923076923,0.9671003757232879,1.0,18/69,14.91%,RUNX1;FLT1;HSPB1;VEGFD;SIRT1;SASH1;ITGAX;STIM1;GAB1;ZNF304;ECM1;VASH2;AQP1;FGF1;RAPGEF3;PRKD1;CHI3L1;HIPK2
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.4796300974481965,0.882238556500421,0.5833333333333334,0.9666913639841269,1.0,3/12,13.08%,NT5E;NT5M;UPP1
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.558608656340605,0.8822297021320242,0.6136363636363636,0.9660924226185853,1.0,2/6,13.45%,P2RX7;PLSCR4
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.551383808083367,-0.8819553139636745,0.6984126984126984,1.0,1.0,3/7,22.85%,PRELP;OMD;OGN
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.4408529632621343,-0.8818273895256775,0.578125,1.0,1.0,1/28,0.77%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.3830913228271081,0.8815241040473206,0.5365853658536586,0.9668181780298866,1.0,10/33,14.64%,HSPB1;CLEC7A;AGER;TMEM106A;P2RX7;TRIM16;MALT1;STMP1;LPL;HMGB1
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.25410018625435254,0.8808101420929719,1.0,0.9678407407783465,1.0,162/905,15.42%,VDR;PDGFB;ZNF423;ONECUT1;TP63;GCM1;CRX;NPAS2;IGF1;ETV1;KAT2A;FLI1;RUNX1;MYRFL;SNAI1;CCDC62;AFAP1L2;ATOH8;IFNA2;ZGLP1;GRHL2;HDAC4;TAL1;EGFR;LEF1;HNF4G;RFX3;RELA;ARNT;RXRG;ZNF516;LMO7;ZXDC;SUPT3H;DLX1;HNRNPU;ATF1;PPARGC1A;PLAC8;CREB5;ARID1B;FOXK1;NPAS3;WWOX;PBX1;MLLT3;ZBTB16;HIVEP3;YAF2;GLI2;SIRT1;AGRN;LMO2;LPIN3;ASCL1;MLLT6;TBL1XR1;BMP6;EAF2;ETV5;PKD1;SMARCA2;NEK4;SERPINF2;MAML2;RYBP;NFIB;PICALM;TESC;TRIM16;NFIA;ZNF451;HCLS1;PHF10;ARRB1;NRF1;NOTCH4;SCX;ZEB2;MEIS1;ST18;MLXIPL;NRIP1;MEIS3;ASXL3;DLL1;TCF12;CD4;DMRT1;TOX3;SOX30;GABPB1;OGT;NFKB1;PID1;GDNF;STAT6;TNKS;MAFB;CRTC1;ACVR1;RNF14;ZNF304;WAC;MITF;TEAD1;ARID1A;RARG;SMAD4;PCGF5;KLF15;SOX12;THRB;RHOQ;FGF1;NCOA7;ZNF318;AUTS2;GRIN1;TEAD2;SCAF8;ELL;RGMB;TRIM44;MEIS2;SMARCD2;PRKD1;ZNF281;SSBP4;NFAT5;ESRRG;VEZF1;CD80;TCF4;LDB2;TFDP2;FOXO3;RPS6KA1;KDM1B;ESRRB;MLLT10;BMPR2;ZNF143;SS18L1;TFEC;CSRNP1;HNRNPD;HMGB1;ATRX;KAT2B;ZNF24;CEP290;HIPK2;SSBP2;SMARCD3;RPRD1B;SFPQ;MED13;BCLAF1;THAP3;NIBAN2;DYRK1A
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.35173054281414945,0.8806632696744612,0.5862068965517241,0.9676306305813511,1.0,18/61,15.10%,MORN5;ZBTB7C;TACC2;GRHL2;ATP12A;MYO5B;MYH14;DNAH3;BPIFB1;KCNMA1;SHANK2;CDS1;SLC12A2;DNAH12;TMCO5A;SHROOM3;ARFGEF3;HYDIN
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.3772046971666933,-0.8805205928642347,0.6575342465753424,1.0,1.0,12/67,19.08%,RPS2;CENPX;FANCM;RBX1;PINK1;BRCA1;PTTG1IP;SPRTN;UBB;SEPTIN4;ANGPT1;FANCI
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.4355509157147613,0.8804658507938484,0.59375,0.9674703363598435,1.0,3/17,8.57%,IGF1;HAP1;NTRK2
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.37075707657377116,0.8804645652930905,0.6363636363636364,0.9668810178514831,1.0,8/58,5.76%,CREB3L1;STAB1;SPRY2;VASH1;YJEFN3;ADGRB1;ADAMTS9;SPRED1
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.40551867634700167,-0.8802446524412286,0.676056338028169,1.0,1.0,6/41,14.02%,BMP5;ALDH1A2;LMX1B;TGFB1;BRCA1;MYH6
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),-0.5844471348385604,-0.8801299350874129,0.6779661016949152,1.0,1.0,2/5,30.42%,GLI3;FAS
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.3466942784014105,0.8799637984434179,0.6666666666666666,0.9675298038712985,1.0,2/59,3.05%,F2;PLK1
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.4933158966328175,-0.8798334073761103,0.6229508196721312,1.0,1.0,2/9,18.94%,SLAMF8;ECSIT
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.4063658515377148,-0.8797381458916467,0.5714285714285714,1.0,1.0,9/36,28.14%,EEF1AKMT2;TRMT112;BHMT;EZH2;METTL21A;ETFBKMT;CSKMT;FAM98A;PRMT2
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.4509721918137086,0.8796881843199059,0.6756756756756757,0.9663918744954495,1.0,5/11,28.78%,PANK1;PANK3;PPCDC;PANK4;ACOT7
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.4509721918137086,0.8796881843199059,0.6756756756756757,0.9663918744954495,1.0,5/11,28.78%,PANK1;PANK3;PPCDC;PANK4;ACOT7
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.4509721918137086,0.8796881843199059,0.6756756756756757,0.9663918744954495,1.0,5/11,28.78%,PANK1;PANK3;PPCDC;PANK4;ACOT7
prerank,GO_Biological_Process_2021__caveolin-mediated endocytosis (GO:0072584),-0.596691390057402,-0.8792066773223619,0.6842105263157895,1.0,1.0,2/5,32.22%,CAV1;MAPK3
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.39333763770767805,0.8791031259637465,0.5357142857142857,0.9669899905468732,1.0,2/30,4.83%,GSTT2;HPGDS
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.406796081192583,0.879074591858374,0.5813953488372093,0.9664524863676255,1.0,9/29,12.99%,HSPB1;CLEC7A;AGER;TMEM106A;P2RX7;TRIM16;MALT1;STMP1;LPL
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.565596106260634,0.8790017228774514,0.6744186046511628,0.9660224869458028,1.0,1/5,16.78%,GHR
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.3721884556249484,-0.8785996501345881,0.6575342465753424,1.0,1.0,2/49,1.75%,SFRP1;ACTG1
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.44260248309560923,-0.8785288558463794,0.6438356164383562,1.0,1.0,3/26,6.62%,TGFBR2;MESP1;CCDC39
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.40248672164629934,0.878259443998315,0.7407407407407407,0.9669072062767236,1.0,6/19,18.82%,TMEM108;NTRK2;RAPGEF1;MAGI2;RAP1A;MAPT
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.6050897633531871,-0.8780981143355424,0.6851851851851852,1.0,1.0,2/5,37.21%,GNPAT;DHRS7B
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.6050897633531871,-0.8780981143355424,0.6851851851851852,1.0,1.0,2/5,37.21%,GNPAT;DHRS7B
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.4813247910706165,-0.8780617825109597,0.6610169491525424,1.0,1.0,3/12,7.17%,TIMP1;NPPC;CALR
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.5037249180863295,-0.8779795458841658,0.5873015873015873,1.0,1.0,3/13,15.79%,CCNB2;NEK6;DCTN1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.35176849542689526,-0.8778301982277882,0.7611940298507462,1.0,1.0,29/118,24.77%,NLRP1;SELENOS;LACC1;VPS35;HYAL2;CXCL17;TMSB4X;GPS2;SELE;GRN;NLRP12;NMI;TNFRSF1A;MAPK7;NINJ1;UFL1;TEK;APOE;IFI35;SERPINE1;SNX6;ZP3;MMP26;DAGLA;ALOX5;ETS1;AOAH;TNFAIP6;NR1D1
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),-0.5720375239507429,-0.8773232784387058,0.6666666666666666,1.0,1.0,1/6,1.60%,GAPDH
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.3653040164453302,0.8772419157530073,0.5,0.9684475301944216,1.0,5/34,8.26%,CERS3;ST8SIA6;SPTSSB;SGMS1;ST8SIA4
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),0.4902844879742666,0.8772162018136812,0.5714285714285714,0.9679104511085254,1.0,3/8,12.34%,SLC26A6;SLC2A5;TJP2
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.3888662377228338,0.8770861266677765,0.6111111111111112,0.967611789584944,1.0,12/37,17.70%,GRM2;HOMER1;GRM8;GRM1;GRM3;CPEB4;GRIN1;GRIK2;GRIN3A;GRIN2B;GRIA2;GNAQ
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.3745973807949361,0.8770839119920736,0.6551724137931034,0.9670267202297871,1.0,2/38,2.14%,PPP1R36;PLIN5
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.34482474189568885,0.8770241800373609,0.64,0.9665406301605375,1.0,30/127,13.70%,ADAM33;TPM2;PCDH18;FBLN5;NRP2;PDGFRA;LMO7;POSTN;SMTN;PDE4DIP;MSRB3;EHD2;AKT2;TMEM47;OBSCN;NOTCH3;CDH11;COL14A1;RGS5;HTRA1;LOX;COL5A1;SGCD;AQP1;SLIT3;ADAMTS5;ACKR3;FBXL7;PLSCR4;LDB2
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.4224339874011419,0.8769947238264089,0.6410256410256411,0.9660387684057338,1.0,5/24,8.38%,DACH1;SRC;GNL3L;HNRNPU;STN1
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.35546379087113417,-0.8769652448669041,0.7375,1.0,1.0,13/119,14.08%,BMP5;RIMS1;JPH3;TCEAL2;TCEAL5;STMN2;PAK5;CHGB;HOPX;PCSK1;DUSP26;SCG3;SLC2A2
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),-0.5842537851435833,-0.8768985059191301,0.7301587301587301,1.0,1.0,3/6,20.86%,RAD51AP1;MEIOSIN;OOEP
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),0.5732128878633193,0.8767817381922196,0.6904761904761905,0.9659955170044576,1.0,3/5,16.10%,KCNMA1;DOCK5;DOCK4
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.37098421188692227,0.8765462471801632,0.6785714285714286,0.966034053502903,1.0,8/35,12.99%,PIEZO2;MAP3K14;MAP2K4;CRADD;MAP3K1;NFKB1;AQP1;TNFRSF10A
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.4422338223020276,-0.8762533733249094,0.625,1.0,1.0,6/16,27.62%,TYMS;PPIA;POLD2;POLD4;CDKN2D;POLL
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),-0.5928809571703939,-0.8762398126050918,0.7213114754098361,1.0,1.0,2/6,20.08%,ATP6AP2;CTSZ
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),-0.5928809571703939,-0.8762398126050918,0.7213114754098361,1.0,1.0,2/6,20.08%,ATP6AP2;CTSZ
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.5397056258263244,0.8760987083331816,0.6388888888888888,0.9662359129558025,1.0,2/6,18.20%,PSPH;SRR
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.37642115422778405,-0.8760337679240929,0.7162162162162162,1.0,1.0,28/103,28.31%,GAPDH;VPS35;NRBP2;RRAGA;TRIM13;LAMTOR5;PINK1;CDK5;CAPNS1;SUPT5H;ATP6V1E1;LAMTOR1;ATP6V1E2;ATP6V1D;SNX6;RRAGC;PRKACA;ATP6V1C2;LAMTOR2;EXOC7;DCN;BNIP3;SMCR8;UCHL1;ATP6V1G1;SNX32;LAMTOR4;SCOC
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.43738782602676307,-0.8757556246736822,0.647887323943662,1.0,1.0,5/19,23.09%,JUP;CALM3;RANGRF;CAV1;CALM1
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),0.49710860805785956,0.8756437465648667,0.5517241379310345,0.9666497771341284,1.0,1/12,1.65%,MAIP1
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.5620278679203832,-0.8754410051529504,0.7457627118644068,1.0,1.0,3/8,22.28%,GPR183;CCR7;ALOX5
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.42649284267281967,-0.875367721027803,0.6470588235294118,1.0,1.0,1/26,0.65%,IRF4
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.4731549588687241,0.8751433395698831,0.5882352941176471,0.9670060262772736,1.0,5/8,32.05%,CAMK2D;WNK1;WNK2;COMMD1;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.3518419599529896,-0.8750330705672751,0.7058823529411765,1.0,1.0,9/142,9.33%,ARHGEF16;SFRP1;TAX1BP3;USP6;ARHGAP42;RHOG;RACK1;RASGRP1;HRAS
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.41025999996491597,0.874910892795239,0.5813953488372093,0.966970470221,1.0,1/15,3.54%,GDAP1
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),-0.5706618777425305,-0.8748607291794213,0.6774193548387096,1.0,1.0,2/6,13.88%,TGFBR2;DOCK2
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.5860665734343394,-0.8743281170122424,0.6935483870967742,1.0,1.0,2/7,21.83%,HMGCL;BCAT2
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.4594157406920726,0.8741740526356185,0.6896551724137931,0.9682468789179624,1.0,7/19,19.54%,MBNL1;PKD1;CHD7;FUT8;PTPRR;ZNF568;LIG4
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.35412054281762173,0.8741139558174885,0.6052631578947368,0.9678197165459731,1.0,4/30,5.18%,SGO1;ZNF207;PLK1;ESPL1
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.4486068620607681,0.8739929606775438,0.5675675675675675,0.9674988769827286,1.0,5/17,8.05%,TCAP;ALPK3;PDGFRA;OBSL1;PDLIM5
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.4631614278143763,0.8737424992401615,0.65625,0.9674712412215517,1.0,3/22,4.47%,RFX3;CLEC7A;CX3CR1
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.3510994211580407,-0.8736216399301174,0.7407407407407407,1.0,1.0,20/111,20.95%,AFP;GLP2R;GFRA3;TCEAL5;STMN2;PAK5;CHGB;PCSK1;CCK;DUSP26;SCG3;CALY;MLN;SCG2;INA;HPCA;GDAP1L1;SCG5;NPSR1;SST
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5297850300202525,-0.873614821331107,0.6470588235294118,1.0,1.0,1/10,0.65%,IRF4
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.41078250633981495,-0.8735531816615562,0.6388888888888888,1.0,1.0,2/32,9.27%,TINF2;TPP1
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.5360381058467254,-0.87353938164569,0.6349206349206349,1.0,1.0,1/8,9.01%,CEACAM1
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.5602338851177837,-0.8734747692336868,0.7090909090909091,1.0,1.0,1/6,1.05%,TTN
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.43579064862166544,-0.8733812415620448,0.6388888888888888,1.0,1.0,1/24,0.14%,EPN1
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.3179006030656982,0.8723184170804247,0.6153846153846154,0.9700123252961205,1.0,19/79,14.91%,RUNX1;FLT1;HSPB1;VEGFD;SIRT1;SASH1;ITGAX;DLL1;STIM1;GAB1;ZNF304;ECM1;VASH2;AQP1;FGF1;RAPGEF3;PRKD1;CHI3L1;HIPK2
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.4825789948680163,-0.872204140356268,0.684931506849315,1.0,1.0,2/10,19.00%,ROMO1;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.3531120451151791,-0.8721740292935495,0.8095238095238095,1.0,1.0,19/140,16.11%,TYRP1;RPL5;CLU;PCNA;RPS4X;FABP3;RBM3;ATAD5;DDAH2;GIPC1;LARP6;EIF3D;EEF2;DUOXA1;RPS27L;EDN1;PYM1;EIF4A3;GCK
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.4425920207882885,-0.8721334003941862,0.6166666666666667,1.0,1.0,3/21,8.35%,HLA-DPA1;LCK;TNIP2
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.5157760941111597,-0.8716019984606502,0.7192982456140351,1.0,1.0,1/8,5.32%,CORO1B
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.45375459864591916,0.8712448769352551,0.5882352941176471,0.9714373576141163,1.0,2/26,1.33%,PTPN6;IGF1
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.3868705067594896,-0.8711313788093029,0.6933333333333334,1.0,1.0,20/65,25.87%,STMN1;CLU;LIMA1;PLEKHH2;TPX2;STMN2;VBP1;MYADM;KATNB1;PFDN2;HSPA8;PFDN6;APOE;PFN2;TUBB4A;PFDN1;APC2;NAV3;PFN1;TWF1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.4226899132374706,0.8710818427273948,0.5862068965517241,0.9711638131572689,1.0,5/18,18.97%,RGPD4;RGPD3;RGPD2;KPNA3;CBLB
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.4016242187173663,0.8704042657158005,0.5652173913043478,0.9721158069268127,1.0,1/28,0.30%,RAB27A
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.5012777814057606,-0.869950178486514,0.58,1.0,1.0,3/9,27.25%,PDZD11;BTD;PCCB
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.3458976659097601,0.8696705878295335,0.6052631578947368,0.9732207168174853,1.0,19/89,17.54%,PDGFB;IGF1;PRR5;TRAF2;TNIK;TGFB2;RICTOR;MALT1;FGF1;MAP4K4;ADCY8;TNFRSF10A;CHI3L1;GHR;PRKACB;PRRC1;KIF14;ABL1;NRG1
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.3628533073828709,0.8693030177209252,0.7083333333333334,0.9734085225969304,1.0,26/64,23.01%,SYCP2L;SORBS1;COL9A1;GREB1;ADRA1A;ACACB;ZNF483;FGF13;GALNT16;TFDP2;ESRRB;CADM2;ACVR2B;LRP1B;PTCHD1;LRRC2;MAPT;ADCYAP1R1;CMYA5;MYH7B;GARNL3;ATP1A2;RYR2;DTNA;ADCY2;SLC35F1
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),-0.5610254804740011,-0.868884324506017,0.7017543859649122,1.0,1.0,1/5,15.61%,CCT2
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),-0.5610254804740011,-0.868884324506017,0.7017543859649122,1.0,1.0,1/5,15.61%,CCT2
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),0.5765883870014156,0.8688255086739676,0.631578947368421,0.9733301714490781,1.0,2/5,8.81%,HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),0.5765883870014156,0.8688255086739676,0.631578947368421,0.9733301714490781,1.0,2/5,8.81%,HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.48711217512983107,0.8686701667521541,0.59375,0.9731050110605427,1.0,3/11,13.08%,NT5E;NT5M;UPP1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,0.33632374456166125,0.8681329644460046,0.59375,0.9737047416555791,1.0,19/112,11.01%,VDR;FGFR1;TNC;PCDH18;LRP4;PDGFRA;POSTN;HMCN1;LTBP2;SSC5D;ADAMTS2;EHD2;COL6A1;CDH11;COL14A1;HTRA1;LOX;COL5A1;NPNT
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),-0.576601476902459,-0.8681130820430173,0.7419354838709677,1.0,1.0,2/6,9.20%,ABHD1;OXSM
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.4585898683902043,-0.8680186930889036,0.5384615384615384,1.0,1.0,3/11,17.48%,CA6;TAS2R39;PIP
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.4378891443249057,-0.8677911070846713,0.6376811594202898,1.0,1.0,11/30,24.86%,SLC27A5;SCD;AWAT1;SLC25A1;HMGCL;HPGD;FASN;ALOX5;FAR2;HSD17B8;PPT1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.5040837815208106,0.8676501138717704,0.5428571428571428,0.9740613588280546,1.0,5/14,12.74%,KCNJ2;ATP12A;ATP1B3;KCNMA1;SLC12A2
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.3548355908992683,-0.8676178957934104,0.7361111111111112,1.0,1.0,12/87,15.93%,RPS27A;SFRP1;TGFBR2;HYAL2;UBA52;OVOL2;BAMBI;TGFB1;FNTA;UBB;APPL2;MAPK7
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.47510711024036856,-0.8674152326963387,0.703125,1.0,1.0,2/15,9.69%,RRAGA;LAMTOR5
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.398049251319528,0.8673307765014177,0.6410256410256411,0.9741430043634501,1.0,1/18,1.25%,BCL2A1
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.44934230385076224,0.8672331839938441,0.5945945945945946,0.9738291286512878,1.0,4/9,22.68%,ADGRB3;C3;ANKS1A;APP
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.45188498950165945,-0.866875978178726,0.6417910447761194,1.0,1.0,2/14,9.74%,SFRP1;LMX1B
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.5008150161400781,0.8668095765520989,0.7567567567567568,0.9741285702427237,1.0,4/8,32.93%,RPS6KB1;SLC27A2;SPX;ACSL1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.3192642442849028,0.8667947375191053,0.7368421052631579,0.9735652182787491,1.0,29/118,13.48%,KCNQ2;GFAP;EFNB3;CELF3;DLX1;NPAS3;SCRT1;ASCL1;CTNND2;IGF1R;P2RX7;SEMA5B;RND3;CACNG4;PCDH8;NXPH1;SNAP91;MEIS3;ADGRL3;TOX3;MEGF10;SRRM3;ZNF536;CAMKV;NCAN;ARX;GPM6B;SLC8A2;DCX
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.38353064179940577,-0.866738955219459,0.7313432835820896,1.0,1.0,8/54,11.87%,GBP2;APOL6;PTAFR;HLA-E;IL6R;IRF1;GPR183;SLAMF8
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.33189606694338447,0.8667336151594353,0.7407407407407407,0.9730508770030644,1.0,5/85,5.47%,F2;RELA;PDGFRA;GUCA1B;ADGRA2
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.484644102453581,0.8667189766436035,0.6363636363636364,0.9724808025847783,1.0,1/7,3.25%,JAM2
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.5602962786789751,-0.8666786654503954,0.6792452830188679,1.0,1.0,4/7,27.31%,STAT1;TBC1D20;IFIT1;DDB1
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.43294891694227833,-0.8666428606568359,0.7272727272727273,1.0,1.0,4/25,17.50%,IRF1;ERAP1;APPL2;RNF135
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.31999686338619066,-0.8665890663396998,0.8023255813953488,1.0,1.0,42/312,13.99%,BMP5;RPL23;GLP2R;IL7;PDGFD;COPS9;XBP1;SFRP1;TIMP1;TGFBR2;RPS6;SLC25A5;IL31RA;RHOG;ROMO1;RPS4X;IL6R;GNAI2;TSHR;RPS9;CALR;KIF20B;CD81;SERTAD1;BAMBI;COX17;HTR2B;HRAS;AQP11;CEP131;CLEC11A;SOX15;TGFB1;CDK4;AR;GRN;STAT1;ESM1;CAPNS1;OSMR;RTKN2;VIP
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.5766952681573547,-0.8665047381311434,0.640625,1.0,1.0,1/5,11.39%,PPP1CA
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.43118176961707877,-0.866389781671501,0.6551724137931034,1.0,1.0,4/32,9.13%,SEMA3E;PLET1;FBLN1;ADAM15
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.33798478346200667,-0.8662592220085449,0.6891891891891891,1.0,1.0,13/158,9.52%,CD44;APIP;IL26;PDGFD;GSTP1;FBLN1;HTR2B;CEACAM1;RASGRP1;HRAS;GPR183;FSHR;PHB2
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.42224155745643066,-0.8662157950413488,0.6623376623376623,1.0,1.0,7/26,24.31%,CORO1B;LIMA1;BAIAP2L2;AIF1L;LCP1;CALD1;USH1C
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.46523252187062536,-0.8661753984274969,0.6724137931034483,1.0,1.0,5/12,28.49%,IFT122;DYNC2H1;DYNC2I1;DYNC2I2;WDR35
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.40938045390074107,-0.8660450249830646,0.647887323943662,1.0,1.0,4/29,7.78%,FGL1;HLA-DPA1;PRELID1;LCK
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.36320049000969984,-0.865821704047951,0.6891891891891891,1.0,1.0,30/67,37.65%,PHB2;SNRPD1;PTTG1IP;SNRPD2;APPL2;CSE1L;NUP50;RAN;DDX20;SMN1;GEMIN6;KPNB1;NXT1;SNRPE;SNUPN;SNRPG;GEMIN2;NUP155;NXT2;SNRPB;POM121;NUP93;NUP88;POM121C;NUP107;EIF4ENIF1;GEMIN4;GCKR;SEC13;STAT3
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",-0.5667795499312764,-0.8656889658400267,0.75,1.0,1.0,2/5,31.74%,TOE1;TRIR
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.5611582012911155,-0.8654421872578404,0.6551724137931034,1.0,1.0,1/5,15.78%,APPL2
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.38514880515555205,-0.8649165488321963,0.7341772151898734,1.0,1.0,16/57,29.57%,RPS3;ANKRD53;BAIAP2L2;PINK1;TPPP3;DCTN1;LMOD1;CDC42EP1;CCR7;PFN2;NAV3;PFN1;ARF6;MAPRE1;FES;EVL
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.44064795044587973,-0.8647457740865306,0.6811594202898551,1.0,1.0,8/26,29.86%,IRF1;FLOT1;RNF135;RIOK3;TOMM70;POLR3D;DHX58;ISG15
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.4058708413166667,0.8646583772436374,0.5454545454545454,0.976119241261849,1.0,4/23,6.84%,FGFR1;VCAN;POSTN;OLR1
prerank,GO_Biological_Process_2021__definitive hemopoiesis (GO:0060216),-0.5498532517982424,-0.8644110109284127,0.7068965517241379,1.0,1.0,1/5,17.76%,TEK
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.4475358880548888,0.8643279332954822,0.5757575757575758,0.9762555897443491,1.0,2/27,1.33%,PTPN6;IGF1
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.48588261344050965,-0.8642880191352735,0.7692307692307693,1.0,1.0,5/16,19.87%,TRPT1;TSEN34;C2ORF49;CLP1;DDX1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.34007815985867396,0.8642629219444278,0.6060606060606061,0.9758292625265137,1.0,24/104,15.40%,DACH1;IGF1;CGNL1;FRZB;PDGFRA;POSTN;KCNT1;TMEM47;SASH1;DOCK1;ARID5A;CDH11;RGS5;HTRA1;AQP1;C3;ADAMTS5;RNF182;PLSCR4;PXDC1;LDB2;LRRC66;SMARCD3;ARVCF
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.4234549652765931,-0.864193462483674,0.6857142857142857,1.0,1.0,2/30,1.77%,SELENOK;ZDHHC12
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.46032566327403174,0.8640745652908447,0.6578947368421053,0.9757407519252955,1.0,1/12,5.59%,ADAMTS9
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.4416558641267718,0.8638545710763146,0.6285714285714286,0.9750266149274733,1.0,3/8,23.90%,SLC1A2;PNPT1;MLKL
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.4416558641267718,0.8638545710763146,0.6285714285714286,0.9750266149274733,1.0,3/8,23.90%,SLC1A2;PNPT1;MLKL
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.43477538188697595,-0.8638444975339554,0.676056338028169,1.0,1.0,3/19,10.62%,JUP;PLN;SRI
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.40897027692691457,0.8637804979779489,0.6774193548387096,0.9745860147288578,1.0,6/22,14.15%,IGF1;HS3ST4;CHST11;CSGALNACT1;CHST8;BMPR2
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.43978856839971797,0.8637119202632816,0.6388888888888888,0.9741619664145622,1.0,8/15,21.71%,RUNX1;CD22;PTPN22;NFAM1;CBFB;ELF1;ELF2;SLC39A10
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.5055534310198214,0.8637090512140011,0.5945945945945946,0.9729953053769399,1.0,5/7,25.61%,CXCL13;WNK1;WNT5A;STK39;OXSR1
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.5055534310198214,0.8637090512140011,0.5945945945945946,0.9729953053769399,1.0,5/7,25.61%,CXCL13;WNK1;WNT5A;STK39;OXSR1
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.36433724096651693,-0.8636696795732544,0.7352941176470589,1.0,1.0,20/99,18.48%,SLC25A4;COX7A1;TTN;NPPC;HSPB8;FABP3;SYNPO2L;PLN;GPIHBP1;PDLIM3;ART3;BDNF;SGPL1;DUSP26;MYH6;COL21A1;LMOD1;CKB;SRL;MYOM2
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.3847716304827606,-0.862949331791432,0.65625,1.0,1.0,3/43,4.38%,RPL23;XBP1;DDX11
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.3450980660661922,0.8628527355175607,0.6551724137931034,0.9741164703599894,1.0,2/42,3.92%,TNFSF13B;SLC7A1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.4518454355375455,-0.8626637021412222,0.6716417910447762,1.0,1.0,3/17,13.45%,CXCL17;TGFB1;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.3583080205296774,0.862650548116269,0.7037037037037037,0.9739814518933594,1.0,8/53,10.95%,NFATC4;CX3CR1;PPARGC1A;ADAM8;NTRK2;TOX3;GDNF;CPEB4
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.4695980245303689,-0.862643794027837,0.7096774193548387,1.0,1.0,4/14,13.37%,CLU;PRELID1;TRIAP1;PPIF
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.3921167316546528,0.8621360774632282,0.6666666666666666,0.9746853189772212,1.0,2/13,9.06%,DCTPP1;NT5M
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.4516926881556891,0.8619388929989757,0.6585365853658537,0.9739443661069094,1.0,6/11,31.48%,NOTCH4;ZFP36;TNRC6A;AGO3;TNRC6C;AGO2
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.4516926881556891,0.8619388929989757,0.6585365853658537,0.9739443661069094,1.0,6/11,31.48%,NOTCH4;ZFP36;TNRC6A;AGO3;TNRC6C;AGO2
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.3871603041604585,0.8614449735015368,0.59375,0.9743838682330366,1.0,5/30,15.68%,CDK6;CDKN2A;DLG1;PTEN;PKD2
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),-0.5509134707015035,-0.8614170718576152,0.7333333333333333,1.0,1.0,2/6,25.05%,RNF26;SQSTM1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.4185142547773418,-0.8612751697840676,0.6461538461538462,1.0,1.0,5/25,8.96%,SFRP1;PTK6;HYAL2;PARP14;SH3BP5
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.3496383094652484,-0.8612643767147252,0.7333333333333333,1.0,1.0,14/136,13.46%,BMP5;SFRP1;ZFPM1;BBS12;EFNA1;IL17RD;OVOL2;CALR;BAMBI;TGFB1;GPS2;HOPX;PAF1;WNT9A
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.45357315621653366,0.8612461144814417,0.675,0.9742650304683197,1.0,2/11,15.27%,PHYH;IDH2
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.3728224361329551,-0.8610435037889598,0.6901408450704225,1.0,1.0,4/63,8.57%,FAM131C;TMEM198;EFNA2;SEZ6L2
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),0.4749192314345123,0.8608751422983956,0.6590909090909091,0.9744808243312225,1.0,1/6,5.34%,SMS
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.42661420186212146,-0.8607005808249432,0.6268656716417911,1.0,1.0,11/31,28.82%,CSTF2T;FIP1L1;LSM10;CPSF3;CLP1;NCBP1;TTF2;SSU72;NCBP2;SNRPE;SNRPG
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.42993808229912683,0.8604039587101369,0.6571428571428571,0.9749112623501865,1.0,5/12,18.27%,INPP1;NUDT3;PTEN;SYNJ2;INPP5B
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.3359237410321025,0.8601957721484154,0.8148148148148148,0.974808232003223,1.0,14/59,12.50%,ACSM1;AK3;RAB23;ADSS2;SULT2A1;HPRT1;AMPD1;AK4;SULT2B1;GPAT4;RHOQ;ACOT6;ENPP1;PTHLH
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.31604590464827886,0.8596349790942213,0.8636363636363636,0.9754526086551695,1.0,20/102,17.63%,KAT2A;HDAC10;HDAC4;EYA4;SUPT3H;SIRT1;TBL1XR1;USP36;AURKC;CPA4;HDAC9;PRMT6;PHC1;CCNA2;EHMT1;CREBBP;UHRF1;PRMT8;USP3;MIER2
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.5143972094926282,-0.8593945269047613,0.65,1.0,1.0,2/6,21.74%,CEACAM1;CD226
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.4533467495791448,0.8591211432031874,0.5833333333333334,0.9759532071637512,1.0,2/13,6.81%,RAB23;RANGAP1
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.3475521723051516,0.8591044468830217,0.7027027027027027,0.9753891989257741,1.0,11/36,16.95%,PIWIL4;PIWIL2;PRKRA;PLD6;XPO5;DICER1;TENT4B;TDRD12;TDRD9;MOV10L1;TDRD1
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.3329186492756246,-0.8589321362905178,0.7529411764705882,1.0,1.0,20/233,13.17%,ARHGEF16;RPS27A;SFRP1;IFIT2;CLU;NEURL1;RPS6;VAV3;RASGRF2;HRK;UBA52;SFRP4;RACK1;APH1A;PRR7;ZNF622;FADD;OLFM1;PDCD2;C1QBP
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.4763116240800245,0.858795904863383,0.5555555555555556,0.9755003926349658,1.0,1/7,3.66%,KCNIP2
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.3357844058804587,0.8587931982749268,0.7666666666666667,0.9749293916134164,1.0,6/39,10.80%,PDGFB;IGF1;DUSP1;OBSL1;DMRT1;RCC1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.5124474514277144,0.8586885034747556,0.675,0.9745413718744882,1.0,1/5,3.25%,JAM2
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.3669304131905926,0.858621263669701,0.6060606060606061,0.9741458905873406,1.0,24/64,17.25%,RELN;NFATC4;AGER;NLGN1;HAP1;CACNG5;CACNG4;ZDHHC3;ADRA1A;SHANK2;NRXN1;ADCY8;CRHR2;NLGN3;SLC8A2;CLSTN2;GRIK2;ZDHHC2;NMU;GPER1;RIMS3;TSHZ3;PRKCZ;GRIN2B
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.5043732026643085,-0.8581360854039646,0.6557377049180327,1.0,1.0,2/9,19.39%,P4HA3;P4HTM
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),-0.3498893965247399,-0.8578384563200363,0.7692307692307693,1.0,1.0,23/129,22.73%,XBP1;SFRP1;ATP6V1F;ATG14;CARTPT;RRAGA;LAMTOR5;HSPA5;GABARAPL2;CEBPB;MYBBP1A;HSPA8;ATP6V1E1;LAMTOR1;ATP6V1E2;ATP6V1D;MAP1LC3B;RRAGC;IMPACT;WDR45B;ATP6V1C2;RRP8;LAMTOR2
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.4377462626677526,0.8575978245219997,0.5666666666666667,0.9759438500107228,1.0,5/18,13.49%,SLC7A1;SLC47A1;SLC7A5;SLC22A2;SLC6A13
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.37679177179358864,0.8573229638932173,0.53125,0.9759436156452138,1.0,1/31,0.30%,RAB27A
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.4174223979919618,0.8571674387270614,0.6923076923076923,0.9757219716179613,1.0,11/29,17.09%,IRS1;FOXK1;SIRT1;AKT2;OGT;GPLD1;RUBCNL;PDK1;PDK4;SLC45A3;FBP1
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.5024765962199842,-0.8571340313985529,0.6666666666666666,1.0,1.0,2/11,18.72%,CEACAM1;ANGPT1
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.4703888329331115,-0.8570658816941525,0.6545454545454545,1.0,1.0,1/16,2.25%,STMN1
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.3159361894454529,0.8570199773713806,0.6521739130434783,0.9754531728066221,1.0,8/65,8.65%,ATP6V0A4;EPS8L2;PIEZO2;CLIC5;GRXCR2;MYH14;PCDH15;MYO3A
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.5273348029170242,-0.8570144884525372,0.6833333333333333,1.0,1.0,4/7,35.45%,GOLGA2;CDK1;STX5;PLK3
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),-0.5658251241032489,-0.8568584121537807,0.7272727272727273,1.0,1.0,2/5,16.33%,SFRP4;KRT10
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.43394288023634847,0.8568123623623092,0.7222222222222222,0.975374247345994,1.0,3/10,13.53%,GAS2;DPYSL3;BAIAP2L1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.46217743141066314,-0.8567504370501731,0.7076923076923077,1.0,1.0,1/16,0.55%,GATA1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.46217743141066314,-0.8567504370501731,0.7076923076923077,1.0,1.0,1/16,0.55%,GATA1
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.5623999488297988,-0.8567265328138971,0.6666666666666666,1.0,1.0,2/5,18.48%,PMP22;EMP3
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.5159302042884094,-0.856701695742161,0.671875,1.0,1.0,2/12,13.96%,BRCA1;DNMT3B
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.4951748563729327,0.8565226150540028,0.6,0.9755006457514912,1.0,1/7,10.73%,DICER1
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.325617199215426,0.8564898027630399,0.75,0.9750036776685458,1.0,12/76,13.85%,NOS2;IRS1;ABCC8;RFX3;ENSA;STX1A;LRRC8A;KCNC2;ACSL4;ITPR1;RAPGEF3;RAPGEF4
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),-0.4831972488206172,-0.8562828773170617,0.5846153846153846,1.0,1.0,3/9,14.08%,AQP9;AQP11;SLC2A2
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),0.5000894417226353,0.8560010991298556,0.6590909090909091,0.9753509023689952,1.0,1/6,4.24%,CPT1C
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.4864176360837561,-0.8559464452696808,0.746268656716418,1.0,1.0,5/15,19.87%,TRPT1;TSEN34;C2ORF49;CLP1;DDX1
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.3315137432308102,0.8558345360648206,0.7272727272727273,0.9751303919369311,1.0,32/162,16.64%,F2;LEPR;VEGFD;FGF17;EGFR;AGER;PROM2;LIMCH1;SIRT1;AKT2;NSMF;ARRB1;TNIK;NTRK2;CD4;WDFY2;NOS1AP;FGF1;C3;CAMTA1;SPPL3;RAPGEF3;TESK1;P2RY1;DYRK1A;GPER1;FXR1;NIBAN1;PELI2;ACVR2A;ASPSCR1;PDE8A
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.5021715710688048,-0.8558313930259636,0.6607142857142857,1.0,1.0,4/11,35.45%,GOLGA2;CDK1;STX5;PLK3
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),-0.5701403598841169,-0.8556281359507664,0.734375,1.0,1.0,3/6,15.68%,ADH4;CYP3A4;LDHD
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),-0.5308699525606331,-0.8555477704841739,0.7592592592592593,1.0,1.0,2/7,10.91%,CD81;FADD
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),-0.5595462603923712,-0.8551560883434887,0.7307692307692307,1.0,1.0,2/6,22.11%,FGF7;TGM1
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.45376891566792193,-0.8549005917028057,0.6833333333333333,1.0,1.0,8/15,34.95%,RBM22;SNRNP200;NCBP2;WBP11;CWC15;DDX23;WBP4;SNRPC
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.5232512431832772,-0.8548834190701455,0.7358490566037735,1.0,1.0,2/8,20.49%,TRMT5;HSD17B10
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.519716691308771,0.8548607283584729,0.6764705882352942,0.9765244917831954,1.0,1/6,6.07%,NLGN1
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),0.414581493089546,0.8546878490436592,0.6451612903225806,0.9763586416165726,1.0,7/19,17.60%,DNAAF1;GLI2;HECA;FGF1;CHI3L1;PCSK5;FGF2
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.4067985761192612,0.8544907763445376,0.7777777777777778,0.9761929866826358,1.0,8/26,17.71%,EFNB3;LRP4;DIP2B;MCF2;FGF13;PTEN;RUFY3;MAP2
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),-0.5750848027531595,-0.8543339265212821,0.7241379310344828,1.0,1.0,1/5,5.57%,CHMP2A
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),-0.5626736910462071,-0.8542865517825711,0.7272727272727273,1.0,1.0,1/5,9.01%,CEACAM1
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),-0.48713226339579113,-0.8541625564690642,0.6666666666666666,1.0,1.0,2/10,18.20%,PGP;DGKG
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.3765220103621262,0.8535989855191602,0.59375,0.9775840012969681,1.0,4/26,13.39%,PLK1;ESPL1;NSFL1C;CLASP1
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.5274474211332232,0.8534914401593875,0.6046511627906976,0.9766001406008539,1.0,2/5,16.94%,CPSF6;DHX9
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.5274474211332232,0.8534914401593875,0.6046511627906976,0.9766001406008539,1.0,2/5,16.94%,CPSF6;DHX9
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),0.5507041327832262,0.8533423295282326,0.68,0.9763562615961654,1.0,1/5,4.45%,CLEC7A
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.5419214005321737,-0.8531775095062256,0.6842105263157895,1.0,1.0,1/6,8.86%,ATP23
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.37820884407705485,-0.8530587425581156,0.7083333333333334,1.0,1.0,8/49,9.84%,COPS9;RPL5;RPS3;RPL11;SVBP;UBXN1;PRR7;VPS28
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.3796537526873483,-0.8527741983978783,0.6933333333333334,1.0,1.0,5/68,5.37%,DPEP2;GATA1;AQP9;CD9;NFATC1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.3911407424072626,-0.8526614910466811,0.7051282051282052,1.0,1.0,10/43,14.16%,ASAH2B;ORMDL2;DEGS1;SGMS2;DEGS2;ORMDL1;SMPD2;SGPL1;ABCA12;ASAH2
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.3343528363029123,0.8524803308315869,0.6923076923076923,0.9776890173885255,1.0,18/69,15.19%,VAPB;KCNJ2;ATP12A;LETM2;SLC24A3;ATP13A1;ATP1B3;KCNMA1;STIM1;DRD4;PTH1R;SLC12A2;ATP2C1;SLC8A2;ATP13A2;TMEM165;STIM2;SLC24A4
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.35647540185322,0.852465142370932,0.7,0.9771312686056867,1.0,3/41,3.92%,ZAP70;ZBTB1;SLC7A1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.3377306935595558,0.8524063228898141,0.7333333333333333,0.9767386737474513,1.0,1/32,0.34%,PDGFB
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.36764814006358315,0.8523033994712604,0.6451612903225806,0.9758766215344397,1.0,6/22,14.60%,ZDHHC11;ZDHHC23;ZDHHC3;ZDHHC11B;GOLGA7B;ZDHHC2
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.36764814006358315,0.8523033994712604,0.6451612903225806,0.9758766215344397,1.0,6/22,14.60%,ZDHHC11;ZDHHC23;ZDHHC3;ZDHHC11B;GOLGA7B;ZDHHC2
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.3359060326775822,-0.8521651316274882,0.7466666666666667,1.0,1.0,23/134,19.94%,RHOC;GAPDH;APOL3;TRIM13;TNIP2;TMED4;HTR2B;TRIM25;LAMTOR5;NEK6;SLC35B2;FADD;PINK1;TNFRSF1A;LGALS1;IFIT5;GPR89A;TMEM9B;HLA-DRB1;ECT2;S100B;DDX1;SHISA5
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.44031617371208753,-0.8521240163959999,0.6716417910447762,1.0,1.0,8/28,12.62%,AQP9;SLC10A3;SLC10A6;SLC16A1;CEACAM1;SLC27A5;SLC16A8;SLC51A
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),-0.49791653723995954,-0.852093692600198,0.660377358490566,1.0,1.0,1/8,4.81%,MESP1
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.5369025769139927,-0.8520913247312109,0.7142857142857143,1.0,1.0,1/6,7.60%,NOP53
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.4068039860563491,-0.8519197848526968,0.7236842105263158,1.0,1.0,4/38,10.42%,STMN1;RPS3;STMN2;ANKRD53
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.3495611293092907,0.8518330924800832,0.7142857142857143,0.9761735734919882,1.0,5/52,10.33%,PDGFB;GRHL2;NAF1;HMBOX1;TNKS
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.5596888707588387,-0.851776273208164,0.6779661016949152,1.0,1.0,2/5,19.52%,DDR1;COL4A6
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.48117574252536777,-0.8515625625764449,0.6615384615384615,1.0,1.0,5/12,29.83%,RACK1;TXN;GPR37L1;PARK7;NR4A3
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.3187990774410516,0.8514975014446201,0.7142857142857143,0.9762591728006083,1.0,24/127,14.39%,SPIRE2;TCAP;CGNL1;TPM2;CASS4;MYO5B;GAS2;KASH5;DPYSL3;ELMO1;COBL;RND3;SPIRE1;CORO6;SCIN;ELMO2;DLG1;MYO1D;SHROOM3;RHOF;BAIAP2L1;ABI2;ELMO3;TMOD2
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.4190453717748492,-0.8513770225033717,0.6875,1.0,1.0,9/29,20.20%,CD63;SFRP4;ARF1;SELE;LRPAP1;FLOT1;GREM1;ANGPT1;WDR54
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.47137092441706696,-0.8513618122459163,0.6984126984126984,1.0,1.0,5/11,35.80%,PARG;MYOCD;PARK7;AKAP8;HPF1
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.3999059098814157,0.8510869108361274,0.6744186046511628,0.9766883316297696,1.0,1/20,0.31%,RELN
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.4336622810809325,-0.8510628708220441,0.6875,1.0,1.0,8/27,19.06%,CENPX;CENPK;CENPH;MIS18BP1;CENPQ;CENPN;ITGB3BP;CENPU
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.31768104058749613,0.8510174061321137,0.76,0.9762115067023519,1.0,15/119,7.14%,RELN;CGNL1;MCF2L;ARAP1;TIAM2;SRC;ARHGAP31;STARD13;ARHGEF7;FAM13B;ARAP2;ARHGEF6;ARHGAP44;ARHGAP10;OBSCN
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.43392822702060796,-0.8509804961862351,0.6307692307692307,1.0,1.0,4/22,16.99%,SIGIRR;C1QBP;NMI;RNF26
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.4145050603965135,-0.8507636526876581,0.676923076923077,1.0,1.0,4/25,20.14%,TYMS;DCTD;GLRX;NME3
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),0.4497157879856892,0.8506313059497947,0.5882352941176471,0.9764763644519059,1.0,3/9,18.18%,AKAP6;NOS1AP;KCNE4
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.38907417141597167,0.8505589531324675,0.7333333333333333,0.9760392034531071,1.0,4/28,11.18%,PTPN6;PKD1;MN1;FBXW7
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.34610647174280496,-0.8505373787941705,0.8072289156626506,1.0,1.0,33/118,29.00%,PKMYT1;CCNB2;DCTN3;SSNA1;TUBB4B;CETN2;DCTN2;CEP131;HAUS6;TUBA1A;CEP72;DYNLL1;DCTN1;TUBA4A;PLK4;CEP135;PRKACA;TUBB;CEP41;FOXM1;TUBB4A;USH1C;NES;DYNC1H1;OFD1;CEP76;BRSK1;BORA;YWHAE;CDK1;MAPRE1;FBXL15;TUBG1
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.504821374947914,0.8504943619368969,0.625,0.9756103444912311,1.0,4/7,18.63%,PLA2G10;LPCAT4;LPCAT1;PLA2G4A
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.3777163549623511,0.8504803926964731,0.625,0.9750885331179525,1.0,2/26,2.01%,NUPR1;BAG2
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.5111856326775673,-0.8504426539765781,0.7536231884057971,1.0,1.0,4/10,28.03%,ART3;ART4;PADI4;PARK7
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.4958063106364954,-0.8503618517198381,0.7547169811320755,1.0,1.0,1/14,0.50%,PLAAT4
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.34711138866509467,0.8503518019201054,0.8275862068965517,0.9747696915042402,1.0,13/44,17.87%,SRC;DUSP10;SASH1;DOCK1;RHOJ;TGFB2;PRKCE;CLASP1;BMPR2;DOCK5;PTPRR;CORO1C;PTPN23
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.5198485283086608,0.8498846429693636,0.6571428571428571,0.9752446404366832,1.0,1/6,1.66%,KAT2A
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.4307750142276815,0.8498379176519414,0.6585365853658537,0.974755048856,1.0,6/16,19.93%,P2RX7;PLEKHA7;NDC1;AFDN;AHCTF1;NUP98
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),-0.47981036312596564,-0.8498330634186296,0.6949152542372882,1.0,1.0,4/10,16.11%,TGFBR2;FUZ;HOXD3;EIF4A3
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.5009147867541746,-0.8496901942241358,0.6949152542372882,1.0,1.0,3/11,14.02%,TGFB1;HOPX;MYH6
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.46697282000224555,-0.8496147533401825,0.7727272727272727,1.0,1.0,6/14,27.05%,CORO1B;LIMA1;AIF1L;CCR7;INPP5K;ARF6
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.47962579336108313,0.8493775174344517,0.7352941176470589,0.9752683019171662,1.0,3/13,5.75%,PDIA5;PPARGC1A;CYB561
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),-0.47909534972434903,-0.848992195368946,0.704225352112676,1.0,1.0,3/11,22.77%,TALDO1;RBKS;G6PD
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.3584128952531579,-0.8484910614104766,0.6756756756756757,1.0,1.0,3/67,1.75%,SLC8A3;SEMA3E;ACTG1
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.5131422629577005,0.8482279335732935,0.6578947368421053,0.9772873805046374,1.0,3/8,13.41%,ROBO1;SLIT3;SLIT2
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.3763096540188233,-0.8481821163705691,0.7857142857142857,1.0,1.0,6/72,5.68%,P2RY10;DPEP2;PSG2;P2RY14;CR2;STAG3
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.33598589450468425,-0.8480148739556543,0.8472222222222222,1.0,1.0,17/152,12.22%,CD44;SFRP1;TIMP1;PPIB;PMP22;FZD8;ACTA2;SFRP4;FBLN1;SGCB;SPARC;FUCA1;MGP;TGFB1;BDNF;GPX7;MEST
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.4257786464529421,-0.8476663188968591,0.7916666666666666,1.0,1.0,7/29,19.91%,B2M;MAG;GORASP1;APPL2;OMG;PTN;GDI1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.36103096112240846,0.8476595598806668,0.5277777777777778,0.9779304962689049,1.0,5/32,8.81%,HSPA1A;PLK1;HNRNPU;FSD1;HSPA1B
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.42297760978334975,0.8474780150945705,0.65625,0.9776576518197179,1.0,5/14,28.78%,PANK1;PANK3;PPCDC;PANK4;ACOT7
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.33404479445630414,0.8472676019306671,0.6764705882352942,0.9775556579842373,1.0,4/42,8.81%,RIDA;HSPA1A;ZC3H12D;HSPA1B
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.42608423291965936,0.8472074357351104,0.625,0.9771051648896741,1.0,2/15,8.50%,NFATC4;ADGRB2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),0.4752307208519913,0.8468390502658804,0.6666666666666666,0.9773597674362989,1.0,1/10,0.22%,VDR
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.39631637241339934,-0.8463450545171786,0.7681159420289855,1.0,1.0,10/38,24.42%,RPS27A;LACC1;UBA52;UBB;CNPY3;HSP90B1;S100A1;CTSS;CTSL;UBC
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),-0.5608114124526583,-0.8461508678158085,0.7213114754098361,1.0,1.0,1/5,9.81%,IRGM
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),-0.5162261782363167,-0.8461186044460836,0.6190476190476191,1.0,1.0,1/6,3.83%,MSRB1
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.5414391841961836,-0.8461102310079254,0.703125,1.0,1.0,2/8,12.48%,MESP1;IFT122
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.35355170059416285,0.8459284004549628,0.7105263157894737,0.978658716493446,1.0,12/32,18.43%,STARD13;PRKX;ADGRA2;PTP4A3;ZEB2;PIK3CA;KANK1;TESK1;ANLN;ABL1;PLEKHG5;LOXL2
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.457514708562862,0.8457573501708405,0.6285714285714286,0.9785022441923399,1.0,2/14,7.76%,TTLL12;OAS3
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.4537699264509667,0.8456383863635732,0.5675675675675675,0.9781990993576554,1.0,3/9,18.14%,PHKA1;GSK3B;PHKG2
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.4547741720545566,-0.8454217498258597,0.6461538461538462,1.0,1.0,4/18,15.19%,IL31RA;STAT5A;STAT1;NMI
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.3553307498916415,0.8454095993382268,0.6774193548387096,0.9781357696100915,1.0,4/48,8.00%,REP15;SNCA;PICALM;ARRB2
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.30590747903058557,-0.8453241654737083,0.8936170212765957,1.0,1.0,65/447,21.97%,PSMB8;RPS27A;DTX3L;FBXW10;SELENOS;PSME1;MAGEF1;NEURL1;HLA-A;MARCHF2;PSMB6;PSMD8;PSMC5;ELOB;PCNA;RNF181;PSMD7;RRAGA;UBA52;RNF8;PEX10;TRIM13;RACK1;TRIM25;DDA1;ARIH2;TRIM17;RTF1;RBX1;PINK1;PSMD3;PSMC3;TRIM61;PAF1;BRCA1;UBB;PSMA4;FBXW8;NHLRC1;RNF167;RNF26;CDC34;PRAME;UBE2D4;RNF135;RNF111;RNF213;PSMD2;PSMA7;FBXL16;FBXL13;DCAF15;ZNF738;PSMD6;PSMB2;ERCC8;PSMB3;PSMB4;UVSSA;PSMA3;CDC23;CBLC;DZIP3;PSMC1;FBXO25
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.46197030012066936,-0.845209518707977,0.6612903225806451,1.0,1.0,4/17,20.80%,TIMP1;TIMP2;APOE;FURIN
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.4125522445539439,0.844898336804552,0.6666666666666666,0.9786283676469509,1.0,3/23,9.28%,SH2B2;PLEKHA1;LAT2
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.3865664195478894,-0.8448812742273315,0.6984126984126984,1.0,1.0,2/36,4.91%,RHOC;RHOG
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.49091043058292333,-0.8447185474436296,0.6862745098039216,1.0,1.0,2/10,9.52%,DNAJC19;PHB2
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.40215404094015483,-0.8446945233726791,0.6956521739130435,1.0,1.0,4/26,9.47%,CHRM5;TSHR;HTR2B;CHRM2
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.39188413397392785,-0.8445846999182169,0.6865671641791045,1.0,1.0,2/25,2.68%,DTX3L;RPS2
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.4905029863332625,0.8445403207146661,0.6578947368421053,0.9787346095854946,1.0,2/6,13.93%,DNMT3A;KDM1B
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.38565274495401347,0.8440132568991637,0.5862068965517241,0.9792571387529068,1.0,3/33,6.47%,SLC38A1;SLC7A9;SLC7A5
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.4472130988716007,0.8438475575549028,0.7222222222222222,0.9790777422289485,1.0,6/15,20.91%,SRC;ABHD2;TGFB2;NR1H3;CATSPERD;CATSPERB
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.3157889180064321,0.8438116887617414,0.8148148148148148,0.9785827539290575,1.0,19/104,12.12%,PDGFB;PDLIM7;TCAP;KAT2A;SGCZ;ALPK3;TBX19;GLI2;PKD1;CHD7;PDLIM5;SGCG;SMG9;RBM20;TGFB2;ACVR1;SGCD;MEGF8;HDAC9
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.4622796710986544,0.8437328861592345,0.5833333333333334,0.9781961074351214,1.0,1/11,1.59%,KCNJ2
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.375366034466841,-0.8433417817705359,0.759493670886076,1.0,1.0,10/57,9.77%,CCDC181;ARMC3;ATP5MK;DCDC2B;TUBB4B;CXCL17;CCDC39;TMEM212;ANKUB1;DNAH9
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),-0.4838370815711878,-0.8431048529762889,0.6785714285714286,1.0,1.0,2/8,12.28%,EFNA1;GRN
prerank,PanglaoDB_Augmented_2021__Eosinophils,0.3345832065717677,0.8430517793194009,0.7307692307692307,0.9789639364688864,1.0,10/52,11.25%,LCP2;C1ORF162;PSTPIP1;PIK3R5;CSF3R;ITGAX;HCLS1;LTC4S;IKZF2;LAIR1
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.3070981486702944,0.8426859254196444,0.8260869565217391,0.9791003749924952,1.0,24/54,26.43%,CDK10;NLK;TNKS;ACVR1;DYRK3;PRKD1;HIPK2;DYRK1A;HIPK3;GSK3B;CAMK2D;MAPK8;SBK1;WNK1;MARK2;MAP3K10;PRKCA;STK39;CSNK2A1;DYRK2;OXSR1;PDPK1;CAD;DYRK1B
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.5033465630496612,0.8426440456081379,0.6857142857142857,0.9785680887994558,1.0,1/7,1.93%,SPRY2
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.5303468040193065,-0.8425791008131859,0.6818181818181818,1.0,1.0,2/6,19.39%,P4HA3;P4HTM
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.34690996381567246,-0.8421036937799956,0.7352941176470589,1.0,1.0,9/108,9.52%,CD44;IL26;PDGFD;HTR2B;RASGRP1;HRAS;GPR183;FSHR;PHB2
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.5181494254943263,-0.8420049378255077,0.7049180327868853,1.0,1.0,1/7,7.80%,PAX8
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.5181494254943263,-0.8420049378255077,0.7049180327868853,1.0,1.0,1/7,7.80%,PAX8
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.2382058544613049,0.8414385917599858,1.0,0.980847393570232,1.0,326/1642,17.92%,CREB3L1;VDR;ONECUT1;NFATC4;TP63;ZNF697;GCM1;DACH1;CRX;NPAS2;IGF1;ETV1;ZBTB1;KAT2A;FLI1;RUNX1;ZNF521;SNAI1;CCDC62;DACH2;MXD3;HES4;PBX3;ZBTB7C;ZNF366;ATOH8;ZGLP1;DUXA;ATXN1;PLK1;AEBP2;ZNF717;HDAC10;ANXA4;ZNF415;GRHL2;HDAC4;TAL1;EGFR;LEF1;HNF4G;RFX3;CPEB3;RELA;CHD5;TBX6;BACH1;ARNT;CNOT2;TBX19;RXRG;HIC2;LMO7;ZXDC;SUPT3H;DLX1;HNRNPU;ATF1;HMX1;PPARGC1A;ID1;ZNF347;PLAC8;CREB5;ZNF202;ZNF264;ARID1B;FOXK1;HAMP;NPAS3;MYT1;SNCA;FRK;WWOX;PBX1;SCRT1;ZBTB16;HIVEP3;GLI2;SIRT1;AGRN;LMO2;LPIN3;ZNF615;ASCL1;MLLT6;TBL1XR1;BMP6;EAF2;ETV5;PKD1;ZNF283;SMARCA2;ZNF668;CCNH;CDK12;BRWD1;SERPINF2;BATF3;MAML2;CDKN2A;NFIB;ZBTB2;ZNF93;SAFB2;FNIP2;MAMSTR;HIVEP2;NFIA;ZHX2;ZNF451;HCLS1;PHF10;HMBOX1;PHF21A;VAX2;ARRB1;ZNF613;ZNF397;ZFP69B;NRF1;ZNF778;ZFHX4;ARID5A;NOTCH4;TAF3;SCX;ZEB2;PHF14;MEIS1;ST18;BACH2;OTUD7B;MLXIPL;NRIP1;JAZF1;MEIS3;ASXL3;DLL1;TCF12;ZNF785;KDM4C;DMRT1;TOX3;SOX30;SMYD2;GABPB1;OGT;AEBP1;ZBTB37;NFKB1;PID1;GDNF;TRPS1;STAT6;ZFP2;TNKS;MAFB;IKZF2;SOX5;NPAS1;ZNF334;PURA;DICER1;ZNF536;ZNF771;CRTC1;ACVR1;RNF14;ZNF304;STRA8;ZNF704;DNMT3A;MITF;PRRX2;TEAD1;KLF11;ARID1A;RARG;SMAD4;ZNF157;PCGF5;KLF15;ARX;MNT;DLG1;LCOR;SOX12;ZNF761;THRB;ZNF483;RHOQ;FGF1;SMURF2;NCOA7;SLA2;HDAC9;AUTS2;HBP1;JMY;GRIN1;TEAD2;CAMTA1;JDP2;ZNF473;MEIS2;ZNF561;EED;SMARCD2;MYPOP;PRKD1;EGR3;MGA;ZNF281;EPC2;SSBP4;NFAT5;ESRRG;TRIB3;VEZF1;TCF4;LDB2;TFDP2;FOXO3;ZNF624;MCPH1;ZNF556;RPS6KA1;KDM1B;ESRRB;MLLT10;BMPR2;ZNF160;ZNF644;ZNF143;JMJD1C;SS18L1;TFEC;CSRNP1;CBFB;PKNOX2;HMGB1;RELB;ACVR2B;ATRX;KAT2B;PTEN;ZNF212;ZNF316;ZNF24;HIPK2;SSBP2;SMARCD3;ZNF254;ZNF41;RPRD1B;SFPQ;MED13;BCLAF1;THAP3;MED13L;RIPPLY2;GPER1;EBF4;NR4A2;PKD2;ZNF467;ZBTB34;ZNF587;BBX;BRIP1;PRDM10;TRIM33;TNRC6B;TSHZ3;HMGA1;CREBBP;PPRC1;SS18;ZNF69;PRDM15;ACVR2A;ADCYAP1;RAI1;VHL;HIVEP1;SOHLH1;KMT2D;SLTM;UHRF1;NR1H3;WWC1;DHX9;FOXP2;KCNIP3;IKZF1;FBP1;ZNF169;PTH;NCOA2;CAMK2D;ZBTB20;MRTFA;UBE2D3;ZNF268;KMT2C;PLAGL1;ZNF146;POU6F2;ELP3;ABL1;E2F5;GLIS1;MYNN;CAMTA2;FGF2;MIER2;MDM4;ELF1;RNF2;NR6A1;ZNF121;ZNF182;ZNF568;CEBPG;MAFF
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.38248362754803633,-0.841362755770166,0.75,1.0,1.0,9/63,13.35%,ZDHHC12;NACA;GRIN3B;YIF1B;RAB11A;AQP11;NECTIN3;GORASP2;NACAD
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),-0.5078393126600081,-0.8413016796158721,0.6885245901639344,1.0,1.0,3/8,30.72%,HSPA5;PTPN1;PPP1R15A
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),-0.46855101894048057,-0.8411725029436116,0.7424242424242424,1.0,1.0,3/13,22.62%,FADD;CIDEB;CYFIP2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.30826522183712723,0.8409436943978923,0.9565217391304348,0.9812358185275146,1.0,44/196,15.68%,RELN;TP63;JCAD;IGF1;HOMER1;IRS1;SRC;TMEM108;ARNT;KLK14;NLGN1;SIRT1;SORBS1;BMP6;SASH1;MAML2;HAP1;TRIM16;NOTCH4;TPD52L1;ROBO1;CRADD;DLL1;TGFB2;NECAB2;RAB34;MN1;FGF1;C3;NRXN1;ULK3;GRIN1;NLGN3;TRIM44;CD80;DCDC2;KANK1;ZRANB1;KAT2B;PTEN;MGAT5;GKAP1;GPER1;PKD2
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.4729719045086829,0.8406253366164207,0.6341463414634146,0.9812862535949128,1.0,2/8,12.29%,ECM1;ENPP1
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),-0.5155771061805574,-0.8400698324740521,0.6716417910447762,1.0,1.0,1/9,6.97%,VAMP8
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.46773420317203496,-0.8395308290848346,0.7538461538461538,1.0,1.0,8/15,38.81%,KAT5;CR1;NAV3;SFTPD;TNFAIP3;HOMER3;PRNP;LAPTM5
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.2783786766485756,0.8394658624518847,1.0,0.9831537220723501,1.0,97/744,12.12%,CREB3L1;VDR;PDGFB;ZNF423;TP63;DACH1;ZBTB1;RUNX1;SNAI1;ZNF366;ATOH8;IFNA2;ZGLP1;ATXN1;SPINDOC;PLK1;GMNN;HDAC10;HDAC4;LEF1;RFX3;CPEB3;RELA;TBX6;BACH1;CNOT2;HIC2;DLX1;HNRNPU;SAMD13;HMX1;ID1;ZNF202;ZNF706;FOXK1;HAMP;SNCA;FRK;WWOX;SCRT1;ZBTB16;YAF2;GLI2;SIRT1;ASCL1;TBL1XR1;BMP6;ETV5;SMARCA2;SFMBT2;BATF3;FOXN3;CDKN2A;ZBTB2;ZNF93;FNIP2;ZHX2;PHF10;HMBOX1;PHF21A;ZFP69B;ZNF778;ARID5A;NOTCH4;TAF3;ZEB2;OTUD7B;MLXIPL;NRIP1;JAZF1;ZNF785;PHC3;DMRT1;BAHD1;SOX30;SMYD2;AEBP1;NFKB1;TRPS1;NPAS1;PURA;DICER1;ZNF536;DNMT3A;MITF;KLF11;PTPRK;RARG;SMAD4;MNT;DLG1;LCOR;THRB;SMURF2;SLA2;ZNF318;HDAC9
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.5227335921864902,0.8394593018862754,0.6956521739130435,0.9826206377622723,1.0,2/7,20.37%,ARHGAP21;RIPOR1
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.43388801662451065,-0.8393695472869397,0.6896551724137931,1.0,1.0,5/16,27.98%,TGFB1;ASPN;GREM1;HEY2;HEY1
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.42179704058789397,0.8392873003171242,0.6,0.9823791784831054,1.0,8/17,21.70%,MTCL1;ERBIN;DLG2;DLG1;DLG3;SCRIB;MARK2;PARD3
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.32668432272235615,0.8392736675942529,0.7272727272727273,0.9818318406618941,1.0,20/130,14.77%,PTPN6;SPRY2;SAMSN1;HSPB1;SPRED3;SPRED2;ERRFI1;SPRED1;SNCA;GSKIP;CEP85;MLXIPL;PID1;ENPP1;PPM1E;SLIT2;DMD;TRIB3;TESK1;PTEN
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.4445431360285523,0.8391104837955639,0.575,0.9815911093252908,1.0,1/10,0.51%,NUPR1
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-0.47199842846264956,-0.8390030849069623,0.6666666666666666,1.0,1.0,2/9,13.12%,RAB11A;RAB8A
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.47415602444207483,0.8385454371222598,0.625,0.9816376842217748,1.0,4/15,16.29%,OGT;JADE2;KANSL2;JADE3
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.47415602444207483,0.8385454371222598,0.625,0.9816376842217748,1.0,4/15,16.29%,OGT;JADE2;KANSL2;JADE3
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.527787187090236,-0.8385167247595402,0.7796610169491526,1.0,1.0,1/7,2.82%,ZFPM1
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.5463378765330755,0.8384932623063244,0.6818181818181818,0.9811836577728129,1.0,4/6,24.31%,TGFB2;ZFPM2;SOX4;BMPR1A
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.3910732691223691,-0.8384549767128479,0.6756756756756757,1.0,1.0,5/47,11.65%,TOMM7;UBL5;ARIH2;PINK1;ABLIM3
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.4600568692249346,-0.8383352190206318,0.7671232876712328,1.0,1.0,5/16,22.13%,COX17;SURF1;SMIM20;COA5;TIMM21
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),-0.5062430434747446,-0.8379915319801811,0.7464788732394366,1.0,1.0,1/8,0.41%,IGSF1
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.39558672408878337,-0.8378916727512704,0.7631578947368421,1.0,1.0,16/37,37.68%,PHAX;SSB;NOL6;NUP50;RAN;NCBP2;NUP155;NUP58;POM121;NUP93;NUP88;POM121C;NUP107;AAAS;SEC13;NPM1
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.5007287337981328,-0.8374241546659242,0.7586206896551724,1.0,1.0,2/6,24.50%,TRDN;NOL3
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.36434215295344896,0.837006899133968,0.6111111111111112,0.9836684785612644,1.0,4/32,11.83%,HSPA1A;HSPA1B;BAG3;FGF1
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.46486088364199274,0.8369496324087969,0.6410256410256411,0.9832366942769895,1.0,3/10,10.96%,TGFB2;SOX5;LTBP3
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.47435072371111897,0.8367230030697974,0.6585365853658537,0.982633647675787,1.0,5/7,33.40%,ABL1;GABPA;ATF4;LRRK2;PRKN
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.47435072371111897,0.8367230030697974,0.6585365853658537,0.982633647675787,1.0,5/7,33.40%,ABL1;GABPA;ATF4;LRRK2;PRKN
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),-0.46850609103100566,-0.8367114798782632,0.6666666666666666,1.0,1.0,1/8,5.76%,HYAL2
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.35857831063760026,0.8365227545669819,0.78125,0.9824620884677288,1.0,4/37,3.24%,IGF1;FGFR3;IFNA2;CTF1
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.46236843910714953,-0.8364988891465627,0.7466666666666667,1.0,1.0,3/19,11.72%,GFRA3;PMP22;BDNF
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),-0.461254237987046,-0.8364754109315691,0.7377049180327869,1.0,1.0,2/19,8.72%,XYLT2;SGSH
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),-0.4589078370136993,-0.8363231144644327,0.6818181818181818,1.0,1.0,1/14,6.21%,FABP3
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.3528421029761786,-0.8362966564210194,0.7352941176470589,1.0,1.0,15/61,23.09%,SLC8A3;NPR2;NPPC;PLN;SRI;APLN;MYH6;FXYD4;CALM3;KCNQ1;PRKACA;TRDN;S100A1;ATP1A1;CALM1
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.34483042869053415,-0.8359808796518213,0.759493670886076,1.0,1.0,12/118,12.31%,GATA1;SERPING1;CLU;RHBDF1;HSPB8;TNS2;VWA1;FSHR;LURAP1L;ABLIM3;AR;S100A16
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.3798527985129066,0.8359443194311389,0.7272727272727273,0.9832267904733901,1.0,3/37,4.85%,IGF1;LEF1;CPNE1
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.4035374037722289,-0.8359124394271472,0.7704918032786885,1.0,1.0,4/30,9.69%,XBP1;NEURL1;RRAGA;LAMTOR5
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.33972709646818655,-0.8358714884954572,0.7692307692307693,1.0,1.0,9/94,11.39%,DDIT3;VAV3;CALR;LCK;ARF1;HRAS;PLA2G12A;CDK4;PPP1CA
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.5099052294695039,-0.835846874170336,0.734375,1.0,1.0,4/9,33.80%,PSMC3;INPP5K;JUN;REST
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.3862999126928405,0.8358205901748964,0.75,0.9829638174461673,1.0,4/20,14.69%,LHFPL2;PLA2G10;SMURF2;TACR3
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.5070541244213306,0.8355126740357971,0.7058823529411765,0.9829519974904767,1.0,4/6,25.72%,ALDH1A1;GAD1;BCAT1;GAD2
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.4074211163205258,-0.8354937974168055,0.7352941176470589,1.0,1.0,9/27,22.25%,SFRP1;TRIM25;CITED4;AR;BRCA1;SFR1;GSTM3;RBBP5;CAV1
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.3710344639551933,-0.8352851116935665,0.75,1.0,1.0,13/47,17.78%,PSME1;PSMC5;RAD23A;RHBDF1;USP19;PINK1;GABARAPL2;PSMC3;NUDT15;ARAF;UBB;UFL1;APOE
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.43796101917011465,0.8352672150887883,0.6285714285714286,0.9828034393631404,1.0,1/15,1.07%,TNNC2
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.47534520375745115,-0.835221735699149,0.676056338028169,1.0,1.0,2/13,12.71%,KIF20B;SEMA3A
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.4512477072153176,-0.8351364484719423,0.7288135593220338,1.0,1.0,1/13,4.95%,PNKP
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.36742587363274104,-0.8350451814912413,0.8428571428571429,1.0,1.0,5/66,7.32%,SLC8A3;GSTP1;INCA1;HYAL2;CDKN1C
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.4706937352887259,-0.8348352816637664,0.7142857142857143,1.0,1.0,1/11,4.57%,LACC1
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.4503169948673732,-0.834398330463423,0.7272727272727273,1.0,1.0,2/17,3.84%,JUP;MADCAM1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.3068553946514533,0.8342647998898693,0.8571428571428571,0.9842268000314646,1.0,15/111,12.69%,COLEC11;STAB1;PDLIM7;AP1G2;TMEM108;SNCA;PICALM;ARRB2;SNAP91;DLL1;MRC1;DNAJC6;HSPH1;ACKR3;NLGN3
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.528477860748426,-0.8340628014601736,0.703125,1.0,1.0,1/6,23.09%,CALM1
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.38434244130437667,-0.8339620056810283,0.7777777777777778,1.0,1.0,4/50,9.39%,AQP9;RBP1;USF1;AQP11
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.3384423779286256,0.83393402818766,0.7241379310344828,0.9843812340487514,1.0,17/71,16.42%,SPRY2;SPRED3;SPRED2;DUSP6;DUSP1;SPRED1;DUSP10;IRAK3;P2RX7;SMAD4;DLG1;PTEN;GPER1;PTPRR;RPS6KA6;SPRY4;PRDM15
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.3522428356698337,-0.8337394385895002,0.7702702702702703,1.0,1.0,13/70,17.43%,RMI1;AP5S1;RPA3;RAD51AP1;BRCA1;KDM4D;PARP1;MEIOB;SFR1;GEN1;RAD50;XRCC2;XRCC3
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.36406165151636294,-0.8331345270529826,0.7246376811594203,1.0,1.0,20/50,28.03%,XBP1;ALDH1A2;ACMSD;OXSM;SLC27A5;ACSM6;ACSM3;NDUFAB1;OSBP;HSD17B10;LIPH;LIPI;AKR1D1;ALOX5;HSD17B8;ACOT8;OSBPL2;CYP27A1;SDS;PARK7
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.48314648251698905,0.8325949683667777,0.6486486486486487,0.9867425463221703,1.0,5/8,25.61%,CXCL13;WNK1;WNT5A;STK39;OXSR1
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.39223231052713997,-0.8325476469414663,0.7794117647058824,1.0,1.0,6/43,15.93%,CLU;PTK6;AQP11;NLRP12;APPL2;MAPK7
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.42689572411988874,0.832546398545306,0.6190476190476191,0.9862738120678131,1.0,1/11,4.24%,CPT1C
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.41633811695837375,0.8323973626210426,0.6341463414634146,0.9859950036930553,1.0,3/24,6.25%,ACADVL;FOXK1;SIRT1
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.3472937616477036,-0.8321448222085771,0.7846153846153846,1.0,1.0,13/66,27.34%,RAB11A;PHB2;PINK1;PTTG1IP;LAMP1;APPL2;CSE1L;NUP50;RAN;ZDHHC15;KPNB1;HK1;NXT1
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.5254947911412187,-0.832075213968389,0.7391304347826086,1.0,1.0,2/7,3.41%,QPRT;NMNAT3
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.42853067545605,-0.8318973979269829,0.7058823529411765,1.0,1.0,3/22,18.26%,CFTR;ABCA12;HLA-DRB1
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),0.548454343174925,0.8318665746354243,0.7142857142857143,0.986572089072622,1.0,1/5,11.91%,MVD
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),-0.3934896948998928,-0.8317529766244818,0.7580645161290323,1.0,1.0,6/25,25.20%,VPS35;PINK1;DNM1L;FIS1;DCN;BNIP3
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.3717959134838626,-0.8316910647665217,0.7105263157894737,1.0,1.0,5/37,19.07%,CPS1;MOCS1;TPI1;ITPKA;PPIP5K1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.30023611980539655,0.8315000786883148,0.8333333333333334,0.9867928626045127,1.0,9/59,13.55%,BCL2A1;FGFR3;TRAF2;P2RX7;CRADD;TGFB2;BAG3;TNFRSF10A;SORT1
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.3612721036749126,-0.8314585674182963,0.6933333333333334,1.0,1.0,16/60,26.23%,TRMT10A;TRPT1;QTRT2;TRMT10B;TSEN34;SSB;SARS1;POP7;AARS1;C2ORF49;CLP1;DDX1;AARS2;URM1;CTU2;TRNT1
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),0.4839816160331515,0.8311966935605788,0.6666666666666666,0.9868696908606683,1.0,1/9,0.51%,NUPR1
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.4027378282345783,-0.8310929415173909,0.7123287671232876,1.0,1.0,4/29,13.31%,GSTP1;GPS2;PINK1;MAPK8IP1
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.341763797888264,0.8310145628985627,0.7083333333333334,0.9867045558029747,1.0,9/44,13.05%,IL1RAPL1;PTPRD;CNTNAP2;NLGN1;NPHP4;NRXN1;MAP4K4;NLGN3;CLSTN2
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.46107135621246,-0.8309245858705594,0.7058823529411765,1.0,1.0,4/16,30.98%,HRAS;TMEM109;CRYAB;XRCC6
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.5123715517283287,-0.8307759745791539,0.6716417910447762,1.0,1.0,2/6,4.50%,HLA-A;HLA-E
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.3381993876060013,0.8304960210633469,0.75,0.987211945910893,1.0,1/48,0.25%,VAPB
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.371286769361867,0.8304660808838755,0.7631578947368421,0.9867297000167297,1.0,2/29,1.51%,RAB39A;ATP6V0A4
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.422656599288355,-0.8304560182579013,0.746031746031746,1.0,1.0,2/21,8.28%,XBP1;RACK1
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.4996049428908771,0.8300615518191501,0.675,0.9870704945890402,1.0,3/5,36.24%,PRKCA;DCAF1;VRK1
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.43326972350604487,0.8298078723564226,0.5945945945945946,0.9870564504811127,1.0,1/12,1.59%,KCNJ2
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),0.5452693577087239,0.8292015595331741,0.673469387755102,0.9877509304525364,1.0,2/5,19.60%,BNIPL;PRUNE2
prerank,MSigDB_Hallmark_2020__Apical Junction,0.2887294495043958,0.8291965016345013,0.8636363636363636,0.9872167365875535,1.0,30/162,14.77%,CLDN15;CLDN9;ICAM1;IRS1;MAPK11;SRC;EGFR;VCAN;ARHGEF6;ITGA10;AKT2;COL9A1;PKD1;CDH11;CDH4;CD276;MPZL1;DLG1;CDH8;MAP4K2;MVD;ADAMTS5;NEGR1;PPP2R2C;NLGN3;RHOF;SLIT2;AMH;CADM2;PTEN
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.4275741190540727,-0.8284719709746826,0.75,1.0,1.0,5/29,10.74%,CPS1;NIT2;GLYATL1;PYCR3;DDAH2
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.4553901127102412,-0.8282363876653311,0.746031746031746,1.0,1.0,5/18,22.25%,IGSF8;MYL6;CAV2;SVIL;CAV1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.4762865895902182,0.8279744806391403,0.7222222222222222,0.9894161095273086,1.0,4/8,18.05%,ELL;SNAPC4;SNAPC3;ICE2
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.2974152903721968,0.8274160271532445,0.9375,0.9899274976007926,1.0,19/206,10.20%,F2;LEPR;HSPB1;VEGFD;FGF17;EGFR;AGER;PROM2;LIMCH1;SIRT1;AKT2;FNIP2;ARRB1;SESN2;TNIK;NTRK2;CD4;WDFY2;PID1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.35196374107663486,-0.8273917538458799,0.7283950617283951,1.0,1.0,8/67,10.89%,CLU;ELOB;RAD23A;NOP53;RACK1;DDA1;ARIH2;RBX1
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.4416167076720943,0.8273708185713253,0.6666666666666666,0.9894456232145469,1.0,4/14,18.63%,PLA2G10;LPCAT4;LPCAT1;PLA2G4A
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.4039235549533793,-0.8273223120135678,0.7096774193548387,1.0,1.0,6/27,13.37%,CLU;SLC25A5;PRELID1;TRIAP1;PINK1;PPIF
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.37145986432263883,0.8271102717716099,0.7575757575757576,0.9894603551591047,1.0,7/27,12.28%,SRC;EGFR;NRG2;ERBIN;GAB1;MATK;PIK3CA
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.3814693971601894,-0.8270382809364089,0.7164179104477612,1.0,1.0,8/43,12.62%,SLC6A12;SLC10A3;SLC10A6;SLC16A1;CEACAM1;SLC27A5;SLC16A8;SLC51A
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),-0.5072748604354103,-0.8268844353124717,0.6551724137931034,1.0,1.0,1/6,10.14%,PRPS1
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),-0.38214436674759167,-0.8267422963812577,0.8235294117647058,1.0,1.0,1/44,0.35%,BMP5
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.36647413772379306,0.8266717312458803,0.7037037037037037,0.9897755465691367,1.0,4/27,13.39%,PLK1;LLGL2;NSFL1C;CLASP1
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.2458661163720682,0.8266296137450234,1.0,0.9892870620159615,1.0,249/1673,15.05%,CREB3L1;VDR;PDGFB;ZNF423;ONECUT1;NFATC4;TP63;ZNF697;GCM1;DACH1;CRX;NPAS2;IGF1;ETV1;ZBTB1;KAT2A;FLI1;RUNX1;MYRFL;ZNF521;SNAI1;DACH2;BNC2;MXD3;AFAP1L2;HES4;SLC39A8;PBX3;ZBTB7C;ZNF366;ATOH8;IFNA2;ZGLP1;DUXA;ATXN1;SPINDOC;AEBP2;ZNF717;GMNN;HDAC10;ANXA4;ZNF415;GRHL2;HDAC4;TAL1;EGFR;LEF1;HNF4G;RFX3;RELA;CHD5;TBX6;BACH1;ARNT;CNOT2;ZNF98;TBX19;RXRG;ZNF516;HIC2;ZXDC;SUPT3H;DLX1;SAMD13;ATF1;HMX1;PPARGC1A;ID1;ZNF347;CREB5;ZNF202;ZNF264;ARID1B;ZNF706;FOXK1;PTP4A3;NPAS3;MYT1;PBX1;MLLT3;SCRT1;ZBTB16;HIVEP3;YAF2;GLI2;SIRT1;ZNF615;ASCL1;MLLT6;TBL1XR1;ETV5;NSD2;ZNF283;SMARCA2;NEK4;ZNF668;CCNH;SFMBT2;BRWD1;BATF3;FOXN3;DHFR;CDKN2A;RYBP;NFIB;ZBTB2;ZNF93;SAFB2;PICALM;TESC;TRIM16;MAMSTR;ZNF488;HIVEP2;NFIA;ZHX2;CHD7;HCLS1;PHF10;HMBOX1;VAX2;ARRB1;ZNF613;ZNF397;ZFP69B;NRF1;ZNF778;ZFHX4;ARID5A;NOTCH4;SCX;ZEB2;PHF14;MEIS1;NLK;ST18;BACH2;MLXIPL;MEIS3;TCF12;ZNF785;PHC3;CD4;KDM4C;DMRT1;TOX3;BAHD1;SOX30;OGT;ZBTB37;NFKB1;TRPS1;STAT6;ZFP2;MAFB;FAM47E;IKZF2;SOX5;NPAS1;ZNF334;PURA;ZNF536;ZNF771;ACVR1;RNF14;ZNF304;STRA8;ZNF704;WAC;CELSR2;MITF;PRRX2;TEAD1;KLF11;ARID1A;ZNF460;PTPRK;SMAD4;ZNF157;PCGF5;KLF15;ARX;MNT;LCOR;SOX12;ZNF761;ZNF483;SMURF2;NCOA7;ZNF318;HDAC9;HBP1;JMY;TEAD2;CAMTA1;JDP2;APBB2;RGMB;ZNF473;TRIM44;MEIS2;ZNF561;EED;SMARCD2;MYPOP;EGR3;MGA;ZNF281;EPC2;NFAT5;ESRRG;TRIB3;VEZF1;CD80;TCF4;TFDP2;FOXO3;ZNF624;ZNF556;RPS6KA1;ESRRB;CDK17;ZNF160;ZNF644;ZNF143;PRMT6;JMJD1C;SS18L1;TFEC;CSRNP1;HNRNPD;CBFB;PKNOX2;HMGB1;RELB;ACVR2B;ATRX;ZNF212;GPBP1L1;ZNF316;ZNF24;CEP290;HIPK2;SSBP2;SMARCD3;ZNF254;PHC1;TIMELESS;ZNF41
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.49278063994283183,-0.8265931422299024,0.6481481481481481,1.0,1.0,1/7,6.69%,DDX60
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.344141291469463,0.8261164666756187,0.7692307692307693,0.9896995418243865,1.0,5/54,3.09%,CREB3L1;SNAI1;HSPA1A;SRC;HSPB1
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),-0.4870964129248312,-0.8257380271864534,0.6721311475409836,1.0,1.0,3/10,18.20%,MYADM;DGKD;DGKG
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),-0.47863122153536697,-0.8256596591242551,0.7333333333333333,1.0,1.0,2/10,9.85%,FBLN1;SPINT2
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.4303842566987287,-0.8254020621467723,0.7397260273972602,1.0,1.0,2/18,9.09%,PRDX1;RASGRP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.41897615870951976,-0.825316750189257,0.6779661016949152,1.0,1.0,2/19,3.59%,IRF4;RPS3
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),-0.4039966284363946,-0.8246962294399258,0.8095238095238095,1.0,1.0,3/36,12.71%,SEMA3E;HTR2B;SEMA3A
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.480844143469081,-0.8246334932333337,0.7183098591549296,1.0,1.0,2/8,7.32%,KIF20B;CHAMP1
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.3520925971334665,0.8244510748388296,0.6538461538461539,0.9923088402289787,1.0,13/50,12.83%,IGSF11;HMCN1;L1CAM;PKD1;OBSL1;DSCAML1;ROBO1;CDH4;CADM1;CELSR2;PLXNB2;CDH2;ROBO2
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.4311323423644789,-0.8241849257261683,0.7580645161290323,1.0,1.0,5/24,15.05%,LIMA1;PLEKHH2;TPX2;STMN2;KATNB1
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),0.4493310588840608,0.8238397956232901,0.7631578947368421,0.9929664991825904,1.0,3/10,9.36%,KYAT1;IDO1;KYNU
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.4985718103903546,0.8237352177199395,0.6363636363636364,0.9926271381787893,1.0,3/6,26.85%,ROBO2;WNT5A;RAPGEF2
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.36547356863858954,-0.8235329416162805,0.6818181818181818,1.0,1.0,1/41,0.15%,VAMP5
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.41649909733319107,-0.8235122564931318,0.7538461538461538,1.0,1.0,7/25,24.40%,FADD;PRSS3;CIDEB;F11;FURIN;CYFIP2;CTSL
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.4927181246296711,-0.8234908381585517,0.7777777777777778,1.0,1.0,4/8,31.74%,GNPTG;GNPTAB;HK1;TKFC
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.4266912317848817,-0.8229909062597002,0.7692307692307693,1.0,1.0,1/14,0.95%,BEST1
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.3223409884333217,-0.8229355111415988,0.8271604938271605,1.0,1.0,51/186,29.15%,PKMYT1;CCNB2;DCTN3;SSNA1;TUBB4B;CHMP2A;CETN2;DCTN2;CEP131;HAUS6;CDK4;CCNJL;CCNE2;TUBA1A;CEP72;DYNLL1;DCTN1;TUBA4A;CDC34;PLK4;MAX;CEP135;CHMP7;PRKACA;TUBB;CEP41;CDC23;DBF4;CHMP4B;FOXM1;TUBB4A;CCNG1;SPDYA;USH1C;NES;DYNC1H1;OFD1;CDKN2D;CRLF3;CEP76;UBE2S;BRSK1;BORA;PLK2;YWHAE;E2F1;CDK1;MAPRE1;FBXL15;TUBG1;CCNJ
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.5539397143135105,-0.8229112287905418,0.8064516129032258,1.0,1.0,1/5,15.93%,MAPK7
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.37828569342551827,-0.822796859732079,0.7397260273972602,1.0,1.0,6/44,10.91%,DDIT3;RPS3;HYAL2;LCK;RACK1;FADD
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.3465411295384288,0.8224472617076343,0.8181818181818182,0.994324526375093,1.0,6/35,10.45%,ADGRB1;EGFR;BANP;SNCA;IRAK3;HMGCR
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),-0.5566737932431004,-0.8223314460974362,0.8333333333333334,1.0,1.0,1/5,16.52%,MMP24
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),-0.5242338846939155,-0.8223261188785438,0.676923076923077,1.0,1.0,4/7,30.11%,CHAF1A;ASF1B;CHAF1B;ASF1A
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),-0.5242338846939155,-0.8223261188785438,0.676923076923077,1.0,1.0,4/7,30.11%,CHAF1A;ASF1B;CHAF1B;ASF1A
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.3926444968202425,-0.8222176229141854,0.6944444444444444,1.0,1.0,3/27,11.97%,TYMS;PCNA;CDK5
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.4262579555254786,0.8219986052535747,0.7073170731707317,0.9945908641798442,1.0,3/10,9.05%,PATL1;DCP1B;DCP1A
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.3376316725992948,0.8218920791567632,0.5862068965517241,0.9943035118035102,1.0,10/55,16.37%,CDK6;CCNH;CDKN2A;EIF4EBP1;EIF4E;RCC1;ACVR1;CCNA2;POLE;NASP
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.4197311060880872,-0.8218826152924822,0.746031746031746,1.0,1.0,5/19,20.34%,TNFRSF21;CEBPB;HLA-DRB1;CR1;PDCD1LG2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.4220626770416268,-0.8217108293347054,0.7833333333333333,1.0,1.0,5/21,23.09%,JPH3;PLN;HPCA;PRKACA;CALM1
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.4085926711648612,-0.8215501701104158,0.7419354838709677,1.0,1.0,6/24,26.74%,ANAPC13;RNF26;UBE2D4;CDC23;RNF4;UBE2S
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.34562284998921217,-0.821448663956785,0.788235294117647,1.0,1.0,7/104,9.94%,ARHGEF16;JUP;TMEM125;NFE2L1;RHBDF1;VWA1;TMEM54
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.418741404139812,-0.821091636161426,0.7213114754098361,1.0,1.0,4/19,15.08%,PPIB;SRP54;PPIA;EDN1
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),0.4847622619035645,0.8206692420783595,0.6511627906976745,0.9961540703351575,1.0,3/7,8.52%,SNAI1;TBX19;SCX
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3965319219394194,0.820569065726537,0.696969696969697,0.9957765264790622,1.0,2/15,6.25%,HSPB1;SIRT1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.32791326554193667,0.8204712304837639,0.6521739130434783,0.9954292674123574,1.0,6/50,6.55%,RELA;TICAM1;MAP3K14;IRAK2;TBKBP1;TRAF2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.5293061918541007,-0.8199516014173686,0.7678571428571429,1.0,1.0,1/5,9.09%,RASGRP1
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.5293061918541007,-0.8199516014173686,0.7678571428571429,1.0,1.0,1/5,9.09%,RASGRP1
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.43715022867954617,0.8199052055500762,0.7272727272727273,0.9958360146671914,1.0,5/15,18.98%,ST8SIA6;FUT8;ST3GAL2;ST3GAL6;FUT9
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.4253652028315134,-0.8198091521225989,0.7727272727272727,1.0,1.0,5/19,19.35%,SFRP1;SBDS;TGFB1;UFL1;MEOX1
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),0.5196103915735569,0.8193678682668412,0.6326530612244898,0.9963690838628747,1.0,2/6,19.60%,BNIPL;PRUNE2
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,-0.3161817572429526,-0.818753575681187,0.8125,1.0,1.0,12/189,13.88%,CENPF;ARHGAP4;BUB1;CCNB2;CENPE;KIF20B;TPX2;CEP131;SMC4;CEP72;UXT;DOCK2
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.3246591973621619,0.8183648065753986,0.75,0.9978779337641228,1.0,18/86,14.93%,EGFR;MFHAS1;AGER;PHLPP1;DUSP10;TRAF2;SERPINF2;TNFRSF19;IGF1R;MTURN;TPD52L1;SH3RF1;MAP4K2;MAP4K4;HMGB1;TRAF3;HIPK2;ITCH
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.3361834550306534,-0.8179054086341614,0.8051948051948052,1.0,1.0,20/123,18.26%,PLAAT4;DTX3L;MUSK;RPS2;DBI;PNKP;EPHA10;PCNA;DSCC1;ZNF622;TGFB1;PINK1;RFC2;CCT2;RFC4;RAD50;GREM1;TEK;DDR1;HLA-DRB1
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),0.5129537521056651,0.8178635244677102,0.6888888888888889,0.9983347795647501,1.0,1/5,9.36%,KYNU
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.49076037800044736,0.8176268804816561,0.6739130434782609,0.9982997501570222,1.0,6/8,37.24%,TBC1D8B;ITGA3;TMEM63C;SULF2;XPNPEP3;SULF1
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.4907107456432601,0.8176252407608142,0.7272727272727273,0.997751344767917,1.0,3/10,9.01%,ALK;CCDC3;ASXL3
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.37515825576407785,-0.8174856813855821,0.7058823529411765,1.0,1.0,2/34,2.82%,GATA1;ZFPM1
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.3473342490874224,0.8171555328120788,0.7083333333333334,0.9981033851445354,1.0,6/45,10.20%,SPIRE2;PSTPIP1;DIAPH1;COBL;SPIRE1;SCIN
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),-0.5621231893084648,-0.8168220451254415,0.7543859649122807,1.0,1.0,3/5,22.25%,COLEC12;FLOT1;CAV1
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.36616077277687337,-0.8166785463368825,0.7333333333333333,1.0,1.0,2/53,4.41%,SFRP1;DNPH1
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.30991421788598394,0.8166284938624367,0.8,0.9985590892129143,1.0,23/91,15.84%,EGFR;NXN;MTCL1;LRP4;CSPG4;EHD2;GLI2;OBSL1;RND3;CHST3;MEIS3;HTRA1;LOX;CD276;NUAK1;TEAD1;TEAD2;FIGN;MPDZ;AMH;AMOTL1;ADAMTS15;COL12A1
prerank,GO_Biological_Process_2021__DNA protection (GO:0042262),-0.513320457992786,-0.8166239836999734,0.7586206896551724,1.0,1.0,2/5,14.07%,NUDT1;NUDT15
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),-0.47794605701137655,-0.816617816833323,0.7586206896551724,1.0,1.0,1/12,1.05%,TTN
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),0.517691403905699,0.8165894258369351,0.725,0.9975015489467163,1.0,1/5,7.86%,ADAM8
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),0.517691403905699,0.8165894258369351,0.725,0.9975015489467163,1.0,1/5,7.86%,ADAM8
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),0.46484322718536764,0.8165710126324964,0.5609756097560976,0.9970070502358038,1.0,2/7,5.71%,DNAH11;DNAAF1
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),-0.4662962979750912,-0.8165007999216136,0.7666666666666667,1.0,1.0,2/14,5.13%,ASAH2B;GBA3
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3000057162781554,0.8162287360316764,0.8,0.9970767180166008,1.0,27/94,17.70%,ADGRB1;VIPR1;VIPR2;GRM8;TBXA2R;LPAR2;GNAO1;NPY1R;ADGRB3;CNR1;ADGRB2;ADGRL3;GRK5;PTH1R;ADCY8;PTHLH;CRHR2;ADGRE1;ADGRE2;LGR5;GPER1;LGR4;ADCYAP1;PRKACB;PTH;GPR26;GNAQ
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.4533253916623585,-0.8161667709215595,0.7384615384615385,1.0,1.0,1/11,4.55%,BTBD18
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.4322824400727819,0.8159799751693926,0.6923076923076923,0.9970054822529046,1.0,4/14,8.38%,EGFR;GLI2;DNA2;STN1
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.34545093433947327,-0.8158605484551992,0.7837837837837838,1.0,1.0,10/65,22.25%,PPP1R17;VAV3;ARHGAP15;ATP5IF1;STMN3;PLXNC1;FGD5;SOD1;PLXND1;CAV1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.4557557768532196,-0.8157443391869788,0.7205882352941176,1.0,1.0,3/14,21.24%,C1QBP;DNM1L;CCR7
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.4557557768532196,-0.8157443391869788,0.7205882352941176,1.0,1.0,3/14,21.24%,C1QBP;DNM1L;CCR7
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.2842337931249241,0.8156548815771862,0.7857142857142857,0.997082481465933,1.0,40/149,16.74%,NMNAT2;TAFA5;TAFA1;CELF3;CYB561;PLPPR4;SCRT1;HIVEP3;OLFM3;ADGRB3;AHDC1;STXBP5;NTRK2;SNAP91;ASXL3;SHC3;MAPK10;AKAP6;ADGRL3;CACNA2D1;SCN7A;CYTH3;ZNF536;NCAN;LRRC4C;NRXN1;PIK3CA;KCTD16;RGMB;RIMBP2;GOLGA7B;CADM2;ZDHHC2;NMU;CA10;NFASC;PLEKHA5;ADGRA1;TTBK2;KIF1B
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.39052376725736865,-0.8154958489066724,0.7246376811594203,1.0,1.0,8/29,21.61%,FGL1;CEACAM1;TNFRSF21;CEBPB;HLA-DRB1;CR1;PDCD1LG2;LGALS3
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.4373317936475586,0.8154015000338752,0.7241379310344828,0.9969743029606617,1.0,2/14,5.48%,KAT2A;C10ORF90
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.4490641639674679,0.8153265127616179,0.6060606060606061,0.9965924591829739,1.0,4/8,26.01%,ADAM8;SYK;PRKCA;TNFRSF11A
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),0.4786313383236721,0.8151620701941238,0.673469387755102,0.9963515525622948,1.0,3/6,28.37%,DLEC1;PLK5;RBMS3
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.4615493894365638,0.8151493333466889,0.65,0.9958448216305374,1.0,2/12,10.88%,SNAI1;ACVR1
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.38539411916584915,0.8150230721052361,0.6896551724137931,0.995515946737279,1.0,3/27,6.25%,YJEFN3;PLA2G10;SIRT1
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.4669674414562873,-0.8148289936321244,0.7,1.0,1.0,6/15,27.18%,OSBP;CAV1;NPC2;ABCG5;OSBPL2;NPC1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.30130873032800043,0.8147461264870036,0.7916666666666666,0.995623046627398,1.0,7/123,5.94%,RELN;PDGFB;LCP2;CASS4;SRC;MMD2;SNCA
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.3909887246180898,-0.814732294654587,0.6794871794871795,1.0,1.0,12/47,14.08%,ADH4;SLC3A1;PDZK1;TSHR;SLC22A9;C4BPB;SMLR1;TMEM45B;CYP3A4;TTF1;CYP3A5;SLC2A2
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.4547261603765605,0.8145946300774703,0.696969696969697,0.9954201032290597,1.0,4/11,17.60%,HSPB1;FGF1;PRKD1;FGF2
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.40101218438295794,0.8144742916749228,0.6857142857142857,0.9951215076009102,1.0,4/13,19.18%,HAP1;NTRK2;SORT1;ZFYVE27
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),-0.4876636005722664,-0.8143244799159278,0.7213114754098361,1.0,1.0,1/8,5.13%,GBA3
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.3684229325170406,-0.8142677657959569,0.7567567567567568,1.0,1.0,15/49,28.03%,VPS35;HRK;PINK1;PPIF;CIDEB;DNM1L;BAX;MOAP1;FIS1;PDCD5;PLAUR;DCN;BNIP3;HTRA2;PARK7
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.49274742811919514,-0.814227603654838,0.7833333333333333,1.0,1.0,2/8,3.27%,PRDX1;PRDX5
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.4556126646158065,-0.8139986723997481,0.676923076923077,1.0,1.0,2/13,4.55%,DDX4;BTBD18
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.46962314676475403,-0.8139591413966389,0.746031746031746,1.0,1.0,4/16,35.84%,BRD8;MSL3;YEATS4;NAA40
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.45043211175044984,-0.8137805205650366,0.7457627118644068,1.0,1.0,4/10,25.20%,BAX;MOAP1;BLOC1S2;BNIP3
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.35708007090479826,0.813434647538558,0.5882352941176471,0.9966291428970206,1.0,10/36,17.70%,YAF2;RYBP;PHC3;EED;MGA;TFDP2;PHC1;RAD51;EHMT1;RNF2
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),-0.4373686989655202,-0.8132978246740429,0.7230769230769231,1.0,1.0,2/18,4.81%,TTN;MESP1
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.41651745498217363,-0.8132680729435516,0.7647058823529411,1.0,1.0,5/38,5.86%,DUOX1;TMC4;CFTR;TMEM125;CXCL17
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),-0.345137395400466,-0.8132209401791771,0.7666666666666667,1.0,1.0,4/74,6.87%,SEMA3E;RHOC;RHOG;PHPT1
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.3446750056647851,-0.8130945086887607,0.7746478873239436,1.0,1.0,9/86,11.97%,ACTG1;PCDHB11;TLN1;PCDHB4;PCDHB2;CDH12;ILK;BDNF;CDK5
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.3053633686112121,-0.8129645046118431,0.8817204301075269,1.0,1.0,31/383,12.76%,IGSF1;GATA1;DDIT3;ZNF100;ZNF492;SPIN2A;PLAG1;RPL10;EDF1;ZNF664;HES6;DRAP1;PPIE;ZSCAN21;SOX21;RBM3;WWC2;HINT1;CALR;BTG1;ZNF92;RPL6;DSCC1;LMX1B;TOM1L1;SOX15;THAP7;ZNF217;CEBPB;ZNF714;THAP1
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.39778016384367126,-0.8128170515276725,0.7272727272727273,1.0,1.0,2/25,0.81%,RIMS1;SLC8A3
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.3455929943047663,0.8126824288183133,0.8666666666666667,0.9975089240954746,1.0,10/43,18.55%,HSD3B7;OSBPL1A;OSBPL6;DHCR7;HMGCR;OSBPL7;SC5D;OSBPL3;DHRS11;FDFT1
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.46426032588129573,-0.812626406256462,0.6779661016949152,1.0,1.0,1/10,1.50%,NOX4
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.37986515145502836,0.8126199992099228,0.7560975609756098,0.9970476872534882,1.0,5/19,10.24%,FGFR1;HSPA1A;EYA4;HSPA1B;GDNF
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),-0.49280145136827547,-0.812601784122983,0.7746478873239436,1.0,1.0,1/5,2.03%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),-0.49280145136827547,-0.812601784122983,0.7746478873239436,1.0,1.0,1/5,2.03%,SELENOS
prerank,GO_Biological_Process_2021__C-terminal protein deglutamylation (GO:0035609),0.5079565172205229,0.8125113318288922,0.6666666666666666,0.996623752630833,1.0,2/5,22.20%,AGTPBP1;FOLH1B
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),0.4158725605824471,0.8119470830405138,0.75,0.9967622835863896,1.0,1/11,0.88%,TP63
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),0.4158725605824471,0.8119470830405138,0.75,0.9967622835863896,1.0,1/11,0.88%,TP63
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),-0.4493481376944333,-0.811340927676746,0.65625,1.0,1.0,1/11,1.05%,TTN
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.4292875637886217,0.8111992687237176,0.7608695652173914,0.997522025869028,1.0,4/11,18.43%,PRKX;DLG1;BMPR2;LOXL2
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),-0.5265897384181709,-0.8105132556274617,0.7727272727272727,1.0,1.0,1/5,11.85%,NCEH1
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.36376264426052163,-0.810244870472976,0.7916666666666666,1.0,1.0,11/51,24.82%,NOP10;FTSJ3;QTRT2;TSR3;SSB;METTL3;AARS1;AARS2;URM1;RBM15B;CTU2
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.3143341986236136,-0.810061713174021,0.8658536585365854,1.0,1.0,13/303,5.57%,VAMP5;CENPF;ATP6V1F;CLU;STX19;SVBP;USP6;SNX17;VPS35;TMED9;ARF5;ARL1;CHMP2A
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),0.4513940964111871,0.8099129991880053,0.7435897435897436,0.9988408637679408,1.0,3/9,9.36%,KYAT1;IDO1;KYNU
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),0.4513940964111871,0.8099129991880053,0.7435897435897436,0.9988408637679408,1.0,3/9,9.36%,KYAT1;IDO1;KYNU
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.5364161937033494,0.8096665280414979,0.7647058823529411,0.9988280795434062,1.0,2/6,19.73%,SLC25A33;ABCC11
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.5009879692243714,-0.8095983372896378,0.765625,1.0,1.0,2/6,22.25%,KCNE1;CAV1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.3509327780964713,-0.809586150615118,0.855072463768116,1.0,1.0,8/99,5.41%,P2RY10;HLA-C;FTL;AQP9;HLA-DPA1;HLA-A;PTAFR;CR2
prerank,MSigDB_Hallmark_2020__Complement,0.3008498331186874,0.8095639773714758,0.8461538461538461,0.9985074244317806,1.0,9/151,3.66%,F2;PDGFB;LCP2;HSPA1A;CD59;SRC;PIK3R5;DUSP6;KCNIP2
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.36564813396692747,0.809554856697951,0.7586206896551724,0.997981976838327,1.0,6/34,9.77%,GCM1;CDK6;SPOCK1;ASCL1;HAP1;TGFB2
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.35225874636197146,-0.8092962218080002,0.863013698630137,1.0,1.0,8/68,22.01%,RPL23;PHB2;PTTG1IP;KPNA2;APPL2;CSE1L;NUP50;RAN
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.38520831280878975,0.8092750997672944,0.7666666666666667,0.9979770068115608,1.0,7/24,17.69%,ADGRB1;ELMO1;DOCK1;MEGF10;XKR8;XKR7;RHOBTB1
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.4271665045838401,-0.8091564667350915,0.7647058823529411,1.0,1.0,1/24,0.77%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.4310994448270272,-0.8089637255555925,0.75,1.0,1.0,5/19,20.16%,CHMP2A;KPNA2;LGALS1;HLA-DRB1;CHMP3
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.3594680967811236,0.8089401938511325,0.7631578947368421,0.9980525462725381,1.0,5/29,8.12%,PPARGC1A;SNCA;IWS1;PAXIP1;ARRB1
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.3231513325087322,-0.8088181708034026,0.8194444444444444,1.0,1.0,9/156,6.58%,CD44;COX7A1;ENTPD2;NOX4;COL4A4;FBLN7;OAF;NFATC1;ACTA2
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.38648795011666737,-0.808775336020775,0.75,1.0,1.0,3/24,13.45%,SFRP1;CALR;BRCA1
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.459467439113289,-0.8087611644375559,0.7638888888888888,1.0,1.0,2/11,9.09%,CR2;RASGRP1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.4673146195387856,0.8085418402429666,0.625,0.9983328102645254,1.0,4/6,16.86%,PLEKHA7;AFDN;CDH2;FER
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.3471143753573358,-0.8084602444169786,0.7361111111111112,1.0,1.0,13/106,14.06%,CYP1A2;PDHX;LDHA;ACOT2;ALDH1A2;SLC16A1;PDZD11;SLC16A8;CYP3A4;SGPL1;ACSBG2;ACOT1;CYP3A5
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.3657282062129626,0.8084199736009207,0.6666666666666666,0.9980133031533577,1.0,3/23,14.28%,CDK6;CHRD;CRIM1
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.2833570766746892,0.8082558630786602,0.9375,0.9977964370551813,1.0,21/136,12.86%,ARAP1;ARHGEF7;EVI5L;EPHA3;RASIP1;ARHGAP44;PROM2;AGRN;PICALM;CPEB2;PLXNA1;MAPRE2;NTRK2;RAPGEF1;SGSM2;PLXNB2;DOCK9;AFDN;MAP4K4;PKP4;RAPGEF3
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.34707293649343424,-0.8080743150862268,0.7941176470588235,1.0,1.0,9/72,11.90%,PKMYT1;CCNB2;INCA1;CNPPD1;CDC37;CDKN1C;SERTAD1;CCNJL;CCNE2
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.43149872201794104,-0.8079911458528561,0.7101449275362319,1.0,1.0,1/19,1.75%,ACTG1
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.4667779798659741,-0.8078994295286213,0.7692307692307693,1.0,1.0,4/16,19.79%,BUD23;TRMT112;DIMT1;METTL18
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.41811507315763985,-0.8078929858509093,0.71875,1.0,1.0,1/19,6.21%,FABP3
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.39069359573155765,-0.8077866912250743,0.796875,1.0,1.0,4/29,15.02%,B2M;ILK;ARG2;CGAS
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.4817056274123528,-0.8070320593739153,0.7222222222222222,1.0,1.0,1/9,6.69%,DDX60
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),-0.4920620437640708,-0.8066040391951013,0.6949152542372882,1.0,1.0,1/7,4.19%,EFNA1
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.29583224560874666,0.806566409561707,0.9629629629629629,1.0,1.0,28/124,18.02%,IGF1;EPS8L2;MAPK11;RRAS2;CNKSR1;PLD1;LIMK1;ELMO1;CDKN2A;SHC3;RAPGEF1;MRAS;CELSR1;ZNF304;CDC42EP4;RAPGEF3;PRKD1;ABI2;RASGRP2;ARHGAP5;G3BP1;CCNA2;CYFIP1;RAP1A;FGF2;PLEKHG5;ARHGEF11;HACE1
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.45395265875919744,-0.8060856851962054,0.7457627118644068,1.0,1.0,4/19,22.67%,ANKRD27;WDR91;SNF8;EEA1
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.4266757790086729,-0.8056811250527971,0.7916666666666666,1.0,1.0,5/18,22.13%,COX17;SURF1;SMIM20;COA5;TIMM21
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.4108555065650114,-0.8055790923465368,0.7384615384615385,1.0,1.0,2/18,10.83%,DBI;PLA2G12A
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),-0.5459001871492203,-0.8054595022642703,0.8113207547169812,1.0,1.0,2/6,9.39%,AQP9;AQP11
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.4210637737095494,-0.8052548739954636,0.7183098591549296,1.0,1.0,5/17,21.61%,PHPT1;CEACAM1;GPS2;CD160;LGALS3
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.4106311321675147,-0.8048695739181763,0.782608695652174,1.0,1.0,6/30,14.75%,RPS3;BCL2L14;BDNF;PPIA;ASAH2;BCL2L12
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.31629102508330886,-0.8048675195061475,0.868421052631579,1.0,1.0,34/142,21.00%,PSMB8;BTN3A1;PSME1;HLA-DPA1;HLA-A;VAV3;PSMB6;PSMD8;PSMC5;PSMD7;HHLA2;LCK;EIF2B1;BTN3A3;PSMD3;BTN2A1;TNFRSF21;PIK3CB;PSMC3;EIF2B2;STOML2;PSMA4;EIF2B4;HLA-DRB1;PSMD2;PSMA7;PRKD2;PSMD6;BMX;PSMB2;HLA-DRA;PSMB3;PSMB4;PSMA3
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.39963632122521336,-0.8047338690484127,0.7121212121212122,1.0,1.0,6/24,9.39%,XBP1;SELENOS;CLU;RACK1;UBXN1;AQP11
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.4447375680376581,0.8046875617789329,0.6896551724137931,1.0,1.0,5/13,17.54%,TCOF1;FBXL17;CDH2;KBTBD8;NRG1
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3292031621152849,0.8046410167261,0.6875,1.0,1.0,18/106,8.51%,NUPR1;ANXA4;HDAC4;TBX6;IRAK2;ID1;PLA2G10;SIRT1;FZD6;PKD1;CDKN2A;IRAK3;PAXIP1;ARRB2;ERBIN;ARRB1;MTURN;TAF3
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.3961479285329018,-0.8045583923599233,0.7808219178082192,1.0,1.0,4/41,4.19%,ARHGEF16;AFP;FGL1;EFNA1
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.33835462042560344,0.8044885001459202,0.65625,1.0,1.0,7/41,10.13%,HOMER1;PLPP4;CRACR2A;CD4;STIM1;CACNA2D1;GRAMD2A
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.4249513663154493,0.8044007433791912,0.7142857142857143,1.0,1.0,5/10,24.97%,PLD6;PID1;TFRC;ADCK1;HUWE1
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.4169139957626447,0.8039738949286338,0.6153846153846154,1.0,1.0,2/10,9.52%,NOS2;STIM1
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.340832747792941,0.8031781424975074,0.7931034482758621,1.0,1.0,3/29,7.25%,CASS4;ARHGEF7;DOCK1
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.38905258056318726,-0.803131089846667,0.8082191780821918,1.0,1.0,6/36,9.38%,IL7;XBP1;VAV3;CD81;TNIP2;GPR183
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,0.3029992687141336,0.8030840607785016,0.8333333333333334,1.0,1.0,15/87,11.72%,ZMYND10;MORN5;GFAP;EFNB3;DNAH6;DNAAF1;HDC;DNAI2;BPIFB1;TTLL9;SPEF1;CFAP54;CELSR2;PLXNB2;AQP1
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.5259518679376797,-0.8029386114495048,0.7619047619047619,1.0,1.0,1/6,8.61%,DOLK
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.5259518679376797,-0.8029386114495048,0.7619047619047619,1.0,1.0,1/6,8.61%,DOLK
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),-0.524689688146684,-0.8027770296396768,0.8088235294117647,1.0,1.0,2/7,34.61%,CAV1;GLA
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),-0.524689688146684,-0.8027770296396768,0.8088235294117647,1.0,1.0,2/7,34.61%,CAV1;GLA
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.512727957939106,-0.8026360282956859,0.7936507936507936,1.0,1.0,2/5,38.58%,SLC6A17;SLC36A1
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.4383300218329417,-0.8025247799895514,0.7534246575342466,1.0,1.0,4/16,14.78%,TYMS;GMPR2;APRT;DCK
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.33492408538632296,0.8024687276830293,0.7083333333333334,1.0,1.0,15/41,21.19%,ANKH;BMP6;P2RX7;ACVR1;ECM1;ENPP1;GPM6B;BMPR2;ACVR2B;ACVR2A;PTH;BMPR1B;SLC8A1;WNT4;NELL1
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.373170104931995,-0.8023329173279771,0.71875,1.0,1.0,5/38,17.16%,RIMS1;PDZD11;CDK5;HSPA8;SNAPIN
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.42950485908268987,-0.8020378468590309,0.7619047619047619,1.0,1.0,5/17,16.80%,RNF212;RNF212B;IHO1;MEIOB;FANCD2
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.42091540432098706,-0.8019549230978131,0.65,1.0,1.0,4/17,15.08%,PPIB;SRP54;PPIA;EDN1
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.3181900915800295,-0.8018521370616555,0.9027777777777778,1.0,1.0,14/166,8.01%,DDIT3;MT1E;GAPDH;LDHA;MT2A;PRDX5;GALK1;EFNA1;PFKL;CDKN1C;B3GALT6;PHKG1;GPC3;BTG1
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.3305961996769384,0.8016799013602819,0.7906976744186046,1.0,1.0,8/52,9.08%,SRC;STON2;MTMR2;EPHA3;SNCA;CD22;PICALM;DLL1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.35847248434789747,-0.8014675327969599,0.7971014492753623,1.0,1.0,9/49,22.75%,EHHADH;ETFB;DECR2;DECR1;ECHDC1;HSD17B10;MTLN;ECHS1;ACOXL
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),-0.39376338462013205,-0.8013743419666921,0.782608695652174,1.0,1.0,4/31,15.08%,RIMS1;CARTPT;ILK;EDN1
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.3366889977127203,-0.8012542690830492,0.8076923076923077,1.0,1.0,13/87,14.41%,CLU;RPL11;ELOB;RAD23A;NOP53;RACK1;UBXN1;DDA1;ARIH2;RBX1;GIPC1;CAMLG;ARAF
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),0.4585631702476979,0.8008456353611882,0.7111111111111111,1.0,1.0,2/7,3.31%,SRC;ARHGEF7
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.3321365376609174,-0.8006902777181236,0.8441558441558441,1.0,1.0,5/114,2.86%,SLC8A3;SEMA3E;MUSK;PCDHB11;PCDHB4
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.3825480284513477,0.8004659354617446,0.7741935483870968,1.0,1.0,1/20,0.40%,PPP1R36
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.47267070064714606,-0.7998816558823708,0.7704918032786885,1.0,1.0,1/10,5.66%,NEFL
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.5010938932755448,-0.7998193996445782,0.7910447761194029,1.0,1.0,1/6,17.15%,GTF3C6
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),0.46304035346005207,0.7992457341222428,0.6,1.0,1.0,1/5,5.11%,EXOSC7
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),0.46304035346005207,0.7992457341222428,0.6,1.0,1.0,1/5,5.11%,EXOSC7
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),0.46304035346005207,0.7992457341222428,0.6,1.0,1.0,1/5,5.11%,EXOSC7
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),0.46304035346005207,0.7992457341222428,0.6,1.0,1.0,1/5,5.11%,EXOSC7
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.46706144304749364,0.799193963685625,0.7209302325581395,1.0,1.0,1/8,2.16%,TSPOAP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.347430329989882,0.7991786403781141,0.8285714285714286,1.0,1.0,5/33,4.45%,NOS2;HSPA1A;AFAP1L2;RELA;CLEC7A
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.36159953006556567,-0.7990892635879054,0.8441558441558441,1.0,1.0,10/51,19.62%,DPEP2;AQP9;PTAFR;CEACAM1;ARG2;DOCK8;CLEC12A;LILRB3;CR1;IGSF6
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.4266011055858013,-0.7987302863178766,0.7611940298507462,1.0,1.0,10/20,29.36%,RBM3;PAF1;NCL;CIRBP;SNW1;NCBP1;LEO1;SF3B4;NCBP2;DHX36
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.5305723475765104,-0.7986589538054034,0.8431372549019608,1.0,1.0,1/7,0.14%,EPN1
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.39289083079706527,-0.7986002461955282,0.7246376811594203,1.0,1.0,8/25,22.52%,ARF1;IRGM;IFI6;LGALS8;EIF5A;BAX;RIOK3;TOMM70
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),-0.3198443343023174,-0.7985869395606155,0.8732394366197183,1.0,1.0,17/144,12.94%,BMP5;DDIT3;SFRP1;TIMP1;EFNA1;IL17RD;WWC2;OVOL2;CALR;RPS19;SYT11;TGFB1;SLAMF8;PROCR;LRPAP1;GRN;PPP1R11
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.38014708120425605,-0.7982854936860717,0.7647058823529411,1.0,1.0,4/48,4.50%,HLA-F;P2RY10;GBP2;HLA-E
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.34243314460083707,0.7982322276243277,0.92,1.0,1.0,5/25,8.09%,MAIP1;EGFR;STX1A;RTP5;REEP1
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.33228945853500796,0.797964389099779,0.8125,1.0,1.0,8/33,17.51%,GLRB;DHFR;IRAK3;KYNU;DRD4;RCN3;DRD2;GLRA3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.3147849852956395,0.7979548463531599,0.8461538461538461,1.0,1.0,2/71,1.33%,PDGFB;IGF1
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4542755172057207,-0.7978835310057064,0.7068965517241379,1.0,1.0,1/9,7.78%,LCK
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.44364004186368905,0.7977548030036286,0.6666666666666666,1.0,1.0,2/10,21.86%,SMAD4;MLIP
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.34241416531030533,-0.7976939421623325,0.7837837837837838,1.0,1.0,8/74,14.34%,IL26;RASGRP1;HRAS;ZNF622;SEMA3A;MAPK8IP1;CD27;ANKRD6
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),0.4446914174576133,0.7975721072584503,0.6944444444444444,1.0,1.0,1/8,4.39%,PLD1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.291726207136352,0.7974833658324584,0.9047619047619048,1.0,1.0,5/154,3.00%,F2;VAPB;BET1;CD59;COL7A1
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.33863205259164486,-0.7973528611364618,0.8481012658227848,1.0,1.0,14/81,20.92%,COPS9;USP1;PCNA;USF1;TRIAP1;PARP1;SPRTN;METTL3;SCARA3;XPA;CIRBP;GTF2H2;ERCC8;UVSSA
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.41416995014850433,0.7972730686825555,0.6428571428571429,1.0,1.0,3/13,25.15%,LPL;NR1H3;PPARA
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),0.4910803261803144,0.7969846930990648,0.7619047619047619,1.0,1.0,2/5,19.26%,HEXB;NEU4
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.4481923377150395,0.796637345943243,0.7333333333333333,1.0,1.0,3/10,12.86%,ADGRB1;EHD2;RAPGEF3
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),-0.4070079939290099,-0.7965615034186633,0.7352941176470589,1.0,1.0,4/25,20.78%,PCNA;RPA3;POLD2;POLD4
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),0.5029630946902832,0.7964586800783051,0.7407407407407407,1.0,1.0,1/6,9.89%,SOX30
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.36466036498163223,-0.7957585688471951,0.7945205479452054,1.0,1.0,14/41,23.07%,DDIT3;BCL2L2;LCK;RACK1;PINK1;PPIF;RTKN2;SEPTIN4;DNM1L;NDUFS3;BAX;FIS1;CAV1;BCAP31
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),0.3385879539455874,0.7955696069168541,0.7777777777777778,1.0,1.0,2/28,4.14%,KCNN4;RELA
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.35005939542938297,-0.7950906458160284,0.765625,1.0,1.0,7/50,13.57%,TGFBR2;IL31RA;EFNA2;SRP54;GPR183;CDK4;PARP1
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.28662584169396366,-0.7945866552133937,0.9777777777777777,1.0,1.0,53/535,11.68%,BMP5;RPL23;GLP2R;IL7;PDGFD;FTH1;COPS9;NOX4;XBP1;SFRP1;TIMP1;CLU;JUP;NEURL1;TGFBR2;RPS6;ALDH1A2;INCA1;SLC25A5;IL31RA;RHOG;ROMO1;RPS4X;IL6R;GNAI2;TSHR;TSPO;RPS9;IFIT3;FABP3;IRF1;BTG3;SFRP4;CALR;KIF20B;CD81;STAT5A;SERTAD1;TNS2;BAMBI;BTG1;COX17;BEX4;HTR2B;HRAS;AQP11;FABP6;CEP131;CLEC11A;TGFB1;CDK4;FUZ;AR
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.3710519417646689,-0.7945703655351611,0.7894736842105263,1.0,1.0,8/31,22.48%,HINT1;MYBBP1A;RPS27L;DDX5;PDK2;SNW1;TMEM109;RRP8
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.33469407081037805,0.794280854417319,0.88,1.0,1.0,8/28,19.03%,FGFR3;DUSP10;DIP2B;FGF13;PTEN;WWC1;MAP2;BBS2
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),-0.47509241742404684,-0.7941381799821348,0.8214285714285714,1.0,1.0,1/7,4.19%,EFNA1
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),0.4940618426716771,0.7934742684500817,0.6923076923076923,1.0,1.0,1/5,5.24%,CD200R1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.5113325416113191,-0.7932180207046118,0.7272727272727273,1.0,1.0,4/5,48.62%,HIF1A;RBPJ;VEGFA;NOTCH1
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.438786496247364,0.793131091861026,0.7441860465116279,1.0,1.0,1/11,6.23%,EHD2
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.37881668319123196,-0.7930753435779871,0.7714285714285715,1.0,1.0,7/29,21.70%,RPL10;RBM3;EIF2B4;RBM4B;METTL18;EIF2A;PGAM1
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.2981368373816384,0.7928041576608031,0.875,1.0,1.0,5/63,5.18%,KIFC2;SGO1;ZNF207;PLK1;ESPL1
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.4014893926981153,0.7927773531647512,0.7096774193548387,1.0,1.0,6/22,17.54%,MAPK11;MAPK12;CTNNA2;CDH2;ABL1;NRG1
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.3942728803464824,-0.79276556905261,0.7702702702702703,1.0,1.0,7/22,19.00%,TNIP2;MAPK7;CD160;TEK;SCG2;ANGPT1;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.42230855439609605,-0.7927417943939209,0.8235294117647058,1.0,1.0,3/16,15.08%,CLU;DDAH2;EDN1
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.3672306076970842,-0.7926646859361149,0.7424242424242424,1.0,1.0,5/39,17.16%,RIMS1;PDZD11;CDK5;HSPA8;SNAPIN
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.40982660535818805,-0.7925470117926661,0.6818181818181818,1.0,1.0,8/17,23.99%,MADCAM1;IL6R;PTN;ZP3;PLVAP;LGALS3;ZNF580;ADAM17
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),-0.3871769354078947,-0.7922413860551542,0.7377049180327869,1.0,1.0,2/27,8.28%,XBP1;RACK1
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.496762066462904,-0.7920082541742489,0.8035714285714286,1.0,1.0,2/8,16.21%,AGBL3;AGBL5
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),-0.47387832600320084,-0.7919946543084063,0.7058823529411765,1.0,1.0,1/11,9.49%,RAG2
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.34301273685499944,-0.7918293084111326,0.8493150684931506,1.0,1.0,12/66,18.61%,RNF8;TRIM13;ABRAXAS1;RAD51AP1;BRCA1;KDM4D;KAT5;FIGNL1;FANCD2;MRNIP;IKBIP;ECT2
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),-0.5406267795928186,-0.7915848859978791,0.8387096774193549,1.0,1.0,1/5,9.90%,AGBL3
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.5328518906569419,-0.79143105114375,0.7833333333333333,1.0,1.0,2/5,21.05%,APOE;SOD1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.5328518906569419,-0.79143105114375,0.7833333333333333,1.0,1.0,2/5,21.05%,APOE;SOD1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.5328518906569419,-0.79143105114375,0.7833333333333333,1.0,1.0,2/5,21.05%,APOE;SOD1
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.3206445186705603,-0.7913072161016942,0.8961038961038961,1.0,1.0,11/124,10.48%,CD44;TSPAN11;CLU;PCDHB4;DBI;GNAI2;HSPB8;TCEAL7;SPARC;SPARCL1;ITM2B
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.38443991520767423,-0.7912853348700423,0.75,1.0,1.0,4/20,21.24%,LCK;HTR2B;HTR2A;CCR7
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.4848014157906142,0.7908522440542718,0.7272727272727273,1.0,1.0,1/6,3.41%,SLC2A9
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),-0.47938722713536414,-0.7907859389615682,0.7413793103448276,1.0,1.0,1/7,8.15%,MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.38361110606702026,-0.7903819765408795,0.7808219178082192,1.0,1.0,8/38,17.59%,DTX3L;DDX11;PNKP;RAD51AP1;KDM4D;PARP1;PARP9;MRNIP
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.5046209142333586,-0.7903746829815822,0.8148148148148148,1.0,1.0,1/5,26.05%,TMBIM1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.37555770242648334,-0.7900958450062684,0.7575757575757576,1.0,1.0,16/36,31.74%,ATG14;PHB2;PINK1;GABARAPL2;CISD2;MAP1LC3B;WDR45B;FIS1;SQSTM1;BNIP3;FUNDC1;ULK2;MAP1LC3A;FBXO7;WIPI2;FUNDC2
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.3525901549856227,-0.7899091786143191,0.8088235294117647,1.0,1.0,3/53,6.39%,PLAAT4;DBI;CHKB
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),-0.37405139275536026,-0.7896870203574923,0.7733333333333333,1.0,1.0,5/41,14.43%,CPTP;GBA3;ST3GAL5;SMPD2;ESYT1
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.3416447545344091,-0.7893197588347998,0.7941176470588235,1.0,1.0,11/68,12.31%,RHOC;MT1E;TAX1BP3;CD9;CLCA2;DNPH1;MT1L;ITGB4;TMEM54;ILK;S100A16
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),0.4309120300347794,0.7893114355330345,0.7692307692307693,1.0,1.0,2/9,2.92%,MTHFD2L;MTHFS
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.4360684964087605,0.7892867654558701,0.8235294117647058,1.0,1.0,1/10,1.66%,KAT2A
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.4149003087348843,0.7891970018823016,0.7647058823529411,1.0,1.0,2/11,8.40%,SLC15A2;SGK1
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.3470278565963694,-0.7890213881378997,0.8589743589743589,1.0,1.0,23/89,26.46%,CPTP;SLC10A3;SLC10A6;PRELID1;FABP3;CEACAM1;SLC27A5;TRIAP1;SLC51A;ABCA12;APOE;OSBP;ATP8B1;ABCA5;APOL2;STARD5;NPC2;MFSD2A;SLCO1B1;SLCO2A1;PCTP;ABCG5;OSBPL2
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.46607566996876315,-0.7889650649237168,0.8035714285714286,1.0,1.0,2/9,10.96%,GSTP1;TGFB1
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.4004090697996426,0.7888611634860211,0.7931034482758621,1.0,1.0,6/14,20.86%,SLC9C2;SLC9A2;SLC12A2;SLC9A9;SLC6A1;SLC8A1
prerank,PanglaoDB_Augmented_2021__B Cells,0.28339268848276594,0.7886592800398681,0.7666666666666667,1.0,1.0,14/91,12.25%,BTLA;FLI1;LCP2;PSTPIP1;TMC8;CD22;EAF2;CD72;HCLS1;BACH2;LAIR1;PXK;CD55;SEMA6D
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),-0.5075530295777193,-0.788651027855802,0.7333333333333333,1.0,1.0,1/5,2.05%,BUB1
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.4707296942962455,-0.7886391225907838,0.8148148148148148,1.0,1.0,2/8,10.96%,GSTP1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.4044810463786509,-0.7885291600965111,0.7142857142857143,1.0,1.0,2/18,4.55%,DDX4;BTBD18
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.3838181567203689,-0.788474309696434,0.7352941176470589,1.0,1.0,2/25,2.40%,SFRP1;H2AZ1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.41907069495489885,0.7883958191696211,0.6666666666666666,1.0,1.0,4/12,15.21%,PTP4A3;CORO2B;CEP290;SCFD1
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),0.39847518422371553,0.7882042191947571,0.7222222222222222,1.0,1.0,2/11,8.03%,TRIM35;TRIM11
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.40630788276167773,-0.7880776584115085,0.8333333333333334,1.0,1.0,5/21,20.70%,CCDC186;TUBA1A;MYO10;TUBA1B;TUBB
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.46652814110604335,-0.787966737252752,0.7142857142857143,1.0,1.0,2/10,9.52%,NLRP1;PHB2
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.45781184670992064,-0.7876183192480807,0.7384615384615385,1.0,1.0,3/10,18.26%,IL31RA;PARP1;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.3922324115170272,0.7875933491288499,0.7647058823529411,1.0,1.0,4/21,11.20%,ACER2;TESC;TGFB2;ADA
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.4566446422733954,-0.7872661759976557,0.71875,1.0,1.0,2/7,29.03%,RAD50;NBN
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.4362122185203798,-0.7872516156188265,0.7692307692307693,1.0,1.0,5/14,26.23%,SSB;INTS5;INTS12;TOE1;TRNT1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.32504688453654457,0.7871453714028616,0.8333333333333334,1.0,1.0,16/47,24.67%,CELF3;HNRNPU;MBNL1;MBNL2;CELF2;RBM5;FXR1;KHDRBS3;NSRP1;CELF1;ZBTB7A;SRSF12;WTAP;RBFOX1;RBM15;RBFOX2
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.3369563567163456,-0.7871384641264978,0.8055555555555556,1.0,1.0,3/51,6.04%,ADH4;EHHADH;ADH5
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.41850494926116805,-0.7870059333336837,0.7454545454545455,1.0,1.0,4/16,18.65%,VAMP8;AR;CDK5;ACTB
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.35017069571096343,-0.7869815937528213,0.8148148148148148,1.0,1.0,3/65,5.70%,SLC8A3;SLC6A12;SLC5A10
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.3576176513245144,0.7867978781627228,0.7073170731707317,1.0,1.0,9/20,23.14%,DLX1;SMAD4;SMURF2;TRIM33;ZNF703;SMAD2;TGFBR3L;LATS2;SMAD3
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.41095941321773244,0.7866747363976095,0.7105263157894737,1.0,1.0,5/12,19.08%,SRC;ZNF304;PIK3CA;PDK4;BCL2
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.3408058407866645,-0.7866200940196268,0.7837837837837838,1.0,1.0,22/72,23.14%,NOX4;TTC36;PDZK1;GBA3;C3P1;SMLR1;CYP3A4;SLC22A8;HAAO;SLC2A2;CYP2E1;SLC28A1;APOE;BHMT;F11;GSTZ1;ADH6;GJB1;SLC5A2;CLDN2;SLC22A1;ALDOB
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.4481929913450663,0.7865180255727667,0.7368421052631579,1.0,1.0,3/11,7.87%,SNCA;SIRT1;ZNF451
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.4447457397731376,-0.7858117707652087,0.7777777777777778,1.0,1.0,3/12,13.37%,PLN;ATP5IF1;PPIF
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.2809632953938269,0.7857376286430088,0.9,1.0,1.0,19/147,11.96%,KCNQ2;KCTD8;CSDC2;CHRNA4;CELF3;MMD2;GALNT14;SCRT1;OLFM3;ADGRB3;IGLON5;PCDH8;PSD2;NXPH1;SNAP91;SRRM3;CAMKV;NCAN;CHRNB3
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.5004629261312765,0.7856659403991605,0.6944444444444444,1.0,1.0,2/5,25.14%,SETD2;SETD5
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),-0.5095625289682306,-0.7853780304889264,0.746031746031746,1.0,1.0,4/5,48.62%,ENG;PROX1;VEGFA;NOTCH1
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.4156502550001492,0.7853677813648343,0.6666666666666666,1.0,1.0,4/9,26.61%,CSRP2;SMO;NF1;SRPK3
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.4376876531884478,0.7852803022883192,0.8181818181818182,1.0,1.0,4/8,37.28%,RPGRIP1L;RP1;RPGRIP1;BBS4
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.4116690856544421,-0.78462085687982,0.7014925373134329,1.0,1.0,3/15,8.82%,SPAG17;CCDC39;SPEF2
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.3032794798313364,0.7845285123428639,0.8888888888888888,1.0,1.0,25/104,17.71%,SAMSN1;SRC;VIPR1;VIPR2;MAPKBP1;ADORA2B;CYSLTR1;IRAK3;HTR4;GPR39;GPR27;PTH1R;ADCY8;PTHLH;CRHR2;HCK;ITCH;PCBP2;SYK;ADCYAP1;CD247;FER;PRKACB;PTH;RHBDF2
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.4253872594392774,-0.7845263747574686,0.78125,1.0,1.0,3/16,12.49%,HSPA5;PINK1;ARL2BP
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),0.4794668259203993,0.7844334300900669,0.6842105263157895,1.0,1.0,2/6,5.71%,DNAH11;DNAAF1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),-0.49631478371456383,-0.7843065907525194,0.7758620689655172,1.0,1.0,1/6,5.44%,ATP6AP2
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.31205820998778466,0.7842808501676027,0.92,1.0,1.0,4/53,6.61%,VDR;HSD17B7;CYP2C8;SULT2A1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3174423599021088,0.7841606091342869,0.8214285714285714,1.0,1.0,8/53,7.87%,ADAMTSL2;SPRY2;HSPA1A;SPRED3;SPRED2;SPRED1;SIRT1;ZNF451
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.4622867376852665,-0.7840901287743314,0.7777777777777778,1.0,1.0,2/7,13.90%,MTHFD1;HAAO
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),-0.45376233141235744,-0.7839348965436901,0.8035714285714286,1.0,1.0,2/9,16.99%,C1QBP;RNF26
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.3452200370553484,0.783850069634838,0.6904761904761905,1.0,1.0,3/22,9.08%,CDK6;ZNF488;DLL1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.41115891212470007,0.7836841524578902,0.8846153846153846,1.0,1.0,2/18,6.07%,EPS8L2;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.3735943271659602,-0.7834463190731389,0.821917808219178,1.0,1.0,1/25,0.55%,GATA1
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),-0.4440284897607678,-0.7826753927094434,0.7571428571428571,1.0,1.0,7/12,31.25%,SLC25A11;LRRC8D;SLC1A6;SLC1A1;SLC25A10;SLC25A30;SLC25A12
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.443936258502753,0.782357000306621,0.7659574468085106,1.0,1.0,2/11,6.48%,PLA2G10;LPCAT4
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.3469354113085129,-0.7814979274792083,0.8333333333333334,1.0,1.0,12/65,14.16%,CLU;GSTP1;SLC25A5;BCL2L2;PRELID1;TRIAP1;PINK1;AR;BDNF;PPIF;RTKN2;ASAH2
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.4133525237789785,-0.7814047374840885,0.7090909090909091,1.0,1.0,1/17,0.86%,TINF2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.4242847022012664,0.7813946281432048,0.7878787878787878,1.0,1.0,3/12,11.29%,NRP2;PLXNA1;PLXNB2
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.36802308034894515,0.7805595711136412,0.7727272727272727,1.0,1.0,6/18,19.27%,ACER2;PDE4B;PPM1E;GPLD1;FBP1;TFRC
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.3187384763806629,-0.7803037589904074,0.8695652173913043,1.0,1.0,14/92,12.22%,RHOC;CLU;NEURL1;RPS3;TMED9;HRK;GPC3;RACK1;TRABD2B;CAMK1;BRK1;TGFB1;AR;FLOT1
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.33924883244781795,0.7802779368529495,0.7333333333333333,1.0,1.0,6/56,5.76%,FGFR1;GALNT3;FGFR3;SPRED2;FGF17;SPRED1
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.31209356821497225,0.7801895117668307,0.9333333333333333,1.0,1.0,10/71,10.95%,NUPR1;NFATC4;PPARGC1A;NSMF;ADAM8;NTRK2;TOX3;TGFB2;GDNF;CPEB4
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.36383257788587753,-0.7800570794171514,0.8125,1.0,1.0,2/33,3.59%,IRF4;RPS3
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),0.4197905693197567,0.7797360630343433,0.7441860465116279,1.0,1.0,1/12,0.22%,VDR
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.40089607297908386,-0.7795542768096074,0.711864406779661,1.0,1.0,6/19,21.61%,PPIB;SRP54;PPIA;EDN1;SCG2;LGALS3
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.4915442134092585,0.7794291625284084,0.8108108108108109,1.0,1.0,3/7,12.08%,AGER;SH3RF1;CD55
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.2564313164347712,0.7792627299554347,1.0,1.0,1.0,84/426,17.09%,VDR;PTPN6;NUPR1;DACT2;NPAS2;CDK6;HSPA1A;PIWIL4;ADGRB1;ZBTB7C;FRZB;GMNN;JAM2;TMEM98;CDK10;CHD5;PIWIL2;OSGIN1;DYSF;IP6K2;DUSP1;FRK;SIRT1;SMARCA2;PRKRA;CDKN2A;TESC;CLMN;PLXNA1;TXNDC12;SESN2;GNRH1;NOTCH4;ST18;HSPA1B;DLL1;ADARB1;TGFB2;CASK;SULT2B1;SMYD2;UTP20;ADRA1A;SCIN;SPEF1;PARP16;KLF11;PLXNB2;PTPRK;RARG;SMAD4;MNT;TEX15;SLIT3;ENPP1;PTHLH;APBB2;PRKD1;SLIT2;MAGI2;GPLD1;RBM5;BMPR2;DLG3;KAT2B;PTEN;NIBAN2;TXNIP;GPER1;ST7L;PKD2;BNIPL;HMGA1;GSDME;DRD2;TDRD9;PTPN14;PDE8A;PLXNA4;VHL;SIPA1;NR1H3;MARCHF5;FBP1
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.4132479322840812,0.778978322863504,0.6666666666666666,1.0,1.0,3/8,20.06%,CRTAM;CD274;SCRIB
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.42350539395439746,0.778777822599344,0.7954545454545454,1.0,1.0,5/8,17.60%,GDNF;NPNT;FGF1;PKD2;FGF2
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.36860917970143964,-0.7787208898892277,0.8082191780821918,1.0,1.0,13/35,36.22%,TOMM20;SSB;NOL6;NUP50;RAN;NUP155;NUP58;POM121;NUP93;NUP88;POM121C;NUP107;AAAS
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5075621519712699,0.7786500004514862,0.7941176470588235,1.0,1.0,4/6,12.02%,KCNIP2;AKAP6;NOS1AP;LRRC38
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.4581387180324273,-0.7783710883477448,0.8225806451612904,1.0,1.0,2/11,11.11%,HLA-A;BTN3A3
prerank,PanglaoDB_Augmented_2021__Podocytes,0.303337265051384,0.7782325383312778,0.9565217391304348,1.0,1.0,48/163,19.63%,DACH1;LIFR;STARD13;EGFR;CLIC5;LIMCH1;TMEM47;BCAM;NPR3;DOCK1;NFIB;RND3;EPB41L1;OPTN;CHST3;GOLIM4;HTRA1;MAFB;NUAK1;TEAD1;CORO2B;PTH1R;MYO1D;APBB2;RASAL2;PLSCR4;MERTK;MAGI2;CD80;RHPN1;RAB3B;MPDZ;KANK1;DOCK5;NAV2;COL12A1;LGR4;COL4A2;PTPRO;QKI;TJP1;LOXL2;MYO1B;RAI14;MAPT;ARHGAP24;ADCY6;TPM1
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.49664214734373724,-0.7782136798705017,0.7758620689655172,1.0,1.0,1/8,6.25%,PFKL
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.37533827437838496,-0.7782031000173586,0.7777777777777778,1.0,1.0,10/42,21.26%,MAGEF1;USP51;RAD51AP1;PARP1;CGAS;FIGNL1;MRNIP;OOEP;POLQ;PPP4C
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",-0.5173156658141227,-0.7779528189398137,0.828125,1.0,1.0,1/6,1.77%,ZDHHC12
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.3457801470411839,0.777786592326135,0.8666666666666667,1.0,1.0,7/48,7.86%,HSPB1;CLEC7A;AGER;CYBA;TMEM106A;OAS3;ADAM8
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),-0.37804634412319715,-0.7776611468729537,0.7794117647058824,1.0,1.0,1/32,0.90%,SEMA3E
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),0.4686072281734229,0.7776525708549697,0.8048780487804879,1.0,1.0,2/6,21.04%,IL33;CSF1R
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.3646564406676255,0.777385211584822,0.8,1.0,1.0,4/31,3.24%,IGF1;FGFR3;IFNA2;CTF1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.34672354008616135,0.7773830523188573,0.7878787878787878,1.0,1.0,5/29,14.05%,GRHL2;NAF1;HMBOX1;TNKS;PTGES3
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.4231089105852787,-0.7773054827797432,0.8125,1.0,1.0,2/12,10.19%,CENPE;NEK6
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.4434912813166791,-0.7767785707554179,0.7818181818181819,1.0,1.0,4/11,26.54%,IRGM;JMJD4;BNIP3;SMCR8
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.43935150243203236,0.7767583623879393,0.75,1.0,1.0,2/8,7.30%,PKD1;COBL
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.42832186585036913,0.776714962278931,0.6875,1.0,1.0,3/9,11.67%,PDE4B;CACNA2D1;NOS1AP
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-0.463028061908051,-0.7766977736653684,0.7666666666666667,1.0,1.0,1/6,5.66%,RAB11A
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.3859695064821981,-0.7766830237091854,0.7540983606557377,1.0,1.0,2/27,3.63%,AQP9;CFTR
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.441529078854805,0.7766526114874873,0.8571428571428571,1.0,1.0,2/10,8.03%,IFNA2;TRIM11
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.3925661996327719,-0.77661970396362,0.8307692307692308,1.0,1.0,3/19,12.30%,SGMS2;TGFB1;CEBPB
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.4411126448063689,-0.7764826590530767,0.7833333333333333,1.0,1.0,5/13,23.73%,RNF8;HEXIM1;SUPT5H;NELFCD;NELFE
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),0.3953098673815839,0.7764292956413883,0.7567567567567568,1.0,1.0,2/10,5.41%,CX3CR1;DYSF
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.31460016479521274,-0.7763291924220702,0.8591549295774648,1.0,1.0,5/97,7.90%,BMP5;RPS27A;TGFBR2;UBA52;BAMBI
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.4753358446916949,-0.7763234155137523,0.7454545454545455,1.0,1.0,4/7,25.20%,PRELID1;BAX;ARL6IP5;BNIP3
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.33561454957599895,-0.7761652438887776,0.7903225806451613,1.0,1.0,5/46,15.61%,TINF2;PNKP;CCT7;EXOSC10;CCT2
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.44650316919432564,-0.7760897288555358,0.7428571428571429,1.0,1.0,4/14,21.15%,RBM22;CAMK1;GTSE1;EMD
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.3829078616645653,-0.7759263760555284,0.8253968253968254,1.0,1.0,8/21,29.86%,VAV3;LAMTOR5;EDN1;RHOA;MSN;VAV2;LAMTOR4;LARS1
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.46372428145713934,0.7759140553367759,0.6818181818181818,1.0,1.0,6/7,39.01%,TBC1D8B;TMEM63C;SULF2;XPNPEP3;SULF1;MYO1E
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.4081142924888496,0.7758031311314932,0.7027027027027027,1.0,1.0,1/12,10.41%,ALG13
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.4564642005748497,0.7757101111742937,0.7391304347826086,1.0,1.0,2/7,14.60%,EHD2;ZDHHC2
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.3433675688750728,-0.7752664428197921,0.8088235294117647,1.0,1.0,5/50,13.46%,SFRP1;FZD8;SFRP4;PPP1CA;WNT9A
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.4838826174105571,0.7747294380596073,0.7674418604651163,1.0,1.0,3/6,29.79%,ERC2;ERC1;PCLO
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",-0.4370230832822404,-0.7745371374622184,0.7076923076923077,1.0,1.0,1/12,1.77%,ZDHHC12
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.4228606340754367,0.7745370125748076,0.7096774193548387,1.0,1.0,3/14,9.87%,SNAI1;SIRT1;BAHD1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.4610519621524871,0.7745280932680331,0.8,1.0,1.0,2/7,21.27%,CLASP1;PDPN
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.518658937041736,-0.7745131397872809,0.84375,1.0,1.0,4/6,24.86%,ATP6AP2;GRN;TMEM9;PPT1
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.4440334535170549,-0.7742122588331014,0.7733333333333333,1.0,1.0,3/16,12.39%,RHBDF1;CEACAM1;IFI6
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.2845654876107094,-0.7741366040106981,1.0,1.0,1.0,53/421,13.99%,BMP5;RPL23;GLP2R;IL7;PDGFD;COPS9;XBP1;SFRP1;TIMP1;PTK6;TGFBR2;RPS6;SLC25A5;DNPH1;IL31RA;RHOG;ROMO1;RAD23A;RPS4X;IL6R;GNAI2;TSHR;RPS9;CALR;RPS19;KIF20B;CD81;SERTAD1;BAMBI;COX17;TRIM13;COLEC12;HTR2B;HRAS;AQP11;PRR7;CEP131;CLEC11A;TGFB1;CDK4;AR;FLOT1;GRN;MYRF;EXOSC4;C1QBP;ESM1;DUSP26;CAPNS1;OSMR;DOCK2;RTKN2;VIP
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),-0.5444729083156256,-0.7740275346389847,0.8,1.0,1.0,3/5,25.43%,EIF5A;USP16;EIF5A2
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.45295843895756,0.7739977173729373,0.6571428571428571,1.0,1.0,4/8,18.63%,CYP2C8;LTC4S;LTA4H;PLA2G4A
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.33084299006045187,0.7739695128771291,0.8947368421052632,1.0,1.0,7/52,10.27%,DYSF;SYTL4;EHD2;MYOF;P2RX7;AHNAK2;COL5A1
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.3709873553674158,0.7739420819324914,0.6666666666666666,1.0,1.0,3/13,15.55%,C3;TRIB3;C2CD5
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.3959857836375994,-0.7737833174776371,0.8115942028985508,1.0,1.0,11/27,29.48%,CHMP2A;CEP131;GEN1;XRCC3;CENATAC;CHMP3;CHMP4B;VPS4B;CEP76;PLK2;RAB6C
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.4130954446619682,-0.773660121129246,0.7857142857142857,1.0,1.0,9/21,30.67%,GPR62;CGAS;GPR61;CDC34;SCTR;PRKAR1B;PDE11A;PDE4D;RASD2
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.4461683265147801,0.7735208651951299,0.7948717948717948,1.0,1.0,4/11,12.74%,HSD3B7;ADAM8;CXCL13;SLC12A2
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.4157335906898732,-0.7735167778156519,0.7692307692307693,1.0,1.0,3/18,11.91%,OVOL2;TGFB1;FAM89B
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.3756938059412873,-0.7735104074356322,0.8088235294117647,1.0,1.0,5/30,12.28%,HES6;BHLHE41;RPS19;SLAMF8;GRN
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.3069823969082629,0.7725574228909949,0.875,1.0,1.0,24/126,13.86%,BACE2;PCOLCE2;STAB1;PDIA5;NXN;POSTN;LTBP2;EHD2;BMP6;TMEM47;DOCK1;COL6A1;COL14A1;HTRA1;LOX;COL5A1;TMTC1;TMEM184B;AQP1;TMTC2;ACKR3;PLSCR4;PXDC1;GXYLT2
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.4884022794137179,-0.7725541806847701,0.8275862068965517,1.0,1.0,1/7,4.38%,DDX11
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.4265806576467409,-0.7723471786065697,0.8253968253968254,1.0,1.0,2/12,10.50%,RACK1;SYT11
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.3267172892715453,0.7722626555013499,0.7741935483870968,1.0,1.0,6/60,7.27%,PTPN6;LIFR;RUNX1;IRAK2;TRAF2;IRAK3
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.32425599974108427,-0.7722540389740151,0.8783783783783784,1.0,1.0,4/108,5.57%,CD44;NOX4;PRDX5;APOL3
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),0.4484394130794456,0.772251401746024,0.717391304347826,1.0,1.0,3/6,19.64%,DUSP1;CDK5RAP2;USP44
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),0.4484394130794456,0.772251401746024,0.717391304347826,1.0,1.0,3/6,19.64%,DUSP1;CDK5RAP2;USP44
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.30564480717390036,0.7720804418556517,0.875,1.0,1.0,3/71,2.76%,KCNN4;SLC39A8;CHRNA4
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.4240145994805147,0.7718536044766312,0.7931034482758621,1.0,1.0,3/7,17.96%,SERPINB9;SFPQ;BCL2L1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.3901322254137096,0.7718083826794582,0.71875,1.0,1.0,3/15,13.08%,NT5E;NT5M;UPP1
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),0.435498842612721,0.7713499549864536,0.7272727272727273,1.0,1.0,1/6,9.79%,CACNA2D1
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),-0.4368106467957813,-0.7706712215032195,0.7571428571428571,1.0,1.0,1/12,11.85%,NCEH1
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),-0.4525121995162645,-0.7706633621683298,0.7666666666666667,1.0,1.0,2/7,13.99%,ZFHX2;VIP
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.3917164858738672,0.7704573838978008,0.8125,1.0,1.0,4/11,18.34%,PLK1;PTEN;CDC14B;BTRC
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.47014759349710916,-0.7703820289119586,0.7833333333333333,1.0,1.0,5/9,33.21%,CADM4;PTPN1;HGS;NEDD4;CNMD
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.29223894777787235,-0.7703518774951371,0.9764705882352941,1.0,1.0,50/247,21.83%,PSMB8;RPS27A;GFRA3;PSME1;PSMB6;IL31RA;PSMD8;PSMC5;RASGRF2;NEFL;PSMD7;IL17RD;UBA52;PEBP1;TNIP2;HTR2B;RASGRP1;IL5;HRAS;PTPN7;RBX1;TGFB1;PSMD3;PIK3CB;PSMC3;LRRC7;FNTA;ARAF;UBB;IL3RA;PSMA4;FRS3;TEK;SCG2;PSMD2;PSMA7;ANGPT1;FGF7;PSMD6;NRG4;PSMB2;FGF22;ITGAV;PSMB3;PSMB4;PLVAP;PSMA3;PSMC1;YWHAB;ZDHHC9
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.45502637979181065,-0.7700191244339153,0.7818181818181819,1.0,1.0,3/11,20.12%,TAF11;GTF2A2;POLR1E
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.39256284124322455,0.7694267577983537,0.8205128205128205,1.0,1.0,3/14,8.52%,SNAI1;TBX19;SCX
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.49797264390749074,-0.7692367864955177,0.7868852459016393,1.0,1.0,1/6,10.96%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.36190674847328613,0.7691865014739322,0.7647058823529411,1.0,1.0,3/26,2.88%,FLT1;VASH1;ATOH8
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.4081225762694577,-0.7690163312134375,0.8059701492537313,1.0,1.0,2/17,10.09%,RHOG;BRK1
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.33455725652890494,-0.768948150644883,0.9102564102564102,1.0,1.0,8/69,13.57%,XBP1;SELENOS;USF1;CEACAM1;RAB8A;SYAP1;CELA2A;PARP1
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.4019410376993082,0.7684090552951452,0.8333333333333334,1.0,1.0,4/19,16.86%,PLA2G10;NFKB1;LPL;NR1H3
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.39867520251770083,0.7680478836574561,0.8181818181818182,1.0,1.0,3/17,11.50%,ATP6V0A4;CLN6;ATP6V0D2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.3978325160747742,0.7679360134604859,0.8205128205128205,1.0,1.0,2/7,9.05%,DCP1B;DCP1A
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.33054161438221913,0.767870042842844,0.8857142857142857,1.0,1.0,5/33,15.59%,SRC;RNF14;ARID1A;UBR5;GPER1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.357641844992307,-0.7677021695081814,0.8064516129032258,1.0,1.0,5/31,18.01%,DND1;PHAX;ZCCHC17;VIP;CIRBP
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.3772399836070365,0.7674585781989163,0.8648648648648649,1.0,1.0,9/26,19.37%,CHKA;LPIN3;GPAT4;SLC44A5;LCAT;ABHD3;LPCAT1;SLC44A1;CHPT1
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.3877256057575295,0.7673182189417599,0.7878787878787878,1.0,1.0,4/11,18.35%,IP6K2;IPMK;FGF2;ITPKC
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.5131079755699806,-0.7672493168574777,0.84375,1.0,1.0,4/5,26.22%,EDN1;SNX6;SCG5;VAMP3
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.43035004400615645,0.7666684500832275,0.7333333333333333,1.0,1.0,4/9,19.82%,UBR3;SLC24A4;DRD2;MKKS
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.44470964389053613,-0.7665503159783027,0.7746478873239436,1.0,1.0,2/10,15.79%,TPP1;DCTN1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.4978972693991287,-0.766307857989857,0.7241379310344828,1.0,1.0,1/5,12.98%,YBX3
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.42274064075396733,0.7662273179590147,0.7441860465116279,1.0,1.0,3/8,16.31%,SLC2A5;BMPR2;DRD2
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.46460915269918857,-0.7659546938499613,0.746031746031746,1.0,1.0,1/8,4.02%,GSTP1
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),0.466704412406228,0.7656162807761548,0.8,1.0,1.0,4/6,28.42%,GRK5;TACR3;TAC1;TAC4
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.40681033747173223,-0.7653916537221842,0.8181818181818182,1.0,1.0,5/18,17.49%,DTX3L;STAT1;CGAS;PARP9;PQBP1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.40666459152468515,-0.7653090274005823,0.8305084745762712,1.0,1.0,6/24,17.49%,DTX3L;STAT1;IFNLR1;CGAS;PARP9;PQBP1
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),0.4156924701123726,0.7652657018693486,0.7692307692307693,1.0,1.0,1/12,0.51%,NUPR1
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.29123555009258334,0.7651789074715939,0.9310344827586207,1.0,1.0,19/101,11.83%,CDK6;FGF17;EGFR;PRKX;MEMO1;OSGIN1;TMSB15B;AKT2;NRG2;DIAPH1;SPOCK3;CAMSAP3;PLXNA1;SGK1;FRMD5;SGK3;PLXNB2;PARD6B;FGF1
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.4769713911965989,-0.7648908510640475,0.7818181818181819,1.0,1.0,1/8,4.02%,GSTP1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.47525782022154284,-0.7647410850401914,0.7368421052631579,1.0,1.0,1/6,10.89%,RBX1
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.43537123724743887,0.7647019066360838,0.8064516129032258,1.0,1.0,1/6,7.00%,XPO1
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.31287887225859473,0.7646131756180495,0.8,1.0,1.0,7/42,12.32%,NOS2;SNCA;IRAK3;ERBIN;MAPKAPK3;PTPN22;PELI1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.29935853522963374,-0.7640737134273923,0.9620253164556962,1.0,1.0,16/139,15.22%,XBP1;SFRP1;SELENOS;H2AZ1;PTK6;CFTR;GSTP1;TNIP2;ADAM15;MAP4K1;IRGM;AR;PAF1;WNT9A;AHR;KAT5
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.35945050942856144,0.764046209647627,0.7105263157894737,1.0,1.0,2/17,6.25%,HSPB1;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.40585872512793875,-0.7638984168576144,0.855072463768116,1.0,1.0,5/17,23.99%,CDKN1C;GIPC1;RNF111;SNW1;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.40585872512793875,-0.7638984168576144,0.855072463768116,1.0,1.0,5/17,23.99%,CDKN1C;GIPC1;RNF111;SNW1;ADAM17
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.3721258652126437,0.7636770630523781,0.7941176470588235,1.0,1.0,7/22,15.42%,EGFR;NOTCH3;ARRB1;DLL1;FBXW7;LFNG;NIBAN2
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.27772252525927366,0.7635526879445784,1.0,1.0,1.0,21/107,16.86%,SH2B2;ATP6V0A4;IRS1;GRB14;LPIN3;AKT2;SORBS1;IGF1R;CPEB2;GAB1;ATP6V0D2;RHOQ;HDAC9;ENPP1;TRIB3;GPLD1;KAT2B;C2CD5;PDK4;GSK3B;FER
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.4738069654996018,-0.7630729841750766,0.8627450980392157,1.0,1.0,2/7,13.88%,PHAX;ZCCHC17
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),-0.4619373546652777,-0.7629481222658914,0.8653846153846154,1.0,1.0,1/9,4.19%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.35838771090065336,0.7622736781265974,0.7575757575757576,1.0,1.0,4/29,10.38%,PPARGC1A;PAXIP1;ARRB1;FAM47E
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.40060458258173637,-0.7619133874816869,0.8088235294117647,1.0,1.0,7/16,24.13%,CXCL17;CALR;C1QBP;SERPINE1;CCR7;LGALS3;CREB3
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.3234095811310397,-0.7615831725407652,0.8795180722891566,1.0,1.0,9/96,10.96%,MT1E;SFRP1;MT2A;TCHP;HYAL2;BTG1;RACK1;ADAM15;TGFB1
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.4284894993090286,-0.7614586530296346,0.8059701492537313,1.0,1.0,1/12,1.75%,ACTG1
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.2747643600711408,-0.7614444590940257,1.0,1.0,1.0,35/377,15.22%,ARHGEF16;GPAT3;ARHGAP4;RHOC;RPL5;RMI1;RPL11;VAV3;NEK8;RHOG;RASGRF2;ATP6AP2;ARHGAP15;WWC2;RPF2;NOP53;CEACAM1;DEPDC7;TPX2;FSHR;RPA3;TMSB4X;PAK5;TAF11;ARHGDIG;CDK5;RGN;RFC2;DEPDC1B;BRCA1;CHD4;ARAF;SETD9;NLRP12;KAT5
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.3387412003082974,-0.7612931003681132,0.8450704225352113,1.0,1.0,3/63,4.02%,BMP5;GATA1;GSTP1
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.3231591903666807,0.7611779077402311,0.6857142857142857,1.0,1.0,3/31,6.25%,PLK1;SNCA;SIRT1
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.38772227431711603,-0.7609460136111151,0.8082191780821918,1.0,1.0,5/28,15.27%,LSM7;LSM2;EXOSC4;NT5C3B;EDC4
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),-0.45064093156340457,-0.7606867866394069,0.75,1.0,1.0,3/8,23.86%,HYAL2;MT1G;FER1L5
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.38372223682041845,0.7598884250741809,0.75,1.0,1.0,1/13,2.64%,YJEFN3
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.3707928812095336,-0.7598087513975625,0.8227848101265823,1.0,1.0,2/29,5.85%,SFRP1;RHBDF1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.28936799827405585,-0.7595891085707519,0.948051948051948,1.0,1.0,24/191,14.16%,BMP5;SIGIRR;SFRP1;TAX1BP3;PTK6;NEURL1;NFATC1;SHISA2;SFRP4;CALR;TNS2;GPC3;RACK1;TRABD2B;GPS2;BDNF;PIK3CB;LRPAP1;IFT122;GLIS2;APOD;APLN;CADM4;ASAH2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.4328957002039182,-0.7591103445612313,0.8028169014084507,1.0,1.0,1/17,3.24%,XYLT2
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.3388533869548069,-0.7591003335734521,0.8405797101449275,1.0,1.0,3/35,8.28%,XBP1;CARTPT;RACK1
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.41012037454635564,-0.7589711905109477,0.8243243243243243,1.0,1.0,2/17,14.16%,ASAH2B;ASAH2
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.38457648521042287,0.7587832247428066,0.75,1.0,1.0,2/13,8.26%,ST8SIA6;ST8SIA4
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.38375664821426225,0.7580756371655241,0.7368421052631579,1.0,1.0,1/12,3.18%,GMNN
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.4191414436658982,-0.7580042807947043,0.8032786885245902,1.0,1.0,5/12,34.66%,VIP;CAV1;NOS1;ACTN2;CAV3
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),-0.4665492442292588,-0.7575659206353771,0.7878787878787878,1.0,1.0,2/7,13.99%,CARTPT;VIP
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.3376951073961024,-0.7574660597155449,0.8208955223880597,1.0,1.0,6/59,11.97%,PCDHB11;PCDHB4;LRRTM3;PCDHB2;BDNF;CDK5
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.435172923909927,-0.7573310379620481,0.8115942028985508,1.0,1.0,5/14,24.13%,CXCL17;SLAMF8;GREM1;SERPINE1;CREB3
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.3735779603125567,-0.7572858342763757,0.8448275862068966,1.0,1.0,5/29,18.26%,CFTR;TM7SF3;MYRIP;GCK;HLA-DRB1
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.3863312902798592,-0.757194085829291,0.8305084745762712,1.0,1.0,5/15,16.93%,NMNAT3;MTHFD1;PRPS1;PRPSAP1;PRPS2
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.3100412626360902,-0.7570216318124836,0.8648648648648649,1.0,1.0,11/83,17.09%,GAPDH;TYMS;RPS3;RPL13A;CALR;RACK1;NCL;PATL2;ILF3;EIF4A3;METTL3
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.3321250154247546,0.7569425799966784,0.8636363636363636,1.0,1.0,5/29,5.87%,STARD13;PRKX;ID1;ADGRA2;PTP4A3
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.28408141724652014,-0.7567947572061782,0.9634146341463414,1.0,1.0,37/275,16.62%,B2M;RPS27A;RHOC;LOXL4;COL9A3;STMN1;COL4A4;FLII;PPIB;RHOG;CORO1B;NEFL;UBA52;ADAMTS14;FAT1;APH1A;P4HA3;B4GALT7;ITGB4;COL10A1;STMN2;ITM2B;MARCKSL1;KIF18A;BFSP1;TPPP3;MYH6;MAP7D3;COL21A1;UBB;STMN3;TLL2;KATNB1;MYO1H;DCTN1;FIGNL1;LMOD1
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),-0.47430938992113136,-0.7565238544120609,0.803030303030303,1.0,1.0,2/5,16.40%,CARTPT;TAC3
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.2733811620995992,0.7563991160478819,1.0,1.0,1.0,17/139,10.47%,PTPN6;TP63;ALK;AIFM2;ACER2;OSGIN1;PHLPP1;SIRT1;TRAF2;USP36;TNFRSF25;CASP10;SGK1;CRADD;TOX3;MALT1;ANP32A
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.3099703953390012,0.756290223206697,0.8387096774193549,1.0,1.0,8/31,21.67%,P2RX7;DLG1;SLMAP;DRD2;NKAIN2;SCN3B;WNK1;PER1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.34596202024778067,-0.7558936233923488,0.8059701492537313,1.0,1.0,3/42,5.76%,XBP1;IL6R;HYAL2
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.4575649771160734,-0.7558037976363076,0.8709677419354839,1.0,1.0,2/8,20.38%,APOE;PRKACA
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.30611393219872524,0.7556878981344441,0.9047619047619048,1.0,1.0,15/69,18.44%,ADGRB1;LRP4;PLPPR4;DOCK7;CTNNA2;DSCAML1;CELSR2;TBCD;PARD6B;NTNG1;DCDC2;RYK;DRD2;MAP2;NRCAM
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.37293032913145496,0.755586484521845,0.9032258064516129,1.0,1.0,10/25,23.53%,TEAD1;NPHP4;TJP2;TEAD2;AMOTL1;MOB1A;WWC1;TJP1;LATS2;DVL2
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),-0.4717515766130459,-0.7555131229342249,0.8245614035087719,1.0,1.0,2/7,29.19%,MAPK7;SMAD7
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.3549359114174567,-0.7554605120939255,0.8529411764705882,1.0,1.0,9/33,26.61%,FTH1;COX17;CP;ATP2C2;CUTC;HEPH;ATOX1;HEPHL1;TRPC6
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.4154371893004884,-0.7554444150048486,0.8253968253968254,1.0,1.0,6/14,19.00%,TNIP2;MAPK7;TEK;SCG2;ANGPT1;SERPINE1
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.38023320003929156,0.7554411909243739,0.8,1.0,1.0,3/15,12.29%,SULT2A1;SULT2B1;ENPP1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.24936917943560089,0.7550638642114532,1.0,1.0,1.0,42/239,19.16%,FHDC1;ARHGEF7;EXOC6;RAB3IP;RFX3;ARHGEF6;RAB23;DNAAF1;EHD2;PKD1;TRAPPC14;TEKT5;P2RX7;TMEM216;TNIK;DNAI2;IFT88;SPEF1;CFAP54;IFT140;MAP4K4;PCM1;DCDC2;CEP290;ASAP1;GOLPH3;RABL2B;INPP5E;TTBK2;CDC14B;CYFIP1;RAP1A;PTPRO;DYNLL2;ARL6;PTPN23;RILP;PPP1R9B;WHAMM;RILPL2;BBS2;GALNT11
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.38397602058888386,-0.7549590268266665,0.8095238095238095,1.0,1.0,11/28,32.41%,CD81;LAMTOR5;GLMP;NAGPA;AP3M1;M6PR;LAMTOR4;AP4M1;HGS;NEDD4;NCOA4
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.38014246951966385,-0.7549198498720054,0.8108108108108109,1.0,1.0,4/26,15.08%,RPS3;GSTP1;MAPK8IP1;EDN1
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.3390721556195399,-0.7549090858319097,0.9104477611940298,1.0,1.0,13/51,27.31%,CEACAM1;TPP1;USE1;RNF5;CELA2A;HSPA8;APOE;FBXO6;DENND3;NR1D1;PPT1;HTRA2;DDB1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.3433014027172303,0.7547076231650262,0.75,1.0,1.0,5/40,8.38%,GMNN;EGFR;GLI2;DNA2;STN1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.44474538918198603,-0.7546260087289306,0.8301886792452831,1.0,1.0,1/11,7.40%,FBLN1
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.44474538918198603,-0.7546260087289306,0.8301886792452831,1.0,1.0,1/11,7.40%,FBLN1
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.3089237817479541,-0.7545867506795279,0.961038961038961,1.0,1.0,13/98,15.07%,RHOC;SFRP1;RPS3;GBA3;RACK1;RASGRP1;HRAS;PINK1;FNTA;TBC1D2;DOCK8;ZC3H15;CAV2
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.33846507188151287,-0.7544261571613138,0.8933333333333333,1.0,1.0,6/43,12.48%,RPL10;ZFPM1;TGFBR2;TEAD3;TGFB1;IFT122
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),-0.43655786168765454,-0.7543819056379358,0.7424242424242424,1.0,1.0,3/11,19.12%,PAX8;HOXD3;DKK3
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),-0.5115278707319555,-0.7543577329990148,0.8620689655172413,1.0,1.0,2/5,22.28%,GRN;ALOX5
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.29811508786310664,0.7541396001524394,1.0,1.0,1.0,36/106,20.84%,VASH1;ADGRA2;ARHGAP44;SARM1;ADGRB3;NSMF;PDLIM5;TNIK;STRIP1;KIF13B;DLL1;ARHGAP35;FMNL2;PID1;GDNF;CXCL13;VASH2;LRRC4C;CDH2;LFNG;CLASP1;ABI2;ZRANB1;RUFY3;GSK3B;MARCHF5;FGF2;LZTS1;CYRIB;MAPT;SRCIN1;SH3D19;EFNA5;PHLDB2;EPHB3;MARK2
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.31566801690834534,0.7533737633298112,0.875,1.0,1.0,9/40,18.22%,CNOT2;PIP4K2A;ARHGAP35;CCP110;CNOT6L;G3BP1;ASAP1;LRSAM1;MARK4
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.39222117502083914,-0.7532877895610477,0.7857142857142857,1.0,1.0,3/18,11.09%,P2RY10;SYNPO2L;GPR17
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),-0.4547636264829279,-0.7529647383239491,0.78125,1.0,1.0,2/6,15.26%,FADD;TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.4658898787792427,-0.7529238022902269,0.7878787878787878,1.0,1.0,2/8,8.01%,SFRP1;BTG1
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.4472989493299547,0.7528763523766777,0.8125,1.0,1.0,4/9,15.68%,NLGN4X;NLGN1;NLGN3;C5AR1
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),0.35208334535038355,0.7527753865189685,0.8108108108108109,1.0,1.0,3/19,7.27%,IFNA2;TICAM1;IRAK3
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),-0.4898242321773966,-0.752572267073259,0.8275862068965517,1.0,1.0,5/6,50.59%,NAGK;GNPDA1;GNPDA2;RENBP;AMDHD2
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.37003801457548174,0.7521846324015683,0.8275862068965517,1.0,1.0,7/22,16.86%,ACADVL;MLXIPL;TRIB3;ADIPOR2;PDK4;SLC45A3;NR1H3
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),0.47573953795852647,0.7521492700549871,0.8043478260869565,1.0,1.0,1/6,8.80%,RHOJ
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.29557228394088336,0.7519426922332868,0.9032258064516129,1.0,1.0,9/42,13.82%,YJEFN3;VEGFD;ADGRA2;ROBO1;DLL1;RECK;EGR3;SLIT2;GPLD1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.25613126699393235,0.7516196736034175,1.0,1.0,1.0,24/203,13.72%,LEPR;NUPR1;DAPL1;GFAP;HSPB1;ACER2;TICAM1;RASIP1;FOXK1;USP36;TRIM65;OPTN;PIP4K2A;EIF4E;RRAGD;FBXW7;PTPN22;ATP6V0D2;ITPR1;ATP13A2;PRKD1;TRIB3;VPS26B;FOXO3
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.3779671738781583,-0.7515764986057062,0.8135593220338984,1.0,1.0,4/20,10.50%,PNKD;ARF1;SLC24A1;SYT11
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.3408130149607558,0.7515502601269228,0.8974358974358975,1.0,1.0,2/27,4.47%,LEF1;CX3CR1
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.3200762191845485,-0.7514486780239348,0.855072463768116,1.0,1.0,25/104,22.32%,XBP1;RPS14;CALR;FKBP14;NHP2;HSPA5;IMP3;SRPRA;CEBPB;EXOSC4;EXOSC10;EEF2;KDELR3;ATF3;EDC4;YIF1A;DCTN1;EIF4A3;HYOU1;HSP90B1;SPCS1;TUBB2A;SERP1;RRP9;SHC1
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.43834483436883065,-0.7514355075938056,0.8307692307692308,1.0,1.0,1/8,10.91%,FADD
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.48572355579901705,-0.7513699622299004,0.8115942028985508,1.0,1.0,4/5,48.24%,TMEM167B;RAB3A;TRAPPC11;TMEM167A
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.2813533881522056,-0.7513042386115181,0.9875,1.0,1.0,14/226,5.78%,XBP1;SFRP1;SELENOS;AQP9;H2AZ1;PTK6;NEURL1;PRDX5;RPS3;CFTR;GSTP1;ROMO1;TSHR;RRAGA
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",-0.49656025535259235,-0.7511929561617988,0.8253968253968254,1.0,1.0,3/5,26.49%,NOP9;NOP14;ABT1
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),-0.49656025535259235,-0.7511929561617988,0.8253968253968254,1.0,1.0,3/5,26.49%,NOP9;NOP14;ABT1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",-0.49656025535259235,-0.7511929561617988,0.8253968253968254,1.0,1.0,3/5,26.49%,NOP9;NOP14;ABT1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.422587983355784,-0.7510925339969202,0.8,1.0,1.0,1/19,0.81%,SLC8A3
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.32893596981105927,-0.7507669644301592,0.855072463768116,1.0,1.0,10/66,18.75%,RPS27A;UBA52;COLEC12;TNIP2;FADD;UBB;NMI;CNPY3;SCARA3;HSP90B1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.4077771714802305,0.750719865604673,0.8518518518518519,1.0,1.0,1/7,5.11%,EXOSC7
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.4077771714802305,0.750719865604673,0.8518518518518519,1.0,1.0,1/7,5.11%,EXOSC7
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.4504644205934495,0.7506149181458902,0.8421052631578947,1.0,1.0,2/8,7.86%,GLI2;ADAM8
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.2807784083546711,-0.7500684403314368,0.9594594594594594,1.0,1.0,21/188,18.18%,FAM131C;PDE4A;CLGN;TMEM107;CARTPT;CNPPD1;CCDC28B;SEZ6L2;SPEF2;LARP6;SGPL1;MAPK8IP1;CADM4;LRRC73;CALB2;LRRC49;KIFBP;CKB;SPA17;ORMDL3;DDR1
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.33396429133967304,0.7496662263375131,0.9032258064516129,1.0,1.0,7/53,9.48%,GPR35;EPS8L2;STARD13;RASIP1;ARRB1;ROBO1;ARHGAP35
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.3601638362759264,0.7496317049983272,0.8181818181818182,1.0,1.0,8/18,29.99%,ACER1;AGMO;ST3GAL6;FUT2;CERK;CYP1B1;ARV1;TECR
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.40098421785242594,0.7495125209364547,0.8181818181818182,1.0,1.0,5/11,14.97%,HPRT1;AMPD1;ADA;AMPD3;GMPR
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3572057641737466,0.7493999695879995,0.8148148148148148,1.0,1.0,3/21,10.41%,EGFR;CDK10;UBE2E2
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),0.4182359489657888,0.74901403097652,0.6052631578947368,1.0,1.0,4/6,35.76%,KMT2D;KMT2A;SETD1B;SETD1A
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.3586378302442069,-0.7488915680007617,0.7878787878787878,1.0,1.0,3/28,10.96%,KIF20B;CEP131;TGFB1
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.3672837318250092,-0.7487129641446358,0.8939393939393939,1.0,1.0,2/23,3.84%,MUSK;MADCAM1
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.31282172661803,-0.7486709920142979,0.95,1.0,1.0,5/94,6.38%,B2M;TMEM50A;DBI;ADRM1;MYL12A
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.4350929868355127,0.7486229973666475,0.92,1.0,1.0,6/13,21.61%,IWS1;SAFB2;SLTM;DHX9;SRPK2;PTCD2
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.3046684306034826,0.748312900643806,0.7714285714285715,1.0,1.0,6/34,12.80%,ENSA;MFHAS1;NSMF;CAMTA1;PPP6R3;SPPL3
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.30479901839500284,-0.7477465682744,0.9459459459459459,1.0,1.0,3/102,3.15%,B2M;MT1E;MT2A
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.31885323114730046,-0.747723289624794,0.8354430379746836,1.0,1.0,10/61,20.55%,CSTF2T;FIP1L1;DHX38;SRSF7;CPSF3;EIF4A3;SRSF3;MAGOHB;CLP1;NCBP1
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.4084327035285196,-0.7476985221090291,0.8450704225352113,1.0,1.0,5/17,25.12%,APOE;SOD1;RAN;KPNB1;SREBF1
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.38505942419858774,-0.7475927072226349,0.8484848484848485,1.0,1.0,3/18,10.96%,EFNA1;NFATC1;TGFB1
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.4834737850919181,0.747506664755881,0.8222222222222222,1.0,1.0,2/5,12.05%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3065366844753392,0.7473837699541956,0.8620689655172413,1.0,1.0,7/48,10.12%,GPR35;HOMER1;CX3CR1;NMBR;GRPR;GRM1;ADRA1A
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.3736385718496499,-0.7471586327330526,0.7857142857142857,1.0,1.0,11/28,29.03%,NOP53;ABRAXAS1;CLSPN;BRCA1;MRNIP;TOPBP1;BLM;BRSK1;CDK1;DONSON;NBN
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.39089553695529755,-0.7467498641870084,0.84375,1.0,1.0,5/24,22.25%,GPS2;ABCA12;APOE;ABCA5;CAV1
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.4343145861436197,0.7465194822774979,0.8205128205128205,1.0,1.0,1/9,2.73%,FGFR3
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.33699163293746465,-0.7464831759237253,0.8714285714285714,1.0,1.0,7/40,21.77%,CHRM5;GNAI2;CHRM2;GRM7;OPRM1;GPR37L1;AKAP5
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.41088711296684727,-0.7461133802917856,0.8405797101449275,1.0,1.0,2/20,12.40%,PSMC5;PSMC3
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.427668377994995,-0.7460977231145836,0.8108108108108109,1.0,1.0,3/12,15.78%,CEACAM1;BRCA1;APPL2
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.3457948477373635,-0.7459374396901974,0.8245614035087719,1.0,1.0,2/44,4.38%,RIMS1;PPIB
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.3451161229283781,-0.7458944776166988,0.8783783783783784,1.0,1.0,7/42,22.60%,EFNA1;ILK;NTNG2;TEK;ITGAV;RHOA;PXN
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.2764758987254654,0.7458324073792099,0.9375,1.0,1.0,9/57,12.28%,SRC;EGFR;NRG2;ERBIN;SHC3;GAB1;MATK;REPS2;PIK3CA
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.2650259344842467,0.7456472400648754,1.0,1.0,1.0,39/171,19.37%,HSPA1A;SPOCK1;FRZB;PTCH2;TMC8;EGFR;OSGIN1;IP6K2;SIRT1;SMARCA2;CDKN2A;SESN2;SGK1;HSPA1B;AKAP6;TGFB2;SGK3;SMAD4;SLIT3;ENPP1;APBB2;SLIT2;RPS6KA1;BMPR2;RASGRP2;ITCH;ST7L;SIPA1;FBP1;KIF14;CAMK2D;ARHGEF11;PPP1R9B;NRG3;SLC25A33;BCL2;RPTOR;TFRC;CHPT1
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.4507199246706628,-0.7451139045692196,0.7818181818181819,1.0,1.0,2/6,22.83%,TGFB1;MSN
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.3159293569132313,-0.7448651512376383,0.9240506329113924,1.0,1.0,3/62,3.97%,RHOC;STMN1;DCTN3
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.29552776491189736,0.7447981799077037,0.8461538461538461,1.0,1.0,9/56,11.91%,MAPK11;ADORA2B;ARHGEF6;IRAK2;MAP2K4;TNFRSF19;MAPK10;NFKB1;MAP4K2
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.39346339363176364,-0.7441732687529331,0.8059701492537313,1.0,1.0,3/15,12.46%,ALDH1A2;TGFB1;ARL13B
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.2918382337658698,0.7428558655416843,1.0,1.0,1.0,15/98,11.92%,SPRY2;BAG2;HSPA1A;ADGRB1;NXN;GNL3L;SASH1;PAXIP1;ARRB2;ARRB1;HSPA1B;OGT;MALT1;FBXW7;DCUN1D1
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.47802416459692376,0.7423497857696997,0.75,1.0,1.0,2/5,24.77%,LIG4;POLB
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.43083420641111175,0.7419996411676938,0.7560975609756098,1.0,1.0,2/5,9.05%,DCP1B;DCP1A
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.35128024244154143,0.74197806255732,0.9090909090909091,1.0,1.0,9/23,28.81%,AUP1;FBXL17;UGGT1;ZER1;KLHL15;RNF185;CUL3;DERL1;LONP1
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.2705211380098433,0.7414343360360084,1.0,1.0,1.0,39/167,20.65%,VAPB;ARHGEF7;SPTSSB;DYSF;ALS2CL;TRAPPC12;MYOF;SPTBN5;OBSL1;OPTN;ZFP69B;NSFL1C;ARHGAP21;PRKD1;CLASP1;TRIP11;RAB30;LEMD3;SEC31A;GOLPH3;SUN3;AP3D1;ATL2;TOR1AIP2;SEC31B;DYM;DNAJC28;HACE1;TRAPPC8;RAB29;MIA3;CUL7;DMPK;SPTBN1;RNF112;WASHC5;SEC61A1;VAPA;SUN2
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.4554577324933757,-0.741375437394069,0.8064516129032258,1.0,1.0,1/5,13.17%,C1QBP
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.2998331910204513,-0.7412256551132933,0.9459459459459459,1.0,1.0,7/108,11.47%,ARHGAP4;SFRP1;TIMP1;HYAL2;CALR;ADAM15;FUZ
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.4104158977245019,-0.7410936323608721,0.8235294117647058,1.0,1.0,5/15,20.55%,RBM3;NCL;CIRBP;SNW1;NCBP1
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.42656060064233714,-0.7410548652612825,0.7931034482758621,1.0,1.0,5/13,29.36%,DDX11;RAD50;GNL3;NBN;DHX36
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.4788142306024333,-0.7406501012938835,0.8301886792452831,1.0,1.0,3/6,22.61%,PRELID1;BAX;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.3278505885605657,0.7402679010132943,0.8378378378378378,1.0,1.0,14/35,23.26%,LIMK1;L1CAM;DIP2B;RUFY3;GSK3B;ABL1;MAP2;NRCAM;MAPT;ZFYVE27;TRIM46;MACF1;DNM2;RNF6
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.4314471640620555,-0.7400290625085423,0.8823529411764706,1.0,1.0,2/11,14.16%,ASAH2B;ASAH2
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.4314471640620555,-0.7400290625085423,0.8823529411764706,1.0,1.0,2/11,14.16%,ASAH2B;ASAH2
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.33207865110498347,-0.7399924923662337,0.8507462686567164,1.0,1.0,4/43,11.72%,SLC6A12;AQP9;SLC16A1;SLC16A8
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),-0.4457144005406774,-0.7398541822252714,0.7936507936507936,1.0,1.0,3/8,25.22%,SUPT5H;NELFE;CTR9
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.43644744303042826,-0.7398244591539537,0.8095238095238095,1.0,1.0,3/9,25.22%,SUPT5H;NELFE;CTR9
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.3043179071201266,0.739445887242591,0.8333333333333334,1.0,1.0,6/34,14.12%,SNAI1;ACADVL;NFKB1;FBXW7;TRIB3;PRMT3
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.4485587631381479,0.7394328675998221,0.7906976744186046,1.0,1.0,2/6,10.37%,MLLT3;SPEF1
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.3635260353300696,-0.7393624453844029,0.796875,1.0,1.0,4/34,11.08%,SLC25A5;CR2;RAG2;GPS2
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.4348376986770268,0.7390796328901144,0.7894736842105263,1.0,1.0,3/6,13.41%,ALCAM;ROBO2;SLIT2
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.35715323300151414,-0.7389301682034265,0.8676470588235294,1.0,1.0,7/39,15.13%,XBP1;STAT5A;EIF2B1;STAT1;CELA2A;EIF2B2;EIF2B4
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.3318960872152847,0.7388769093544624,0.85,1.0,1.0,1/28,0.56%,ZNF423
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),-0.3615029009508493,-0.738852209841081,0.8571428571428571,1.0,1.0,1/21,1.75%,ACTG1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.38803080459928374,0.7388124365057303,0.8285714285714286,1.0,1.0,3/14,13.39%,ESPL1;LLGL2;CLASP1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.41727035151731334,-0.7388008148457201,0.803030303030303,1.0,1.0,1/13,0.44%,P2RY10
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.4047986416623801,-0.7385913644668026,0.8,1.0,1.0,3/15,15.92%,AP2S1;CLTA;CALY
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.3206031997925155,0.7385333613996687,0.78125,1.0,1.0,8/29,18.17%,SRC;ARHGEF7;AUTS2;PIK3CA;ABI2;CORO1C;CYFIP1;AKIRIN1
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.32709918074933886,-0.7385240161760671,0.8507462686567164,1.0,1.0,8/29,24.10%,BRF2;TTF1;TCEA2;POLR2A;NAT14;SMN1;TTF2;SMARCA5
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.33246662547484646,0.7383344575784546,0.8823529411764706,1.0,1.0,12/37,21.45%,FLT1;RASIP1;ID1;SERPINF2;LOX;CDH2;SYK;ITGB8;CUL7;TGFBR3L;KDR;LAMA1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),-0.4938689711806399,-0.7380355448858688,0.847457627118644,1.0,1.0,1/5,7.24%,CD81
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.40177719125861766,-0.7379976149096804,0.8360655737704918,1.0,1.0,5/17,24.26%,GSTP1;EDN1;HPGD;PTGR1;PRXL2B
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.4498866445112202,0.7379912623667668,0.7567567567567568,1.0,1.0,1/7,10.48%,PUS7
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.36087474044122336,-0.7379025426100979,0.8970588235294118,1.0,1.0,2/25,5.81%,SFRP1;SGMS2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.46601843999880793,-0.7374500275482508,0.7727272727272727,1.0,1.0,2/7,8.01%,SFRP1;BTG1
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),-0.3805042806132278,-0.737343475992707,0.828125,1.0,1.0,4/21,19.01%,SELENOS;GCK;PGP;PDK2
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.3371991053517476,0.7373053426859937,0.7692307692307693,1.0,1.0,3/22,6.16%,IGF1;AGER;IDO1
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.3072294592922089,-0.7371163223095806,0.9444444444444444,1.0,1.0,3/85,4.41%,RIMS1;SFRP1;DNPH1
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),-0.4473162486474333,-0.7371101921175522,0.8571428571428571,1.0,1.0,1/5,9.64%,CAMK1
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.2554619423536407,0.7370074111955986,1.0,1.0,1.0,32/146,17.79%,BICDL1;TMEM108;CNTNAP2;L1CAM;AGER;NLGN1;CTNND2;FRYL;DOCK7;NPY;TNIK;SGK1;GDNF;IFT88;DICER1;VASH2;MAP4K4;GPM6B;HMGB1;PTEN;TBC1D23;TRIO;RYK;UHMK1;ATXN10;ADCYAP1;GSK3B;NYAP2;CAMSAP2;CNTNAP1;MAP2;GPM6A
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.42954451664010673,-0.7366034513049406,0.8571428571428571,1.0,1.0,3/11,8.01%,MESP1;SFRP4;BTG1
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.3462735113025882,-0.7364355490408603,0.8709677419354839,1.0,1.0,5/30,11.97%,ACTG1;USP6;RAB11A;PINK1;CDK5
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.3709716824604697,0.7364076947427399,0.8620689655172413,1.0,1.0,6/18,23.07%,TAFA1;KDM1A;SLC16A2;KDM2B;PTPRZ1;MDK
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.4008534529501824,0.7364043637439606,0.7435897435897436,1.0,1.0,3/10,24.13%,YOD1;UBE2G2;DERL3
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.45716655471903445,-0.7362816570847707,0.8035714285714286,1.0,1.0,2/7,8.80%,TTN;HTR2B
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.36530513631222855,-0.7359356778473296,0.84375,1.0,1.0,4/21,21.24%,LCK;HTR2B;HTR2A;CCR7
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.4503504850036155,0.7358502988767781,0.7666666666666667,1.0,1.0,3/6,17.18%,RELA;NFKB1;PNPT1
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),0.39015770502299696,0.7358118183528405,0.7692307692307693,1.0,1.0,3/11,7.25%,MTHFD2L;MTHFS;DHFR
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.28419296500050356,0.7349804174245828,0.896551724137931,1.0,1.0,5/77,7.27%,NUPR1;HDAC4;HNRNPU;SIRT1;CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.301642667536851,-0.734969140409872,0.9710144927536232,1.0,1.0,17/157,12.71%,SEMA3E;PDGFD;RHOC;DUOX1;XBP1;ACTG1;PLET1;PHPT1;CEMIP;RACK1;VIL1;HRAS;HSPA5;TGFB1;FAM89B;GRN;SEMA3A
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.45133687441683124,-0.7348076438122144,0.8387096774193549,1.0,1.0,2/8,15.32%,TAF11;GTF2A2
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.45600864876076613,-0.7347398206015587,0.8,1.0,1.0,2/8,14.58%,TEFM;MGME1
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.3268878582238924,-0.7342558990594221,0.9210526315789473,1.0,1.0,4/57,5.10%,F8;TRAPPC1;TRAPPC4;F5
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.3268878582238924,-0.7342558990594221,0.9210526315789473,1.0,1.0,4/57,5.10%,F8;TRAPPC1;TRAPPC4;F5
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.3268878582238924,-0.7342558990594221,0.9210526315789473,1.0,1.0,4/57,5.10%,F8;TRAPPC1;TRAPPC4;F5
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.4448174807522358,-0.7342478270808598,0.8360655737704918,1.0,1.0,4/10,24.22%,DCK;TK2;UCK1;UCKL1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.4448174807522358,-0.7342478270808598,0.8360655737704918,1.0,1.0,4/10,24.22%,DCK;TK2;UCK1;UCKL1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.3492864865518201,-0.7341872701912304,0.8648648648648649,1.0,1.0,4/39,14.11%,NPR2;NPPC;SLC35B2;IMPDH2
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.35366476776215267,-0.7339764537238949,0.9047619047619048,1.0,1.0,2/35,2.64%,DDIT3;CLU
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.34048281430250416,0.7338464393052062,0.725,1.0,1.0,6/19,11.85%,PDGFRA;DSCAML1;ALDH1A3;ACVR1;RARG;MEGF8
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3134797849465898,0.7337876785626056,0.9375,1.0,1.0,12/44,20.52%,CLEC7A;SIRT1;MALT1;GRIN1;TBC1D10A;HMGB1;GPER1;SYK;ACVR1C;GRIN2B;ASPH;DDX3X
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.4285483494503866,-0.732982553207257,0.7857142857142857,1.0,1.0,2/10,13.31%,GSTP1;MAPK8IP1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.42478836064345193,0.7325641985357008,0.7435897435897436,1.0,1.0,2/8,7.63%,CPEB3;CPEB2
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.39352704038729314,0.73253402002003,0.8571428571428571,1.0,1.0,2/6,10.07%,PRR5;RICTOR
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.3727704167108558,-0.7324067894786884,0.8142857142857143,1.0,1.0,8/32,9.52%,IRF4;SERPING1;CLU;CR2;C4BPB;CD81;C4BPA;PHB2
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.3709238818296513,0.7321255281280823,0.8717948717948718,1.0,1.0,2/16,6.20%,SAMSN1;CD22
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.4271662271985124,0.7320497666347453,0.7647058823529411,1.0,1.0,1/9,1.51%,ATP6V0A4
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.46049119406325345,-0.7318737571007449,0.8888888888888888,1.0,1.0,2/6,19.51%,FNTA;PRKD2
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.3686567804500148,0.7316525255836621,0.7222222222222222,1.0,1.0,2/13,10.38%,TTLL12;FAM47E
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.3530513484345805,0.7315089918741033,0.8333333333333334,1.0,1.0,3/20,11.84%,NMNAT2;AK4;FHIT
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.34884195578406113,-0.7314294155236991,0.8840579710144928,1.0,1.0,1/26,1.67%,SFRP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.34096452089218454,-0.7312210194780722,0.8888888888888888,1.0,1.0,11/23,32.05%,PLN;SRI;CALM3;KCNQ1;PRKACA;CALM1;CHGA;SMAD7;PDE4D;NOS1;ATP1B1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.2991964878475835,-0.7311853553735895,0.9444444444444444,1.0,1.0,8/68,15.78%,RPS27A;TGFBR2;UBA52;BAMBI;TGFB1;FNTA;UBB;APPL2
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.4616758816541095,0.7311670682126673,0.813953488372093,1.0,1.0,2/6,10.48%,PUS10;PUS7
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.3041125371618418,0.7309254432623213,0.8235294117647058,1.0,1.0,11/51,15.59%,IGF1;MYOM1;SYTL4;BMP6;ADAM8;LRRC8A;TGFB2;ACSL4;ATP13A2;GOLPH3;GPER1
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),-0.4248949755675536,-0.7308047805698081,0.8208955223880597,1.0,1.0,1/8,10.09%,BRK1
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.2806580260364484,-0.7305361650016202,1.0,1.0,1.0,26/346,12.76%,IGSF1;DDIT3;ZNF100;ZNF492;SPIN2A;PLAG1;EDF1;ZNF664;HES6;DRAP1;PPIE;ZSCAN21;SOX21;WWC2;HINT1;CALR;BTG1;ZNF92;RPL6;LMX1B;SOX15;THAP7;ZNF217;CEBPB;ZNF714;THAP1
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.31041855433046545,0.7302965414822228,0.9411764705882353,1.0,1.0,9/57,11.81%,KCNJ14;KCNJ2;CHRNA4;SNCA;P2RX7;SYT3;GDNF;CA2;PXK
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.34003428216085574,-0.7300795108836411,0.9692307692307692,1.0,1.0,2/37,3.89%,AQP9;PTAFR
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.3815052736245717,-0.7299247286877976,0.8666666666666667,1.0,1.0,5/14,29.03%,PARP1;RAD50;TERF2IP;TERF1;NBN
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.31285121278225986,0.729822981802162,0.96,1.0,1.0,12/55,14.91%,MFHAS1;AGER;TRAF2;SERPINF2;TNFRSF19;MTURN;TPD52L1;SH3RF1;MAP4K2;HMGB1;TRAF3;HIPK2
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.37496675517619393,-0.7295619019470364,0.84,1.0,1.0,5/23,12.81%,GPC3;RACK1;RFX4;IFT122;GLIS2
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.3111239915429545,0.7295190115527773,0.9310344827586207,1.0,1.0,9/34,21.61%,IWS1;SAFB2;PAPOLA;KHDRBS3;SLTM;DHX9;QKI;SRPK2;PTCD2
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.3557260062533684,-0.7295028258162856,0.8873239436619719,1.0,1.0,8/40,25.50%,CHMP2A;RPS19;REEP4;CHMP7;CHMP3;CHMP4B;VPS4B;SYNE1
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.3895399018624122,-0.7294546627395626,0.8428571428571429,1.0,1.0,1/21,1.05%,TTN
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),-0.46265842429141674,-0.729420988588066,0.7857142857142857,1.0,1.0,4/6,43.53%,SLC6A17;SLC36A1;SLC1A4;SLC36A4
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),0.3979774472801906,0.7293274748214948,0.8409090909090909,1.0,1.0,2/8,10.73%,PRKRA;DICER1
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.4285358577617552,0.7290038506443213,0.8157894736842105,1.0,1.0,4/5,29.39%,FGF13;DCC;ULK1;PTPRS
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),-0.4370618904307968,-0.7289814964574302,0.8169014084507042,1.0,1.0,1/7,18.67%,PAICS
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.35045047830378645,-0.7287699525858858,0.8714285714285714,1.0,1.0,7/27,23.09%,TGFB1;DUSP26;PPIA;ANKLE2;PTPA;CALM3;CALM1
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.34980715620711816,-0.7282402556784892,0.8493150684931506,1.0,1.0,13/37,29.03%,NOP53;ZNF830;ABRAXAS1;CLSPN;BRCA1;MRNIP;TOPBP1;BLM;BRSK1;HUS1;CDK1;DONSON;NBN
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.28022479409798506,-0.7281912143234921,1.0,1.0,1.0,23/160,18.35%,DDIT3;GSTP1;BCL2L2;HYAL2;PEBP1;WWC2;NOP53;RACK1;TMSB4X;NLRX1;PINK1;PIK3CB;STAT1;PPIF;RTKN2;PIK3IP1;MYADM;NLRP12;NMI;CDC34;DGKD;DGKG;IFI35
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.32019381685139314,-0.7280886343697717,0.9178082191780822,1.0,1.0,6/59,12.99%,XBP1;OXSM;SCD;ACSM6;ACSM3;NDUFAB1
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),-0.4748484402958914,-0.7276902715652505,0.8305084745762712,1.0,1.0,1/6,3.63%,CFTR
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.41527378149848865,0.7273715333522413,0.7857142857142857,1.0,1.0,1/14,2.23%,SGO1
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.2757314830328252,0.7271733851276364,0.9090909090909091,1.0,1.0,10/78,10.83%,NPAS2;HSPA1A;RRAS2;ACER2;SNCA;SARM1;TXNDC12;HSPA1B;SPEF1;PARP16
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),-0.39205346407561703,-0.7270633351555167,0.84375,1.0,1.0,1/17,9.86%,SLC27A5
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.3592020078078072,-0.7270334528388941,0.8387096774193549,1.0,1.0,2/19,17.02%,PNKP;RAD50
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.3532360143123602,-0.7268981485813693,0.8260869565217391,1.0,1.0,4/24,17.91%,STMN1;STMN2;STMN3;MAP1A
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.41303360749819096,-0.7266450411591943,0.8507462686567164,1.0,1.0,2/16,8.35%,IL31RA;TNIP2
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.3673785889495025,0.7263488588298082,0.8378378378378378,1.0,1.0,2/22,3.91%,ATP6V0A4;ATP12A
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.4140784251740519,-0.726341381569932,0.835820895522388,1.0,1.0,4/13,24.22%,DCK;TK2;UCK1;UCKL1
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.37626745926437677,0.7262507499839421,0.7941176470588235,1.0,1.0,4/11,15.68%,PKD1;GDNF;ROBO2;PKD2
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.3135781519871857,0.7260740887452659,0.7857142857142857,1.0,1.0,12/31,21.19%,BMP6;P2RX7;ACVR1;GPM6B;BMPR2;ACVR2B;ACVR2A;PTH;BMPR1B;SLC8A1;WNT4;NELL1
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),-0.41356395467876295,-0.7260612990338274,0.8709677419354839,1.0,1.0,2/11,17.78%,HTR2B;APOE
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.4617681508289909,-0.7260457948407666,0.8301886792452831,1.0,1.0,3/6,26.76%,FUZ;NPHP1;BRSK1
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.39314632446682396,-0.7259161233424892,0.8909090909090909,1.0,1.0,4/15,23.07%,SELP;PRKACA;FIS1;BCAP31
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.3404414900782912,-0.7258516320155063,0.9315068493150684,1.0,1.0,5/41,9.00%,RPS3;USP1;PCNA;RNF8;ABRAXAS1
prerank,GO_Biological_Process_2021__cellular water homeostasis (GO:0009992),-0.48347104779991845,-0.7257581581216638,0.8363636363636363,1.0,1.0,1/5,9.39%,AQP11
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),-0.4302094332506132,-0.7256594709050099,0.8771929824561403,1.0,1.0,5/10,13.78%,FAM111A;KLK6;AFG3L2;MYRF;SPRTN
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.44228882164778155,-0.7255682434772447,0.8620689655172413,1.0,1.0,1/10,7.64%,STAT5A
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.32170293328694416,-0.725555841682312,0.8970588235294118,1.0,1.0,3/54,4.56%,SLC25A4;SLC25A5;SLC25A11
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.33252112637584424,-0.7255196182416322,0.8933333333333333,1.0,1.0,2/54,2.82%,GATA1;ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.40886075301822294,-0.7254361197437827,0.8360655737704918,1.0,1.0,3/12,18.72%,FGFBP3;TGFB1;ANGPT1
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.45084807796172804,-0.7253537713269657,0.863013698630137,1.0,1.0,3/7,21.61%,PRELID1;PIP;LGALS3
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),-0.4769545115591757,-0.7252977916383225,0.859375,1.0,1.0,2/5,17.78%,GPIHBP1;APOE
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.40056896990404495,-0.725065889378981,0.8059701492537313,1.0,1.0,4/11,28.59%,LAMP1;CCDC91;ANKFY1;AP4M1
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.4326223019031674,-0.7249679929374443,0.8115942028985508,1.0,1.0,5/10,18.76%,ATP23;AFG3L2;PMPCA;STOML2;IMMP1L
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),0.44373987849163027,0.7248325549953347,0.6666666666666666,1.0,1.0,1/5,4.47%,CX3CR1
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.3103172412848616,-0.7248183829150645,0.9324324324324325,1.0,1.0,7/73,15.16%,MAGEF1;METAP2;APH1A;PCSK1;AFG3L2;NDUFAB1;CIAO2B
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.2656389405495367,0.724648137391959,1.0,1.0,1.0,31/137,18.79%,LIFR;DPPA2;CD59;PIWIL4;LEF1;NXN;PIWIL2;LRP4;GLI2;FBLIM1;DOCK1;RND3;CD276;TEAD1;SMAD4;TEAD2;SHROOM3;PAWR;ESRRB;NAV2;ROR1;SPRY4;LGR4;PTPN14;KCNIP3;COL4A2;NR6A1;SMAD2;TJP1;MYO1B;RAI14
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.3567569941772779,0.72460407007111,0.7428571428571429,1.0,1.0,1/11,7.49%,PICALM
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.33597589224101826,0.7243828309841802,0.8,1.0,1.0,6/25,13.57%,JAM2;CLDN12;ESAM;TJP2;SLC12A2;DMD
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.4097461895596303,-0.7239198348509974,0.8867924528301887,1.0,1.0,2/11,10.07%,RHOC;GPIHBP1
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.44421426937357056,-0.7237228627695682,0.8545454545454545,1.0,1.0,2/8,9.98%,TMSB10;TMSB4X
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.40323066017312825,0.7235602653723672,0.7948717948717948,1.0,1.0,2/8,13.84%,LRRC8A;UGDH
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),0.46800761343457903,0.7231242734505748,0.7948717948717948,1.0,1.0,2/6,15.59%,NMU;GPER1
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.42165075989822165,-0.7228365891769227,0.8245614035087719,1.0,1.0,3/10,29.25%,INPP5K;MORC2;SETDB1
prerank,GO_Biological_Process_2021__dehydroascorbic acid transport (GO:0070837),-0.4897870533731079,-0.7226975373378123,0.8656716417910447,1.0,1.0,1/5,14.08%,SLC2A2
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.4526284711095093,-0.7226470459788142,0.8153846153846154,1.0,1.0,2/6,10.19%,CENPE;NEK6
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.3167726400675122,0.7226294958817949,0.8571428571428571,1.0,1.0,8/29,17.49%,CLN6;OSBPL1A;SULT2A1;SOAT1;SULT2B1;LCAT;IDH2;FDX1
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),-0.45865461939903873,-0.722586016464653,0.8153846153846154,1.0,1.0,3/8,31.15%,TSFM;MTRES1;NSUN3
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.33210658746889615,0.7224637435156688,0.8846153846153846,1.0,1.0,11/41,22.49%,EXOSC7;ADAMTS9;SIAH2;FBXO2;HNRNPD;MTREX;PNPT1;UBE2G2;NEU4;DNASE1L2;SND1
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),-0.38422818277291576,-0.7224450446915922,0.8333333333333334,1.0,1.0,1/18,0.81%,SLC8A3
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.3436885908953919,-0.7216979550986027,0.8142857142857143,1.0,1.0,11/31,26.12%,NEFL;BLOC1S4;AP3B2;DCTN1;SNAPIN;KIF4A;SOD1;BLOC1S2;DTNBP1;DYNC1H1;AP3M1
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.41008221045702875,-0.721673098172842,0.8235294117647058,1.0,1.0,2/11,10.47%,TTN;NEB
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.4275735543585688,-0.7216277588802993,0.8461538461538461,1.0,1.0,3/10,27.98%,CEACAM1;HEY2;HEY1
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),-0.46143492948112075,-0.7214047686298733,0.8135593220338984,1.0,1.0,2/7,22.66%,MYRF;PLP1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.3200427349978436,0.7213831483607678,0.9310344827586207,1.0,1.0,6/46,7.76%,HSPB1;CLEC7A;AGER;CYBA;TMEM106A;OAS3
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.37219399052390173,0.7213543772246113,0.7631578947368421,1.0,1.0,3/11,11.63%,SLCO2B1;SLCO1C1;SLCO1A2
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.3158062412995031,-0.7210877582254689,0.9210526315789473,1.0,1.0,7/64,13.13%,XBP1;SELENOS;GSTP1;TNIP2;IRGM;TGFB1;PAF1
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.42435663930145684,0.7207611301952176,0.8048780487804879,1.0,1.0,2/6,12.14%,ARRB1;AUTS2
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.3304033927531486,0.7207516071174553,0.7941176470588235,1.0,1.0,3/35,5.77%,PLPP4;CYP2C8;PLPPR4
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),-0.4408684976324673,-0.7206410859671786,0.8461538461538461,1.0,1.0,5/9,40.39%,GCLM;CHAC2;GSS;GGCT;MGST2
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.44926933881862835,-0.7204898955783272,0.8823529411764706,1.0,1.0,4/8,24.86%,ATP6AP2;GRN;TMEM9;PPT1
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.4029745904809853,-0.7204617286853952,0.84375,1.0,1.0,4/14,11.99%,MADCAM1;GCNT1;SELE;SELP
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.40940646778461126,-0.7203139046587541,0.8571428571428571,1.0,1.0,3/12,25.12%,RAN;KPNB1;SREBF1
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.30133612105134966,0.7203130999495657,0.9032258064516129,1.0,1.0,6/41,8.16%,HSPB1;SPRED3;SPRED2;SPRED1;FNIP2;SESN2
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.35182219551153543,0.720305661446197,0.8,1.0,1.0,4/27,10.19%,PLIN5;MTMR2;OPTN;NFKB1
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.45299948929409806,-0.7201060199609424,0.8548387096774194,1.0,1.0,2/6,10.62%,PLN;SRI
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.30316687620496036,-0.7200434864766435,0.9259259259259259,1.0,1.0,14/98,14.43%,PDXDC1;CPTP;ORMDL2;DEGS1;GBA3;SGMS2;ELOVL2;DEGS2;ORMDL1;SMPD2;SGPL1;ABCA12;ASAH2;ESYT1
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.3014004490577146,-0.7198259887394968,0.875,1.0,1.0,25/91,27.66%,SNRNP25;SCNM1;RNPC3;DHX16;PRPF3;SNRPD1;SNRPN;SRSF7;PRPF6;PRPF4;SNRPD2;PRPF18;ZCRB1;MAGOHB;PRPF8;RRAGC;NCBP1;WDR83;PDCD7;NOL3;DHX8;SRSF10;MPHOSPH10;SF3B4;NCBP2
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),-0.46817316962750244,-0.7192300776775179,0.8245614035087719,1.0,1.0,2/6,18.26%,AHR;HLA-DRB1
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.3203223153005006,0.7191478198978007,0.9285714285714286,1.0,1.0,2/36,2.84%,KIFC2;ZNF207
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.41030494141730944,-0.7189665437423705,0.7931034482758621,1.0,1.0,2/12,10.26%,ZNF830;CLSPN
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.469951231541219,0.7184077133657939,0.7755102040816326,1.0,1.0,2/6,29.09%,SETD2;RB1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.3412295509719431,0.718374231201415,0.9736842105263158,1.0,1.0,3/16,11.83%,PICALM;PID1;RHOQ
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.3092740491368269,0.7183622281900905,0.8787878787878788,1.0,1.0,5/45,9.42%,MTHFD2L;MTHFS;ALDH1L1;DHFR;PHYH
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.37851648025810336,0.7181535209458312,0.7560975609756098,1.0,1.0,1/10,4.67%,IRAK2
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.3405086900510913,0.7181195736810762,0.8648648648648649,1.0,1.0,5/21,15.64%,HSD3B7;OSBPL1A;OSBPL6;OSBPL7;OSBPL3
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),0.4724297064560634,0.7180441826663495,0.7727272727272727,1.0,1.0,5/5,52.77%,IL18;IL12RB1;IL1R1;SLC11A1;IL23A
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.4206656953033523,-0.7179759814350996,0.8591549295774648,1.0,1.0,1/10,3.24%,XYLT2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.3026070110632216,-0.7179643323560435,0.9696969696969697,1.0,1.0,9/85,12.28%,BMP5;XBP1;SFRP1;STAT5A;HTR2B;HRAS;MYDGF;PDCL3;GRN
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.2635904796689296,0.7179540245872749,0.9411764705882353,1.0,1.0,29/105,19.63%,BICDL1;TMEM108;CNTNAP2;FAM161B;L1CAM;AGER;NLGN1;FRYL;DOCK7;NPY;PLEKHA1;GDNF;GPM6B;HMGB1;TBC1D23;RYK;UHMK1;ATXN10;PKD2;ADCYAP1;GSK3B;CYFIP1;MAP2;GPM6A;MARK4;PPP1R9B;MAPT;ZFYVE27;TPM1
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.42390443875432393,-0.7172711313172262,0.7796610169491526,1.0,1.0,2/8,17.78%,OLFM1;APOE
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.31892941472818176,-0.7170348937474428,0.9166666666666666,1.0,1.0,10/83,14.56%,IGSF1;RPS27A;TGFBR2;IL17RD;UBA52;BAMBI;TGFB1;FAM89B;ASPN;UBB
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.39538525133033364,-0.7169911781935704,0.8307692307692308,1.0,1.0,4/19,22.25%,GPS2;ABCA12;APOE;CAV1
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.4229541059896199,-0.7168079517805807,0.859375,1.0,1.0,3/9,32.45%,ABHD12B;GGACT;CHAC2
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.3595664765853384,0.7166285209662832,0.7435897435897436,1.0,1.0,3/13,9.36%,KYAT1;IDO1;KYNU
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.33223043012999687,-0.7165440950859927,0.8970588235294118,1.0,1.0,7/52,15.56%,TNFAIP2;RNASE1;CXCL17;SCD;SLAMF8;DUOXA1;CEBPD
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.45043460102109834,-0.7163457069670723,0.8333333333333334,1.0,1.0,1/6,15.26%,TNFRSF1A
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.30695211416158863,-0.7163245380988291,0.9605263157894737,1.0,1.0,6/61,13.45%,DTX3L;RNF181;RNF8;TRIM13;TRIM17;BRCA1
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),0.4182712719468067,0.7163160963978373,0.8648648648648649,1.0,1.0,2/8,16.20%,KYAT1;QDPR
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.38469756651196785,0.7162438236415769,0.8421052631578947,1.0,1.0,1/12,2.16%,TSPOAP1
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.3005456455253823,0.7161110506847476,0.8648648648648649,1.0,1.0,10/38,17.70%,YAF2;RYBP;PHC3;EED;MGA;TFDP2;PHC1;RAD51;EHMT1;RNF2
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.3150346780544128,0.7160009301926025,0.8108108108108109,1.0,1.0,7/21,16.72%,PIWIL2;DMC1;NANOS3;STRA8;FMN2;M1AP;KMT2D
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.28119091542536545,-0.715944342734738,0.961038961038961,1.0,1.0,29/162,20.82%,RBMS2;SNRNP25;SCNM1;RBM3;RNPC3;DHX16;PRPF3;SF3A1;SNRPD1;SNRPN;TFIP11;TSEN34;SRSF7;PRPF6;PRPF4;SNRPD2;PRPF18;PRMT9;METTL3;KIN;ZCRB1;MAGOHB;CLP1;PRPF8;RRAGC;PRKACA;NCBP1;FASTKD2;AURKAIP1
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.35470070242863605,0.7153037003239578,0.8157894736842105,1.0,1.0,4/11,18.27%,INPP1;PTEN;SYNJ2;INPP5B
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.35470070242863605,0.7153037003239578,0.8157894736842105,1.0,1.0,4/11,18.27%,INPP1;PTEN;SYNJ2;INPP5B
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.3519482261045138,-0.7152379371492957,0.9032258064516129,1.0,1.0,4/24,15.02%,B2M;NEK6;ARG2;CGAS
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),0.45894772243152515,0.7152033832140556,0.725,1.0,1.0,1/5,11.83%,FGF1
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.3278072402072081,-0.7150311636833414,0.8970588235294118,1.0,1.0,11/37,22.57%,HLA-DPA1;TNFRSF21;CEBPB;TNFSF9;HLA-DRB1;CR1;PDCD1LG2;ZP3;LGALS3;CD46;HLA-DPB1
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),0.27939671000912686,0.7149725889940184,0.8461538461538461,1.0,1.0,3/49,7.86%,PTPN6;IRAK3;ADAM8
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.39297270845762317,0.714968317042955,0.7142857142857143,1.0,1.0,4/11,12.63%,OXTR;GUCA1B;GPAT4;SLC22A2
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.26233211982574695,0.7147477316925124,0.9545454545454546,1.0,1.0,43/135,20.78%,SCN9A;GDAP1;PIEZO2;PTPRD;PRKX;MMD2;PLPPR4;OLFM3;ADGRB3;AMER2;SNAP91;ASXL3;AHNAK2;MAPK10;SCN7A;DLG2;ZNF536;NCAN;NRXN1;KCTD16;ADCY8;FGF13;MAGI2;CADM2;ZDHHC2;CA10;RUFY3;NFASC;ADGRA1;KIF1B;GRIA2;MAP2;NKAIN2;SPHKAP;TMEM196;SCN3B;ERC2;PRUNE2;ADCYAP1R1;ST8SIA3;KCNAB2;GRM5;SLC6A1
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),-0.45951627979255577,-0.714684933871008,0.8448275862068966,1.0,1.0,1/5,12.66%,BFSP1
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.46306150496011955,-0.7145974365539549,0.8688524590163934,1.0,1.0,2/7,19.58%,APPL2;PTN
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.2845217818293016,0.7145908971692155,1.0,1.0,1.0,13/79,14.11%,RELN;ALK;EPHA3;ZNF804A;DPYSL3;COBL;NTRK2;ARHGAP35;RAPGEF1;PLXNB2;PRKD1;MAGI2;LRP8
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.4555994953380136,-0.7144331395009529,0.8135593220338984,1.0,1.0,2/5,14.58%,PARP1;MGME1
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),-0.4359364670713791,-0.7143635651308271,0.8813559322033898,1.0,1.0,1/6,17.95%,ORMDL3
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.4138968379194727,-0.7131996214134658,0.8709677419354839,1.0,1.0,2/10,17.09%,RACK1;CRB2
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.34858604255315795,-0.7131700732703103,0.8,1.0,1.0,6/30,23.09%,PPP1R11;BOD1L1;PTPA;HSP90B1;CALM3;CALM1
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.42413284483989133,0.7128234103475505,0.775,1.0,1.0,7/7,57.60%,SLC27A2;ABCD2;ACOX1;ABCD3;ABCD1;SLC27A4;ABCD4
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.4355483671194215,-0.712466178469133,0.8260869565217391,1.0,1.0,3/9,22.91%,RPS27L;KAT5;FOXM1
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.2815728810151374,-0.712163483925528,0.9620253164556962,1.0,1.0,22/178,18.60%,RPS27A;DTX3L;XBP1;ADRM1;UBA52;RNF8;TRIM25;ARIH2;RBX1;PINK1;PSMD3;RNF5;PPP1R11;WDR91;UBB;ANAPC15;UBL7;RNF167;CDC34;UBE2D4;RNF111;RNF213
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3277976870210127,0.7120864009834383,0.8787878787878788,1.0,1.0,3/23,5.66%,PLK1;ESPL1;DUSP1
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.2819055274537476,-0.7119057327585236,0.9857142857142858,1.0,1.0,31/176,21.55%,RHOC;GAPDH;GSTP1;APOL3;TRIM13;TNIP2;TMED4;HTR2B;TRIM25;LAMTOR5;NEK6;SLC35B2;NLRX1;FADD;PINK1;STAT1;NLRP12;TNFRSF1A;LGALS1;IFIT5;GPR89A;UFL1;TMEM9B;HLA-DRB1;ECT2;S100B;DDX1;SHISA5;PPM1N;CCR7;RIOK3
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.4347663821844908,-0.7118356800443871,0.8703703703703703,1.0,1.0,1/9,7.64%,STAT5A
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.4347663821844908,-0.7118356800443871,0.8703703703703703,1.0,1.0,1/9,7.64%,STAT5A
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),-0.47899223392240126,-0.7117995208180199,0.8225806451612904,1.0,1.0,2/6,17.78%,LAMTOR1;APOE
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),0.3971925035930573,0.7117826983103511,0.7714285714285715,1.0,1.0,1/9,6.43%,DLAT
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.36452215274803784,0.7116956972992077,0.8529411764705882,1.0,1.0,3/17,10.19%,YJEFN3;OSBPL6;NFKB1
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.41817353498889953,-0.7116911863610389,0.8070175438596491,1.0,1.0,1/8,7.80%,PAX8
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.3878687438352645,0.7110796760253364,0.8222222222222222,1.0,1.0,1/9,7.40%,PKD2L1
prerank,GO_Biological_Process_2021__regulation of urine volume (GO:0035809),-0.46225086343489086,-0.7104113317381504,0.8392857142857143,1.0,1.0,1/5,5.76%,HYAL2
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.29612449083833964,-0.7102547233087145,0.9746835443037974,1.0,1.0,9/91,13.13%,CPS1;XBP1;SELENOS;GSTP1;TNIP2;IRGM;SELE;SELP;PAF1
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.476708849337112,0.7101959093231786,0.8378378378378378,1.0,1.0,2/5,12.14%,SIRT1;AUTS2
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.28227485159437976,-0.709906678014825,1.0,1.0,1.0,18/183,15.08%,DDIT3;RPS27A;CLU;JUP;BEX1;RPS3;UBA52;COPS5;TRIM13;TRIM25;PHB2;LAMTOR5;AR;FLOT1;PPIA;RTKN2;UBB;EDN1
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.29500877505902773,-0.7098773974409216,0.9436619718309859,1.0,1.0,12/115,15.73%,JUP;PDZK1;RAB11A;CD81;NECTIN3;GORASP2;FLOT1;RAB8A;ABCA12;MYADM;TNFRSF1A;GORASP1
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.33079288963696574,0.70962070482718,0.8333333333333334,1.0,1.0,3/16,11.42%,SRC;ST18;SMAD4
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.359998795102096,0.7094771279074357,0.8571428571428571,1.0,1.0,7/22,15.73%,SIRT1;PAXIP1;OGT;FAM47E;SMAD4;AUTS2;PHF1
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.245479246062381,0.7089434662368836,1.0,1.0,1.0,16/195,10.55%,FHDC1;EXOC6;RAB3IP;RFX3;RAB23;FAM161B;DNAAF1;EHD2;PKD1;TRAPPC14;TEKT5;TMEM216;DNAI2;CCP110;IFT88;CFAP54
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.3943831705625641,-0.7087321121416635,0.8620689655172413,1.0,1.0,3/13,15.08%,CBR1;PTGES2;EDN1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.3571501636157839,-0.7086255931725787,0.7962962962962963,1.0,1.0,1/22,0.86%,TINF2
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.3537924915239723,-0.7084920947689067,0.8852459016393442,1.0,1.0,6/26,19.91%,HSPB8;HSPA2;HSPA5;TM7SF3;HSPA8;BAX
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),0.4585420401994803,0.7083957753450656,0.8333333333333334,1.0,1.0,2/5,35.58%,CRKL;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3317644066149543,-0.7082952483694732,0.9047619047619048,1.0,1.0,3/29,15.61%,PNKP;CCT7;CCT2
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.3034212634821941,0.7080531685039854,0.8947368421052632,1.0,1.0,2/44,1.51%,REP15;ATP6V0A4
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.29362298197053976,-0.7080394032731203,0.9487179487179487,1.0,1.0,4/92,6.63%,LOXL4;EEF1AKMT2;RNF212;RNF212B
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.39439396854895337,-0.707922164419956,0.8448275862068966,1.0,1.0,4/12,23.73%,RNF8;HEXIM1;NELFCD;NELFE
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.4385565441235427,-0.7078167211475951,0.8225806451612904,1.0,1.0,1/6,15.79%,DCTN1
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.45953327786181863,0.7077775167852942,0.8157894736842105,1.0,1.0,3/5,28.86%,GOLPH3;VPS13D;SORL1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3039641392439316,-0.707243045247434,0.9,1.0,1.0,4/58,11.22%,BMP5;CDKN1C;TGFB1;GIPC1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.40070293362201326,-0.7072062699621515,0.8676470588235294,1.0,1.0,1/13,1.10%,PARP2
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2996224429196303,0.7071908606321509,0.926829268292683,1.0,1.0,5/45,8.81%,HSPA1A;CPNE1;TRAF2;CCDC3;HSPA1B
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),0.30687927691928785,0.7066148109602312,0.9642857142857143,1.0,1.0,1/35,1.30%,UBA7
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.3163136178714549,-0.7062762666457548,0.9090909090909091,1.0,1.0,9/64,20.55%,TGFBR2;TST;DHX38;SRSF7;FLOT1;EIF4A3;SRSF3;MAGOHB;NCBP1
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),0.35389036234202575,0.7062744283664496,0.8787878787878788,1.0,1.0,7/18,20.91%,ABHD2;TGFB2;SLIT3;SLIT2;NR1H3;CATSPERD;CATSPERB
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),0.40801322828583014,0.7059941501996545,0.7948717948717948,1.0,1.0,1/6,2.93%,IFNA2
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.29836446277775364,-0.7059513001495819,0.927536231884058,1.0,1.0,9/70,19.15%,RPS13;MBNL3;RBM22;RPS26;C9ORF78;POLR2A;PQBP1;SRSF3;HNRNPH2
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.2794368932825096,0.7058445000890151,0.9259259259259259,1.0,1.0,13/64,15.04%,VASH1;ADGRB1;ATOH8;NRP2;ADAMTS9;SASH1;RHOJ;FGF1;PRKD1;SLIT2;GPLD1;BMPR2;DNAJA4
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.30637802549502374,0.7057825375878114,0.8571428571428571,1.0,1.0,18/67,19.81%,ACER2;CNOT2;PAXIP1;SESN2;CRADD;CNOT11;CNOT4;PIDD1;CNOT6L;TFDP2;ATRX;HIPK2;RPS6KA6;PLAGL1;MDM4;RGCC;SOX4;NDRG1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.38306254553836344,-0.7057356781613779,0.8703703703703703,1.0,1.0,2/11,15.41%,LACTB2;POP7
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.3950982223973783,0.7055762259678525,0.7948717948717948,1.0,1.0,2/6,10.84%,RAB34;MAPKAPK3
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.38460774695262606,0.7054509811525824,0.7941176470588235,1.0,1.0,4/8,35.21%,MIA3;ZDHHC17;PPARG;VMP1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.43420340820127895,-0.7050932619305811,0.8833333333333333,1.0,1.0,2/6,25.66%,FURIN;LAPTM4B
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.26021648350565146,0.704905138145419,1.0,1.0,1.0,50/140,22.21%,LUZP2;GFAP;FGFR3;MMD2;ALDH1L1;PLPPR4;SORBS1;ADGRB3;AMER2;CDH20;PSD2;NTRK2;SNPH;HTRA1;WNT3;SLCO1C1;RCAN2;NCAN;TEAD1;SLC4A4;FGF1;NRXN1;ADCY8;GPM6B;LCAT;RAPGEF4;SLC1A2;CADM2;CA10;NFASC;SLIT1;ADGRA1;SLC6A11;SLC25A46;GRIA2;SRR;SPHKAP;NTM;ADCYAP1R1;KCNIP1;FABP7;GRM5;SLC6A1;GABRG1;DAAM2;NFATC3;ATP1A2;SOCS3;SLC16A2;IGSF21
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.39766485161257314,-0.7048394224748376,0.8769230769230769,1.0,1.0,5/14,32.41%,AR;DDX5;ESR1;SAFB;NCOA4
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.3994163569921869,0.7046845110370415,0.8,1.0,1.0,5/12,20.62%,EGFR;IGF1R;DYRK1A;ABL1;KDR
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.31360072214497275,-0.7045478918833044,0.926829268292683,1.0,1.0,2/65,1.82%,SLC8A3;SLC6A12
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.3609728685475916,0.7044141977094174,0.8947368421052632,1.0,1.0,6/12,29.18%,SPEF1;PPP1R9B;DNM3;ARHGEF4;FGD3;FGD4
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),-0.33564457022343597,-0.7043690710622968,0.9206349206349206,1.0,1.0,5/32,19.83%,PDZK1;PHB2;PPIF;FXYD4;RANGRF
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.31761045550753597,0.7041527510440968,0.90625,1.0,1.0,6/29,14.60%,MTCL1;CAMSAP3;ERBIN;DLG2;DLG1;DLG3
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.3368886490767742,0.703965082689304,0.7741935483870968,1.0,1.0,5/22,22.19%,OTUD7B;YOD1;OTUD4;OTUD7A;USP25
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.33799498851311455,0.7038980900567575,0.8461538461538461,1.0,1.0,4/24,7.16%,DYSF;AGER;SNCA;TMEM106A
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.25316520867190423,0.7036970738994074,1.0,1.0,1.0,14/102,14.66%,IFNA2;HSPB1;EGFR;SIRT1;CDKN2A;FNIP2;SESN2;OGT;PLXNB2;NDC1;NUP42;LDB2;PTGES3;TESK1
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.43499207046240174,0.7036948753304474,0.8571428571428571,1.0,1.0,2/5,25.46%,SLC25A29;SLC16A10
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),-0.44938887715518716,-0.7034875836329537,0.8421052631578947,1.0,1.0,3/8,27.98%,HEY2;MYOCD;HEY1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.447452305057329,0.7030979299018935,0.9090909090909091,1.0,1.0,5/5,55.27%,GNAI1;EPB41;EPB41L2;GPSM2;NUMA1
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.4136438516426367,0.7028203619993237,0.8611111111111112,1.0,1.0,1/7,7.00%,XPO1
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.38690365399890775,-0.7027646994465893,0.835820895522388,1.0,1.0,4/14,28.03%,VIP;EDN1;LTBP4;PARK7
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.2975023313639433,-0.7025958456573422,0.9041095890410958,1.0,1.0,8/63,17.22%,TLN1;JUP;CDH12;TGFB1;NECTIN3;CDH17;MYADM;SDK2
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.3567511509863578,-0.7025033938243169,0.9027777777777778,1.0,1.0,2/23,11.02%,PRELID1;TRIAP1
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.31538356131063944,-0.7024370143482438,0.8875,1.0,1.0,11/45,28.67%,HRAS;RAD51AP1;KDM4D;FIGNL1;ECT2;TMEM109;RAD9A;BLM;HUS1;CRYAB;NUCKS1
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.42418175526468005,-0.7022292826387506,0.8135593220338984,1.0,1.0,2/7,14.58%,PARP1;MGME1
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.3165876810046031,-0.702210284551471,0.9594594594594594,1.0,1.0,5/62,9.81%,XBP1;SELENOS;GSTP1;TNIP2;IRGM
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.3300681591348313,0.7018901417096576,0.8,1.0,1.0,7/22,18.82%,CAMSAP3;AEBP1;PIK3CA;CAMSAP2;ABL1;MAP2;MAPT
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.309282871166047,-0.7018779982930938,0.9420289855072463,1.0,1.0,8/73,14.08%,AFP;TPH1;CFTR;TREH;SMLR1;PCSK1;RGN;SLC2A2
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.3213648957507842,0.7017531172513184,0.9666666666666667,1.0,1.0,4/30,10.90%,RUNX1;SAFB2;KDM4C;RNF14
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),-0.4395604649228946,-0.7014635318518002,0.9166666666666666,1.0,1.0,1/6,17.95%,ORMDL3
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),0.4202431797191255,0.7013484943362291,0.8857142857142857,1.0,1.0,1/8,11.20%,PTPN22
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.24499196427264883,-0.7011762083124422,1.0,1.0,1.0,129/852,21.12%,PSMB8;AFP;GLYCTK;PARP2;FBXW10;BTBD6;PSME1;MEPE;UBL5;B3GNT9;TIMP1;PTK6;TGFBR2;USP6;PIGH;COPS6;PSMB6;PP2D1;PSMD8;NRBP2;PSMC5;ELOB;F5;ASB18;RAB11A;COPS7A;ALG10B;PSMD7;FUCA2;UBA52;PARP14;PHPT1;METAP2;LCK;COPS5;GPC3;VWA1;DAD1;PTPN7;MAP4K1;PTPRM;DDA1;B4GALT7;CAMK1;ATG10;NEK6;SPARCL1;PAK5;GMFG;RBX1;TGFB1;ST3GAL5;CHGB;ART3;PINK1;STRADB;CDK4;PPP1CA;PPM1G;PSMD3;ILK;JMJD4;CDK5;PSMC3;TIMM50;DDOST;RAB8A;DUSP26;PARP1;SCG3;FLG;NUCB1;ARAF;B3GALT9;PSMA4;B3GALT5;LGALS1;ASB13;ILF3;FBXW8;PARP9;KRT10;MAP3K12;RCN1;UFL1;RABGGTB;CDC34;PRSS23;PLK4;MAN2A2;PPP2R5D;STK10;CTDSP1;APOE;CST3;CKAP4;SCG2;AGA;GLRX;PSMD2;FSTL1;PSMA7;CP;NAGPA;HSP90B1;FBXL16;GOLGA2;MFGE8;SPSB3;PDK2;FBXL13;GGCX;PRKD2;PSMD6;SHISA5;BMX;RBBP5;IGFBP7;PSMB2;ERCC8;PRKACA;NEK3;PSMB3;PSMB4;PRAG1;WDR45B;PSMA3;B3GALT4;CDK11B
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.38366726205859053,0.7009967753506766,0.90625,1.0,1.0,5/12,24.29%,PKD1;PKD2;NFKBIE;FLNA;NFKBIA
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.38985792783321754,-0.7008896402282409,0.8428571428571429,1.0,1.0,2/13,18.02%,CARTPT;LILRB3
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),-0.3833022180165695,-0.7008225542402374,0.8923076923076924,1.0,1.0,3/16,15.00%,SEPHS2;MTHFD1;SARS1
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.25224844483738545,0.700313477165082,1.0,1.0,1.0,7/73,10.22%,U2AF1;ATXN1;PKD1;XPO1;EIF4E;XPO5;MALT1
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.37469193948603563,-0.7002121613211311,0.8615384615384616,1.0,1.0,1/17,2.25%,STMN1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.2955444715238559,-0.7001544537363704,0.963855421686747,1.0,1.0,16/89,18.01%,RPL5;VPS35;RPS4X;RBM3;ATG10;FADD;TGFB1;LARP6;EIF3D;PTTG1IP;EEF2;RPS27L;PYM1;EIF4A3;METTL3;CIRBP
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),-0.4591345359800132,-0.6997558924334311,0.855072463768116,1.0,1.0,1/5,4.76%,DNAJC19
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.3490440298111425,-0.6997031088705122,0.8153846153846154,1.0,1.0,4/22,15.26%,EFNA1;NFATC1;TGFB1;TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3403844367426253,-0.6996724983398153,0.8923076923076924,1.0,1.0,6/27,23.99%,PHB2;LSM10;PAF1;TFDP1;EZH2;ADAM17
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.4459726832902919,0.699647942357741,0.7924528301886793,1.0,1.0,1/5,8.14%,LRRC8A
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.3638936603178729,-0.6996341979562121,0.8620689655172413,1.0,1.0,3/19,9.30%,DDX4;BTBD18;ASZ1
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.30996124380695267,-0.6994808159396871,0.9324324324324325,1.0,1.0,11/63,24.77%,RPS27A;UBA52;CTSO;UBB;CTSZ;CHMP4B;CTSS;VPS4B;CTSL;UBC;NR1D1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3046962373731788,0.6993214193924941,0.9411764705882353,1.0,1.0,10/26,18.34%,PLK1;ARRDC4;FBXW7;ARRDC3;DCUN1D1;DCUN1D4;TRIB3;PTEN;CDC14B;BTRC
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.34052702492955,0.6982683133964058,0.8529411764705882,1.0,1.0,3/16,11.83%,PICALM;PID1;RHOQ
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),0.4341234385922371,0.6982256990793414,0.8333333333333334,1.0,1.0,1/5,7.00%,XPO1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.34330883104871657,0.6981781563869505,0.9705882352941176,1.0,1.0,3/13,19.18%,REEP1;ATL2;ZFYVE27
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.4122303171265168,-0.697620827465621,0.8275862068965517,1.0,1.0,4/12,30.98%,IKBIP;BLM;NUCKS1;XRCC6
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),0.4281833955832457,0.6975737157632015,0.8409090909090909,1.0,1.0,1/5,2.41%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.38401420997858987,-0.6974884275317255,0.9193548387096774,1.0,1.0,4/14,13.37%,COX7A1;COX7A2;PINK1;PPIF
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.3438741959677958,0.6974313702048932,0.8695652173913043,1.0,1.0,8/19,19.71%,KCNIP2;KCNMB4;AGER;CELF2;CAMK2D;KCNMB2;TPM1;DMPK
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.3701064710752758,0.6973907753265194,0.90625,1.0,1.0,4/10,22.63%,CLMN;SYNE2;SUN2;FBXW11
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),-0.5019607386313177,-0.6973901658344214,0.9038461538461539,1.0,1.0,2/5,21.54%,YBX3;RCSD1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.4355317176821387,-0.6970353857837864,0.8823529411764706,1.0,1.0,3/10,22.91%,RPS27L;KAT5;FOXM1
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),-0.4665169546566667,-0.6970024541759567,0.8947368421052632,1.0,1.0,2/5,11.32%,TGFB1;CUEDC2
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.30049013224070453,-0.6967194985323494,0.9367088607594937,1.0,1.0,8/80,20.22%,VPS35;TMED9;ARL1;STX16;CLTCL1;DCTN1;RAB7B;SNX6
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.36794398516295457,0.6967065081603945,0.7647058823529411,1.0,1.0,4/9,18.07%,CXXC4;COBL;RIPPLY2;SMAD2
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.3498014991518105,-0.6966342318222071,0.8701298701298701,1.0,1.0,6/21,27.67%,PRELP;OMD;CHST2;OGN;CHST6;SLC35D2
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.3728459466376382,0.6965908277811503,0.7906976744186046,1.0,1.0,4/12,27.27%,GPLD1;AGTPBP1;FOLH1B;ATG7
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.39175624197333536,0.6965466015434355,0.8292682926829268,1.0,1.0,3/9,11.56%,SNCA;SIRT1;KLF15
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),0.46224224172408773,0.6964633230647086,0.8260869565217391,1.0,1.0,1/5,5.53%,PLA2G10
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.316351256712058,-0.6960022961273953,0.9285714285714286,1.0,1.0,5/69,6.83%,ARHGEF16;TMC4;EFNA1;TMEM125;OVOL2
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.36231712242960634,0.69573847188924,0.8823529411764706,1.0,1.0,7/19,17.69%,ADGRB1;MEGF10;XKR8;HMGB1;XKR7;NR1H3;RHOBTB1
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.389425157662047,0.6956242367838633,0.8125,1.0,1.0,1/8,4.04%,BDH2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.40280853998209,0.6955457443108938,0.71875,1.0,1.0,1/9,5.24%,CD200R1
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.3341543641950099,0.6954794258246124,0.8181818181818182,1.0,1.0,2/12,8.65%,CHD7;MYO3A
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),0.4064991604652907,0.6952176996047301,0.7435897435897436,1.0,1.0,1/5,7.83%,CHD7
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),-0.37971059553752873,-0.6952002372747944,0.8360655737704918,1.0,1.0,3/14,16.99%,C1QBP;IFNLR1;RNF26
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.2847238999778449,-0.6951904538452383,0.987012987012987,1.0,1.0,24/106,32.26%,VPS35;ARL1;ANKRD27;WDR91;LAMP1;SNF8;STX16;CLTCL1;DCTN1;SNX6;EEA1;DOP1B;CCDC91;VAMP3;KLHL20;SNX32;AP2A1;ANKFY1;AP4M1;RAB6C;YKT6;HEATR5B;RAB14;VPS13A
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.368503530321514,0.6951246127821872,0.8648648648648649,1.0,1.0,2/7,15.20%,SERPINB9;SFPQ
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.35307807053697887,0.6949770957355978,0.9333333333333333,1.0,1.0,3/15,14.63%,ADSS2;AMPD1;AMPD3
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),0.43608583090344677,0.6949340820117632,0.8285714285714286,1.0,1.0,1/5,12.99%,LPL
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),-0.3049502009069161,-0.694630330715869,0.9558823529411765,1.0,1.0,9/55,17.86%,TTN;KIF20B;RACK1;VPS28;CEP131;TGFB1;PPIA;DNM1L;MYH10
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.29156150632330574,0.6945207963626293,0.92,1.0,1.0,11/42,22.07%,TRIM67;UNC13D;PARD6B;ADGRE2;FER;WWC1;CAMK2D;MAP2;EFNA5;TRIM46;KDM1A
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),0.4047000684535945,0.694402082198991,0.8108108108108109,1.0,1.0,1/5,10.06%,SGSM2
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.4739902193226927,-0.6940316663155728,0.8769230769230769,1.0,1.0,1/5,33.96%,CCDC66
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.3671878589048935,-0.693883386305907,0.88,1.0,1.0,4/24,10.96%,JUP;SVBP;PTPRM;TGFB1
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),0.3403681530305436,0.6938748713959051,0.84375,1.0,1.0,1/10,2.83%,SRC
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),-0.43865904059437827,-0.6932499931401637,0.896551724137931,1.0,1.0,1/5,21.74%,CD226
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.36009825498955034,0.6932488383679561,0.7560975609756098,1.0,1.0,2/14,6.25%,SAMSN1;SIRT1
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.3321791932116034,0.6931270321639718,0.8787878787878788,1.0,1.0,3/15,10.11%,TMEM108;HAP1;DLG2
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.24139000304838398,0.6927188635513496,1.0,1.0,1.0,18/100,14.15%,HSPA1A;FRZB;OSGIN1;IP6K2;SIRT1;SMARCA2;CDKN2A;SESN2;HSPA1B;DIP2B;TGFB2;SMAD4;SLIT3;ENPP1;APBB2;FGF13;SLIT2;BMPR2
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),-0.41586034832344765,-0.6920656879624557,0.7727272727272727,1.0,1.0,1/11,4.56%,SLC25A11
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),-0.41586034832344765,-0.6920656879624557,0.7727272727272727,1.0,1.0,1/11,4.56%,SLC25A11
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.366714602501619,0.691815077814473,0.9,1.0,1.0,2/11,8.03%,IFNA2;TRIM11
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.30833496246849573,-0.6918076272843232,0.9090909090909091,1.0,1.0,6/54,12.62%,TMC4;PTK6;VAMP8;TRIM25;LRP10;TMCO4
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.34037311513129226,-0.6914915123794564,0.8823529411764706,1.0,1.0,4/19,22.29%,TPX2;GOLGA2;TUBGCP4;TUBGCP2
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),-0.4553897073046981,-0.691448626839043,0.8979591836734694,1.0,1.0,2/5,13.22%,CORO1B;SYAP1
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.3172782053796627,-0.6913255076140309,0.9117647058823529,1.0,1.0,2/33,10.96%,SFRP1;TGFB1
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.26870676538988153,0.6912130484621606,0.9565217391304348,1.0,1.0,7/68,8.65%,ATP6V0A4;EPS8L2;CLIC5;GRXCR2;MYH14;PCDH15;MYO3A
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),-0.4319684511912056,-0.6909760152843122,0.9166666666666666,1.0,1.0,4/7,29.26%,HTR2B;HTR2A;HTR1E;HTR1F
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.29185529689484246,-0.690897976514989,0.9516129032258065,1.0,1.0,3/83,2.80%,P2RY10;TRPM1;JPH3
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.2605008656424052,0.6908240485641539,1.0,1.0,1.0,13/60,17.51%,PLPP4;SRC;LIMK1;ELMO1;DOCK1;ELMO2;PIK3CA;PRKCE;HCK;SYK;CD247;CYFIP1;ABL1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.2605008656424052,0.6908240485641539,1.0,1.0,1.0,13/60,17.51%,PLPP4;SRC;LIMK1;ELMO1;DOCK1;ELMO2;PIK3CA;PRKCE;HCK;SYK;CD247;CYFIP1;ABL1
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.3873584304552703,0.6908156314971939,0.9393939393939394,1.0,1.0,2/6,15.20%,SERPINB9;SFPQ
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.39041272692004675,0.6907389358059298,0.8780487804878049,1.0,1.0,4/13,21.84%,MYH14;PID1;PNPT1;MTM1
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.3537726559664049,0.6904047838727443,0.9230769230769231,1.0,1.0,5/10,27.62%,PUS10;SMAD2;SMAD3;SMAD1;DROSHA
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.26059154545751234,0.6903036306329245,0.9285714285714286,1.0,1.0,14/72,16.37%,CDK6;BACH1;CCNH;DHFR;CDKN2A;EIF4EBP1;EIF4E;RCC1;ACVR1;KLF11;TFDP2;CDK17;POLE;NASP
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.3332050069677567,-0.6902031499094,0.9538461538461539,1.0,1.0,6/30,19.91%,HSPB8;HSPA2;HSPA5;TM7SF3;HSPA8;BAX
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.42886968301055994,-0.6901545426236713,0.8363636363636363,1.0,1.0,5/8,29.36%,TGFB1;GREM1;MYOCD;EFNB2;DHX36
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.33078000084060977,0.689916787382022,0.9714285714285714,1.0,1.0,5/16,19.08%,SRC;ZNF304;PIK3CA;PDK4;BCL2
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.27776984232530316,0.6896569441720852,0.9230769230769231,1.0,1.0,15/62,15.19%,VAPB;SNCA;SLC24A3;ATP13A1;STIM1;DRD4;PTH1R;TMTC2;GRIN1;ATP2C1;SLC8A2;ATP13A2;TMEM165;STIM2;SLC24A4
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.4010913317001988,-0.689157747515409,0.8571428571428571,1.0,1.0,6/9,30.75%,BHMT;SMOX;HNMT;COMT;LRTOMT;DMGDH
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.29241956335097974,-0.6889511060034659,0.9866666666666667,1.0,1.0,18/74,27.01%,POLR1G;POLR2L;POLR1F;POLR1H;DNMT3B;MYBBP1A;CGGBP1;TAF1D;ACTB;ZFP57;POLR1E;EZH2;DDX21;SMARCA5;POLR1B;MORC2;POLR2K;WBP2
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),0.40718520642845096,0.6888457806086594,0.8571428571428571,1.0,1.0,1/8,2.93%,IFNA2
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.3837796572442247,-0.688492897874879,0.8648648648648649,1.0,1.0,5/12,26.48%,MESP1;MEST;BMX;GDF11;MESD
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.43499129030633477,0.6882241345343731,0.825,1.0,1.0,2/5,24.10%,MLIP;TRPC3
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.3250923287774432,-0.688139810163335,0.9420289855072463,1.0,1.0,6/27,23.85%,SRI;MTCH1;IGFBP7;SCG5;TRDN;GRK6
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.34378214250621003,-0.6879968488937476,0.8356164383561644,1.0,1.0,2/25,3.97%,CD63;PDZK1
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),-0.433006344413086,-0.6873156502150682,0.9298245614035088,1.0,1.0,1/6,11.08%,GPS2
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.34830359425994606,0.6872195242597452,0.875,1.0,1.0,2/12,10.96%,HNRNPU;LTBP3
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.34781628915088814,-0.6871990346891116,0.9358974358974359,1.0,1.0,7/27,17.78%,RHBDF1;VAMP8;PNKD;SYT11;TNFRSF1A;GRM7;APOE
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),-0.44859308881822424,-0.6871002777810061,0.8793103448275862,1.0,1.0,1/5,15.78%,APPL2
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.2958191346394786,-0.6869847638106271,0.9210526315789473,1.0,1.0,11/70,20.55%,CSTF2T;FIP1L1;DHX38;SRSF7;PAF1;CPSF3;EIF4A3;SRSF3;MAGOHB;CLP1;NCBP1
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.29121353991337695,-0.686923841681898,0.9701492537313433,1.0,1.0,3/57,8.26%,RHOC;RHOG;CNN2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.2411976896818335,0.6867445259485998,1.0,1.0,1.0,51/280,15.68%,VDR;GCM1;ZBTB1;HDAC10;HNF4G;RXRG;PPARGC1A;MLLT3;TBL1XR1;EAF2;CCNH;CDK12;MAML2;NOTCH3;IWS1;NABP1;ARRB2;NOTCH4;TAF3;PAPOLA;TAF4;NFKB1;WDR33;SOX5;PCF11;TEAD1;INTS6;RARG;CPSF7;MNT;THRB;HDAC9;PIR;TEAD2;SCAF8;ELL;ZNF473;ESRRG;TAF12;TRIP11;ELL2;ESRRB;SNAPC4;ZNF143;CBFB;KAT2B;ERCC2;RPRD1B;INTS9;NR4A2;C5AR1
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.4187668596253702,-0.686531940572262,0.875,1.0,1.0,5/11,29.36%,PAF1;NCBP1;LEO1;NCBP2;DHX36
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.3327579139641053,-0.6864920426612623,0.9428571428571428,1.0,1.0,5/35,16.36%,RPS27A;UBA52;GPS2;UBB;MAP3K12
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.3769872207431971,-0.6862594747999877,0.8676470588235294,1.0,1.0,3/14,14.30%,PRELID1;NOP53;IFNLR1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.25548812530394827,-0.6862472099921304,1.0,1.0,1.0,24/341,11.27%,RPS27A;DTX3L;SELENOS;MAGEF1;UFC1;HLA-A;RNF212;MARCHF2;ELOB;PCNA;RNF181;RRAGA;UBA52;RNF212B;RNF8;PEX10;TRIM13;RACK1;ATG10;ARIH2;TRIM17;RTF1;RBX1;PINK1
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.2744890540707935,-0.6860289250543689,0.987012987012987,1.0,1.0,13/112,17.38%,PIGH;PGAP4;PIGC;CDIPT;PGAP2;ARF1;DPM3;PIK3CB;PLEKHA2;IMPA1;PI4K2A;PLEKHA4;ITPKA
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.2567733454428786,0.6860000741825394,1.0,1.0,1.0,13/61,17.51%,PLPP4;SRC;LIMK1;ELMO1;DOCK1;ELMO2;PIK3CA;PRKCE;HCK;SYK;CD247;CYFIP1;ABL1
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.4009936807259276,0.6857286575716776,0.868421052631579,1.0,1.0,3/9,24.13%,YOD1;UBE2G2;DERL3
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.410506045708408,0.6849271304373467,0.9,1.0,1.0,4/9,11.42%,LEF1;CHD7;TGFB2;SMAD4
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),0.41173474448817726,0.6845804829195636,0.7906976744186046,1.0,1.0,1/5,5.94%,SNCA
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.4500666938428395,0.6845366927261314,0.7948717948717948,1.0,1.0,2/5,13.57%,NOS1AP;DMD
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.3971314983117717,-0.6843711411667632,0.8714285714285714,1.0,1.0,3/9,21.27%,TMSB4X;ANTKMT;GCLM
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.3524895426701057,0.6842584527339913,0.696969696969697,1.0,1.0,2/9,18.76%,KCNN2;SCN3B
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.39822366059097314,0.6840384400220532,0.9230769230769231,1.0,1.0,2/9,16.86%,PROM2;NR1H3
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.43504646491854626,-0.683863485133744,0.8840579710144928,1.0,1.0,2/5,46.42%,SLC25A37;PRMT1
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.3906459277733987,-0.6838104055025135,0.8524590163934426,1.0,1.0,5/16,23.99%,APH1A;KLK6;APOE;BACE1;ADAM17
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3214483674219033,-0.6837659868848182,0.9166666666666666,1.0,1.0,4/31,15.05%,STMN1;TPX2;STMN2;KATNB1
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.28960816216194374,0.683625528364296,0.9,1.0,1.0,5/51,11.15%,CTSK;AFG1L;CPA2;MALT1;SIAH2
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.32876284734069555,-0.683470666903195,0.875,1.0,1.0,4/33,13.59%,GSTP1;GPS2;PINK1;PPIA
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),-0.5020327488985663,-0.6834563794973355,0.9259259259259259,1.0,1.0,2/5,21.54%,YBX3;RCSD1
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.4496634355443564,0.682891660641372,0.9130434782608695,1.0,1.0,3/6,21.77%,SNCA;FBP1;RYR3
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.31981273366058893,0.6827713754717747,0.9166666666666666,1.0,1.0,5/24,15.64%,HSD3B7;OSBPL1A;OSBPL6;OSBPL7;OSBPL3
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.2771195549477362,0.6825705465643904,0.9411764705882353,1.0,1.0,6/55,8.52%,HSPB1;HNRNPU;SPRED1;SNCA;GSKIP;CEP85
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.3870674877197282,0.6821704645119219,0.7777777777777778,1.0,1.0,1/7,13.01%,SLC8A2
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.41799956927893034,-0.6820019344797199,0.8852459016393442,1.0,1.0,2/7,14.92%,CBR1;PTGES2
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.2777080136508003,-0.68193205215689,0.9878048780487805,1.0,1.0,9/130,10.56%,CACNA2D4;LRTM1;TCEAL6;GPR179;RNPC3;TCEAL5;STMN2;PCBP3;PAK5
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.3864614482468287,-0.6816248333679794,0.8904109589041096,1.0,1.0,6/19,22.65%,CHMP2A;NEMP1;DCTN1;CHMP7;EMD;CHMP4B
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.28641525349302616,-0.6811403252667294,0.9859154929577465,1.0,1.0,26/91,27.13%,COPE;CD63;ARF1;TOM1L1;ARCN1;AP2S1;CLTA;STX16;CAV2;DNM1L;SSPN;SOD1;SCAMP3;GNAS;ZW10;TMED2;ATP1A1;NAPA;VPS4B;PPT1;GOLGA4;BNIP3;RAB2A;VAMP3;RER1;M6PR
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.39194879607880334,0.6810063671380955,0.8235294117647058,1.0,1.0,1/8,3.84%,EGFR
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.2680432617103933,0.6808508738194045,1.0,1.0,1.0,15/75,17.51%,ZBTB1;HOMER1;SNCA;LRRC8A;TMEM120B;CPSF6;KCNC2;CPSF7;ADCY8;UGDH;PKD2;PRMT8;ATL2;PNPT1;GLRA3
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.3169376467200609,0.6804740377018543,0.9230769230769231,1.0,1.0,6/25,13.57%,TCAP;SGCZ;SGCG;SGCD;PIK3CA;DMD
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.3631136168358402,-0.680440678950889,0.9104477611940298,1.0,1.0,5/20,23.09%,CEMIP;IRGM;TGFB1;CALM3;CALM1
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.34616878977251253,-0.6803010785300506,0.9452054794520548,1.0,1.0,3/26,15.08%,CLU;DDAH2;EDN1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),-0.4361963483755978,-0.680281165775025,0.8636363636363636,1.0,1.0,2/6,34.33%,HEY2;ENG
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.3423764777157684,0.6802279074933527,0.9024390243902439,1.0,1.0,3/14,13.77%,CHRNA4;CHRNB3;CHRNA5
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.3804956822760934,0.6801644997583223,0.875,1.0,1.0,5/11,17.69%,ADGRB1;MEGF10;XKR8;XKR7;RHOBTB1
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.3022607034470975,0.6801258223496971,0.9459459459459459,1.0,1.0,5/31,9.66%,CX3CR1;ASCL1;DOCK7;DLL1;WNT3
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.369589153330702,-0.6801120021757624,0.8596491228070176,1.0,1.0,3/13,17.43%,ANAPC15;GEN1;XRCC3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.26956868553830954,0.6796856698464543,1.0,1.0,1.0,3/43,7.60%,BCL2A1;SIRT1;FNIP2
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.41216096238950467,0.6793305467021236,0.8181818181818182,1.0,1.0,1/6,6.07%,NLGN1
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),-0.4423173751663681,-0.6791404834377013,0.8636363636363636,1.0,1.0,1/6,17.78%,APOE
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.2608001029491579,0.6791211617504311,1.0,1.0,1.0,31/95,23.72%,PIK3R5;MTMR2;PGAP1;PLA2G10;MTMR11;PLEKHA1;PIP4K2A;CDS1;PIK3CA;PI4KA;PITPNM1;PTEN;INPP5E;SYNJ2;FGF2;INPP5D;INPP5B;MTMR3;PLA2G4A;MTMR12;PIKFYVE;CSF1R;PIK3R1;PLA2G4C;PIP4P2;MTM1;PLEKHA8;PIK3R3;PLCB1;PIP5K1B;MTMR9
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.3797901294072407,0.6790202847316027,0.7931034482758621,1.0,1.0,4/9,15.68%,NPNT;ROBO2;SLIT2;PKD2
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.44524691880451484,-0.6786614899196959,0.8709677419354839,1.0,1.0,1/6,5.22%,POLE3
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),-0.37391924264094817,-0.6786219127770048,0.8548387096774194,1.0,1.0,3/13,10.91%,RPS3;HHLA2;FADD
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),0.34392740250496895,0.6785022296280613,0.9210526315789473,1.0,1.0,6/13,24.14%,TICAM1;IPMK;PGAM5;TRPM7;MLKL;CYLD
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.3903506685064471,0.678460705423439,0.8,1.0,1.0,7/7,60.98%,NTN1;SHTN1;NRP1;SDCBP;CD2AP;P2RY12;OPHN1
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.26629294656010316,-0.6782638196465619,1.0,1.0,1.0,17/161,18.08%,GPX4;PLAAT4;PNKP;PFKL;G6PC3;HTR2B;TGFB1;PPP1CA;CDK5;PIK3CB;NT5C;IMPA1;GCK;DUSP28;PGP;ITPKA;DUSP23
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.41243849826276513,-0.6782359949880077,0.9245283018867925,1.0,1.0,3/8,17.36%,COQ3;TPI1;PGP
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),0.4086778628859604,0.6782331696998746,0.7948717948717948,1.0,1.0,5/5,59.14%,SMO;AJAP1;CITED2;PKHD1;SAPCD2
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),-0.43345382686756484,-0.6778691098111906,0.9206349206349206,1.0,1.0,1/9,10.96%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.29723852834435904,0.6775943942254636,0.9333333333333333,1.0,1.0,5/29,10.91%,BMP6;SASH1;CYBA;ADAM8;USP15
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),0.3929721238560563,0.6773998953229744,0.7692307692307693,1.0,1.0,3/5,22.97%,FBXW7;LILRB1;FBN1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.42397407470256593,-0.6771352311611719,0.9038461538461539,1.0,1.0,2/6,13.03%,GSTP1;APOD
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.3369254977642251,0.6769890123440124,0.8918918918918919,1.0,1.0,7/16,24.08%,ADGRB3;C3;PICK1;ANKS1A;B4GALT6;APP;B4GALT5
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.3534966237596835,0.6769819497289966,0.918918918918919,1.0,1.0,2/14,8.08%,SNCA;OPTN
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),-0.4455741271746467,-0.6769756887769097,0.8548387096774194,1.0,1.0,2/6,12.56%,TBCC;VBP1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.279556157557658,-0.6769441293574137,0.9861111111111112,1.0,1.0,12/114,14.56%,RPS27A;CLU;RPS3;UBA52;TRIM13;TRIM25;LAMTOR5;AR;FLOT1;PPIA;RTKN2;UBB
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.30987703555120655,-0.6767758231025085,0.9863013698630136,1.0,1.0,7/47,15.20%,GPX4;MSRB1;CHMP2A;VIL1;TPPP3;MAP7D3;DIAPH3
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.325952767926724,-0.6766515802780074,0.9027777777777778,1.0,1.0,9/25,31.19%,PEX10;ACBD5;PEX1;FIS1;ATAD1;PXMP4;PEX16;PEX12;PXMP2
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),0.39348424549003025,0.6765979218091706,0.8780487804878049,1.0,1.0,2/10,11.31%,HSD17B7;HSD17B6
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.31682531053465773,0.6763694442499195,0.9393939393939394,1.0,1.0,13/28,21.06%,IQCJ-SCHIP1;KANK4;SMAD4;PIK3CA;CLASP1;SLIT2;KANK1;FKBP4;TJP1;CYRIB;SSH2;SSH1;SHANK1
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.4288828979310219,-0.6760446663654665,0.8923076923076924,1.0,1.0,2/6,21.35%,WIZ;DBF4
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.36267387989677824,-0.6759692398188206,0.8548387096774194,1.0,1.0,2/20,7.32%,INCA1;CDKN1C
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.3149695535224025,-0.6758132074718938,0.927536231884058,1.0,1.0,4/28,12.48%,MTHFD1;TGFB1;FUZ;IFT122
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.3149695535224025,-0.6758132074718938,0.927536231884058,1.0,1.0,4/28,12.48%,MTHFD1;TGFB1;FUZ;IFT122
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.37685144400256937,-0.6752971871885964,0.8787878787878788,1.0,1.0,1/10,21.46%,ERH
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.43465925351929047,-0.6751604921342457,0.8518518518518519,1.0,1.0,1/7,12.03%,PIK3CB
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.414090395814496,0.6750664117815419,0.8604651162790697,1.0,1.0,1/6,11.18%,FBXW7
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),0.4172891193681907,0.6749994844901512,0.8809523809523809,1.0,1.0,5/5,58.28%,RRM1;SAMHD1;RRM2;RRM2B;DERA
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.3770284278613975,0.6747639247945186,0.8888888888888888,1.0,1.0,5/8,29.39%,PTPN22;HMGB1;RSAD2;RTN4;PTPRS
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.3364868887190239,-0.6746646769669862,0.921875,1.0,1.0,5/23,20.34%,TNFRSF21;CEBPB;HLA-DRB1;CR1;PDCD1LG2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.3810958632466461,-0.6744474495879897,0.8333333333333334,1.0,1.0,2/11,10.04%,STMN1;STMN2
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.35221887142504565,0.6744385229655778,0.868421052631579,1.0,1.0,4/10,26.20%,DICER1;CNTNAP1;PARD3;NF1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),-0.44422434688949686,-0.674409981501205,0.8548387096774194,1.0,1.0,2/5,28.33%,KCNQ1;GJA1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,0.25552092058384474,0.6743295493591358,1.0,1.0,1.0,27/113,18.95%,KCNQ2;FGFR3;CPEB3;ZBTB16;CKM;MAGIX;SGK1;CPA2;TGFB2;GDNF;PDE6B;CELSR2;KCNN1;THRB;TEX15;ARPP21;LFNG;CD80;NGB;GP1BA;NR4A2;SLC5A5;KMT2D;KLHDC8A;NR6A1;SLC30A3;BMPR1B
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),0.375499402141111,0.6742640460252031,0.8409090909090909,1.0,1.0,1/8,9.11%,VPS8
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.2847947676535719,-0.6741727406812161,0.9855072463768116,1.0,1.0,22/127,20.84%,GLP2R;SELENOS;GSTP1;VPS35;TSHR;CXCL17;RPS19;FSHR;GPS2;SLAMF8;GRN;VIP;NLRP12;TNFRSF1A;MAPK7;TEK;APOE;HLA-DRB1;PRKACA;FURIN;MMP26;NPSR1
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.3424714634967678,-0.6737372556263963,0.9180327868852459,1.0,1.0,1/20,2.57%,ROGDI
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-0.45074405941682005,-0.6735944698688385,0.8676470588235294,1.0,1.0,1/5,15.99%,CPSF3
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.34636492720009476,0.6734939636940153,0.8529411764705882,1.0,1.0,1/11,3.84%,EGFR
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.2829931180822419,0.6733559764050888,1.0,1.0,1.0,9/42,17.51%,CASS4;ARHGEF7;DOCK1;KANK1;TESK1;DOCK5;SPRY4;CORO1C;ABL1
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.3665882495581614,-0.6726793613293875,0.8214285714285714,1.0,1.0,1/11,10.96%,TGFB1
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.41643809663347187,-0.6721205031595165,0.967741935483871,1.0,1.0,2/7,21.35%,WIZ;DBF4
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.3500045597165302,0.6717695309198134,0.8936170212765957,1.0,1.0,1/10,7.40%,PKD2L1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.4304807138882193,-0.6716852173521534,0.8703703703703703,1.0,1.0,2/5,24.75%,LRPAP1;MYOCD
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.35343544386909365,0.6716698452217825,0.9142857142857143,1.0,1.0,1/11,6.25%,SIRT1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.31916758935318984,-0.671487071453796,0.890625,1.0,1.0,9/35,22.61%,PRELID1;PINK1;ATP5IF1;STOML2;UBB;BAX;SOD1;MTLN;ARL6IP5
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.40747902958998217,-0.6714077626799128,0.8421052631578947,1.0,1.0,1/8,13.57%,PARP1
prerank,GO_Biological_Process_2021__positive regulation of respiratory burst (GO:0060267),-0.4299798564863739,-0.6713942894132836,0.8301886792452831,1.0,1.0,1/5,7.21%,RPS19
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.3208380724233202,0.6709266941178506,0.8666666666666667,1.0,1.0,5/18,16.86%,MFHAS1;CYBA;PTPN22;HMGB1;NR1H3
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.31825749184438235,-0.6705249909062473,0.8840579710144928,1.0,1.0,5/37,17.50%,RNF8;ARIH2;RNF5;UBE2D4;RNF135
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.3531564581988742,0.6704750259149839,0.9459459459459459,1.0,1.0,2/20,4.92%,ENSA;MFHAS1
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.44735768635260337,0.6701969168286952,0.8260869565217391,1.0,1.0,1/6,5.53%,PLA2G10
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.29809956313971453,0.6700426519407099,0.9534883720930233,1.0,1.0,16/58,19.27%,CDK6;VASH1;FGFR3;ZNF706;NFIB;NOTCH4;DLL1;RAPGEF3;KANK1;GRIN3A;RPS6KA6;IL17D;MARCHF5;LOXL2;MAPT;TFRC
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.26981387349282876,0.6694622897490525,1.0,1.0,1.0,3/59,4.01%,NUPR1;HSPB1;ACER2
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),-0.42657019761519854,-0.6692780748313264,0.9027777777777778,1.0,1.0,1/7,7.12%,ACMSD
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.25117030171666693,0.6692401495888568,1.0,1.0,1.0,7/82,7.95%,SRC;STON2;PLD1;CD22;PICALM;HAP1;STXBP5
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.3801664769615336,-0.6692033868888159,0.8870967741935484,1.0,1.0,3/10,14.06%,ALDH1A2;CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.3350549697282556,-0.669139759123504,0.8524590163934426,1.0,1.0,7/22,29.36%,DDX11;RAD50;RECQL;DDX1;BLM;NBN;DHX36
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.36787558937919906,0.6689792866355586,0.8333333333333334,1.0,1.0,3/13,5.94%,CX3CR1;AGER;SNCA
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),-0.4464717246280715,-0.6688844804463249,0.8983050847457628,1.0,1.0,2/6,9.38%,ZFPM1;GPR183
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),-0.4067771160007865,-0.6683634679310689,0.875,1.0,1.0,3/5,39.34%,BAD;GCKR;DUSP12
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.3671140292549732,-0.6681536525475384,0.9365079365079365,1.0,1.0,1/18,0.56%,DDIT3
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.2940492862639742,0.6677660900805896,0.96875,1.0,1.0,11/26,28.98%,OGT;ATPSCKMT;KMT2D;TET2;KMT5B;SETD2;SETD5;KMT2A;TET3;VCPKMT;KMT5C
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),0.3842177845478369,0.6674250848154345,0.9230769230769231,1.0,1.0,2/8,16.31%,DRD4;DRD2
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.3028848820647547,-0.6673911592779326,0.9523809523809523,1.0,1.0,11/39,24.22%,RPS3;PHB2;ILK;CD27;RTKN2;NLRP12;NMI;IFI35;TCIM;RHOA;TERF2IP
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.28128159843528144,-0.6672624797683426,0.9714285714285714,1.0,1.0,15/79,24.40%,MBNL3;RBM3;RBM11;SRSF7;C1QBP;C9ORF78;NCL;CIRBP;DDX5;SRSF3;SNW1;NCBP1;SAP18;SRSF9;RBM15B
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.3021102693183519,0.6670619303748003,0.9615384615384616,1.0,1.0,8/28,21.33%,AUTS2;PIK3CA;SLIT2;ABI2;FER;CYFIP1;AKIRIN1;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),-0.43342001961930254,-0.6667472377009829,0.921875,1.0,1.0,2/5,22.61%,GRM7;ARL6IP5
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.34327032395642765,0.6661986734032601,0.925,1.0,1.0,3/10,19.23%,CYP2C8;UGDH;SLC35D1
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),0.3767841439226813,0.6661848107962991,0.7857142857142857,1.0,1.0,1/7,5.21%,RAB23
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),0.3767841439226813,0.6661848107962991,0.7857142857142857,1.0,1.0,1/7,5.21%,RAB23
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.32349907799638405,-0.6658867934840539,0.8970588235294118,1.0,1.0,10/31,25.97%,GSTP1;NLRX1;STAT1;NLRP12;PPM1N;RIOK3;NR1D1;CCDC22;ESR1;RHOH
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.31779296871489865,-0.6651575408204057,0.9344262295081968,1.0,1.0,3/31,15.61%,PNKP;CCT7;CCT2
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),-0.4188870808327292,-0.6648263190442825,0.9411764705882353,1.0,1.0,1/6,14.79%,MYADM
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.28421505931183233,-0.6646634551328315,1.0,1.0,1.0,13/97,13.93%,SEMA3E;COL4A4;RHBDF1;HSPB8;FBLN1;TEAD3;ITGB4;TMEM54;HOPX;S100A16;THSD4;OSMR;RTKN2
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),-0.45828082070263393,-0.6639960921523543,0.9,1.0,1.0,3/5,34.33%,HEY2;HEY1;ENG
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),-0.45828082070263393,-0.6639960921523543,0.9,1.0,1.0,3/5,34.33%,HEY2;HEY1;ENG
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.2744778178695279,0.6638854774359463,0.9615384615384616,1.0,1.0,12/44,20.77%,SPRY2;SPOCK1;DPYSL3;KANK1;PTEN;GRIN2B;PTPRO;FKBP4;RAB29;ADCY6;CBFA2T2;MINAR1
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.3433411048199077,0.6638329534345803,0.84375,1.0,1.0,7/7,65.68%,SMO;NF1;PTCH1;EFEMP2;PROX1;MYLK;ENG
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.3730877224004253,0.6633230906646428,0.8717948717948718,1.0,1.0,4/9,21.70%,ITGAX;DICER1;TNFRSF1B;PARD3
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.24903393462287832,0.663089294204584,1.0,1.0,1.0,6/64,9.42%,BDH2;ECHDC2;ACADVL;LPIN3;ABHD2;PHYH
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),0.40489104577029206,0.6629229029942453,0.825,1.0,1.0,6/6,59.52%,TCF7L2;AXIN2;MSH2;RMI2;MSH6;MSH3
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),-0.4053033429312467,-0.6628837444661401,0.8727272727272727,1.0,1.0,1/8,7.64%,STAT5A
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),-0.4053033429312467,-0.6628837444661401,0.8727272727272727,1.0,1.0,1/8,7.64%,STAT5A
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.36173650414984443,-0.6627998677975244,0.8732394366197183,1.0,1.0,3/19,9.27%,ERAP1;ERAP2;TPP1
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.2603697271390682,0.6625380195225172,1.0,1.0,1.0,16/80,14.96%,DSE;VCAN;CHST7;CSPG4;AGRN;CHST3;HS2ST1;CHST11;CHSY3;NCAN;CSGALNACT1;B4GALT3;UGDH;CHST15;GPC6;EXT2
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.3327176297573445,-0.662415230766095,0.9852941176470589,1.0,1.0,7/25,25.56%,TPX2;STMN2;KATNB1;MAP1A;MAP1S;APC2;NAV3
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.33516408332897885,-0.6623332275542642,0.9701492537313433,1.0,1.0,4/31,15.93%,SPINT2;TGFB1;MYADM;MAPK7
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.3193982676818959,-0.6621490370244224,0.8831168831168831,1.0,1.0,4/29,17.78%,HTR2B;AHR;MAPK7;APOE
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),-0.4156097452798201,-0.6621209658840609,0.8448275862068966,1.0,1.0,1/5,29.19%,SMAD7
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.42821868583298717,-0.6618313272970661,0.9117647058823529,1.0,1.0,2/7,19.75%,IL5;LCP1
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.3077049709797175,-0.6617741366333417,0.925,1.0,1.0,13/33,37.60%,SSB;NOL6;NUP50;RAN;NUP155;NUP58;POM121;NUP93;NUP88;POM121C;NUP107;AAAS;SEC13
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.3077049709797175,-0.6617741366333417,0.925,1.0,1.0,13/33,37.60%,SSB;NOL6;NUP50;RAN;NUP155;NUP58;POM121;NUP93;NUP88;POM121C;NUP107;AAAS;SEC13
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.2946130316680934,-0.6616692530707118,0.9285714285714286,1.0,1.0,10/56,22.46%,FBXO43;CHMP2A;TOM1L1;BRCA1;UXT;MAX;TFDP1;AURKAIP1;EZH2;L3MBTL2
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.3149082589701163,-0.6613187315742372,0.9583333333333334,1.0,1.0,9/40,22.83%,XBP1;SRP54;PAX8;FADD;HOXD3;DKK3;SOD1;CAV1;MSN
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",-0.2624752522926033,-0.6606398946692299,0.9759036144578314,1.0,1.0,13/148,11.68%,POLR2G;POLR1G;GTF2F1;POLR3H;POLR2J;POLR2L;POLR2I;POLR1F;TEAD3;POLR1H;BRF2;TAF11;AR
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.3875053002116354,0.6603259215447461,0.8333333333333334,1.0,1.0,1/9,4.04%,BDH2
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.3331559108072552,-0.6602756257747756,0.8666666666666667,1.0,1.0,2/25,10.96%,BTG1;TGFB1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.33220719276214106,0.6601990622755114,0.90625,1.0,1.0,5/20,14.63%,HPRT1;NT5E;NUDT3;PRTFDC1;AMPD3
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.3285210419509229,0.6600618484949005,0.9142857142857143,1.0,1.0,2/18,4.85%,RELA;CPNE1
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.28025730513061414,-0.6599123025122683,1.0,1.0,1.0,7/79,11.59%,APOL6;GSAP;AQP9;HLA-DPA1;HSPA2;ANKUB1;RASSF4
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.39541636357583143,0.6598436571007328,0.868421052631579,1.0,1.0,4/11,21.84%,MYH14;PID1;PNPT1;MTM1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.2867204418983368,-0.6596863699199502,0.9428571428571428,1.0,1.0,11/78,14.56%,RPS27A;TGFBR2;IL17RD;UBA52;CDKN1C;BAMBI;TGFB1;GIPC1;FAM89B;ASPN;UBB
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.33961954297111535,0.6595935384799613,0.8709677419354839,1.0,1.0,7/19,22.97%,ALDH1A3;COL5A1;RARG;AGTPBP1;NIPBL;MFAP5;FBN1
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.2876204607370802,0.6594831033628719,0.9487179487179487,1.0,1.0,9/59,8.25%,ANXA4;IRAK2;SIRT1;CDKN2A;IRAK3;ARRB2;ERBIN;ARRB1;MTURN
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.2697559608036661,0.659292990389334,1.0,1.0,1.0,15/88,12.04%,ADAM33;TPM2;FRZB;TMEM98;PDGFRA;POSTN;TMEM47;COL6A1;CDH11;COL14A1;HTRA1;ALDH1A3;INTS6;AQP1;ADAMTS5
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.27555833156206083,-0.6592213769689199,1.0,1.0,1.0,8/84,13.57%,XBP1;SELENOS;TSHR;USF1;CEACAM1;RAB8A;SYAP1;PARP1
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.2950699639402726,0.6589887286446593,0.8260869565217391,1.0,1.0,10/27,17.91%,TAL1;AURKC;FGF1;PKP4;PRKCE;CDC25B;DRD2;CDC14B;KIF14;CSPP1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.35428654351440236,-0.6589636167028692,0.9027777777777778,1.0,1.0,3/18,21.24%,C1QBP;DNM1L;CCR7
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.3362571168266069,-0.6587577632330327,0.95,1.0,1.0,3/19,15.78%,HYAL2;TGFB1;APPL2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.364714000467404,-0.6587534767649932,0.875,1.0,1.0,2/18,7.32%,INCA1;CDKN1C
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.36408894265965697,-0.6586806404372488,0.8923076923076924,1.0,1.0,1/14,3.46%,FGL1
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.2804316553984288,0.6586574396482647,0.9583333333333334,1.0,1.0,16/82,11.21%,TPM2;EGFR;CSPG4;POSTN;STK40;ZBTB16;EHD2;TMEM47;RND3;COL6A1;CHST3;HTRA1;CACNA2D1;ENO3;COL5A1;TEAD1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.3197799755125743,-0.6579796781423001,0.9354838709677419,1.0,1.0,1/30,1.88%,TAX1BP3
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.3258144052668761,-0.6578397357302259,0.9365079365079365,1.0,1.0,3/28,7.28%,TTN;FLII;SYNPO2L
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.32386861315642473,-0.6572162621553326,0.873015873015873,1.0,1.0,8/18,31.49%,HAX1;PINK1;DNM1L;SREBF1;HTRA2;PARK7;FBXO7;VDAC1
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.30164142546345113,0.6569647492421438,0.9459459459459459,1.0,1.0,2/24,2.73%,IGF1;FGFR3
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.2960714862842663,-0.6560664612702548,0.9722222222222222,1.0,1.0,9/58,21.19%,RNF8;ATP23;ABRAXAS1;CYREN;BRCA1;KAT5;RAD50;ERCC8;POLQ
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.3040463002459679,-0.6557368243555484,0.9466666666666667,1.0,1.0,9/37,30.22%,IRF1;FLOT1;RNF135;RIOK3;TOMM70;POLR3D;DHX58;ISG15;REL
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.40755185241397207,-0.6553283438450734,0.9298245614035088,1.0,1.0,2/5,27.10%,DNM1L;ARMC1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.40581741540286775,-0.6553078986905564,0.9315068493150684,1.0,1.0,4/10,24.40%,BRCA1;LRIF1;METTL3;RBM15B
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.3429589462363632,-0.6552989941471763,0.921875,1.0,1.0,2/16,9.38%,EFNA2;GPR183
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.3058020334483038,0.6550353764630258,0.896551724137931,1.0,1.0,5/22,14.25%,DNAAF1;GLI2;CHD7;FGF1;CHI3L1
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.31665680001157315,0.6545852538068032,0.8974358974358975,1.0,1.0,7/15,27.73%,ADCY8;PRKACB;PRRC1;ADCY6;ADCY2;ADCY5;ADCY9
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.34091213126831255,-0.6540602675173909,0.8939393939393939,1.0,1.0,1/16,8.61%,DOLK
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.3841651996003237,0.6538368615331027,0.9069767441860465,1.0,1.0,7/7,61.60%,LIG4;MSH2;TCF3;MSH6;MSH3;XRCC4;PRKDC
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.2823393740556294,0.6535009030530481,0.9615384615384616,1.0,1.0,6/26,18.76%,KCNJ2;CACNA2D1;CACNA1G;CAMK2D;KCNE4;SCN3B
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.3540407054482664,-0.6532946707513484,0.96875,1.0,1.0,5/13,28.94%,IMPDH2;PAICS;RFK;PFAS;GART
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.30897464548155684,-0.6532265561309858,0.9571428571428572,1.0,1.0,3/38,9.01%,CD9;CD81;CEACAM1
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.3385612951971421,-0.6530622859723546,0.9242424242424242,1.0,1.0,5/20,12.62%,SLC10A3;SLC10A6;CEACAM1;SLC27A5;SLC51A
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.32256666141206514,-0.6529454418817745,0.9230769230769231,1.0,1.0,5/18,23.09%,SRI;CALM3;PRKACA;TRDN;CALM1
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),-0.42490881601514674,-0.6528672121526891,0.8870967741935484,1.0,1.0,1/5,12.46%,ARL13B
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.25552694716388863,0.6524482585743572,1.0,1.0,1.0,12/53,17.71%,TRIM67;MMD2;PICALM;FBXW7;DLG1;AFDN;DNAJB6;TESK1;CEP290;ADCYAP1;MAPK8;MAP2
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),0.37541444461222484,0.6522689299789267,0.8055555555555556,1.0,1.0,2/6,17.52%,SERPINB9;S100A13
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.3570181800548565,-0.6520389249385501,0.9076923076923077,1.0,1.0,1/16,4.38%,DDX11
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.3561387699544762,0.6519229090091089,0.8108108108108109,1.0,1.0,5/9,24.62%,SNCA;CBLB;PTPRJ;CBL;NDRG4
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.3609264504648594,0.6512726772740416,0.9285714285714286,1.0,1.0,3/7,17.48%,RAPGEF1;MAGI2;RAP1A
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.41168291873195817,-0.6512214271637786,0.9090909090909091,1.0,1.0,2/9,20.23%,ABCA5;ITGAV
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.2704091299285676,0.6508489283165848,0.9629629629629629,1.0,1.0,13/40,22.20%,ARID1B;SMARCA2;ARID1A;SMARCD2;MBD3;SMARCAD1;NASP;HDAC1;SMARCC1;HNRNPC;PBRM1;SMARCE1;ACTR5
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.3524810064983613,-0.6507755100962705,0.9305555555555556,1.0,1.0,2/17,15.08%,RPS3;EDN1
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.3345770172304695,0.6505753332661611,0.8857142857142857,1.0,1.0,2/11,13.53%,AUP1;UGGT1
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3720648892159372,-0.6494266774964409,0.9027777777777778,1.0,1.0,3/12,23.09%,PTPA;CALM3;CALM1
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),0.38042922146538627,0.6493432205505927,0.8571428571428571,1.0,1.0,1/5,3.84%,EGFR
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),0.38042922146538627,0.6493432205505927,0.8571428571428571,1.0,1.0,1/5,3.84%,EGFR
prerank,GO_Biological_Process_2021__skin morphogenesis (GO:0043589),-0.4343145033807367,-0.6492251968203515,0.8805970149253731,1.0,1.0,2/5,13.23%,ITGB4;ABCA12
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),0.2708596911162666,0.6491186324627184,0.9666666666666667,1.0,1.0,4/37,7.27%,SPRY2;DUSP1;DUSP10;IRAK3
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.4126053515619855,0.6490931887013627,0.9393939393939394,1.0,1.0,2/6,10.32%,ARNT;SLCO1C1
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.342456647733046,-0.648598593486796,0.9428571428571428,1.0,1.0,4/13,21.95%,HTR2B;PIK3CB;APOE;S100A1
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.3926553399016459,-0.6483836185673275,0.8571428571428571,1.0,1.0,1/7,6.17%,SLC22A9
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.3560987010406818,0.6475241720352622,0.8604651162790697,1.0,1.0,2/7,18.36%,TJP2;TJP1
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.30434236908229184,0.6474171956870612,0.9024390243902439,1.0,1.0,2/21,6.81%,RAB23;RANGAP1
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.334660873359412,0.6473511155286579,0.9411764705882353,1.0,1.0,1/14,2.41%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.28407317009471383,-0.6473169658859673,0.9841269841269841,1.0,1.0,11/65,23.24%,CENPX;PINK1;BRCA1;PTTG1IP;SPRTN;UBB;SEPTIN4;ANGPT1;FANCI;CAV1;PSMD10
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.3293537222467865,0.646759970561844,0.9210526315789473,1.0,1.0,2/21,8.18%,GDAP1;PLD6
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.3662058211347138,-0.6457449175725434,0.8793103448275862,1.0,1.0,5/11,23.93%,SELE;SELP;ALOX5;RHOA;ETS1
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.3283308071168263,0.6456888696604373,1.0,1.0,1.0,2/15,5.60%,PPARGC1A;ACADVL
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.30817797465627933,-0.6450822455066136,0.9583333333333334,1.0,1.0,6/46,16.19%,CPTP;GBA3;FUCA1;SMPD2;ESYT1;ST6GALNAC4
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.38692487034305545,0.6450678743765353,0.8571428571428571,1.0,1.0,7/7,61.32%,TP53;BOK;FAP;SIRT2;TP53BP2;PTGIS;DLC1
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.32752472955570805,-0.6448663230215523,0.9393939393939394,1.0,1.0,2/20,10.96%,TGFBR2;TGFB1
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.2631028089616409,-0.6443132512445675,1.0,1.0,1.0,5/115,3.63%,SFRP1;AQP9;H2AZ1;JUP;CFTR
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.3563194783909548,0.6441374135645423,0.8636363636363636,1.0,1.0,3/8,14.30%,DCUN1D1;DCUN1D4;UBA3
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.3022671340718614,-0.6437428336927669,0.9402985074626866,1.0,1.0,7/33,25.70%,DNAJC9;GABARAPL2;RGN;DYNLL1;PFN2;ALDOB;PFN1
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.375418232029111,0.6437255470080502,0.967741935483871,1.0,1.0,3/10,22.44%,PRMT6;CAMK2D;NIPBL
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.2882650074711298,0.6434472109942374,1.0,1.0,1.0,13/31,26.87%,PRKCE;FGF13;DMD;SLMAP;CAMK2D;FGF14;SCN3B;WNK1;STK39;HECW2;UTRN;WNK2;NETO1
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.2586075144245274,0.6430306832694209,1.0,1.0,1.0,8/46,19.81%,ACER2;PAXIP1;SESN2;ATRX;BRIP1;ABL1;MDM4;NDRG1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),-0.39976339389300336,-0.6429608261815462,0.8888888888888888,1.0,1.0,3/7,32.00%,FIS1;BCAP31;MICU1
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),-0.30105914708075354,-0.6425550357528288,0.9411764705882353,1.0,1.0,4/41,11.62%,JUP;CDH12;NECTIN3;CDH17
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.39307351487268616,0.6420449839893703,0.9090909090909091,1.0,1.0,1/6,5.94%,SNCA
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.38050147011442165,-0.6414198017492682,0.9117647058823529,1.0,1.0,4/12,23.86%,DOCK2;NMI;IFI35;FER1L5
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.3001890490617316,-0.6413252130817592,0.9295774647887324,1.0,1.0,3/33,14.59%,STMN1;STMN2;STMN3
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.42443478144160174,-0.6412385060226705,0.9344262295081968,1.0,1.0,2/5,29.83%,CD226;NR4A3
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.31825728998882286,-0.6411494024708895,0.9193548387096774,1.0,1.0,1/21,3.71%,ENO4
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.42553086478846236,-0.6411468538757247,0.8840579710144928,1.0,1.0,2/8,20.05%,APOE;ABCA5
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.35349031457570346,0.6410790003456862,0.8529411764705882,1.0,1.0,2/8,14.72%,EXOSC7;ERI1
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.35349031457570346,0.6410790003456862,0.8529411764705882,1.0,1.0,2/8,14.72%,EXOSC7;ERI1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.38072858997982795,0.6410456537714814,0.8809523809523809,1.0,1.0,1/7,6.35%,AKT2
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.24222269505389044,-0.6410373940619156,1.0,1.0,1.0,35/274,17.50%,TMEM107;TTC36;DCTN3;SSNA1;TUBB4B;RAB11A;RSPH6A;CCDC39;CCDC28B;CETN2;DCTN2;CEP131;HAUS6;FUZ;ABLIM3;BBOF1;ARL13B;IFT122;TXNDC15;TUBA1A;DYNLRB1;RAB8A;IFT81;SCLT1;DYNLRB2;CEP72;DNAH5;FAM149B1;DYNLL1;DCTN1;DYNC2H1;CFAP410;TUBA4A;RP2;PLK4
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.39536351933838365,0.6408718587218366,0.8604651162790697,1.0,1.0,2/7,11.20%,SASH1;PTPN22
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.3618879704284446,0.6403201743355382,0.9310344827586207,1.0,1.0,2/10,9.08%,AGER;DLL1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.39878129675623064,-0.6397500311023109,0.8714285714285714,1.0,1.0,1/7,11.43%,TFIP11
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.3100391874072534,0.639557409340325,0.975609756097561,1.0,1.0,1/22,1.33%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.37291843398779956,-0.6395167359932368,0.9701492537313433,1.0,1.0,2/13,16.14%,RACK1;CFL1
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),0.3745963390646775,0.6394613711848509,0.8333333333333334,1.0,1.0,2/7,9.39%,TRIM11;CD4
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),0.3745963390646775,0.6394613711848509,0.8333333333333334,1.0,1.0,2/7,9.39%,TRIM11;CD4
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.3472688342273565,-0.6394549022333257,0.9305555555555556,1.0,1.0,3/17,21.15%,REEP4;NEMP1;EMD
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.3822722392951872,-0.6391766135525628,0.9375,1.0,1.0,2/10,18.88%,INTU;GLI3
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.32395792838780624,0.6390455435577369,0.8285714285714286,1.0,1.0,3/12,18.18%,CACNA2D1;NOS1AP;KCNE4
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.33403692470012225,0.6389226635259075,0.868421052631579,1.0,1.0,1/12,3.83%,ADAM19
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),-0.4216282903146863,-0.6387294003578353,0.8666666666666667,1.0,1.0,2/5,18.33%,ABHD1;GLYATL2
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.3592880961496214,0.6386783920607262,0.8787878787878788,1.0,1.0,1/9,7.24%,CAMSAP3
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.4087630112316036,-0.6383635952019794,0.896551724137931,1.0,1.0,3/6,32.55%,FANCB;RAD21L1;REC8
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.3632365586311419,0.6380987121263146,0.9,1.0,1.0,4/9,19.13%,ELL;ZNF143;ICE2;RPTOR
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.2561563380703806,0.6380918105782091,0.967741935483871,1.0,1.0,5/53,6.52%,SPOCK1;EFNB3;LRP4;NLGN1;DPYSL3
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.2924564009371062,0.638078010090589,0.9772727272727273,1.0,1.0,4/25,11.61%,PICALM;SNAP91;DLL1;DNAJC6
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell differentiation (GO:2001200),0.4002273310338039,0.6380103507845176,0.8723404255319149,1.0,1.0,2/5,14.64%,AGER;HMGB1
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.35764640231309436,0.637751992522125,0.8648648648648649,1.0,1.0,2/10,13.85%,SLC25A18;SLC1A2
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.3144259940830634,-0.637582600925704,0.9420289855072463,1.0,1.0,2/21,9.64%,NEURL1;CAMK1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.3657351284299247,-0.637557994268129,0.9,1.0,1.0,2/11,13.45%,CAMK1;BRCA1
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.3310766100400324,-0.637043549137072,0.9344262295081968,1.0,1.0,1/18,1.67%,SFRP1
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.35511239624646485,0.6370015671662936,0.967741935483871,1.0,1.0,5/10,25.61%,DUSP1;SLC12A2;WNK1;STK39;OXSR1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.3139284155935878,-0.6368359211378989,0.9305555555555556,1.0,1.0,8/29,23.09%,HTR2B;DDAH2;PIK3CB;APOE;NOSTRIN;S100A1;CAV1;CALM1
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.35000696094679457,0.636709658962792,0.8846153846153846,1.0,1.0,2/11,11.07%,RFWD3;WAC
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.3714823785951161,0.6364274370307438,0.9117647058823529,1.0,1.0,3/11,16.51%,MTMR2;NECAB2;ANKRD13D
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.2653043123565373,-0.6359231488384394,0.9444444444444444,1.0,1.0,16/64,25.90%,RPS3;RAB11A;ABRAXAS1;TPX2;NEK6;HAUS6;GOLGA8B;GOLGA2;WRAP73;TUBGCP4;GOLGA8M;TUBGCP2;RHOA;KPNB1;SMC1A;OFD1
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.35810113795099874,-0.6356048551526255,0.9824561403508771,1.0,1.0,2/12,15.22%,CAMK1;KAT5
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.39134686580229694,-0.6355857768040648,0.8805970149253731,1.0,1.0,2/6,21.77%,ORAI1;AKAP5
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.2805116187363861,-0.6354972608542817,1.0,1.0,1.0,7/58,11.67%,MADCAM1;FBLN1;CEACAM1;ADAM15;ITGB4;CDH17;ILK
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.24766174129844643,-0.635312405481285,1.0,1.0,1.0,28/283,15.05%,STX19;RPL11;USP6;SNX17;VPS35;TMED9;ARF5;ARL1;VPS25;CDC37;CALR;ARF1;TMED4;PHB2;VPS28;RAB32;GPIHBP1;TGFB1;SRPRA;GIPC1;STRADB;ARCN1;ABCA12;PTTG1IP;TBC1D2;SNF8;STX16;KATNB1
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.34712920451868035,0.6340262433110105,0.972972972972973,1.0,1.0,2/20,6.48%,PLA2G10;LPCAT4
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.29383671079394696,-0.6338434900812469,0.9583333333333334,1.0,1.0,4/31,12.48%,MTHFD1;TGFB1;FUZ;IFT122
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.3125023244561892,-0.6335016434626104,0.9672131147540983,1.0,1.0,4/29,22.25%,APH1A;SOD1;YWHAB;CAV1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.41572179838979234,-0.6333632386241913,0.8688524590163934,1.0,1.0,1/5,13.45%,BRCA1
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.36133258521916595,0.6333474384543575,0.8333333333333334,1.0,1.0,1/12,1.33%,IGF1
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),0.2881479427070527,0.6332034463320729,1.0,1.0,1.0,4/17,16.62%,SLC2A9;SLC2A5;SLC50A1;SLC45A3
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.3168902273564181,-0.6331834818251358,0.9493670886075949,1.0,1.0,5/22,22.49%,KIF20B;GIPC1;ECT2;SVIL;RHOA
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.2508457200664821,-0.63272976977558,1.0,1.0,1.0,22/230,15.74%,RIMS1;F8;TRAPPC1;TRAPPC4;ELOB;F5;CLDN14;WDCP;VIL1;NIFK;PDZD11;RBX1;FADD;MCFD2;AFG3L2;TRAPPC2L;STOML2;KAT5;TNFRSF1A;NDUFAF1;GORASP1;TRAPPC3
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.2629167974655719,0.6327045883509512,0.9629629629629629,1.0,1.0,19/76,17.71%,SRC;VIPR1;VIPR2;ADORA2B;CYSLTR1;HTR4;GPR39;GPR27;PTH1R;ADCY8;PTHLH;CRHR2;HCK;SYK;ADCYAP1;CD247;PRKACB;PTH;RHBDF2
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),-0.35370714343276294,-0.6326461378646631,0.8939393939393939,1.0,1.0,2/12,17.68%,WNT9A;GREM1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.34254122365686723,0.6326225825873218,0.9,1.0,1.0,1/9,7.42%,RNF157
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.2629453341801502,-0.6324806299546363,1.0,1.0,1.0,10/119,15.26%,JUP;PDZK1;RAB11A;CD81;PDZD11;FLOT1;RAB8A;ABCA12;MYADM;TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.3474703862104388,-0.6316649117183881,0.90625,1.0,1.0,1/13,12.38%,STAT1
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.37698528697958267,-0.6316401171732416,0.90625,1.0,1.0,3/12,11.93%,CYB5R3;DDAH2;ARG2
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.3000186086211404,-0.6313996799440902,1.0,1.0,1.0,4/33,11.72%,TGFBR2;BAMBI;TGFB1;OLFM1
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.37103880990319055,0.631268270645158,0.9,1.0,1.0,3/9,14.66%,ERRFI1;ENPP1;TESK1
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.3100733959690885,-0.6312662255772407,0.9577464788732394,1.0,1.0,7/29,25.20%,TST;PRELP;OMD;TXN2;OGN;MPST;DCN
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),0.3430718926627378,0.6312562907218606,0.9047619047619048,1.0,1.0,1/9,3.73%,DENND1B
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.2925810822270082,0.6310676930200262,0.96875,1.0,1.0,2/22,11.46%,PLK1;NSFL1C
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.355636673638408,0.6307947396701005,0.8888888888888888,1.0,1.0,4/7,20.25%,SMS;MSRA;MTRR;MTR
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.2768985874488717,0.6306529192767202,0.9032258064516129,1.0,1.0,5/20,18.86%,MOGAT1;DGKI;DGKE;DGKK;DGKB
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.35104434510152005,0.6306070809406915,0.8857142857142857,1.0,1.0,1/10,4.06%,CPEB3
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.24698043779932813,-0.6305286357612485,1.0,1.0,1.0,41/271,22.90%,GRIN3B;STX19;CD63;USP6;SNX17;VPS35;TMED9;ARF5;CORO1B;ARL1;RRAGA;ARF1;TMED4;RAB32;GPIHBP1;RIC3;ARCN1;ABCA12;TBC1D2;DUOXA1;STX16;SEPTIN12;LAMTOR1;SEPTIN4;GRTP1;ANGPT1;ARL17A;FGF7;COPZ1;TBC1D16;SNX6;RRAGC;SCG5;WDR45B;NPHP1;ARMCX3;ZDHHC15;TMED2;LAMTOR2;NAPA;SEPTIN2
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.27708797345926117,0.6304135956283414,0.9615384615384616,1.0,1.0,12/42,16.86%,CLEC7A;SLC40A1;CSF3R;ITGAX;CLEC5A;ADGRE1;MERTK;HCK;NFAM1;TFEC;C5AR1;NR1H3
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.3559882969388506,-0.6302682694477807,0.9,1.0,1.0,5/11,38.22%,FNTA;SAP30BP;AKAP8;BRMS1;ING2
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.3103149514206945,-0.6302204960697676,0.9577464788732394,1.0,1.0,1/22,4.55%,BTBD18
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.29406568825246876,-0.6300647723284657,1.0,1.0,1.0,13/51,27.18%,XBP1;FABP3;LIMA1;GPIHBP1;ACSM3;LAMTOR1;APOE;ABCA5;CAV1;NPC2;NR1D1;ABCG5;NPC1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),0.3644622487416277,0.629906033073494,0.8333333333333334,1.0,1.0,1/5,11.81%,CRTAM
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),0.3644622487416277,0.629906033073494,0.8333333333333334,1.0,1.0,1/5,11.81%,CRTAM
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.29420162996302224,-0.6298045490384099,1.0,1.0,1.0,13/50,27.18%,XBP1;FABP3;LIMA1;GPIHBP1;ACSM3;LAMTOR1;APOE;ABCA5;CAV1;NPC2;NR1D1;ABCG5;NPC1
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.27508915399524386,0.6297881135745003,1.0,1.0,1.0,10/57,13.50%,EGFR;RELA;CPNE1;AGER;PTP4A3;SASH1;PTPN22;DLG1;TRIM44;NFAT5
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.3412153312398871,0.6296385274935242,0.8918918918918919,1.0,1.0,3/11,19.88%,ATP1B3;DMD;WNK1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.2739975896248681,-0.6295945481724846,1.0,1.0,1.0,8/62,16.52%,TCN2;CYB5R3;MTHFD1;PDZD11;AMN;DHFR2;PRSS3;MMACHC
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3153343428984711,-0.629480336723296,0.9846153846153847,1.0,1.0,4/25,19.12%,SFRP4;TGFB1;FSTL1;DKK3
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.349774393052024,-0.6293809508383438,0.9393939393939394,1.0,1.0,3/17,22.70%,HRAS;FICD;TMED2
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.34549027783710895,-0.6291015596187671,0.9032258064516129,1.0,1.0,4/12,27.11%,CCT7;CCT2;GNL3;CCT6A
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.34207060785979326,-0.6290300596351641,0.896551724137931,1.0,1.0,4/12,23.30%,APLN;EDN1;KCNQ1;CHGA
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.36016017997220007,-0.6286642729795554,0.9193548387096774,1.0,1.0,5/15,27.18%,APOE;ABCA5;NPC2;ABCG5;NPC1
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.36984135078417424,-0.6284381719012838,0.9482758620689655,1.0,1.0,2/7,18.88%,INTU;GLI3
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.32067842578946915,-0.6282583491545063,1.0,1.0,1.0,3/22,13.22%,RPS6;PINK1;SYAP1
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.3150975105921071,0.6278311874500672,0.9574468085106383,1.0,1.0,4/13,17.73%,EIF4EBP1;LARP1;EIF3E;EIF4EBP2
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.332602134383592,-0.6277290105573089,0.9166666666666666,1.0,1.0,2/18,10.96%,APH1A;TGFB1
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.3760862435272416,0.6275680827400605,0.9,1.0,1.0,3/13,9.77%,SIRT1;IRAK3;TGFB2
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.31008159653066947,-0.6275473805976466,0.9714285714285714,1.0,1.0,9/27,31.19%,PEX10;ACBD5;PEX1;FIS1;ATAD1;PXMP4;PEX16;PEX12;PXMP2
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.39410808414460463,0.6272856922331727,0.8974358974358975,1.0,1.0,2/7,22.03%,BMPR2;RYR2
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.31107374723325926,-0.6271652143430969,0.9629629629629629,1.0,1.0,5/21,25.61%,PEX11A;PEX11G;DNM1L;FIS1;ACOT8
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.30771809826367336,0.6270280293247196,0.9166666666666666,1.0,1.0,7/17,20.53%,CASK;SLC12A2;CLASP1;PTEN;FGF2;SERPINE2;PHLDB2
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.37396517270910656,0.6266965971413637,0.8387096774193549,1.0,1.0,6/6,62.61%,ERC1;MAP3K7;DAB2IP;CHUK;TLR2;PRDX4
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),-0.3177500585936335,-0.6265671586808552,0.9508196721311475,1.0,1.0,3/16,18.92%,CCT7;CCT2;CEP135
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.36131016492688073,0.6262849133809835,0.8285714285714286,1.0,1.0,2/5,14.64%,CDH26;HMGB1
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),0.38598410961511,0.6254619602097878,0.8163265306122449,1.0,1.0,5/5,61.41%,TET2;PON1;EPHX2;PON2;ACAA1
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),-0.3934248610001416,-0.6244355208723328,0.8524590163934426,1.0,1.0,2/5,31.54%,DDX21;DDX23
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.29306026672501795,0.624047343972295,0.9743589743589743,1.0,1.0,4/18,19.01%,TTLL11;TTLL9;AGTPBP1;TTLL1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.2840999553650318,0.6240062886686675,0.8947368421052632,1.0,1.0,1/24,2.46%,TAFA5
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,-0.24735805098679417,-0.623496182428779,1.0,1.0,1.0,34/169,26.22%,GJC3;TCEAL6;TMEM125;ARSG;LRRTM3;CLDN14;KLK6;ITGB4;TCEAL5;OPALIN;SPARCL1;GPR62;MYRF;MAG;OLIG1;OMG;TMEM151A;HEPN1;HPCA;ERMN;GJB1;NFE2L3;FASN;ZDHHC9;BRINP2;LGI3;PLP1;BACE1;SP7;PLEKHH1;NTSR2;MOG;NKX6-2;PNPLA2
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.27075783242303386,-0.623466157414097,0.987012987012987,1.0,1.0,21/68,27.44%,UBL5;USP6;PIGH;UBA52;B4GALT7;PARP1;ARAF;RABGGTB;CDC34;NAGPA;GGCX;SERP1;TGM1;UBL4A;MCRS1;FBXL2;UBE2S;UBE2M;PADI4;RPN1;PARP4
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.27872587795258036,0.6234601098367851,1.0,1.0,1.0,2/21,8.22%,COL7A1;COL6A1
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.2719478527604934,-0.6228538949490204,0.9873417721518988,1.0,1.0,11/62,23.09%,RAB11A;KIF20B;CETN2;ANKRD53;GIPC1;PLK4;ECT2;CALM3;SVIL;RHOA;CALM1
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),-0.3544795400721822,-0.6228336556017204,0.9076923076923077,1.0,1.0,2/11,17.68%,WNT9A;GREM1
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.35330752626200856,0.6223740693688004,0.8857142857142857,1.0,1.0,2/6,13.94%,SASH1;MARCHF7
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.26777847869396526,-0.6223210591792901,0.9855072463768116,1.0,1.0,22/96,25.45%,GBP2;HSPB8;TNS2;LURAP1L;AR;S100A16;OSMR;CALB2;CAV2;SCARA3;FAM114A1;FSTL1;RASL11A;FLNC;PKHD1L1;CAV1;C2;MATN2;MUC16;AOX1;DCN;SLCO2A1
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.29776784799614786,0.6221741189127697,0.9743589743589743,1.0,1.0,4/22,12.80%,SRC;NSMF;CAMTA1;SPPL3
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.3260765591842014,0.6219071802513965,0.8285714285714286,1.0,1.0,3/10,24.51%,CORO2B;MAPT;NDFIP2
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),-0.40348432033449405,-0.6216520620643795,0.95,1.0,1.0,4/5,30.44%,CALM3;TRDN;CALM1;GSTO1
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.287603017003762,-0.6216100810749821,0.9620253164556962,1.0,1.0,16/41,38.00%,LACC1;GCK;NUP50;PGAM1;NUP155;NUP58;POM121;JMJD8;NUP93;NUP88;POM121C;NUP107;AAAS;GCKR;SEC13;HIF1A
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.38338014969204515,0.6215184182972345,0.8536585365853658,1.0,1.0,1/5,11.32%,MGLL
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.41503216669784715,0.6212329400986972,0.8378378378378378,1.0,1.0,1/5,17.87%,ATP8A1
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),-0.3205640336562273,-0.6210347832543935,0.9850746268656716,1.0,1.0,2/23,9.33%,CALR;HRAS
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.3108724431856311,0.6207468135292147,1.0,1.0,1.0,1/16,3.92%,LEF1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.3870228485723479,0.6206939351268025,0.8604651162790697,1.0,1.0,3/5,32.92%,E2F3;PDCD4;PPARG
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.2987528963342909,-0.6203684099509921,0.9863013698630136,1.0,1.0,8/41,18.15%,BUD23;TRMT112;RBM22;HRAS;TGFB1;DIMT1;POLR2A;DDX5
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.23353775222946632,-0.6200360685130011,1.0,1.0,1.0,68/357,26.25%,ARHGAP4;ZMYM6;TMED9;ARL1;CHMP2A;MNS1;GOLGB1;PEX11A;CHCHD2;PEX10;CNN2;TMED4;PHB2;RAB32;ATP5F1B;HAX1;PAK5;GORASP2;PINK1;PARP1;PPIA;STOML2;GOLGA8B;CAV2;DIAPH3;GORASP1;FBXW8;PI4K2A;CFL1;DYNC2H1;CFAP410;KIF4A;APOE;DNM1L;FGD5;MCOLN1;GOLGA2;LMAN2;ATP8B1;PEX1;CHMP7;CHMP3;ZNF501;HSD17B10;REEP5;RHOU;ATL3;GOLGA8M;ZW10;CAV1;CHMP4B;TMED2;DOP1B;BNIP1;TBC1D20;CHGA;VPS4B;TMED1;RAB2A;SYNE1;REEP6;RAB31;ESRRA;MSTO1;DNAJA3;SURF4;LYSMD3;TWNK
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.3540816895273534,0.6194684348983707,1.0,1.0,1.0,1/8,9.90%,ABHD17C
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.3540816895273534,0.6194684348983707,1.0,1.0,1.0,1/8,9.90%,ABHD17C
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.30295803900667173,0.6192805126351547,0.9428571428571428,1.0,1.0,5/13,23.72%,ELP3;ELP4;ALKBH1;TRMT9B;MTO1
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.40522997941686145,0.6192424351331745,0.8857142857142857,1.0,1.0,1/6,2.22%,HOMER1
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),-0.40135046413689784,-0.6188934180592625,0.9344262295081968,1.0,1.0,2/5,26.23%,HSD17B10;TRNT1
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.3447636982854133,0.6188494903399623,0.9302325581395349,1.0,1.0,5/12,26.33%,SMAD4;CACNA1G;SMAD5;BMPR1A;SMAD1
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),0.3314842890949411,0.6188222807952143,0.8717948717948718,1.0,1.0,2/9,11.20%,CD22;PTPN22
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),-0.34998637933003407,-0.6183366322837421,0.864406779661017,1.0,1.0,2/11,19.71%,PEX10;PEX1
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.2504757382384589,0.618086823612203,0.9615384615384616,1.0,1.0,10/56,16.14%,LEF1;RELA;CDKN2A;ZNF451;PAXIP1;NFKB1;CBFB;PTEN;MED13;TNRC6B
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.3571787534405117,0.618025259051913,0.9047619047619048,1.0,1.0,1/10,6.87%,DIAPH1
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.3557551827573624,-0.6178128344287627,0.9107142857142857,1.0,1.0,1/11,12.91%,ARCN1
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.29952030878578517,-0.6177332898033963,0.974025974025974,1.0,1.0,9/38,20.23%,CLU;AZIN1;EIF2AK1;VBP1;EDN1;PFDN2;PFDN6;APOE;ITGAV
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.37277571605290705,0.6176053351472244,0.925,1.0,1.0,6/6,62.73%,FERMT2;CX3CL1;ITGB1BP1;COL16A1;FERMT3;FN1
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.2619062611602428,-0.6175654751730024,0.9857142857142858,1.0,1.0,3/54,4.94%,PRDX5;RPS3;ROMO1
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.24713831296242295,0.6173727987751555,1.0,1.0,1.0,12/59,18.14%,CNOT2;CRADD;RFWD3;CNOT11;WAC;CNOT4;PIDD1;CNOT6L;TFDP2;PLAGL1;MDM4;RGCC
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.35047725757235704,-0.6169742334989229,0.9333333333333333,1.0,1.0,1/13,7.64%,STAT5A
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.3269150573997581,-0.6169629498712159,0.9130434782608695,1.0,1.0,3/14,21.92%,GPIHBP1;APOE;MTLN
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),-0.2912834612571493,-0.6167899764177243,0.9545454545454546,1.0,1.0,8/28,27.15%,TMED9;IRGM;PFDN2;KATNBL1;ATL3;SURF4;SMCR8;HTRA2
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.3078027134616023,-0.6158232874773009,0.958904109589041,1.0,1.0,10/26,30.02%,STMN1;STMN2;MYADM;PFN2;TUBB4A;PFN1;TWF1;MAPRE1;CLIP3;HIP1R
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),0.39386395772760097,0.6158004589741152,0.918918918918919,1.0,1.0,2/6,15.79%,HDC;CARNMT1
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),0.39386395772760097,0.6158004589741152,0.918918918918919,1.0,1.0,2/6,15.79%,HDC;CARNMT1
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.3135401079080369,0.6150400449531273,0.9736842105263158,1.0,1.0,2/18,8.18%,GDAP1;PLD6
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.3697042390788524,-0.614832209359052,0.9166666666666666,1.0,1.0,2/10,13.20%,EXOSC4;EXOSC10
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),0.3401903778583555,0.6147281099733015,0.9354838709677419,1.0,1.0,2/6,13.41%,DUSP1;SLIT2
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.30352499832742197,-0.6145652335722139,0.9850746268656716,1.0,1.0,7/34,19.68%,ENDOG;TSN;GEN1;RAD50;XRCC2;XRCC3;RECQL
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),-0.3567359741175207,-0.6142529415753663,0.918918918918919,1.0,1.0,3/9,25.53%,APOE;PPT1;ABHD17A
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.3492719409046979,0.6142022323570568,0.9142857142857143,1.0,1.0,2/6,21.76%,MAPT;FYCO1
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),0.3561063799419574,0.6136592249221399,0.9523809523809523,1.0,1.0,5/5,64.40%,SLC6A15;SLC6A7;SLC36A4;SLC1A4;SLC6A17
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.29109068573128927,0.6136553520419141,0.9375,1.0,1.0,6/21,21.33%,AUTS2;PIK3CA;ABI2;CYFIP1;AKIRIN1;PIK3R1
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.29029350044858876,-0.6136155489855162,1.0,1.0,1.0,16/45,24.67%,TMC4;TMEM125;CXCL17;OVOL2;CEACAM1;GGH;ATP2C2;KLF5;SMIM22;CBLC;LIPH;C9ORF152;C6ORF132;MUC16;EPCAM;GPX2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),0.3214466405855806,0.613437747458181,0.9,1.0,1.0,2/9,13.41%,DUSP1;SLIT2
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.3942822734894129,-0.613327396116883,0.9206349206349206,1.0,1.0,1/6,10.96%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.3221327333183267,-0.6130700742182795,0.9692307692307692,1.0,1.0,2/15,19.58%,TGFB1;PTN
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.31732351606615594,0.6130562924430804,0.8518518518518519,1.0,1.0,5/12,16.86%,HDAC9;LPL;SORT1;PCSK5;NR1H3
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.3085306008190906,0.6129918414620344,0.9722222222222222,1.0,1.0,1/17,5.60%,ACADVL
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.33912956771853053,-0.6126794332861872,0.9508196721311475,1.0,1.0,2/16,7.28%,TTN;SYNPO2L
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.2671675543959271,0.6124702053671552,1.0,1.0,1.0,10/46,18.70%,CNTNAP2;TNIK;SGK1;DICER1;MAP4K4;TRIO;NYAP2;CNTNAP1;GPM6A;SNX1
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.31365655697653105,-0.6117749793976707,0.9482758620689655,1.0,1.0,4/26,16.11%,AIMP1;TM7SF3;MYRIP;GCK
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.3841911975172028,-0.6117004011594525,0.9491525423728814,1.0,1.0,1/8,10.96%,TGFB1
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.31685299167053527,0.6109959080928911,0.9166666666666666,1.0,1.0,5/8,26.37%,RAB34;MAPKAPK3;MAPKAPK2;SNX5;CARMIL1
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),-0.38782738758161595,-0.609757460922881,0.8888888888888888,1.0,1.0,3/6,29.87%,USH1C;LRTOMT;PDZD7
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.3142187882986141,-0.6095909049827022,0.9545454545454546,1.0,1.0,4/23,14.79%,TMSB10;VIL1;TMSB4X;MYADM
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.3158655111250766,0.6095148533762084,0.8709677419354839,1.0,1.0,1/12,7.24%,CAMSAP3
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.35684812131865934,0.6095077177540158,0.9705882352941176,1.0,1.0,6/13,18.98%,MTERF1;TFB1M;FOXO3;FASTKD1;PNPT1;SLC25A33
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),-0.40790291248793087,-0.6092442697611143,0.8813559322033898,1.0,1.0,2/5,24.75%,ENO1;MYOCD
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.31907866093143566,0.6091896354360454,0.9375,1.0,1.0,2/18,7.49%,MTMR2;PICALM
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.2768240328300787,0.6089897334316091,1.0,1.0,1.0,7/34,15.29%,TVP23B;LTBP2;RAB3B;MTTP;TANGO6;GOLPH3;RCN3
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),-0.3669102797790962,-0.6089011393308208,0.9180327868852459,1.0,1.0,1/8,16.36%,MAP3K12
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.31313915934367165,0.6088911147407643,0.96875,1.0,1.0,2/13,8.82%,PROM2;SNAP91
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.37109928591094077,-0.608806043689835,0.9206349206349206,1.0,1.0,2/7,22.65%,DNM1L;CHMP4B
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.35030740347339906,0.6087938691018138,0.9,1.0,1.0,2/8,14.64%,AGER;HMGB1
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),-0.36900523108293215,-0.6086320104035546,0.9152542372881356,1.0,1.0,1/8,6.97%,VAMP8
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.3835440233312647,0.6080853044163099,0.9444444444444444,1.0,1.0,1/8,1.75%,RUNX1
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.2889952536319442,-0.6080064040964928,0.9230769230769231,1.0,1.0,9/34,22.57%,HLA-DPA1;RPS3;HHLA2;FADD;TNFSF9;PDCD1LG2;ZP3;CD46;HLA-DPB1
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.3727407502897221,-0.6079110925131141,0.95,1.0,1.0,3/8,21.92%,STOML2;GLRX;MTLN
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.3113810107261101,-0.6072776828134415,0.9848484848484849,1.0,1.0,4/17,32.91%,HYKK;SDS;CRYM;DLST
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.37633201463837807,-0.6070155541835865,0.9154929577464789,1.0,1.0,2/6,18.35%,NINJ1;IFI35
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.33165744942312975,-0.6069735673585356,0.9552238805970149,1.0,1.0,4/15,22.25%,IGSF8;MYL6;SVIL;CAV1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.35792382512258436,0.6068936361787548,0.975,1.0,1.0,3/9,16.65%,PLXNA1;PLXNB2;PLXNA4
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),-0.362123367487042,-0.6068030667001822,0.921875,1.0,1.0,1/8,9.67%,PRR7
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.3676967227062031,-0.6067519490527234,0.9642857142857143,1.0,1.0,1/5,17.85%,MAN1B1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.3676967227062031,-0.6067519490527234,0.9642857142857143,1.0,1.0,1/5,17.85%,MAN1B1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.3676967227062031,-0.6067519490527234,0.9642857142857143,1.0,1.0,1/5,17.85%,MAN1B1
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.35953452137171926,-0.6065918977250612,0.9104477611940298,1.0,1.0,3/10,18.26%,HLA-A;PGLYRP1;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.25454422924036785,0.6064831547953256,0.975,1.0,1.0,12/39,18.82%,PPARGC1A;USP36;PID1;FBXW7;ATP13A2;PRMT6;GOLPH3;RHOT1;GSK3B;MARCHF5;CYRIB;MAPT
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",-0.3834910873023615,-0.6059365573036742,0.8529411764705882,1.0,1.0,2/6,25.77%,APPL2;RAB31
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.311419995845152,-0.6052926247071538,0.9491525423728814,1.0,1.0,3/25,18.01%,DND1;VIP;CIRBP
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.3697106689138003,-0.6051549474745611,0.9523809523809523,1.0,1.0,2/9,13.20%,EXOSC4;EXOSC10
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),-0.36269243893673514,-0.605109985458403,0.9310344827586207,1.0,1.0,1/7,7.80%,PAX8
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),-0.3867932233314245,-0.6041426415038165,0.9259259259259259,1.0,1.0,2/6,34.29%,CDC23;TACC3
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),-0.3867932233314245,-0.6041426415038165,0.9259259259259259,1.0,1.0,2/6,34.29%,CDC23;TACC3
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.35044483562491063,0.6038541143024511,0.925,1.0,1.0,5/5,64.96%,HES1;PRKCI;CHRM1;NOTCH1;PRKCH
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.2845452028325443,-0.6027253452610295,0.9710144927536232,1.0,1.0,14/33,31.74%,PINK1;GABARAPL2;CISD2;MAP1LC3B;WDR45B;FIS1;SQSTM1;BNIP3;FUNDC1;ULK2;MAP1LC3A;FBXO7;WIPI2;FUNDC2
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.28345999557205215,-0.6026717821590808,0.9393939393939394,1.0,1.0,5/26,22.01%,CALR;TGFB1;STRADB;CSE1L;RAN
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.2650185001619765,-0.602537166228102,0.9857142857142858,1.0,1.0,4/49,11.37%,RAB11A;PHB2;LSM10;CDK4
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.29993066356077047,0.6025137643060191,0.8571428571428571,1.0,1.0,6/14,20.55%,PDGFRA;DSCAML1;MEGF8;PCSK5;XYLT1;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),-0.37571014573662376,-0.6025114354094568,0.9322033898305084,1.0,1.0,2/7,11.27%,TMSB4X;PINK1
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.3083148865656268,-0.6017470758938656,0.9666666666666667,1.0,1.0,8/22,30.68%,BRK1;HAX1;WDR1;PFN2;PFN1;COTL1;RASA1;ARHGAP18
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.3738901368061197,-0.6013854520876819,0.9846153846153847,1.0,1.0,1/9,7.04%,ETFB
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.3621140922079802,-0.6010832385926612,0.9375,1.0,1.0,3/9,22.49%,APOD;DOCK8;RHOA
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),0.38993265359587126,0.6009957347223644,0.8947368421052632,1.0,1.0,1/5,4.23%,CYP4F11
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),-0.3691759247788806,-0.6004295715989704,0.9384615384615385,1.0,1.0,1/5,29.35%,SDC4
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.356655634221405,0.5999427472163684,0.9090909090909091,1.0,1.0,6/9,32.94%,SLC22A2;RAB29;ANTXR1;SLC22A3;ADAM10;RAB40B
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.32223068138561095,0.5998007093724733,0.975609756097561,1.0,1.0,8/8,67.79%,CSF1R;MAPK1;CSF1;IL34;LYN;IL12A;PTK2;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),-0.37759081351896673,-0.5988007137422289,0.9682539682539683,1.0,1.0,1/7,5.84%,PRELID1
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.2527237932058669,0.5986604290909939,0.9583333333333334,1.0,1.0,11/71,12.34%,ADGRB1;L1CAM;PLPPR4;DHFR;DOCK7;CTNNA2;DSCAML1;ARHGAP35;PARD6B;VASH2;NTNG1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.33510947676428376,-0.598518255577685,0.9090909090909091,1.0,1.0,5/13,22.00%,TMSB4X;PINK1;PARP1;ANTKMT;ENO1
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.3691662167996269,0.5978510076373759,0.9302325581395349,1.0,1.0,1/5,4.10%,PDE4B
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.3488186174492437,0.5978071169532594,0.8947368421052632,1.0,1.0,1/5,11.47%,CSGALNACT1
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.3413852051251922,-0.5977221376106112,0.9384615384615385,1.0,1.0,2/13,13.20%,EXOSC4;EXOSC10
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.36835093729184515,0.59765902225638,0.9130434782608695,1.0,1.0,6/6,63.18%,SENP1;SENP6;SENP2;SENP5;USPL1;SENP7
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),-0.3681552625662392,-0.5975051048846007,0.967741935483871,1.0,1.0,3/9,32.99%,TMC2;PDZD7;HPN
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.36045294509468073,0.5973840799082938,0.8823529411764706,1.0,1.0,6/6,63.96%,NIPBL;LRWD1;PIH1D1;RUVBL2;MACROH2A1;MACROH2A2
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.32128724021191196,0.5969057964486524,0.85,1.0,1.0,3/9,18.22%,NSFL1C;GSK3B;MARK4
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),0.34867012418518334,0.5959485619348296,0.8571428571428571,1.0,1.0,7/7,65.14%,TYK2;JAK2;IL12RB1;IL23A;STAT4;STAT3;P4HB
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.31261063570652814,-0.595906751415652,0.96875,1.0,1.0,5/17,26.11%,CDKN1C;DYNLL1;ANKLE2;INPP5K;CDKN2D
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.3439277023759054,0.5957008252189588,0.9574468085106383,1.0,1.0,3/8,20.88%,AGER;HMGB1;LILRB1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.35582731380612176,0.5955780358291326,1.0,1.0,1.0,3/10,13.60%,ACADVL;SIRT1;TRIB3
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),0.32816059099970885,0.5953803732509966,0.9743589743589743,1.0,1.0,5/12,16.72%,PIWIL2;NANOS3;STRA8;FMN2;KMT2D
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.26285508880664943,-0.5953732787176992,0.9857142857142858,1.0,1.0,3/48,9.67%,CLU;TRIM13;PRR7
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.3404254488800068,0.5952307644797771,0.8108108108108109,1.0,1.0,2/6,16.45%,ADARB1;CORO1C
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),-0.3648573452731201,-0.5943963464521478,0.9298245614035088,1.0,1.0,2/8,21.24%,CDC42EP1;CCR7
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),-0.3648573452731201,-0.5943963464521478,0.9298245614035088,1.0,1.0,2/8,21.24%,CDC42EP1;CCR7
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.34044279245529235,-0.594181269465153,0.971830985915493,1.0,1.0,1/14,2.76%,ASAH2B
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.29672473140480377,0.5937337891050237,0.8787878787878788,1.0,1.0,3/14,18.18%,CACNA2D1;NOS1AP;KCNE4
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.340282873672743,-0.5936400496460544,0.9047619047619048,1.0,1.0,1/10,23.94%,GNE
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.34429998343993734,-0.5934186188229452,0.953125,1.0,1.0,3/8,28.03%,TXN;GPR37L1;PARK7
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.2606764369624887,-0.593004690329951,1.0,1.0,1.0,3/75,5.65%,GLP2R;SELENOS;TSHR
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.3153498363301061,-0.5929477026746869,0.9230769230769231,1.0,1.0,4/11,28.94%,IMPDH2;PAICS;PFAS;GART
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),-0.23155032148697396,-0.5929433076783218,1.0,1.0,1.0,10/155,13.79%,GPAT3;LCLAT1;CHKB;CDIPT;DDHD2;ARF1;PLA2G12A;PIK3CB;PLEKHA2;IMPA1
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.2743122274922736,0.5925980194957288,0.967741935483871,1.0,1.0,2/19,12.46%,ACAD8;BCKDHB
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.2743122274922736,0.5925980194957288,0.967741935483871,1.0,1.0,2/19,12.46%,ACAD8;BCKDHB
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.3474576047585732,-0.592226313272,0.9473684210526315,1.0,1.0,1/12,7.40%,FBLN1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),0.31374321880650996,0.5919956922145998,0.9032258064516129,1.0,1.0,10/10,68.64%,SCN3B;ANK3;WNK3;AHCYL1;SCN4B;CNKSR3;PKP2;GPD1L;SCN1B;NOS1
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.2575614215947,-0.5919803408427793,1.0,1.0,1.0,18/87,23.04%,GSTM4;GSTP1;GSTK1;SLC35B2;PRELP;AKR1A1;MGST3;OMD;CHPF;GSTM3;CHST9;ANGPT1;GSTZ1;GCLM;CHST2;MAT2B;OGN;MPST
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.303659697592442,-0.591944561699256,0.9846153846153847,1.0,1.0,4/14,24.94%,GPR68;MCOLN1;IMPACT;HVCN1
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.3095132946054839,-0.5917983564924214,0.9696969696969697,1.0,1.0,3/15,16.61%,METAP2;FNTA;NMT1
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.2693990625530172,0.5907782872655846,1.0,1.0,1.0,4/15,18.76%,PRKRA;DICER1;DHX9;CELF1
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.3805128693087206,0.5906194534691286,0.8913043478260869,1.0,1.0,5/5,61.96%,CSNK2A1;TPR;PLSCR1;NUMA1;CSNK2A2
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.3179609404933115,0.5905973600522146,0.9743589743589743,1.0,1.0,2/9,16.94%,DICER1;DHX9
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.324942994972651,0.5904252297553282,1.0,1.0,1.0,4/9,21.06%,PCDH15;NRXN1;MYO7A;SHANK1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),0.36230382477453316,0.590313139168784,0.8269230769230769,1.0,1.0,3/5,26.71%,GPER1;BAIAP3;STX1B
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.29673147552969525,-0.5902861609799482,0.9636363636363636,1.0,1.0,3/20,13.99%,PLN;SYT11;VIP
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),-0.3036183967059998,-0.5900876141015674,0.9545454545454546,1.0,1.0,2/25,9.47%,TSHR;FSHR
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),-0.33885240515481807,-0.5900430533956806,0.9655172413793104,1.0,1.0,1/10,5.37%,NFATC1
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),0.33035162011704816,0.5900053883011183,0.9444444444444444,1.0,1.0,7/7,66.98%,CAD;CTPS1;DHODH;CMPK1;UMPS;CTPS2;AK5
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.3386956516903137,-0.5890820837273566,0.9333333333333333,1.0,1.0,3/9,28.03%,TXN;GPR37L1;PARK7
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.3009742262934343,-0.5889717088067107,0.9682539682539683,1.0,1.0,3/18,17.02%,BRCA1;KAT5;RAD50
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.305219381914924,0.5889680850379595,0.9534883720930233,1.0,1.0,3/13,11.28%,ARID1B;FAM47E;ARID1A
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),-0.3817535417814173,-0.5889535870918038,0.9615384615384616,1.0,1.0,4/6,43.93%,ACAA2;STPG1;CAMK2A;THEM4
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.32116595522122127,0.5888416920306735,0.9473684210526315,1.0,1.0,2/10,17.65%,TMEM65;MDM4
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.3087449767363841,0.5887488549261275,0.9512195121951219,1.0,1.0,1/20,1.33%,IGF1
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.2864091090939797,-0.5882045636820157,0.9714285714285714,1.0,1.0,5/31,22.25%,DGAT2L6;APOE;DGKD;DGKG;CAV1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3169490534835354,-0.5881292511946581,1.0,1.0,1.0,5/16,18.77%,FLOT1;APPL2;NINJ1;IFI35;RAB7B
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),-0.29153976314688324,-0.5881139593624306,1.0,1.0,1.0,5/30,16.19%,CFTR;ATP5F1B;SLC9C1;GPR89A;SLC9B1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.3130776392945495,0.5879411448773174,0.9259259259259259,1.0,1.0,1/13,3.67%,PIEZO2
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.32637306345141265,0.5875768885293868,0.9705882352941176,1.0,1.0,5/11,22.63%,CTNNA2;PTEN;BBS2;MKKS;FBXW11
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.2507205711138616,0.5874850173117275,0.9642857142857143,1.0,1.0,9/32,16.74%,HSPB1;RAB27B;HAP1;DLG2;KIF5C;AP3D1;KIF1C;AP3B1;KIF1B
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.35684069842565225,-0.587482491514332,0.9090909090909091,1.0,1.0,2/8,12.66%,NEFL;BFSP1
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),-0.30798279030648135,-0.5867292624609101,1.0,1.0,1.0,1/19,4.69%,IL31RA
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.2870068987476322,0.586692066783561,1.0,1.0,1.0,2/17,10.73%,PRKRA;DICER1
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.2584858344722644,0.5865842093513034,0.9666666666666667,1.0,1.0,14/38,23.20%,CHRNA4;CHD7;SOBP;SLC8A2;LINS1;C5AR1;CYFIP1;PTCHD1;DGCR2;GRM5;NIPBL;MGAT3;APP;HRH3
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.37741532009649215,-0.5858225265477381,0.9152542372881356,1.0,1.0,1/6,10.09%,BRK1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.26657798378968456,-0.5856340621278163,0.987012987012987,1.0,1.0,6/53,13.65%,MED10;MED8;CDK4;CEBPB;CCNC;MED31
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),-0.34807509253249214,-0.5851972177369089,0.9833333333333333,1.0,1.0,2/8,18.67%,PRPS1;PAICS
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.3486277815965595,-0.5851795458804181,0.9333333333333333,1.0,1.0,1/8,11.72%,BDNF
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.234357838840957,-0.585145804362721,1.0,1.0,1.0,13/166,15.26%,JUP;MADCAM1;PDZK1;RAB11A;CD81;RAB32;PDZD11;FLOT1;LRRC7;RAB8A;ABCA12;MYADM;TNFRSF1A
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.3929875808280736,-0.5850049814251466,0.9552238805970149,1.0,1.0,2/6,35.44%,NUP155;NUP107
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.29814788311616003,-0.5839303636813126,0.9868421052631579,1.0,1.0,4/25,16.19%,LACC1;ATP5F1B;SLC9C1;SLC9B1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),-0.30840050905294514,-0.5837283853149706,0.9736842105263158,1.0,1.0,7/21,19.08%,KREMEN1;RSPO2;IFT122;GREM1;INTU;GLI3;IQCE
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.2871775183260178,0.5828565435903424,0.9,1.0,1.0,5/12,25.13%,HAP1;MAPT;TRAK1;MTM1;TRAK2
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.31968203916510807,-0.5821155946733424,0.9848484848484849,1.0,1.0,2/12,13.45%,THAP7;BRCA1
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.3006677898904133,0.5818885761274747,1.0,1.0,1.0,1/20,3.54%,GDAP1
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),-0.3586457256176469,-0.5817809154094945,0.9122807017543859,1.0,1.0,4/12,27.18%,OSBP;NPC2;OSBPL2;NPC1
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.33450496688186726,0.5815986246502169,1.0,1.0,1.0,2/11,15.07%,IGF2BP2;PCBP2
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.29050385412214846,0.5810412048846341,0.9705882352941176,1.0,1.0,4/11,18.77%,SCIN;ABI2;CYFIP1;WHAMM
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.3258303987817647,0.580992829133564,0.918918918918919,1.0,1.0,10/10,67.43%,NIPBL;ACD;LRWD1;PIH1D1;POT1;RUVBL2;MACROH2A1;BRCA2;MACROH2A2;NABP2
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),-0.3859084179032871,-0.5809656673205605,0.96875,1.0,1.0,2/5,25.77%,APPL2;RAB31
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",-0.3859084179032871,-0.5809656673205605,0.96875,1.0,1.0,2/5,25.77%,APPL2;RAB31
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.31917984040641456,-0.5798977195224775,0.9682539682539683,1.0,1.0,4/17,24.27%,C1QBP;DNM1L;CCR7;CD99
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.38790218160328976,-0.5795907384102724,0.9122807017543859,1.0,1.0,2/6,22.25%,FLOT1;CAV1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.26115736695674346,0.579587806864944,1.0,1.0,1.0,8/25,21.87%,KCNIP2;KCNN2;DLG1;DRD2;KCNIP3;KCNIP1;KCNAB2;FHL1
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.286810937355956,-0.5793394768918855,1.0,1.0,1.0,4/25,23.58%,VIL1;SYAP1;EEF1A1;INPP5K
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.28589005326836747,-0.5791011602752762,1.0,1.0,1.0,2/26,7.59%,BTBD18;RNF8
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.35794832754436884,0.5788129300157921,0.9591836734693877,1.0,1.0,7/7,64.22%,NUFIP1;PIH1D1;RUVBL2;ZNHIT3;RUVBL1;PIH1D2;ZNHIT6
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.25857319575661775,-0.5778607661823412,0.987012987012987,1.0,1.0,2/50,6.63%,RNF212;RNF212B
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.341488168019348,-0.5767569950097741,0.9411764705882353,1.0,1.0,3/10,21.45%,VPS25;SNX6;CBLC
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.3407419496723427,0.576706910755597,0.9574468085106383,1.0,1.0,1/8,5.94%,SNCA
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.2671234156447889,-0.5766182830619146,0.9836065573770492,1.0,1.0,7/39,22.54%,RPS3;PPIF;MAPK7;ECT2;IMPACT;SOD1;ZNF580
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.34993131444066794,0.576363696104814,0.9302325581395349,1.0,1.0,1/6,6.35%,AKT2
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.2781014942706742,-0.5763572966862145,0.9726027397260274,1.0,1.0,3/37,14.38%,USP1;TOM1L1;KPNA2
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.27612153986501126,-0.5763177125180331,0.9852941176470589,1.0,1.0,6/29,22.54%,RPS3;PPIF;MAPK7;ECT2;IMPACT;ZNF580
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),-0.37605348700050595,-0.5762779006481097,0.9464285714285714,1.0,1.0,2/5,24.55%,BLOC1S2;DTNBP1
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),-0.3444601837473874,-0.576188734340146,0.967741935483871,1.0,1.0,4/14,27.18%,OSBP;NPC2;OSBPL2;NPC1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.25617976214280813,0.5756937062974157,0.967741935483871,1.0,1.0,2/24,6.25%,HSPB1;SIRT1
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.2878592558058811,-0.575364025520197,1.0,1.0,1.0,8/40,25.66%,CAV2;PI4K2A;RNF26;LAMTOR1;USP8;CAV1;SQSTM1;LAPTM4B
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.2653985129115819,0.575242345553163,0.9722222222222222,1.0,1.0,7/30,18.82%,CAMSAP3;HCLS1;ESAM;CAMSAP2;ABL1;MAP2;MAPT
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.24719033463835316,-0.5749163219336018,1.0,1.0,1.0,19/85,20.82%,NUDT12;LSM2;PRPF3;SF3A1;PCBP3;LSM10;SRSF7;SSB;CPSF3;PRPF18;RNH1;PRMT9;METTL3;KIN;DDX5;PRPF8;PRKACA;NCBP1;AURKAIP1
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.2823524424902769,0.5748338941290254,0.9428571428571428,1.0,1.0,1/12,7.24%,CAMSAP3
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.3192561240480948,0.5742557401428294,0.9777777777777777,1.0,1.0,3/9,16.88%,DUSP6;PTEN;WWC1
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),-0.38704953390815483,-0.5736710528751252,0.9333333333333333,1.0,1.0,1/5,25.22%,CTR9
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),0.3606633960931517,0.573662663475577,0.8723404255319149,1.0,1.0,2/5,15.42%,DLL1;NIBAN2
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),-0.3740502673628759,-0.5730602536630927,0.9830508474576272,1.0,1.0,2/5,26.74%,UBE2D4;UBE2S
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.23870606098002375,-0.5728548314603896,1.0,1.0,1.0,6/98,12.41%,RIMS1;ELOB;CLDN14;VIL1;NIFK;AFG3L2
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.3047687001998135,-0.5718768528285743,0.9571428571428572,1.0,1.0,3/23,16.03%,PPP1CA;PER3;RBM4B
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.3151112684618243,0.5711359190657663,0.9090909090909091,1.0,1.0,2/12,18.11%,ZNF304;SETDB2
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.2811974239686744,-0.5710105660850422,1.0,1.0,1.0,10/48,26.46%,CPTP;PRELID1;TRIAP1;ABCA12;APOE;ATP8B1;NPC2;MFSD2A;PCTP;OSBPL2
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),-0.3803179090530884,-0.570800306219682,0.9166666666666666,1.0,1.0,4/5,28.16%,HPGD;ALOX5;PTGR1;ALOX12
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.3356310015671954,-0.570344144919164,1.0,1.0,1.0,2/7,25.20%,VAT1;BNIP3
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),-0.3000255485302673,-0.570287348225004,1.0,1.0,1.0,1/19,1.86%,MUSK
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.2482335901832952,-0.5701561619924466,0.9850746268656716,1.0,1.0,14/76,25.12%,EDF1;SCD;GPS2;HELZ2;C1QTNF2;FASN;CAV1;LACTB;NPC2;OPA3;TM7SF2;NR1D1;CERS2;SREBF1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.31242936229767937,-0.5701295050953991,0.9508196721311475,1.0,1.0,3/12,25.05%,ACBD5;MAP1LC3B;SQSTM1
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.33675143542928515,-0.5700641144307298,0.9473684210526315,1.0,1.0,3/9,30.73%,EDN1;PRXL2B;CD74
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.30039420580158743,-0.5694808049910884,0.958904109589041,1.0,1.0,3/24,16.03%,PPP1CA;PER3;RBM4B
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.3409142116412307,0.5694443057236745,0.9705882352941176,1.0,1.0,2/11,11.42%,BMP6;SMAD4
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.3008332602894082,-0.5690925572370206,0.9846153846153847,1.0,1.0,3/21,15.05%,TPX2;STMN2;KATNB1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),0.34668633141443456,0.5686337688846196,0.9166666666666666,1.0,1.0,5/5,65.34%,CAD;CTPS1;DHODH;UMPS;CTPS2
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.32355923044243845,-0.5686141032041363,0.9863013698630136,1.0,1.0,4/12,24.40%,BRCA1;LRIF1;METTL3;RBM15B
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.3229178507808336,-0.5684578721667085,0.9365079365079365,1.0,1.0,1/14,8.01%,BTG1
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),-0.35000514774874447,-0.5680730858821081,0.9649122807017544,1.0,1.0,3/8,34.76%,GSTZ1;TYR;FAH
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),-0.3664238449544185,-0.5678812886802491,0.9384615384615385,1.0,1.0,2/6,21.54%,AQP11;SLC14A2
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.3446181950985646,-0.5678227397237365,0.927536231884058,1.0,1.0,4/9,40.27%,IFIT1;ISG15;SMPD1;SHMT2
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.35233382499881044,0.5676642784643718,0.9210526315789473,1.0,1.0,7/7,64.78%,THOC2;THOC1;THOC6;THOC3;THOC7;ALYREF;THOC5
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.35233382499881044,0.5676642784643718,0.9210526315789473,1.0,1.0,7/7,64.78%,THOC2;THOC1;THOC6;THOC3;THOC7;ALYREF;THOC5
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.2805665814793274,0.5673209553432473,0.9444444444444444,1.0,1.0,1/13,4.03%,COQ2
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.2805665814793274,0.5673209553432473,0.9444444444444444,1.0,1.0,1/13,4.03%,COQ2
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.24699086927831984,-0.567286376584417,1.0,1.0,1.0,12/53,25.64%,RAB11A;STMN3;DCTN1;FIGNL1;TRDN;TUBGCP4;KATNA1;TUBGCP2;RHOA;KPNB1;VPS4B;DYNC1H1
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.249448656973731,0.5671272966706983,0.9714285714285714,1.0,1.0,3/36,9.96%,GFAP;TRAF2;RAPGEF1
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.2922915024938414,-0.5670909146009058,1.0,1.0,1.0,4/21,11.72%,HTR2B;PHB2;SELE;BDNF
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.31763026409707346,0.5668811288398455,0.9714285714285714,1.0,1.0,9/9,68.25%,ATXN2;RBFOX1;HNRNPA2B1;SIDT1;YBX1;RTRAF;SIDT2;NXF5;CKAP5
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.31303527515504936,-0.5665324475828413,0.9571428571428572,1.0,1.0,1/12,12.98%,YBX3
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.33104110466679254,0.5661720153653128,0.9285714285714286,1.0,1.0,2/7,17.30%,PRKD1;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),0.37278016722254487,0.5657653247186277,0.9230769230769231,1.0,1.0,1/5,3.73%,DENND1B
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.2673816624440633,-0.5652187071841804,0.9824561403508771,1.0,1.0,10/32,28.99%,LAMP1;ANTKMT;LCP1;NEFH;REEP5;REEP6;DYNC1H1;CRYAB;PTPN1;DNAJC30
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),-0.37392718562016836,-0.5650341486488827,0.9464285714285714,1.0,1.0,3/5,39.22%,HIP1R;LRP1;PTPN12
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.31793945112612854,-0.5644106731340817,0.9545454545454546,1.0,1.0,3/15,24.75%,CHRM2;CAV1;MYOCD
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),0.34463291550584574,0.5640884952358413,0.8787878787878788,1.0,1.0,1/5,12.63%,SLC22A2
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),0.34463291550584574,0.5640884952358413,0.8787878787878788,1.0,1.0,1/5,12.63%,SLC22A2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.25856397971050926,0.5639280296593301,0.9714285714285714,1.0,1.0,5/27,14.72%,NAF1;PPP1R10;TNKS;HNRNPD;ATRX
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.27087088865702375,-0.5638321406124338,0.9838709677419355,1.0,1.0,8/31,24.28%,PTK6;WNT9A;MEIOSIN;SNW1;PTK7;BRINP2;WNT8B;ZNF35
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.24701074643779627,-0.5632311300027648,1.0,1.0,1.0,12/66,22.73%,ATP6V1F;RRAGA;LAMTOR5;CEBPB;ATP6V1E1;LAMTOR1;ATP6V1E2;ATP6V1D;RRAGC;IMPACT;ATP6V1C2;LAMTOR2
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.32400976313681173,0.5631767430810177,0.9705882352941176,1.0,1.0,2/11,18.11%,ZNF304;SETDB2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.2590601599514633,0.5630555031044283,0.9555555555555556,1.0,1.0,3/16,15.68%,HAP1;AKAP6;PKD2
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),-0.33895047360556285,-0.5630297802804058,0.9818181818181818,1.0,1.0,1/7,21.27%,GCLM
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),-0.33895047360556285,-0.5630297802804058,0.9818181818181818,1.0,1.0,1/7,21.27%,GCLM
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.2537008048034308,0.5629972191510488,1.0,1.0,1.0,4/22,18.66%,PUS7;ZC3H13;METTL8;NSUN2
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.3455281446283875,0.5629503983575204,0.8809523809523809,1.0,1.0,1/7,5.52%,AGER
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),-0.35743426791176897,-0.5623501513287655,0.9420289855072463,1.0,1.0,1/5,16.66%,STPG4
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),-0.35743426791176897,-0.5623501513287655,0.9420289855072463,1.0,1.0,1/5,16.66%,STPG4
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),-0.2765356568543272,-0.5620386806484856,1.0,1.0,1.0,19/35,32.48%,PHAX;SNRPD1;SNRPD2;NCBP1;LSG1;DDX20;SMN1;GEMIN6;RBM15B;NXT1;NCBP2;SNRPE;SNUPN;SNRPG;RITA1;GEMIN2;RSRC1;NXT2;SNRPB
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.3329411433051317,0.5618378647230385,0.8888888888888888,1.0,1.0,2/9,11.72%,KCNC2;AQP1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.278051423954579,-0.5618188018421958,1.0,1.0,1.0,2/28,17.78%,FABP3;APOE
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.35793129698353776,0.5618088243311101,0.8536585365853658,1.0,1.0,6/6,64.22%,FBL;PIH1D1;ZNHIT3;PRPF31;NOP58;ZNHIT6
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.3348270073023296,0.5608528751397771,0.9117647058823529,1.0,1.0,2/8,11.49%,MAN2A1;ENGASE
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),-0.2932424822271201,-0.5607397097298685,1.0,1.0,1.0,5/27,18.18%,XYLT2;B3GALT6;B4GALT7;CHST10;CHST9
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.3591995495747592,0.5603963132656877,0.9117647058823529,1.0,1.0,1/7,6.47%,SLC7A5
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.30092786883929956,-0.5601643367596225,0.96875,1.0,1.0,4/19,24.47%,VPS25;SNX6;CBLC;HFE
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.3401423432508036,-0.5596919712450109,0.9811320754716981,1.0,1.0,1/8,8.85%,RANBP1
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.3164407922999415,-0.5593695591835456,0.96875,1.0,1.0,6/15,32.26%,DOP1B;KLHL20;AP2A1;AP4M1;RAB14;VPS13A
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.3396612427443143,0.5579909623320307,0.8571428571428571,1.0,1.0,6/6,66.04%,CDS2;PLA2G6;PGS1;SLC27A1;TAMM41;GPAM
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.3075534564236924,0.5577331264514761,0.918918918918919,1.0,1.0,4/11,21.45%,ADAM8;GPLD1;SH3D19;TNFRSF1B
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),0.3110978791605995,0.5575719276747225,0.9393939393939394,1.0,1.0,1/10,6.25%,DNA2
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),0.3110978791605995,0.5575719276747225,0.9393939393939394,1.0,1.0,1/10,6.25%,DNA2
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),0.3110978791605995,0.5575719276747225,0.9393939393939394,1.0,1.0,1/10,6.25%,DNA2
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.2719872154475351,0.5575216518032549,0.9767441860465116,1.0,1.0,6/21,19.55%,MYO5B;AQP1;ADCY8;PRKACB;RAB11FIP2;ADCY6
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.36341498222060115,0.5572013469358699,0.918918918918919,1.0,1.0,4/6,30.02%,ATP13A2;MGAT3;LDLR;LRP2
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.2566700173033252,-0.5568719106052793,1.0,1.0,1.0,12/55,23.95%,HTR2B;DDAH2;SELE;GPR62;CXCR6;EDN1;APOE;DGKD;TPCN2;CCR7;CCR3;MCTP2
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.31395855861207034,0.5567237055999416,1.0,1.0,1.0,2/13,18.11%,ZNF304;SETDB2
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),0.3595294654007214,0.5566990145418866,0.9318181818181818,1.0,1.0,2/5,18.36%,TJP2;TJP1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.27507404327697427,-0.5560929970934592,0.9873417721518988,1.0,1.0,3/27,15.79%,RPS3;ANKRD53;DCTN1
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.25481985598329226,-0.5547080331144637,1.0,1.0,1.0,8/32,29.13%,CLSPN;FBXO6;RAD9A;HUS1;E2F1;DONSON;NBN;H2AX
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.28436369973923287,0.5546711246318731,1.0,1.0,1.0,5/11,27.25%,PRKG2;QDPR;GCH1;MTHFD1L;FTCD
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.267208708272534,0.5541879645930975,0.9642857142857143,1.0,1.0,7/29,18.65%,PAXIP1;SMYD2;ASH2L;KMT2D;CXXC1;SETDB2;KDM6A
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.26932980499417536,-0.5539386053603739,1.0,1.0,1.0,4/36,18.01%,DND1;YBX3;VIP;CIRBP
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.33447815091361793,-0.5533390233827902,0.9375,1.0,1.0,2/9,13.96%,BRCA1;DNMT3B
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.29925201624730646,-0.5533137002384056,1.0,1.0,1.0,5/17,23.99%,VPS25;SNX6;CBLC;SHC1;ADAM17
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.31486200533243364,0.5530118001082565,0.95,1.0,1.0,2/7,17.99%,IFT88;SLC4A7
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.3536479463384731,-0.5526123662901496,0.9666666666666667,1.0,1.0,2/6,19.41%,CEP135;WRAP73
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.2816230565747972,-0.5522897693965629,0.9861111111111112,1.0,1.0,6/25,27.67%,PRELP;OMD;CHST2;OGN;CHST6;SLC35D2
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),-0.3108995878794968,-0.552249418245065,1.0,1.0,1.0,2/12,18.09%,ACTA2;TPCN2
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.26238328188803156,-0.552060144436977,0.9852941176470589,1.0,1.0,6/24,24.77%,PHKG1;PYGL;NHLRC1;AGL;CALM1;NR1D1
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.30468734317800183,-0.551950694513966,1.0,1.0,1.0,7/16,31.25%,GIPC1;LRRC8D;ARL6IP5;SLC1A6;SLC1A1;GJA1;SLC25A12
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.2900564471148041,-0.551370935653579,0.9571428571428572,1.0,1.0,5/19,25.85%,APOE;RAN;KPNB1;SREBF1;FMO5
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),-0.3024594065358833,-0.5509832942320045,0.9852941176470589,1.0,1.0,2/11,18.15%,AR;DDX5
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.25296898257535,0.5507043889440913,0.975,1.0,1.0,4/17,21.09%,ADAMTS9;FBXO2;NEU4;NAGA
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.23452731843167063,-0.5487577540555407,1.0,1.0,1.0,6/97,11.59%,SERPING1;RNASE1;TCEAL6;OPALIN;SPARCL1;RASSF4
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.2588187331206152,0.547882448635078,1.0,1.0,1.0,5/24,13.55%,CRADD;ZDHHC3;BAG3;TNFRSF10A;SORT1
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.3329611838505113,-0.547798341275777,0.9322033898305084,1.0,1.0,3/9,21.11%,ACTB;ATP8B1;GOPC
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.2874953777228414,0.5476483287257549,1.0,1.0,1.0,1/16,4.40%,ARNT
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.3219228432813884,0.5474994180621784,0.9117647058823529,1.0,1.0,2/9,21.76%,SORT1;TRARG1
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),-0.363805703943662,-0.5472484512706578,0.9482758620689655,1.0,1.0,2/5,19.41%,CEP135;WRAP73
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.37531162236153004,-0.5466551116376062,0.9454545454545454,1.0,1.0,2/5,30.98%,NUCKS1;XRCC6
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.28330183563528416,0.5454780586294665,0.9393939393939394,1.0,1.0,6/15,21.47%,INTS6;INTS9;INTS11;MTREX;INTS1;ZCCHC8
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.24391786263475568,-0.5450451971685021,1.0,1.0,1.0,6/47,18.75%,SVBP;RAB8A;VIP;CANX;SCG2;NAGPA
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.2692032619181319,-0.5447794214561148,0.9859154929577465,1.0,1.0,4/24,18.26%,IFITM3;TRIM25;LGALS1;HLA-DRB1
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.24401851610822323,0.5438410841814846,0.9714285714285714,1.0,1.0,1/20,6.27%,LPIN3
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),-0.34682606449297315,-0.5431446863899896,0.9433962264150944,1.0,1.0,1/5,13.57%,CD27
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.24030182317519305,-0.5431253784301396,1.0,1.0,1.0,12/67,22.73%,ATP6V1F;RRAGA;LAMTOR5;CEBPB;ATP6V1E1;LAMTOR1;ATP6V1E2;ATP6V1D;RRAGC;IMPACT;ATP6V1C2;LAMTOR2
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),-0.3484754021878335,-0.5425371188486386,0.9655172413793104,1.0,1.0,2/7,24.22%,CHMP3;VPS4B
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),0.27399465975141685,0.5424514086684635,0.8888888888888888,1.0,1.0,3/13,12.78%,NOXRED1;HDC;PYCR1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.31052531404644074,0.5423409092594313,0.9411764705882353,1.0,1.0,8/8,68.96%,GSK3B;DYRK2;HOMER2;FHL2;ATP2B4;PRNP;HOMER3;CHP1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.31052531404644074,0.5423409092594313,0.9411764705882353,1.0,1.0,8/8,68.96%,GSK3B;DYRK2;HOMER2;FHL2;ATP2B4;PRNP;HOMER3;CHP1
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.3305190128052844,-0.5415763983598435,0.9523809523809523,1.0,1.0,2/6,19.87%,SSB;DDX1
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.33037264669539285,0.5413656556154881,0.9230769230769231,1.0,1.0,3/7,23.60%,ACADS;PCCA;MMAA
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.31974171570561977,-0.540320203839669,0.9666666666666667,1.0,1.0,2/10,22.61%,ZNF622;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.29467221917052505,-0.5402132520938131,0.9722222222222222,1.0,1.0,3/16,19.58%,OPALIN;TNFRSF21;PTN
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.31725612565820765,-0.5394431294865192,0.984375,1.0,1.0,4/9,22.34%,HLA-DRB1;CR1;HLA-DRA;CD46
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.3383610198295499,-0.539410271955177,0.9122807017543859,1.0,1.0,1/7,17.81%,DNM1L
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.3383610198295499,-0.539410271955177,0.9122807017543859,1.0,1.0,1/7,17.81%,DNM1L
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.32136220775403623,-0.5393818963630579,0.9571428571428572,1.0,1.0,2/10,24.91%,CELA2A;PLAUR
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),-0.30705611933159277,-0.5388601203131715,0.9848484848484849,1.0,1.0,5/13,27.07%,ETFB;ETFRF1;UQCRFS1;NDUFA5;ETFA
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.2615170850830847,-0.5386813311381589,1.0,1.0,1.0,2/30,9.69%,RRAGA;LAMTOR5
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.3371457923087515,-0.5384291228774819,1.0,1.0,1.0,4/8,32.81%,PDK2;GSTZ1;PDPR;PDK3
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.3371457923087515,-0.5384291228774819,1.0,1.0,1.0,4/8,32.81%,PDK2;GSTZ1;PDPR;PDK3
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.3147471478870074,-0.5380671019654419,0.96875,1.0,1.0,6/10,33.65%,PRR7;PLAUR;HTRA2;PARK7;FAS;GSN
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.2841614371013006,0.5375828984764474,1.0,1.0,1.0,2/11,15.59%,ABHD2;GPER1
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),0.3180356567959108,0.5371863635074451,1.0,1.0,1.0,2/6,15.68%,GPLD1;C5AR1
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),-0.3472996758527317,-0.537033663459804,0.9166666666666666,1.0,1.0,1/5,22.09%,KCNE1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.22273201796497583,0.5370235721906724,1.0,1.0,1.0,1/44,1.39%,TRIM67
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.24598055381102718,0.5364980086722898,1.0,1.0,1.0,6/25,17.71%,STXBP5;LLGL2;ARFIP1;ATP13A2;SCFD1;RHBDF2
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.236277567267,0.5358659227214766,1.0,1.0,1.0,3/23,12.15%,FBLN5;PTPRK;GGA2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.318504068135319,0.5354572250346186,0.9347826086956522,1.0,1.0,7/7,68.16%,STK39;CAB39;CASQ2;NEDD4L;KCNAB1;CAV3;ACTN2
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),-0.29200383546929565,-0.5353903595443106,0.9701492537313433,1.0,1.0,1/13,11.78%,JMJD4
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.30574115168638616,-0.5347470877347674,0.9298245614035088,1.0,1.0,2/9,28.03%,SLC18A2;PARK7
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),-0.2779615918888535,-0.5344697087702123,0.9436619718309859,1.0,1.0,2/12,24.31%,CRB2;USH1C
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.29066016779803916,0.5342318002037122,0.975609756097561,1.0,1.0,5/13,14.15%,ROBO1;TGFB2;ROBO2;SLIT2;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.28754060772845613,0.5340782953066417,0.9743589743589743,1.0,1.0,7/11,28.98%,PAXIP1;TFRC;SHLD1;KMT5B;HMCES;TP53BP1;KMT5C
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.2289036554212271,-0.5340433518317543,1.0,1.0,1.0,9/75,17.95%,TRIM13;PHB2;IRGM;PINK1;PIK3CB;KAT5;SUPT5H;UFL1;ORMDL3
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.27338055903239944,0.5339973275591258,0.9722222222222222,1.0,1.0,3/10,17.56%,CEP290;AGTPBP1;MYO7A
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),-0.32245939375044086,-0.5336510987161734,0.9841269841269841,1.0,1.0,1/7,21.24%,CCR7
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.30487605592135525,-0.5333161488754162,0.9411764705882353,1.0,1.0,3/13,21.39%,SLC5A10;SLC2A2;SLC5A2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.2308119904710749,0.533149615297213,1.0,1.0,1.0,11/51,19.74%,CNOT2;CRADD;CNOT11;CNOT4;PIDD1;CNOT6L;TFDP2;PLAGL1;MDM4;RGCC;SOX4
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.2887069080404585,-0.5329327947855796,1.0,1.0,1.0,3/18,21.54%,YBX3;LRRC8D;RCSD1
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),0.3334650963841491,0.5327631977599986,0.9047619047619048,1.0,1.0,2/5,12.92%,PNPO;PDXK
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.290005444230914,-0.5327003053158971,0.9666666666666667,1.0,1.0,2/14,18.64%,SFRP4;FSTL1
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.29619612649229093,-0.532589244456856,0.9855072463768116,1.0,1.0,2/19,17.78%,RHBDF1;APOE
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.3170150889596104,-0.5318228312048748,1.0,1.0,1.0,1/7,16.33%,KRT10
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.2726619753124975,0.5312158145093168,0.9,1.0,1.0,4/19,19.23%,UGDH;GFPT2;GFPT1;SLC35D1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.2753067140392799,-0.5311661404962102,0.9861111111111112,1.0,1.0,6/19,30.24%,RACK1;CAV1;INPP5K;SMAD7;DDIT4;PDE4D
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.2924558454822289,-0.5304972209047383,0.9558823529411765,1.0,1.0,6/14,34.66%,PLN;GOPC;YWHAE;ACTN2;NEDD4;CAV3
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.30039182553219923,0.5301514763131493,0.8979591836734694,1.0,1.0,2/5,17.98%,CHDH;SLC44A1
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.29458543135607723,0.5296374714660149,0.9722222222222222,1.0,1.0,1/9,9.39%,CD4
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),-0.3602741036350971,-0.5293980983703617,0.9846153846153847,1.0,1.0,1/6,10.91%,FADD
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.24119891514710062,0.5289154670106769,1.0,1.0,1.0,2/19,13.53%,AUP1;UGGT1
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),0.2698458023986293,0.5287458177842669,0.9736842105263158,1.0,1.0,12/12,73.03%,DLD;PIPOX;OGDH;ALDH7A1;GCDH;PHYKPL;AADAT;SLC25A21;AASS;DLST;CRYM;HYKK
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),0.2698458023986293,0.5287458177842669,0.9736842105263158,1.0,1.0,12/12,73.03%,DLD;PIPOX;OGDH;ALDH7A1;GCDH;PHYKPL;AADAT;SLC25A21;AASS;DLST;CRYM;HYKK
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.25680788648599817,-0.5283752098377607,0.972972972972973,1.0,1.0,4/24,19.44%,FIP1L1;PAF1;CPSF3;CLP1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.25680788648599817,-0.5283752098377607,0.972972972972973,1.0,1.0,4/24,19.44%,FIP1L1;PAF1;CPSF3;CLP1
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.31474520626159763,0.5282722136635097,0.95,1.0,1.0,7/7,68.54%,TRNAU1AP;SEPSECS;DIO2;SECISBP2L;SELENOT;SECISBP2;EEFSEC
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.31474520626159763,0.5282722136635097,0.95,1.0,1.0,7/7,68.54%,TRNAU1AP;SEPSECS;DIO2;SECISBP2L;SELENOT;SECISBP2;EEFSEC
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.23011953286212855,-0.5282554711708362,1.0,1.0,1.0,13/68,23.95%,HTR2B;IRGM;SELE;SELP;CXCR6;EDN1;TPCN2;PRKACA;CCR7;FIS1;BCAP31;CCR3;MCTP2
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.22154381135632673,-0.5278704496305673,1.0,1.0,1.0,30/89,36.30%,FIP1L1;DHX38;SRSF7;UPF2;MCM3AP;CPSF3;EIF4A3;SRSF3;MAGOHB;NCBP1;NUP50;SRSF9;RBM15B;SRSF5;NXT1;NCBP2;DDX39A;GLE1;NUP155;NUP58;POM121;SLU7;NUP93;NUP88;POM121C;NXF5;THOC5;NUP107;AAAS;SRSF2
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.29495779619867524,-0.5271265404600646,0.9838709677419355,1.0,1.0,2/13,14.44%,PPIF;ATF3
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.26408498977702666,-0.526858483242749,1.0,1.0,1.0,1/24,6.81%,TRMT112
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),0.31481411249381575,0.5263587277698586,0.9333333333333333,1.0,1.0,1/5,12.55%,STARD4
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),0.31481411249381575,0.5263587277698586,0.9333333333333333,1.0,1.0,1/5,12.55%,STARD4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),0.3078796098884671,0.525943448372803,0.9310344827586207,1.0,1.0,1/10,4.45%,CLEC7A
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.321010562375107,0.5259179565724063,0.9736842105263158,1.0,1.0,6/6,67.91%,NFKBIA;EIF2AK4;FOXO1;DNAJC3;SAXO1;EIF2AK3
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.32610529382619213,0.525460243367492,0.8717948717948718,1.0,1.0,2/5,12.83%,ROBO1;ROBO2
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.2466361774803329,0.5252360965772451,1.0,1.0,1.0,11/29,26.53%,OTUD7B;YOD1;ZRANB1;OTUD1;UIMC1;OTUD4;OTUD7A;USP25;CYLD;USP27X;USP7
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.2188518462269493,-0.5252004275467108,1.0,1.0,1.0,13/88,20.80%,C4BPB;GPC3;C4BPA;AZIN1;VPS28;WDR91;VIP;SNF8;EEF1A1;CENATAC;DACT1;TMEM9;FURIN
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.27492930264963905,-0.525017729268325,1.0,1.0,1.0,4/26,20.86%,RAD51AP1;PARP1;MRNIP;OOEP
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),-0.3370767773422898,-0.5248765057987889,0.9558823529411765,1.0,1.0,2/5,17.43%,FANCM;XRCC3
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),0.3053099225956273,0.5248538439372038,0.9285714285714286,1.0,1.0,1/6,18.11%,SETDB2
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.3007436003431344,-0.5232490059919852,0.9850746268656716,1.0,1.0,3/13,14.59%,PIK3CB;CADM4;STMN3
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.2876718846647951,0.5231696600701484,0.9411764705882353,1.0,1.0,7/7,71.24%,DHX9;DDX3X;AGO3;AGO2;AGO1;DHX36;AGO4
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.30404867785772016,-0.522705007509651,0.9552238805970149,1.0,1.0,4/12,25.22%,BRCA1;DNMT3B;SNW1;CTR9
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.33963410498852237,0.5225730430567156,0.9761904761904762,1.0,1.0,3/5,26.71%,NAPB;UNC13B;STX1B
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.3280841143727104,0.5222121319682806,0.9772727272727273,1.0,1.0,5/5,67.20%,FAM120B;PPARG;RXRA;ACTN4;PDK3
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),-0.3348783237241616,-0.5212844836990249,0.9827586206896551,1.0,1.0,1/5,28.77%,AGO4
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),-0.22085237760453896,-0.5211893180606334,1.0,1.0,1.0,5/68,14.59%,VPS35;TMED9;SYT11;PINK1;STMN3
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.28264536864145895,-0.521073883246932,0.9692307692307692,1.0,1.0,1/16,12.38%,STAT1
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.3067052111133553,0.5199253686690519,1.0,1.0,1.0,2/6,19.82%,AKIRIN1;PPP3CA
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.33897461678262913,-0.5194059540068933,0.9833333333333333,1.0,1.0,2/5,28.24%,ETS1;HABP4
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),-0.34242997825442045,-0.5191004748418893,0.9841269841269841,1.0,1.0,2/6,27.17%,DKK3;INSM1
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.27328588028746553,-0.5190521856678476,0.9583333333333334,1.0,1.0,3/18,24.69%,IFT122;C12ORF57;NES
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),0.32218469004234274,0.5189044360097568,0.9772727272727273,1.0,1.0,5/5,67.79%,CSF1R;MAPK1;IL34;PTK2;MAPK3
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.29074400641110076,0.5188762375513724,0.975609756097561,1.0,1.0,1/8,7.25%,DHFR
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.2727494885904315,-0.5182136594815341,0.9850746268656716,1.0,1.0,4/14,25.84%,BTN3A3;HLA-DRB1;CD46;BTN3A2
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.2793931174049102,-0.5159324475602652,0.9852941176470589,1.0,1.0,3/18,15.45%,EXOSC4;INTS5;INTS12
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.3221846900423425,0.5158212374923005,0.9736842105263158,1.0,1.0,5/5,67.79%,RPS6KA4;RPS6KA5;FMR1;CDK9;MAPK3
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.27771935453511953,-0.5145950626696706,1.0,1.0,1.0,6/20,26.05%,TGFB1;GDI1;KCNE1;INPP5K;MRAP;TMBIM1
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.24244637644645706,-0.5140347316272775,1.0,1.0,1.0,3/33,13.23%,KIF20B;CEP131;ABCA12
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.2132862626098713,-0.5136909749813373,1.0,1.0,1.0,19/92,29.17%,FIP1L1;DHX38;SRSF7;UPF2;MCM3AP;CPSF3;EIF4A3;SRSF3;MAGOHB;NCBP1;NUP50;RAN;SRSF9;RBM15B;SRSF5;NXT1;NCBP2;DDX39A;GLE1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.2518204749892916,0.5132483425124174,0.9705882352941176,1.0,1.0,13/13,74.83%,RPTOR;RPS6KB1;UCP1;ATF4;FAM107A;ULK1;MTOR;EIF4G1;KCNB1;PRKAA1;PRKAA2;MEAK7;SCTR
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.33195052801833413,-0.5115102977078989,0.96875,1.0,1.0,2/8,32.22%,AKAP8;MAPK3
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.2359474739638272,0.511371353975499,1.0,1.0,1.0,4/13,23.72%,ELP3;ELP4;TRMT9B;MTO1
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.26881720716186125,-0.5107832091360185,1.0,1.0,1.0,7/26,22.48%,HINT1;TRIAP1;MYBBP1A;GREM1;DDX5;PDK2;RRP8
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.3214096281871084,0.5106293718604298,0.9722222222222222,1.0,1.0,1/6,8.40%,SLC25A18
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.26320430883523843,-0.5105471917446365,1.0,1.0,1.0,4/24,19.61%,TCEA2;SUPT5H;HTATSF1;TSFM
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.25862445814550583,-0.5104883410575518,1.0,1.0,1.0,7/28,20.55%,RBM3;RBM22;NCL;POLR2A;CIRBP;SNW1;NCBP1
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.2912856837889306,-0.5098671162196594,0.96875,1.0,1.0,4/13,23.09%,PHKG1;PYGL;AGL;CALM1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.26769644317948504,-0.5098127549520312,0.9836065573770492,1.0,1.0,2/19,14.02%,TGFB1;MYH6
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.24294855555547187,-0.50858813507182,0.9855072463768116,1.0,1.0,6/28,22.29%,TPX2;TPPP3;MAP7D3;GOLGA2;TUBGCP4;TUBGCP2
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.26304465041243463,-0.508379463681537,0.984375,1.0,1.0,4/22,21.15%,RBM22;CAMK1;GTSE1;EMD
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),-0.32345508822933267,-0.507497411163537,0.9591836734693877,1.0,1.0,2/6,17.62%,SCARA3;XPA
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),0.29710315159786166,0.5065251600187765,0.9622641509433962,1.0,1.0,1/6,7.86%,ADAM8
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.3279442512950608,-0.506508576010502,0.9841269841269841,1.0,1.0,2/7,21.24%,C1QBP;CCR7
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.309844411666746,0.50599861367919,0.9772727272727273,1.0,1.0,7/7,69.03%,LIG4;TOP2A;MGMT;XRCC4;LIG3;LIG1;XRCC6
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),-0.33112624627241993,-0.5059976192923435,0.9545454545454546,1.0,1.0,2/5,23.98%,SLC22A1;SLC18A2
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.24712777675644035,0.5058621114932842,1.0,1.0,1.0,9/16,31.21%,CASK;SIGLEC10;FGF2;MDK;INPP5F;RTN4RL1;PTPRS;GIT1;CRK
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.2916662917556459,-0.5054642231940909,0.9577464788732394,1.0,1.0,1/9,15.93%,MAPK7
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.24461376794694176,0.505294068858646,1.0,1.0,1.0,7/22,26.87%,ATP1B3;DLG1;FHL1;STK39;CAB39;CASQ2;NETO1
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.23362995317992807,0.5052279111913427,1.0,1.0,1.0,5/21,18.55%,NOXRED1;HDC;PYCR1;DHRS11;FDFT1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.22474540771276652,0.5048410499882702,1.0,1.0,1.0,4/19,19.69%,SIRT1;HIPK2;TP73;AEN
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.29163345982952454,0.5045520393495637,0.9743589743589743,1.0,1.0,3/9,18.63%,LTC4S;LTA4H;PLA2G4A
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.2713623632014184,-0.5041295746848314,0.9850746268656716,1.0,1.0,1/15,7.80%,PAX8
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),-0.29748714078859473,-0.5032998879236996,0.9848484848484849,1.0,1.0,3/9,25.54%,OMG;PTN;GAP43
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.30015051288769445,-0.5029625229315414,0.984375,1.0,1.0,4/11,24.22%,DCK;TK2;UCK1;UCKL1
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.297661285875223,-0.5026628789449246,1.0,1.0,1.0,5/15,35.54%,WDR45B;ULK2;WIPI2;ATG12;ATG2A
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.27773355566632296,-0.5026395512813612,1.0,1.0,1.0,7/14,38.31%,NTNG2;CTSS;NID2;LAMB1;HPN;COL4A1;NTN4
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.3121383049046082,0.5014683907750601,0.9210526315789473,1.0,1.0,2/5,23.88%,KMT2D;LMO3
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.2993148729660291,0.5014228002109437,0.9473684210526315,1.0,1.0,6/6,70.08%,KDR;F3;NTRK3;VEGFA;CDH13;ANGPT2
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.2610896664642594,0.5008673781359513,1.0,1.0,1.0,5/12,28.12%,PCM1;NINL;BICD2;NIN;CCDC68
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),0.3199961939197868,0.5004726364030482,0.9787234042553191,1.0,1.0,5/5,68.01%,EFHD1;SLC25A23;CLN3;LETM1;MICU1
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.2592143172826347,-0.4997208910366925,0.9692307692307692,1.0,1.0,1/24,5.54%,ARL1
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.30182216090204095,0.4994091625622103,0.972972972972973,1.0,1.0,5/5,69.82%,TIRAP;CD14;CD36;TLR2;TLR1
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),-0.2705187635221144,-0.4992959298182198,1.0,1.0,1.0,3/15,23.93%,INTS5;INTS12;TOE1
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.327551037185315,-0.498293032369079,0.9852941176470589,1.0,1.0,3/5,38.62%,GOPC;ABCB1;PRNP
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.28127113014207816,-0.4981950071682959,1.0,1.0,1.0,3/12,25.64%,PATL2;LSM3;DYNC1H1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.29956604613118487,-0.4980065986977396,0.9629629629629629,1.0,1.0,2/8,25.20%,BLOC1S2;BNIP3
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.2830473073742371,-0.497348256480821,0.9859154929577465,1.0,1.0,4/16,25.22%,BRCA1;DNMT3B;SNW1;CTR9
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.3341846461512542,-0.495391269365986,0.9818181818181818,1.0,1.0,3/5,30.44%,KCNQ1;CHGA;GSTO1
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),0.3172909704369808,0.49534834045304826,0.9523809523809523,1.0,1.0,1/5,11.23%,CIAO3
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),-0.31731819477202655,-0.4945949089386751,1.0,1.0,1.0,3/8,30.69%,PEX1;PEX16;PEX12
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),0.3009064690262555,0.49438862872749445,0.9473684210526315,1.0,1.0,2/5,20.18%,PID1;E2F3
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.20677538637521414,-0.49422961953859174,1.0,1.0,1.0,18/93,29.17%,FIP1L1;DHX38;SRSF7;UPF2;MCM3AP;CPSF3;EIF4A3;SRSF3;MAGOHB;NCBP1;NUP50;SRSF9;RBM15B;SRSF5;NXT1;NCBP2;DDX39A;GLE1
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),-0.31986390435981227,-0.4938969532038005,0.9827586206896551,1.0,1.0,2/5,29.83%,CHGA;NR4A3
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),-0.31986390435981227,-0.4938969532038005,0.9827586206896551,1.0,1.0,2/5,29.83%,CHGA;NR4A3
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.26597734208607965,0.4933646176645613,1.0,1.0,1.0,3/13,14.65%,UBQLN4;CLEC16A;TMEM39A
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.24549889453671453,0.4924464345359833,1.0,1.0,1.0,7/24,21.84%,ABHD2;TGFB2;SOX30;NR1H3;CATSPERD;CATSPERB;ATP1A2
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.2667063125111476,0.4924289943358066,0.972972972972973,1.0,1.0,3/13,20.41%,IWS1;THOC2;SARNP
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),-0.31012816916113967,-0.49118251436936133,1.0,1.0,1.0,1/7,19.58%,PTN
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.26627271276217124,-0.4910962304126379,0.972972972972973,1.0,1.0,3/14,23.09%,PTPA;CALM3;CALM1
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),-0.29458684084260955,-0.4885827686163721,1.0,1.0,1.0,1/7,20.90%,CEND1
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.23674765709486267,0.4883302304826319,1.0,1.0,1.0,7/17,27.73%,ADCY8;PRKACB;ADCY6;ADCY2;CRY1;ADCY5;ADCY9
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.22482922724958276,0.4882122882347413,1.0,1.0,1.0,9/30,24.08%,CLASP1;NIBAN2;RPS6KA6;EHMT1;PHLDB2;NIPBL;TLE6;PLCB1;B4GALT5
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),0.3375517389028975,0.4865562809974537,0.9534883720930233,1.0,1.0,5/5,66.25%,SLF2;PARP3;IFFO1;XRCC4;SLF1
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.23438992620627278,0.4864697817714709,1.0,1.0,1.0,6/15,27.73%,ADCY8;PRKACB;ADCY6;ADCY2;ADCY5;ADCY9
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.20742113845708907,-0.48630257854604403,1.0,1.0,1.0,19/94,29.17%,FIP1L1;DHX38;SRSF7;UPF2;MCM3AP;CPSF3;EIF4A3;SRSF3;MAGOHB;NCBP1;NUP50;ENY2;SRSF9;RBM15B;SRSF5;NXT1;NCBP2;DDX39A;GLE1
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.26148108318103047,0.4848867181359703,0.9705882352941176,1.0,1.0,2/10,14.68%,PCM1;NINL
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.2912127123079117,0.4842570395992018,1.0,1.0,1.0,5/5,70.89%,FYCO1;KIF13A;KIFAP3;KIF3B;KIF3A
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.30335336274409747,-0.4838496470863266,0.9848484848484849,1.0,1.0,1/8,16.95%,CD160
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.263916544168165,-0.48343735081232203,0.9857142857142858,1.0,1.0,3/15,25.69%,NTNG2;MFSD2A;DVL3
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),0.3314620519127055,0.4832393636745337,1.0,1.0,1.0,2/5,13.79%,RUNDC3A;PDE10A
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.2084784876981683,-0.4829519548767578,1.0,1.0,1.0,16/60,30.68%,VIL1;HAX1;BAIAP2L2;MYADM;LMOD1;CDC42EP1;CCR7;PFN2;PFN1;COTL1;TWF1;ARF6;EVL;HIP1R;RASA1;ARHGAP18
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.27418227968363473,-0.4810277681893033,1.0,1.0,1.0,2/11,15.22%,CAMK1;KAT5
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.312134503564484,-0.4806724625737906,0.9594594594594594,1.0,1.0,1/5,21.83%,BCAT2
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),-0.31940289181406584,-0.4801782567228828,1.0,1.0,1.0,3/7,30.69%,PEX1;PEX16;PEX12
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),-0.2508612577200955,-0.4801665957046871,1.0,1.0,1.0,2/23,15.22%,DSCC1;KAT5
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),-0.2853924251342852,-0.4797091764074002,0.9714285714285714,1.0,1.0,2/8,25.54%,PIK3IP1;PIP4K2C
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),-0.28192707784920834,-0.47872300297167375,1.0,1.0,1.0,2/10,18.20%,DGKD;DGKG
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.3283451842417519,-0.47670503434267497,0.9838709677419355,1.0,1.0,1/5,23.48%,PBLD
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),-0.31122731192988184,-0.47645886171727714,0.98,1.0,1.0,1/5,20.80%,IMPACT
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),-0.29166858840682364,-0.47462294940886307,1.0,1.0,1.0,1/5,23.07%,BCAP31
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.22003217896535066,-0.4736086132114658,1.0,1.0,1.0,9/35,29.86%,RRAGA;LAMTOR5;LAMTOR1;RRAGC;LAMTOR2;SMCR8;PIP4P1;LAMTOR4;LARS1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.25843012857510017,-0.47354349443136085,1.0,1.0,1.0,2/12,22.09%,KCNQ1;KCNE1
prerank,"GO_Biological_Process_2021__negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)",0.32403334496046504,0.47246386999085027,1.0,1.0,1.0,2/5,20.88%,CD274;LILRB1
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.23907865996744143,0.472394451746203,1.0,1.0,1.0,3/23,13.57%,SGCZ;MEGF10;DMD
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.3073885532137589,0.47180172593472874,0.9655172413793104,1.0,1.0,5/5,69.27%,MAPK8;CAP2;MAPK14;MAPK3;CAP1
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.2511895698515417,0.467432359388924,1.0,1.0,1.0,8/8,74.89%,ARHGEF10L;SCAP;ERLIN1;INSIG2;INSIG1;SREBF2;ERLIN2;SREBF1
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.2511895698515417,0.467432359388924,1.0,1.0,1.0,8/8,74.89%,ARHGEF10L;SCAP;ERLIN1;INSIG2;INSIG1;SREBF2;ERLIN2;SREBF1
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.23607987170130623,0.46639010024506417,1.0,1.0,1.0,3/14,15.34%,DMC1;NSMCE2;RAD51
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),-0.27923976642222,-0.4646595515803968,0.9848484848484849,1.0,1.0,1/8,15.44%,NTNG2
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.26104214912514434,-0.4641314557700883,0.9838709677419355,1.0,1.0,3/11,23.99%,DOCK8;RHOA;ADAM17
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.2780817355725772,0.46223339639942207,1.0,1.0,1.0,5/5,72.20%,PPP1R15B;NCK1;ABCA7;PPP1R15A;PTPN1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.23530418155831972,-0.4607600294574926,1.0,1.0,1.0,5/17,32.05%,CALM3;PRKACA;CALM1;GSTO1;ATP1B1
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.2819399436475448,0.4599161205764474,0.9767441860465116,1.0,1.0,3/5,26.30%,POLH;MAP3K4;YY1
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),-0.28338474894904786,-0.458138055105707,1.0,1.0,1.0,1/10,8.48%,TEFM
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.29132271512504126,0.45729305450483454,1.0,1.0,1.0,1/5,14.69%,TACR3
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),0.29132271512504126,0.45729305450483454,1.0,1.0,1.0,1/5,14.69%,TACR3
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),0.29132271512504126,0.45729305450483454,1.0,1.0,1.0,1/5,14.69%,TACR3
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),0.29132271512504126,0.45729305450483454,1.0,1.0,1.0,1/5,14.69%,TACR3
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),0.24308892801065812,0.45707293574414537,1.0,1.0,1.0,7/7,75.70%,ERCC2;MYO6;CTNNB1;USH2A;ERCC3;SPINK5;USH1C
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.25694708793300336,0.4561088113463862,1.0,1.0,1.0,8/8,74.32%,WNT5A;DVL2;GRIP1;DLG4;FZD4;MAP3K13;DVL1;DVL3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.2459438025948584,-0.45610477313966397,1.0,1.0,1.0,3/14,23.09%,CALM3;PRKACA;CALM1
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),-0.273519993877538,-0.4560438271500045,0.9846153846153847,1.0,1.0,3/7,29.87%,SOD1;USH1C;PDZD7
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.2694764348389361,0.4554490039475669,0.9743589743589743,1.0,1.0,3/6,29.05%,MAPT;SIAH3;LRRK2
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.25451255220510366,0.4554077633795576,0.975,1.0,1.0,1/8,9.94%,MEGF10
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),-0.24432056105355562,-0.4551730220284356,1.0,1.0,1.0,3/13,24.36%,GRWD1;SMARCD1;SET
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),-0.24432056105355562,-0.4551730220284356,1.0,1.0,1.0,3/13,24.36%,GRWD1;SMARCD1;SET
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.2680211257553408,0.4522650415577533,1.0,1.0,1.0,7/7,73.21%,ATG2B;ATG13;ATG7;ULK1;RB1CC1;ATG2A;ULK2
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.2680211257553408,0.4522650415577533,1.0,1.0,1.0,7/7,73.21%,ATG2B;ATG13;ATG7;ULK1;RB1CC1;ATG2A;ULK2
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.2829799714100727,-0.45143323909957733,0.9777777777777777,1.0,1.0,2/8,20.37%,LAMP1;NEFH
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.26510080758549626,0.45134928911454564,0.9782608695652174,1.0,1.0,2/6,21.33%,GHR;PIK3R1
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),0.2751320234073933,0.44994061006633473,0.9574468085106383,1.0,1.0,5/5,72.49%,PRKCZ;IL18;TNFSF4;RARA;NLRP3
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),0.2751320234073933,0.44994061006633473,0.9574468085106383,1.0,1.0,5/5,72.49%,PRKCZ;IL18;TNFSF4;RARA;NLRP3
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.26626064614359807,-0.4489523012802529,1.0,1.0,1.0,7/7,73.39%,CERS2;THY1;EPHA4;RTN4R;PTPRS;RTN4RL1;INPP5F
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),-0.25432198047490007,-0.44697661684867,1.0,1.0,1.0,4/11,29.09%,SERTAD1;SMARCD1;ELOF1;ZMIZ2
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.24407188225440846,0.4459387328392454,1.0,1.0,1.0,3/13,24.13%,YOD1;UBE2G2;DERL3
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.2228603263014051,-0.44502560462281754,1.0,1.0,1.0,9/30,30.30%,LAMTOR1;SNAPIN;BLOC1S2;CHGA;FAM98A;PIP4P1;KXD1;NR4A3;PLEKHM2
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.251915178242859,0.44478782849846826,0.9782608695652174,1.0,1.0,2/8,20.00%,CPEB4;PICK1
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),-0.24927676699131826,-0.4436581420448988,1.0,1.0,1.0,5/12,33.08%,ADH6;SOD1;GLRA2;ADCY7;SDF4
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.26800837377485964,0.4431792315539031,1.0,1.0,1.0,6/6,73.21%,ATG2B;ATG7;ULK1;ATG9A;ATG2A;ULK2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.28088324470383763,-0.4430557451471665,1.0,1.0,1.0,2/7,22.25%,RANGRF;CAV1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),-0.2515541128348424,-0.4426968059737082,1.0,1.0,1.0,3/9,34.66%,CAV1;ACTN2;CAV3
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.24911642064404216,0.4424497440468218,1.0,1.0,1.0,2/9,17.43%,TBCD;ZNF703
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),-0.2939074970975899,-0.43966664142208695,1.0,1.0,1.0,1/5,20.23%,ITGAV
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.2640187878701986,0.4362099470055358,1.0,1.0,1.0,1/7,12.48%,ADCY8
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.24168455178384463,-0.435626884752849,1.0,1.0,1.0,2/11,19.25%,EDN1;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),0.24746633677499175,0.434751185881197,1.0,1.0,1.0,7/7,75.26%,GPER1;KIT;EFEMP2;CTH;SOD2;ENG;MYOCD
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.2929201828638278,-0.43438231283020484,0.9814814814814815,1.0,1.0,1/5,14.92%,NLRP12
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.2692645603181216,-0.4325703971882758,0.9841269841269841,1.0,1.0,1/7,20.23%,ITGAV
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.26809339610974886,-0.4325440837068597,0.9836065573770492,1.0,1.0,2/10,17.43%,RAD50;XRCC3
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.21944586828446133,0.43179574489124334,1.0,1.0,1.0,4/15,23.17%,ZC3H13;METTL8;NSUN2;WTAP
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),-0.29031757567379457,-0.4316920574083485,1.0,1.0,1.0,1/6,18.72%,ANGPT1
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.25265324803803235,-0.43043673238672825,1.0,1.0,1.0,2/9,26.76%,MAP1A;BRSK1
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.286861383075973,-0.4291119297086557,0.9846153846153847,1.0,1.0,2/5,29.09%,CLIP3;PEX16
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.23968241317364603,-0.42829321081756283,1.0,1.0,1.0,6/13,36.52%,CAV1;BCAP31;USP13;HERPUD1;UBQLN2;BAG6
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),-0.28467400131509135,-0.4281286466675375,1.0,1.0,1.0,1/5,22.21%,TRPV3
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.22212580240421037,0.42793094084492456,1.0,1.0,1.0,2/11,16.37%,ATRX;NASP
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),0.2538665694821459,0.42497134147511767,1.0,1.0,1.0,2/7,20.56%,PJVK;PEX5
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.21575433692159546,-0.4240490969360725,1.0,1.0,1.0,2/24,13.20%,EXOSC4;EXOSC10
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),-0.2698032491096429,-0.423288173089403,1.0,1.0,1.0,1/5,23.14%,ALDOB
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.20812060251064377,0.4215710335135815,1.0,1.0,1.0,4/21,18.76%,DLG1;SLMAP;CAMK2D;SCN3B
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),-0.25271674470832317,-0.4212118331633331,1.0,1.0,1.0,2/10,31.20%,WDR45B;WIPI2
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.2213399352563608,0.4210675307117883,1.0,1.0,1.0,5/14,22.68%,FUT8;ST3GAL2;ST3GAL6;FUT9;FUT2
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.2662479779236845,-0.4205793913559096,1.0,1.0,1.0,6/6,73.39%,CERS2;EPHA4;RTN4R;PTPRS;RTN4RL1;INPP5F
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),0.2666790580429211,0.42053598183422586,1.0,1.0,1.0,1/5,15.06%,RPRD1B
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.21870216943417653,-0.4173241738329941,1.0,1.0,1.0,2/12,24.77%,NHLRC1;NR1D1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.21870216943417653,-0.4173241738329941,1.0,1.0,1.0,2/12,24.77%,NHLRC1;NR1D1
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),-0.24415124602055713,-0.4172345904689141,1.0,1.0,1.0,4/11,31.61%,EDN1;RFK;PARK7;AGT
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.23620490856677134,-0.4168549263836731,1.0,1.0,1.0,3/11,32.13%,PRKD2;SAP30BP;AKAP8
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),-0.27301643278354965,-0.4143026453830808,0.9836065573770492,1.0,1.0,1/5,23.98%,SLC18A2
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.22677179005063006,-0.4129929789060012,0.9852941176470589,1.0,1.0,1/11,12.28%,GRN
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.24712204049025002,-0.41005766852321884,1.0,1.0,1.0,3/13,24.93%,TMSB4X;PSMD10;CCDC22
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.22894052315977917,-0.40879870162864806,1.0,1.0,1.0,2/14,21.74%,C17ORF99;CD226
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.22249714503235624,0.4082326107212271,1.0,1.0,1.0,8/8,77.76%,VHL;SOCS3;SH2B3;PTPRT;NF2;ADIPOR1;HGS;CAV1
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.23241482986516832,-0.4082146351080382,1.0,1.0,1.0,1/12,21.70%,PGAM1
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.19733346310435826,-0.40807755010797714,1.0,1.0,1.0,7/26,28.52%,SF3A1;SRSF9;NOL3;SRSF10;SRSF5;KHDC4;PUF60
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.27593865975840304,-0.40784024154168835,1.0,1.0,1.0,1/5,24.91%,PLAUR
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.26214377468005146,0.4037977240719914,1.0,1.0,1.0,5/5,73.79%,PPARA;OSBPL8;ABHD5;PPARG;PNPLA2
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),-0.22029296468828444,-0.39195229859028885,1.0,1.0,1.0,5/14,33.14%,ROBO3;ROBO4;VSTM2L;PALLD;BSG
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),-0.2504533788742992,-0.390228650992784,1.0,1.0,1.0,2/7,24.47%,GLI3;HFE
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.19832468706867856,0.3892064031350904,1.0,1.0,1.0,13/13,80.18%,CAMK2D;SCN3B;FHL1;LRRK2;NEDD4L;SCN2B;ABCD1;PTPN3;GPD1L;CAV3;SCN1B;SMAD7;RANGRF
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.2270854638889283,-0.38844409030504534,1.0,1.0,1.0,2/14,26.22%,ITGAV;PNPLA2
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),-0.25044381801751914,-0.3860046735310405,1.0,1.0,1.0,2/6,30.98%,ERCC8;XRCC6
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.16136872706476652,0.38191005454503274,1.0,1.0,1.0,41/41,83.89%,OGT;NDC1;NUP42;NUP98;ZBTB7A;PRKAG2;RAE1;NUP210;NUP153;EP300;NUP205;SEH1L;NUP214;TPR;NUP85;NUP133;NUP43;NUP160;NUP54;RANBP2;NUP37;NUP188;NUP35;SLC2A6;EIF6;SCARB2;HIF1A;SEC13;GCKR;AAAS;NUP107;POM121C;NUP88;NUP93;JMJD8;POM121;NUP58;NUP155;PGAM1;NUP50;GCK
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),-0.2296888184992089,-0.3759223844690728,1.0,1.0,1.0,3/9,31.37%,DAGLA;ALDH9A1;NOS1
prerank,GO_Biological_Process_2021__neurotransmitter loading into synaptic vesicle (GO:0098700),0.239783053427851,0.37588780169970437,1.0,1.0,1.0,5/5,76.03%,SLC32A1;SLC17A8;SLC17A7;SLC17A6;SLC18A2
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),0.2432676753259111,0.37196132344234023,1.0,1.0,1.0,6/6,75.68%,SMO;PTPRJ;YAP1;FAP;PAK1;CDHR2
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.2156423782295411,-0.36741363656289616,1.0,1.0,1.0,1/13,15.19%,NMI
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),-0.22897389224797243,-0.3647092166625897,1.0,1.0,1.0,1/6,18.86%,CNNM4
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.18496550929861888,0.3639192134386823,1.0,1.0,1.0,2/11,18.77%,JMY;WHAMM
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.23277205654192262,0.35486157140533314,1.0,0.9998718113062428,1.0,1/5,14.77%,PTEN
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),-0.23054183872810974,-0.3526123385866658,1.0,1.0,1.0,3/6,34.78%,GPR37L1;SOD2;PRCP
prerank,GO_Biological_Process_2021__glycerol-3-phosphate metabolic process (GO:0006072),-0.22122841099795937,-0.3456679708340137,1.0,1.0,1.0,2/5,33.97%,GPD1;GPAM
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),-0.18225097428966772,-0.33589127268949215,1.0,0.9999632639681696,1.0,2/20,15.93%,AHR;MAPK7
